gene_name,drug_name,interaction_source_db_name,interaction_score,interaction_type
NUDT2,ETORPHINE,GuideToPharmacology,1,agonist
DTNB,COMPOUND 8E [PMID: 24432909],GuideToPharmacology,1,inhibitor
F10,GDC-0339,GuideToPharmacology,1,inhibitor
RYR3,RYANODINE,GuideToPharmacology,1,activator
AQP1,[125I]TYR11-SRIF-14,GuideToPharmacology,1,agonist
ANXA2P1,NEUROPEPTIDE B-29,GuideToPharmacology,1,agonist
PRMT1,RM65,GuideToPharmacology,1,inhibitor
F10,SGI-1776,GuideToPharmacology,1,inhibitor
CACNA1D,AMLODIPINE BESYLATE,GuideToPharmacology,1,inhibitor
AQP3,"[SAR9,MET(O2)11]SP",GuideToPharmacology,1,agonist
GCNT2,BIX-01294,GuideToPharmacology,1,inhibitor
ASAH1,PICROTOXIN,GuideToPharmacology,1,blocker
CD8B,BUPROPION HYDROCHLORIDE,GuideToPharmacology,1,inhibitor
PTK2B,GILTERITINIB,GuideToPharmacology,1,inhibitor
CTRB1,Y27632,GuideToPharmacology,1,inhibitor
CCR3,DALUTRAFUSP ALFA,GuideToPharmacology,1,antibody
SLC25A6,AZD6538,GuideToPharmacology,1,modulator
APLP1,LV-2172,GuideToPharmacology,1,agonist
ABL2,WB 4101,GuideToPharmacology,1,inhibitor
RND3,ALPROSTADIL,GuideToPharmacology,1,activator
AZF1,R-L3,GuideToPharmacology,1,activator
CD8B2,COMPOUND 58 [PMID: 25037917],GuideToPharmacology,1,inhibitor
NATP,THIORIDAZINE,GuideToPharmacology,1,inhibitor
AADAC,(-)-YM796,GuideToPharmacology,1,agonist
BBS1,GNE-131,GuideToPharmacology,1,inhibitor
ABCC6,TOLVAPTAN,GuideToPharmacology,1,inhibitor
A12M3,NEFAZODONE,GuideToPharmacology,1,inhibitor
GCNT1,PINOMETOSTAT,GuideToPharmacology,1,inhibitor
AQP3,ROLAPITANT,GuideToPharmacology,1,inhibitor
DRD2,AXITINIB,GuideToPharmacology,1,inhibitor
A12M4,METHYLERGONOVINE,GuideToPharmacology,1,agonist
TRDMT1,COMPOUND 13R [PMID: 23639540],GuideToPharmacology,1,inhibitor
APAF1,NOR-BINALTORPHIMINE,GuideToPharmacology,1,inhibitor
ABCA2,AS95,GuideToPharmacology,1,inhibitor
ARSL,PICROTOXIN,GuideToPharmacology,1,blocker
ELAVL2,COMPOUND 17 [PMID: 23642479],GuideToPharmacology,1,inhibitor
BNIP3,ANDROGRAPHOLIDE,GuideToPharmacology,1,agonist
BARD1,VERATRIDINE,GuideToPharmacology,1,activator
A1BG,(R)-UH 301,GuideToPharmacology,1,agonist
GATM,GLOFITAMAB,GuideToPharmacology,1,antibody
BTNL1,HG2+,GuideToPharmacology,1,inhibitor
NMUR2,CPN-219,GuideToPharmacology,1,agonist
ABCC6,"[PHAA1,D-TYR(ET)2,VAL4,LYS6,TYR-NH28,DES-GLY9]AVP",GuideToPharmacology,1,inhibitor
A1BG,(-)-TERTATOLOL,GuideToPharmacology,1,inhibitor
FOS,ODANACATIB,GuideToPharmacology,1,inhibitor
ABR,BI-167107,GuideToPharmacology,1,agonist
DHFR,TRIMETREXATE,GuideToPharmacology,1,inhibitor
ABCA2,BW-A1433,GuideToPharmacology,1,inhibitor
DCR,MARIMASTAT,GuideToPharmacology,1,inhibitor
H2AZ1,ERW1041E,GuideToPharmacology,1,inhibitor
DPH1,BMS-536924,GuideToPharmacology,1,inhibitor
ABCA3,MRS1505,GuideToPharmacology,1,inhibitor
KLF5,5-HYDROXYMETHYL-2-FURFURAL,GuideToPharmacology,1,blocker
DXO,ERLOTINIB,GuideToPharmacology,1,inhibitor
FRA5D,COMPOUND 9 [PMID: 3514912],GuideToPharmacology,1,inhibitor
CBLN1,THREO-3-METHYLGLUTAMATE,GuideToPharmacology,1,inhibitor
APOF,PZM21,GuideToPharmacology,1,agonist
A12M1,ZIPRASIDONE,GuideToPharmacology,1,agonist
CSTF3,PIFUSERTIB,GuideToPharmacology,1,inhibitor
DPYS,PF-562271,GuideToPharmacology,1,inhibitor
GRIN2C,L689560,GuideToPharmacology,1,inhibitor
SLC29A1,LADUVIGLUSIB,GuideToPharmacology,1,inhibitor
F2R,"N-(5-{4-CHLORO-3-[(2-HYDROXYETHYL)SULFAMOYL]PHENYL}-4-METHYL-1,3-THIAZOL-2-YL)ACETAMIDE",GuideToPharmacology,1,inhibitor
EEF1D,KW-2449,GuideToPharmacology,1,inhibitor
C4BPAP2,CARBENOXOLONE,GuideToPharmacology,1,inhibitor
FRA1L,NTE-1,GuideToPharmacology,1,inhibitor
ALDH2,SERTINDOLE,GuideToPharmacology,1,inhibitor
MSTN,DACINOSTAT,GuideToPharmacology,1,inhibitor
GNRHR,ALARELIN,GuideToPharmacology,1,agonist
BBS4,AM-6120,GuideToPharmacology,1,inhibitor
CTAA1,G&OUML; 6983,GuideToPharmacology,1,inhibitor
A2MP1,XANOMELINE,GuideToPharmacology,1,agonist
AQP8,MISOPROSTOL,GuideToPharmacology,1,agonist
ABL2,APOMORPHINE,GuideToPharmacology,1,inhibitor
ACACA,CASOXIN C,GuideToPharmacology,1,agonist
F5,AZD8835,GuideToPharmacology,1,inhibitor
NATP,E6801,GuideToPharmacology,1,agonist
ABCA3,MRS1041,GuideToPharmacology,1,inhibitor
AOC1,XYLAZINE,GuideToPharmacology,1,agonist
ALB,[125I]SAUVAGINE (FROG),GuideToPharmacology,1,agonist
ABCA4,CYPROHEPTADINE HYDROCHLORIDE,GuideToPharmacology,1,inhibitor
ABCA1,N(6)-CYCLOHEXYLADENOSINE,GuideToPharmacology,1,agonist
CPT1B,FR122047,GuideToPharmacology,1,inhibitor
FMO2,COMPOUND 9 [PMID: 3514912],GuideToPharmacology,1,inhibitor
AQP3,R116031,GuideToPharmacology,1,inhibitor
ANK3,GR 196429,GuideToPharmacology,1,agonist
AMD1,UR-PG131A,GuideToPharmacology,1,agonist
APBB1,FILOREXANT,GuideToPharmacology,1,inhibitor
AMD1,QUETIAPINE FUMARATE,GuideToPharmacology,1,inhibitor
CTRB1,HSD1590,GuideToPharmacology,1,inhibitor
ACTG1,CXCL12-(1-17),GuideToPharmacology,1,agonist
C9,CARBENOXOLONE,GuideToPharmacology,1,inhibitor
ABCA3,I-ABOPX,GuideToPharmacology,1,inhibitor
SLC25A4,DCG-IV,GuideToPharmacology,1,agonist
DCC,MARIMASTAT,GuideToPharmacology,1,inhibitor
DCK,TP0556351,GuideToPharmacology,1,inhibitor
BBS1,AFT-II,GuideToPharmacology,1,inhibitor
ABCA3,MSX-2,GuideToPharmacology,1,inhibitor
AMY1C,FINGOLIMOD-PHOSPHATE,GuideToPharmacology,1,agonist
EEF1G,NIK INHIBITOR 12F,GuideToPharmacology,1,inhibitor
CDH13,KETANSERIN,GuideToPharmacology,1,inhibitor
SLC25A6,MPEP,GuideToPharmacology,1,modulator
FRA2G,COMPOUND 11 [PMID: 16413183],GuideToPharmacology,1,inhibitor
HPGD,DALCETRAPIB,GuideToPharmacology,1,inhibitor
ABCB7,HEAT (BE2254),GuideToPharmacology,1,inhibitor
APOF,NMRA-140,GuideToPharmacology,1,inhibitor
SHROOM2,SRIF-28,GuideToPharmacology,1,agonist
ANXA4,NPY-(2-36) (PIG),GuideToPharmacology,1,agonist
AXL,SLC-391,GuideToPharmacology,1,inhibitor
ATP3,H2O2,GuideToPharmacology,1,activator
ABCC6,"D(CH2)5[TYR(ME)2,THR4,TYR-NH29]OVT",GuideToPharmacology,1,inhibitor
DPP6,M4205,GuideToPharmacology,1,inhibitor
DMP1,RESIQUIMOD,GuideToPharmacology,1,agonist
A2M,DIHYDROERGOTAMINE MESYLATE,GuideToPharmacology,1,agonist
ALDH2,APOMORPHINE,GuideToPharmacology,1,agonist
FFAR3,BUTYRIC ACID,GuideToPharmacology,1,agonist
ANOP1,YM298198,GuideToPharmacology,1,modulator
ANK2,AGOMELATINE,GuideToPharmacology,1,agonist
APBB2,MRS2179,GuideToPharmacology,1,inhibitor
ACAT1,"[125I]BH-NMB (HUMAN, MOUSE, RAT)",GuideToPharmacology,1,agonist
ACACB,DF3016A,GuideToPharmacology,1,inhibitor
FOLR1,COMPOUND 1 [PMID: 11425539],GuideToPharmacology,1,inhibitor
GART,DACINOSTAT,GuideToPharmacology,1,inhibitor
COL10A1,RS-25344,GuideToPharmacology,1,inhibitor
DRD2,TIVOZANIB,GuideToPharmacology,1,inhibitor
FRA5B,WX-UK1,GuideToPharmacology,1,inhibitor
AMY2A,ASP4058,GuideToPharmacology,1,agonist
ALPI,HUMAN GIP(3-42)NH2,GuideToPharmacology,1,inhibitor
MSTN,BELINOSTAT,GuideToPharmacology,1,inhibitor
ABL1,IDAZOXAN,GuideToPharmacology,1,inhibitor
ABCA2,ISAM-140,GuideToPharmacology,1,inhibitor
ARF5,LEIUROTOXIN I,GuideToPharmacology,1,blocker
GRIA1,NEOCEPTIN-3,GuideToPharmacology,1,agonist
SLC13A5,ETG-5773,GuideToPharmacology,1,inhibitor
ALOX12P2,M1160,GuideToPharmacology,1,agonist
ANGPT2,PG-901,GuideToPharmacology,1,inhibitor
APOE,AZ8838,GuideToPharmacology,1,inhibitor
AMH,CP-195543,GuideToPharmacology,1,agonist
GRK3,COMPOUND 2 [PMID: 19230660],GuideToPharmacology,1,agonist
AMH,CP-195543,GuideToPharmacology,1,inhibitor
APOC1,PGN-9856,GuideToPharmacology,1,agonist
EPHB3,ILGINATINIB,GuideToPharmacology,1,inhibitor
APEX1,2MESADP,GuideToPharmacology,1,agonist
COL16A1,ASPIRIN,GuideToPharmacology,1,inhibitor
BCL7A,CALCIPOTRIENE,GuideToPharmacology,1,agonist
ALOX15,[125I][TYR4]GHRELIN (HUMAN),GuideToPharmacology,1,agonist
AZF2,TETRAMETHYLAMMONIUM,GuideToPharmacology,1,blocker
MAP3K9,GNE-3511,GuideToPharmacology,1,inhibitor
HP,GNE-7883,GuideToPharmacology,1,inhibitor
A12M3,LUMATEPERONE,GuideToPharmacology,1,inhibitor
ALDH2,SULPIRIDE,GuideToPharmacology,1,inhibitor
ABCA4,NOREPINEPHRINE,GuideToPharmacology,1,agonist
ALDH3A2,WKYMVM,GuideToPharmacology,1,agonist
CXCR5,COMPOUND 47 [PMID: 18800762],GuideToPharmacology,1,inhibitor
DXO,DOSIMERTINIB,GuideToPharmacology,1,inhibitor
FZD6,SAG1.3,GuideToPharmacology,1,agonist
APEX1,2MESADP,GuideToPharmacology,1,agonist
APBB2,ADP&BETA;S,GuideToPharmacology,1,agonist
FRA20B,TOLCAPONE,GuideToPharmacology,1,inhibitor
FCGRT,DX-2507,GuideToPharmacology,1,antibody
SLC25A4,LY341495,GuideToPharmacology,1,inhibitor
CDH16,COMPOUND 9 [PMID: 15615544],GuideToPharmacology,1,inhibitor
APOD,F16357,GuideToPharmacology,1,agonist
CTNND1,PEXMETINIB,GuideToPharmacology,1,inhibitor
CHI3L2,ASPIRIN,GuideToPharmacology,1,inhibitor
DR1,MK-2461,GuideToPharmacology,1,inhibitor
FANCG,GSK'547,GuideToPharmacology,1,inhibitor
ARCN1,BAY 55-9837,GuideToPharmacology,1,agonist
EFNA4,COMPOUND 2 [PMID: 25408830],GuideToPharmacology,1,inhibitor
ABCA3,"CP608,039",GuideToPharmacology,1,agonist
EIF4G1,COMPOUND 18 [PMID: 20873740],GuideToPharmacology,1,inhibitor
ATF4P1,&ALPHA;-BUNGAROTOXIN,GuideToPharmacology,1,inhibitor
COL9A2,ANAGRELIDE HYDROCHLORIDE,GuideToPharmacology,1,inhibitor
AANAT,BRUCINE,GuideToPharmacology,1,modulator
CXCR5,COMPOUND 14 [PMID: 18800762],GuideToPharmacology,1,inhibitor
ABCB7,NOREPINEPHRINE,GuideToPharmacology,1,agonist
ACTA1,CCL23,GuideToPharmacology,1,agonist
FTH1P4,ADENOSINE,GuideToPharmacology,1,inhibitor
FCER1A,COMPOUND 27D [PMID: 28231433],GuideToPharmacology,1,inhibitor
BCL7A,LG190178,GuideToPharmacology,1,agonist
ARF5,B-TPMF,GuideToPharmacology,1,inhibitor
ATR,VERAPAMIL,GuideToPharmacology,1,blocker
F7,TORIN 2,GuideToPharmacology,1,inhibitor
EFNA3,WNY0824,GuideToPharmacology,1,inhibitor
DRD1,ZM-306416,GuideToPharmacology,1,inhibitor
ADH1C,FIRUGLIPEL,GuideToPharmacology,1,agonist
ABCA1,PSB36,GuideToPharmacology,1,inhibitor
ALDH1B1,BQ123,GuideToPharmacology,1,inhibitor
ARVD3,ZN2+,GuideToPharmacology,1,modulator
A12M3,ORG-37684,GuideToPharmacology,1,agonist
A12M4,SB 221284,GuideToPharmacology,1,inhibitor
ELAVL1,NG-25,GuideToPharmacology,1,inhibitor
SERPINC1,&ALPHA;-CONOTOXIN GI,GuideToPharmacology,1,inhibitor
AQP9,RELCOVAPTAN,GuideToPharmacology,1,inhibitor
LHCGR,[125I]LH,GuideToPharmacology,1,agonist
AAMP,SCH 57790,GuideToPharmacology,1,inhibitor
HOXD11,CW85319,GuideToPharmacology,1,inhibitor
MAP3K9,CEP-1347,GuideToPharmacology,1,inhibitor
FAH,ZM336372,GuideToPharmacology,1,inhibitor
AANAT,ARECAIDINE PROPARGYL ESTER,GuideToPharmacology,1,agonist
F9,RUBOXISTAURIN,GuideToPharmacology,1,inhibitor
BLMH,"ANALOG 3 [VLATTAS ET AL., 1996]",GuideToPharmacology,1,inhibitor
EPHX2,COMPOUND 19A [PMID: 21855335],GuideToPharmacology,1,inhibitor
A12M3,ROXINDOLE,GuideToPharmacology,1,inhibitor
DDX10,BMS-561392,GuideToPharmacology,1,inhibitor
F3,SAR260301,GuideToPharmacology,1,inhibitor
ACE2,COMPOUND 28 [PMID: 18324760],GuideToPharmacology,1,inhibitor
ACAT2,MK-5046,GuideToPharmacology,1,agonist
AANAT,MUSCARINIC TOXIN 7,GuideToPharmacology,1,inhibitor
EREG,E6201,GuideToPharmacology,1,inhibitor
ALPL,DANUGLIPRON,GuideToPharmacology,1,agonist
A1BG,(S)-UH 301,GuideToPharmacology,1,inhibitor
A1BG,[3H]ROBALZOTAN,GuideToPharmacology,1,inhibitor
A2M,"L-775,606",GuideToPharmacology,1,agonist
A12M1,FLUSPIRILENE,GuideToPharmacology,1,inhibitor
A12M2,[3H]LY334370,GuideToPharmacology,1,agonist
A12M2,DIHYDROERGOTAMINE MESYLATE,GuideToPharmacology,1,agonist
A12M2,LASMIDITAN,GuideToPharmacology,1,agonist
A12M2,SERTINDOLE,GuideToPharmacology,1,inhibitor
A12M4,5-CT,GuideToPharmacology,1,agonist
HTR2C,BROMOCRIPTINE,GuideToPharmacology,1,agonist
HTR2C,KETANSERIN,GuideToPharmacology,1,inhibitor
HTR2C,SB 228357,GuideToPharmacology,1,inhibitor
NATP,5-CT,GuideToPharmacology,1,agonist
NATP,SB357134,GuideToPharmacology,1,inhibitor
SERPINA3,LP-44,GuideToPharmacology,1,agonist
SERPINA3,CLOZAPINE,GuideToPharmacology,1,inhibitor
SERPINA3,XANOMELINE,GuideToPharmacology,1,agonist
ABL1,ASCIMINIB,GuideToPharmacology,1,modulator
SERPINA3,ZIPRASIDONE,GuideToPharmacology,1,inhibitor
CREB1,BW B70C,GuideToPharmacology,1,inhibitor
CACNA1S,WP814,GuideToPharmacology,1,inhibitor
FRA10F,K-604,GuideToPharmacology,1,inhibitor
ABL2,PEXMETINIB,GuideToPharmacology,1,inhibitor
HBEGF,TL13-112,GuideToPharmacology,1,inhibitor
GNA12,SORBINIL,GuideToPharmacology,1,inhibitor
HBEGF,CEP-37440,GuideToPharmacology,1,inhibitor
ABCF1,RO-70-0004,GuideToPharmacology,1,inhibitor
ABCF1,KETANSERIN,GuideToPharmacology,1,inhibitor
ABCA4,PHENYLEPHRINE,GuideToPharmacology,1,agonist
ABCA4,RO-70-0004,GuideToPharmacology,1,inhibitor
ABL1,XYLOMETAZOLINE,GuideToPharmacology,1,agonist
ABL2,NOREPINEPHRINE,GuideToPharmacology,1,agonist
BEVI,DROMOSTANOLONE,GuideToPharmacology,1,agonist
ANPEP,COMPOUND I3 [PMID: 23428964],GuideToPharmacology,1,inhibitor
BEVI,METRIBOLONE,GuideToPharmacology,1,agonist
ABAT,IMARADENANT,GuideToPharmacology,1,inhibitor
ABCA1,NAMODENOSON,GuideToPharmacology,1,agonist
ABCA1,CV-1808,GuideToPharmacology,1,agonist
ABCA3,PSB1115,GuideToPharmacology,1,inhibitor
ABCA3,NICARDIPINE,GuideToPharmacology,1,inhibitor
ABCA3,THEOPHYLLINE,GuideToPharmacology,1,inhibitor
ABCA3,MRS1476,GuideToPharmacology,1,inhibitor
EEF1D,AURORA KINASE INHIBITOR II,GuideToPharmacology,1,inhibitor
ACADM,LOSARTAN POTASSIUM,GuideToPharmacology,1,inhibitor
CD69,FUROSEMIDE,GuideToPharmacology,1,inhibitor
ACAT2,"[LEU14, &PSI; 13-14)]BOMBESIN",GuideToPharmacology,1,inhibitor
ASIC2,COMPOUND 8A [PMID: 24900283],GuideToPharmacology,1,agonist
ABO,LEVOBUNOLOL,GuideToPharmacology,1,inhibitor
ABO,PRENALTEROL,GuideToPharmacology,1,agonist
ABO,BUPRANOLOL,GuideToPharmacology,1,inhibitor
ABR,FORMOTEROL FUMARATE,GuideToPharmacology,1,agonist
ACAA1,BUPRANOLOL,GuideToPharmacology,1,inhibitor
EFNA1,ZYBT1,GuideToPharmacology,1,inhibitor
EFNA4,BI-2536,GuideToPharmacology,1,inhibitor
EFNB2,BIIB091,GuideToPharmacology,1,inhibitor
EFNA4,XD1,GuideToPharmacology,1,inhibitor
EFNA4,MOLIBRESIB,GuideToPharmacology,1,inhibitor
GCLC,WNY0824,GuideToPharmacology,1,inhibitor
ASIC1,[DES-ARG10]KALLIDIN,GuideToPharmacology,1,agonist
ASIC1,CHROMAN 28,GuideToPharmacology,1,inhibitor
ASIC1,NPC 18565,GuideToPharmacology,1,inhibitor
BDKRB2,"[HYP3,TYR(ME)8]BK",GuideToPharmacology,1,agonist
ACACB,RIBOSOMAL PROTEIN S19,GuideToPharmacology,1,agonist
ACACB,RPR121154,GuideToPharmacology,1,inhibitor
CPN1,COMPOUND 3 [PMID: 14640538],GuideToPharmacology,1,inhibitor
CYP27B1,"SQ-24,798",GuideToPharmacology,1,inhibitor
DAZ1,AS101,GuideToPharmacology,1,inhibitor
ATP6V0B,ZICONOTIDE,GuideToPharmacology,1,blocker
CACNA1D,FPL64176,GuideToPharmacology,1,activator
FOS,VBY-825,GuideToPharmacology,1,inhibitor
FOLR1,COMPOUND 4G [PMID: 22595175],GuideToPharmacology,1,inhibitor
FOLR2,COMPOUND 23 [PMID: 35944849],GuideToPharmacology,1,inhibitor
ACTA2,[125I]CCL7 (HUMAN),GuideToPharmacology,1,agonist
CCKBR,[3H]L365260,GuideToPharmacology,1,inhibitor
ACTB,BMS COMPOUND 87B,GuideToPharmacology,1,inhibitor
ACTB,LAZUCIRNON,GuideToPharmacology,1,inhibitor
ACTB,CCL24,GuideToPharmacology,1,agonist
CCR4,[125I]CCL27 (HUMAN),GuideToPharmacology,1,agonist
EGR3,SIMUROSERTIB,GuideToPharmacology,1,inhibitor
CPT2,OXAPROZIN,GuideToPharmacology,1,inhibitor
CPT2,CELECOXIB,GuideToPharmacology,1,inhibitor
CPT1B,PIROXICAM-BETA-CYCLODEXTRIN,GuideToPharmacology,1,inhibitor
CPT1B,PHENYLBUTAZONE,GuideToPharmacology,1,inhibitor
ALAS2,UROCORTIN 2,GuideToPharmacology,1,agonist
ACTG1,PLERIXAFOR,GuideToPharmacology,1,inhibitor
EGR4,AMINOPURVALANOL A,GuideToPharmacology,1,inhibitor
CDK4,ABEMACICLIB,GuideToPharmacology,1,inhibitor
CDK4,CROZBACICLIB,GuideToPharmacology,1,inhibitor
CDK4,CDK4 INHIBITOR II,GuideToPharmacology,1,inhibitor
EIF4A1,VTX-11E,GuideToPharmacology,1,inhibitor
CDK4,R547,GuideToPharmacology,1,inhibitor
EIF4EBP1,PALBOCICLIB,GuideToPharmacology,1,inhibitor
EIF4G1,ATUVECICLIB,GuideToPharmacology,1,inhibitor
CPB2,ABIRATERONE ACETATE,GuideToPharmacology,1,inhibitor
CYP2A13,KAEMPHEROL,GuideToPharmacology,1,inhibitor
CPN1,COMPOUND 4D [PMID: 20655626],GuideToPharmacology,1,inhibitor
CYP2C19,COMPOUND 30 [PMID: 22239545],GuideToPharmacology,1,inhibitor
CSHL1,AMINOETHOXYVINYLGLYCINE,GuideToPharmacology,1,inhibitor
APAF1,BNTX,GuideToPharmacology,1,inhibitor
APAF1,FENTANYL CITRATE,GuideToPharmacology,1,agonist
APAF1,ATICAPRANT,GuideToPharmacology,1,inhibitor
APAF1,ENDOMORPHIN-1,GuideToPharmacology,1,agonist
APAF1,BU08028,GuideToPharmacology,1,agonist
CRIP1,DH376,GuideToPharmacology,1,inhibitor
DHODH,S312,GuideToPharmacology,1,inhibitor
ABCD1,SULPIRIDE,GuideToPharmacology,1,inhibitor
ABCD1,(+)-S-14297,GuideToPharmacology,1,inhibitor
ALDH3A1,SKF-76783,GuideToPharmacology,1,agonist
ALDH3A1,CABERGOLINE,GuideToPharmacology,1,agonist
FRZB,POCIREDIR,GuideToPharmacology,1,modulator
EN2,COMPOUND 34 [PMID: 24749861],GuideToPharmacology,1,inhibitor
DXO,JBJ-09-063,GuideToPharmacology,1,modulator
EZH2,GSK343,GuideToPharmacology,1,inhibitor
DXO,PD 174265,GuideToPharmacology,1,inhibitor
DXO,TUCATINIB,GuideToPharmacology,1,inhibitor
BLVRA,NE10790,GuideToPharmacology,1,inhibitor
BLVRA,COMPOUND 31 [PMID: 17963374],GuideToPharmacology,1,inhibitor
CRP,LY2077855,GuideToPharmacology,1,inhibitor
ABCD2,FASIGLIFAM,GuideToPharmacology,1,agonist
FCGRT,ZILTIVEKIMAB,GuideToPharmacology,1,antibody
ABCD2,PALMITATE,GuideToPharmacology,1,agonist
ABCD2,TUG-424,GuideToPharmacology,1,agonist
DPYSL2,COMPOUND 8H [PMID: 22765894],GuideToPharmacology,1,inhibitor
DPYSL2,TINENGOTINIB,GuideToPharmacology,1,inhibitor
DPYSL3,ERDAFITINIB,GuideToPharmacology,1,inhibitor
GAPDHP67,ANHYDROUS TACROLIMUS,GuideToPharmacology,1,inhibitor
SLC26A3,TASURGRATINIB,GuideToPharmacology,1,inhibitor
ONECUT1,SLF,GuideToPharmacology,1,inhibitor
DRD1,PEXMETINIB,GuideToPharmacology,1,inhibitor
DRD3,COMPOUND 8H [PMID: 22765894],GuideToPharmacology,1,inhibitor
ALDH3B2,WKYMVM,GuideToPharmacology,1,agonist
DRD3,PEXMETINIB,GuideToPharmacology,1,inhibitor
ALDH9A1,N36,GuideToPharmacology,1,agonist
APOC2,BIMATOPROST (FREE ACID FORM),GuideToPharmacology,1,agonist
GABRA1,L838417,GuideToPharmacology,1,modulator
GABRA1,FLUMAZENIL,GuideToPharmacology,1,modulator
ARNT,ZK93426,GuideToPharmacology,1,modulator
ARNT,TBPS,GuideToPharmacology,1,blocker
ALOX12P2,[125I]SPEXIN-1,GuideToPharmacology,1,agonist
ALOX12P2,M1145,GuideToPharmacology,1,agonist
CD14,NNC-711,GuideToPharmacology,1,inhibitor
GUCY1A2,GROWTH DIFFERENTIATION FACTOR 15,GuideToPharmacology,1,agonist
GRIA3,NBQX,GuideToPharmacology,1,inhibitor
ASS1P2,PIRACETAM,GuideToPharmacology,1,modulator
ASS1P8,DOMOIC ACID,GuideToPharmacology,1,agonist
GRIN2C,"SERINE, D-",GuideToPharmacology,1,agonist
GRIN2B,LY233053,GuideToPharmacology,1,inhibitor
GRIN2B,HOMOQUINOLINIC ACID,GuideToPharmacology,1,agonist
GRIN2B,[3H]MDL105519,GuideToPharmacology,1,inhibitor
ASS1P14,HOMOQUINOLINIC ACID,GuideToPharmacology,1,agonist
DLX3,ATRIAL NATRIURETIC PEPTIDE,GuideToPharmacology,1,agonist
DHFR,ANUMIGILIMAB,GuideToPharmacology,1,antibody
GDF2,CHR-3996,GuideToPharmacology,1,inhibitor
GAPDHP1,TRICHOSTATIN A,GuideToPharmacology,1,inhibitor
GARS1,APICIDIN,GuideToPharmacology,1,inhibitor
GARS1,RESMINOSTAT,GuideToPharmacology,1,inhibitor
MSTN,TRICHOSTATIN A,GuideToPharmacology,1,inhibitor
GDF9,BELINOSTAT,GuideToPharmacology,1,inhibitor
GAS1,J27644,GuideToPharmacology,1,inhibitor
GAS1,RESMINOSTAT,GuideToPharmacology,1,inhibitor
GPLD1,LONAFARNIB,GuideToPharmacology,1,inhibitor
AMD1,DIMETHYLHISTAPRODIFEN,GuideToPharmacology,1,agonist
AMD1,(&PLUSMN;)-TRANS-H2-PAT,GuideToPharmacology,1,inhibitor
HRH3,JNJ-39758979,GuideToPharmacology,1,inhibitor
GMFA,BMS-823778,GuideToPharmacology,1,inhibitor
PRDM1,COMPOUND 1A [PMID: 2153213],GuideToPharmacology,1,inhibitor
PRDM1,"COMPOUND 6A [PATIL ET AL., 1989]",GuideToPharmacology,1,inhibitor
PRDM1,SIMVASTATIN,GuideToPharmacology,1,inhibitor
ADH1C,COMPOUND 3A [PMID: 21444206],GuideToPharmacology,1,agonist
ADARB2,COMPOUND 15 [PMID: 25313322],GuideToPharmacology,1,agonist
ADCY3,AM281,GuideToPharmacology,1,inhibitor
XCR1,TRYPTANTHRIN,GuideToPharmacology,1,inhibitor
CSNK2A2,AS1949490,GuideToPharmacology,1,inhibitor
CMR3A,COMPOUND 2E [PMID: 19013076],GuideToPharmacology,1,inhibitor
CRK,ARN19874,GuideToPharmacology,1,inhibitor
APOC3,FR181157,GuideToPharmacology,1,agonist
FOXL2,PICROTOXININ,GuideToPharmacology,1,agonist
EPHB3,FILGOTINIB,GuideToPharmacology,1,inhibitor
NUDT2,U69593,GuideToPharmacology,1,agonist
DRD2,MK-2461,GuideToPharmacology,1,inhibitor
DRD2,CABOZANTINIB S-MALATE,GuideToPharmacology,1,inhibitor
DRD2,CENISERTIB,GuideToPharmacology,1,inhibitor
DRD2,ZM-306416,GuideToPharmacology,1,inhibitor
DPT,COMPOUND 8H [PMID: 22765894],GuideToPharmacology,1,inhibitor
ATP5ME,LYSOPHOSPHATIDYLCHOLINE,GuideToPharmacology,1,activator
DPT,SEMAXANIB,GuideToPharmacology,1,inhibitor
ARF6,DC-EBIO,GuideToPharmacology,1,activator
ARF5,UCL1684,GuideToPharmacology,1,inhibitor
ASNSP2,TOLBUTAMIDE,GuideToPharmacology,1,inhibitor
AZGP1,BEPRIDIL,GuideToPharmacology,1,blocker
AZF1,XE991,GuideToPharmacology,1,inhibitor
FRA10D,COMPOUND 5 [PMID: 22533316],GuideToPharmacology,1,inhibitor
KCNQ5,XE991,GuideToPharmacology,1,inhibitor
CTSV,DEFACTINIB,GuideToPharmacology,1,inhibitor
EPS8,COMPOUND 20 [PMID: 30998356],GuideToPharmacology,1,inhibitor
EPS8,GSK2646264,GuideToPharmacology,1,inhibitor
EPHX2,COMPOUND 23 [PMID: 17600705],GuideToPharmacology,1,inhibitor
EPS8,JAK3 INHIBITOR VI,GuideToPharmacology,1,inhibitor
GDI2,PF-9363,GuideToPharmacology,1,inhibitor
GEM,CC-90011,GuideToPharmacology,1,inhibitor
ERVT5,COMPOUND 16 [PMID: 17480064],GuideToPharmacology,1,inhibitor
ANCR,&ALPHA;-MSH,GuideToPharmacology,1,agonist
AMY2B,[125I](3-IODO-TYR13)-MCH,GuideToPharmacology,1,inhibitor
ANG,CORTICOTROPHIN-RELEASING HORMONE,GuideToPharmacology,1,agonist
ANK1,PG-901,GuideToPharmacology,1,agonist
DRD4,VEBRELTINIB,GuideToPharmacology,1,inhibitor
ANOP1,[3H]R214127,GuideToPharmacology,1,modulator
ANPEP,[3H]LY341495,GuideToPharmacology,1,inhibitor
SLC25A4,COMPOUND 4 [PMID: 21105727],GuideToPharmacology,1,modulator
MAP2K1,MS432,GuideToPharmacology,1,inhibitor
MAP2K1,ZAPNOMETINIB,GuideToPharmacology,1,inhibitor
AADAC,ARECOLINE,GuideToPharmacology,1,agonist
AADAC,TRIHEXYPHENIDYL,GuideToPharmacology,1,inhibitor
AAMP,[3H]ACETYLCHOLINE,GuideToPharmacology,1,agonist
AADAC,MUSCARINIC TOXIN 1,GuideToPharmacology,1,inhibitor
AADAC,[3H]QNB,GuideToPharmacology,1,inhibitor
AAMP,DOTHIEPIN,GuideToPharmacology,1,inhibitor
AAMP,SILAHEXOCYCLIUM,GuideToPharmacology,1,inhibitor
AANAT,DARIFENACIN,GuideToPharmacology,1,inhibitor
AANAT,"WIN 51,708",GuideToPharmacology,1,modulator
AANAT,SABCOMELINE,GuideToPharmacology,1,agonist
AARS1,[3H]ACETYLCHOLINE,GuideToPharmacology,1,agonist
AANAT,OTENZEPAD,GuideToPharmacology,1,inhibitor
AARS1,CEVIMELINE,GuideToPharmacology,1,agonist
AANAT,DARIFENACIN,GuideToPharmacology,1,inhibitor
AANAT,OXYBUTYNIN,GuideToPharmacology,1,inhibitor
AARS1,DOTHIEPIN,GuideToPharmacology,1,inhibitor
AARS1,PD 102807,GuideToPharmacology,1,inhibitor
AARS1,SILAHEXOCYCLIUM,GuideToPharmacology,1,inhibitor
AARS1,METHSCOPOLAMINE,GuideToPharmacology,1,inhibitor
AARS1,AFDX384,GuideToPharmacology,1,inhibitor
AAVS1,P-F-HHSID,GuideToPharmacology,1,inhibitor
ANK2,UCSF3384,GuideToPharmacology,1,agonist
ANK2,DIFLUOROAGOMELATINE,GuideToPharmacology,1,agonist
ANK2,S22153,GuideToPharmacology,1,inhibitor
APOF,ADL5859,GuideToPharmacology,1,agonist
APOF,EWB-3-14,GuideToPharmacology,1,agonist
APOF,METHADONE HYDROCHLORIDE,GuideToPharmacology,1,agonist
BAK1,BC-III,GuideToPharmacology,1,inhibitor
APOF,[3H]CTOP,GuideToPharmacology,1,inhibitor
NKX3-2,BC-III,GuideToPharmacology,1,inhibitor
NKX3-2,AFT-II,GuideToPharmacology,1,inhibitor
BBS2,AFT-II,GuideToPharmacology,1,inhibitor
SCN9A,AM-6120,GuideToPharmacology,1,inhibitor
BBS2,BC-III,GuideToPharmacology,1,inhibitor
DLX5,PL-3994,GuideToPharmacology,1,agonist
CD8B,DOTHIEPIN,GuideToPharmacology,1,inhibitor
ATF4,LY2087101,GuideToPharmacology,1,modulator
EVC,COMPOUND 22 [PMID: 20462760],GuideToPharmacology,1,inhibitor
AQP3,CP 99994,GuideToPharmacology,1,inhibitor
AQP5,[125I][MEPHE7]NKB,GuideToPharmacology,1,agonist
DNAH9,SELNOFLAST,GuideToPharmacology,1,inhibitor
AQP5,SB 235375,GuideToPharmacology,1,inhibitor
NMUR2,[125I]NEUROMEDIN U-8 (PIG),GuideToPharmacology,1,agonist
NMUR1,[125I]NEUROMEDIN U-8 (PIG),GuideToPharmacology,1,agonist
APBA1,[ARG14LYS15]N/OFQ,GuideToPharmacology,1,agonist
ANXA7,JMV457,GuideToPharmacology,1,agonist
SLCO1B1,GLYCYRRHIZIC ACID,GuideToPharmacology,1,inhibitor
ARAF,L-372662,GuideToPharmacology,1,inhibitor
ARAF,ARGIPRESSIN,GuideToPharmacology,1,agonist
ARAF,"D(CH2)5[TYR(ME)2,THR4,TYR-NH29]OVT",GuideToPharmacology,1,inhibitor
APBB2,MRS2279,GuideToPharmacology,1,inhibitor
APBB2,SURAMIN,GuideToPharmacology,1,inhibitor
APBB2,ATP&GAMMA;S,GuideToPharmacology,1,agonist
APC,SURAMIN,GuideToPharmacology,1,inhibitor
APLP2,RP-52770,GuideToPharmacology,1,inhibitor
HPRTP1,ATGLISTATIN,GuideToPharmacology,1,inhibitor
SLC15A2,LYS[Z(NO2)]-VAL,GuideToPharmacology,1,inhibitor
BCKDHB,SELADELPAR,GuideToPharmacology,1,agonist
BCKDHA,RAGAGLITAZAR,GuideToPharmacology,1,agonist
CCND1,LINOLEIC ACID,GuideToPharmacology,1,agonist
CCND1,ROSIGLITAZONE,GuideToPharmacology,1,agonist
F3,PIK-III,GuideToPharmacology,1,inhibitor
F5,COMPOUND 27 [PMID: 35834807],GuideToPharmacology,1,inhibitor
CCND1,BARDOXOLONE METHYL,GuideToPharmacology,1,inhibitor
F5,GILMELISIB,GuideToPharmacology,1,inhibitor
F5,RV6153,GuideToPharmacology,1,inhibitor
PIK3CB,IDELALISIB,GuideToPharmacology,1,inhibitor
F7,PIK-108,GuideToPharmacology,1,modulator
PIK3CB,RV6153,GuideToPharmacology,1,inhibitor
PIK3CB,TG-100-115,GuideToPharmacology,1,inhibitor
PIK3CB,"5-QUINOXALIN-6-YLMETHYLENE-THIAZOLIDINE-2,4-DIONE",GuideToPharmacology,1,inhibitor
F7R,AMDIZALISIB,GuideToPharmacology,1,inhibitor
F7R,AZ2,GuideToPharmacology,1,inhibitor
F7R,DEZAPELISIB,GuideToPharmacology,1,inhibitor
COL9A2,CYCLIC GMP,GuideToPharmacology,1,inhibitor
COL19A1,COMPOUND 19 [PMID: 22142545],GuideToPharmacology,1,inhibitor
COL7A1,CRISABOROLE,GuideToPharmacology,1,inhibitor
COL12A1,LEO 239652,GuideToPharmacology,1,inhibitor
COL12A1,RO20-1724,GuideToPharmacology,1,inhibitor
NBEAP1,CLOTRIMAZOLE,GuideToPharmacology,1,agonist
NBEAP1,SR12813,GuideToPharmacology,1,agonist
NBEAP1,NIFEDIPINE,GuideToPharmacology,1,agonist
FXN,ARI-3531,GuideToPharmacology,1,inhibitor
FRA4A,ALIROCUMAB,GuideToPharmacology,1,antibody
XIAP,"[ALA1,12,AIB3,GLN10,HARG11,TRP14]PTH-(1-14)-NH2",GuideToPharmacology,1,agonist
XIAP,"[TRP23,TYR36]PTHRP-(1-36)-NH2 (HUMAN)",GuideToPharmacology,1,agonist
XIAP,"PTHRP-(7-34) (HUMAN, RAT, MOUSE)",GuideToPharmacology,1,inhibitor
BIRC5,"PTHRP-(7-34) (HUMAN, RAT, MOUSE)",GuideToPharmacology,1,inhibitor
FAH,BALAMAPIMOD,GuideToPharmacology,1,inhibitor
APLP1,QRFP26 (26RFA),GuideToPharmacology,1,agonist
FAH,L779450,GuideToPharmacology,1,inhibitor
H1-2,COMPOUND 24 [PMID: 36723914],GuideToPharmacology,1,modulator
BAK1P1,GNE-3500,GuideToPharmacology,1,agonist
BCL2L1,CD2314,GuideToPharmacology,1,agonist
FANCG,FLIZASERTIB,GuideToPharmacology,1,inhibitor
BAK1P1,SR1555,GuideToPharmacology,1,agonist
BAK1P1,25-HYDROXYCHOLESTEROL,GuideToPharmacology,1,agonist
COL6A3,HJC 0350,GuideToPharmacology,1,inhibitor
CX3CR1,COMPOUND 23 [PMID: 35816678],GuideToPharmacology,1,inhibitor
TEX28,BI-D1870,GuideToPharmacology,1,inhibitor
CYB5P1,BI-D1870,GuideToPharmacology,1,inhibitor
APP,ML290,GuideToPharmacology,1,modulator
DYT7,"COMPOUND 7B [HAFTCHENARY ET AL., 2013]",GuideToPharmacology,1,inhibitor
APP,INSL3,GuideToPharmacology,1,agonist
CXADR,GNE-3511,GuideToPharmacology,1,inhibitor
CUX1,COMPOUND 23 [PMID: 35816678],GuideToPharmacology,1,inhibitor
CUX1,SB-747651A,GuideToPharmacology,1,inhibitor
AMY1A,COMPOUND 16 [PMID: 26794040],GuideToPharmacology,1,inhibitor
AMY1C,DIHYDROSPHINGOSINE 1-PHOSPHATE,GuideToPharmacology,1,agonist
AMY1C,COMPOUND 5C [PMID: 27894870],GuideToPharmacology,1,agonist
AMY1B,SPM-354,GuideToPharmacology,1,inhibitor
AMY1B,ASP4058,GuideToPharmacology,1,agonist
FAU,COMPOUND 2C [PMID: 24900538],GuideToPharmacology,1,inhibitor
GBE1,DANAPAROID,GuideToPharmacology,1,activator
CD9,FLUOXETINE HYDROCHLORIDE,GuideToPharmacology,1,inhibitor
CD9,DOTHIEPIN,GuideToPharmacology,1,inhibitor
FASLG,BIM 23197,GuideToPharmacology,1,agonist
FASLG,EDOTREOTIDE,GuideToPharmacology,1,agonist
AQP2,BIM 23268,GuideToPharmacology,1,agonist
DMP1,3M-002,GuideToPharmacology,1,agonist
SARDH,IMIQUIMOD,GuideToPharmacology,1,agonist
TLX2,PABINAFUSP ALFA,GuideToPharmacology,1,antibody
H1-5,NAPTUMOMAB ESTAFENATOX,GuideToPharmacology,1,antibody
AQP6,TALTIRELIN,GuideToPharmacology,1,agonist
FRA8C,NAFAMOSTAT,GuideToPharmacology,1,inhibitor
ATP2B2,PYRAZOLOPYRIMIDINE 4N,GuideToPharmacology,1,activator
ATP2B2,LYSOPHOSPHATIDYLCHOLINE,GuideToPharmacology,1,activator
TRPM8,AMTB,GuideToPharmacology,1,blocker
TRPM8,CLOTRIMAZOLE,GuideToPharmacology,1,blocker
TRPM8,ANHYDROUS TACROLIMUS,GuideToPharmacology,1,activator
ATP5F1A,MG2+,GuideToPharmacology,1,activator
ATP5F1A,MG2+,GuideToPharmacology,1,blocker
ATP5F1BP1,A778317,GuideToPharmacology,1,blocker
SLC26A2,LDC1267,GuideToPharmacology,1,inhibitor
ARCN2,PHI,GuideToPharmacology,1,agonist
ARCN1,PHI,GuideToPharmacology,1,agonist
AQP9,LVP,GuideToPharmacology,1,agonist
ANXA5,"[PP1-17,ALA31,AIB32]NPY (HUMAN)",GuideToPharmacology,1,agonist
TAS2R46,AMAROGENTIN,GuideToPharmacology,1,agonist
KCNQ3,TETRAMETHYLAMMONIUM,GuideToPharmacology,1,blocker
BARD1,BC-III,GuideToPharmacology,1,inhibitor
ATP5F1C,ISOCHLOROGENIC ACID A,GuideToPharmacology,1,blocker
ESRRG,MNK1 INHIBITOR,GuideToPharmacology,1,inhibitor
ATF1,&ALPHA;-CONOTOXIN-GIC,GuideToPharmacology,1,inhibitor
BCKDHA,(R)-16 [PMID: 32267688],GuideToPharmacology,1,agonist
GYPA,COMPOUND 19A [PMID: 26506089],GuideToPharmacology,1,inhibitor
ABCD2,MEDICA 16,GuideToPharmacology,1,agonist
EIF4G1,ZEMIRCICLIB,GuideToPharmacology,1,inhibitor
EXTL3,GSK690693,GuideToPharmacology,1,inhibitor
AMPD3,AM095,GuideToPharmacology,1,inhibitor
MLKL,MLKL COMPOUND 1,GuideToPharmacology,1,inhibitor
AQP9,"D(CH2)5[D-ILE2,ILE4,ALA-NH29]AVP",GuideToPharmacology,1,inhibitor
ATP5BL2,RUTHENIUM RED,GuideToPharmacology,1,blocker
DXO,PYROTINIB,GuideToPharmacology,1,inhibitor
ADCY3,CP55940,GuideToPharmacology,1,agonist
GCKR,FEBUXOSTAT,GuideToPharmacology,1,inhibitor
ANK3,2-(INDOLIN-1YL)-MELATONIN,GuideToPharmacology,1,inhibitor
ADRA1A,R-SPONDIN-3,GuideToPharmacology,1,agonist
ALDH1A3,SOVATELTIDE,GuideToPharmacology,1,agonist
GM2A,RETIFANLIMAB,GuideToPharmacology,1,antibody
ETFB,PANULISIB,GuideToPharmacology,1,inhibitor
ACTBP2,BP-CCL3,GuideToPharmacology,1,agonist
ACTG1P8,TC14012,GuideToPharmacology,1,agonist
DAZ1,Z-YVAD-FMK,GuideToPharmacology,1,inhibitor
ACTBP8,[125I]CXCL8 (HUMAN),GuideToPharmacology,1,agonist
GPR15,OZANEZUMAB,GuideToPharmacology,1,antibody
F11,LGB321,GuideToPharmacology,1,inhibitor
DHFRP3,PEGVISOMANT,GuideToPharmacology,1,inhibitor
GABRA1,GABOXADOL,GuideToPharmacology,1,agonist
DCR,BATIMASTAT,GuideToPharmacology,1,inhibitor
GRM8,"(1S,3R)-ACPD",GuideToPharmacology,1,agonist
CTPS1,COMPOUND 35 [PMID: 20684608],GuideToPharmacology,1,inhibitor
SLC25A4,LY2389575,GuideToPharmacology,1,modulator
ACAA1,LEVOBUNOLOL,GuideToPharmacology,1,inhibitor
ARAF,RO5028442,GuideToPharmacology,1,inhibitor
NR4A2,VIDOFLUDIMUS,GuideToPharmacology,1,agonist
BEVI,CLASCOTERONE,GuideToPharmacology,1,inhibitor
EIF4E,AMINOPURVALANOL A,GuideToPharmacology,1,inhibitor
EMD,COMPOUND 68 [PMID: 24900699],GuideToPharmacology,1,inhibitor
EPHA8,COMPOUND 4G [PMID: 21316219],GuideToPharmacology,1,inhibitor
AMY2B,C3,GuideToPharmacology,1,agonist
APLP1,QRFP43 (43RFA),GuideToPharmacology,1,agonist
ATP6V1E1,FPL64176,GuideToPharmacology,1,activator
PRMT5,LLY-283,GuideToPharmacology,1,inhibitor
BIRC5,"[TRP23,TYR36]PTHRP-(1-36)-NH2 (HUMAN)",GuideToPharmacology,1,agonist
ABR,NOREPINEPHRINE,GuideToPharmacology,1,agonist
BNIP3,CHLORAMPHENICOL,GuideToPharmacology,1,agonist
GNAI2P1,"COMPOUND 5 [TOMASSI ET AL., 2020]",GuideToPharmacology,1,inhibitor
FUT4,METHIMAZOLE,GuideToPharmacology,1,inhibitor
NUDT2,BNTX,GuideToPharmacology,1,inhibitor
A12M4,SB 277011-A,GuideToPharmacology,1,inhibitor
NUDT2,FENTANYL CITRATE,GuideToPharmacology,1,agonist
CPT1B,SUPROFEN,GuideToPharmacology,1,inhibitor
ALOX15B,JMR-132,GuideToPharmacology,1,agonist
ARAF,"D(CH2)5[TYR(ME)2,THR4,TYR(3125I)-NH29]OVT",GuideToPharmacology,1,inhibitor
ATP2A2,PYRAZOLOPYRIMIDINE 4N,GuideToPharmacology,1,activator
BIRC5,PTH-(1-34) (RAT),GuideToPharmacology,1,agonist
A1BG,ARIPIPRAZOLE LAUROXIL,GuideToPharmacology,1,agonist
COL19A1,TC-E 5005,GuideToPharmacology,1,inhibitor
CNC2,EPZ020411,GuideToPharmacology,1,inhibitor
CDC6,AZD3965,GuideToPharmacology,1,inhibitor
COL10A1,RO20-1724,GuideToPharmacology,1,inhibitor
TRPV5,MG2+,GuideToPharmacology,1,blocker
DXO,EGFR INHIBITOR 57,GuideToPharmacology,1,modulator
HTR2C,5-CT,GuideToPharmacology,1,agonist
ABO,EPINEPHRINE,GuideToPharmacology,1,agonist
TRPV6,MG2+,GuideToPharmacology,1,blocker
BAAT,TERFENADINE,GuideToPharmacology,1,blocker
EYA3,OTS964,GuideToPharmacology,1,inhibitor
FAH,CCT241161,GuideToPharmacology,1,inhibitor
ABCA2,CCPA,GuideToPharmacology,1,agonist
DTNA,BMS-777607,GuideToPharmacology,1,inhibitor
ERVT4,COMPOUND 16 [PMID: 17480064],GuideToPharmacology,1,inhibitor
ATP1B1P1,ISOVELLERAL,GuideToPharmacology,1,activator
ATP4A,NN-DIMETHYL-D-ERYTHROSPHINGOSINE,GuideToPharmacology,1,activator
AOC1,IDAZOXAN,GuideToPharmacology,1,inhibitor
ACTBP9,CXCL2,GuideToPharmacology,1,agonist
ALPI,GASTRIC INHIBITORY POLYPEPTIDE,GuideToPharmacology,1,agonist
ALDH3B2,DIAMIDE 7,GuideToPharmacology,1,inhibitor
BCL2,HEME,GuideToPharmacology,1,agonist
UTS2R,DS37001789,GuideToPharmacology,1,inhibitor
A12M3,LP-12,GuideToPharmacology,1,agonist
APOBER1,ZK110841,GuideToPharmacology,1,agonist
ABCB7,DABUZALGRON,GuideToPharmacology,1,agonist
ANK2,6-HYDROXYMELATONIN,GuideToPharmacology,1,agonist
A2MP1,ZIPRASIDONE,GuideToPharmacology,1,agonist
ABR,ATENOLOL,GuideToPharmacology,1,inhibitor
ABCA1,LUF7602,GuideToPharmacology,1,inhibitor
ACAA1,SR59230A,GuideToPharmacology,1,inhibitor
ABCF1,SPIROXATRINE,GuideToPharmacology,1,inhibitor
ABO,NOREPINEPHRINE,GuideToPharmacology,1,agonist
CHD4,COMPOUND 5K [PMID: 23528296],GuideToPharmacology,1,inhibitor
AMD1,CLOZAPINE,GuideToPharmacology,1,inhibitor
SLCO2B1,ERLOTINIB,GuideToPharmacology,1,inhibitor
DRD5,MK-2461,GuideToPharmacology,1,inhibitor
NKX2-5,SOTRASTAURIN,GuideToPharmacology,1,inhibitor
ANXA13,&BETA;-D-HYDROXYBUTYRIC ACID,GuideToPharmacology,1,agonist
FSHMD1B,MOCLOBEMIDE,GuideToPharmacology,1,inhibitor
AANAT,BETHANECHOL,GuideToPharmacology,1,agonist
BAX,AFT-II,GuideToPharmacology,1,inhibitor
GNAI2,VENADAPARIB,GuideToPharmacology,1,inhibitor
ARHGAP4,SG-005,GuideToPharmacology,1,inhibitor
APOF,DYNORPHIN A-(1-8),GuideToPharmacology,1,agonist
CSRP2,COMPOUND 1O [PMID: 24210504],GuideToPharmacology,1,inhibitor
ACAA1,EPINEPHRINE,GuideToPharmacology,1,agonist
APBA1,BU08028,GuideToPharmacology,1,agonist
TRPM5,APV207010A,GuideToPharmacology,1,modulator
CPB1,FADROZOLE,GuideToPharmacology,1,inhibitor
APBA2,RTOXA-43,GuideToPharmacology,1,agonist
CDK11B,LYS[Z(NO2)]-VAL,GuideToPharmacology,1,inhibitor
BCHEL3,TRETINOIN,GuideToPharmacology,1,agonist
ABAT,"CP608,039",GuideToPharmacology,1,agonist
COL4A1,NKY80,GuideToPharmacology,1,inhibitor
CD27,BENZTROPINE,GuideToPharmacology,1,inhibitor
BCYRN1P2,AMCENESTRANT,GuideToPharmacology,1,inhibitor
APOF,BUTORPHANOL,GuideToPharmacology,1,agonist
F2RL1,TORIN 2,GuideToPharmacology,1,inhibitor
ABL1,APOMORPHINE,GuideToPharmacology,1,agonist
ABCA3,VUF5574,GuideToPharmacology,1,inhibitor
ALDOA,1-METHYLCYCLOPROPANECARBOXYLIC ACID,GuideToPharmacology,1,agonist
ARG1,DC-EBIO,GuideToPharmacology,1,activator
FCGR2B,COMPOUND 13 [PMID: 34333981],GuideToPharmacology,1,inhibitor
SERPINH1,DL-TBOA,GuideToPharmacology,1,inhibitor
EPHB1,RITLECITINIB,GuideToPharmacology,1,inhibitor
CTBP2,GSK690693,GuideToPharmacology,1,inhibitor
ALDH9A1,LL-37,GuideToPharmacology,1,agonist
GABRR3,TBPS,GuideToPharmacology,1,blocker
AQP3,"L-732,138",GuideToPharmacology,1,inhibitor
EFNB2,ATUZABRUTINIB,GuideToPharmacology,1,inhibitor
BLVRA,GERANYL BIPHOSPHONATE,GuideToPharmacology,1,inhibitor
AOC1,ARC-239,GuideToPharmacology,1,inhibitor
DR1,DEBIO-1347,GuideToPharmacology,1,inhibitor
ANXA11,L-LACTIC ACID,GuideToPharmacology,1,agonist
NUDT2,[3H]DIPRENORPHINE,GuideToPharmacology,1,inhibitor
BDKRB2,GSK4716,GuideToPharmacology,1,agonist
BAD,MK-7145,GuideToPharmacology,1,blocker
ACE,COMPOUND 1 [PMID: 24900526],GuideToPharmacology,1,inhibitor
BPGM,SINIGRIN,GuideToPharmacology,1,agonist
F7R,IDELALISIB,GuideToPharmacology,1,inhibitor
AMHR2,N-METHYL LTC4,GuideToPharmacology,1,agonist
FRA16E,CPP-115,GuideToPharmacology,1,inhibitor
E11S,UTOMILUMAB,GuideToPharmacology,1,antibody
A1BG,LP-211,GuideToPharmacology,1,agonist
A1BG,SPIROXATRINE,GuideToPharmacology,1,agonist
A1BG,CLOZAPINE,GuideToPharmacology,1,agonist
A1BG,ZIPRASIDONE,GuideToPharmacology,1,agonist
A1BG,REPINOTAN,GuideToPharmacology,1,inhibitor
A2MP1,CLOZAPINE,GuideToPharmacology,1,agonist
A2M,"[3H]GR 125,743",GuideToPharmacology,1,inhibitor
A2MP1,5-CT,GuideToPharmacology,1,agonist
A2MP1,BROMOCRIPTINE,GuideToPharmacology,1,agonist
A2MP1,"[3H]GR 125,743",GuideToPharmacology,1,inhibitor
A2MP1,SERTINDOLE,GuideToPharmacology,1,inhibitor
A12M1,5-BODMT,GuideToPharmacology,1,agonist
A12M1,DIHYDROERGOTAMINE MESYLATE,GuideToPharmacology,1,agonist
A12M3,MIRTAZAPINE,GuideToPharmacology,1,inhibitor
HTR2C,MK-212,GuideToPharmacology,1,agonist
HTR2C,CABERGOLINE,GuideToPharmacology,1,agonist
HTR2C,RS-127445,GuideToPharmacology,1,inhibitor
HTR2C,SERTINDOLE,GuideToPharmacology,1,inhibitor
NATP,INTEPIRDINE,GuideToPharmacology,1,inhibitor
NATP,CLOZAPINE,GuideToPharmacology,1,inhibitor
SERPINA3,CYPROHEPTADINE HYDROCHLORIDE,GuideToPharmacology,1,inhibitor
SERPINA3,ILOPERIDONE,GuideToPharmacology,1,inhibitor
SERPINA3,DIPROPYL-5-CT,GuideToPharmacology,1,agonist
CNN1,COMPOUND 2E [PMID: 31900320],GuideToPharmacology,1,inhibitor
CSTP1,PHT-427,GuideToPharmacology,1,inhibitor
ABCB7,EPINEPHRINE,GuideToPharmacology,1,agonist
ABCB7,SILODOSIN,GuideToPharmacology,1,inhibitor
AAK1,COMPOUND 13 [PMID: 34333981],GuideToPharmacology,1,inhibitor
DAPK3,BENAZEPRIL,GuideToPharmacology,1,inhibitor
ACADSB,AZELAPRAG,GuideToPharmacology,1,agonist
ACADSB,CYCLOUREA APELIN-12 (1-7),GuideToPharmacology,1,agonist
BST2,ASC06-IGG1,GuideToPharmacology,1,blocker
CMR1A,2(S)-AMINO-6-BORONOHEXANOIC ACID,GuideToPharmacology,1,inhibitor
ABCC2,2(S)-AMINO-6-BORONOHEXANOIC ACID,GuideToPharmacology,1,inhibitor
BST2,NAFAMOSTAT,GuideToPharmacology,1,blocker
BTC,A-317567,GuideToPharmacology,1,blocker
BST2,JNJ-799760,GuideToPharmacology,1,blocker
ABAT,COMPOUND 10 [PMID: 31306001],GuideToPharmacology,1,agonist
ABCA1,COMPOUND 10 [PMID: 31306001],GuideToPharmacology,1,inhibitor
ABCA1,MRS1086,GuideToPharmacology,1,inhibitor
ABCA2,AS101,GuideToPharmacology,1,inhibitor
ABCA2,CPX,GuideToPharmacology,1,inhibitor
ABCA2,ATL802,GuideToPharmacology,1,inhibitor
ABCA3,COMPOUND 6C [PMID: 34435786],GuideToPharmacology,1,agonist
ABCA3,LUF7602,GuideToPharmacology,1,inhibitor
ABCA3,ATL802,GuideToPharmacology,1,inhibitor
ABCA3,N(6)-CYCLOHEXYLADENOSINE,GuideToPharmacology,1,agonist
ABCA3,DPCPX,GuideToPharmacology,1,inhibitor
EEF1G,CENISERTIB,GuideToPharmacology,1,inhibitor
EEF1D,DUBERMATINIB,GuideToPharmacology,1,inhibitor
ABR,INDACATEROL,GuideToPharmacology,1,agonist
ABR,TERBUTALINE,GuideToPharmacology,1,agonist
ABR,EPINEPHRINE,GuideToPharmacology,1,agonist
ABR,OLODATEROL,GuideToPharmacology,1,agonist
ABR,VILANTEROL,GuideToPharmacology,1,agonist
ACAA1,NOREPINEPHRINE,GuideToPharmacology,1,agonist
AMH,12-HYDROXYHEPTADECATRIENOIC ACID,GuideToPharmacology,1,agonist
ACAA1,TERTATOLOL,GuideToPharmacology,1,inhibitor
BMP2K,COMPOUND 6 [PMID: 34333981],GuideToPharmacology,1,inhibitor
EFNA2,L779450,GuideToPharmacology,1,inhibitor
HOXB@,BAY-069,GuideToPharmacology,1,inhibitor
GLUD1P3,CHLORTHALIDONE,GuideToPharmacology,1,inhibitor
CA4,ACETAZOLAMIDE,GuideToPharmacology,1,inhibitor
DBIP1,COMPOUND 4 [PMID: 12408711],GuideToPharmacology,1,inhibitor
ACP5,RONACALERET,GuideToPharmacology,1,modulator
FNTBL1,VBY-825,GuideToPharmacology,1,inhibitor
CTSC,ICATCXPZ-01,GuideToPharmacology,1,inhibitor
FOLH1,COMPOUND 3 [PMID: 8410973],GuideToPharmacology,1,inhibitor
FRA20B,OPICAPONE,GuideToPharmacology,1,inhibitor
ACRV1,GAT211,GuideToPharmacology,1,modulator
ACRV1,JD5037,GuideToPharmacology,1,inhibitor
CCKBR,SINCALIDE,GuideToPharmacology,1,agonist
CNR2,SURINABANT,GuideToPharmacology,1,inhibitor
CCKAR,CCK-33,GuideToPharmacology,1,agonist
ACTA1,CCL7,GuideToPharmacology,1,agonist
ACTB,UCB35625,GuideToPharmacology,1,inhibitor
ACTBP3,PF-07054894,GuideToPharmacology,1,inhibitor
ACTBP2,BMS-753426,GuideToPharmacology,1,inhibitor
H1-6,LILOTOMAB,GuideToPharmacology,1,antibody
GNG4,INOTUZUMAB OZOGAMICIN,GuideToPharmacology,1,antibody
GYPC,IBALIZUMAB,GuideToPharmacology,1,antibody
CMA1,JNJ-10311795,GuideToPharmacology,1,inhibitor
CELA1,TELAPREVIR,GuideToPharmacology,1,inhibitor
CNA1,SGC2085,GuideToPharmacology,1,inhibitor
DPYD,CABIRALIZUMAB,GuideToPharmacology,1,antibody
DPYD,JNJ-28312141,GuideToPharmacology,1,inhibitor
CPT1B,(R)-ARN2508,GuideToPharmacology,1,inhibitor
CPT1B,FENOPROFEN,GuideToPharmacology,1,inhibitor
CPT1B,KETOPROFEN,GuideToPharmacology,1,inhibitor
CPT2,ETODOLAC,GuideToPharmacology,1,inhibitor
ALAS2,ASTRESSIN 2B,GuideToPharmacology,1,inhibitor
ALB,CORTICOTROPHIN-RELEASING HORMONE,GuideToPharmacology,1,agonist
EGR4,2-({6-[(3-CHLOROPHENYL)AMINO]-9-ISOPROPYL-9H-PURIN-2-YL}AMINO)ETHANOL,GuideToPharmacology,1,inhibitor
DUSP1,COMPOUND 4 [PMID: 26191369],GuideToPharmacology,1,inhibitor
GBX1,(S)-DRF-1042,GuideToPharmacology,1,inhibitor
ALCAM,KETANSERIN,GuideToPharmacology,1,inhibitor
ALCAM,SKF-76783,GuideToPharmacology,1,agonist
ALCAM,PERICIAZINE,GuideToPharmacology,1,inhibitor
ALCAM,LY3154885,GuideToPharmacology,1,modulator
ABCD1,BENZQUINAMIDE,GuideToPharmacology,1,agonist
ABCD1,LP-211,GuideToPharmacology,1,agonist
ABCD1,LP-44,GuideToPharmacology,1,agonist
ABCD1,AMISULPRIDE,GuideToPharmacology,1,inhibitor
ABCD1,SULPIRIDE,GuideToPharmacology,1,inhibitor
ABCD1,SERTINDOLE,GuideToPharmacology,1,inhibitor
ALDH2,CABERGOLINE,GuideToPharmacology,1,agonist
ALDH3A1,SKF-83566,GuideToPharmacology,1,inhibitor
EML1,COMPOUND 68 [PMID: 24900699],GuideToPharmacology,1,inhibitor
DXO,AG 9,GuideToPharmacology,1,inhibitor
DXO,AZ5104,GuideToPharmacology,1,inhibitor
DXO,EXAMPLE 10 [CN110740999A],GuideToPharmacology,1,inhibitor
GTF2IP1,DUAL SEH/FAAH INHIBITOR 11,GuideToPharmacology,1,inhibitor
APOBER1,CARBACYCLIN,GuideToPharmacology,1,agonist
APOC1,CARBACYCLIN,GuideToPharmacology,1,agonist
APOC1P1,CLOPROSTENOL,GuideToPharmacology,1,agonist
EN1,LAPATINIB,GuideToPharmacology,1,inhibitor
EN1,MUBRITINIB,GuideToPharmacology,1,inhibitor
EN1,PIROTINIB,GuideToPharmacology,1,inhibitor
EN1,PYROTINIB,GuideToPharmacology,1,inhibitor
EN1,TUCATINIB,GuideToPharmacology,1,inhibitor
BCYRN1P2,PRINABEREL,GuideToPharmacology,1,agonist
BDH1,GENISTEIN,GuideToPharmacology,1,agonist
ALDH1B1,CLAZOSENTAN,GuideToPharmacology,1,inhibitor
ALDH1B1,APROCITENTAN,GuideToPharmacology,1,inhibitor
ALDH1A3,CLAZOSENTAN,GuideToPharmacology,1,inhibitor
BCL5,CILOFEXOR,GuideToPharmacology,1,agonist
BCL5,22R-HYDROXYCHOLESTEROL,GuideToPharmacology,1,agonist
SERPINH1,THREO-3-METHYLGLUTAMATE,GuideToPharmacology,1,inhibitor
CCR10,LB42908,GuideToPharmacology,1,inhibitor
BLVRA,MINODRONIC ACID,GuideToPharmacology,1,inhibitor
ARNT,[3H]GABAZINE,GuideToPharmacology,1,inhibitor
BMAL1,TPA023,GuideToPharmacology,1,modulator
ARRB2,GABOXADOL,GuideToPharmacology,1,agonist
ARRB1,RY024,GuideToPharmacology,1,modulator
ARRB1,&ALPHA;3IA,GuideToPharmacology,1,modulator
ARSF,TBPS,GuideToPharmacology,1,blocker
ARRB2,FLUMAZENIL,GuideToPharmacology,1,modulator
ARRB2,[3H]CGS8216,GuideToPharmacology,1,modulator
ARSL,TBPS,GuideToPharmacology,1,blocker
ALOX12P1,M1160,GuideToPharmacology,1,agonist
CNR1,ANISINDIONE,GuideToPharmacology,1,inhibitor
ALOX15B,SOMATORELIN,GuideToPharmacology,1,agonist
ALOX15B,BIM28011,GuideToPharmacology,1,agonist
ALPI,MK-0893,GuideToPharmacology,1,inhibitor
ASS1,FLUORO-WILLARDIINE,GuideToPharmacology,1,agonist
GRIA3,FLUORO-WILLARDIINE,GuideToPharmacology,1,agonist
ASS1,PIRACETAM,GuideToPharmacology,1,modulator
BDM,FOSDAGROCORAT,GuideToPharmacology,1,agonist
ASS1P10,[3H]DIZOCILPINE,GuideToPharmacology,1,inhibitor
ASS1P14,LY233053,GuideToPharmacology,1,inhibitor
GRIN2C,[3H]CGS19755,GuideToPharmacology,1,inhibitor
GRIN2C,MG2+,GuideToPharmacology,1,blocker
ASS1P14,MG2+,GuideToPharmacology,1,blocker
ASS1P14,[3H]MDL105519,GuideToPharmacology,1,inhibitor
GNRHR,"[125I][TYR5,DALA6,NMELEU7,PRO9-NET]GNRH",GuideToPharmacology,1,agonist
AOAH,D-PHENYLALANINE,GuideToPharmacology,1,agonist
GARS1,BELINOSTAT,GuideToPharmacology,1,inhibitor
PRDM1,ATORVASTATIN CALCIUM TRIHYDRATE,GuideToPharmacology,1,inhibitor
ADH1C,(R)-N-OLEOYLTYROSINOL,GuideToPharmacology,1,agonist
ADH1C,LYSOPHOSPHATIDYLINOSITOL,GuideToPharmacology,1,agonist
ADCY3,2-ARACHIDONOYLGLYCEROLPHOSPHOINOSITOL,GuideToPharmacology,1,agonist
ADCY6,SPHINGOSINE 1-PHOSPHATE,GuideToPharmacology,1,agonist
ADCY8,CARTPT (76-96),GuideToPharmacology,1,agonist
ADD3,DIM,GuideToPharmacology,1,modulator
ADFN,KI16425,GuideToPharmacology,1,inhibitor
EPHA7,ZABEDOSERTIB,GuideToPharmacology,1,inhibitor
EPHA7,GLPG2534,GuideToPharmacology,1,inhibitor
DHODH,ANIFROLUMAB,GuideToPharmacology,1,antibody
IL2RA,DACLIZUMAB,GuideToPharmacology,1,antibody
BRCA2,6-METHYLFLAVONE,GuideToPharmacology,1,inhibitor
BSG,SINIGRIN,GuideToPharmacology,1,agonist
BRCA2,NARINGENIN,GuideToPharmacology,1,agonist
BSG,METHIMAZOLE,GuideToPharmacology,1,agonist
ZFP36L2,3-METHYLHEXANAL,GuideToPharmacology,1,inhibitor
ZFP36L2,ALLOIN,GuideToPharmacology,1,agonist
ZFP36L1,AMAROGENTIN,GuideToPharmacology,1,agonist
ZFP36L2,AMAROGENTIN,GuideToPharmacology,1,agonist
EPHB1,DEURUXOLITINIB,GuideToPharmacology,1,inhibitor
BNIP3,S6821,GuideToPharmacology,1,inhibitor
EPHB2,AZ960,GuideToPharmacology,1,inhibitor
EPHB1,XL019,GuideToPharmacology,1,inhibitor
EPHB2,PF-06263276,GuideToPharmacology,1,inhibitor
EPHB2,SOLCITINIB,GuideToPharmacology,1,inhibitor
EPHB2,GSK2646264,GuideToPharmacology,1,inhibitor
EPHB2,SAR-20347,GuideToPharmacology,1,inhibitor
EPHB2,IVARMACITINIB,GuideToPharmacology,1,inhibitor
EPHB2,JAK INHIBITOR 17B,GuideToPharmacology,1,inhibitor
GPR42,COMPOUND 3 [PMID: 23849879],GuideToPharmacology,1,inhibitor
EPHB3,SAR-20347,GuideToPharmacology,1,inhibitor
EPHB3,RITLECITINIB,GuideToPharmacology,1,inhibitor
NUDT2,U50488,GuideToPharmacology,1,agonist
CD68,PIRETANIDE,GuideToPharmacology,1,inhibitor
GPR26,MONALIZUMAB,GuideToPharmacology,1,antibody
DPT,CEDIRANIB,GuideToPharmacology,1,inhibitor
GPM6B,AZD4625,GuideToPharmacology,1,modulator
ATP5F1E,CHLOROFORM,GuideToPharmacology,1,activator
ARF4P1,ESTRADIOL VALERATE,GuideToPharmacology,1,activator
ARG1,LEIUROTOXIN I,GuideToPharmacology,1,blocker
ARF6,P05,GuideToPharmacology,1,blocker
ARG2,CLOTRIMAZOLE,GuideToPharmacology,1,blocker
BAAT,IMIPRAMINE HYDROCHLORIDE,GuideToPharmacology,1,blocker
KCNJ8,TOLBUTAMIDE,GuideToPharmacology,1,inhibitor
BAG1,&GAMMA;-KTX1.7,GuideToPharmacology,1,inhibitor
ALDH7A1P3,TETRAMETHYLAMMONIUM,GuideToPharmacology,1,blocker
KIF1A,RY796,GuideToPharmacology,1,inhibitor
ATR,TETRAMETHYLAMMONIUM,GuideToPharmacology,1,blocker
ALDH7A1P2,DPO-1,GuideToPharmacology,1,blocker
ADH1A,FARNESYL MONOPHOSPHATE,GuideToPharmacology,1,agonist
ETFB,PP-242,GuideToPharmacology,1,inhibitor
ETFB,TORIN 2,GuideToPharmacology,1,inhibitor
ETFB,DS-7423,GuideToPharmacology,1,inhibitor
DTNA,DENFIVONTINIB,GuideToPharmacology,1,inhibitor
CYP2F1,COMPOUND 14 [PMID: 23634668],GuideToPharmacology,1,inhibitor
DTNA,SLC-391,GuideToPharmacology,1,inhibitor
SLC25A5,COMPOUND 22A [PMID: 21688779],GuideToPharmacology,1,modulator
SLC25A5,VU0361737,GuideToPharmacology,1,modulator
SLC25A6,CHPG,GuideToPharmacology,1,agonist
ANTP2,"(1S,3R)-ACPD",GuideToPharmacology,1,agonist
GRM6,"(S)-3,4-DCPG",GuideToPharmacology,1,agonist
ESR1,COMPOUND 14 [PMID: 34333981],GuideToPharmacology,1,inhibitor
ESR2,PCC0208017,GuideToPharmacology,1,inhibitor
GRM8,MPPG,GuideToPharmacology,1,inhibitor
ANTP2,[3H]LY341495,GuideToPharmacology,1,inhibitor
NR3C2,CORTICOSTERONE,GuideToPharmacology,1,agonist
ESRRB,PEXMETINIB,GuideToPharmacology,1,inhibitor
H1-1,LONIDAMINE,GuideToPharmacology,1,inhibitor
CTNNA1,VTX-11E,GuideToPharmacology,1,inhibitor
CTNNA1P1,JNK INHIBITOR V,GuideToPharmacology,1,inhibitor
CTNNA1,ULIXERTINIB,GuideToPharmacology,1,inhibitor
CTNNA1P1,COMPOUND 20 [PMID: 30998356],GuideToPharmacology,1,inhibitor
ERCC4,GNE-3511,GuideToPharmacology,1,inhibitor
ERCC4,GNE-8505,GuideToPharmacology,1,inhibitor
DCN,CM-352,GuideToPharmacology,1,inhibitor
ACE,AZD6605,GuideToPharmacology,1,inhibitor
HNRNPC,SR-0813,GuideToPharmacology,1,inhibitor
MMP7,MARIMASTAT,GuideToPharmacology,1,inhibitor
DCR,COMPOUND 15 [PMID: 22017539],GuideToPharmacology,1,inhibitor
DBT,MARIMASTAT,GuideToPharmacology,1,inhibitor
DCR,TP0556351,GuideToPharmacology,1,inhibitor
DCR,"5-(2-ETHOXYETHYL)-5-[4-(4-FLUOROPHENOXY)PHENOXY]PYRIMIDINE-2,4,6(1H,3H,5H)-TRIONE",GuideToPharmacology,1,inhibitor
FSHMD1B,SAFINAMIDE,GuideToPharmacology,1,inhibitor
AADAC,"WIN 51,708",GuideToPharmacology,1,modulator
AAMP,ACECLIDINE,GuideToPharmacology,1,agonist
AAMP,BETHANECHOL,GuideToPharmacology,1,agonist
AAMP,BRUCINE,GuideToPharmacology,1,modulator
AAMP,VU0255035,GuideToPharmacology,1,inhibitor
AAMP,DARIFENACIN,GuideToPharmacology,1,inhibitor
ANK3,6-HYDROXYMELATONIN,GuideToPharmacology,1,agonist
ANK3,UCM 454,GuideToPharmacology,1,inhibitor
ANK3,GR 128107,GuideToPharmacology,1,agonist
ANK3,S26131,GuideToPharmacology,1,inhibitor
ANK3,ICOA-13,GuideToPharmacology,1,agonist
ANK3,LY 156735,GuideToPharmacology,1,agonist
APOF,METHYLNALTREXONE,GuideToPharmacology,1,inhibitor
APOF,BMS-986124,GuideToPharmacology,1,modulator
APOF,NALTRINDOLE,GuideToPharmacology,1,inhibitor
HLA-DOB,ENFORTUMAB VEDOTIN-EJFV,GuideToPharmacology,1,antibody
CD8B,VENLAFAXINE,GuideToPharmacology,1,inhibitor
DRG2,SELITRECTINIB,GuideToPharmacology,1,inhibitor
DRG2,GW-2580,GuideToPharmacology,1,inhibitor
ZFHX3,LY2087101,GuideToPharmacology,1,modulator
CHRNA3,[3H]CYTISINE,GuideToPharmacology,1,agonist
AQP3,APREPITANT,GuideToPharmacology,1,inhibitor
AQP4,R396,GuideToPharmacology,1,inhibitor
AQP4,NEPADUTANT,GuideToPharmacology,1,inhibitor
AQP3,R-486,GuideToPharmacology,1,inhibitor
ANXA2,NEUROPEPTIDE S,GuideToPharmacology,1,agonist
ANXA6,SR142948A,GuideToPharmacology,1,inhibitor
TNFRSF4,VONLEROLIZUMAB,GuideToPharmacology,1,antibody
EXT3,COMPOUND 3 [PMID: 26191365],GuideToPharmacology,1,modulator
PAK4,FRAX486,GuideToPharmacology,1,inhibitor
EXT3,FRAX486,GuideToPharmacology,1,inhibitor
EXTL1,COMPOUND 3 [PMID: 26191365],GuideToPharmacology,1,modulator
APBB1,SB-334867,GuideToPharmacology,1,inhibitor
EXTL1,FRAX486,GuideToPharmacology,1,inhibitor
EXTL2,FRAX486,GuideToPharmacology,1,inhibitor
ATP1B1,BZATP,GuideToPharmacology,1,agonist
APEH,2MESATP,GuideToPharmacology,1,agonist
ATP1B3P1,LL-37,GuideToPharmacology,1,modulator
APEX1,ADP&BETA;S,GuideToPharmacology,1,agonist
BIRC2,2MESATP,GuideToPharmacology,1,agonist
APEX1,BX 667,GuideToPharmacology,1,inhibitor
BIRC2,ATP&GAMMA;S,GuideToPharmacology,1,agonist
APCS,DIQUAFOSOL,GuideToPharmacology,1,agonist
AIRE,MRS2693,GuideToPharmacology,1,agonist
ADCYAP1R1,[125I][AC-HIS1]PACAP-27,GuideToPharmacology,1,agonist
BCKDHA,BEZAFIBRATE,GuideToPharmacology,1,agonist
BCKDHA,8S-HETE,GuideToPharmacology,1,agonist
F7,DS-7423,GuideToPharmacology,1,inhibitor
F7R,EGANELISIB,GuideToPharmacology,1,inhibitor
F7R,"5-QUINOXALIN-6-YLMETHYLENE-THIAZOLIDINE-2,4-DIONE",GuideToPharmacology,1,inhibitor
F7R,RV6153,GuideToPharmacology,1,inhibitor
COL11A1,RS-25344,GuideToPharmacology,1,inhibitor
COL11A1,PF-07038124,GuideToPharmacology,1,inhibitor
COL11A1,APREMILAST,GuideToPharmacology,1,inhibitor
FRA5B,6-AMINOCAPROIC ACID,GuideToPharmacology,1,inhibitor
FRA5B,TRANEXAMIC ACID,GuideToPharmacology,1,inhibitor
DPP6,IACS-9439,GuideToPharmacology,1,inhibitor
DPP6,COMPOUND 8H [PMID: 22765894],GuideToPharmacology,1,inhibitor
DPP6,LUCITANIB,GuideToPharmacology,1,inhibitor
DPP4,LUCITANIB,GuideToPharmacology,1,inhibitor
DPP4,COMPOUND 8H [PMID: 22765894],GuideToPharmacology,1,inhibitor
DPP6,CEDIRANIB,GuideToPharmacology,1,inhibitor
DPP6,QUIZARTINIB,GuideToPharmacology,1,inhibitor
DPP6,PDGF RTK INHIBITOR,GuideToPharmacology,1,inhibitor
GNAI2,AG14361,GuideToPharmacology,1,inhibitor
HMBS,ETC-1922159,GuideToPharmacology,1,inhibitor
PRLR,CHORIOMAMMOTROPIN,GuideToPharmacology,1,agonist
FRA3C,PEPTIDE 18 [PMID: 24350995],GuideToPharmacology,1,inhibitor
FRA6F,BORTEZOMIB,GuideToPharmacology,1,inhibitor
CNGB1,DS-437,GuideToPharmacology,1,inhibitor
FRA6A,COMPOUND 4G [PMID: 22595175],GuideToPharmacology,1,inhibitor
CSTF1,GSK690693,GuideToPharmacology,1,inhibitor
CTBP2,SOTRASTAURIN,GuideToPharmacology,1,inhibitor
ACSL4,TILFRINIB,GuideToPharmacology,1,inhibitor
GTF3C2,TEGEPROTAFIB,GuideToPharmacology,1,inhibitor
NRG1,COMPOUND 8A [PMID: 23713581],GuideToPharmacology,1,inhibitor
RIPK2,RIPK2 INHIBITOR 5,GuideToPharmacology,1,inhibitor
GP1BA,"(5Z)-1-(2-FLUOROPHENYL)-2-SULFANYLIDENE-5-(THIOPHEN-2-YLMETHYLIDENE)-1,3-DIAZINANE-4,6-DIONE",GuideToPharmacology,1,inhibitor
GP1BA,RGS4 INHIBITOR 11B,GuideToPharmacology,1,inhibitor
BCHE,CD666,GuideToPharmacology,1,agonist
GP1BA,CCG-50014,GuideToPharmacology,1,inhibitor
GP2,CCG-50014,GuideToPharmacology,1,inhibitor
BCL2,SR8278,GuideToPharmacology,1,inhibitor
CYB5A,COMPOUND 8H [PMID: 22765894],GuideToPharmacology,1,inhibitor
CTRB1,COMPOUND 22 [PMID: 20462760],GuideToPharmacology,1,inhibitor
APPL1,INSL3,GuideToPharmacology,1,agonist
KLK3,EUROPIUM-LABELLED RELAXIN-3-B/INSL5 A CHIMERA,GuideToPharmacology,1,agonist
KLK3,JK1,GuideToPharmacology,1,agonist
AMT,SPM-354,GuideToPharmacology,1,inhibitor
ALOX12,PURMORPHAMINE,GuideToPharmacology,1,agonist
CD44,MARALIXIBAT,GuideToPharmacology,1,inhibitor
ALOX12,MRT-92,GuideToPharmacology,1,inhibitor
MS4A2,TAK-020,GuideToPharmacology,1,inhibitor
MS4A2,COMPOUND 8H [PMID: 22765894],GuideToPharmacology,1,inhibitor
SHROOM2,BIM 23068,GuideToPharmacology,1,agonist
SHROOM2,BIM 23197,GuideToPharmacology,1,agonist
SHROOM2,[125I]LTT-SRIF-28,GuideToPharmacology,1,agonist
SHROOM2,CORTISTATIN-14,GuideToPharmacology,1,agonist
SHROOM2,SRIF-14,GuideToPharmacology,1,agonist
AQP1,[125I]LTT-SRIF-28,GuideToPharmacology,1,agonist
HLA-DMA,AZ6102,GuideToPharmacology,1,inhibitor
HPD,GNE-7883,GuideToPharmacology,1,inhibitor
AQP7,RO5166017,GuideToPharmacology,1,agonist
1-Feb,COMPOUND 18 [PMID: 20873740],GuideToPharmacology,1,inhibitor
TEC,ZYBT1,GuideToPharmacology,1,inhibitor
MPL,ROMIPLOSTIM,GuideToPharmacology,1,agonist
APOC4,CARBACYCLIN,GuideToPharmacology,1,agonist
APOC4,FLUPROSTENOL,GuideToPharmacology,1,agonist
APOC4,ICI 192605,GuideToPharmacology,1,inhibitor
ATP1B1P1,A-967079,GuideToPharmacology,1,blocker
FXYD2,SKF96365,GuideToPharmacology,1,blocker
ATP2B1,BTD,GuideToPharmacology,1,activator
ATP3,MICONAZOLE NITRATE,GuideToPharmacology,1,blocker
ATP5F1BP1,S-RHTX,GuideToPharmacology,1,modulator
FRA8F,GABEXATE,GuideToPharmacology,1,inhibitor
TRPV5,ECONAZOLE NITRATE,GuideToPharmacology,1,blocker
TYK2,SOLCITINIB,GuideToPharmacology,1,inhibitor
UTS2R,[BZ-PHE6]U-II (HUMAN),GuideToPharmacology,1,agonist
BCL7A,ZK159222,GuideToPharmacology,1,inhibitor
AQP9,F180,GuideToPharmacology,1,agonist
AQP9,RO5028442,GuideToPharmacology,1,inhibitor
AQP9,SSR126768A,GuideToPharmacology,1,inhibitor
ABCC6,"D[VAL4,DARG8]VP",GuideToPharmacology,1,agonist
ABCC6,[3H]DDAVP,GuideToPharmacology,1,agonist
ABCC6,DESMOPRESSIN,GuideToPharmacology,1,agonist
ABCC6,OH-LVA,GuideToPharmacology,1,inhibitor
ATP6V1B2,ENOXACIN,GuideToPharmacology,1,inhibitor
ANXA3,NPY-(13-36) (PIG),GuideToPharmacology,1,agonist
GPR19,EXAMPLE 373 [WO2012093101],GuideToPharmacology,1,inhibitor
ERBB4,PIROTINIB,GuideToPharmacology,1,inhibitor
DPYS,CEDIRANIB,GuideToPharmacology,1,inhibitor
GABRA1,ZK93426,GuideToPharmacology,1,modulator
APAF1,NMRA-140,GuideToPharmacology,1,inhibitor
BST2,PI-HEXATOXIN-HI1A,GuideToPharmacology,1,blocker
ABAT,CCPA,GuideToPharmacology,1,agonist
CDK4,NARAZACICLIB,GuideToPharmacology,1,inhibitor
ACAA1,ABEDITEROL,GuideToPharmacology,1,agonist
HRH3,IMMEPIP,GuideToPharmacology,1,agonist
FASLG,[125I]TYR3 SMS 201-995,GuideToPharmacology,1,agonist
A12M3,TRAZODONE,GuideToPharmacology,1,inhibitor
SERPINA3,LURASIDONE HYDROCHLORIDE,GuideToPharmacology,1,inhibitor
BMX,CHLOROQUINE,GuideToPharmacology,1,agonist
NATP,BROMOCRIPTINE,GuideToPharmacology,1,agonist
ABL2,CABERGOLINE,GuideToPharmacology,1,inhibitor
FOXL2,(+/-)-ERIODICTYOL,GuideToPharmacology,1,agonist
NATP,CYPROHEPTADINE HYDROCHLORIDE,GuideToPharmacology,1,inhibitor
GART,CHR-3996,GuideToPharmacology,1,inhibitor
ATP2B1,SKF96365,GuideToPharmacology,1,blocker
CPT1B,OXAPROZIN,GuideToPharmacology,1,inhibitor
ANXA7,NEUROTENSIN,GuideToPharmacology,1,agonist
ANK2,K185,GuideToPharmacology,1,inhibitor
SCN9A,ABBV-318,GuideToPharmacology,1,blocker
ANPEP,JFD00064,GuideToPharmacology,1,inhibitor
FRA9D,SJB2-043,GuideToPharmacology,1,inhibitor
DBIP2,COMPOUND 4 [PMID: 12408711],GuideToPharmacology,1,inhibitor
A12M2,CLOZAPINE,GuideToPharmacology,1,agonist
ARRB1,TPA023,GuideToPharmacology,1,modulator
AMT,W146,GuideToPharmacology,1,inhibitor
ARNT,[3H]CGS8216,GuideToPharmacology,1,modulator
ALDH3B1,ESTRADIOL VALERATE,GuideToPharmacology,1,agonist
ATP1A4,AF353,GuideToPharmacology,1,inhibitor
ATP1B1P1,MORPHANTHRIDINE,GuideToPharmacology,1,activator
EPS15,COMPOUND 23 [PMID: 17600705],GuideToPharmacology,1,inhibitor
ACTBP9,[125I]CXCL8 (HUMAN),GuideToPharmacology,1,agonist
CTRB1,ZELASUDIL,GuideToPharmacology,1,inhibitor
RYR2,MG2+,GuideToPharmacology,1,inhibitor
A2M,ARIPIPRAZOLE LAUROXIL,GuideToPharmacology,1,agonist
BTD,LYSOPHOSPHATIDYLCHOLINE,GuideToPharmacology,1,activator
ADK,"COMPOUND 33 [TODA ET AL., 2013]",GuideToPharmacology,1,agonist
APOE,GB110,GuideToPharmacology,1,agonist
CREB1,CJ13610,GuideToPharmacology,1,inhibitor
BLVRB,COMPOUND 21 [PMID: 19191557],GuideToPharmacology,1,inhibitor
AQP2,BIM 23313,GuideToPharmacology,1,agonist
DXO,AG 112,GuideToPharmacology,1,inhibitor
APP,TAMRLX,GuideToPharmacology,1,agonist
ANK3,N-[2-(2-IODO-5-METHOXY-1H-INDOL-3-YL)ETHYL]ACETAMIDE,GuideToPharmacology,1,agonist
ASS1P14,DIZOCILPINE,GuideToPharmacology,1,blocker
F2,COMPOUND 2C [PMID: 24900538],GuideToPharmacology,1,inhibitor
KCNQ3,GABAPENTIN,GuideToPharmacology,1,activator
APEH,NF546,GuideToPharmacology,1,agonist
DPP6,DEBIO-1347,GuideToPharmacology,1,inhibitor
FASLG,[111IN]DOTA-NOC,GuideToPharmacology,1,agonist
CNR2,[3H]WIN55212-2,GuideToPharmacology,1,agonist
FASLG,"L-363,301",GuideToPharmacology,1,agonist
DAP,THIORPHAN,GuideToPharmacology,1,inhibitor
A1BG,"L-694,247",GuideToPharmacology,1,agonist
CCR4,FLX475,GuideToPharmacology,1,inhibitor
DPYS,RUSERONTINIB,GuideToPharmacology,1,inhibitor
GDF9,TRICHOSTATIN A,GuideToPharmacology,1,inhibitor
PTK2B,LUCITANIB,GuideToPharmacology,1,inhibitor
ACTA2,PF-04634817,GuideToPharmacology,1,inhibitor
ALDH1A1,(+)-S-14297,GuideToPharmacology,1,inhibitor
APEH,BZATP,GuideToPharmacology,1,agonist
PIK3CB,DEZAPELISIB,GuideToPharmacology,1,inhibitor
CPA3,FADROZOLE,GuideToPharmacology,1,inhibitor
EN1,RITUXIMAB,GuideToPharmacology,1,antibody
ABCC6,ARGIPRESSIN,GuideToPharmacology,1,agonist
ACTBP9,REPARIXIN,GuideToPharmacology,1,modulator
BIN1,KI16425,GuideToPharmacology,1,inhibitor
AANAT,METHSCOPOLAMINE,GuideToPharmacology,1,inhibitor
ABCF1,SILODOSIN,GuideToPharmacology,1,inhibitor
NMUR1,NEUROMEDIN U-8,GuideToPharmacology,1,agonist
BIRC2,ADP&BETA;S,GuideToPharmacology,1,agonist
CNN1,FIRSOCOSTAT,GuideToPharmacology,1,modulator
ALDH9A1,QUIN-C7,GuideToPharmacology,1,inhibitor
ETFB,COMPOUND 11J [PMID: 23021994],GuideToPharmacology,1,inhibitor
GAPDHP67,SLF,GuideToPharmacology,1,inhibitor
CTSV,TRULI,GuideToPharmacology,1,inhibitor
GNAI2,SARUPARIB,GuideToPharmacology,1,inhibitor
ASIC1,PS020990,GuideToPharmacology,1,inhibitor
ALAS2,R121919,GuideToPharmacology,1,inhibitor
CYP4F2,17-OCTADECYNOIC ACID,GuideToPharmacology,1,inhibitor
ARRB1,TBPS,GuideToPharmacology,1,blocker
AOC1,MIRTAZAPINE,GuideToPharmacology,1,inhibitor
ATP1B1P1,1'-ACETOXYCHAVICOL ACETATE,GuideToPharmacology,1,activator
FRA6B,RO4929097,GuideToPharmacology,1,inhibitor
ALDH1A1,APOMORPHINE,GuideToPharmacology,1,agonist
TRDMT1,GALUNISERTIB,GuideToPharmacology,1,inhibitor
ADH1C,1-STEAROYL-LYSOPHOSPHATIDYLCHOLINE,GuideToPharmacology,1,agonist
ACTN3,ABNORMAL CANNABIDIOL,GuideToPharmacology,1,agonist
DPH1,AZD-4547,GuideToPharmacology,1,inhibitor
ANXA1,DNPA,GuideToPharmacology,1,agonist
APOF,ENDOMORPHIN-1,GuideToPharmacology,1,agonist
DPP4,OLARATUMAB,GuideToPharmacology,1,antibody
ABO,TIMOLOL,GuideToPharmacology,1,inhibitor
A2M,DIPROPYL-5-CT,GuideToPharmacology,1,agonist
A2M,KETANSERIN,GuideToPharmacology,1,inhibitor
A12M3,LY320954,GuideToPharmacology,1,inhibitor
A12M3,ARIPIPRAZOLE LAUROXIL,GuideToPharmacology,1,agonist
A12M3,APOMORPHINE,GuideToPharmacology,1,inhibitor
A12M3,AMESERGIDE,GuideToPharmacology,1,inhibitor
HTR2C,ZIPRASIDONE,GuideToPharmacology,1,inhibitor
HTR2C,AC-90179,GuideToPharmacology,1,inhibitor
NATP,[11C]GSK215083,GuideToPharmacology,1,inhibitor
HCRT,TH5487,GuideToPharmacology,1,inhibitor
ABL1,SIAIS178,GuideToPharmacology,1,inhibitor
PLK3,FIRSOCOSTAT,GuideToPharmacology,1,modulator
ABL1,PONATINIB,GuideToPharmacology,1,inhibitor
CNN1,CP-640186,GuideToPharmacology,1,inhibitor
HBEGF,UNECRITINIB,GuideToPharmacology,1,inhibitor
GNA12,LIDORESTAT ANHYDROUS,GuideToPharmacology,1,inhibitor
ABCF1,HEAT (BE2254),GuideToPharmacology,1,inhibitor
ABCF1,METHOXAMINE,GuideToPharmacology,1,agonist
ABCF1,UPIDOSIN,GuideToPharmacology,1,inhibitor
ABCF1,PHENYLEPHRINE,GuideToPharmacology,1,agonist
ABCA4,SILODOSIN,GuideToPharmacology,1,inhibitor
ABCA4,CLOZAPINE,GuideToPharmacology,1,inhibitor
ABCA4,PHENOXYBENZAMINE,GuideToPharmacology,1,inhibitor
ABL1,XYLAZINE,GuideToPharmacology,1,agonist
ABL1,BROMOCRIPTINE,GuideToPharmacology,1,inhibitor
ABL1,MIRTAZAPINE,GuideToPharmacology,1,inhibitor
ABL1,BRIMONIDINE,GuideToPharmacology,1,agonist
ABL1,ETHYLISOPROPYLAMILORIDE,GuideToPharmacology,1,modulator
AOC1,BRIMONIDINE,GuideToPharmacology,1,agonist
ABL2,BROMOCRIPTINE,GuideToPharmacology,1,inhibitor
ABL2,XYLAZINE,GuideToPharmacology,1,agonist
ABL2,APRACLONIDINE,GuideToPharmacology,1,agonist
BEVI,FLUOXYMESTERONE,GuideToPharmacology,1,agonist
ABCA1,KF 17837S,GuideToPharmacology,1,inhibitor
ABCA1,CPX,GuideToPharmacology,1,inhibitor
ABCA3,MRS1042,GuideToPharmacology,1,inhibitor
ABCA3,MRS1486,GuideToPharmacology,1,inhibitor
ACADS,ANGIOTENSIN II,GuideToPharmacology,1,agonist
ACADM,TRV-120027,GuideToPharmacology,1,inhibitor
GNG11,AZD5582,GuideToPharmacology,1,inhibitor
GTF2A1,BCL6 PROTAC 15,GuideToPharmacology,1,inhibitor
ASIC2,COMPOUND 9G [PMID: 24412111],GuideToPharmacology,1,agonist
ASIC2,"[D-PHE6,&BETA;-ALA11,PHE13,NLE14]BOMBESIN-(6-14)",GuideToPharmacology,1,agonist
ABO,INDACATEROL,GuideToPharmacology,1,agonist
ABO,FORMOTEROL FUMARATE,GuideToPharmacology,1,agonist
ABO,TERBUTALINE,GuideToPharmacology,1,agonist
ABR,ABEDITEROL,GuideToPharmacology,1,agonist
ABO,SR59230A,GuideToPharmacology,1,inhibitor
EFNA1,NEMTABRUTINIB,GuideToPharmacology,1,inhibitor
BMP2K,COMPOUND 13 [PMID: 34333981],GuideToPharmacology,1,inhibitor
EFNA4,MZ1,GuideToPharmacology,1,inhibitor
EFNA4,NHWD-870,GuideToPharmacology,1,inhibitor
EFNB2,SPEBRUTINIB,GuideToPharmacology,1,inhibitor
EFNB2,TIRABRUTINIB,GuideToPharmacology,1,inhibitor
EFNB2,EVOBRUTINIB,GuideToPharmacology,1,inhibitor
EFNB2,CGI1746,GuideToPharmacology,1,inhibitor
EFNB2,NEMTABRUTINIB,GuideToPharmacology,1,inhibitor
ASIC1,COMPOUND 11 [PMID: 12812482],GuideToPharmacology,1,inhibitor
ASIC1,[DES-ARG9]BRADYKININ,GuideToPharmacology,1,agonist
ACACA,C3A RECEPTOR AGONIST,GuideToPharmacology,1,agonist
BDKRB2,WIN 64338,GuideToPharmacology,1,inhibitor
BDKRB2,ICATIBANT,GuideToPharmacology,1,inhibitor
ACACA,SQ007-5,GuideToPharmacology,1,agonist
GAPDH,ETHOXZOLAMIDE,GuideToPharmacology,1,inhibitor
GAPDH,DORZOLAMIDE,GuideToPharmacology,1,inhibitor
GAPDH,ACETAZOLAMIDE,GuideToPharmacology,1,inhibitor
ELAVL3,IC261,GuideToPharmacology,1,inhibitor
CYP27B1,"UK-396,082",GuideToPharmacology,1,inhibitor
CYP27B1,COMPOUND 3 [PMID: 14640538],GuideToPharmacology,1,inhibitor
ELF4,COMPOUND 14 [PMID: 24900428],GuideToPharmacology,1,inhibitor
DAZL,COMPOUND 4 [PMID: 12408711],GuideToPharmacology,1,inhibitor
ELF1,COMPOUND 14 [PMID: 24900428],GuideToPharmacology,1,inhibitor
ACP5,NPS 2143,GuideToPharmacology,1,modulator
ATP6V1G2,PB2+,GuideToPharmacology,1,blocker
ATP6AP1,ML218,GuideToPharmacology,1,blocker
FOLR2,GC-376,GuideToPharmacology,1,inhibitor
ACTA2,CCL7,GuideToPharmacology,1,agonist
ACTA1,COMPOUND 2B-1 [PMID: 12614873],GuideToPharmacology,1,inhibitor
ACTA1,CCL3,GuideToPharmacology,1,agonist
ACTA2,INCB8761,GuideToPharmacology,1,inhibitor
ACTA2,CCL24,GuideToPharmacology,1,inhibitor
ACTBP2,CCL3,GuideToPharmacology,1,agonist
ACTBP2,CCL13,GuideToPharmacology,1,agonist
CPT2,NIMESULIDE,GuideToPharmacology,1,inhibitor
CPT2,KETOROLAC TROMETHAMINE,GuideToPharmacology,1,inhibitor
CPT2,PIROXICAM-BETA-CYCLODEXTRIN,GuideToPharmacology,1,inhibitor
ACTG1,CXCL12&GAMMA;,GuideToPharmacology,1,agonist
ACTG1,"SDF-1, 1-9[P2G] DIMER",GuideToPharmacology,1,inhibitor
ACTG1,MAVORIXAFOR,GuideToPharmacology,1,inhibitor
ACTG1,T140,GuideToPharmacology,1,inhibitor
ACTG1P2,CX3CL1,GuideToPharmacology,1,agonist
CDK4,COMPOUND 9B [PMID: 18986805],GuideToPharmacology,1,inhibitor
CDK4,PALBOCICLIB,GuideToPharmacology,1,inhibitor
CDK4,CP-10,GuideToPharmacology,1,inhibitor
EIF4EBP1,CROZBACICLIB,GuideToPharmacology,1,inhibitor
CORD4,ESCULETIN,GuideToPharmacology,1,inhibitor
CORD1,5H78PF,GuideToPharmacology,1,inhibitor
AMPD1,HAMI3379,GuideToPharmacology,1,inhibitor
AMPD1,N-METHYL LTC4,GuideToPharmacology,1,agonist
APAF1,DADLE,GuideToPharmacology,1,agonist
DHFR,PRALATREXATE,GuideToPharmacology,1,inhibitor
DHODH,BREQUINAR,GuideToPharmacology,1,inhibitor
GPI,COMPOUND 5B [PMID: 25349648],GuideToPharmacology,1,inhibitor
ABCD1,CLOZAPINE,GuideToPharmacology,1,inhibitor
ALDH1A1,[3H]7-OH-DPAT,GuideToPharmacology,1,agonist
ALDH1A1,CABERGOLINE,GuideToPharmacology,1,agonist
ALDH1A1,BROMOCRIPTINE,GuideToPharmacology,1,agonist
ALDH1A1,SB 277011-A,GuideToPharmacology,1,inhibitor
ALDH2,CLOZAPINE,GuideToPharmacology,1,inhibitor
ALDH1A1,SULPIRIDE,GuideToPharmacology,1,inhibitor
ALDH2,BROMOCRIPTINE,GuideToPharmacology,1,inhibitor
FPR2,BAY-678,GuideToPharmacology,1,inhibitor
GRID2,CAROTUXIMAB,GuideToPharmacology,1,antibody
CRMP1,PF-04457845,GuideToPharmacology,1,inhibitor
CRP,OL135,GuideToPharmacology,1,inhibitor
ADH4,MYRISTIC ACID,GuideToPharmacology,1,agonist
ADH4,GW9508,GuideToPharmacology,1,agonist
ABCD2,ROSIGLITAZONE,GuideToPharmacology,1,agonist
ALDOA,(S)-4-CMTB,GuideToPharmacology,1,agonist
DPYSL2,DEBIO-1347,GuideToPharmacology,1,inhibitor
DPYSL2,AZD-4547,GuideToPharmacology,1,inhibitor
DPYSL2,ERDAFITINIB,GuideToPharmacology,1,inhibitor
DPYSL2,TASURGRATINIB,GuideToPharmacology,1,inhibitor
SLC26A3,ERDAFITINIB,GuideToPharmacology,1,inhibitor
DPYSL3,DEBIO-1347,GuideToPharmacology,1,inhibitor
DPYSL3,PEMIGATINIB,GuideToPharmacology,1,inhibitor
DR1,TINENGOTINIB,GuideToPharmacology,1,inhibitor
DPYSL3,LIRAFUGRATINIB,GuideToPharmacology,1,inhibitor
DR1,PEMIGATINIB,GuideToPharmacology,1,inhibitor
DR1,ERDAFITINIB,GuideToPharmacology,1,inhibitor
DRD1,MOTESANIB,GuideToPharmacology,1,inhibitor
DRD1,COMPOUND 8H [PMID: 22765894],GuideToPharmacology,1,inhibitor
DRD1,SEMAXANIB,GuideToPharmacology,1,inhibitor
DPYS,COMPOUND 2C [PMID: 24900538],GuideToPharmacology,1,inhibitor
DPYS,TAFETINIB,GuideToPharmacology,1,inhibitor
DRD3,MOTESANIB,GuideToPharmacology,1,inhibitor
DRD3,TAFETINIB,GuideToPharmacology,1,inhibitor
ALDH3B2,AG-14,GuideToPharmacology,1,agonist
ALDH3B2,[125I]CHIPS,GuideToPharmacology,1,inhibitor
ALDH9A1,AG-26,GuideToPharmacology,1,agonist
APOC2,SEPETAPROST,GuideToPharmacology,1,agonist
APOC2,FLUPROSTENOL,GuideToPharmacology,1,agonist
ALDH9A1,FPRL1-INHIBITOR PROTEIN,GuideToPharmacology,1,inhibitor
GABRA1,TPA023,GuideToPharmacology,1,modulator
FRA1G,PEPTIDE 18 [PMID: 24350995],GuideToPharmacology,1,inhibitor
GABRA1,TBPS,GuideToPharmacology,1,blocker
GALR2,GALANIN(1-16) (RAT/MOUSE/PIG),GuideToPharmacology,1,agonist
GALR2,SNAP 398299,GuideToPharmacology,1,inhibitor
ALOX12P2,GALANIN(3-29) (PIG),GuideToPharmacology,1,agonist
ALOX12P2,GALANIN(1-16) (RAT/MOUSE/PIG),GuideToPharmacology,1,agonist
GALR2,M1153,GuideToPharmacology,1,agonist
GALR2,GALANIN,GuideToPharmacology,1,agonist
ALOX12P2,GALANIN,GuideToPharmacology,1,agonist
CXCR5,"COMPOUND 1 [OVERHAND ET AL., 1997]",GuideToPharmacology,1,inhibitor
GRIA3,PIRACETAM,GuideToPharmacology,1,modulator
BDM,GSK866,GuideToPharmacology,1,agonist
ASS1P10,[3H]CGS19755,GuideToPharmacology,1,inhibitor
ASS1P6,SYM2081,GuideToPharmacology,1,agonist
ASS1P8,SYM2081,GuideToPharmacology,1,agonist
ASS1P9,DOMOIC ACID,GuideToPharmacology,1,agonist
ASS1P8,[3H]KAINATE,GuideToPharmacology,1,agonist
ASS1P5,LY466195,GuideToPharmacology,1,inhibitor
GRIN2B,[3H]CGS19755,GuideToPharmacology,1,inhibitor
GNRHR,[TYR8]GNRH,GuideToPharmacology,1,agonist
GNRHR,LEUPROLIDE ACETATE,GuideToPharmacology,1,agonist
ALDH3B1,2-METHOXYESTRADIOL,GuideToPharmacology,1,agonist
CST1,COMPOUND 1O [PMID: 24210504],GuideToPharmacology,1,inhibitor
DLX4,PEPTIDE P19 [PMID: 15652659],GuideToPharmacology,1,inhibitor
DLX3,PL-3994,GuideToPharmacology,1,agonist
ACP3,GLUTAMINE,GuideToPharmacology,1,agonist
ANXA13,3-PYRIDINE-ACETIC ACID,GuideToPharmacology,1,agonist
ANXA13,NIACIN,GuideToPharmacology,1,agonist
ENUR2,PEXMETINIB,GuideToPharmacology,1,inhibitor
GDF2,APICIDIN,GuideToPharmacology,1,inhibitor
GDF2,SCRIPTAID,GuideToPharmacology,1,inhibitor
HDAC4,SCRIPTAID,GuideToPharmacology,1,inhibitor
GART,TRICHOSTATIN A,GuideToPharmacology,1,inhibitor
GART,BAVAROSTAT,GuideToPharmacology,1,inhibitor
GAS2,SCRIPTAID,GuideToPharmacology,1,inhibitor
GAS1,TRICHOSTATIN A,GuideToPharmacology,1,inhibitor
GDF9,DACINOSTAT,GuideToPharmacology,1,inhibitor
GAS1,BELINOSTAT,GuideToPharmacology,1,inhibitor
AMD1,UR-PG146,GuideToPharmacology,1,agonist
AMD1,SERTINDOLE,GuideToPharmacology,1,inhibitor
AMD1,THIOTHIXENE,GuideToPharmacology,1,inhibitor
AMD1,MOLINDONE,GuideToPharmacology,1,inhibitor
AMD1,TERFENADINE,GuideToPharmacology,1,inhibitor
AMD1,ZIPRASIDONE,GuideToPharmacology,1,inhibitor
AMD1,LEVOCETIRIZINE,GuideToPharmacology,1,inhibitor
PRDM1,COMPOUND 11JJ [PMID: 1656041],GuideToPharmacology,1,inhibitor
ADH1C,OLVANIL,GuideToPharmacology,1,agonist
ACTL4,NE 52-QQ57,GuideToPharmacology,1,inhibitor
ADCY3,MANSC (415-431),GuideToPharmacology,1,agonist
FRA1L,QUINOLINE 2,GuideToPharmacology,1,inhibitor
FRA2C,COMPOUND 3 [PMID: 23849879],GuideToPharmacology,1,inhibitor
NUDT2,NORMORPHINE,GuideToPharmacology,1,agonist
NUDT2,NALBUPHINE HYDROCHLORIDE,GuideToPharmacology,1,agonist
DRD2,DUAL VEGFR/PARP INHIBITOR 14B,GuideToPharmacology,1,inhibitor
DRD2,AST-487,GuideToPharmacology,1,inhibitor
DRD2,TINENGOTINIB,GuideToPharmacology,1,inhibitor
DPT,M4205,GuideToPharmacology,1,inhibitor
DPT,BARZOLVOLIMAB,GuideToPharmacology,1,antibody
DPT,JNJ-28312141,GuideToPharmacology,1,inhibitor
ATP6V1B1,CHLOROFORM,GuideToPharmacology,1,blocker
ARG1,LEI-DAB7,GuideToPharmacology,1,blocker
ARF6,APAMIN,GuideToPharmacology,1,inhibitor
ARF6,EBIO,GuideToPharmacology,1,activator
ARF6,TETRAMETHYLAMMONIUM,GuideToPharmacology,1,blocker
KCNJ5,AZD2927,GuideToPharmacology,1,blocker
BAD,A-935142,GuideToPharmacology,1,activator
ATR,KETOCONAZOLE,GuideToPharmacology,1,blocker
KIF1A,QUININE,GuideToPharmacology,1,blocker
AZF2,(S)-N-[1-(3-MORPHOLIN-4-YL-PHENYL)-ETHYL]-3-PHENYL-ACRYLAMIDE,GuideToPharmacology,1,activator
AZGP1,LINOPIRDINE,GuideToPharmacology,1,inhibitor
AZGP1,TETRAMETHYLAMMONIUM,GuideToPharmacology,1,blocker
KCNQ5,TETRAMETHYLAMMONIUM,GuideToPharmacology,1,blocker
FRA10D,RO 48-8071,GuideToPharmacology,1,inhibitor
EPHX2,TAK-020,GuideToPharmacology,1,inhibitor
DTNB,COMPOUND 20 [PMID: 30998356],GuideToPharmacology,1,inhibitor
CRHR2,UBENIMEX,GuideToPharmacology,1,inhibitor
EPS8,LRRK2-IN-1,GuideToPharmacology,1,inhibitor
EPS8,JH-XII-03-02,GuideToPharmacology,1,inhibitor
EPS8,XL01126,GuideToPharmacology,1,inhibitor
BCL3,GSK2033,GuideToPharmacology,1,inhibitor
BAK1P2,GSK9772,GuideToPharmacology,1,modulator
AMPD3,AM966,GuideToPharmacology,1,inhibitor
AMPD3,OLEOYL-THIOPHOSPHATE,GuideToPharmacology,1,agonist
GGCX,ZAVONDEMSTAT,GuideToPharmacology,1,inhibitor
GEM,ORY-1001,GuideToPharmacology,1,activator
GEM,GSK2879552,GuideToPharmacology,1,inhibitor
GDNF,PF-9363,GuideToPharmacology,1,inhibitor
KMT5C,A-196,GuideToPharmacology,1,inhibitor
ANCR,SETMELANOTIDE,GuideToPharmacology,1,agonist
ANG,ACTH-(11-24),GuideToPharmacology,1,inhibitor
AMY2B,S36539,GuideToPharmacology,1,inhibitor
AMY2B,TPI 1361-17,GuideToPharmacology,1,inhibitor
ANOP1,PHCCC,GuideToPharmacology,1,modulator
ANOP1,COMPOUND 23H [PMID: 17929793],GuideToPharmacology,1,modulator
ANPEP,COMPOUND 4 [PMID: 21105727],GuideToPharmacology,1,modulator
ANOP1,COMPOUND 9N [PMID: 23084894],GuideToPharmacology,1,modulator
ANPEP,COMPOUND 34 [PMID: 20409708],GuideToPharmacology,1,modulator
ANPEP,COMPOUND 48 [PMID: 22364337],GuideToPharmacology,1,modulator
MAP2K1,CI-1040,GuideToPharmacology,1,modulator
AADAC,SABCOMELINE,GuideToPharmacology,1,agonist
AADAC,OTENZEPAD,GuideToPharmacology,1,inhibitor
AAMP,ARECOLINE,GuideToPharmacology,1,agonist
AANAT,DOTHIEPIN,GuideToPharmacology,1,inhibitor
AARS1,ARECOLINE,GuideToPharmacology,1,agonist
AARS1,BETHANECHOL,GuideToPharmacology,1,agonist
AANAT,SILAHEXOCYCLIUM,GuideToPharmacology,1,inhibitor
AANAT,VU0255035,GuideToPharmacology,1,inhibitor
AARS1,FURTRETHONIUM IODIDE,GuideToPharmacology,1,agonist
AAVS1,SABCOMELINE,GuideToPharmacology,1,agonist
AAVS1,ARECOLINE,GuideToPharmacology,1,agonist
AAVS1,[3H]ACETYLCHOLINE,GuideToPharmacology,1,agonist
AARS1,OXYBUTYNIN,GuideToPharmacology,1,inhibitor
AAVS1,[3H]QNB,GuideToPharmacology,1,inhibitor
AAVS1,SILAHEXOCYCLIUM,GuideToPharmacology,1,inhibitor
ANK2,LY 156735,GuideToPharmacology,1,agonist
ANK2,UCSF7447,GuideToPharmacology,1,agonist
BBS1,BC-III,GuideToPharmacology,1,inhibitor
BBS4,ABBV-318,GuideToPharmacology,1,blocker
BBS2,AM-6120,GuideToPharmacology,1,inhibitor
ATF4,[3H]AZ11637326,GuideToPharmacology,1,agonist
AQP4,TALNETANT,GuideToPharmacology,1,inhibitor
AQP3,VOFOPITANT,GuideToPharmacology,1,inhibitor
AQP4,SCH 206272,GuideToPharmacology,1,inhibitor
AQP5,PAVINETANT,GuideToPharmacology,1,inhibitor
AQP5,"N',2-DIPHENYLQUINOLINE-4-CARBOHYDRAZIDE 8M",GuideToPharmacology,1,inhibitor
AQP5,TALNETANT,GuideToPharmacology,1,inhibitor
DNAH9,MCC950,GuideToPharmacology,1,inhibitor
DNAH9,CY-09,GuideToPharmacology,1,inhibitor
NMUR1,CPN-267,GuideToPharmacology,1,agonist
NMUR1,NM4-C16,GuideToPharmacology,1,agonist
NUAK1,NARAZACICLIB,GuideToPharmacology,1,inhibitor
NUAK1,HTH-01-015,GuideToPharmacology,1,inhibitor
SLCO1B1,ESTROPIPATE,GuideToPharmacology,1,inhibitor
EWSR1,HTH-02-006,GuideToPharmacology,1,inhibitor
GTF2H1,GSK-7975A,GuideToPharmacology,1,blocker
GTF2F2P1,GSK-7975A,GuideToPharmacology,1,blocker
ARAF,"L-366,948",GuideToPharmacology,1,inhibitor
ARAF,"L-369,020",GuideToPharmacology,1,inhibitor
ARAF,D(CH2)5[TYR(ME)2]AVP,GuideToPharmacology,1,inhibitor
APBB2,2MESADP,GuideToPharmacology,1,agonist
BIRC3,MRS4174,GuideToPharmacology,1,inhibitor
APBB2,[3H]MRS2279,GuideToPharmacology,1,inhibitor
ADCYAP1R1,MK-0893,GuideToPharmacology,1,inhibitor
APOD,[3H]HATRAP,GuideToPharmacology,1,agonist
SLC15A2,4-AMBA,GuideToPharmacology,1,inhibitor
BCKDHB,TRETINOIN,GuideToPharmacology,1,agonist
BCKDHA,LY-518674,GuideToPharmacology,1,agonist
CCND1,(R)-16 [PMID: 32267688],GuideToPharmacology,1,agonist
F5,AZD7648,GuideToPharmacology,1,inhibitor
F5,DS-7423,GuideToPharmacology,1,inhibitor
F5,SELETALISIB,GuideToPharmacology,1,inhibitor
F5,ZANDELISIB,GuideToPharmacology,1,inhibitor
PIK3CB,AZD3458,GuideToPharmacology,1,inhibitor
F7,AZD3458,GuideToPharmacology,1,inhibitor
PIK3CB,PANULISIB,GuideToPharmacology,1,inhibitor
F7R,COMPOUND 5D [PMID: 31335136],GuideToPharmacology,1,inhibitor
F7R,COMPOUND 27 [PMID: 35834807],GuideToPharmacology,1,inhibitor
GPR34P,BAY-297,GuideToPharmacology,1,inhibitor
COL11A2,RS-25344,GuideToPharmacology,1,inhibitor
PDE5A,TUNODAFIL,GuideToPharmacology,1,inhibitor
COL17A1,ASPIRIN,GuideToPharmacology,1,inhibitor
COL12A1,COMPOUND 3M [PMID: 32603117],GuideToPharmacology,1,inhibitor
COL15A1,ASPIRIN,GuideToPharmacology,1,inhibitor
NBEAP1,S20,GuideToPharmacology,1,agonist
BDNF,PROGESTERONE,GuideToPharmacology,1,agonist
FRA4D,COMPOUND 3 [PMID: 8410973],GuideToPharmacology,1,inhibitor
NBEAP1,ESTRADIOL VALERATE,GuideToPharmacology,1,agonist
ERCC8,ETHINYL ESTRADIOL,GuideToPharmacology,1,inhibitor
ERCC8,ESTRADIOL VALERATE,GuideToPharmacology,1,inhibitor
APOA4,PTHRP,GuideToPharmacology,1,agonist
H1-3,ETAVOPIVAT,GuideToPharmacology,1,modulator
H1-2,DASA-58,GuideToPharmacology,1,activator
FANCG,COMPOUND 21 [PMID: 24900635],GuideToPharmacology,1,inhibitor
FANCG,GSK2982772,GuideToPharmacology,1,inhibitor
CX3CR1,COMPOUND 8 [PMID: 17480064],GuideToPharmacology,1,inhibitor
AMY1B,FINGOLIMOD-PHOSPHATE,GuideToPharmacology,1,agonist
AMY1A,CYM5520,GuideToPharmacology,1,agonist
SELP,INCLACUMAB,GuideToPharmacology,1,antibody
AMY2A,RP-101075,GuideToPharmacology,1,agonist
AMY2A,SPHINGOSINE 1-PHOSPHATE,GuideToPharmacology,1,agonist
FCP1,COMPOUND 1 [PMID: 21742770],GuideToPharmacology,1,inhibitor
FRA5D,NAFAMOSTAT,GuideToPharmacology,1,inhibitor
FCGR3A,COMPOUND 7 [PMID: 34333981],GuideToPharmacology,1,inhibitor
CD9,NORZOTEPINE,GuideToPharmacology,1,inhibitor
CYB561,EMD638683,GuideToPharmacology,1,inhibitor
ALOX12,GSA-10,GuideToPharmacology,1,modulator
ALOX12,AZD8542,GuideToPharmacology,1,inhibitor
FUS,SPHINGOMYELIN SYNTHASE 2 INHIBITOR 15W,GuideToPharmacology,1,inhibitor
FUS,COMPOUND D24 [PMID: 24374347],GuideToPharmacology,1,inhibitor
MS4A2,BALAMAPIMOD,GuideToPharmacology,1,inhibitor
BLVRB,COMPOUND 4Q [PMID: 7650673],GuideToPharmacology,1,inhibitor
FDX1,SOVLEPLENIB,GuideToPharmacology,1,inhibitor
FAS,SRA880,GuideToPharmacology,1,inhibitor
FASLG,DOTA-BASS,GuideToPharmacology,1,inhibitor
AQP2,BIM 23056,GuideToPharmacology,1,agonist
AQP2,BIM 23056,GuideToPharmacology,1,inhibitor
FRA8A,COMPOUND 3 [PMID: 23849879],GuideToPharmacology,1,inhibitor
FEN1,TBK1 PROTAC 3I,GuideToPharmacology,1,inhibitor
BCGF1,LEVOTHYROXINE,GuideToPharmacology,1,agonist
SARDH,RESIQUIMOD,GuideToPharmacology,1,agonist
ATP1B1P1,BROMOACETONE,GuideToPharmacology,1,activator
ATP4A,ROSIGLITAZONE,GuideToPharmacology,1,blocker
MCOLN2,ML2-SA1,GuideToPharmacology,1,activator
TRPM8,ACAA,GuideToPharmacology,1,blocker
GLUL,COMBRETASTATIN A4,GuideToPharmacology,1,inhibitor
TYK2,JAK INHIBITOR 17B,GuideToPharmacology,1,inhibitor
DTYMK,BIIB091,GuideToPharmacology,1,inhibitor
HCVS,VANIN-1 INHIBITOR [PMID: 33196323],GuideToPharmacology,1,inhibitor
AQP9,D(CH2)5[TYR(ME)2]AVP,GuideToPharmacology,1,inhibitor
AQP9,"D(CH2)5[TYR(ME)2,THR4,TYR-NH29]OVT",GuideToPharmacology,1,inhibitor
ANXA4,[125I]PP (HUMAN),GuideToPharmacology,1,agonist
ANXA5,[D-TRP32]NPY,GuideToPharmacology,1,agonist
CTNNB1,SKF-86002,GuideToPharmacology,1,inhibitor
CTNNA1P1,GNE-3511,GuideToPharmacology,1,inhibitor
AANAT,CEVIMELINE,GuideToPharmacology,1,agonist
AARS1,MUSCARINIC TOXIN 1,GuideToPharmacology,1,inhibitor
ARAF,DESMOPRESSIN,GuideToPharmacology,1,agonist
BCHE,ADAPALENE,GuideToPharmacology,1,agonist
ASGR1,TETRAMETHYLAMMONIUM,GuideToPharmacology,1,blocker
NR3C2,PF-03882845,GuideToPharmacology,1,inhibitor
ACTC1,CXCL10,GuideToPharmacology,1,agonist
BDKRB1,GENISTEIN,GuideToPharmacology,1,agonist
HCN2,K-80003,GuideToPharmacology,1,inhibitor
CCR4,3-DEAZAADENOSINE,GuideToPharmacology,1,inhibitor
APAF1,SRI22141,GuideToPharmacology,1,agonist
ALDH7A1P2,BUPIVACAINE,GuideToPharmacology,1,blocker
FANCG,ODITRASERTIB,GuideToPharmacology,1,inhibitor
FGF7,COMPOUND 34 [PMID: 25974391],GuideToPharmacology,1,inhibitor
BDKRB2,FR173657,GuideToPharmacology,1,inhibitor
CLN8,COMPOUND 30 [PMID: 22902653],GuideToPharmacology,1,inhibitor
RND3,PROGESTERONE,GuideToPharmacology,1,activator
GABRA1,[3H]CGS8216,GuideToPharmacology,1,modulator
DNAH6,MURAMYL DIPEPTIDE,GuideToPharmacology,1,agonist
EPHA3,IRAK-1/4 INHIBITOR,GuideToPharmacology,1,inhibitor
ASIC1,"[SAR,D-PHE8,DES-ARG9]BRADYKININ",GuideToPharmacology,1,agonist
ANGPT2,BREMELANOTIDE,GuideToPharmacology,1,agonist
NMUR1,NEUROMEDIN U-8,GuideToPharmacology,1,agonist
BAD,RPR260243,GuideToPharmacology,1,activator
AARS1,VU0255035,GuideToPharmacology,1,inhibitor
CDK4,LEROCICLIB,GuideToPharmacology,1,inhibitor
DRD1,MK-2461,GuideToPharmacology,1,inhibitor
DXO,BRIGATINIB,GuideToPharmacology,1,inhibitor
SLC26A3,COMPOUND A34 [PMID: 35635004],GuideToPharmacology,1,inhibitor
ABCB7,UPIDOSIN,GuideToPharmacology,1,inhibitor
ATP2A2,SKF96365,GuideToPharmacology,1,blocker
EIF4A1,R547,GuideToPharmacology,1,inhibitor
XCR1,LINRODOSTAT,GuideToPharmacology,1,inhibitor
ATP4A,(S)-LIQUIRITIGENIN,GuideToPharmacology,1,blocker
CHKB,VERAPAMIL,GuideToPharmacology,1,inhibitor
ANK1,BREMELANOTIDE,GuideToPharmacology,1,agonist
SLC29A1,GSK-3&BETA; INHIBITOR 3 [PMID: 25845281],GuideToPharmacology,1,inhibitor
TSHR,THYROTROPIN ALFA,GuideToPharmacology,1,agonist
ARVD3,PICROTOXININ,GuideToPharmacology,1,blocker
NPFFR1,AC262970,GuideToPharmacology,1,inhibitor
GAPDH,CHLORTHALIDONE,GuideToPharmacology,1,inhibitor
GALR2,[125I]SPEXIN-1,GuideToPharmacology,1,agonist
EFNA2,SB590885,GuideToPharmacology,1,inhibitor
ACHE,&BETA;-CGRP,GuideToPharmacology,1,agonist
APBB1,[3H]-ALMOREXANT,GuideToPharmacology,1,inhibitor
CRMP1,PF3845,GuideToPharmacology,1,inhibitor
CCKBR,CCK-33,GuideToPharmacology,1,agonist
GSK1,GLCC14C18,GuideToPharmacology,1,agonist
ETFB,RAPALINK-1,GuideToPharmacology,1,inhibitor
GNG5P1,AMINOPYRIDINE 2,GuideToPharmacology,1,inhibitor
BRINP1,CASP 4 INHIB,GuideToPharmacology,1,inhibitor
ERBB4,BIX02188,GuideToPharmacology,1,inhibitor
AAVS1,AMIODARONE HYDROCHLORIDE,GuideToPharmacology,1,modulator
CREB1,5-LOX INHIBITOR 2M [PMID: 30199704],GuideToPharmacology,1,inhibitor
CD9,CITALOPRAM,GuideToPharmacology,1,inhibitor
BAK1P2,ROVAZOLAC,GuideToPharmacology,1,agonist
BCKDHB,(R)-16 [PMID: 32267688],GuideToPharmacology,1,agonist
ALDH3B2,METHIONINE BENZIMIDAZOLE 6,GuideToPharmacology,1,inhibitor
HRH3,JB 98064,GuideToPharmacology,1,inhibitor
F5,EGANELISIB,GuideToPharmacology,1,inhibitor
ACTA2,PLOZALIZUMAB,GuideToPharmacology,1,antibody
BCYRN1P2,FULVESTRANT,GuideToPharmacology,1,inhibitor
AQP5,GSK 256471,GuideToPharmacology,1,inhibitor
FMOD,COMPOUND 3 [PMID: 27347366],GuideToPharmacology,1,inhibitor
CTNNB1,MW150,GuideToPharmacology,1,inhibitor
CASP3,COMPOUND 4 [PMID: 12408711],GuideToPharmacology,1,inhibitor
ART4,TBPS,GuideToPharmacology,1,blocker
NKX2-5,INGENOL MEBUTATE,GuideToPharmacology,1,activator
ABL1,LURASIDONE HYDROCHLORIDE,GuideToPharmacology,1,inhibitor
DPH1,ISTIRATUMAB,GuideToPharmacology,1,antibody
F7R,PANULISIB,GuideToPharmacology,1,inhibitor
ALDH2,L745870,GuideToPharmacology,1,inhibitor
DRD2,MLKL COMPOUND 1,GuideToPharmacology,1,inhibitor
APOF,BU08028,GuideToPharmacology,1,agonist
F7R,COMPOUND 11J [PMID: 23021994],GuideToPharmacology,1,inhibitor
DPYS,AST-487,GuideToPharmacology,1,inhibitor
CSTP1,BAY1125976,GuideToPharmacology,1,modulator
ZFP36L2,BENGALENSOL,GuideToPharmacology,1,agonist
AAMP,OTENZEPAD,GuideToPharmacology,1,inhibitor
DRP2,COMPOUND 20 [PMID: 23489211],GuideToPharmacology,1,inhibitor
HDAC4,TASQUINIMOD,GuideToPharmacology,1,modulator
ATP2B3,PYRAZOLOPYRIMIDINE 4N,GuideToPharmacology,1,activator
ACAA1,L-748337,GuideToPharmacology,1,agonist
ACAA1,L-748337,GuideToPharmacology,1,inhibitor
RYR3,RUTHENIUM RED,GuideToPharmacology,1,blocker
TLE5,NF-56-EJ40,GuideToPharmacology,1,inhibitor
ABCB7,CABERGOLINE,GuideToPharmacology,1,inhibitor
ATP6V0A1,ML218,GuideToPharmacology,1,blocker
AADAC,VU0255035,GuideToPharmacology,1,inhibitor
TESK2,COMPOUND 30 [PMID: 22902653],GuideToPharmacology,1,inhibitor
AAVS1,OTENZEPAD,GuideToPharmacology,1,inhibitor
ARF5,EBIO,GuideToPharmacology,1,activator
A12M1,CLOZAPINE,GuideToPharmacology,1,agonist
BMAL1,[3H]GABAZINE,GuideToPharmacology,1,inhibitor
AMY1B,AFD(R),GuideToPharmacology,1,agonist
EFNB2,ZYBT1,GuideToPharmacology,1,inhibitor
ALDH7A1P4,AMIODARONE HYDROCHLORIDE,GuideToPharmacology,1,blocker
AQP3,SUBSTANCE P-(6-11),GuideToPharmacology,1,agonist
PRMT5,DS-437,GuideToPharmacology,1,inhibitor
NATP,XANOMELINE,GuideToPharmacology,1,agonist
CPT1B,MEFENAMIC ACID,GuideToPharmacology,1,inhibitor
FOLR1,ALOXISTATIN,GuideToPharmacology,1,inhibitor
ADCY3,LYSOPHOSPHATIDYLINOSITOL,GuideToPharmacology,1,agonist
ALDH7A1P4,FLECAINIDE ACETATE,GuideToPharmacology,1,blocker
APOH,ML354,GuideToPharmacology,1,inhibitor
GPC3,COMPOUND 33 [PMID: 26230603],GuideToPharmacology,1,inhibitor
ANTP4,[125I]MOTILIN (HUMAN),GuideToPharmacology,1,agonist
CPT2,NS-398,GuideToPharmacology,1,inhibitor
ASPH,PIRACETAM,GuideToPharmacology,1,modulator
SCN9A,LACOSAMIDE,GuideToPharmacology,1,blocker
CD24P4,LP-403812,GuideToPharmacology,1,inhibitor
ARRB1,[3H]CGS8216,GuideToPharmacology,1,modulator
GRM8,AZ12216052,GuideToPharmacology,1,modulator
FOLR3,VBY-825,GuideToPharmacology,1,inhibitor
A12M4,VOLINANSERIN,GuideToPharmacology,1,inhibitor
DMP1,"COMPOUND 12P [LARSON ET AL., 2017]",GuideToPharmacology,1,agonist
A1BG,FROVATRIPTAN,GuideToPharmacology,1,agonist
CTSO,COMPOUND 1 [PMID: 20005102],GuideToPharmacology,1,inhibitor
A1BG,NARATRIPTAN,GuideToPharmacology,1,agonist
ABAT,3-ISOBUTYL-1-METHYL-7H-XANTHINE,GuideToPharmacology,1,inhibitor
A1BG,CP 93129,GuideToPharmacology,1,agonist
A1BG,OCAPERIDONE,GuideToPharmacology,1,agonist
ABCA1,MRS923,GuideToPharmacology,1,inhibitor
ABCA2,IMARADENANT,GuideToPharmacology,1,inhibitor
ABCA2,NAMODENOSON,GuideToPharmacology,1,agonist
ABCA3,[3H]HEMADO,GuideToPharmacology,1,agonist
ACADM,CANDESARTAN CILEXETIL,GuideToPharmacology,1,inhibitor
EEF1G,GSK2646264,GuideToPharmacology,1,inhibitor
EEF1D,GSK2646264,GuideToPharmacology,1,inhibitor
EEF1G,DUBERMATINIB,GuideToPharmacology,1,inhibitor
EEF1D,TINENGOTINIB,GuideToPharmacology,1,inhibitor
EEF1G,BARASERTIB,GuideToPharmacology,1,inhibitor
A1BG,VILAZODONE HYDROCHLORIDE,GuideToPharmacology,1,agonist
GNGT1,AZD5582,GuideToPharmacology,1,inhibitor
ACAT2,RHODEI-LITORIN,GuideToPharmacology,1,agonist
FMO5,AZ-4217,GuideToPharmacology,1,inhibitor
FMO5,TAK-070,GuideToPharmacology,1,inhibitor
ABR,EPHEDRINE,GuideToPharmacology,1,agonist
ABR,SR59230A,GuideToPharmacology,1,inhibitor
ABR,BUPRANOLOL,GuideToPharmacology,1,inhibitor
EFNA2,COMPOUND 2 [PMID: 26061392],GuideToPharmacology,1,inhibitor
EFNA2,CCT241161,GuideToPharmacology,1,inhibitor
A1BG,RACLOPRIDE,GuideToPharmacology,1,inhibitor
GRIA4,BAY-069,GuideToPharmacology,1,inhibitor
GLUD1P3,SULPIRIDE,GuideToPharmacology,1,inhibitor
A2MP1,&ALPHA;-METHYL-5-HT,GuideToPharmacology,1,agonist
CA14,CHLORTHALIDONE,GuideToPharmacology,1,inhibitor
GLUD1P3,ACETAZOLAMIDE,GuideToPharmacology,1,inhibitor
CA14,ACETAZOLAMIDE,GuideToPharmacology,1,inhibitor
GLUD1P3,DORZOLAMIDE,GuideToPharmacology,1,inhibitor
CASP3,Z-DQMD-FMK,GuideToPharmacology,1,inhibitor
ATP6V1C1,FPL64176,GuideToPharmacology,1,activator
ATP6V1E1,BENIDIPINE,GuideToPharmacology,1,blocker
A2M,OCAPERIDONE,GuideToPharmacology,1,inhibitor
CYP7A1,EXAMPLE 166  [WO2014154727],GuideToPharmacology,1,inhibitor
ACRV1,CP55940,GuideToPharmacology,1,agonist
RHOG,PROGESTERONE,GuideToPharmacology,1,activator
ACRV1,WIN55212-2,GuideToPharmacology,1,agonist
CNR2,AM10257,GuideToPharmacology,1,inhibitor
CNR2,WIN55212-2,GuideToPharmacology,1,agonist
CNR2,LENABASUM,GuideToPharmacology,1,agonist
CCKBR,DESULFATED GASTRIN-71,GuideToPharmacology,1,agonist
ABCD1,PIPOTHIAZINE,GuideToPharmacology,1,inhibitor
ALDH2,DOPAMINE,GuideToPharmacology,1,agonist
ALDH2,FENOLDOPAM MESYLATE,GuideToPharmacology,1,agonist
ALDH1A1,SULPIRIDE,GuideToPharmacology,1,inhibitor
ALDH3A1,KETANSERIN,GuideToPharmacology,1,inhibitor
CCR3,QUEMLICLUSTAT,GuideToPharmacology,1,inhibitor
RAPGEF1,PSB-6426,GuideToPharmacology,1,inhibitor
DXO,COMPOUND 18J [PMID: 35446588],GuideToPharmacology,1,inhibitor
A2MP1,ROXINDOLE,GuideToPharmacology,1,agonist
DXO,AG1478,GuideToPharmacology,1,inhibitor
DXO,AUMOLERTINIB,GuideToPharmacology,1,inhibitor
DXO,ALLITINIB,GuideToPharmacology,1,inhibitor
APOBER1,CLOPROSTENOL,GuideToPharmacology,1,agonist
GTF2IP1,SMTP-7,GuideToPharmacology,1,inhibitor
APOC1P1,FLUPROSTENOL,GuideToPharmacology,1,agonist
APOC1,TG8-260,GuideToPharmacology,1,inhibitor
AQP8,CARBACYCLIN,GuideToPharmacology,1,agonist
BCYRN1P2,ESTRADIOL VALERATE,GuideToPharmacology,1,agonist
A2MP1,TERGURIDE,GuideToPharmacology,1,agonist
DPAGT1,ISTIRATUMAB,GuideToPharmacology,1,antibody
A2MP1,CYANOPINDOLOL,GuideToPharmacology,1,inhibitor
ESR2,(S)-LIQUIRITIGENIN,GuideToPharmacology,1,agonist
ESR2,FULVESTRANT,GuideToPharmacology,1,inhibitor
ESR2,ESTRADIOL VALERATE,GuideToPharmacology,1,agonist
ESR2,"R,R-THC",GuideToPharmacology,1,inhibitor
ALDH1B1,PD164333,GuideToPharmacology,1,inhibitor
BDKRB1,BIOCHANIN A,GuideToPharmacology,1,agonist
EMX1,PKR INHIBITOR,GuideToPharmacology,1,inhibitor
EMP3,COMPOUND 34 [PMID: 20189382],GuideToPharmacology,1,inhibitor
A12M1,OLANZAPINE,GuideToPharmacology,1,agonist
SLC1A1,NBI-59159,GuideToPharmacology,1,inhibitor
CBLN1,SYM2081,GuideToPharmacology,1,inhibitor
DHCR24,EPOETIN ALFA,GuideToPharmacology,1,agonist
CRMP1,BIA 10-2639,GuideToPharmacology,1,inhibitor
ARNT,L838417,GuideToPharmacology,1,modulator
ARR3,[3H]GABAZINE,GuideToPharmacology,1,inhibitor
ARR3,TBPS,GuideToPharmacology,1,blocker
ARRB1,BASMISANIL,GuideToPharmacology,1,modulator
ARRB2,FUROSEMIDE,GuideToPharmacology,1,modulator
ARSB,TBPS,GuideToPharmacology,1,blocker
A12M4,ROXINDOLE,GuideToPharmacology,1,inhibitor
STS,TBPS,GuideToPharmacology,1,blocker
ARSF,GABOXADOL,GuideToPharmacology,1,agonist
GABRR3,AZA-THIP,GuideToPharmacology,1,inhibitor
ALOX12P1,GALANIN(1-16) (RAT/MOUSE/PIG),GuideToPharmacology,1,agonist
ALOX12P1,GALANIN,GuideToPharmacology,1,agonist
ALOX15,GSK1614343,GuideToPharmacology,1,inhibitor
ALOX15,YIL781,GuideToPharmacology,1,inhibitor
ASS1P2,FLUORO-WILLARDIINE,GuideToPharmacology,1,agonist
A12M4,MESULERGINE,GuideToPharmacology,1,inhibitor
BDM,COMPOUND 17 [PMID: 29741897],GuideToPharmacology,1,agonist
BDM,VELSECORAT,GuideToPharmacology,1,agonist
ASS1P5,SYM2081,GuideToPharmacology,1,agonist
GRIN2A,NVP-AAM077,GuideToPharmacology,1,inhibitor
GRIN2A,LY233053,GuideToPharmacology,1,inhibitor
GRIN2C,DIZOCILPINE,GuideToPharmacology,1,blocker
GLRA1,PICROTOXININ,GuideToPharmacology,1,blocker
SLC29A1,COMPOUND 4G [PMID: 2680437],GuideToPharmacology,1,inhibitor
SLC29A1,2-({6-[(3-CHLOROPHENYL)AMINO]-9-ISOPROPYL-9H-PURIN-2-YL}AMINO)ETHANOL,GuideToPharmacology,1,inhibitor
SLC29A1,SB-415286,GuideToPharmacology,1,inhibitor
SLC29A1,COMPOUND 5 [PMID: 19338355],GuideToPharmacology,1,inhibitor
SLC29A1,TIDEGLUSIB,GuideToPharmacology,1,inhibitor
ANXA13,COMPOUND 9N [PMID: 18752940],GuideToPharmacology,1,modulator
HTR2C,&ALPHA;-METHYL-5-HT,GuideToPharmacology,1,agonist
DLX6,[125I]STA,GuideToPharmacology,1,agonist
TNFRSF17,LINOLEIC ACID,GuideToPharmacology,1,agonist
GDF2,BELINOSTAT,GuideToPharmacology,1,inhibitor
GAPDHP1,APICIDIN,GuideToPharmacology,1,inhibitor
HTR2C,METHYLERGONOVINE,GuideToPharmacology,1,agonist
AMELX,[125I]CCL16 (HUMAN),GuideToPharmacology,1,agonist
AMELX,IMMEPIP,GuideToPharmacology,1,agonist
AMELX,CLOZAPINE,GuideToPharmacology,1,inhibitor
ADH1C,N-OLEOYLDOPAMINE,GuideToPharmacology,1,agonist
HTR2C,OXYMETAZOLINE HYDROCHLORIDE,GuideToPharmacology,1,agonist
ADH1C,COMPOUND 1 [PMID: 21939274],GuideToPharmacology,1,agonist
ACTN4,25-HYDROXYCHOLESTEROL,GuideToPharmacology,1,agonist
ADCY3,CLUL1 (52-77),GuideToPharmacology,1,agonist
ADCY8,MS48107,GuideToPharmacology,1,modulator
ADRA1B,R-SPONDIN-2,GuideToPharmacology,1,agonist
NAT1,ML 10302,GuideToPharmacology,1,agonist
ADRA2A,CGEN-856,GuideToPharmacology,1,agonist
LGR6,R-SPONDIN-3,GuideToPharmacology,1,agonist
LGR6,R-SPONDIN-4,GuideToPharmacology,1,agonist
APOF,FENTANYL CITRATE,GuideToPharmacology,1,agonist
APOF,NALBUPHINE HYDROCHLORIDE,GuideToPharmacology,1,agonist
DRD5P1,JNJ-28312141,GuideToPharmacology,1,inhibitor
NAT1,VILAZODONE HYDROCHLORIDE,GuideToPharmacology,1,agonist
HTR2C,MIANSERIN,GuideToPharmacology,1,inhibitor
DRD5P2,GW-2580,GuideToPharmacology,1,inhibitor
DAP,CANDOXATRILAT,GuideToPharmacology,1,inhibitor
DAP,FASIDOTRILAT,GuideToPharmacology,1,inhibitor
DAP,COMPOUND 1A [PMID: 25692029],GuideToPharmacology,1,inhibitor
CHRNA3,&ALPHA;-CONOTOXIN-GIC,GuideToPharmacology,1,inhibitor
SERPINC1,&ALPHA;-BUNGAROTOXIN,GuideToPharmacology,1,inhibitor
NAT2,SB 699551,GuideToPharmacology,1,inhibitor
AQP3,NETUPITANT,GuideToPharmacology,1,inhibitor
AQP4,SB 414240,GuideToPharmacology,1,inhibitor
NMUR2,NEUROMEDIN U-8,GuideToPharmacology,1,agonist
ANXA2P2,NEUROPEPTIDE B-23,GuideToPharmacology,1,agonist
NPFFR1,1DME,GuideToPharmacology,1,agonist
NPFFR1,[125I]1DME,GuideToPharmacology,1,agonist
ANXA6,KH28,GuideToPharmacology,1,agonist
ANXA1,RFRP-3,GuideToPharmacology,1,agonist
ANXA6,JMV431,GuideToPharmacology,1,agonist
APBA2,ALMOREXANT,GuideToPharmacology,1,inhibitor
APBA2,CVN45502,GuideToPharmacology,1,inhibitor
APBA2,FILOREXANT,GuideToPharmacology,1,inhibitor
APBA2,SB-649868,GuideToPharmacology,1,inhibitor
APBA2,[3H]-ALMOREXANT,GuideToPharmacology,1,inhibitor
APBA2,SB-334867,GuideToPharmacology,1,inhibitor
APBB1,SB-649868,GuideToPharmacology,1,inhibitor
EXT3,COMPOUND 1 [PMID: 20005102],GuideToPharmacology,1,inhibitor
ATP1A4,BZATP,GuideToPharmacology,1,agonist
ATP1A3,&ALPHA;&BETA;-MEATP,GuideToPharmacology,1,agonist
ATP1A3,BZATP,GuideToPharmacology,1,agonist
ATP1A4,&ALPHA;&BETA;-MEATP,GuideToPharmacology,1,agonist
APEH,ADP&BETA;S,GuideToPharmacology,1,agonist
APEH,DATP,GuideToPharmacology,1,agonist
ATP1B3P1,GSK1370319A,GuideToPharmacology,1,inhibitor
BIRC2,2MESADP,GuideToPharmacology,1,agonist
APEX1,CANGRELOR,GuideToPharmacology,1,inhibitor
BIRC2,SURAMIN,GuideToPharmacology,1,inhibitor
SERPINA3,MIANSERIN,GuideToPharmacology,1,inhibitor
APBB2,2MESADP,GuideToPharmacology,1,agonist
AIRE,MRS2782,GuideToPharmacology,1,agonist
AIRE,2MESATP,GuideToPharmacology,1,agonist
APC,MRS2768,GuideToPharmacology,1,agonist
APLP2,PLATELET ACTIVATING FACTOR,GuideToPharmacology,1,agonist
SERPINA3,JNJ-18038683,GuideToPharmacology,1,inhibitor
RYR2,SURAMIN,GuideToPharmacology,1,activator
CA9,VALSPODAR,GuideToPharmacology,1,inhibitor
KLK3,[125I]RELAXIN-3 (HUMAN),GuideToPharmacology,1,agonist
GYPB,SD-91,GuideToPharmacology,1,inhibitor
FBN2,COMPOUND 11J [PMID: 23021994],GuideToPharmacology,1,inhibitor
FCER1A,SLC4101431,GuideToPharmacology,1,inhibitor
FDX1,BAY 61-3606,GuideToPharmacology,1,inhibitor
FAS,[125I]LTT-SRIF-28,GuideToPharmacology,1,agonist
FAS,CORTISTATIN-14,GuideToPharmacology,1,agonist
FAS,"DES-AA1,5-[TYR2,D-TRP8,IAMP9]SRIF",GuideToPharmacology,1,agonist
FASLG,ANALOG 32 [PMID:18543899],GuideToPharmacology,1,inhibitor
DNM2,COMPOUND 13R [PMID: 23639540],GuideToPharmacology,1,inhibitor
SHROOM2,MK-4256,GuideToPharmacology,1,inhibitor
SHROOM2,"L-363,301",GuideToPharmacology,1,agonist
AQP1,BIM 23068,GuideToPharmacology,1,agonist
GRIN1,ADU-S100,GuideToPharmacology,1,agonist
DNCM,COMPOUND 13R [PMID: 23639540],GuideToPharmacology,1,inhibitor
ECM2,PEXMETINIB,GuideToPharmacology,1,inhibitor
APOC4,LAROPIPRANT,GuideToPharmacology,1,inhibitor
APOC4,U46609,GuideToPharmacology,1,agonist
FRA8C,OTAMIXABAN,GuideToPharmacology,1,inhibitor
DHX9,ILOMASTAT,GuideToPharmacology,1,inhibitor
ATP2B1,AM237,GuideToPharmacology,1,activator
ATP2B2,ML9,GuideToPharmacology,1,blocker
ATP2B2,GSMTX-4,GuideToPharmacology,1,blocker
ATP3,ACAA,GuideToPharmacology,1,blocker
ATP2B2,BTDM,GuideToPharmacology,1,blocker
ATP4A,NIFEDIPINE,GuideToPharmacology,1,activator
ATP4A,NARINGENIN,GuideToPharmacology,1,blocker
ATP4A,SPHINGOSINE,GuideToPharmacology,1,activator
CSTF3,AFURESERTIB,GuideToPharmacology,1,inhibitor
PKD2L1,ETHYLISOPROPYLAMILORIDE,GuideToPharmacology,1,blocker
ATP5F1BP1,PHENYLACETYLRINVANIL,GuideToPharmacology,1,activator
ATP5F1BP1,OLVANIL,GuideToPharmacology,1,activator
TRPV6,DEHYDRATED ALCOHOL,GuideToPharmacology,1,activator
ADAM10,ILOMASTAT,GuideToPharmacology,1,inhibitor
TYK2,PF-06263276,GuideToPharmacology,1,inhibitor
TYK2,COMPOUND 13 [PMID: 34333981],GuideToPharmacology,1,inhibitor
AQP9,MOZAVAPTAN,GuideToPharmacology,1,inhibitor
ABCB7,ROXINDOLE,GuideToPharmacology,1,inhibitor
AR,DESMOPRESSIN,GuideToPharmacology,1,agonist
AR,MOZAVAPTAN,GuideToPharmacology,1,inhibitor
AR,ARGIPRESSIN,GuideToPharmacology,1,agonist
GCKR,ALLOPURINOL,GuideToPharmacology,1,inhibitor
ABCB7,CIRAZOLINE,GuideToPharmacology,1,agonist
FKBP1AP1,COMPOUND 2C [PMID: 24900538],GuideToPharmacology,1,inhibitor
GNG10,AZD5582,GuideToPharmacology,1,inhibitor
ANXA3,NPY-(2-36) (PIG),GuideToPharmacology,1,agonist
BTF3P11,HG2+,GuideToPharmacology,1,inhibitor
BTK,HG2+,GuideToPharmacology,1,inhibitor
KLF5,HG2+,GuideToPharmacology,1,inhibitor
ACADSB,[3H](PYR1)[MET(0)11]-APELIN-13,GuideToPharmacology,1,agonist
BST2,COMPOUND 5B [PMID: 25974655],GuideToPharmacology,1,blocker
BST2,"IBUPROFEN, SODIUM SALT",GuideToPharmacology,1,blocker
BST2,ZN2+,GuideToPharmacology,1,blocker
BTD,UGR 9-1,GuideToPharmacology,1,blocker
ABAT,ROLOFYLLINE,GuideToPharmacology,1,inhibitor
ABCA1,APADENOSON,GuideToPharmacology,1,agonist
ABCA1,MRS1132,GuideToPharmacology,1,inhibitor
ABCA2,MRS1754,GuideToPharmacology,1,inhibitor
ABCA2,TONAPOFYLLINE,GuideToPharmacology,1,inhibitor
ABCA3,TCPA,GuideToPharmacology,1,agonist
ABCA3,LUF6000,GuideToPharmacology,1,modulator
ACADM,COMPOUND 1 [PMID: 28379944],GuideToPharmacology,1,inhibitor
EEF1G,AT-9283,GuideToPharmacology,1,inhibitor
EEF1G,IBCASERTIB,GuideToPharmacology,1,inhibitor
EEF1D,JNJ-7706621,GuideToPharmacology,1,inhibitor
EEF1D,RG-1530,GuideToPharmacology,1,inhibitor
EEF1G,KW-2449,GuideToPharmacology,1,inhibitor
EEF2,DANUSERTIB,GuideToPharmacology,1,inhibitor
GNGT1,SM-337,GuideToPharmacology,1,inhibitor
ASIC2,COMPOUND 17C [PMID: 25497965],GuideToPharmacology,1,agonist
LPAR4,ABT-737,GuideToPharmacology,1,inhibitor
ABO,CGP 12177,GuideToPharmacology,1,agonist
ABO,CGP 12177,GuideToPharmacology,1,inhibitor
ABO,NADOLOL,GuideToPharmacology,1,inhibitor
ABR,CHF-6366,GuideToPharmacology,1,agonist
ACAA1,MIRABEGRON,GuideToPharmacology,1,agonist
ACAA1,L742791,GuideToPharmacology,1,agonist
ACAA1,NADOLOL,GuideToPharmacology,1,inhibitor
EFNA2,AZ628,GuideToPharmacology,1,inhibitor
HIP1,COMPOUND 5B  [PMID: 31287314],GuideToPharmacology,1,inhibitor
DBIP1,Z-IETD-FMK,GuideToPharmacology,1,inhibitor
ACP5,CALHEX 231,GuideToPharmacology,1,modulator
A2M,SERTINDOLE,GuideToPharmacology,1,inhibitor
FMO3,ARI-3099,GuideToPharmacology,1,inhibitor
NUDT2,ADL5859,GuideToPharmacology,1,agonist
ACP5,UPACICALCET,GuideToPharmacology,1,modulator
LTB4R,TELOTRISTAT ETHYL,GuideToPharmacology,1,inhibitor
SLC25A6,SIB-1893,GuideToPharmacology,1,modulator
AADAC,P-F-HHSID,GuideToPharmacology,1,inhibitor
ARCN2,SOMATORELIN,GuideToPharmacology,1,agonist
CYP7A1,COMPOUND 8A [PMID: 22861813],GuideToPharmacology,1,inhibitor
CTSC,COMPOUND 3D [PMID: 3941405],GuideToPharmacology,1,inhibitor
CACNA1H,ABT-639,GuideToPharmacology,1,blocker
CNR2,GW842166,GuideToPharmacology,1,agonist
COL12A1,LEO 29102,GuideToPharmacology,1,inhibitor
APP,RELAXIN,GuideToPharmacology,1,agonist
CCKAR,CCK-39,GuideToPharmacology,1,agonist
CCKBR,GASTRIN-71,GuideToPharmacology,1,agonist
CCKAR,[3H]DEVAZEPIDE,GuideToPharmacology,1,inhibitor
CCKBR,GASTRIN-34,GuideToPharmacology,1,agonist
ASAH1,NIFEDIPINE,GuideToPharmacology,1,inhibitor
CCND1,RAGAGLITAZAR,GuideToPharmacology,1,agonist
CHKB,FLUOXETINE HYDROCHLORIDE,GuideToPharmacology,1,inhibitor
CCKAR,SR146131,GuideToPharmacology,1,agonist
ACTBP2,[125I]CCL5 (HUMAN),GuideToPharmacology,1,agonist
GART,RESMINOSTAT,GuideToPharmacology,1,inhibitor
ACTBP6,CCL25,GuideToPharmacology,1,agonist
CDC5L,AZD3965,GuideToPharmacology,1,inhibitor
GYPC,TREGALIZUMAB,GuideToPharmacology,1,antibody
GATM,UBLITUXIMAB,GuideToPharmacology,1,antibody
E4F1,BRENTUXIMAB VEDOTIN,GuideToPharmacology,1,antibody
BBS1,BUPIVACAINE,GuideToPharmacology,1,blocker
ELANE,COMPOUND 17 [PMID: 23642479],GuideToPharmacology,1,inhibitor
GLE1,COMPOUND 50 [PMID: 24313754],GuideToPharmacology,1,inhibitor
CDC42BPA,RKI-1447,GuideToPharmacology,1,inhibitor
ATP1B3P1,BZATP,GuideToPharmacology,1,agonist
ELAVL2,TOMIVOSERTIB,GuideToPharmacology,1,inhibitor
GPER1,POLATUZUMAB VEDOTIN,GuideToPharmacology,1,antibody
CFTR,GLPG1837,GuideToPharmacology,1,activator
CTNND1,TALMAPIMOD,GuideToPharmacology,1,inhibitor
HTR2C,TRAZODONE,GuideToPharmacology,1,inhibitor
TSPO,NS5818,GuideToPharmacology,1,blocker
ABCB7,KETANSERIN,GuideToPharmacology,1,inhibitor
FMO5,COMPOUND 2 [PMID: 22911925],GuideToPharmacology,1,inhibitor
ANPEP,PTBE,GuideToPharmacology,1,modulator
DPP4,CP-673451,GuideToPharmacology,1,inhibitor
CMA1,NK3201,GuideToPharmacology,1,inhibitor
BVR1,NIFLUMIC ACID,GuideToPharmacology,1,activator
CDH12P2,RESERPINE,GuideToPharmacology,1,inhibitor
BVR1,NIFLUMIC ACID,GuideToPharmacology,1,blocker
BUB1B,NIFLUMIC ACID,GuideToPharmacology,1,activator
CPT1B,"IBUPROFEN, SODIUM SALT",GuideToPharmacology,1,inhibitor
SLCO1B3,GLYCYRRHIZIC ACID,GuideToPharmacology,1,inhibitor
F5,TG-100-115,GuideToPharmacology,1,inhibitor
ALAS2,NBI-34041,GuideToPharmacology,1,inhibitor
ALB,UROCORTIN 1,GuideToPharmacology,1,agonist
AANAT,[3H]TIOTROPIUM,GuideToPharmacology,1,inhibitor
ACHE,AMYLIN,GuideToPharmacology,1,agonist
ACHE,AC187,GuideToPharmacology,1,inhibitor
HLA-G,LITIFILIMAB,GuideToPharmacology,1,antibody
DTX1,COMPOUND 8E [PMID: 24432909],GuideToPharmacology,1,inhibitor
AAMP,XANOMELINE,GuideToPharmacology,1,agonist
FXYD2,GSMTX-4,GuideToPharmacology,1,blocker
ACHE,KBP-066,GuideToPharmacology,1,agonist
ARF5,LEI-DAB7,GuideToPharmacology,1,blocker
EPS8,GNE-9605,GuideToPharmacology,1,inhibitor
HGD,TEPODITAMAB,GuideToPharmacology,1,antibody
EPHB2,XL019,GuideToPharmacology,1,inhibitor
C3,CARBENOXOLONE,GuideToPharmacology,1,inhibitor
ACTG1P1,CXCL16,GuideToPharmacology,1,agonist
EIF2S1,SY-5609,GuideToPharmacology,1,inhibitor
AMHR2,TRIPLE MODULATOR 10 [PMID: 29878767],GuideToPharmacology,1,inhibitor
COX11,FUREGRELATE SODIUM,GuideToPharmacology,1,inhibitor
APLP2,SDZ 64-412,GuideToPharmacology,1,inhibitor
FPR1,1G244,GuideToPharmacology,1,inhibitor
A2MP1,DIPROPYL-5-CT,GuideToPharmacology,1,agonist
DUSP2,NILOTINIB,GuideToPharmacology,1,inhibitor
DUSP2,IMATINIB,GuideToPharmacology,1,inhibitor
APOBEC1,ARRY-502,GuideToPharmacology,1,inhibitor
APOBEC1,PGD2,GuideToPharmacology,1,agonist
APOB,ALPROSTADIL,GuideToPharmacology,1,agonist
APPL1,COMPOUND 6641,GuideToPharmacology,1,agonist
ALCAM,NORADRENALINE,GuideToPharmacology,1,agonist
APOBEC1,QAV680,GuideToPharmacology,1,inhibitor
ACLY,BEMPEDOIC ACID,GuideToPharmacology,1,inhibitor
CYP7A1,TELAPREVIR,GuideToPharmacology,1,inhibitor
APAF1,DYNORPHIN A-(1-8),GuideToPharmacology,1,agonist
FASLG,Y-KE88,GuideToPharmacology,1,agonist
ALDH2,ROXINDOLE,GuideToPharmacology,1,agonist
ALDH3A1,NORADRENALINE,GuideToPharmacology,1,agonist
XIAP,TIP39-(7-39) (HUMAN/BOVINE),GuideToPharmacology,1,inhibitor
PDE5A,COMPOUND 53 [PMID: 19631533],GuideToPharmacology,1,inhibitor
CXCR3,DDO-3055,GuideToPharmacology,1,inhibitor
F2RL2,TORIN 2,GuideToPharmacology,1,inhibitor
FABP2,BI-2536,GuideToPharmacology,1,inhibitor
EMD,COMPOUND 17 [PMID: 23642479],GuideToPharmacology,1,inhibitor
AQP9,[125I]OH-LVA,GuideToPharmacology,1,inhibitor
DAP,KC-12615,GuideToPharmacology,1,inhibitor
HRH3,HISTAMINE,GuideToPharmacology,1,agonist
GLI1,CURCUMIN,GuideToPharmacology,1,inhibitor
NMUR1,HAS-NMU,GuideToPharmacology,1,agonist
DPYS,SITRAVATINIB,GuideToPharmacology,1,inhibitor
APEH,SURAMIN,GuideToPharmacology,1,inhibitor
APOBER1,ILOPROST,GuideToPharmacology,1,agonist
ALDH1A1,QUINELORANE,GuideToPharmacology,1,agonist
APOBER1,PGD2,GuideToPharmacology,1,agonist
APOBER1,ONO-8713,GuideToPharmacology,1,inhibitor
AADAC,T532,GuideToPharmacology,1,modulator
APOC1,TAPRENEPAG,GuideToPharmacology,1,agonist
BCHEL1,ADAPALENE,GuideToPharmacology,1,agonist
APOC1,BUTAPROST (FREE ACID FORM),GuideToPharmacology,1,agonist
APOC1P1,DINOPROST,GuideToPharmacology,1,agonist
APLP2,RUPATADINE,GuideToPharmacology,1,inhibitor
GPR183,TIGATUZUMAB,GuideToPharmacology,1,antibody
AQP8,DINOPROST,GuideToPharmacology,1,agonist
CXCR5,MINODRONIC ACID,GuideToPharmacology,1,inhibitor
GART,J27644,GuideToPharmacology,1,inhibitor
AMPD3,SYN-BRP-LPA,GuideToPharmacology,1,inhibitor
KCNQ5,GABAPENTIN,GuideToPharmacology,1,activator
AQP8,MISOPROSTOL,GuideToPharmacology,1,agonist
AQP8,COMPOUND 47 [PMID: 35640059],GuideToPharmacology,1,inhibitor
AQP8,BAY1316957,GuideToPharmacology,1,inhibitor
EN1,IBRUTINIB,GuideToPharmacology,1,inhibitor
EN1,AFATINIB,GuideToPharmacology,1,inhibitor
EN1,FALNIDAMOL,GuideToPharmacology,1,inhibitor
BCYRN1P2,NORENDOXIFEN,GuideToPharmacology,1,inhibitor
ESR2,FERB 033,GuideToPharmacology,1,agonist
GLI3,LTK-14,GuideToPharmacology,1,inhibitor
ALDH1B1,[125I]PD164333,GuideToPharmacology,1,inhibitor
GLRA2,BLINATUMOMAB,GuideToPharmacology,1,antibody
APPL1,[125I]INSL3 (HUMAN),GuideToPharmacology,1,agonist
ALDH1B1,[3H]S0139,GuideToPharmacology,1,inhibitor
ALDH1A3,"[ALA1,3,11,15]ET-1",GuideToPharmacology,1,agonist
ALDH1A3,K-8794,GuideToPharmacology,1,inhibitor
GPM6B,ADAGRASIB,GuideToPharmacology,1,inhibitor
ARR3,[3H]CGS8216,GuideToPharmacology,1,modulator
PIK3CB,DS-7423,GuideToPharmacology,1,inhibitor
OPN1MW,BIX-01294,GuideToPharmacology,1,inhibitor
AXL,LDC1267,GuideToPharmacology,1,inhibitor
ABCD1,LP-12,GuideToPharmacology,1,agonist
NAT1,PRUCALOPRIDE,GuideToPharmacology,1,agonist
ARHGAP5,CYCLIC GMP,GuideToPharmacology,1,activator
ALDH1A3,MACITENTAN,GuideToPharmacology,1,inhibitor
ARSA,TBPS,GuideToPharmacology,1,blocker
HDAC4,TRICHOSTATIN A,GuideToPharmacology,1,inhibitor
GCNT2,UNC0638,GuideToPharmacology,1,inhibitor
CBLB,UCPH-101,GuideToPharmacology,1,inhibitor
ANK1,&ALPHA;-MSH,GuideToPharmacology,1,agonist
BLVRA,NE97220,GuideToPharmacology,1,inhibitor
ABCA3,LJ-4517,GuideToPharmacology,1,inhibitor
BNIP3,OLEUROPEIN,GuideToPharmacology,1,agonist
BCHEL1,AROTINOID ACID,GuideToPharmacology,1,agonist
CRMP1,JZL195,GuideToPharmacology,1,inhibitor
DKC1,MAB92,GuideToPharmacology,1,antibody
NUDT2,GR 89696,GuideToPharmacology,1,agonist
CTSV,AST-487,GuideToPharmacology,1,inhibitor
ARNT,[18F]FLUOROETHYLFLUMAZENIL,GuideToPharmacology,1,modulator
ABO,NDD-713,GuideToPharmacology,1,inhibitor
GM2A,CEMIPLIMAB-RWLC,GuideToPharmacology,1,antibody
FEN1,AZ13102909,GuideToPharmacology,1,inhibitor
ARR3,[18F]FLUOROETHYLFLUMAZENIL,GuideToPharmacology,1,modulator
NR2E1,TRETINOIN,GuideToPharmacology,1,agonist
BMAL1,OCINAPLON,GuideToPharmacology,1,modulator
BMAL1,FLUMAZENIL,GuideToPharmacology,1,modulator
ARVD4,WIN55212-2,GuideToPharmacology,1,inhibitor
DBT,CGS-27023A,GuideToPharmacology,1,inhibitor
BMAL1,[18F]FLUOROETHYLFLUMAZENIL,GuideToPharmacology,1,modulator
A12M4,MELATONIN,GuideToPharmacology,1,inhibitor
ARRB1,OCINAPLON,GuideToPharmacology,1,modulator
ABCB7,A-123189,GuideToPharmacology,1,inhibitor
ARRB1,ISOGUVACINE,GuideToPharmacology,1,agonist
ABCD2,LINOLEIC ACID,GuideToPharmacology,1,agonist
GALR2,GAL-B2-MPEG4,GuideToPharmacology,1,agonist
ADCY8,OGERIN,GuideToPharmacology,1,modulator
ARRB2,[18F]FLUOROETHYLFLUMAZENIL,GuideToPharmacology,1,modulator
BAD,&GAMMA;-KTX1.7,GuideToPharmacology,1,blocker
GDI2P1,PF-9363,GuideToPharmacology,1,inhibitor
COMP,TADALAFIL,GuideToPharmacology,1,inhibitor
DPP6,SEMAXANIB,GuideToPharmacology,1,inhibitor
ARRB2,ISOGUVACINE,GuideToPharmacology,1,agonist
PRKG1,RP-8-CPT-CGMPS,GuideToPharmacology,1,inhibitor
ARRB2,RO15-4513,GuideToPharmacology,1,modulator
UTS2R,SACITUZUMAB GOVITECAN,GuideToPharmacology,1,antibody
ARSB,PICROTOXIN,GuideToPharmacology,1,blocker
GABRR3,PICROTOXIN,GuideToPharmacology,1,blocker
ALAS2,CORTICOTROPHIN-RELEASING HORMONE,GuideToPharmacology,1,agonist
GABRR3,ISONIPECOTIC ACID,GuideToPharmacology,1,inhibitor
SLC25A6,COMPOUND 8 [PMID: 15482908],GuideToPharmacology,1,modulator
CD8B,IMIPRAMINE HYDROCHLORIDE,GuideToPharmacology,1,inhibitor
ART4,TRANS-3-ACPBPA,GuideToPharmacology,1,inhibitor
GABRR3,TPMPA,GuideToPharmacology,1,inhibitor
ART4,PICROTOXIN,GuideToPharmacology,1,blocker
ATP6V1B2,CHLOROFORM,GuideToPharmacology,1,blocker
CTNNB1,SB203580,GuideToPharmacology,1,inhibitor
AMPD2,5-OXO-ODE,GuideToPharmacology,1,agonist
ART4,ISOGUVACINE,GuideToPharmacology,1,agonist
ACSL3,PF-562271,GuideToPharmacology,1,inhibitor
ART4,[3H]MUSCIMOL,GuideToPharmacology,1,agonist
ALOX12P1,M242,GuideToPharmacology,1,agonist
ALOX5,LESOGABERAN,GuideToPharmacology,1,agonist
GALR2,GAL-B2-C12,GuideToPharmacology,1,agonist
ALPI,HUMAN GIP(5-30)NH2,GuideToPharmacology,1,inhibitor
ALOX15,IBUTAMOREN,GuideToPharmacology,1,agonist
GATM,IBRITUMOMAB TIUXETAN,GuideToPharmacology,1,antibody
ALPL,LSN3318839,GuideToPharmacology,1,modulator
ASS1,CX516,GuideToPharmacology,1,modulator
PRDM1,"COMPOUND 1 [PATEL ET AL., 1991]",GuideToPharmacology,1,inhibitor
ASPH,LY392098,GuideToPharmacology,1,modulator
ASS1,LY392098,GuideToPharmacology,1,modulator
GRIA3,GYKI53784,GuideToPharmacology,1,inhibitor
GRIN1,H-151,GuideToPharmacology,1,inhibitor
SIRT5,"COMPOUND 2 [MAURER ET AL., 2012]",GuideToPharmacology,1,inhibitor
SARDH,852A,GuideToPharmacology,1,agonist
ASS1P10,NMDA,GuideToPharmacology,1,agonist
GRIN2A,D-CCPENE,GuideToPharmacology,1,inhibitor
ASS1P14,"SERINE, D-",GuideToPharmacology,1,agonist
GRIN2A,UBP141,GuideToPharmacology,1,inhibitor
GRIN2A,L689560,GuideToPharmacology,1,inhibitor
GRIN2B,ASPARTIC ACID,GuideToPharmacology,1,agonist
GRIN2A,GLYCINE,GuideToPharmacology,1,agonist
GRIN2A,D-AP5,GuideToPharmacology,1,inhibitor
GRIN2A,NMDA,GuideToPharmacology,1,agonist
GRIN2A,GLYCINE,GuideToPharmacology,1,agonist
CTTN,GSK2606414,GuideToPharmacology,1,inhibitor
ARG1,APAMIN,GuideToPharmacology,1,inhibitor
GRIN2C,D-CCPENE,GuideToPharmacology,1,inhibitor
ASS1P14,L689560,GuideToPharmacology,1,inhibitor
GRIN2C,GV196771A,GuideToPharmacology,1,inhibitor
CPT2,PHENYLBUTAZONE,GuideToPharmacology,1,inhibitor
GRIN2B,DIZOCILPINE,GuideToPharmacology,1,blocker
GRIN2C,UBP141,GuideToPharmacology,1,inhibitor
ATP1B1P1,DIBUTYLPHTHALATE,GuideToPharmacology,1,activator
GLRA1,TROPISETRON,GuideToPharmacology,1,inhibitor
GLRA1,GINKGOLIDE B,GuideToPharmacology,1,blocker
ACRV1,MRI-1867,GuideToPharmacology,1,agonist
ANCR,HS014,GuideToPharmacology,1,agonist
DRD5P1,CH7057288,GuideToPharmacology,1,inhibitor
F7,IDELALISIB,GuideToPharmacology,1,inhibitor
ARVD4,GINKGOLIDE B,GuideToPharmacology,1,blocker
ARVD3,PICROTOXIN,GuideToPharmacology,1,blocker
ENSA,"6-PHENYL[5H]PYRROLO[2,3-B]PYRAZINE",GuideToPharmacology,1,inhibitor
SLC29A1,7-HYDROXYSTAUROSPORINE,GuideToPharmacology,1,inhibitor
ANXA13,GSK256073,GuideToPharmacology,1,agonist
CSHL1,&BETA;-CYANO-L-ALANINE,GuideToPharmacology,1,inhibitor
BDM,FLUTICASONE,GuideToPharmacology,1,agonist
GDF2,CUDC-101,GuideToPharmacology,1,inhibitor
APOC3,CAY10441,GuideToPharmacology,1,inhibitor
GAPDHP1,CUDC-101,GuideToPharmacology,1,inhibitor
ADH1C,PALMIDROL,GuideToPharmacology,1,agonist
ACTN2,UDP-GALACTOSE,GuideToPharmacology,1,agonist
ADARB2,ZN2+,GuideToPharmacology,1,agonist
ACRV1,AM6538,GuideToPharmacology,1,inhibitor
ADCY2,"DERIVATIVE 17 [NAKAHATA ET AL., 2018]",GuideToPharmacology,1,agonist
ADD3,ZQ-16,GuideToPharmacology,1,agonist
A12M2,NARATRIPTAN,GuideToPharmacology,1,agonist
ACHE,SALMON CALCITONIN,GuideToPharmacology,1,agonist
BDKRB2,GENISTEIN,GuideToPharmacology,1,agonist
EPHA8,GNE-4997,GuideToPharmacology,1,inhibitor
ADRA1B,R-SPONDIN-1,GuideToPharmacology,1,agonist
EPHA8,IBRUTINIB,GuideToPharmacology,1,inhibitor
NOS2,2-AMINO-4-METHYLPYRIDINE,GuideToPharmacology,1,inhibitor
NAAA,ARN726,GuideToPharmacology,1,inhibitor
SERPINA3,LP-12,GuideToPharmacology,1,agonist
GAPDH,EPINEPHRINE,GuideToPharmacology,1,activator
GRIN2A,[3H]CGS19755,GuideToPharmacology,1,inhibitor
NUDT2,TIFLUADOM,GuideToPharmacology,1,agonist
FRA13C,COMPOUND 7 [PMID: 31381331],GuideToPharmacology,1,inhibitor
DPH1,PODOFILOX,GuideToPharmacology,1,inhibitor
ALDH1A1,DOMPERIDONE,GuideToPharmacology,1,inhibitor
AMD1P2,JNJ-39758979,GuideToPharmacology,1,inhibitor
GRM6,MPPG,GuideToPharmacology,1,inhibitor
FRA5C,COMPOUND 37 [PMID: 24418773],GuideToPharmacology,1,inhibitor
ATP5BL2,SKF96365,GuideToPharmacology,1,blocker
FRA15A,COMPOUND 7 [PMID: 31381331],GuideToPharmacology,1,inhibitor
IL13RA1,EBLASAKIMAB,GuideToPharmacology,1,antibody
DFNA19,BEMPEGALDESLEUKIN,GuideToPharmacology,1,agonist
APOC3,TAPROSTENE,GuideToPharmacology,1,agonist
BRCA2,LUTEOLIN,GuideToPharmacology,1,agonist
BRAFPS1,ACESULFAME,GuideToPharmacology,1,agonist
BSG,PROPYLTHIOURACIL,GuideToPharmacology,1,agonist
ZFP36L2,CITRONELLAL,GuideToPharmacology,1,inhibitor
ZFP36L2,GIV3727,GuideToPharmacology,1,inhibitor
EPHB1,JAK3 INHIBITOR IV,GuideToPharmacology,1,inhibitor
EPHB1,ZOTIRACICLIB,GuideToPharmacology,1,inhibitor
EPHB2,RG-1530,GuideToPharmacology,1,inhibitor
EPHB2,REPOTRECTINIB,GuideToPharmacology,1,inhibitor
EPHB2,HG-10-102-01,GuideToPharmacology,1,inhibitor
NUDT2,AR-M1000390,GuideToPharmacology,1,agonist
FRA1M,PEPTIDE KLK2B(C1),GuideToPharmacology,1,inhibitor
EPHB3,RUXOLITINIB,GuideToPharmacology,1,inhibitor
FRA1M,HK2P01 DERIVATIVE KLK2 INHIBITOR,GuideToPharmacology,1,inhibitor
CD79A,DIOA,GuideToPharmacology,1,inhibitor
DRD2,PLX-4720,GuideToPharmacology,1,inhibitor
DRD2,SU-14813,GuideToPharmacology,1,inhibitor
AMELY,TAK-448,GuideToPharmacology,1,agonist
DRD2,SU-11652,GuideToPharmacology,1,inhibitor
DPT,BEZUCLASTINIB,GuideToPharmacology,1,inhibitor
DPT,ELENESTINIB,GuideToPharmacology,1,inhibitor
DPT,SU-14813,GuideToPharmacology,1,inhibitor
DPT,RG-1530,GuideToPharmacology,1,inhibitor
ARF5,TAMAPIN,GuideToPharmacology,1,blocker
ARG2,NS309,GuideToPharmacology,1,activator
ASGR1,TENIDAP,GuideToPharmacology,1,activator
ASGR2,H+,GuideToPharmacology,1,inhibitor
ASNSP2,GLYBURIDE,GuideToPharmacology,1,inhibitor
ALDH7A1P2,CLOFILIUM,GuideToPharmacology,1,blocker
CMM,3-CHLOROTYROSINE,GuideToPharmacology,1,inhibitor
ADH1A,COMPOUND 66 [PMID: 36126387],GuideToPharmacology,1,inhibitor
LTB4R,6-FLUOROTRYPTOPHAN,GuideToPharmacology,1,inhibitor
TPH2,FENCLONINE,GuideToPharmacology,1,inhibitor
GPR31,COMPOUND 21B [PMID: 31430136],GuideToPharmacology,1,inhibitor
ETFB,KU-0063794,GuideToPharmacology,1,inhibitor
ETFB,CZ415,GuideToPharmacology,1,inhibitor
HNRNPA2B1,STM2457,GuideToPharmacology,1,inhibitor
DRD4,ELZOVANTINIB,GuideToPharmacology,1,inhibitor
ANPEP,CBIPES,GuideToPharmacology,1,modulator
SLC25A6,GRN-529,GuideToPharmacology,1,modulator
SLC25A6,COMPOUND 16A [PMID: 14697765],GuideToPharmacology,1,modulator
SLC25A6,COMPOUND 29B [PMID: 20809633],GuideToPharmacology,1,modulator
SLC25A6,LSN2814617,GuideToPharmacology,1,modulator
SLC25A6,VU0360172,GuideToPharmacology,1,modulator
SLC25A6,FENOBAM ANHYDROUS,GuideToPharmacology,1,modulator
ANTP2,(+)-MCPG,GuideToPharmacology,1,inhibitor
CTNNA1P1,TANZISERTIB,GuideToPharmacology,1,inhibitor
CTNNB1,PF-03715455,GuideToPharmacology,1,inhibitor
ERPL1,NG-25,GuideToPharmacology,1,inhibitor
MAP3K5,COMPOUND 10 [PMID: 23147077],GuideToPharmacology,1,inhibitor
MAP3K9,APITOLISIB,GuideToPharmacology,1,inhibitor
ERV3-1,NG-25,GuideToPharmacology,1,inhibitor
MAP3K9,COMPOUND 8E [PMID: 24432909],GuideToPharmacology,1,inhibitor
DCR,PRINOMASTAT,GuideToPharmacology,1,inhibitor
DCTN1,ILOMASTAT,GuideToPharmacology,1,inhibitor
DCR,PF-152,GuideToPharmacology,1,inhibitor
CRKL,JZL195,GuideToPharmacology,1,inhibitor
MOGAT2,BMS-963272,GuideToPharmacology,1,inhibitor
CRKL,KML29,GuideToPharmacology,1,inhibitor
ANTP4,MOTILIN-(1-13) (HUMAN),GuideToPharmacology,1,agonist
FSHMD1B,PHENELZINE,GuideToPharmacology,1,inhibitor
ANTP4,CAMICINAL,GuideToPharmacology,1,agonist
FSHMD1A,PHENELZINE,GuideToPharmacology,1,inhibitor
ANTP4,MA-2029,GuideToPharmacology,1,inhibitor
ANTP4,MOTILIN-(1-11) (HUMAN),GuideToPharmacology,1,agonist
AADAC,AMITRIPTYLINE HYDROCHLORIDE,GuideToPharmacology,1,inhibitor
AAMP,IPEROXO,GuideToPharmacology,1,agonist
AAMP,NNC 11-1314,GuideToPharmacology,1,agonist
AADAC,UMECLIDINIUM BROMIDE,GuideToPharmacology,1,inhibitor
AAMP,KT 5823,GuideToPharmacology,1,modulator
AAMP,GALLAMINE TRIETHIODIDE,GuideToPharmacology,1,modulator
AAMP,STAUROSPORINE,GuideToPharmacology,1,modulator
AAMP,MUSCARINIC TOXIN 7,GuideToPharmacology,1,inhibitor
SLC47A1,CIMETIDINE,GuideToPharmacology,1,inhibitor
ANK3,S26284,GuideToPharmacology,1,agonist
APOF,DIPRENORPHINE,GuideToPharmacology,1,inhibitor
APOF,BMS-986123,GuideToPharmacology,1,modulator
APOF,LEVALLORPHAN,GuideToPharmacology,1,inhibitor
APOF,NOR-BINALTORPHIMINE,GuideToPharmacology,1,inhibitor
CD8B,LEVOMILNACIPRAN,GuideToPharmacology,1,inhibitor
DRD5P1,REPOTRECTINIB,GuideToPharmacology,1,inhibitor
DRD5P1,AZD1332,GuideToPharmacology,1,inhibitor
DRD5P2,COMPOUND 8E [PMID: 24432909],GuideToPharmacology,1,inhibitor
DRD5P2,AZD1332,GuideToPharmacology,1,inhibitor
SERPINC1,[3H]&ALPHA;-BUNGAROTOXIN,GuideToPharmacology,1,inhibitor
ATD,[125I]EPIBATIDINE,GuideToPharmacology,1,agonist
ZFHX3,MECAMYLAMINE,GuideToPharmacology,1,blocker
ATD,[125I]EPIBATIDINE,GuideToPharmacology,1,agonist
ATD,VARENICLINE,GuideToPharmacology,1,agonist
CTSO,PHT-427,GuideToPharmacology,1,inhibitor
A1BG,LP-12,GuideToPharmacology,1,agonist
A1BG,KETANSERIN,GuideToPharmacology,1,inhibitor
A2M,5-CT,GuideToPharmacology,1,agonist
A2M,CP-122288,GuideToPharmacology,1,agonist
A2M,NARATRIPTAN,GuideToPharmacology,1,agonist
A2MP1,DIHYDROERGOTAMINE MESYLATE,GuideToPharmacology,1,agonist
A2MP1,CP-122288,GuideToPharmacology,1,agonist
A2MP1,"L-694,247",GuideToPharmacology,1,agonist
A2MP1,ARIPIPRAZOLE LAUROXIL,GuideToPharmacology,1,agonist
A2MP1,SB 277011-A,GuideToPharmacology,1,inhibitor
A12M1,NARATRIPTAN,GuideToPharmacology,1,agonist
A12M3,AC-90179,GuideToPharmacology,1,inhibitor
A12M4,CLOZAPINE,GuideToPharmacology,1,inhibitor
A12M4,FLUOXETINE HYDROCHLORIDE,GuideToPharmacology,1,inhibitor
A12M4,TRAZODONE,GuideToPharmacology,1,inhibitor
NAT1,ML 10375,GuideToPharmacology,1,inhibitor
NAT1,TEGASEROD,GuideToPharmacology,1,agonist
NATP,WAY-181187,GuideToPharmacology,1,agonist
NATP,ILOPERIDONE,GuideToPharmacology,1,inhibitor
CSTF3,BAY1125976,GuideToPharmacology,1,modulator
CSTF3,COMPOUND 1 [PMID: 20005102],GuideToPharmacology,1,inhibitor
CTD,NKY80,GuideToPharmacology,1,inhibitor
CRABP2,KV-37,GuideToPharmacology,1,inhibitor
AFP,PHOSPHATIDYLSERINE,GuideToPharmacology,1,agonist
CSTP1,GSK690693,GuideToPharmacology,1,inhibitor
ABCB7,CLOZAPINE,GuideToPharmacology,1,inhibitor
ABCB7,METHOXAMINE,GuideToPharmacology,1,agonist
ABCB7,PHENYLEPHRINE,GuideToPharmacology,1,agonist
ABCB7,CYPROHEPTADINE HYDROCHLORIDE,GuideToPharmacology,1,inhibitor
ABCB7,RS-100329,GuideToPharmacology,1,inhibitor
ACE2,MLN-4760,GuideToPharmacology,1,inhibitor
KLF5,PCMBS,GuideToPharmacology,1,inhibitor
BTG1,AUPHEN,GuideToPharmacology,1,inhibitor
KLF5,AG+,GuideToPharmacology,1,inhibitor
ACADSB,[125I](PYR1)APELIN-13,GuideToPharmacology,1,agonist
BTD,DIMINAZENE,GuideToPharmacology,1,blocker
BTC,DIMINAZENE,GuideToPharmacology,1,blocker
ABAT,AS99,GuideToPharmacology,1,inhibitor
ABAT,8-CYCLOPENTYLTHEOPHYLLINE,GuideToPharmacology,1,inhibitor
ABAT,NAMODENOSON,GuideToPharmacology,1,agonist
ABAT,ATL802,GuideToPharmacology,1,inhibitor
ABCA1,"UK-432,097",GuideToPharmacology,1,agonist
ABCA1,MRS1084,GuideToPharmacology,1,inhibitor
ABCA1,[3H]ZM 241385,GuideToPharmacology,1,inhibitor
ABCA1,LJ-4517,GuideToPharmacology,1,inhibitor
ABCA2,DAX,GuideToPharmacology,1,inhibitor
ABCA2,DPCPX,GuideToPharmacology,1,inhibitor
ABCA2,I-ABOPX,GuideToPharmacology,1,inhibitor
ABCA2,AS99,GuideToPharmacology,1,inhibitor
ABCA2,THEOPHYLLINE,GuideToPharmacology,1,inhibitor
ABCA2,PSB1115,GuideToPharmacology,1,inhibitor
ABCA3,BW-A1433,GuideToPharmacology,1,inhibitor
ACADM,"L-163,101",GuideToPharmacology,1,agonist
ACADM,ANGIOTENSIN II,GuideToPharmacology,1,agonist
ACADM,TRV026,GuideToPharmacology,1,agonist
EEF1D,VTX-11E,GuideToPharmacology,1,inhibitor
AXL,DUBERMATINIB,GuideToPharmacology,1,inhibitor
EEF1G,TINENGOTINIB,GuideToPharmacology,1,inhibitor
ACAT2,PD 168368,GuideToPharmacology,1,inhibitor
ASIC2,"PHENYLACETYL-ALA,DTRP-PHENTHYLAMIDE",GuideToPharmacology,1,agonist
FMO5,COMPOUND 15 [PMID: 25699151],GuideToPharmacology,1,inhibitor
ABO,ABEDITEROL,GuideToPharmacology,1,agonist
ABO,[3H](-)CGP 12177,GuideToPharmacology,1,agonist
ABO,[3H](-)CGP 12177,GuideToPharmacology,1,inhibitor
ABO,BI-167107,GuideToPharmacology,1,agonist
ABR,LEVOBUNOLOL,GuideToPharmacology,1,inhibitor
ABR,TIMOLOL,GuideToPharmacology,1,inhibitor
GRIA4,COMPOUND 42 [PMID: 26938474],GuideToPharmacology,1,inhibitor
GLUD1P3,ETHOXZOLAMIDE,GuideToPharmacology,1,inhibitor
ADAM3B,COMPOUND 3 [PMID: 14640538],GuideToPharmacology,1,inhibitor
CASP3,Z-DEVD-FMK,GuideToPharmacology,1,inhibitor
ACP5,AC265347,GuideToPharmacology,1,modulator
DBI,Z-VEID-FMK,GuideToPharmacology,1,inhibitor
CTSF,COMPOUND (R)-26 [PMID: 22686657],GuideToPharmacology,1,inhibitor
RHOB,PROGESTERONE,GuideToPharmacology,1,activator
FOLR2L,VBY-825,GuideToPharmacology,1,inhibitor
ACRV1,TM38837,GuideToPharmacology,1,inhibitor
ACRV1,SURINABANT,GuideToPharmacology,1,inhibitor
CNR2,AM1241,GuideToPharmacology,1,agonist
CCKAR,DEXLOXIGLUMIDE,GuideToPharmacology,1,inhibitor
CCKAR,SINCALIDE,GuideToPharmacology,1,agonist
ACTA1,CCX354,GuideToPharmacology,1,inhibitor
ACTA1,CCL13,GuideToPharmacology,1,agonist
CCKBR,NETAZEPIDE,GuideToPharmacology,1,inhibitor
ACTBP2,E913,GuideToPharmacology,1,inhibitor
ACTBP6,COMPOUND 24 [PMID: 26987013 ],GuideToPharmacology,1,inhibitor
ACTBP3,CCL20,GuideToPharmacology,1,agonist
H1-6,NARATUXIMAB EMTANSINE,GuideToPharmacology,1,antibody
GPR39,LULIZUMAB PEGOL,GuideToPharmacology,1,antibody
GATM,OCRELIZUMAB,GuideToPharmacology,1,antibody
GMPR,MK-0159,GuideToPharmacology,1,inhibitor
ZBTB48,PEPTIDE 5A,GuideToPharmacology,1,inhibitor
E2F4,CFZ533,GuideToPharmacology,1,antibody
ELANE,COMPOUND 20 [PMID: 30998356],GuideToPharmacology,1,inhibitor
ACTG1P7,COMPOUND 14F [PMID: 35063894],GuideToPharmacology,1,inhibitor
GUCY1A1,COMPOUND 7F [PMID: 29283260],GuideToPharmacology,1,inhibitor
FRA1C,BIVALIRUDIN,GuideToPharmacology,1,inhibitor
ARHGAP5,L-(CIS)-DILTIAZEM,GuideToPharmacology,1,blocker
FRA1C,AZ12971554,GuideToPharmacology,1,inhibitor
DPYD,QUIZARTINIB,GuideToPharmacology,1,inhibitor
DPYD,TANDUTINIB,GuideToPharmacology,1,inhibitor
FRA1A,OSOCIMAB,GuideToPharmacology,1,antibody
DPYD,IACS-9439,GuideToPharmacology,1,inhibitor
BCL9,CLOTRIMAZOLE,GuideToPharmacology,1,inhibitor
CPT1B,KETOROLAC TROMETHAMINE,GuideToPharmacology,1,inhibitor
CPT1B,NIMESULIDE,GuideToPharmacology,1,inhibitor
CPT1B,ACETAMINOPHEN,GuideToPharmacology,1,inhibitor
CPT2,SUPROFEN,GuideToPharmacology,1,inhibitor
CRYGGP,COMPOUND 57 [PMID: 16610804],GuideToPharmacology,1,inhibitor
ACTG1,CXCL12&DELTA;,GuideToPharmacology,1,agonist
ACTC1,ACT-660602,GuideToPharmacology,1,inhibitor
ACTG1P1,[125I]CXCL16 (HUMAN),GuideToPharmacology,1,agonist
AMHR2,IRALUKAST,GuideToPharmacology,1,inhibitor
CYP4A11,TP0472993,GuideToPharmacology,1,inhibitor
DAPK1,COMPOUND 24DD [PMID: 20684603],GuideToPharmacology,1,inhibitor
FPGS,COMPOUND 24DD [PMID: 20684603],GuideToPharmacology,1,inhibitor
DUSP2,NAPORAFENIB,GuideToPharmacology,1,inhibitor
APOBEC1,15(R)-15-METHYL-PGD2,GuideToPharmacology,1,agonist
ALCAM,BROMOCRIPTINE,GuideToPharmacology,1,agonist
ALCAM,FENOLDOPAM MESYLATE,GuideToPharmacology,1,agonist
ALCAM,CABERGOLINE,GuideToPharmacology,1,agonist
ALCAM,APOMORPHINE,GuideToPharmacology,1,agonist
ALCAM,FENOLDOPAM MESYLATE,GuideToPharmacology,1,agonist
ABCD1,DOPAMINE,GuideToPharmacology,1,agonist
ABCD1,QUINELORANE,GuideToPharmacology,1,agonist
ALCAM,SKF-83566,GuideToPharmacology,1,inhibitor
ABCD1,BROMOCRIPTINE,GuideToPharmacology,1,agonist
ALDH1A1,PRAMIPEXOLE,GuideToPharmacology,1,agonist
ALDH3A1,SKF-38393,GuideToPharmacology,1,agonist
ALDH2,SPIPERONE,GuideToPharmacology,1,inhibitor
ALDH3A1,CLOZAPINE,GuideToPharmacology,1,inhibitor
ALDH3A1,(+)-ADTN,GuideToPharmacology,1,agonist
GPR12,VALEMETOSTAT,GuideToPharmacology,1,inhibitor
DXO,COMPOUND 52 [PMID: 36749735],GuideToPharmacology,1,inhibitor
GTF2IP1,MPPA,GuideToPharmacology,1,inhibitor
GTF2IP1,OXAPROZIN,GuideToPharmacology,1,inhibitor
AQP8,AH23848,GuideToPharmacology,1,inhibitor
EN1,ALLITINIB,GuideToPharmacology,1,inhibitor
ERBB4,TUCATINIB,GuideToPharmacology,1,inhibitor
ESR2,GENISTEIN,GuideToPharmacology,1,agonist
ESR2,WAY200070,GuideToPharmacology,1,agonist
BCYRN1P2,WAY200070,GuideToPharmacology,1,agonist
ESR2,PRINABEREL,GuideToPharmacology,1,agonist
ALDH1B1,[125I]ET-2 (HUMAN),GuideToPharmacology,1,agonist
ALDH1A3,BQ788,GuideToPharmacology,1,inhibitor
ALDH1A3,ATRASENTAN,GuideToPharmacology,1,inhibitor
ALDH1A3,APROCITENTAN,GuideToPharmacology,1,inhibitor
CBLB,DL-TBOA,GuideToPharmacology,1,inhibitor
BMAL1,ZK93426,GuideToPharmacology,1,modulator
BMAL1,L838417,GuideToPharmacology,1,modulator
ARR3,GABOXADOL,GuideToPharmacology,1,agonist
ARRB1,[3H]GABAZINE,GuideToPharmacology,1,inhibitor
ARRB1,ZK93426,GuideToPharmacology,1,modulator
ARSC2,TBPS,GuideToPharmacology,1,blocker
ART1,TBPS,GuideToPharmacology,1,blocker
ARSD,TBPS,GuideToPharmacology,1,blocker
ART2P,TBPS,GuideToPharmacology,1,blocker
ALOX12P1,GAL-B2-MPEG4,GuideToPharmacology,1,agonist
ALOX12P1,M1153,GuideToPharmacology,1,agonist
GALR2,GALANIN(10-29) (PIG),GuideToPharmacology,1,agonist
GALR2,GAL-R2-DPEG24,GuideToPharmacology,1,agonist
CXCR5,COMPOUND 16 [PMID: 18800762],GuideToPharmacology,1,inhibitor
ALOX12P2,SNAP 398299,GuideToPharmacology,1,inhibitor
ALOX15,[125I]TYR-ALA-HEXARELIN,GuideToPharmacology,1,agonist
ALPL,GLUCAGON (RDNA),GuideToPharmacology,1,agonist
ASPH,[3H]CNQX,GuideToPharmacology,1,inhibitor
ATD,NS1738,GuideToPharmacology,1,blocker
AQP3,EZLOPITANT,GuideToPharmacology,1,inhibitor
AQP3,FK-888,GuideToPharmacology,1,inhibitor
GPR36,TAREXTUMAB,GuideToPharmacology,1,antibody
ANXA2P2,NEUROPEPTIDE B-29,GuideToPharmacology,1,agonist
ALPP,TEDUGLUTIDE,GuideToPharmacology,1,agonist
ASS1P5,DOMOIC ACID,GuideToPharmacology,1,agonist
GRIN2A,DIZOCILPINE,GuideToPharmacology,1,blocker
GRIN2A,MG2+,GuideToPharmacology,1,blocker
GRIN2C,[3H]DIZOCILPINE,GuideToPharmacology,1,blocker
GRIN2C,LY233053,GuideToPharmacology,1,inhibitor
ARVD4,NIFEDIPINE,GuideToPharmacology,1,inhibitor
SLC29A1,GSK-3BETA INHIBITOR II,GuideToPharmacology,1,inhibitor
ENSA,SB-415286,GuideToPharmacology,1,inhibitor
GNRHR,"[125I][DES-GLY10,D-ALA6]GNRH N-ETHYLAMIDE",GuideToPharmacology,1,agonist
ANXA13,COMPOUND 2G [PMID: 19309152],GuideToPharmacology,1,agonist
DLX6,GUANYLIN,GuideToPharmacology,1,agonist
GDF2,DACINOSTAT,GuideToPharmacology,1,inhibitor
AMELX,JNJ-39758979,GuideToPharmacology,1,inhibitor
AMELX,JNJ-10191584,GuideToPharmacology,1,inhibitor
ACTL6A,SPHINGOSINE 1-PHOSPHATE,GuideToPharmacology,1,agonist
ANXA2P1,[125I]NPW-23 (HUMAN),GuideToPharmacology,1,agonist
ACTN4,"7&BETA;, 27-DIHYDROXYCHOLESTEROL",GuideToPharmacology,1,agonist
ACTL5,EXAMPLE 31 [WO2018183145],GuideToPharmacology,1,agonist
LGR6,R-SPONDIN-3,GuideToPharmacology,1,agonist
LGR6,R-SPONDIN-2,GuideToPharmacology,1,agonist
ADD3,GLPG1205,GuideToPharmacology,1,inhibitor
ADRA1A,R-SPONDIN-2,GuideToPharmacology,1,agonist
ANXA2P2,[125I]NPW-23 (HUMAN),GuideToPharmacology,1,agonist
GATA3,MYCOPHENOLATE MOFETIL,GuideToPharmacology,1,inhibitor
ANXA1,PANCREATIC POLYPEPTIDE,GuideToPharmacology,1,agonist
CSNK1G2,ROSIPTOR,GuideToPharmacology,1,activator
DPEP1,BMS-536924,GuideToPharmacology,1,inhibitor
DPH2,LINSITINIB,GuideToPharmacology,1,inhibitor
EPHA7,ND-2158,GuideToPharmacology,1,inhibitor
ANXA2,NEUROPEPTIDE S,GuideToPharmacology,1,agonist
IL6R,IL-6,GuideToPharmacology,1,agonist
AEBP1,SPHINGOSINE 1-PHOSPHATE,GuideToPharmacology,1,agonist
ANXA2,[CY5-LYS19]NPS,GuideToPharmacology,1,agonist
BRS3,CHLORAMPHENICOL,GuideToPharmacology,1,agonist
BNIP1,PROCYANIDIN C2,GuideToPharmacology,1,agonist
TAS2R46,BENGALENSOL,GuideToPharmacology,1,agonist
TAS2R46,ABSINTHIN,GuideToPharmacology,1,agonist
ARAF,RETOSIBAN,GuideToPharmacology,1,inhibitor
EPHB1,COMPOUND 5E [PMID: 28580438],GuideToPharmacology,1,inhibitor
EPHB1,ILGINATINIB,GuideToPharmacology,1,inhibitor
EPHB1,FILGOTINIB,GuideToPharmacology,1,inhibitor
EPHB1,PF-06263276,GuideToPharmacology,1,inhibitor
EPHB1,SOLCITINIB,GuideToPharmacology,1,inhibitor
EPHB2,ILGINATINIB,GuideToPharmacology,1,inhibitor
EPHB3,XL019,GuideToPharmacology,1,inhibitor
FRA2D,COMPOUND 5 {PMID: 24900446],GuideToPharmacology,1,inhibitor
NUDT2,NALFURAFINE,GuideToPharmacology,1,agonist
EXT2,COMPOUND 74 [PMID: 24793884],GuideToPharmacology,1,inhibitor
NUDT2,E2078,GuideToPharmacology,1,agonist
NUDT2,JDTIC,GuideToPharmacology,1,inhibitor
HOXD10,LY3522348,GuideToPharmacology,1,inhibitor
NUDT2,ATICAPRANT,GuideToPharmacology,1,inhibitor
CD74,VU0240551,GuideToPharmacology,1,inhibitor
APBA2,TCS 1102,GuideToPharmacology,1,inhibitor
DPT,OSI-930,GuideToPharmacology,1,inhibitor
GPM6B,MRTX1133,GuideToPharmacology,1,inhibitor
DPT,SITRAVATINIB,GuideToPharmacology,1,inhibitor
ARF6,LEIUROTOXIN I,GuideToPharmacology,1,blocker
ARF5,TETRAMETHYLAMMONIUM,GuideToPharmacology,1,blocker
ARF6,LEI-DAB7,GuideToPharmacology,1,blocker
ASGR1,MG2+,GuideToPharmacology,1,blocker
APBB1,DARIDOREXANT,GuideToPharmacology,1,inhibitor
ASCL1,MK-7145,GuideToPharmacology,1,blocker
ASGR2,MG2+,GuideToPharmacology,1,inhibitor
BAAT,ASTEMIZOLE,GuideToPharmacology,1,blocker
BAD,ASTEMIZOLE,GuideToPharmacology,1,blocker
BAD,AZD3778,GuideToPharmacology,1,blocker
EXTL1,STAUROSPORINE,GuideToPharmacology,1,inhibitor
ATP7B,VM24,GuideToPharmacology,1,blocker
ALDH7A1P2,DILTIAZEM HYDROCHLORIDE,GuideToPharmacology,1,blocker
KIF1A,TETRAMETHYLAMMONIUM,GuideToPharmacology,1,blocker
ALDH7A1P2,DRONEDARONE,GuideToPharmacology,1,inhibitor
ALDH7A1P2,FLECAINIDE ACETATE,GuideToPharmacology,1,blocker
ALDH7A1P2,S9947,GuideToPharmacology,1,blocker
EYA1,COMPOUND 4 [PMID: 24432870],GuideToPharmacology,1,inhibitor
ACVRL1,AM966,GuideToPharmacology,1,inhibitor
BIN1,VPC32179,GuideToPharmacology,1,inhibitor
CMKLR1,SAPROPTERIN,GuideToPharmacology,1,activator
ADH1A,COMPOUND 65 [PMID: 36126387],GuideToPharmacology,1,inhibitor
ACVRL1,FARNESYL MONOPHOSPHATE,GuideToPharmacology,1,inhibitor
GLI3,H3-COA-20,GuideToPharmacology,1,inhibitor
PAK4,COMPOUND 4 [PMID: 24432870],GuideToPharmacology,1,inhibitor
GGTL2,ZAVONDEMSTAT,GuideToPharmacology,1,inhibitor
ERVT4,GAMCEMETINIB,GuideToPharmacology,1,inhibitor
AMY2B,7-FLUOROCHROMONE-2-CARBOXAMIDE,GuideToPharmacology,1,inhibitor
DTNA,LDC1267,GuideToPharmacology,1,inhibitor
DRD4,SITRAVATINIB,GuideToPharmacology,1,inhibitor
DRD4,SGX-523,GuideToPharmacology,1,inhibitor
EXTL2,COMPOUND 4 [PMID: 24432870],GuideToPharmacology,1,inhibitor
BLK,DOLICHOL PHOSPHATE,GuideToPharmacology,1,inhibitor
SLC25A4,ISOSPAGLUMIC ACID,GuideToPharmacology,1,agonist
SLC25A6,FENOBAM ANHYDROUS,GuideToPharmacology,1,modulator
SLC25A6,COMPOUND 41 [PMID: 23434029],GuideToPharmacology,1,modulator
SLC25A6,COMPOUND 11A [PMID: 14697765],GuideToPharmacology,1,modulator
SLC25A5,PHCCC,GuideToPharmacology,1,modulator
GRM6,[3H]LY341495,GuideToPharmacology,1,inhibitor
EXTL3,COMPOUND 4 [PMID: 24432870],GuideToPharmacology,1,inhibitor
SLC25A6,MTEP,GuideToPharmacology,1,modulator
ANTP2,MPPG,GuideToPharmacology,1,inhibitor
ESR2,PCC0105003,GuideToPharmacology,1,inhibitor
ESB3,PCC0105003,GuideToPharmacology,1,inhibitor
ESR1,PCC0208017,GuideToPharmacology,1,inhibitor
ATP1B3P1,IVERMECTIN,GuideToPharmacology,1,modulator
CTNNA1,COMPOUND 27 [PMID: 29775310],GuideToPharmacology,1,inhibitor
CTNNA1,LADUVIGLUSIB,GuideToPharmacology,1,inhibitor
NR3C2,PROGESTERONE,GuideToPharmacology,1,inhibitor
CTNNA2,COMPOUND 35 [PMID: 23916259],GuideToPharmacology,1,inhibitor
CTNNB1,TALMAPIMOD,GuideToPharmacology,1,inhibitor
ATP1B3P1,BRILLIANT BLUE G,GuideToPharmacology,1,inhibitor
MAP3K5,COMPOUND 26 [PMID: 31710475],GuideToPharmacology,1,inhibitor
ERCC5,GNE-3511,GuideToPharmacology,1,inhibitor
DCN,MARIMASTAT,GuideToPharmacology,1,inhibitor
ATP1B3P1,CHELERYTHRINE,GuideToPharmacology,1,modulator
ERVK2,COMPOUND 8H [PMID: 22765894],GuideToPharmacology,1,inhibitor
ERV3-1,BAY 61-3606,GuideToPharmacology,1,inhibitor
DCR,AZD6605,GuideToPharmacology,1,inhibitor
ATP1B3P1,AZ11657312 (SALT FREE),GuideToPharmacology,1,inhibitor
DCR,WAY170523,GuideToPharmacology,1,inhibitor
DBT,TANOMASTAT,GuideToPharmacology,1,inhibitor
DCT,TP0556351,GuideToPharmacology,1,inhibitor
DBT,AZD6605,GuideToPharmacology,1,inhibitor
DCC,CGS-27023A,GuideToPharmacology,1,inhibitor
BIRC3,UDP-GLUCURONIC ACID,GuideToPharmacology,1,agonist
CRKL,ABD-1970,GuideToPharmacology,1,inhibitor
ECI1,MARIMASTAT,GuideToPharmacology,1,inhibitor
DCK,CGS-27023A,GuideToPharmacology,1,inhibitor
FSHMD1B,BIFEMELANE,GuideToPharmacology,1,inhibitor
CDC5L,COMPOUND 30 [PMID: 16455256],GuideToPharmacology,1,inhibitor
APEX1,CLOPIDOGREL (ACTIVE METABOLITE),GuideToPharmacology,1,inhibitor
AADAC,[11C]XANOMELINE,GuideToPharmacology,1,agonist
AADAC,[3H]ACETYLCHOLINE,GuideToPharmacology,1,agonist
AADAC,DARIFENACIN,GuideToPharmacology,1,inhibitor
AADAC,DARIFENACIN,GuideToPharmacology,1,inhibitor
AADAC,OXYBUTYNIN,GuideToPharmacology,1,inhibitor
AAMP,CEVIMELINE,GuideToPharmacology,1,agonist
AAMP,[3H]TIOTROPIUM,GuideToPharmacology,1,inhibitor
ANK3,5-METHOXY-LUZINDOLE,GuideToPharmacology,1,agonist
ANK3,UCSF7447,GuideToPharmacology,1,agonist
ANK3,K185,GuideToPharmacology,1,inhibitor
APOF,NALOXONE BENZOYLHYDRAZONE,GuideToPharmacology,1,inhibitor
APOF,BMS-986122,GuideToPharmacology,1,modulator
BIRC3,MRS4183,GuideToPharmacology,1,agonist
APOF,SUFENTANIL,GuideToPharmacology,1,agonist
HLCS,NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 3 LIGAND 1,GuideToPharmacology,1,activator
APEX1,AR-C67085,GuideToPharmacology,1,inhibitor
DLX5,OSTEOCRIN,GuideToPharmacology,1,inhibitor
CD8B,NORZOTEPINE,GuideToPharmacology,1,inhibitor
DRD5P1,PONAZURIL,GuideToPharmacology,1,modulator
DRD5P1,ANIZATRECTINIB,GuideToPharmacology,1,inhibitor
CD8B,[3H]NISOXETINE,GuideToPharmacology,1,inhibitor
DRD5P1,SITRAVATINIB,GuideToPharmacology,1,inhibitor
DRD5P1,GW-2580,GuideToPharmacology,1,inhibitor
DRG2,CH7057288,GuideToPharmacology,1,inhibitor
DRD5P2,EMZELTRECTINIB,GuideToPharmacology,1,inhibitor
APCS,PPADS,GuideToPharmacology,1,inhibitor
ATHS,&ALPHA;-BUNGAROTOXIN,GuideToPharmacology,1,inhibitor
ATD,LY2087101,GuideToPharmacology,1,modulator
APCS,ITP,GuideToPharmacology,1,agonist
AQP4,MEN 10376,GuideToPharmacology,1,inhibitor
APBA1,AC-RYYRIK-NH2,GuideToPharmacology,1,agonist
NMUR2,NM4-C16,GuideToPharmacology,1,agonist
ANXA2,PI1,GuideToPharmacology,1,inhibitor
ANXA2,QA1,GuideToPharmacology,1,inhibitor
APLP2,APAFANT,GuideToPharmacology,1,inhibitor
GPM6A,LONAFARNIB,GuideToPharmacology,1,inhibitor
AMPD2,5S-HETE,GuideToPharmacology,1,agonist
AMPD2,5S-HPETE,GuideToPharmacology,1,agonist
APBB1,CVN45502,GuideToPharmacology,1,inhibitor
APEX1,PCMBS,GuideToPharmacology,1,inhibitor
APC,DIQUAFOSOL,GuideToPharmacology,1,agonist
GALNT2,CETILISTAT,GuideToPharmacology,1,inhibitor
APOD,SCH-79797,GuideToPharmacology,1,inhibitor
APOD,VORAPAXAR,GuideToPharmacology,1,inhibitor
CDK11B,4-AMBA,GuideToPharmacology,1,inhibitor
APOE,AZ3451,GuideToPharmacology,1,modulator
COL12A1,"6-HYDROXY-5,7-DIMETHOXYFLAVONE",GuideToPharmacology,1,inhibitor
COL11A1,NERANDOMILAST,GuideToPharmacology,1,inhibitor
BCKDHA,CHIGLITAZAR,GuideToPharmacology,1,agonist
COL10A1,NERANDOMILAST,GuideToPharmacology,1,inhibitor
F9,AKT INHIBITOR X,GuideToPharmacology,1,inhibitor
F9,LGB321,GuideToPharmacology,1,inhibitor
CHKB,ASPIRIN,GuideToPharmacology,1,inhibitor
DPP4,SERALUTINIB,GuideToPharmacology,1,inhibitor
DPP4,M4205,GuideToPharmacology,1,inhibitor
DPP4,SITRAVATINIB,GuideToPharmacology,1,inhibitor
GLUD1P5,VOCLOSPORIN,GuideToPharmacology,1,inhibitor
DPP6,MK-2461,GuideToPharmacology,1,inhibitor
FABP1,WNY0824,GuideToPharmacology,1,inhibitor
CSE1L,ADP-RIBOSYLATION FACTOR 1,GuideToPharmacology,1,activator
DPP6,NAPORAFENIB,GuideToPharmacology,1,inhibitor
FABP1,COMPOUND 6 [PMID: 30125504],GuideToPharmacology,1,inhibitor
DPP6,SERALUTINIB,GuideToPharmacology,1,inhibitor
FABP1,BI-2536,GuideToPharmacology,1,inhibitor
F7,COMPOUND (S)-29 [PMID: 37606563],GuideToPharmacology,1,inhibitor
GNAI2,DUAL VEGFR/PARP INHIBITOR 14B,GuideToPharmacology,1,inhibitor
GNAI2P1,PAMIPARIB,GuideToPharmacology,1,inhibitor
FABP3,BI-2536,GuideToPharmacology,1,inhibitor
F7,PUQUITINIB,GuideToPharmacology,1,inhibitor
FABP5,OCIFISERTIB,GuideToPharmacology,1,inhibitor
PRMT5,ONAMETOSTAT,GuideToPharmacology,1,inhibitor
COL10A1,PICLAMILAST,GuideToPharmacology,1,inhibitor
PRMT1,C21,GuideToPharmacology,1,inhibitor
FRA6F,OPROZOMIB,GuideToPharmacology,1,inhibitor
CTAG1B,COMPOUND 23 [PMID: 35816678],GuideToPharmacology,1,inhibitor
CTAA1,INGENOL MEBUTATE,GuideToPharmacology,1,activator
MAPK14,DARAPLADIB,GuideToPharmacology,1,inhibitor
CTBS,SOTRASTAURIN,GuideToPharmacology,1,inhibitor
CTAA2,INGENOL MEBUTATE,GuideToPharmacology,1,activator
CTBP2,DAROVASERTIB,GuideToPharmacology,1,inhibitor
GP1BA,CCG-203920,GuideToPharmacology,1,inhibitor
PTK2B,CABOZANTINIB S-MALATE,GuideToPharmacology,1,inhibitor
PTK2B,COMPOUND 1 [PMID: 34917254],GuideToPharmacology,1,inhibitor
APOA1,TRIAZINE COMPOUND PC7,GuideToPharmacology,1,inhibitor
OPN1SW,UVI3003,GuideToPharmacology,1,inhibitor
PTK2B,QUIZARTINIB,GuideToPharmacology,1,inhibitor
PTK2B,TAFETINIB,GuideToPharmacology,1,inhibitor
CTPS1,COMPOUND 22 [PMID: 20462760],GuideToPharmacology,1,inhibitor
FRA5A,WX-UK1,GuideToPharmacology,1,inhibitor
GBA1LP,FLUDARABINE,GuideToPharmacology,1,inhibitor
APRT,EUROPIUM-LABELLED RELAXIN-3-B/INSL5 A CHIMERA,GuideToPharmacology,1,agonist
DPP6,IBCASERTIB,GuideToPharmacology,1,inhibitor
APPL1,RELAXIN-3,GuideToPharmacology,1,agonist
AMT,SPHINGOSINE 1-PHOSPHATE,GuideToPharmacology,1,agonist
CD9,ZIPRASIDONE,GuideToPharmacology,1,inhibitor
SIRT2,COMPOUND 86 [PMID: 26982234],GuideToPharmacology,1,inhibitor
CD5L,FENOPROFEN,GuideToPharmacology,1,inhibitor
DPP4,IBCASERTIB,GuideToPharmacology,1,inhibitor
SIGMAR1,PRE-084,GuideToPharmacology,1,agonist
GJB3,SIRT1 ACTIVATOR 3,GuideToPharmacology,1,activator
SIGMAR1,BD-1047,GuideToPharmacology,1,inhibitor
SIGMAR1,[3H]PENTAZOCINE,GuideToPharmacology,1,agonist
ALOX12,SONIDEGIB,GuideToPharmacology,1,inhibitor
PRLR,CHORIONIC SOMATOMAMMOTROPIN HORMONE-LIKE 1,GuideToPharmacology,1,agonist
GAST,SPHINGOMYELIN SYNTHASE 2 INHIBITOR 15W,GuideToPharmacology,1,inhibitor
FDX1,GSK2646264,GuideToPharmacology,1,inhibitor
FCAR,SLC4101431,GuideToPharmacology,1,inhibitor
FAS,KE 108,GuideToPharmacology,1,agonist
CTAG1B,RUBOXISTAURIN,GuideToPharmacology,1,inhibitor
FAS,SRIF-14,GuideToPharmacology,1,agonist
SHROOM2,BIM 23050,GuideToPharmacology,1,agonist
FASLG,GA-NODAGA-LM3,GuideToPharmacology,1,inhibitor
FASLG,SRIF-14,GuideToPharmacology,1,agonist
AQP1,CORTISTATIN-14,GuideToPharmacology,1,agonist
AQP2,[125I]TYR3 SMS 201-995,GuideToPharmacology,1,agonist
CTAG1B,7-HYDROXYSTAUROSPORINE,GuideToPharmacology,1,inhibitor
HPFH2,BEXMARILIMAB,GuideToPharmacology,1,antibody
CTAG1B,ENZASTAURIN,GuideToPharmacology,1,inhibitor
TEAD4,GNE-7883,GuideToPharmacology,1,inhibitor
FGF12,COMPOUND 20 [PMID: 30998356],GuideToPharmacology,1,inhibitor
CTBS,7-HYDROXYSTAUROSPORINE,GuideToPharmacology,1,inhibitor
ARHGAP1,VERAPAMIL,GuideToPharmacology,1,blocker
APOC4,AH23848,GuideToPharmacology,1,inhibitor
ARHGAP4,TPC2-A1-N,GuideToPharmacology,1,activator
H2AZ1,COMPOUND 11 [PMID: 37449845],GuideToPharmacology,1,inhibitor
CTAA2,ENZASTAURIN,GuideToPharmacology,1,inhibitor
DNMT3A,COMPOUND 15B [PMID: 16539403],GuideToPharmacology,1,inhibitor
ATP2A2,PYR3,GuideToPharmacology,1,blocker
ATP2A2,ACAA,GuideToPharmacology,1,blocker
ATP2B2,GSK2332255B,GuideToPharmacology,1,blocker
GTF3C2,I-C11,GuideToPharmacology,1,inhibitor
ATP4A,MEFENAMIC ACID,GuideToPharmacology,1,blocker
ATP4B,CLOTRIMAZOLE,GuideToPharmacology,1,inhibitor
ATP5F1BP1,[3H]RESINIFERATOXIN,GuideToPharmacology,1,activator
NRG1,I-C11,GuideToPharmacology,1,inhibitor
ATP5F1AP2,SKF96365,GuideToPharmacology,1,blocker
TRPV5,RUTHENIUM RED,GuideToPharmacology,1,blocker
TYK2,JAK INHIBITOR 20A,GuideToPharmacology,1,inhibitor
TYK2,ILGINATINIB,GuideToPharmacology,1,inhibitor
FAP,SZM594,GuideToPharmacology,1,inhibitor
UTS2R,SB-611812,GuideToPharmacology,1,inhibitor
ARCN2,HELODERMIN,GuideToPharmacology,1,agonist
AQP9,DESMOPRESSIN,GuideToPharmacology,1,agonist
AR,"D(CH2)5[D-ILE2,ILE4,ALA-NH29]AVP",GuideToPharmacology,1,inhibitor
AQP9,[3H]D(CH2)5[TYR(ME)2]AVP,GuideToPharmacology,1,inhibitor
AR,OH-LVA,GuideToPharmacology,1,inhibitor
OPN1SW,BEXAROTENE,GuideToPharmacology,1,agonist
ANXA2P3,[125I]PYY (PIG),GuideToPharmacology,1,agonist
ANXA3,[D-TRP32]NPY,GuideToPharmacology,1,agonist
PTK2B,RG-1530,GuideToPharmacology,1,inhibitor
CTPS1,SAR407899,GuideToPharmacology,1,inhibitor
DAGLA,DANTROLENE,GuideToPharmacology,1,inhibitor
KLK3,INSL5 ANALOGUE 13,GuideToPharmacology,1,agonist
RYR2,RYANODINE,GuideToPharmacology,1,activator
RYR2,RYANODINE,GuideToPharmacology,1,blocker
CD9,MILNACIPRAN,GuideToPharmacology,1,inhibitor
GJB3,SPLITOMICIN,GuideToPharmacology,1,inhibitor
CD3D,ENAVOGLIFLOZIN,GuideToPharmacology,1,inhibitor
ALOX12,GLASDEGIB,GuideToPharmacology,1,inhibitor
DPYSL2,MK-2461,GuideToPharmacology,1,inhibitor
ALDH3A1,FENOLDOPAM MESYLATE,GuideToPharmacology,1,agonist
CDH12P2,KETANSERIN,GuideToPharmacology,1,inhibitor
DPYSL3,AZD-4547,GuideToPharmacology,1,inhibitor
ACAT2,(D-ALA11]BOMBESIN,GuideToPharmacology,1,agonist
AAVS1,OXYBUTYNIN,GuideToPharmacology,1,inhibitor
NR3C2,APARARENONE,GuideToPharmacology,1,inhibitor
FZD7,FZ7-21,GuideToPharmacology,1,inhibitor
CA4,CHLORTHALIDONE,GuideToPharmacology,1,inhibitor
RPS6KA6,BI-D1870,GuideToPharmacology,1,inhibitor
A12M3,LY063518,GuideToPharmacology,1,inhibitor
EFNB2,RILZABRUTINIB,GuideToPharmacology,1,inhibitor
ABCC6,SKF-105494,GuideToPharmacology,1,inhibitor
FCAR,COMPOUND 49 [PMID: 30889352],GuideToPharmacology,1,inhibitor
ALDH1B1,AVOSENTAN,GuideToPharmacology,1,inhibitor
DRD3,SITRAVATINIB,GuideToPharmacology,1,inhibitor
GNAI2,PAMIPARIB,GuideToPharmacology,1,inhibitor
CACNA1F,NIFEDIPINE,GuideToPharmacology,1,inhibitor
APOB,CARBACYCLIN,GuideToPharmacology,1,agonist
MS4A2,ELZOVANTINIB,GuideToPharmacology,1,inhibitor
ALPG,NNC1702,GuideToPharmacology,1,agonist
SLC26A2,BMS-777607,GuideToPharmacology,1,inhibitor
ALDOA,TUG-1375,GuideToPharmacology,1,agonist
HTR2C,APOMORPHINE,GuideToPharmacology,1,inhibitor
AMT,A-971432,GuideToPharmacology,1,agonist
ERVT3,BIX02188,GuideToPharmacology,1,inhibitor
NPFFR1,AC262620,GuideToPharmacology,1,inhibitor
ALOX12P1,GALANIN(3-29) (PIG),GuideToPharmacology,1,agonist
BDKRB2,BIOCHANIN A,GuideToPharmacology,1,agonist
SERPINA3,DR-4004,GuideToPharmacology,1,inhibitor
DPT,QUIZARTINIB,GuideToPharmacology,1,inhibitor
ACAT2,"[D-PRO4,D-TRP7,9,10]SUBSTANCE P (4-11)",GuideToPharmacology,1,inhibitor
AMD1,HYDROXYZINE,GuideToPharmacology,1,inhibitor
DOCK3,GALUNISERTIB,GuideToPharmacology,1,inhibitor
SHROOM2,BIM 23052,GuideToPharmacology,1,agonist
ANTP2,DCG-IV,GuideToPharmacology,1,inhibitor
SHROOM2,BIM 23454,GuideToPharmacology,1,inhibitor
SHROOM2,[125I]TYR10-CST14,GuideToPharmacology,1,agonist
AQP1,"L-803,087",GuideToPharmacology,1,agonist
EIF4A1,COMPOUND 9B [PMID: 18986805],GuideToPharmacology,1,inhibitor
DR1,AZD-4547,GuideToPharmacology,1,inhibitor
TLE5,MALEIC ACID,GuideToPharmacology,1,agonist
FRA8A,"INHIBITOR 1 [COLOMBO ET AL., 2012]",GuideToPharmacology,1,inhibitor
A12M3,ZIPRASIDONE,GuideToPharmacology,1,inhibitor
AQP2,[125I]TYR10-CST14,GuideToPharmacology,1,agonist
ABCA2,PSB-0788,GuideToPharmacology,1,inhibitor
ASS1,[3H]CNQX,GuideToPharmacology,1,inhibitor
BIRC2,CANGRELOR,GuideToPharmacology,1,inhibitor
GRIN1,2'3'-CGAMP,GuideToPharmacology,1,agonist
FAH,PLIXORAFENIB,GuideToPharmacology,1,inhibitor
NATP,RO 63-0563,GuideToPharmacology,1,inhibitor
ART4,CIS-3-ACPBPA,GuideToPharmacology,1,inhibitor
AQP2,S5A1,GuideToPharmacology,1,inhibitor
SARDH,COMPOUND 27 [WO2019226977A1],GuideToPharmacology,1,agonist
BAK1P1,RORC2 INVERSE AGONIST 66 [PMID: 30130103],GuideToPharmacology,1,agonist
APOC4,[125I]PTA-OH,GuideToPharmacology,1,inhibitor
DOCK3,H. POLYGYRUS TGF-&BETA; MIMIC,GuideToPharmacology,1,agonist
ATP2B1,RILUZOLE,GuideToPharmacology,1,activator
HNRNPAB,TEMELIMAB,GuideToPharmacology,1,antibody
ATP4A,NA+,GuideToPharmacology,1,blocker
ATP4A,DIHYDROSPHINGOSINE,GuideToPharmacology,1,activator
MCOLN3,MK6-83,GuideToPharmacology,1,activator
AAVS1,METHSCOPOLAMINE,GuideToPharmacology,1,inhibitor
ATP5F1BP1,DIPHENYLBORONIC ANHYDRIDE,GuideToPharmacology,1,activator
ABCF1,NOREPINEPHRINE,GuideToPharmacology,1,agonist
FCAR,COMPOUND 60 [PMID: 30889352],GuideToPharmacology,1,inhibitor
FGFR4,NMS-P715,GuideToPharmacology,1,inhibitor
HOXD13,GPX4 INHIBITOR C18,GuideToPharmacology,1,inhibitor
ANXA6,LARGE NEUROTENSIN,GuideToPharmacology,1,agonist
FGR,COMPOUND 31 [PMID: 24915291],GuideToPharmacology,1,inhibitor
TYK2,ZOTIRACICLIB,GuideToPharmacology,1,inhibitor
FGF1,COMPOUND 30 [PMID: 17280833],GuideToPharmacology,1,inhibitor
TYK2,RUXOLITINIB,GuideToPharmacology,1,inhibitor
CHRM5,VIGABATRIN,GuideToPharmacology,1,inhibitor
BLVRB,COMPOUND 13 [PMID: 19456099],GuideToPharmacology,1,inhibitor
EFNA1,BIIB091,GuideToPharmacology,1,inhibitor
CDH15,AMINOBENZOVESAMICOL,GuideToPharmacology,1,inhibitor
ABCA2,[3H]ZM 241385,GuideToPharmacology,1,inhibitor
EFNA3,MOLIBRESIB,GuideToPharmacology,1,inhibitor
ALDH3A1,FENOLDOPAM MESYLATE,GuideToPharmacology,1,agonist
GRIN2C,[3H]MDL105519,GuideToPharmacology,1,inhibitor
FOXL2,QUININE,GuideToPharmacology,1,agonist
MELK,MELK-TI,GuideToPharmacology,1,inhibitor
AQP7,EPPTB,GuideToPharmacology,1,inhibitor
UTS2R,SR101099,GuideToPharmacology,1,inhibitor
UTS2R,URANTIDE,GuideToPharmacology,1,inhibitor
ACTA1,BP-CCL3,GuideToPharmacology,1,agonist
CDH13,[125I]IODOVINYL-TBZ,GuideToPharmacology,1,inhibitor
KLK3,COMPOUND 20 [PMID: 23692593],GuideToPharmacology,1,inhibitor
ARCN2,"[125I]VIP (HUMAN, MOUSE, RAT)",GuideToPharmacology,1,agonist
DBIL3,Z-LEHD-FMK,GuideToPharmacology,1,inhibitor
AQP9,TOLVAPTAN,GuideToPharmacology,1,inhibitor
DXO,CH7233163,GuideToPharmacology,1,inhibitor
AR,YM 218,GuideToPharmacology,1,inhibitor
ACRV1,LENABASUM,GuideToPharmacology,1,agonist
ADD3,UNDECANOIC ACID,GuideToPharmacology,1,agonist
COL10A1,APREMILAST,GuideToPharmacology,1,inhibitor
ABCC6,"[PHAA1,D-TYR2,VAL4,ARG6,ARG-NH29]AVP",GuideToPharmacology,1,inhibitor
AAK1,COMPOUND 6 [PMID: 34333981],GuideToPharmacology,1,inhibitor
ABO,H87/07,GuideToPharmacology,1,inhibitor
AMD1,TRIPROLIDINE,GuideToPharmacology,1,inhibitor
AANAT,ACECLIDINE,GuideToPharmacology,1,agonist
ABCC6,YM 471,GuideToPharmacology,1,inhibitor
ERCC2,COMPOUND 1K [PMID: 35912476],GuideToPharmacology,1,inhibitor
A1BG,ILOPERIDONE,GuideToPharmacology,1,inhibitor
HTR2C,CLOZAPINE,GuideToPharmacology,1,inhibitor
ASIC1,ICATIBANT,GuideToPharmacology,1,inhibitor
NPBWR1,MS40,GuideToPharmacology,1,inhibitor
ANXA2P3,NEUROPEPTIDE Y,GuideToPharmacology,1,agonist
ANXA3,[125I]PYY-(3-36) (HUMAN),GuideToPharmacology,1,agonist
ALCAM,FENOLDOPAM MESYLATE,GuideToPharmacology,1,agonist
ABCD1,ARIPIPRAZOLE LAUROXIL,GuideToPharmacology,1,agonist
AQP9,"D(CH2)5[TYR(ME)2,ARG8]VP",GuideToPharmacology,1,inhibitor
EFNA2,NAPORAFENIB,GuideToPharmacology,1,inhibitor
GART,COMPOUND 7D [PMID: 19111466],GuideToPharmacology,1,inhibitor
AMD1,ASTEMIZOLE,GuideToPharmacology,1,inhibitor
EZH2,EPZ005687,GuideToPharmacology,1,inhibitor
ERVT4,COMPOUND 8 [PMID: 17480064],GuideToPharmacology,1,inhibitor
ABCA4,EPINEPHRINE,GuideToPharmacology,1,agonist
ATP2B1,TONANTZITLOLONE,GuideToPharmacology,1,activator
DRD2,COMPOUND 8H [PMID: 22765894],GuideToPharmacology,1,inhibitor
DPP6,CP-673451,GuideToPharmacology,1,inhibitor
GALR2,M1145,GuideToPharmacology,1,agonist
EIF4A1,AMINOPURVALANOL A,GuideToPharmacology,1,inhibitor
DAPK3,FASIDOTRILAT,GuideToPharmacology,1,inhibitor
CACNA1H,FLUNARIZINE,GuideToPharmacology,1,blocker
ACTB,CCL13,GuideToPharmacology,1,agonist
ALAS2,DMP696,GuideToPharmacology,1,inhibitor
HOXD@,RP-6685,GuideToPharmacology,1,inhibitor
BCHE,TRETINOIN,GuideToPharmacology,1,agonist
AMT,SAR247799,GuideToPharmacology,1,agonist
H4F3,LONIDAMINE,GuideToPharmacology,1,inhibitor
CTAA1,SOTRASTAURIN,GuideToPharmacology,1,inhibitor
FASLG,NODAGA-[TYR3]-OCTREOTIDE,GuideToPharmacology,1,agonist
ATP1B1P1,ACROLEIN,GuideToPharmacology,1,activator
ABCC6,LVP,GuideToPharmacology,1,agonist
DCT,CGS-27023A,GuideToPharmacology,1,inhibitor
ABL1,ATROPINE,GuideToPharmacology,1,inhibitor
APOBEC1,PGD2,GuideToPharmacology,1,agonist
ABCD1,ROXINDOLE,GuideToPharmacology,1,agonist
ABCD1,ROXINDOLE,GuideToPharmacology,1,inhibitor
ACTB,CXCL9,GuideToPharmacology,1,inhibitor
GABRA1,OCINAPLON,GuideToPharmacology,1,modulator
GDF2,PANOBINOSTAT,GuideToPharmacology,1,inhibitor
SLC25A5,ADX88178,GuideToPharmacology,1,modulator
EIF5AP3,SB 218078,GuideToPharmacology,1,inhibitor
EPHA8,PRN694,GuideToPharmacology,1,inhibitor
GRINA,GELDANAMYCIN,GuideToPharmacology,1,inhibitor
AADAC,GLYCOPYRRONIUM,GuideToPharmacology,1,inhibitor
NUDT2,DIPRENORPHINE,GuideToPharmacology,1,inhibitor
AQP2,BOC-ATE,GuideToPharmacology,1,agonist
ABCB7,PRAZOSIN,GuideToPharmacology,1,inhibitor
BDKRB2,COMPOUND 3 [PMID: 32636746],GuideToPharmacology,1,inhibitor
BCL5,FEXARAMINE,GuideToPharmacology,1,agonist
AMY2B,[3H]SNAP-7941,GuideToPharmacology,1,inhibitor
BBS2,FUNAPIDE,GuideToPharmacology,1,inhibitor
ACTBP9,SB 225002,GuideToPharmacology,1,inhibitor
ARRB2,CGS8216,GuideToPharmacology,1,agonist
GRIN2C,DEXTROMETHORPHAN POLISTIREX,GuideToPharmacology,1,blocker
GNRHR,RELUGOLIX,GuideToPharmacology,1,inhibitor
AQP5,NEUROKININ A,GuideToPharmacology,1,agonist
FAS,CH 275,GuideToPharmacology,1,agonist
A2M,LYSERGOL,GuideToPharmacology,1,agonist
A2M,ZIPRASIDONE,GuideToPharmacology,1,agonist
A2M,BROMOCRIPTINE,GuideToPharmacology,1,agonist
A12M2,5-CT,GuideToPharmacology,1,agonist
A12M2,XANOMELINE,GuideToPharmacology,1,agonist
A12M1,SERTINDOLE,GuideToPharmacology,1,inhibitor
A12M3,CABERGOLINE,GuideToPharmacology,1,agonist
A12M3,5-CT,GuideToPharmacology,1,agonist
A12M3,BLONANSERIN,GuideToPharmacology,1,inhibitor
A12M3,FLUSPIRILENE,GuideToPharmacology,1,inhibitor
A12M3,BROMOCRIPTINE,GuideToPharmacology,1,agonist
A12M3,KETANSERIN,GuideToPharmacology,1,inhibitor
A12M3,XANOMELINE,GuideToPharmacology,1,inhibitor
A12M4,MK-212,GuideToPharmacology,1,agonist
A12M4,APOMORPHINE,GuideToPharmacology,1,inhibitor
NAT2,KETANSERIN,GuideToPharmacology,1,inhibitor
NATP,RO 63-0563,GuideToPharmacology,1,inhibitor
SERPINA3,KETANSERIN,GuideToPharmacology,1,inhibitor
ABL1,COMPOUND 2C [PMID: 24900538],GuideToPharmacology,1,inhibitor
ABL1,PEXMETINIB,GuideToPharmacology,1,inhibitor
CXCL1,WWL123,GuideToPharmacology,1,inhibitor
HBEGF,BRIGATINIB,GuideToPharmacology,1,inhibitor
ABCF1,AH 11110,GuideToPharmacology,1,inhibitor
ABCF1,(+)-ADRENALINE,GuideToPharmacology,1,agonist
ABCF1,CLOZAPINE,GuideToPharmacology,1,inhibitor
ABCF1,TERAZOSIN,GuideToPharmacology,1,inhibitor
ABCF1,EPINEPHRINE,GuideToPharmacology,1,agonist
ABCA4,(+)-ADRENALINE,GuideToPharmacology,1,agonist
ABCA4,KETANSERIN,GuideToPharmacology,1,inhibitor
ABL1,CABERGOLINE,GuideToPharmacology,1,inhibitor
ABL1,SPIROXATRINE,GuideToPharmacology,1,inhibitor
ABL1,EPINEPHRINE,GuideToPharmacology,1,agonist
AOC1,BROMOCRIPTINE,GuideToPharmacology,1,inhibitor
AOC1,SPIROXATRINE,GuideToPharmacology,1,inhibitor
AOC1,CABERGOLINE,GuideToPharmacology,1,inhibitor
ABL2,MIRTAZAPINE,GuideToPharmacology,1,inhibitor
ABL2,BRIMONIDINE,GuideToPharmacology,1,agonist
ABL2,EPINEPHRINE,GuideToPharmacology,1,agonist
ABL2,ARC-239,GuideToPharmacology,1,inhibitor
ABL2,SPIROXATRINE,GuideToPharmacology,1,inhibitor
BEVI,PF-03882845,GuideToPharmacology,1,inhibitor
ABAT,DPCPX,GuideToPharmacology,1,inhibitor
ABCA3,VUF8507,GuideToPharmacology,1,inhibitor
ACADM,TASOSARTAN,GuideToPharmacology,1,inhibitor
CD69,PIRETANIDE,GuideToPharmacology,1,inhibitor
ACAT1,RHODEI-LITORIN,GuideToPharmacology,1,agonist
ACAT1,NEUROMEDIN B (1-30) (HUMAN),GuideToPharmacology,1,agonist
GSTA1,OBRINDATAMAB,GuideToPharmacology,1,antibody
ACAT2,"[D-PHE6,&BETA;-ALA11,PHE13,NLE14]BOMBESIN-(6-14)",GuideToPharmacology,1,agonist
EFNA2,PLIXORAFENIB,GuideToPharmacology,1,inhibitor
EFNA4,CPI-203,GuideToPharmacology,1,inhibitor
BRD3,WNY0824,GuideToPharmacology,1,inhibitor
BRD3,ARV-771,GuideToPharmacology,1,inhibitor
EFNA4,MS436,GuideToPharmacology,1,inhibitor
EFNB2,TAK-020,GuideToPharmacology,1,inhibitor
BDKRB2,[DES-ARG9]BRADYKININ,GuideToPharmacology,1,agonist
CD27,INHIBITOR E4,GuideToPharmacology,1,inhibitor
BDKRB2,[TYR8]BRADYKININ,GuideToPharmacology,1,agonist
ACACB,ACT-1014-6470,GuideToPharmacology,1,inhibitor
ACADL,P59 [PMID: 27108698],GuideToPharmacology,1,agonist
ACACA,WWGKKYRASKLGLAR,GuideToPharmacology,1,agonist
ACACA,JR14A,GuideToPharmacology,1,inhibitor
C1QBP,FLUOXETINE HYDROCHLORIDE,GuideToPharmacology,1,blocker
CYP2C8,MELK-TI,GuideToPharmacology,1,inhibitor
CYP27A1,COMPOUND 3 [PMID: 14640538],GuideToPharmacology,1,inhibitor
CASP3,AC-DEVD-CHO,GuideToPharmacology,1,inhibitor
CACNA1D,NIFEDIPINE,GuideToPharmacology,1,inhibitor
ATP6V1E1,PB2+,GuideToPharmacology,1,blocker
ATP6V0A1,FLUNARIZINE,GuideToPharmacology,1,blocker
RHOC,PROGESTERONE,GuideToPharmacology,1,activator
CTSH,COMPOUND 1E [PMID: 27285276],GuideToPharmacology,1,inhibitor
ACRV1,CANNABINOL,GuideToPharmacology,1,agonist
ACTA1,UCB35625,GuideToPharmacology,1,inhibitor
ACTB,CCL7,GuideToPharmacology,1,agonist
ACTB,CCL11,GuideToPharmacology,1,agonist
ACTA2,BMS-741672,GuideToPharmacology,1,inhibitor
ACTB,AZD3778,GuideToPharmacology,1,inhibitor
CCR4,AZD2098,GuideToPharmacology,1,inhibitor
CPT2,(R)-ARN2508,GuideToPharmacology,1,inhibitor
CPT2,ACETAMINOPHEN,GuideToPharmacology,1,inhibitor
CPT2,SC-560,GuideToPharmacology,1,inhibitor
CPT2,SC-58125,GuideToPharmacology,1,inhibitor
ALB,UROCORTIN 2,GuideToPharmacology,1,agonist
ACTBP9,CXCL7,GuideToPharmacology,1,agonist
ACTC1,CCL11,GuideToPharmacology,1,inhibitor
ACTC1,CCL20,GuideToPharmacology,1,agonist
ACTG1,CXCL12&PHI;,GuideToPharmacology,1,agonist
EIF4A1,BS-181,GuideToPharmacology,1,inhibitor
EIF4EBP1,TIBREMCICLIB,GuideToPharmacology,1,inhibitor
EIF4EBP1,CP-10,GuideToPharmacology,1,inhibitor
CPD,FADROZOLE,GuideToPharmacology,1,inhibitor
APAF1,ADL5859,GuideToPharmacology,1,agonist
APAF1,SNC80,GuideToPharmacology,1,agonist
APAF1,NORMORPHINE,GuideToPharmacology,1,agonist
DHFR,COMPOUND 9 [PMID: 15615544],GuideToPharmacology,1,inhibitor
DHODH,LEFLUNOMIDE,GuideToPharmacology,1,inhibitor
HOXB1,ERVOGASTAT,GuideToPharmacology,1,inhibitor
DHODH,S416,GuideToPharmacology,1,inhibitor
ABCD1,LUMATEPERONE,GuideToPharmacology,1,inhibitor
ALDH1A1,SERTINDOLE,GuideToPharmacology,1,inhibitor
ALDH3A1,BROMOCRIPTINE,GuideToPharmacology,1,agonist
ALDH3A1,DOPAMINE,GuideToPharmacology,1,agonist
EMP1,COMPOUND 20 [PMID: 30998356],GuideToPharmacology,1,inhibitor
FPR2,COMPOUND 10F [PMID: 24556381],GuideToPharmacology,1,inhibitor
GPR12,GSK343,GuideToPharmacology,1,inhibitor
DARS1,KC-12615,GuideToPharmacology,1,inhibitor
DSC1,SITRAVATINIB,GuideToPharmacology,1,inhibitor
EZH2,VALEMETOSTAT,GuideToPharmacology,1,inhibitor
DXO,MOBOCERTINIB,GuideToPharmacology,1,inhibitor
DXO,OLMUTINIB,GuideToPharmacology,1,inhibitor
BCL5,GUGGULSTERONE,GuideToPharmacology,1,inhibitor
BLVRA,IBANDRONATE,GuideToPharmacology,1,inhibitor
ABCD2,GW9508,GuideToPharmacology,1,agonist
DPYSL2,PEXMETINIB,GuideToPharmacology,1,inhibitor
DPYSL3,MK-2461,GuideToPharmacology,1,inhibitor
DPYSL3,TASURGRATINIB,GuideToPharmacology,1,inhibitor
DRD1,CEDIRANIB,GuideToPharmacology,1,inhibitor
GAPDHP67,SIROLIMUS,GuideToPharmacology,1,inhibitor
DRD1,LUCITANIB,GuideToPharmacology,1,inhibitor
SLC29A2,GPI-1046,GuideToPharmacology,1,inhibitor
DRD1,TINENGOTINIB,GuideToPharmacology,1,inhibitor
DPYS,COMPOUND 5E [PMID: 28580438],GuideToPharmacology,1,inhibitor
DPYS,QUIZARTINIB,GuideToPharmacology,1,inhibitor
DPYS,MELK-TI,GuideToPharmacology,1,inhibitor
DPYS,MK-2461,GuideToPharmacology,1,inhibitor
DRD3,CEDIRANIB,GuideToPharmacology,1,inhibitor
ALDH3B2,AG-11/03,GuideToPharmacology,1,agonist
ALDH3B2,T-BOC-FLFLF,GuideToPharmacology,1,inhibitor
APOC2,AS604872,GuideToPharmacology,1,inhibitor
APOC2,AL12180,GuideToPharmacology,1,agonist
ALDH9A1,WKYMVM,GuideToPharmacology,1,agonist
ENO2,PEXMETINIB,GuideToPharmacology,1,inhibitor
FZD4,FZM1,GuideToPharmacology,1,modulator
FZD6,WNT-4,GuideToPharmacology,1,agonist
ARNT,&ALPHA;3IA,GuideToPharmacology,1,modulator
ARNT,GABOXADOL,GuideToPharmacology,1,agonist
GABRA1,[3H]GABAZINE,GuideToPharmacology,1,inhibitor
BMAL1,[3H]CGS8216,GuideToPharmacology,1,modulator
GALR2,M1160,GuideToPharmacology,1,agonist
CXCR5,2-[METHYL-(5-GERANYL-4-METHYL-PENT-3-ENYL)-AMINO]-ETHYL-DIPHOSPHATE,GuideToPharmacology,1,inhibitor
GUCY1A2,LY3463251,GuideToPharmacology,1,agonist
ALPG,MK-0893,GuideToPharmacology,1,modulator
ALPG,GLUCAGON (RDNA),GuideToPharmacology,1,agonist
BDM,DEXAMETHASONE,GuideToPharmacology,1,agonist
GRIK3,[3H]KAINATE,GuideToPharmacology,1,agonist
ASS1P9,[3H]KAINATE,GuideToPharmacology,1,agonist
ASS1P10,HOMOQUINOLINIC ACID,GuideToPharmacology,1,agonist
ASS1P9,SYM2081,GuideToPharmacology,1,agonist
GRIN2C,HOMOQUINOLINIC ACID,GuideToPharmacology,1,agonist
GRIN2B,[3H]DIZOCILPINE,GuideToPharmacology,1,blocker
GRIN2B,NVP-AAM077,GuideToPharmacology,1,inhibitor
CD24P2,ALX 1393,GuideToPharmacology,1,inhibitor
GNRHR,FERTIRELIN,GuideToPharmacology,1,agonist
GNRHR,[TRP8]GNRH,GuideToPharmacology,1,agonist
GNRHR,BAY1214784,GuideToPharmacology,1,inhibitor
ACADVL,DEOXYCHOLIC ACID,GuideToPharmacology,1,agonist
DLX4,C-TYPE NATRIURETIC PEPTIDE,GuideToPharmacology,1,agonist
ALDH3B1,G36,GuideToPharmacology,1,inhibitor
DLX3,A-71915,GuideToPharmacology,1,inhibitor
ACP3,CITRULLINE,GuideToPharmacology,1,agonist
CSF3R,COMPOUND 1 [PMID: 16821802],GuideToPharmacology,1,inhibitor
ANXA11,NIACIN,GuideToPharmacology,1,agonist
AOAH,IBC 293,GuideToPharmacology,1,agonist
HDAC4,BELINOSTAT,GuideToPharmacology,1,inhibitor
GARS1,TRICHOSTATIN A,GuideToPharmacology,1,inhibitor
GARS1,SCRIPTAID,GuideToPharmacology,1,inhibitor
GART,SCRIPTAID,GuideToPharmacology,1,inhibitor
MSTN,SCRIPTAID,GuideToPharmacology,1,inhibitor
GAS2,BELINOSTAT,GuideToPharmacology,1,inhibitor
GAS1,MARBOSTAT-100,GuideToPharmacology,1,inhibitor
GAS2,TRICHOSTATIN A,GuideToPharmacology,1,inhibitor
EEF1G,JNJ-7706621,GuideToPharmacology,1,inhibitor
AMD1,UR-PG153,GuideToPharmacology,1,agonist
AMD1,PITOLISANT,GuideToPharmacology,1,inhibitor
AMD1,A-349821,GuideToPharmacology,1,inhibitor
HRH3,VUF 5207,GuideToPharmacology,1,agonist
HRH3,GSK334429,GuideToPharmacology,1,inhibitor
HRH3,A-349821,GuideToPharmacology,1,inhibitor
PRDM1,COMPOUND 33 [PMID: 17574412],GuideToPharmacology,1,inhibitor
PRDM1,COMPOUND 42 [PMID: 17574411],GuideToPharmacology,1,inhibitor
ADCY3,ABNORMAL CANNABIDIOL,GuideToPharmacology,1,agonist
ADCY8,LORAZEPAM,GuideToPharmacology,1,modulator
DMTN,COMPOUND 47 [PMID: 28737909],GuideToPharmacology,1,inhibitor
DMTN,IKK-BETA INHIBITOR R-28,GuideToPharmacology,1,inhibitor
FASLG,AM3,GuideToPharmacology,1,agonist
APOC3,BAY-73-1449,GuideToPharmacology,1,inhibitor
NUDT2,NALOXONE BENZOYLHYDRAZONE,GuideToPharmacology,1,agonist
DRD2,CEDIRANIB,GuideToPharmacology,1,inhibitor
DRD2,ERDAFITINIB,GuideToPharmacology,1,inhibitor
DRD2,MOTESANIB,GuideToPharmacology,1,inhibitor
AMELY,KISSPEPTIN-14,GuideToPharmacology,1,agonist
GPM6B,OPNURASIB,GuideToPharmacology,1,inhibitor
ARF5,APAMIN,GuideToPharmacology,1,inhibitor
ARG1,P05,GuideToPharmacology,1,blocker
ALDH7A1P4,TETRAMETHYLAMMONIUM,GuideToPharmacology,1,blocker
ALDH7A1P4,VERAPAMIL,GuideToPharmacology,1,blocker
AZF2,XE991,GuideToPharmacology,1,inhibitor
AZF1,MEFENAMIC ACID,GuideToPharmacology,1,activator
CTSV,EXAMPLE 320 [WO2018198077A2],GuideToPharmacology,1,inhibitor
EPHX2,JNJ-28312141,GuideToPharmacology,1,inhibitor
EPHX2,CCT241161,GuideToPharmacology,1,inhibitor
LNPEP,INHIBITOR 19 [PMID: 21476495],GuideToPharmacology,1,inhibitor
BCL3,22R-HYDROXYCHOLESTEROL,GuideToPharmacology,1,agonist
BAK1P2,GSK2033,GuideToPharmacology,1,inhibitor
EGR4,RO3306,GuideToPharmacology,1,inhibitor
GALNT3,COMPOUND 12 [PMID: 31990537],GuideToPharmacology,1,inhibitor
AMPH,AM966,GuideToPharmacology,1,inhibitor
AMPH,UCM-14216,GuideToPharmacology,1,inhibitor
AMPD3,BMS-986020,GuideToPharmacology,1,inhibitor
BIN1,FARNESYL MONOPHOSPHATE,GuideToPharmacology,1,inhibitor
ADH1A,AS2717638,GuideToPharmacology,1,inhibitor
KAT6B,PF-9363,GuideToPharmacology,1,inhibitor
GEM,OG-L002,GuideToPharmacology,1,inhibitor
GDI1,PF-9363,GuideToPharmacology,1,inhibitor
AMY2B,MCH (SALMON),GuideToPharmacology,1,agonist
MELK,CC-401,GuideToPharmacology,1,inhibitor
ERVT4,MK2A INHIBITOR,GuideToPharmacology,1,inhibitor
ANG,CORTICOTROPIN-ZINC HYDROXIDE,GuideToPharmacology,1,agonist
ANG,[125I]ACTH-(1-24),GuideToPharmacology,1,agonist
AMYP1,MCH (SALMON),GuideToPharmacology,1,agonist
ANCR,BREMELANOTIDE,GuideToPharmacology,1,agonist
ANG,COSYNTROPIN,GuideToPharmacology,1,agonist
ANGPT1,BREMELANOTIDE,GuideToPharmacology,1,agonist
ANK1,SETMELANOTIDE,GuideToPharmacology,1,agonist
ANGPT1,PG-901,GuideToPharmacology,1,inhibitor
ANGPT2,SETMELANOTIDE,GuideToPharmacology,1,agonist
ANGPT2,MBP10,GuideToPharmacology,1,inhibitor
ANGPT1,&ALPHA;-MSH,GuideToPharmacology,1,agonist
ANPEP,MNI-137,GuideToPharmacology,1,modulator
SLC25A4,"(1S,3R)-ACPD",GuideToPharmacology,1,agonist
NR2F6,MS432,GuideToPharmacology,1,inhibitor
AADAC,CEVIMELINE,GuideToPharmacology,1,agonist
PTGES,ZALOGLANSTAT,GuideToPharmacology,1,inhibitor
AADAC,BETHANECHOL,GuideToPharmacology,1,agonist
AADAC,BRUCINE,GuideToPharmacology,1,modulator
AAMP,IMIPRAMINE HYDROCHLORIDE,GuideToPharmacology,1,inhibitor
AANAT,[3H]ACETYLCHOLINE,GuideToPharmacology,1,agonist
AAMP,METHSCOPOLAMINE,GuideToPharmacology,1,inhibitor
AANAT,CLIDINIUM,GuideToPharmacology,1,inhibitor
AANAT,P-F-HHSID,GuideToPharmacology,1,inhibitor
AARS1,ACECLIDINE,GuideToPharmacology,1,agonist
AANAT,[3H]QNB,GuideToPharmacology,1,inhibitor
AARS1,DARIFENACIN,GuideToPharmacology,1,inhibitor
AARS1,XANOMELINE,GuideToPharmacology,1,agonist
AARS1,"WIN 51,708",GuideToPharmacology,1,modulator
AARS1,BRUCINE,GuideToPharmacology,1,modulator
AARS1,SABCOMELINE,GuideToPharmacology,1,agonist
AAVS1,DARIFENACIN,GuideToPharmacology,1,inhibitor
AAVS1,BRUCINE,GuideToPharmacology,1,modulator
ANK2,MELATONIN,GuideToPharmacology,1,agonist
AAVS1,VU0255035,GuideToPharmacology,1,inhibitor
ABR,[3H]DIHYDROALPRENOLOL,GuideToPharmacology,1,inhibitor
ANK2,GR 196429,GuideToPharmacology,1,agonist
ANK2,S26131,GuideToPharmacology,1,inhibitor
APOF,DADLE,GuideToPharmacology,1,agonist
APOF,SRI22141,GuideToPharmacology,1,agonist
CTAG1B,G&OUML; 6983,GuideToPharmacology,1,inhibitor
GAS8-AS1,VERAPAMIL,GuideToPharmacology,1,blocker
CYP2A13,GSK2606414,GuideToPharmacology,1,inhibitor
BBS1,JINGZHAOTOXIN-III,GuideToPharmacology,1,inhibitor
BBS1,ELECLAZINE,GuideToPharmacology,1,inhibitor
BAX,BC-III,GuideToPharmacology,1,inhibitor
FGD1,XMD8-92,GuideToPharmacology,1,inhibitor
ATF3,"&ALPHA;-CONOTOXIN MII [H9A, L15A]",GuideToPharmacology,1,inhibitor
ATF4,&ALPHA;-BUNGAROTOXIN,GuideToPharmacology,1,inhibitor
AQP3,CASOPITANT,GuideToPharmacology,1,inhibitor
AQP3,FOSAPREPITANT,GuideToPharmacology,1,inhibitor
MECOM,COMPOUND 22 [PMID: 20462760],GuideToPharmacology,1,inhibitor
AQP5,SENKTIDE,GuideToPharmacology,1,agonist
AQP5,GR138676,GuideToPharmacology,1,inhibitor
AQP5,SCH 206272,GuideToPharmacology,1,inhibitor
NMUR2,NEUROMEDIN U-8,GuideToPharmacology,1,agonist
APBA1,NOCICEPTIN/ORPHANIN FQ,GuideToPharmacology,1,agonist
NMUR2,NY0116,GuideToPharmacology,1,agonist
ANXA2,NEUROPEPTIDE S,GuideToPharmacology,1,agonist
ANXA6,NEUROTENSIN,GuideToPharmacology,1,agonist
DNA2,MURAMYL DIPEPTIDE,GuideToPharmacology,1,agonist
BIRC3,MRS4625,GuideToPharmacology,1,inhibitor
APBB2,"2,2'-PYRIDYLISATOGEN TOSYLATE",GuideToPharmacology,1,modulator
AIRE,MRS2578,GuideToPharmacology,1,inhibitor
AIRE,SURAMIN,GuideToPharmacology,1,inhibitor
APOH,P4PAL-10,GuideToPharmacology,1,inhibitor
APOH,BMS-986120,GuideToPharmacology,1,inhibitor
APOE,SLIGKV-NH2,GuideToPharmacology,1,agonist
EYA2,PP-242,GuideToPharmacology,1,inhibitor
CCND1,MRL20,GuideToPharmacology,1,agonist
CCND1,TIROTUNDIN,GuideToPharmacology,1,agonist
CCND1,BARDOXOLONE,GuideToPharmacology,1,agonist
F5,PIK-108,GuideToPharmacology,1,modulator
F3,TORIN 2,GuideToPharmacology,1,inhibitor
F5,COMPOUND 11J [PMID: 23021994],GuideToPharmacology,1,inhibitor
F5,PANULISIB,GuideToPharmacology,1,inhibitor
F5,QUINOSTATIN,GuideToPharmacology,1,inhibitor
F5,DEZAPELISIB,GuideToPharmacology,1,inhibitor
PIK3CB,EGANELISIB,GuideToPharmacology,1,inhibitor
PIK3CB,PIK-108,GuideToPharmacology,1,modulator
PIK3CB,AZD8835,GuideToPharmacology,1,inhibitor
PIK3CB,COMPOUND 27 [PMID: 35834807],GuideToPharmacology,1,inhibitor
F7,AZD8835,GuideToPharmacology,1,inhibitor
F7,SELETALISIB,GuideToPharmacology,1,inhibitor
COL9A3,CYCLIC GMP,GuideToPharmacology,1,inhibitor
COMT,COMPOUND 53 [PMID: 19631533],GuideToPharmacology,1,inhibitor
FRA3D,PEPTIDE 18 [PMID: 24350995],GuideToPharmacology,1,inhibitor
SLC36A2,5-HYDROXYTRYPTOPHAN,GuideToPharmacology,1,inhibitor
XIAP,PTH-(1-34) (RAT),GuideToPharmacology,1,agonist
BIRC5,TIP39,GuideToPharmacology,1,agonist
BCL2L1,CHOLESTEROL,GuideToPharmacology,1,agonist
FANCG,ECLITASERTIB,GuideToPharmacology,1,inhibitor
CTRB1,COMPOUND 23 [PMID: 35816678],GuideToPharmacology,1,inhibitor
CTRB1,COMPOUND 35 [PMID: 20684608],GuideToPharmacology,1,inhibitor
CYB5A,BI-D1870,GuideToPharmacology,1,inhibitor
NIPSNAP2,FLUDARABINE,GuideToPharmacology,1,inhibitor
PTPRM,COMPOUND 8A [PMID: 23713581],GuideToPharmacology,1,inhibitor
APP,RELAXIN-3,GuideToPharmacology,1,agonist
APRT,RELAXIN-3,GuideToPharmacology,1,agonist
AMT,FINGOLIMOD-PHOSPHATE,GuideToPharmacology,1,agonist
RYR2,RUTHENIUM RED,GuideToPharmacology,1,blocker
AMY1A,FINGOLIMOD-PHOSPHATE,GuideToPharmacology,1,agonist
AMY1A,S1P D20:1,GuideToPharmacology,1,agonist
AMY2A,AFD(R),GuideToPharmacology,1,agonist
AMY1A,SPHINGOSINE 1-PHOSPHATE,GuideToPharmacology,1,agonist
AMY1C,AFD(R),GuideToPharmacology,1,agonist
AMY1C,SPHINGOSINE 1-PHOSPHATE,GuideToPharmacology,1,agonist
AMY1C,ASP4058,GuideToPharmacology,1,agonist
SCTR,"[(CH2NH)4,5]SECRETIN",GuideToPharmacology,1,inhibitor
FCGR2B,COMPOUND 6 [PMID: 34333981],GuideToPharmacology,1,inhibitor
STK4,XMU-MP-1,GuideToPharmacology,1,inhibitor
CD9,VENLAFAXINE,GuideToPharmacology,1,inhibitor
CD9,IMIPRAMINE HYDROCHLORIDE,GuideToPharmacology,1,inhibitor
CD9,LUMATEPERONE,GuideToPharmacology,1,inhibitor
FUSE,LX2931,GuideToPharmacology,1,inhibitor
SLC28A2,COMPOUND 48 [PMID: 25815140],GuideToPharmacology,1,inhibitor
FCAR,COMPOUND 27D [PMID: 28231433],GuideToPharmacology,1,inhibitor
BLVRB,COMPOUND 3A [PMID: 12238936],GuideToPharmacology,1,inhibitor
HBG2,SLB1122168,GuideToPharmacology,1,inhibitor
FASLG,BIM 23056,GuideToPharmacology,1,agonist
FASLG,CORTISTATIN-14,GuideToPharmacology,1,agonist
AQP1,KE 108,GuideToPharmacology,1,agonist
AQP1,"H-C[CYS-PHE-LAGL(N&BETA;ME,BENZOYL)-DTRP-LYS-THR-PHE-CYS]-OH",GuideToPharmacology,1,agonist
AQP2,SRIF-14,GuideToPharmacology,1,agonist
GBP1,FINASTERIDE,GuideToPharmacology,1,inhibitor
HLA-DMA,"COMPOUND 5 [TOMASSI ET AL., 2020]",GuideToPharmacology,1,inhibitor
GK4P,EXAMPLE 203 [WO2017058503A1],GuideToPharmacology,1,inhibitor
TLE5,COMPOUND 130 [PMID: 29157600],GuideToPharmacology,1,agonist
GPC4,COMPOUND 30 [PMID: 22902653],GuideToPharmacology,1,inhibitor
FGF13,COMPOUND 2C [PMID: 24900538],GuideToPharmacology,1,inhibitor
DNM1,HYDROXYCHLOROQUINE,GuideToPharmacology,1,inhibitor
TLR4,NEOCEPTIN-3,GuideToPharmacology,1,agonist
THRB,LEVOTHYROXINE,GuideToPharmacology,1,agonist
DNMT3A,GALUNISERTIB,GuideToPharmacology,1,inhibitor
FRA8E,PEPTIDE 4 [PMID: 18294843],GuideToPharmacology,1,inhibitor
ATP1B1P1,THYMOL,GuideToPharmacology,1,activator
ATP2A3,SKF96365,GuideToPharmacology,1,blocker
ATP2B1,PB2+,GuideToPharmacology,1,activator
ATP2B1,AM12,GuideToPharmacology,1,blocker
ATP2B1,ROSIGLITAZONE,GuideToPharmacology,1,activator
ATP2B1,PROGESTERONE,GuideToPharmacology,1,blocker
ATP2B2,AM-0883,GuideToPharmacology,1,activator
ATP2B1,GENISTEIN,GuideToPharmacology,1,activator
ALDH7A1,SF-51,GuideToPharmacology,1,activator
ALDH7A1,ML1-SA1,GuideToPharmacology,1,activator
TRPM8,LINOLEIC ACID,GuideToPharmacology,1,blocker
TRPM8,KPR-5714,GuideToPharmacology,1,inhibitor
ATP5F1A,RUTHENIUM RED,GuideToPharmacology,1,blocker
FGFR4,COMPOUND 20 [PMID: 30998356],GuideToPharmacology,1,inhibitor
FH,SBI-0206965,GuideToPharmacology,1,inhibitor
AQP9,"D(CH2)5[TYR(ME)2,THR4,TYR(3125I)-NH29]OVT",GuideToPharmacology,1,inhibitor
ANXA4,[125I]PYY (PIG),GuideToPharmacology,1,agonist
BMAL1,&ALPHA;3IA,GuideToPharmacology,1,modulator
ANXA6,LARGE NEUROMEDIN N,GuideToPharmacology,1,agonist
APBA1,PWT2-N/OFQ,GuideToPharmacology,1,agonist
F7R,AZD7648,GuideToPharmacology,1,inhibitor
F5,"5-QUINOXALIN-6-YLMETHYLENE-THIAZOLIDINE-2,4-DIONE",GuideToPharmacology,1,inhibitor
FASLG,"[111IN,90Y]DOTA-TOC",GuideToPharmacology,1,agonist
CXCR5,BPH-608,GuideToPharmacology,1,inhibitor
APOF,BNTX,GuideToPharmacology,1,inhibitor
FGR,RIPK3 INHIBITOR 18,GuideToPharmacology,1,inhibitor
APBB1,ALMOREXANT,GuideToPharmacology,1,inhibitor
ANOP1,COMPOUND 23C [PMID: 17929793],GuideToPharmacology,1,modulator
ATP2B2,DS88790512,GuideToPharmacology,1,blocker
ACTG1P8,PLERIXAFOR,GuideToPharmacology,1,agonist
COL12A1,ROLIPRAM,GuideToPharmacology,1,inhibitor
EIF4EBP1,ABEMACICLIB,GuideToPharmacology,1,inhibitor
GDF2,RESMINOSTAT,GuideToPharmacology,1,inhibitor
LATS2,GSK690693,GuideToPharmacology,1,inhibitor
ZFHX3,[3H]CYTISINE,GuideToPharmacology,1,agonist
AQP4,GR94800,GuideToPharmacology,1,inhibitor
DPYS,CERITINIB,GuideToPharmacology,1,inhibitor
ATP5F1BP1,ANANDAMIDE,GuideToPharmacology,1,activator
LTC4S,AZD9898,GuideToPharmacology,1,inhibitor
EML1,COMPOUND 72 [WO2013026806],GuideToPharmacology,1,inhibitor
AMH,12-EPI LTB4,GuideToPharmacology,1,agonist
KCNQ5,LINOPIRDINE,GuideToPharmacology,1,inhibitor
ATP1B1,&ALPHA;&BETA;-MEATP,GuideToPharmacology,1,agonist
FAS,BIM 23050,GuideToPharmacology,1,agonist
ARRB1,FLUMAZENIL,GuideToPharmacology,1,modulator
AMD1,AZD3778,GuideToPharmacology,1,inhibitor
GLRA1,NIFEDIPINE,GuideToPharmacology,1,inhibitor
GNRHR,NAFARELIN,GuideToPharmacology,1,agonist
PDE5A,TADALAFIL,GuideToPharmacology,1,inhibitor
COL11A1,CRISABOROLE,GuideToPharmacology,1,inhibitor
HIVEP1,SOS1 PROTAC 9D,GuideToPharmacology,1,agonist
ABCF1,CYPROHEPTADINE HYDROCHLORIDE,GuideToPharmacology,1,inhibitor
F5,COMPOUND 5D [PMID: 31335136],GuideToPharmacology,1,inhibitor
DAPK3,ENALAPRIL MALEATE,GuideToPharmacology,1,inhibitor
ACRV1,AM841,GuideToPharmacology,1,agonist
EPHA7,ND-2110,GuideToPharmacology,1,inhibitor
BLVRB,COMPOUND 6 [PMID: 7629799],GuideToPharmacology,1,inhibitor
ABCD1,ZIPRASIDONE,GuideToPharmacology,1,inhibitor
DPYS,FLT-3 INHIBITOR II,GuideToPharmacology,1,inhibitor
CRMP1,(R)-ARN2508,GuideToPharmacology,1,inhibitor
EPHB2,DEURUXOLITINIB,GuideToPharmacology,1,inhibitor
ABCA1,CIFORADENANT,GuideToPharmacology,1,inhibitor
EIF5AP3,AZD7762,GuideToPharmacology,1,inhibitor
ACTA2,BMS-753426,GuideToPharmacology,1,inhibitor
BCYRN1P2,"R,R-THC",GuideToPharmacology,1,agonist
GRIN2A,HOMOQUINOLINIC ACID,GuideToPharmacology,1,agonist
ADAM10,CXCL17,GuideToPharmacology,1,agonist
ABCC6,"D(CH2)5[D-ILE2,VAL4,TYR-NH29]AVP",GuideToPharmacology,1,inhibitor
ARRB1,GABOXADOL,GuideToPharmacology,1,agonist
DCT,COMPOUND 29E [PMID: 23631440],GuideToPharmacology,1,inhibitor
FAH,OSI-930,GuideToPharmacology,1,inhibitor
ABCA1,[3H]CGS 21680,GuideToPharmacology,1,agonist
CHUK,BAY 61-3606,GuideToPharmacology,1,inhibitor
ALAS2,ASTRESSIN,GuideToPharmacology,1,inhibitor
EFNA4,BMS-986158,GuideToPharmacology,1,inhibitor
AADAC,DOTHIEPIN,GuideToPharmacology,1,inhibitor
GAPDH,SULPIRIDE,GuideToPharmacology,1,inhibitor
CTSF,VBY-825,GuideToPharmacology,1,inhibitor
SLC29A1,GSK2646264,GuideToPharmacology,1,inhibitor
GPM6B,LONAFARNIB,GuideToPharmacology,1,inhibitor
A2MP1,NARATRIPTAN,GuideToPharmacology,1,agonist
ARRB1,L838417,GuideToPharmacology,1,modulator
PTGES,VIPOGLANSTAT,GuideToPharmacology,1,inhibitor
GBE1,TINZAPARIN SODIUM,GuideToPharmacology,1,activator
MKNK2,MELK-TI,GuideToPharmacology,1,inhibitor
ASPH,NBQX,GuideToPharmacology,1,inhibitor
EPHB3,PF-06263276,GuideToPharmacology,1,inhibitor
SLC26A3,AZD-4547,GuideToPharmacology,1,inhibitor
AADAC,METHSCOPOLAMINE,GuideToPharmacology,1,inhibitor
FMO5,EXAMPLE 2 [WO2013004676],GuideToPharmacology,1,inhibitor
EFNB2,CINSEBRUTINIB,GuideToPharmacology,1,inhibitor
ALPL,GLUCAGON-LIKE PEPTIDE 1-(7-36) AMIDE,GuideToPharmacology,1,agonist
ADRA1B,R-SPONDIN-3,GuideToPharmacology,1,agonist
ABCA4,UPIDOSIN,GuideToPharmacology,1,inhibitor
AOC1,EPINEPHRINE,GuideToPharmacology,1,agonist
C1QBP,9-ANTHROIC ACID,GuideToPharmacology,1,blocker
ALOX12P1,M1145,GuideToPharmacology,1,agonist
ATP1A4,SURAMIN,GuideToPharmacology,1,inhibitor
APOBEC1,&DELTA;12-PGJ2,GuideToPharmacology,1,agonist
ASS1P10,"SERINE, D-",GuideToPharmacology,1,agonist
ASIP,AZD2927,GuideToPharmacology,1,blocker
A1BG,S-14671,GuideToPharmacology,1,agonist
DAGLA,RUTHENIUM RED,GuideToPharmacology,1,blocker
CAPN1,GC-376,GuideToPharmacology,1,inhibitor
ACTBP9,[125I]CXCL7 (HUMAN),GuideToPharmacology,1,agonist
BCL5,BMS-986318,GuideToPharmacology,1,agonist
GAS1,DACINOSTAT,GuideToPharmacology,1,inhibitor
APOF,NORMORPHINE,GuideToPharmacology,1,agonist
PIK3CB,SELETALISIB,GuideToPharmacology,1,inhibitor
ATP3,ECONAZOLE NITRATE,GuideToPharmacology,1,blocker
ABCC6,MOZAVAPTAN,GuideToPharmacology,1,inhibitor
FASLG,EC 5-21,GuideToPharmacology,1,agonist
C8A,CARBENOXOLONE,GuideToPharmacology,1,inhibitor
DPYSL2,COMPOUND 29 [PMID: 36356320],GuideToPharmacology,1,inhibitor
ABCA1,CCPA,GuideToPharmacology,1,agonist
DPYS,COMPOUND 8H [PMID: 22765894],GuideToPharmacology,1,inhibitor
A1BG,CABERGOLINE,GuideToPharmacology,1,agonist
ALDOA,GLPG0974,GuideToPharmacology,1,inhibitor
ARVCF,GABOXADOL,GuideToPharmacology,1,inhibitor
ATP1A4,SIVOPIXANT,GuideToPharmacology,1,inhibitor
APOC4,CLOPROSTENOL,GuideToPharmacology,1,agonist
ATP2B1,LYSOPHOSPHATIDYLCHOLINE,GuideToPharmacology,1,activator
APAF1,DSTBULET,GuideToPharmacology,1,agonist
BTS1,9-ANTHROIC ACID,GuideToPharmacology,1,blocker
PAK4,GSK690693,GuideToPharmacology,1,inhibitor
ACP5,COMPOUND (S)-3H [PMID: 15686947],GuideToPharmacology,1,inhibitor
ANGPT1,HS014,GuideToPharmacology,1,inhibitor
ABAT,APADENOSON,GuideToPharmacology,1,agonist
CD9,FLUVOXAMINE,GuideToPharmacology,1,inhibitor
ALDH2,[3H]NGD941,GuideToPharmacology,1,inhibitor
CNR2,TM38837,GuideToPharmacology,1,inhibitor
BBS4,SUZETRIGINE,GuideToPharmacology,1,inhibitor
F7,COMPOUND 5D [PMID: 31335136],GuideToPharmacology,1,inhibitor
XCR1,TRYPTANTHRIN 5I,GuideToPharmacology,1,inhibitor
F7,TG-100-115,GuideToPharmacology,1,inhibitor
F7,COPANLISIB,GuideToPharmacology,1,inhibitor
GRM6,NEXINHIB20,GuideToPharmacology,1,inhibitor
APOA1,IS1,GuideToPharmacology,1,agonist
GLRA1,ANANDAMIDE,GuideToPharmacology,1,modulator
LATS2,AST-487,GuideToPharmacology,1,inhibitor
KLK3,RELAXIN-3,GuideToPharmacology,1,agonist
APOC4,NTP42,GuideToPharmacology,1,inhibitor
ABCD1,DOMPERIDONE,GuideToPharmacology,1,inhibitor
ANTP4,"[L-BPA5,ILE13]MOTILIN (HUMAN)",GuideToPharmacology,1,agonist
ABCA4,RS-100329,GuideToPharmacology,1,inhibitor
DLX6,DOLCANATIDE,GuideToPharmacology,1,agonist
HRH3,PF-03654746,GuideToPharmacology,1,inhibitor
AZGP1,(S)-N-[1-(3-MORPHOLIN-4-YL-PHENYL)-ETHYL]-3-PHENYL-ACRYLAMIDE,GuideToPharmacology,1,activator
ANXA2P1,DES-BR-NEUROPEPTIDE B-29,GuideToPharmacology,1,agonist
AANAT,[3H]4-DAMP,GuideToPharmacology,1,inhibitor
ATP3,NAADP,GuideToPharmacology,1,activator
ALDH1A1,TERGURIDE,GuideToPharmacology,1,agonist
TRPV5,TETRAHYDROCANNABIVARIN,GuideToPharmacology,1,inhibitor
HTR2C,THIORIDAZINE,GuideToPharmacology,1,inhibitor
CD40LG,URSODIOL,GuideToPharmacology,1,inhibitor
ATP5BL2,CANNABIDIOL,GuideToPharmacology,1,activator
AARS1,VU0010010,GuideToPharmacology,1,modulator
ATP5F1BP1,MRS-1477,GuideToPharmacology,1,modulator
CNTFR,METHYLDOPA ANHYDROUS,GuideToPharmacology,1,inhibitor
NATP,AMITRIPTYLINE HYDROCHLORIDE,GuideToPharmacology,1,inhibitor
FASLG,BIM 23454,GuideToPharmacology,1,inhibitor
DRD1,K-00546,GuideToPharmacology,1,inhibitor
EPHB3,GANDOTINIB,GuideToPharmacology,1,inhibitor
CTSV,SUNITINIB,GuideToPharmacology,1,inhibitor
CRKL,JZL184,GuideToPharmacology,1,inhibitor
ARAF,COMPOUND 37 [PMID: 16250654],GuideToPharmacology,1,inhibitor
APRT,R3(B&DELTA;23-27)R/I5 CHIMERIC PEPTIDE,GuideToPharmacology,1,agonist
APRT,R3(B&DELTA;23-27)R/I5 CHIMERIC PEPTIDE,GuideToPharmacology,1,inhibitor
ABCA1,PENECA,GuideToPharmacology,1,agonist
F5,PICTILISIB,GuideToPharmacology,1,inhibitor
ARRB1,FLUNITRAZEPAM,GuideToPharmacology,1,modulator
AMELX,(R)-&ALPHA;-METHYLHISTAMINE,GuideToPharmacology,1,agonist
ATP5F1C,KS0365,GuideToPharmacology,1,activator
ANXA2P3,BIBP3226,GuideToPharmacology,1,inhibitor
ADH5,NOX-6-18,GuideToPharmacology,1,inhibitor
DPP4,VIMSELTINIB,GuideToPharmacology,1,inhibitor
A1BG,LP-44,GuideToPharmacology,1,agonist
A1BG,XANOMELINE,GuideToPharmacology,1,agonist
A1BG,APOMORPHINE,GuideToPharmacology,1,agonist
A2M,"L-694,247",GuideToPharmacology,1,agonist
A2MP1,CABERGOLINE,GuideToPharmacology,1,agonist
A2MP1,(+)-WAY 100135,GuideToPharmacology,1,inhibitor
A12M1,XANOMELINE,GuideToPharmacology,1,agonist
A12M1,LYSERGOL,GuideToPharmacology,1,agonist
A12M3,MOLINDONE,GuideToPharmacology,1,inhibitor
A12M3,[11C]GSK215083,GuideToPharmacology,1,inhibitor
A12M3,SB 228357,GuideToPharmacology,1,inhibitor
A12M3,SERTINDOLE,GuideToPharmacology,1,inhibitor
A12M4,SPIROXATRINE,GuideToPharmacology,1,inhibitor
A12M4,XANOMELINE,GuideToPharmacology,1,inhibitor
HTR2C,XANOMELINE,GuideToPharmacology,1,inhibitor
NAT2,CLOZAPINE,GuideToPharmacology,1,inhibitor
NAT1,[11C]SB207145,GuideToPharmacology,1,inhibitor
NAT2,5-CT,GuideToPharmacology,1,agonist
CACNB1,ESTRADIOL DISULFATE,GuideToPharmacology,1,inhibitor
ABL1,VODOBATINIB,GuideToPharmacology,1,inhibitor
PLK3,CP-640186,GuideToPharmacology,1,inhibitor
CSTF3,GSK690693,GuideToPharmacology,1,inhibitor
COL1AR,SKF-83566,GuideToPharmacology,1,inhibitor
HELLS,DO264,GuideToPharmacology,1,inhibitor
ABCB7,&RHO;-DA1A,GuideToPharmacology,1,inhibitor
AAK1,COMPOUND 21B [PMID: 31136173],GuideToPharmacology,1,inhibitor
ACADSB,COMPOUND 14A [PMID: 34795866],GuideToPharmacology,1,agonist
DAPK3,TRANDOLAPRIL,GuideToPharmacology,1,inhibitor
BST2,DIMINAZENE,GuideToPharmacology,1,blocker
BTC,NAFAMOSTAT,GuideToPharmacology,1,blocker
BST2,PSALMOTOXIN 1,GuideToPharmacology,1,blocker
BST2,MAMBALGIN-1,GuideToPharmacology,1,blocker
BST2,ETHYLISOPROPYLAMILORIDE,GuideToPharmacology,1,blocker
ABAT,VPC171,GuideToPharmacology,1,modulator
ABAT,LUF7602,GuideToPharmacology,1,inhibitor
ABCA1,ATL802,GuideToPharmacology,1,inhibitor
ABCA1,MRS1042,GuideToPharmacology,1,inhibitor
ABCA1,MRS1041,GuideToPharmacology,1,inhibitor
ABCA1,THEOPHYLLINE,GuideToPharmacology,1,inhibitor
ABCA1,MORIN,GuideToPharmacology,1,inhibitor
ABCA2,N(6)-CYCLOHEXYLADENOSINE,GuideToPharmacology,1,agonist
ACADM,ANGIOTENSIN IV,GuideToPharmacology,1,agonist
ATR,ELIMUSERTIB,GuideToPharmacology,1,inhibitor
ATR,AZ20,GuideToPharmacology,1,inhibitor
EEF1D,PF-562271,GuideToPharmacology,1,inhibitor
EEF1G,AURORA KINASE INHIBITOR II,GuideToPharmacology,1,inhibitor
EEF1G,COMPOUND 1 [PMID: 21742770],GuideToPharmacology,1,inhibitor
GRIK5,ZIRITAXESTAT,GuideToPharmacology,1,inhibitor
AXL,BMS-777607,GuideToPharmacology,1,inhibitor
ACAT1,PD 168368,GuideToPharmacology,1,inhibitor
FMOD,EXAMPLE 2 [WO2013004676],GuideToPharmacology,1,inhibitor
FMO5,PF-06684511,GuideToPharmacology,1,inhibitor
ABO,XAMOTEROL,GuideToPharmacology,1,agonist
ABR,ALBUTEROL SULFATE,GuideToPharmacology,1,agonist
ABR,BUTOXAMINE,GuideToPharmacology,1,inhibitor
EFNA3,ARV-771,GuideToPharmacology,1,inhibitor
CA14,ETHOXZOLAMIDE,GuideToPharmacology,1,inhibitor
CA14,DORZOLAMIDE,GuideToPharmacology,1,inhibitor
UBE2K,DEXTROAMPHETAMINE SULFATE,GuideToPharmacology,1,activator
CA14,BRINZOLAMIDE,GuideToPharmacology,1,inhibitor
CASP3,AZ10417808,GuideToPharmacology,1,inhibitor
ACP5,ETELCALCETIDE,GuideToPharmacology,1,modulator
ATP6V0B,PB2+,GuideToPharmacology,1,blocker
ATP6AP1,FLUNARIZINE,GuideToPharmacology,1,blocker
FRA20B,ENTACAPONE,GuideToPharmacology,1,inhibitor
CNR2,CP55940,GuideToPharmacology,1,agonist
ACTA1,"CP-481,715",GuideToPharmacology,1,inhibitor
ACTA2,CCL13,GuideToPharmacology,1,agonist
ACTBP2,CCL7,GuideToPharmacology,1,inhibitor
EGR3,COMPOUND 18 [PMID: 20873740],GuideToPharmacology,1,inhibitor
ACTG1P7,TETHERED CHEMERIN 9,GuideToPharmacology,1,agonist
HNRNPH1,GLPG4716,GuideToPharmacology,1,inhibitor
GUCY1A1,GLPG4716,GuideToPharmacology,1,inhibitor
ARHGDIA,CYCLIC GMP,GuideToPharmacology,1,activator
FRA1D,COMPOUND 11 [PMID: 16413183],GuideToPharmacology,1,inhibitor
FRA1C,AR-H067637,GuideToPharmacology,1,inhibitor
FRA1A,ALPHA-KETOTHIAZOLE ANALOGUE 36,GuideToPharmacology,1,inhibitor
CHUK,COMPOUND 47 [PMID: 28737909],GuideToPharmacology,1,inhibitor
GPR19,COMPOUND 2 [PMID: 28621538],GuideToPharmacology,1,inhibitor
FNTA,COMPOUND 51 [PMID: 19743866],GuideToPharmacology,1,inhibitor
FN1,SUTIMLIMAB,GuideToPharmacology,1,antibody
ALAS2,VERUCERFONT,GuideToPharmacology,1,inhibitor
ALAS2,ANTALARMIN,GuideToPharmacology,1,inhibitor
GLG1,ISCHEMIN,GuideToPharmacology,1,inhibitor
ALB,K41498,GuideToPharmacology,1,inhibitor
ACTG1,X4-HIV-1 GP120,GuideToPharmacology,1,agonist
EGR4,COMPOUND 9B [PMID: 18986805],GuideToPharmacology,1,inhibitor
CDK19,PONATINIB,GuideToPharmacology,1,inhibitor
CYP4F2,TP0472993,GuideToPharmacology,1,inhibitor
COX6A1,VERAPAMIL,GuideToPharmacology,1,inhibitor
COX7A2P2,HET0016,GuideToPharmacology,1,inhibitor
APOB,CLOPROSTENOL,GuideToPharmacology,1,agonist
APOBEC1,RAMATROBAN,GuideToPharmacology,1,inhibitor
ALCAM,SKF-38393,GuideToPharmacology,1,agonist
ALCAM,(+)-ADTN,GuideToPharmacology,1,agonist
ABCD1,CABERGOLINE,GuideToPharmacology,1,agonist
ABCD1,PRAMIPEXOLE,GuideToPharmacology,1,agonist
ALDH1A1,CLOZAPINE,GuideToPharmacology,1,inhibitor
EMD,COMPOUND 72 [WO2013026806],GuideToPharmacology,1,inhibitor
GLI1,H3-COA-20,GuideToPharmacology,1,inhibitor
DXO,NECITUMUMAB,GuideToPharmacology,1,antibody
GTF2IP1,ZAFIRLUKAST,GuideToPharmacology,1,inhibitor
DXO,ZM-306416,GuideToPharmacology,1,inhibitor
APOC1P1,CARBACYCLIN,GuideToPharmacology,1,agonist
ARG1,RILUZOLE,GuideToPharmacology,1,activator
EN1,MIFANERTINIB,GuideToPharmacology,1,inhibitor
AQP3,LANEPITANT,GuideToPharmacology,1,inhibitor
AQP8,ONO-AE3-208,GuideToPharmacology,1,inhibitor
BLVRB,ZARAGOZIC ACID A,GuideToPharmacology,1,inhibitor
EN1,MARGETUXIMAB,GuideToPharmacology,1,antibody
DPAGT1,ELGEMTUMAB,GuideToPharmacology,1,antibody
ERBB4,ALLITINIB,GuideToPharmacology,1,inhibitor
ESR2,ETHINYL ESTRADIOL,GuideToPharmacology,1,agonist
BCYRN1P2,ETHINYL ESTRADIOL,GuideToPharmacology,1,agonist
ALDH1B1,ATRASENTAN,GuideToPharmacology,1,inhibitor
BDH1,BIOCHANIN A,GuideToPharmacology,1,agonist
ALDH1B1,PD-156707,GuideToPharmacology,1,inhibitor
ALDH1A3,ENDOTHELIN-3,GuideToPharmacology,1,agonist
CBLN1,WAY-213613,GuideToPharmacology,1,inhibitor
SLC1A7,DL-TBOA,GuideToPharmacology,1,inhibitor
CBLN1,DL-TBOA,GuideToPharmacology,1,inhibitor
BCL5,OBETICHOLIC ACID,GuideToPharmacology,1,agonist
CRMP1,DUAL SEH/FAAH INHIBITOR 11,GuideToPharmacology,1,inhibitor
BLVRA,NE58018,GuideToPharmacology,1,inhibitor
ARNT,FLUMAZENIL,GuideToPharmacology,1,modulator
BMAL1,TBPS,GuideToPharmacology,1,blocker
ARRB1,ONO-8590580,GuideToPharmacology,1,modulator
ARRB2,[3H]GABAZINE,GuideToPharmacology,1,inhibitor
ARRB2,TBPS,GuideToPharmacology,1,blocker
ARVCF,CIS-3-ACPBPA,GuideToPharmacology,1,inhibitor
ART4,GABOXADOL,GuideToPharmacology,1,inhibitor
ART4,AZA-THIP,GuideToPharmacology,1,inhibitor
GABRR3,CIS-3-ACPBPA,GuideToPharmacology,1,inhibitor
ARVCF,TBPS,GuideToPharmacology,1,blocker
ART3,TBPS,GuideToPharmacology,1,blocker
GABRR3,GABOXADOL,GuideToPharmacology,1,inhibitor
ARVCF,AZA-THIP,GuideToPharmacology,1,inhibitor
GALR2,GALANIN(3-29) (PIG),GuideToPharmacology,1,agonist
CXCR5,LAURYL ALCOHOL DIPHOSPHONIC ACID,GuideToPharmacology,1,inhibitor
ALOX15,"SM-130,686",GuideToPharmacology,1,agonist
ALPL,SEMAGLUTIDE,GuideToPharmacology,1,agonist
ASPH,FLUORO-WILLARDIINE,GuideToPharmacology,1,agonist
ASS1P5,[3H]KAINATE,GuideToPharmacology,1,agonist
BDM,MAPRACORAT,GuideToPharmacology,1,agonist
GRIN2A,"SERINE, D-",GuideToPharmacology,1,agonist
GRIN2A,[3H]DIZOCILPINE,GuideToPharmacology,1,blocker
GRIN2A,[3H]MDL105519,GuideToPharmacology,1,inhibitor
ASS1P14,[3H]CGS19755,GuideToPharmacology,1,inhibitor
GRIA2,TELAGLENASTAT,GuideToPharmacology,1,inhibitor
ASS1P14,[3H]DIZOCILPINE,GuideToPharmacology,1,blocker
ENSA,LADUVIGLUSIB,GuideToPharmacology,1,inhibitor
ARVD4,PICROTOXININ,GuideToPharmacology,1,blocker
ASAH1,PICROTOXININ,GuideToPharmacology,1,blocker
ARVD3,WIN55212-2,GuideToPharmacology,1,inhibitor
ANXA11,4-HYDROXYBUTYRIC ACID,GuideToPharmacology,1,agonist
AOAH,NIACIN,GuideToPharmacology,1,agonist
GDF2,J27644,GuideToPharmacology,1,inhibitor
GARS1,CHR-3996,GuideToPharmacology,1,inhibitor
GAPDHP1,SCRIPTAID,GuideToPharmacology,1,inhibitor
GAPDHP1,MARBOSTAT-100,GuideToPharmacology,1,inhibitor
GAPDHP1,DACINOSTAT,GuideToPharmacology,1,inhibitor
GAPDHP1,BELINOSTAT,GuideToPharmacology,1,inhibitor
GAPDHP1,CHR-3996,GuideToPharmacology,1,inhibitor
AMELX,HISTAMINE,GuideToPharmacology,1,agonist
AMELX,PITOLISANT,GuideToPharmacology,1,inhibitor
AMELX,"N,N-DIMETHYLHISTAMINE",GuideToPharmacology,1,agonist
ADCY6,DIHYDROSPHINGOSINE 1-PHOSPHATE,GuideToPharmacology,1,agonist
ADCY3,SPAG11B (61-103),GuideToPharmacology,1,agonist
DPH1,LINSITINIB,GuideToPharmacology,1,inhibitor
DPH1,BRIGATINIB,GuideToPharmacology,1,inhibitor
DPH1,CERITINIB,GuideToPharmacology,1,inhibitor
EPHA7,IRAK-1/4 INHIBITOR,GuideToPharmacology,1,inhibitor
EPHA5,IRAK3 PROTAC 23,GuideToPharmacology,1,inhibitor
CYB5R3,IL-10,GuideToPharmacology,1,agonist
BPI,METHOXSALEN,GuideToPharmacology,1,agonist
BRDT,QUININE,GuideToPharmacology,1,agonist
TAS2R46,PICROTOXININ,GuideToPharmacology,1,agonist
EPHB2,EMZELTRECTINIB,GuideToPharmacology,1,inhibitor
EPHB2,ABROCITINIB,GuideToPharmacology,1,inhibitor
EPHB1,SAR-20347,GuideToPharmacology,1,inhibitor
EPHB2,FILGOTINIB,GuideToPharmacology,1,inhibitor
NUDT2,NMRA-140,GuideToPharmacology,1,inhibitor
NUDT2,METHYLNALTREXONE,GuideToPharmacology,1,inhibitor
DRD2,OSI-930,GuideToPharmacology,1,inhibitor
DPT,CP-673451,GuideToPharmacology,1,inhibitor
DPT,AST-487,GuideToPharmacology,1,inhibitor
AMELY,KISSPEPTIN-15,GuideToPharmacology,1,agonist
DPT,TANDUTINIB,GuideToPharmacology,1,inhibitor
GPM6B,ERAS-5024,GuideToPharmacology,1,inhibitor
ARG1,EBIO,GuideToPharmacology,1,activator
ARG1,TETRAMETHYLAMMONIUM,GuideToPharmacology,1,blocker
ARG2,SENICAPOC,GuideToPharmacology,1,blocker
ARG2,NS6180,GuideToPharmacology,1,blocker
ARG2,DC-EBIO,GuideToPharmacology,1,activator
ARG1,UCL1684,GuideToPharmacology,1,inhibitor
ARG2,EBIO,GuideToPharmacology,1,activator
ATRX,RY796,GuideToPharmacology,1,inhibitor
GRIA1,L6H21,GuideToPharmacology,1,inhibitor
GUCY1B1,PECAZINE,GuideToPharmacology,1,inhibitor
GUCY1B1,SAFIMALTIB,GuideToPharmacology,1,inhibitor
DRD5,BMS-777607,GuideToPharmacology,1,inhibitor
ESAT,COMPOUND 16 [PMID: 17480064],GuideToPharmacology,1,inhibitor
ANGPT2,HS014,GuideToPharmacology,1,inhibitor
ANK1,AGOUTI-RELATED PROTEIN,GuideToPharmacology,1,inhibitor
ANGPT1,AGOUTI-RELATED PROTEIN,GuideToPharmacology,1,inhibitor
DRD4,TIVANTINIB,GuideToPharmacology,1,inhibitor
ANPEP,GSK1331258,GuideToPharmacology,1,modulator
ANPEP,[3H]JNJ-40068782,GuideToPharmacology,1,modulator
SLC25A6,BOMA,GuideToPharmacology,1,modulator
ESR2,COMPOUND 14 [PMID: 34333981],GuideToPharmacology,1,inhibitor
GRM8,"(S)-3,4-DCPG",GuideToPharmacology,1,agonist
ESD,PCC0105003,GuideToPharmacology,1,inhibitor
H1-1,ENTACAPONE,GuideToPharmacology,1,inhibitor
NR3C2,DROSPIRENONE,GuideToPharmacology,1,inhibitor
H4F3,ENTACAPONE,GuideToPharmacology,1,inhibitor
CTNNA2,HALICIN,GuideToPharmacology,1,inhibitor
ERPL1,COMPOUND 25 [PMID: 28038940],GuideToPharmacology,1,inhibitor
ACE,RXP470.1,GuideToPharmacology,1,inhibitor
DBP,BATIMASTAT,GuideToPharmacology,1,inhibitor
ACE,COMPOUND 20 [PMID: 22153340],GuideToPharmacology,1,inhibitor
DBP,CIPEMASTAT,GuideToPharmacology,1,inhibitor
DCC,UK-356618,GuideToPharmacology,1,inhibitor
DCC,BATIMASTAT,GuideToPharmacology,1,inhibitor
GADD45A,CGS-27023A,GuideToPharmacology,1,inhibitor
FSHMD1A,SELEGILINE,GuideToPharmacology,1,inhibitor
DCK,COMPOUND 29E [PMID: 23631440],GuideToPharmacology,1,inhibitor
MOGAT2,BMS-986172,GuideToPharmacology,1,inhibitor
DCK,ANDECALIXIMAB,GuideToPharmacology,1,antibody
FSHMD1A,MOCLOBEMIDE,GuideToPharmacology,1,inhibitor
DCK,MARIMASTAT,GuideToPharmacology,1,inhibitor
AADAC,XANOMELINE,GuideToPharmacology,1,agonist
AADAC,ACECLIDINE,GuideToPharmacology,1,agonist
AADAC,VU0090157,GuideToPharmacology,1,modulator
AAMP,CLIDINIUM,GuideToPharmacology,1,inhibitor
AANAT,FURTRETHONIUM IODIDE,GuideToPharmacology,1,agonist
AANAT,ARECOLINE,GuideToPharmacology,1,agonist
AAMP,AFDX384,GuideToPharmacology,1,inhibitor
ANK2,UCM 793,GuideToPharmacology,1,agonist
ANK2,N-[2-(2-IODO-5-METHOXY-1H-INDOL-3-YL)ETHYL]ACETAMIDE,GuideToPharmacology,1,agonist
SLC47A1,PYRIMETHAMINE,GuideToPharmacology,1,inhibitor
ANK3,UCM 793,GuideToPharmacology,1,agonist
ANK3,EFPPEA,GuideToPharmacology,1,agonist
ANK3,MELATONIN,GuideToPharmacology,1,agonist
DLX5,AP811,GuideToPharmacology,1,inhibitor
DRD5P1,SELITRECTINIB,GuideToPharmacology,1,inhibitor
DRD5P1,EMZELTRECTINIB,GuideToPharmacology,1,inhibitor
DRD5P1,UTATRECTINIB,GuideToPharmacology,1,inhibitor
DRD5P1,COMPOUND 2C [PMID: 24900538],GuideToPharmacology,1,inhibitor
DRD5P2,SELITRECTINIB,GuideToPharmacology,1,inhibitor
DRD5P2,MK-2461,GuideToPharmacology,1,inhibitor
DRD5P2,CH7057288,GuideToPharmacology,1,inhibitor
SERPINC1,&ALPHA;-CONOTOXIN MI,GuideToPharmacology,1,inhibitor
ATD,[3H]CYTISINE,GuideToPharmacology,1,agonist
ATF4,ENCENICLINE,GuideToPharmacology,1,agonist
AQP3,SCH 206272,GuideToPharmacology,1,inhibitor
APBA1,[NPHE1]N/OFQ-(1-13)-NH2,GuideToPharmacology,1,inhibitor
APBA1,UFP-112,GuideToPharmacology,1,agonist
NPFFR1,RFRP-3,GuideToPharmacology,1,agonist
ANXA2P1,DES-BR-NEUROPEPTIDE B-23,GuideToPharmacology,1,agonist
NPFFR1,[125I]Y-RFRP-3,GuideToPharmacology,1,agonist
ANXA6,JMV457,GuideToPharmacology,1,agonist
ANXA1,1DME,GuideToPharmacology,1,agonist
ARAF,SSR126768A,GuideToPharmacology,1,inhibitor
APBB1,RTOXA-43,GuideToPharmacology,1,agonist
EYA1,GSK690693,GuideToPharmacology,1,inhibitor
BAD,PD-118057,GuideToPharmacology,1,activator
ATP12A,NF770,GuideToPharmacology,1,inhibitor
ATP1A3,NF279,GuideToPharmacology,1,inhibitor
ATP1B3P1,GW791343,GuideToPharmacology,1,modulator
ATP1B3P1,A438079,GuideToPharmacology,1,inhibitor
APEH,ATP&GAMMA;S,GuideToPharmacology,1,agonist
APEH,NF340,GuideToPharmacology,1,inhibitor
APEX1,BX 048,GuideToPharmacology,1,inhibitor
APOD,RWJ-56110,GuideToPharmacology,1,inhibitor
F7,PANULISIB,GuideToPharmacology,1,inhibitor
F7,DEZAPELISIB,GuideToPharmacology,1,inhibitor
F7,"5-QUINOXALIN-6-YLMETHYLENE-THIAZOLIDINE-2,4-DIONE",GuideToPharmacology,1,inhibitor
F7R,TG-100-115,GuideToPharmacology,1,inhibitor
COL11A2,"6-HYDROXY-5,7-DIMETHOXYFLAVONE",GuideToPharmacology,1,inhibitor
COL11A1,ROLIPRAM,GuideToPharmacology,1,inhibitor
DPP4,CEDIRANIB,GuideToPharmacology,1,inhibitor
CHKB,QUININE,GuideToPharmacology,1,inhibitor
DPP6,FLT-3 INHIBITOR II,GuideToPharmacology,1,inhibitor
FABP1,GSK-461364A,GuideToPharmacology,1,inhibitor
GNAI2P1,SARUPARIB,GuideToPharmacology,1,inhibitor
GM2A,AUNP-12,GuideToPharmacology,1,inhibitor
PRMT5,PF-06939999,GuideToPharmacology,1,inhibitor
CTAG1B,INGENOL MEBUTATE,GuideToPharmacology,1,activator
NKX2-5,DAROVASERTIB,GuideToPharmacology,1,inhibitor
CSTB,GSK690693,GuideToPharmacology,1,inhibitor
CTBS,INGENOL MEBUTATE,GuideToPharmacology,1,activator
GOLGA1,TORIN 2,GuideToPharmacology,1,inhibitor
CTF1,COMPOUND 13C [PMID: 20684591],GuideToPharmacology,1,inhibitor
GTF3C2,"COMPOUND 7B [HAFTCHENARY ET AL., 2013]",GuideToPharmacology,1,inhibitor
ACSL1,PF-562271,GuideToPharmacology,1,inhibitor
ACSL1,YHJ1039,GuideToPharmacology,1,inhibitor
GOLGA2,IRIGENOL,GuideToPharmacology,1,inhibitor
RIPK2,PONATINIB,GuideToPharmacology,1,inhibitor
FANCG,SIR1-365,GuideToPharmacology,1,inhibitor
BCHEL1,AC55649,GuideToPharmacology,1,agonist
BCHEL3,CD666,GuideToPharmacology,1,agonist
PTK2B,AST-487,GuideToPharmacology,1,inhibitor
HCN2,HX 531,GuideToPharmacology,1,inhibitor
BCL2A1,HEME,GuideToPharmacology,1,agonist
PTK2B,WF-47-JS03,GuideToPharmacology,1,inhibitor
CTPS1,VEROSUDIL,GuideToPharmacology,1,inhibitor
PTK2B,PONATINIB,GuideToPharmacology,1,inhibitor
APPL1,TAMRLX,GuideToPharmacology,1,agonist
APRT,[125I]RELAXIN-3 (HUMAN),GuideToPharmacology,1,agonist
APRT,[G(B24)S]R3/I5,GuideToPharmacology,1,agonist
APRT,RELAXIN-3 B CHAIN DIMER,GuideToPharmacology,1,agonist
DAGLA,MG2+,GuideToPharmacology,1,inhibitor
DAGLA,SURAMIN,GuideToPharmacology,1,activator
AMT,AFD(R),GuideToPharmacology,1,agonist
AMT,ASP4058,GuideToPharmacology,1,agonist
GJB3,SRT2104,GuideToPharmacology,1,activator
ALOX12,VISMODEGIB,GuideToPharmacology,1,inhibitor
CD5L,KETOPROFEN,GuideToPharmacology,1,inhibitor
FCER1A,COMPOUND 60 [PMID: 30889352],GuideToPharmacology,1,inhibitor
FDX1,COMPOUND 23 [PMID: 17600705],GuideToPharmacology,1,inhibitor
FCAR,COMPOUND 28 [PMID: 35439002],GuideToPharmacology,1,inhibitor
FDX1,ENTOSPLETINIB,GuideToPharmacology,1,inhibitor
FCER1G,COMPOUND 66 [PMID: 21802293],GuideToPharmacology,1,inhibitor
FASLG,[125I]LTT-SRIF-28,GuideToPharmacology,1,agonist
SHROOM2,"BN-81,674",GuideToPharmacology,1,agonist
SHROOM2,BIM 23056,GuideToPharmacology,1,agonist
SHROOM2,KE 108,GuideToPharmacology,1,agonist
SHROOM2,"[111IN,90Y]DOTA-TOC",GuideToPharmacology,1,agonist
HOXA5,PEPTIDE 22D,GuideToPharmacology,1,inhibitor
BCGF1,DEXTROTHYROXINE,GuideToPharmacology,1,agonist
TLR2,PEPTIDOGLYCAN,GuideToPharmacology,1,agonist
SARDH,HYDROXYCHLOROQUINE,GuideToPharmacology,1,inhibitor
ARHGAP4,VERAPAMIL,GuideToPharmacology,1,blocker
APOC4,STA2,GuideToPharmacology,1,agonist
DNMT3A,4-(3-PYRIDIN-2-YL-1H-PYRAZOL-4-YL)QUINOLINE,GuideToPharmacology,1,inhibitor
DNMT3A,TGF-BETA RI INHIBITOR III,GuideToPharmacology,1,inhibitor
APOC4,DOMITROBAN,GuideToPharmacology,1,inhibitor
ATP1B1P1,APOMORPHINE,GuideToPharmacology,1,activator
ATP2B2,ACAA,GuideToPharmacology,1,blocker
ATP3,CLOTRIMAZOLE,GuideToPharmacology,1,blocker
ATP2B2,AM-1473,GuideToPharmacology,1,blocker
ATP4A,CHLOROFORM,GuideToPharmacology,1,blocker
MCOLN3,ML3-SA1,GuideToPharmacology,1,activator
ATP5F1BP1,5S-HETE,GuideToPharmacology,1,activator
MCOLN3,SN-1,GuideToPharmacology,1,activator
TRPV5,MICONAZOLE NITRATE,GuideToPharmacology,1,blocker
TRPV4,NSC151066,GuideToPharmacology,1,blocker
TRPV4,GSK2798745,GuideToPharmacology,1,inhibitor
TRPV4,RN-9893,GuideToPharmacology,1,blocker
FRA8F,NAFAMOSTAT,GuideToPharmacology,1,inhibitor
TRPV4,ACETAMINOPHEN,GuideToPharmacology,1,inhibitor
FGR,COMPOUND 23 [PMID: 17600705],GuideToPharmacology,1,inhibitor
TYK2,COMPOUND 6 [PMID: 34333981],GuideToPharmacology,1,inhibitor
TYK2,FILGOTINIB,GuideToPharmacology,1,inhibitor
AQP9,CONIVAPTAN,GuideToPharmacology,1,inhibitor
AQP9,OH-LVA,GuideToPharmacology,1,inhibitor
AR,LVP,GuideToPharmacology,1,agonist
AR,"D(CH2)5[TYR(ME)2,THR4,TYR-NH29]OVT",GuideToPharmacology,1,inhibitor
AR,D(CH2)5[TYR(ME)2]AVP,GuideToPharmacology,1,inhibitor
ABCC6,D(CH2)5[TYR(ME)2]AVP,GuideToPharmacology,1,inhibitor
ABCC6,"D(CH2)5[D-ILE2,ILE4,ALA-NH29]AVP",GuideToPharmacology,1,inhibitor
ABCC6,CONIVAPTAN,GuideToPharmacology,1,inhibitor
ABCC6,RO5028442,GuideToPharmacology,1,inhibitor
GNG10,SM-122,GuideToPharmacology,1,inhibitor
FKBP1AP3,SPEBRUTINIB,GuideToPharmacology,1,inhibitor
ANXA3,NPY-(2-36),GuideToPharmacology,1,agonist
EIF4EBP1,NARAZACICLIB,GuideToPharmacology,1,inhibitor
ALDH1A1,(+)-AJ76,GuideToPharmacology,1,inhibitor
ALCAM,DOPAMINE,GuideToPharmacology,1,agonist
ALDH7A1P2,NIFEDIPINE,GuideToPharmacology,1,blocker
GATM,MOSUNETUZUMAB,GuideToPharmacology,1,antibody
ALPL,T-0632,GuideToPharmacology,1,inhibitor
DRG2,EMZELTRECTINIB,GuideToPharmacology,1,inhibitor
A2M,XANOMELINE,GuideToPharmacology,1,agonist
CNR2,PHENYLACETYLRINVANIL,GuideToPharmacology,1,agonist
DGKA,VIPIVOTIDE TETRAXETAN,GuideToPharmacology,1,inhibitor
ARNT,TPA023,GuideToPharmacology,1,modulator
EGR4,LADUVIGLUSIB,GuideToPharmacology,1,inhibitor
HRH3,PITOLISANT,GuideToPharmacology,1,inhibitor
DHODH,ORLUDODSTAT,GuideToPharmacology,1,inhibitor
DNAH9,DAPANSUTRILE,GuideToPharmacology,1,inhibitor
A12M3,LP-44,GuideToPharmacology,1,agonist
ACAT1,"[D-PHE6,&BETA;-ALA11,PHE13,NLE14]BOMBESIN-(6-14)",GuideToPharmacology,1,agonist
GRIN2B,"SERINE, D-",GuideToPharmacology,1,agonist
BCKDHB,GW501516,GuideToPharmacology,1,agonist
DPYD,RO0094889,GuideToPharmacology,1,inhibitor
DPYD,ARRY-382,GuideToPharmacology,1,inhibitor
ARF4P1,TETRAMETHYLAMMONIUM,GuideToPharmacology,1,blocker
HLA-DMB,"COMPOUND 5 [TOMASSI ET AL., 2020]",GuideToPharmacology,1,inhibitor
AQP2,[111IN]DOTA-NOC,GuideToPharmacology,1,agonist
FOS,COMPOUND (R)-26 [PMID: 22686657],GuideToPharmacology,1,inhibitor
APOC1,PF-04418948,GuideToPharmacology,1,inhibitor
ERCC8,5-HYDROXYTRYPTOPHAN,GuideToPharmacology,1,inhibitor
CREBL2,COMPOUND 21N [PMID: 17656086],GuideToPharmacology,1,inhibitor
BTD,SALICYLIC ACID,GuideToPharmacology,1,blocker
ABCA3,NAMODENOSON,GuideToPharmacology,1,agonist
CFTR,GENISTEIN,GuideToPharmacology,1,activator
NPFFR1,[3H]NPVF,GuideToPharmacology,1,agonist
CYP2J2,BELORANIB,GuideToPharmacology,1,inhibitor
ACTN3,ARACHIDONYLCYCLOPROPYLAMIDE,GuideToPharmacology,1,agonist
ECI1,CGS-27023A,GuideToPharmacology,1,inhibitor
PRDM1,PRAVASTATIN SODIUM,GuideToPharmacology,1,inhibitor
F5,AZ2,GuideToPharmacology,1,inhibitor
AQP8,PGD2,GuideToPharmacology,1,agonist
ATP5F1BP1,RHTX,GuideToPharmacology,1,activator
TEC,NEMTABRUTINIB,GuideToPharmacology,1,inhibitor
AMPD1,BAYCYSLT2,GuideToPharmacology,1,inhibitor
FGF12,CERITINIB,GuideToPharmacology,1,inhibitor
A12M4,CABERGOLINE,GuideToPharmacology,1,agonist
SERPINA3,DIHYDROERGOTAMINE MESYLATE,GuideToPharmacology,1,inhibitor
ATP3,TATM2NX,GuideToPharmacology,1,blocker
ABO,ATENOLOL,GuideToPharmacology,1,inhibitor
ABCF1,A-123189,GuideToPharmacology,1,inhibitor
AMD1,JNJ-39758979,GuideToPharmacology,1,inhibitor
SHROOM2,"L-796,778",GuideToPharmacology,1,agonist
FPR3,OTAMIXABAN,GuideToPharmacology,1,inhibitor
BTD,ARCAINE,GuideToPharmacology,1,activator
APOC4,PBT-3,GuideToPharmacology,1,inhibitor
ACTC1,CCL13,GuideToPharmacology,1,agonist
BLVRB,BPH-830,GuideToPharmacology,1,inhibitor
SHROOM2,[111IN]DOTA-NOC,GuideToPharmacology,1,agonist
SLC25A6,COMPOUND 24D [PMID: 23357634],GuideToPharmacology,1,modulator
AAMP,"WIN 51,708",GuideToPharmacology,1,modulator
DRD5P1,MK-2461,GuideToPharmacology,1,inhibitor
ANXA2P3,[PRO34]NPY,GuideToPharmacology,1,agonist
DMTN,MLN-120B,GuideToPharmacology,1,inhibitor
ADH1C,YH18968,GuideToPharmacology,1,agonist
SLC1A1,DL-TBOA,GuideToPharmacology,1,inhibitor
ANTP2,ADX71743,GuideToPharmacology,1,modulator
A12M4,TEGASEROD,GuideToPharmacology,1,inhibitor
APOD,TFLLR-NH2,GuideToPharmacology,1,agonist
ATP5F1BP1,MAVATREP,GuideToPharmacology,1,blocker
CYP1B1,"2,3',4,5'-TETRAMETHOXYSTILBENE",GuideToPharmacology,1,inhibitor
AMPD3,BRP-LPA,GuideToPharmacology,1,inhibitor
GART,BELINOSTAT,GuideToPharmacology,1,inhibitor
AQP2,[125I]LTT-SRIF-28,GuideToPharmacology,1,agonist
AQP9,ARGIPRESSIN,GuideToPharmacology,1,agonist
A1BG,SERTINDOLE,GuideToPharmacology,1,inhibitor
ASS1P5,"2-AMINO-3-(3-HYDROXY-7,8-DIHYDRO-6H-CYCLOHEPTA[D]-4-ISOXAZOLYL)PROPIONIC ACID",GuideToPharmacology,1,agonist
DPT,LUCITANIB,GuideToPharmacology,1,inhibitor
F7R,AZD8835,GuideToPharmacology,1,inhibitor
CFTR,ABBV-3221,GuideToPharmacology,1,activator
COX5BP1,COMPOUND 23 [PMID: 17125252],GuideToPharmacology,1,inhibitor
GLUD1P3,DEXTROAMPHETAMINE SULFATE,GuideToPharmacology,1,activator
ANK3,S22153,GuideToPharmacology,1,agonist
KCNQ3,AZETUKALNER,GuideToPharmacology,1,activator
FPR1,COMPOUND 24DD [PMID: 20684603],GuideToPharmacology,1,inhibitor
PRDM1,COMPOUND 4FF [PMID: 1656041],GuideToPharmacology,1,inhibitor
EPHA7,ZIMLOVISERTIB,GuideToPharmacology,1,inhibitor
AADAC,CLOZAPINE,GuideToPharmacology,1,modulator
FRA7J,ST074946,GuideToPharmacology,1,inhibitor
A12M3,CLOZAPINE,GuideToPharmacology,1,inhibitor
F7R,QUINOSTATIN,GuideToPharmacology,1,inhibitor
ACTG1,TIQ-15,GuideToPharmacology,1,inhibitor
NKX3-2,PROTOXIN II,GuideToPharmacology,1,inhibitor
FASLG,LANREOTIDE ACETATE,GuideToPharmacology,1,agonist
ATP2A2,GD3+,GuideToPharmacology,1,blocker
GLUD1P3,BRINZOLAMIDE,GuideToPharmacology,1,inhibitor
DXO,EGFR INHIBITOR,GuideToPharmacology,1,inhibitor
DRD4,MK-2461,GuideToPharmacology,1,inhibitor
FSHMD1A,BIFEMELANE,GuideToPharmacology,1,inhibitor
FRA2E,COMPOUND 3 [PMID: 23849879],GuideToPharmacology,1,inhibitor
ABCA1,CV-1674,GuideToPharmacology,1,agonist
ABL2,LURASIDONE HYDROCHLORIDE,GuideToPharmacology,1,inhibitor
AMHR2,BAYCYSLT2,GuideToPharmacology,1,inhibitor
ABCD1,UNC0006,GuideToPharmacology,1,agonist
ADH4,LINOLEIC ACID,GuideToPharmacology,1,agonist
BBS1,AM-6120,GuideToPharmacology,1,inhibitor
COL11A2,ROLIPRAM,GuideToPharmacology,1,inhibitor
FASLG,TYR3-OCTREOTIDE,GuideToPharmacology,1,agonist
GRM7,ITOLIZUMAB,GuideToPharmacology,1,antibody
ATP4A,ISOSAKURANETIN,GuideToPharmacology,1,blocker
FEN1,COMPOUND 6 [PMID: 34333981],GuideToPharmacology,1,inhibitor
ASIC1,D-LYS0-[DES-ARG10]KALLIDIN,GuideToPharmacology,1,agonist
BEVI,HYDROXYFLUTAMIDE,GuideToPharmacology,1,inhibitor
GRK3,CORTISTATIN-14,GuideToPharmacology,1,agonist
SLC26A3,DEBIO-1347,GuideToPharmacology,1,inhibitor
DPYS,TANDUTINIB,GuideToPharmacology,1,inhibitor
MS4A2,CCT241161,GuideToPharmacology,1,inhibitor
ACTBP9,CXCL1,GuideToPharmacology,1,agonist
AAVS1,HIMBACINE,GuideToPharmacology,1,inhibitor
OPN1MW,UNC0638,GuideToPharmacology,1,inhibitor
DRD4,SAVOLITINIB,GuideToPharmacology,1,inhibitor
BIRC5,[ILE5]PTHRP-(1-36),GuideToPharmacology,1,agonist
DRD2,FORETINIB,GuideToPharmacology,1,inhibitor
AANAT,AMITRIPTYLINE HYDROCHLORIDE,GuideToPharmacology,1,inhibitor
CD8B,TRIMIPRAMINE,GuideToPharmacology,1,inhibitor
ABL2,MK-912,GuideToPharmacology,1,inhibitor
ABCA1,MRS3558,GuideToPharmacology,1,agonist
GAPDHP1,BUTYRIC ACID,GuideToPharmacology,1,inhibitor
A2M,"BMS 181,101",GuideToPharmacology,1,agonist
A12M2,DIPROPYL-5-CT,GuideToPharmacology,1,agonist
A12M2,5-BODMT,GuideToPharmacology,1,agonist
A12M3,MK-212,GuideToPharmacology,1,agonist
A12M4,DIHYDROERGOCRYPTINE,GuideToPharmacology,1,agonist
A12M4,RS-127445,GuideToPharmacology,1,inhibitor
HTR2C,LY334362,GuideToPharmacology,1,inhibitor
NAT1,BIMU 8,GuideToPharmacology,1,agonist
HTR2C,VOLINANSERIN,GuideToPharmacology,1,inhibitor
DNCM,PANULISIB,GuideToPharmacology,1,inhibitor
ABCB7,(+)-ADRENALINE,GuideToPharmacology,1,agonist
ABCA4,SPIROXATRINE,GuideToPharmacology,1,inhibitor
ABCA4,TERAZOSIN,GuideToPharmacology,1,inhibitor
ABCA4,HEAT (BE2254),GuideToPharmacology,1,inhibitor
ABCA4,METHOXAMINE,GuideToPharmacology,1,agonist
ABCA4,A-123189,GuideToPharmacology,1,inhibitor
ABL1,BRL 44408,GuideToPharmacology,1,inhibitor
ABL1,APRACLONIDINE,GuideToPharmacology,1,agonist
ABL1,NOREPINEPHRINE,GuideToPharmacology,1,agonist
ABL1,ARC-239,GuideToPharmacology,1,inhibitor
AOC1,APOMORPHINE,GuideToPharmacology,1,inhibitor
AOC1,BRL 44408,GuideToPharmacology,1,inhibitor
AOC1,XYLOMETAZOLINE,GuideToPharmacology,1,agonist
AOC1,PHENOXYBENZAMINE,GuideToPharmacology,1,inhibitor
AOC1,NOREPINEPHRINE,GuideToPharmacology,1,agonist
ABL2,BRL 44408,GuideToPharmacology,1,inhibitor
ABL2,IDAZOXAN,GuideToPharmacology,1,inhibitor
ABL2,XYLOMETAZOLINE,GuideToPharmacology,1,agonist
ANPEP,BTB07018,GuideToPharmacology,1,inhibitor
BEVI,STANOLONE,GuideToPharmacology,1,agonist
ANPEP,COMPOUND 1A [PMID: 25692029],GuideToPharmacology,1,inhibitor
ABAT,THEOPHYLLINE,GuideToPharmacology,1,inhibitor
ABAT,PSB1115,GuideToPharmacology,1,inhibitor
ABCA1,IMARADENANT,GuideToPharmacology,1,inhibitor
ABCA1,DPCPX,GuideToPharmacology,1,inhibitor
ABCA3,CCPA,GuideToPharmacology,1,agonist
EEF1B2P2,AZD0156,GuideToPharmacology,1,inhibitor
ABCA3,MRE 3010F20,GuideToPharmacology,1,inhibitor
ACADM,AZILSARTAN MEDOXOMIL,GuideToPharmacology,1,inhibitor
EEF1D,BARASERTIB,GuideToPharmacology,1,inhibitor
GNG11,SM-122,GuideToPharmacology,1,inhibitor
AXL,SITRAVATINIB,GuideToPharmacology,1,inhibitor
GNGT1,SM-122,GuideToPharmacology,1,inhibitor
ACAT2,NEUROMEDIN B (1-30) (HUMAN),GuideToPharmacology,1,agonist
ACAT2,AM-37,GuideToPharmacology,1,inhibitor
GPR21,NAVITOCLAX,GuideToPharmacology,1,inhibitor
GPR22,NAVITOCLAX,GuideToPharmacology,1,inhibitor
ABR,CGP 12177,GuideToPharmacology,1,agonist
ABR,CGP 12177,GuideToPharmacology,1,inhibitor
ACAA1,CGP 12177,GuideToPharmacology,1,agonist
EEGV1,NEMTABRUTINIB,GuideToPharmacology,1,inhibitor
DNMT3B,GALUNISERTIB,GuideToPharmacology,1,inhibitor
EFNA2,GDC-0879,GuideToPharmacology,1,inhibitor
EFNA4,COMPOUND 6 [PMID: 30125504],GuideToPharmacology,1,inhibitor
EFNA4,ARV-771,GuideToPharmacology,1,inhibitor
BRD3,MOLIBRESIB,GuideToPharmacology,1,inhibitor
EFNA4,WNY0824,GuideToPharmacology,1,inhibitor
EFNB2,COMPOUND 2C [PMID: 24900538],GuideToPharmacology,1,inhibitor
ASIC1,[125I]HPP-DESARG10HOE140,GuideToPharmacology,1,inhibitor
BDKRB2,LABRADIMIL,GuideToPharmacology,1,agonist
BDKRB2,[3H]NPC17731,GuideToPharmacology,1,inhibitor
FRA20A,BAMBUTEROL,GuideToPharmacology,1,inhibitor
BDKRB2,NPC 18565,GuideToPharmacology,1,inhibitor
ACACA,ORYZATENSIN,GuideToPharmacology,1,agonist
GAPDH,BRINZOLAMIDE,GuideToPharmacology,1,inhibitor
C1QBP,"INS(3,4,5,6)P4",GuideToPharmacology,1,blocker
GAPDH,BENZOLAMIDE,GuideToPharmacology,1,inhibitor
CYP2C8,COMPOUND 15B [PMID: 18334293],GuideToPharmacology,1,inhibitor
C1QBP,TANNIC ACID,GuideToPharmacology,1,blocker
DAZL,Z-VDVAD-FMK,GuideToPharmacology,1,inhibitor
ELAVL3,COMPOUND 14 [PMID: 24900428],GuideToPharmacology,1,inhibitor
ELF1,IC261,GuideToPharmacology,1,inhibitor
CPN1,"SQ-24,798",GuideToPharmacology,1,inhibitor
ELF2,IC261,GuideToPharmacology,1,inhibitor
HRG,ONC201,GuideToPharmacology,1,modulator
FNZ,COMPOUND 3 [PMID: 8410973],GuideToPharmacology,1,inhibitor
CACNA1H,ML218,GuideToPharmacology,1,blocker
FOLR2L,GC-376,GuideToPharmacology,1,inhibitor
ACRV1,[3H]WIN55212-2,GuideToPharmacology,1,agonist
CCKBR,YM-022,GuideToPharmacology,1,inhibitor
ACTA2,CCL11,GuideToPharmacology,1,agonist
ACTA2,AZD2423,GuideToPharmacology,1,modulator
ACTB,[125I]CCL7 (HUMAN),GuideToPharmacology,1,agonist
ACTB,CXCL10,GuideToPharmacology,1,inhibitor
ACTBP2,BMS-741672,GuideToPharmacology,1,inhibitor
ACTBP2,CCL11,GuideToPharmacology,1,agonist
CFTR,UCCF-853,GuideToPharmacology,1,activator
CPT2,BENZQUINAMIDE,GuideToPharmacology,1,inhibitor
CPT2,KETOPROFEN,GuideToPharmacology,1,inhibitor
CPT1B,SC-560,GuideToPharmacology,1,inhibitor
CPT2,MEFENAMIC ACID,GuideToPharmacology,1,inhibitor
ALB,SAUVAGINE,GuideToPharmacology,1,agonist
ACTG1,ULOCUPLUMAB,GuideToPharmacology,1,antibody
EGR4,R547,GuideToPharmacology,1,inhibitor
EIF4A1,CDK4 INHIBITOR II,GuideToPharmacology,1,inhibitor
EIF4A1,BOHEMINE,GuideToPharmacology,1,inhibitor
CDK4,TIBREMCICLIB,GuideToPharmacology,1,inhibitor
EIF4EBP1,LEROCICLIB,GuideToPharmacology,1,inhibitor
EIF4EP1,PONATINIB,GuideToPharmacology,1,inhibitor
EIF4EBP2,BS-181,GuideToPharmacology,1,inhibitor
EIF4G2,COMPOUND 9B [PMID: 18986805],GuideToPharmacology,1,inhibitor
ENO3,SB203580,GuideToPharmacology,1,inhibitor
CLDN3,COMPOUND 4D [PMID: 20655626],GuideToPharmacology,1,inhibitor
COX5BP3,TERFENADINE,GuideToPharmacology,1,inhibitor
CORD4,COMPOUND 23 [PMID: 17125252],GuideToPharmacology,1,inhibitor
COX4I1,COMPOUND 9 [PMID: 11606127],GuideToPharmacology,1,inhibitor
AMHR2,ZAFIRLUKAST,GuideToPharmacology,1,inhibitor
AMPD1,IRALUKAST,GuideToPharmacology,1,inhibitor
AMPD1,ICI198615,GuideToPharmacology,1,inhibitor
AMPD1,ZAFIRLUKAST,GuideToPharmacology,1,inhibitor
APAF1,NALBUPHINE HYDROCHLORIDE,GuideToPharmacology,1,agonist
APAF1,NALTRINDOLE,GuideToPharmacology,1,inhibitor
APAF1,[3H]DIPRENORPHINE,GuideToPharmacology,1,agonist
APAF1,METHYLNALTREXONE,GuideToPharmacology,1,inhibitor
CRIP2,DH376,GuideToPharmacology,1,inhibitor
DHODH,DSM705,GuideToPharmacology,1,inhibitor
ALDH1A1,DOPAMINE,GuideToPharmacology,1,agonist
ALDH3A1,APOMORPHINE,GuideToPharmacology,1,agonist
FPR2,COMPOUND 4G [PMID: 22595175],GuideToPharmacology,1,inhibitor
FPR2,ALVELESTAT,GuideToPharmacology,1,inhibitor
EZH2,EBI-2511,GuideToPharmacology,1,inhibitor
DXO,TIGOZERTINIB,GuideToPharmacology,1,inhibitor
DXO,MIFANERTINIB,GuideToPharmacology,1,inhibitor
DXO,LAPATINIB,GuideToPharmacology,1,inhibitor
DXO,PIROTINIB,GuideToPharmacology,1,inhibitor
BLVRA,COMPOUND 2 [PMID: 18295483],GuideToPharmacology,1,inhibitor
CRMP1,OL135,GuideToPharmacology,1,inhibitor
FASN,GSK2194069,GuideToPharmacology,1,inhibitor
ALDOA,CATPB,GuideToPharmacology,1,inhibitor
ABCD2,MYRISTIC ACID,GuideToPharmacology,1,agonist
ALDOA,PROPIONIC ACID,GuideToPharmacology,1,agonist
FGR,COMPOUND 2C [PMID: 24900538],GuideToPharmacology,1,inhibitor
FFAR3,PROPIONIC ACID,GuideToPharmacology,1,agonist
FFAR3,1-METHYLCYCLOPROPANECARBOXYLIC ACID,GuideToPharmacology,1,agonist
DPYSL2,COMPOUND 2C [PMID: 24900538],GuideToPharmacology,1,inhibitor
DPYSL2,LUCITANIB,GuideToPharmacology,1,inhibitor
FRA1F,ARI-3099,GuideToPharmacology,1,inhibitor
DPYSL2,PEMIGATINIB,GuideToPharmacology,1,inhibitor
DR1,TASURGRATINIB,GuideToPharmacology,1,inhibitor
GAPDHP67,CYCLOHEXIMIDE,GuideToPharmacology,1,inhibitor
HNMT,SLF,GuideToPharmacology,1,inhibitor
DRD1,OSI-930,GuideToPharmacology,1,inhibitor
DRD1,SITRAVATINIB,GuideToPharmacology,1,inhibitor
DPYS,DENFIVONTINIB,GuideToPharmacology,1,inhibitor
DPYS,AKN-028,GuideToPharmacology,1,inhibitor
DRD3,MK-2461,GuideToPharmacology,1,inhibitor
DPYS,JNJ-28312141,GuideToPharmacology,1,inhibitor
ALDH3B2,DEOXYCHOLIC ACID,GuideToPharmacology,1,inhibitor
ALDH9A1,"PYRAZOLONE, 1",GuideToPharmacology,1,agonist
ALDH9A1,MMK-1,GuideToPharmacology,1,agonist
APOC2,CLOPROSTENOL,GuideToPharmacology,1,agonist
ALDH9A1,COMPOUND 1754-31 [PMID: 23788657],GuideToPharmacology,1,inhibitor
ALDH9A1,T-BOC-FLFLF,GuideToPharmacology,1,inhibitor
APOC2,TAFLUPROST,GuideToPharmacology,1,agonist
APOC2,CARBACYCLIN,GuideToPharmacology,1,agonist
ALS3,[125I]FSH (HUMAN),GuideToPharmacology,1,agonist
GABRA1,&ALPHA;3IA,GuideToPharmacology,1,modulator
BMAL1,GABOXADOL,GuideToPharmacology,1,agonist
ALOX12P2,M1153,GuideToPharmacology,1,agonist
CD14,TIAGABINE HYDROCHLORIDE,GuideToPharmacology,1,inhibitor
ASS1,NBQX,GuideToPharmacology,1,inhibitor
ASS1P2,NBQX,GuideToPharmacology,1,inhibitor
ASS1P6,DOMOIC ACID,GuideToPharmacology,1,agonist
GRIN2B,MG2+,GuideToPharmacology,1,blocker
GNRHR,GOSERELIN ACETATE,GuideToPharmacology,1,agonist
CD24P2,ALX 1405,GuideToPharmacology,1,inhibitor
ALDH3B1,FULVESTRANT,GuideToPharmacology,1,agonist
GNRHR,T-98475,GuideToPharmacology,1,inhibitor
GNRHR,WAY-207024,GuideToPharmacology,1,inhibitor
GNRHR,CYCLORELIX,GuideToPharmacology,1,inhibitor
GDF2,TRICHOSTATIN A,GuideToPharmacology,1,inhibitor
GARS1,DACINOSTAT,GuideToPharmacology,1,inhibitor
MSTN,CHR-3996,GuideToPharmacology,1,inhibitor
HDAC4,DACINOSTAT,GuideToPharmacology,1,inhibitor
GART,MARBOSTAT-100,GuideToPharmacology,1,inhibitor
GAS1,APICIDIN,GuideToPharmacology,1,inhibitor
GAS2,DACINOSTAT,GuideToPharmacology,1,inhibitor
GDF9,SCRIPTAID,GuideToPharmacology,1,inhibitor
GAS1,SCRIPTAID,GuideToPharmacology,1,inhibitor
AMD1,ARIPIPRAZOLE LAUROXIL,GuideToPharmacology,1,inhibitor
AMD1,BILASTINE,GuideToPharmacology,1,inhibitor
AMD1,(&PLUSMN;)-CIS-H2-PAT,GuideToPharmacology,1,inhibitor
AMD1,FLUSPIRILENE,GuideToPharmacology,1,inhibitor
AMD1,RUPATADINE,GuideToPharmacology,1,inhibitor
AMD1,CYPROHEPTADINE HYDROCHLORIDE,GuideToPharmacology,1,inhibitor
AMD1,FEXOFENADINE HYDROCHLORIDE,GuideToPharmacology,1,inhibitor
AMD1,DOTHIEPIN,GuideToPharmacology,1,inhibitor
AMD1P2,UR-PG146,GuideToPharmacology,1,agonist
AMD1P2,PITOLISANT,GuideToPharmacology,1,inhibitor
HOXC5,BI-3231,GuideToPharmacology,1,inhibitor
PRDM1,COMPOUND 41 [PMID: 17574411],GuideToPharmacology,1,inhibitor
ACTG1P10,SPHINGOSINE 1-PHOSPHATE,GuideToPharmacology,1,agonist
ADAM10,FUROSEMIDE,GuideToPharmacology,1,agonist
ADD3,2-HYDROXY CAPRIC ACID,GuideToPharmacology,1,agonist
GRK2,CHLOROQUINE,GuideToPharmacology,1,agonist
IDO2,TRYPTANTHRIN 5I,GuideToPharmacology,1,inhibitor
GRK3,ERAS-5024,GuideToPharmacology,1,agonist
APOC3,CARBACYCLIN,GuideToPharmacology,1,agonist
FOXL2,COUMESTROL,GuideToPharmacology,1,agonist
EPHB3,JAK INHIBITOR 17B,GuideToPharmacology,1,inhibitor
EPHB3,JAK INHIBITOR 20A,GuideToPharmacology,1,inhibitor
NUDT2,DYNORPHIN A-(1-8),GuideToPharmacology,1,agonist
NUDT2,&BETA;-NEOENDORPHIN,GuideToPharmacology,1,agonist
NUDT2,BUTORPHANOL,GuideToPharmacology,1,agonist
NUDT2,5'-GUANIDINONALTRINDOLE,GuideToPharmacology,1,inhibitor
DRD2,GSK2646264,GuideToPharmacology,1,inhibitor
DRD2,LUCITANIB,GuideToPharmacology,1,inhibitor
DRD2,AZD-4547,GuideToPharmacology,1,inhibitor
DRD2,SITRAVATINIB,GuideToPharmacology,1,inhibitor
AMELY,[125I]TYR45-KISSPEPTIN-15,GuideToPharmacology,1,agonist
DPT,LABUXTINIB,GuideToPharmacology,1,inhibitor
DPT,AKN-028,GuideToPharmacology,1,inhibitor
ATP5MC2P1,RUTHENIUM RED,GuideToPharmacology,1,inhibitor
KCNJ5,NIP-142,GuideToPharmacology,1,blocker
KCNT2,TETRAMETHYLAMMONIUM,GuideToPharmacology,1,blocker
BAD,TERFENADINE,GuideToPharmacology,1,blocker
ATP5PO,&KAPPA;M-CONOTOXIN RIIIK,GuideToPharmacology,1,blocker
ATP7B,HSTX1[R14A],GuideToPharmacology,1,blocker
AZF2,AZETUKALNER,GuideToPharmacology,1,activator
AZGP1,XE991,GuideToPharmacology,1,inhibitor
AVPR1A,TETRAMETHYLAMMONIUM,GuideToPharmacology,1,blocker
AZF2,LINOPIRDINE,GuideToPharmacology,1,inhibitor
KCNQ5,(S)-N-[1-(3-MORPHOLIN-4-YL-PHENYL)-ETHYL]-3-PHENYL-ACRYLAMIDE,GuideToPharmacology,1,activator
LATS2,COMPOUND 35 [PMID: 20684608],GuideToPharmacology,1,inhibitor
EPS8,GNE-7915,GuideToPharmacology,1,inhibitor
LATS2,TRULI,GuideToPharmacology,1,inhibitor
EPHX2,GSK2646264,GuideToPharmacology,1,inhibitor
STX2,COMPOUND 30 [PMID: 22902653],GuideToPharmacology,1,inhibitor
LTC4S,EXAMPLE 36 [WO2016177845],GuideToPharmacology,1,inhibitor
CRHR2,COMPOUND 1A [PMID: 25692029],GuideToPharmacology,1,inhibitor
GAMT,COMPOUND 41 [PMID: 15026062],GuideToPharmacology,1,inhibitor
BAK1P2,22R-HYDROXYCHOLESTEROL,GuideToPharmacology,1,agonist
AMPH,KI16425,GuideToPharmacology,1,inhibitor
AMPD3,VPC32179,GuideToPharmacology,1,inhibitor
BIN1,AM966,GuideToPharmacology,1,inhibitor
GEM,NCL-1,GuideToPharmacology,1,inhibitor
EPS15,PEXMETINIB,GuideToPharmacology,1,inhibitor
GFRA2,ML324,GuideToPharmacology,1,inhibitor
ANGPT2,AGOUTI-RELATED PROTEIN,GuideToPharmacology,1,inhibitor
ANOP1,COMPOUND 11S [PMID: 19433355],GuideToPharmacology,1,modulator
ANPEP,"(1S,3R)-ACPD",GuideToPharmacology,1,agonist
ANOP1,COMPOUND 9A [PMID: 22266036],GuideToPharmacology,1,modulator
ANPEP,DCG-IV,GuideToPharmacology,1,agonist
ANPEP,4-MPPTS,GuideToPharmacology,1,modulator
SLC25A5,"(S)-3,4-DCPG",GuideToPharmacology,1,agonist
SLC25A4,[3H]LY341495,GuideToPharmacology,1,inhibitor
NR2F6,MEK1/2 INHIBITOR,GuideToPharmacology,1,inhibitor
CTNS,COMPOUND 20 [PMID: 30998356],GuideToPharmacology,1,inhibitor
AADAC,FURTRETHONIUM IODIDE,GuideToPharmacology,1,agonist
AAMP,OXYBUTYNIN,GuideToPharmacology,1,inhibitor
AAMP,[3H]QNB,GuideToPharmacology,1,inhibitor
AANAT,XANOMELINE,GuideToPharmacology,1,agonist
AARS1,P-F-HHSID,GuideToPharmacology,1,inhibitor
AARS1,[3H]QNB,GuideToPharmacology,1,inhibitor
AARS1,OTENZEPAD,GuideToPharmacology,1,inhibitor
AAVS1,BETHANECHOL,GuideToPharmacology,1,agonist
AAVS1,ACECLIDINE,GuideToPharmacology,1,agonist
AAVS1,XANOMELINE,GuideToPharmacology,1,agonist
AAVS1,DOTHIEPIN,GuideToPharmacology,1,inhibitor
ANK2,EFPPEA,GuideToPharmacology,1,agonist
ANK2,ICOA-13,GuideToPharmacology,1,agonist
ANK2,GR 128107,GuideToPharmacology,1,agonist
APOF,3F-MT-45,GuideToPharmacology,1,agonist
BAK1,AFT-II,GuideToPharmacology,1,inhibitor
CD70,HYDROCHLOROTHIAZIDE,GuideToPharmacology,1,inhibitor
BARD1,AFT-II,GuideToPharmacology,1,inhibitor
BAX,AM-6120,GuideToPharmacology,1,inhibitor
ATP1A1,PHTX-11,GuideToPharmacology,1,inhibitor
AQP3,SUBSTANCE P-OME,GuideToPharmacology,1,agonist
DNAH9,"CP-424,174",GuideToPharmacology,1,inhibitor
AQP5,"N&#8242;,2-DIPHENYLQUINOLINE-4-CARBOHYDRAZIDE",GuideToPharmacology,1,inhibitor
NMUR1,NEUROMEDIN U-23,GuideToPharmacology,1,agonist
NMUR2,HAS-NMU,GuideToPharmacology,1,agonist
NMUR2,CPN-116,GuideToPharmacology,1,agonist
NMUR2,NEUROMEDIN U-23,GuideToPharmacology,1,agonist
ANXA7,JMV431,GuideToPharmacology,1,agonist
NUAK1,HTH-02-006,GuideToPharmacology,1,inhibitor
GTF2F2P1,CRAC CHANNEL INHIBITOR 1 [PMID: 26256403],GuideToPharmacology,1,blocker
HK3,LY3372689,GuideToPharmacology,1,inhibitor
APBB2,2MESATP,GuideToPharmacology,1,agonist
APBB2,2MESATP,GuideToPharmacology,1,inhibitor
APBB2,[32P]MRS2500,GuideToPharmacology,1,inhibitor
FRA4C,COMPOUND 3 [PMID: 8410973],GuideToPharmacology,1,inhibitor
APOE,ISOX-CHA-CHG-ARK(SULFO-CY5)-NH2,GuideToPharmacology,1,agonist
APOH,AYPGKF-NH2,GuideToPharmacology,1,agonist
BCKDHA,NS-220,GuideToPharmacology,1,agonist
BCKDHA,SELADELPAR,GuideToPharmacology,1,agonist
CCND1,SELADELPAR,GuideToPharmacology,1,agonist
CCND1,ZAFIRLUKAST,GuideToPharmacology,1,agonist
CCND1,TAGITININ A,GuideToPharmacology,1,agonist
CCND1,MDG 548,GuideToPharmacology,1,agonist
F5,AZD3458,GuideToPharmacology,1,inhibitor
F5,IDELALISIB,GuideToPharmacology,1,inhibitor
PIK3CB,AMDIZALISIB,GuideToPharmacology,1,inhibitor
PIK3CB,AZ2,GuideToPharmacology,1,inhibitor
PIK3CB,COMPOUND 5D [PMID: 31335136],GuideToPharmacology,1,inhibitor
F7,AMDIZALISIB,GuideToPharmacology,1,inhibitor
F7,AZ2,GuideToPharmacology,1,inhibitor
PIK3CB,ZANDELISIB,GuideToPharmacology,1,inhibitor
F7R,DS-7423,GuideToPharmacology,1,inhibitor
F7,ZANDELISIB,GuideToPharmacology,1,inhibitor
F7R,AZD3458,GuideToPharmacology,1,inhibitor
COL8A2,COMPOUND 3M [PMID: 32603117],GuideToPharmacology,1,inhibitor
COL9A1,CYCLIC GMP,GuideToPharmacology,1,activator
PDE5A,PF-00489791,GuideToPharmacology,1,inhibitor
PDE5A,GISADENAFIL,GuideToPharmacology,1,inhibitor
PDE5A,COMPOUND 3M [PMID: 32603117],GuideToPharmacology,1,inhibitor
COL13A1,CRISABOROLE,GuideToPharmacology,1,inhibitor
PDE5A,TPN171,GuideToPharmacology,1,inhibitor
COL12A1,NERANDOMILAST,GuideToPharmacology,1,inhibitor
F10,LGB321,GuideToPharmacology,1,inhibitor
FRA6B,SEMAGACESTAT,GuideToPharmacology,1,inhibitor
BDNF,WAY-255348,GuideToPharmacology,1,inhibitor
FABP4,(S)-RP-6306,GuideToPharmacology,1,inhibitor
APOA4,PRRP-20,GuideToPharmacology,1,agonist
BIRC5,TIP39-(7-39) (HUMAN/BOVINE),GuideToPharmacology,1,inhibitor
FAH,NAPORAFENIB,GuideToPharmacology,1,inhibitor
FAH,SB590885,GuideToPharmacology,1,inhibitor
BCL2L2,CD2314,GuideToPharmacology,1,agonist
BAK1P1,TAK-828F,GuideToPharmacology,1,agonist
BAK1P1,SR2211,GuideToPharmacology,1,agonist
BCL2L2,TRETINOIN,GuideToPharmacology,1,agonist
BCL2L2,TRETINOIN,GuideToPharmacology,1,inhibitor
BCL2L1,7-HYDROXYCHOLESTEROL,GuideToPharmacology,1,agonist
CTRB1,VEROSUDIL,GuideToPharmacology,1,inhibitor
DVL2,COMPOUND 1 [PMID: 21882820],GuideToPharmacology,1,inhibitor
APP,B-R13/17K H2 RELAXIN,GuideToPharmacology,1,inhibitor
CXADR,COMPOUND 1 [PMID: 20005102],GuideToPharmacology,1,inhibitor
APP,SA10SC-RLX,GuideToPharmacology,1,agonist
AMT,RP-101075,GuideToPharmacology,1,agonist
RYR3,MG2+,GuideToPharmacology,1,inhibitor
AMY2A,A-971432,GuideToPharmacology,1,agonist
AMY1B,SPHINGOSINE 1-PHOSPHATE,GuideToPharmacology,1,agonist
AMY2A,FINGOLIMOD-PHOSPHATE,GuideToPharmacology,1,agonist
FCN1,XMU-MP-1,GuideToPharmacology,1,inhibitor
CTSLP2,COMPOUND 35 [PMID: 20684608],GuideToPharmacology,1,inhibitor
GBE1,TINZAPARIN SODIUM,GuideToPharmacology,1,activator
BLVRB,COMPOUND 15 [PMID: 19456099],GuideToPharmacology,1,inhibitor
BLVRB,COMPOUND 35 [PMID: 19191557],GuideToPharmacology,1,inhibitor
FASLG,"[GA-DOTA,TYR3,THR8]OCTREOTIDE",GuideToPharmacology,1,agonist
FASLG,KE 108,GuideToPharmacology,1,agonist
FASLG,BIM 23068,GuideToPharmacology,1,agonist
AQP2,"L-363,301",GuideToPharmacology,1,agonist
AQP2,KE 108,GuideToPharmacology,1,agonist
AQP2,BIM 23050,GuideToPharmacology,1,agonist
AQP2,CORTISTATIN-14,GuideToPharmacology,1,agonist
AQP1,ANALOG 32 [PMID:18543899],GuideToPharmacology,1,inhibitor
AQP1,SRIF-14,GuideToPharmacology,1,agonist
AQP2,BIM 23197,GuideToPharmacology,1,agonist
AQP2,"[111IN,90Y]DOTA-TOC",GuideToPharmacology,1,agonist
GRIN1,STING AGONIST 3,GuideToPharmacology,1,agonist
HPCAL1,GNE-7883,GuideToPharmacology,1,inhibitor
THRB,DEXTROTHYROXINE,GuideToPharmacology,1,agonist
NR2C2,TRETINOIN,GuideToPharmacology,1,agonist
DOCK3,COMPOUND 15B [PMID: 16539403],GuideToPharmacology,1,inhibitor
ATP2A3,TONANTZITLOLONE,GuideToPharmacology,1,activator
ATP2B1,GSMTX-4,GuideToPharmacology,1,blocker
ATP5A2,NAFAMOSTAT,GuideToPharmacology,1,blocker
TRPM5,APV207095A,GuideToPharmacology,1,modulator
ATP5F1BP1,RUTHENIUM RED,GuideToPharmacology,1,blocker
TRPV4,QUINAZOLIN-4(3H) DERIVATIVE 36,GuideToPharmacology,1,activator
ATP5F1BP1,5'-IODORESINIFERATOXIN,GuideToPharmacology,1,blocker
FGFR4,GNE-7915,GuideToPharmacology,1,inhibitor
SLC26A2,SLC-391,GuideToPharmacology,1,inhibitor
TYK2,SAR-20347,GuideToPharmacology,1,inhibitor
UTS2R,UROTENSIN-II,GuideToPharmacology,1,agonist
FRA9B,LDN-91946,GuideToPharmacology,1,inhibitor
UTS2R,UROTENSIN-II,GuideToPharmacology,1,agonist
FUT6,MIGLUSTAT,GuideToPharmacology,1,inhibitor
CDH13,RESERPINE,GuideToPharmacology,1,inhibitor
ARCN1,HELODERMIN,GuideToPharmacology,1,agonist
FKBP1AP3,NEMTABRUTINIB,GuideToPharmacology,1,inhibitor
ANXA2P3,"[125I][LEU31,PRO34]NPY",GuideToPharmacology,1,agonist
ANXA5,NPY-(2-36),GuideToPharmacology,1,agonist
ANXA5,NPY-(13-36) (PIG),GuideToPharmacology,1,agonist
ANXA4,NPY-(13-36) (PIG),GuideToPharmacology,1,agonist
FKBP5,COMPOUND 15B [PMID: 16539403],GuideToPharmacology,1,inhibitor
A1BG,5-CT,GuideToPharmacology,1,agonist
A1BG,FLUSPIRILENE,GuideToPharmacology,1,inhibitor
A1BG,BROMOCRIPTINE,GuideToPharmacology,1,agonist
A2M,CLOZAPINE,GuideToPharmacology,1,agonist
A2M,CABERGOLINE,GuideToPharmacology,1,agonist
A2M,(+)-WAY 100135,GuideToPharmacology,1,inhibitor
A2MP1,LYSERGOL,GuideToPharmacology,1,agonist
A2MP1,FLUSPIRILENE,GuideToPharmacology,1,inhibitor
A2MP1,KETANSERIN,GuideToPharmacology,1,inhibitor
A12M1,5-CT,GuideToPharmacology,1,agonist
A12M3,VOLINANSERIN,GuideToPharmacology,1,inhibitor
A12M3,THIOTHIXENE,GuideToPharmacology,1,inhibitor
A12M3,RS-127445,GuideToPharmacology,1,inhibitor
A12M4,SB 228357,GuideToPharmacology,1,inhibitor
A12M4,KETANSERIN,GuideToPharmacology,1,inhibitor
A12M4,BROMOCRIPTINE,GuideToPharmacology,1,inhibitor
HTR2C,ARIPIPRAZOLE LAUROXIL,GuideToPharmacology,1,agonist
HTR2C,MIRTAZAPINE,GuideToPharmacology,1,inhibitor
NATP,EMD-386088,GuideToPharmacology,1,agonist
SERPINA3,5-CT,GuideToPharmacology,1,agonist
SERPINA3,OLEAMIDE,GuideToPharmacology,1,modulator
FRA10E,K-604,GuideToPharmacology,1,inhibitor
FRA17A,BW284C51,GuideToPharmacology,1,inhibitor
FKBP2,COMPOUND 1 [PMID: 20005102],GuideToPharmacology,1,inhibitor
FKBP2,GSK690693,GuideToPharmacology,1,inhibitor
CSTP1,COMPOUND 1 [PMID: 20005102],GuideToPharmacology,1,inhibitor
HBEGF,CERITINIB,GuideToPharmacology,1,inhibitor
ABCB7,RO-70-0004,GuideToPharmacology,1,inhibitor
ABCB7,SPIROXATRINE,GuideToPharmacology,1,inhibitor
ABCB7,TERAZOSIN,GuideToPharmacology,1,inhibitor
ACADSB,[PYR1]APELIN-13,GuideToPharmacology,1,agonist
BTF3P11,AUDIEN,GuideToPharmacology,1,inhibitor
ACADSB,E339-3D6,GuideToPharmacology,1,agonist
BTF3P11,AUPHEN,GuideToPharmacology,1,inhibitor
BTD,A-317567,GuideToPharmacology,1,blocker
BST2,PB2+,GuideToPharmacology,1,blocker
ABAT,CCPA,GuideToPharmacology,1,agonist
BTD,NAFAMOSTAT,GuideToPharmacology,1,blocker
CCKBR,CCK-4,GuideToPharmacology,1,agonist
ACTA1,[125I]CCL7 (HUMAN),GuideToPharmacology,1,agonist
ACTBP2,MARAVIROC,GuideToPharmacology,1,inhibitor
GMFB,BLINATUMOMAB,GuideToPharmacology,1,antibody
ACTBP5,ZK 756326,GuideToPharmacology,1,agonist
GLRA2,MOSUNETUZUMAB,GuideToPharmacology,1,antibody
GMPR,ISATUXIMAB,GuideToPharmacology,1,antibody
GATM,VELTUZUMAB,GuideToPharmacology,1,antibody
CHEK2,AZD7762,GuideToPharmacology,1,inhibitor
FRA1C,MELAGATRAN,GuideToPharmacology,1,inhibitor
ARHGDIA,L-(CIS)-DILTIAZEM,GuideToPharmacology,1,blocker
DPYD,GW-2580,GuideToPharmacology,1,inhibitor
DPYD,CEDIRANIB,GuideToPharmacology,1,inhibitor
DPYD,OSI-930,GuideToPharmacology,1,inhibitor
DPYD,M4205,GuideToPharmacology,1,inhibitor
AFF2,NAFAMOSTAT,GuideToPharmacology,1,inhibitor
BCL9,CITCO,GuideToPharmacology,1,agonist
CPT1B,CELECOXIB,GuideToPharmacology,1,inhibitor
CPT2,LUMIRACOXIB,GuideToPharmacology,1,inhibitor
ALAS2,[125I]CRF (OVINE),GuideToPharmacology,1,agonist
ALAS2,SAUVAGINE,GuideToPharmacology,1,agonist
ALAS2,[125I]SAUVAGINE (FROG),GuideToPharmacology,1,agonist
ALB,ASTRESSIN 2B,GuideToPharmacology,1,inhibitor
ALB,ASTRESSIN,GuideToPharmacology,1,inhibitor
ACTC1,CCL7,GuideToPharmacology,1,inhibitor
ACTC1,HYPOGLAUCIN A,GuideToPharmacology,1,inhibitor
ACTG1,CXCL12-(1-9) DIMER,GuideToPharmacology,1,agonist
EGR4,BOHEMINE,GuideToPharmacology,1,inhibitor
COX6A1,BMS-536924,GuideToPharmacology,1,inhibitor
COX6A1,KETOCONAZOLE,GuideToPharmacology,1,inhibitor
AMHR2,ICI198615,GuideToPharmacology,1,inhibitor
AMHR2,SULUKAST,GuideToPharmacology,1,inhibitor
DHODH,VIDOFLUDIMUS,GuideToPharmacology,1,inhibitor
DUSP2,SITRAVATINIB,GuideToPharmacology,1,inhibitor
DUSP1,NAPORAFENIB,GuideToPharmacology,1,inhibitor
APOB,ZK110841,GuideToPharmacology,1,agonist
APOB,&DELTA;12-PGJ2,GuideToPharmacology,1,agonist
ALCAM,CLOZAPINE,GuideToPharmacology,1,inhibitor
ABCD1,BLONANSERIN,GuideToPharmacology,1,inhibitor
ABCD1,APOMORPHINE,GuideToPharmacology,1,agonist
GATA2,MYCOPHENOLATE MOFETIL,GuideToPharmacology,1,inhibitor
CSNK1G2,3 ALPHA-AMINOCHOLESTANE,GuideToPharmacology,1,inhibitor
DPEP1,CERITINIB,GuideToPharmacology,1,inhibitor
DPEP1,BRIGATINIB,GuideToPharmacology,1,inhibitor
DPEP1,LINSITINIB,GuideToPharmacology,1,inhibitor
DPEP1,"INSULIN, REGULAR, HUMAN",GuideToPharmacology,1,agonist
FOXL2,GENISTEIN,GuideToPharmacology,1,agonist
BRCA2,EPICATECHIN GALLATE,GuideToPharmacology,1,agonist
BRCA2,GENISTEIN,GuideToPharmacology,1,agonist
POLR3D,ABSCISIC ACID,GuideToPharmacology,1,inhibitor
BNIP3,S7958,GuideToPharmacology,1,inhibitor
EPHB1,IVARMACITINIB,GuideToPharmacology,1,inhibitor
EPHB1,ABROCITINIB,GuideToPharmacology,1,inhibitor
EPHB1,JAK INHIBITOR 20A,GuideToPharmacology,1,inhibitor
EPHB1,JAK INHIBITOR 17B,GuideToPharmacology,1,inhibitor
EPHB1,POVORCITINIB,GuideToPharmacology,1,inhibitor
EPHB2,TINENGOTINIB,GuideToPharmacology,1,inhibitor
EPHB2,JAK INHIBITOR 20A,GuideToPharmacology,1,inhibitor
EPHB2,SAFIMALTIB,GuideToPharmacology,1,inhibitor
EPHB2,ROVADICITINIB,GuideToPharmacology,1,inhibitor
FFAR3,EXAMPLE 131 [WO2009133348],GuideToPharmacology,1,inhibitor
NUDT2,BU08028,GuideToPharmacology,1,agonist
EPHB3,SOLCITINIB,GuideToPharmacology,1,inhibitor
NUDT2,NALTRINDOLE,GuideToPharmacology,1,inhibitor
CD68,FUROSEMIDE,GuideToPharmacology,1,inhibitor
DRD2,TAFETINIB,GuideToPharmacology,1,inhibitor
DRD2,SEMAXANIB,GuideToPharmacology,1,inhibitor
ATP5ME,LINOLEIC ACID,GuideToPharmacology,1,activator
ARF5,SKA-20,GuideToPharmacology,1,activator
ARF6,UCL1684,GuideToPharmacology,1,inhibitor
ASCL1,TERTIAPIN-Q,GuideToPharmacology,1,blocker
ASD1,MG2+,GuideToPharmacology,1,inhibitor
ARG2,SKA-121,GuideToPharmacology,1,activator
ASNSP2,NICORANDIL,GuideToPharmacology,1,activator
ATP7B,PSORA-4,GuideToPharmacology,1,blocker
ATRX,LINOLEIC ACID,GuideToPharmacology,1,activator
ATRX,LINOLEIC ACID,GuideToPharmacology,1,blocker
LTB4R,LP533401,GuideToPharmacology,1,inhibitor
GGT3P,ML324,GuideToPharmacology,1,inhibitor
GLA,A-196,GuideToPharmacology,1,inhibitor
GGTA1,COMPOUND 9  [DOI:10.26434/CHEMRXIV.7072592.V1],GuideToPharmacology,1,inhibitor
MKNK2,MNK1 INHIBITOR,GuideToPharmacology,1,inhibitor
ANGPT2,&ALPHA;-MSH,GuideToPharmacology,1,agonist
ANGPT1,SETMELANOTIDE,GuideToPharmacology,1,agonist
ETFB,AZD8055,GuideToPharmacology,1,inhibitor
DRD4,COMPOUND 1O [PMID: 24210504],GuideToPharmacology,1,inhibitor
ETFB,ZANDELISIB,GuideToPharmacology,1,inhibitor
DRD4,BMS-777607,GuideToPharmacology,1,inhibitor
DTNA,MK-2461,GuideToPharmacology,1,inhibitor
DRD4,CABOZANTINIB S-MALATE,GuideToPharmacology,1,inhibitor
CYP2J2,XMT-1191,GuideToPharmacology,1,inhibitor
DTNA,SITRAVATINIB,GuideToPharmacology,1,inhibitor
SLC25A5,SIB-1893,GuideToPharmacology,1,modulator
SLC25A6,MTEB,GuideToPharmacology,1,modulator
GRM6,"(1S,3R)-ACPD",GuideToPharmacology,1,agonist
CTSH,COMPOUND 35 [PMID: 23916259],GuideToPharmacology,1,inhibitor
GRM8,DCG-IV,GuideToPharmacology,1,inhibitor
ESR1,PCC0105003,GuideToPharmacology,1,inhibitor
CTNNA1,TIZATERKIB,GuideToPharmacology,1,inhibitor
CTNND1,SB203580,GuideToPharmacology,1,inhibitor
CTNNB1,PEXMETINIB,GuideToPharmacology,1,inhibitor
MAPK3,ULIXERTINIB,GuideToPharmacology,1,inhibitor
CTNNA2,GNE-3511,GuideToPharmacology,1,inhibitor
CTNNA2,COMPOUND 20 [PMID: 30998356],GuideToPharmacology,1,inhibitor
ACE,TP0556351,GuideToPharmacology,1,inhibitor
DBP,MARIMASTAT,GuideToPharmacology,1,inhibitor
DBP,CGS-27023A,GuideToPharmacology,1,inhibitor
DBT,TP0556351,GuideToPharmacology,1,inhibitor
DCC,CM-352,GuideToPharmacology,1,inhibitor
ECI1,TP0556351,GuideToPharmacology,1,inhibitor
DCK,AZD6605,GuideToPharmacology,1,inhibitor
ANTP4,MOTILIN-(1-12) (HUMAN),GuideToPharmacology,1,agonist
FSHMD1B,SELEGILINE,GuideToPharmacology,1,inhibitor
AADAC,AZD6088,GuideToPharmacology,1,agonist
AAMP,FURTRETHONIUM IODIDE,GuideToPharmacology,1,agonist
AAMP,DIMETHYL-W84,GuideToPharmacology,1,modulator
AAMP,P-F-HHSID,GuideToPharmacology,1,inhibitor
ANK3,UCSF3384,GuideToPharmacology,1,agonist
APOF,ATICAPRANT,GuideToPharmacology,1,inhibitor
F7,COMPOUND 27 [PMID: 35834807],GuideToPharmacology,1,inhibitor
F7,EGANELISIB,GuideToPharmacology,1,inhibitor
F7,RV6153,GuideToPharmacology,1,inhibitor
F7R,ZANDELISIB,GuideToPharmacology,1,inhibitor
F7R,SELETALISIB,GuideToPharmacology,1,inhibitor
F2R,TORIN 2,GuideToPharmacology,1,inhibitor
COL11A2,APREMILAST,GuideToPharmacology,1,inhibitor
COL10A1,MK-0873,GuideToPharmacology,1,inhibitor
COL12A1,APREMILAST,GuideToPharmacology,1,inhibitor
COL10A1,ROLIPRAM,GuideToPharmacology,1,inhibitor
COL10A1,"6-HYDROXY-5,7-DIMETHOXYFLAVONE",GuideToPharmacology,1,inhibitor
COL11A1,RO20-1724,GuideToPharmacology,1,inhibitor
COL11A1,"6-HYDROXY-5,7-DIMETHOXYFLAVONE",GuideToPharmacology,1,inhibitor
COL11A2,RO20-1724,GuideToPharmacology,1,inhibitor
COL12A1,RS-25344,GuideToPharmacology,1,inhibitor
DPP4,QUIZARTINIB,GuideToPharmacology,1,inhibitor
DPP6,COMPOUND 5E [PMID: 28580438],GuideToPharmacology,1,inhibitor
DPP6,TANDUTINIB,GuideToPharmacology,1,inhibitor
DPP6,TAFETINIB,GuideToPharmacology,1,inhibitor
GNAI2,"COMPOUND 5 [TOMASSI ET AL., 2020]",GuideToPharmacology,1,inhibitor
FRA2K,PEPTIDE 18 [PMID: 24350995],GuideToPharmacology,1,inhibitor
BDNF,PF-03882845,GuideToPharmacology,1,inhibitor
FRA6A,COMPOUND 11 [PMID: 29442501],GuideToPharmacology,1,inhibitor
PSMB8,HT1042,GuideToPharmacology,1,inhibitor
PRMT5,EPZ015666,GuideToPharmacology,1,inhibitor
FRA6D,COMPOUND 3B [PMID: 24946214],GuideToPharmacology,1,inhibitor
CMTX3,COMPOUND 1 [PMID: 22795084],GuideToPharmacology,1,inhibitor
CNC2,C21,GuideToPharmacology,1,inhibitor
CTBP1,SOTRASTAURIN,GuideToPharmacology,1,inhibitor
CTAG1B,SOTRASTAURIN,GuideToPharmacology,1,inhibitor
GOLGA1,AZD7648,GuideToPharmacology,1,inhibitor
PRKG1,GSK690693,GuideToPharmacology,1,inhibitor
PRKG1,ALLOSTERIC MODULATOR 33 [PMID: 35878399],GuideToPharmacology,1,modulator
FANCA,GSK690693,GuideToPharmacology,1,inhibitor
ACSL1,CEP-37440,GuideToPharmacology,1,inhibitor
HOXA6,VOCIPROTAFIB,GuideToPharmacology,1,inhibitor
FAP,PONATINIB,GuideToPharmacology,1,inhibitor
GOLGA3,CCG-50014,GuideToPharmacology,1,inhibitor
FANCG,PONATINIB,GuideToPharmacology,1,inhibitor
GP2,RGS4 INHIBITOR 11B,GuideToPharmacology,1,inhibitor
BCHEL1,TRETINOIN,GuideToPharmacology,1,agonist
BCHEL1,CD666,GuideToPharmacology,1,agonist
BCHEL1,KCL-286,GuideToPharmacology,1,agonist
BCHE,AROTINOID ACID,GuideToPharmacology,1,agonist
GP2,CCG-203920,GuideToPharmacology,1,inhibitor
BCHEL3,AROTINOID ACID,GuideToPharmacology,1,agonist
BCHEL3,ADAPALENE,GuideToPharmacology,1,agonist
PTK2B,ZETELETINIB,GuideToPharmacology,1,inhibitor
EFNA4,COMPOUND 7D [PMID: 25703523],GuideToPharmacology,1,inhibitor
CCKBR,[3H]L365260,GuideToPharmacology,1,inhibitor
FMOD,JNJ-67569762,GuideToPharmacology,1,inhibitor
A12M1,[3H]5-HT,GuideToPharmacology,1,agonist
A12M3,DOI,GuideToPharmacology,1,agonist
FOLR2L,LHVS,GuideToPharmacology,1,inhibitor
GRK3,QWF,GuideToPharmacology,1,inhibitor
AMYP1,COMPOUND 38 [PMID: 22123324],GuideToPharmacology,1,inhibitor
GLRA1,GINKGOLIDE X,GuideToPharmacology,1,inhibitor
DBH,Z-WEHD-FMK,GuideToPharmacology,1,inhibitor
BCYRN1P2,AC-186,GuideToPharmacology,1,agonist
CD24P1,ORG 24598,GuideToPharmacology,1,inhibitor
BCKDHA,CLOFIBRATE,GuideToPharmacology,1,agonist
FRA1A,ABELACIMAB,GuideToPharmacology,1,antibody
APOF,&BETA;-FNA,GuideToPharmacology,1,inhibitor
BIRC2,ADENOSINE TRIPHOSPHATE,GuideToPharmacology,1,agonist
ANK2,2-[125I]MELATONIN,GuideToPharmacology,1,agonist
FKBP1AP3,XILIERTINIB,GuideToPharmacology,1,inhibitor
AANAT,OXOTREMORINE-M,GuideToPharmacology,1,agonist
BAK1P1,COMPOUND 32 [PMID: 31638797],GuideToPharmacology,1,agonist
DXO,TUXOBERTINIB,GuideToPharmacology,1,inhibitor
ANPEP,LY379268,GuideToPharmacology,1,agonist
ARAF,[PHE3]OT,GuideToPharmacology,1,agonist
BMAL1,TETRAHYDRODEOXYCORTICOSTERONE,GuideToPharmacology,1,modulator
FOXL2,DATISCETIN,GuideToPharmacology,1,agonist
DPP6,SOTULETINIB,GuideToPharmacology,1,inhibitor
STK4,COMPOUND 38 [PMID: 20817473],GuideToPharmacology,1,inhibitor
ATP2B1,(-)-ENGLERIN A,GuideToPharmacology,1,activator
APOC1,PF-04852946,GuideToPharmacology,1,inhibitor
ASCL1,BA2+,GuideToPharmacology,1,blocker
LRRC32,QUISINOSTAT,GuideToPharmacology,1,inhibitor
AANAT,METHYLFURMETHIDE,GuideToPharmacology,1,agonist
AQP1,&BETA;3-TETRAPEPTIDE,GuideToPharmacology,1,agonist
DUSP1,DDR1/2 INHIBITOR 5N,GuideToPharmacology,1,inhibitor
ALDH3B2,FMET-MET-TRP-LEU-LEU,GuideToPharmacology,1,agonist
IL6R,SARILUMAB,GuideToPharmacology,1,antibody
F7,AZD6482,GuideToPharmacology,1,inhibitor
FDX1,MIVAVOTINIB,GuideToPharmacology,1,inhibitor
F5,COMPOUND 82 [PMID: 21332118],GuideToPharmacology,1,inhibitor
CYP3A51P,APSTATIN,GuideToPharmacology,1,inhibitor
DPAGT1,TX2-121-1,GuideToPharmacology,1,inhibitor
AAMP,HEXAHYDROSILADIFENIDOL,GuideToPharmacology,1,inhibitor
AANAT,REVEFENACIN,GuideToPharmacology,1,inhibitor
EIF4A1,VORUCICLIB,GuideToPharmacology,1,inhibitor
DPYSL2,3-[(3-(2-CARBOXYETHYL)-4-METHYLPYRROL-2-YL)METHYLENE]-2-INDOLINONE,GuideToPharmacology,1,inhibitor
GPT,ABL127,GuideToPharmacology,1,inhibitor
EWSR1,WZ4003,GuideToPharmacology,1,inhibitor
ELANE,MW01,GuideToPharmacology,1,inhibitor
AQP8,CICAPROST,GuideToPharmacology,1,agonist
SLC25A4,LY379268,GuideToPharmacology,1,agonist
FNTA,IPTACOPAN,GuideToPharmacology,1,inhibitor
BCL5,TROPIFEXOR,GuideToPharmacology,1,agonist
PRDM1,COMPOUND 9 [PMID: 1992149],GuideToPharmacology,1,inhibitor
XCR1,1-METHYL-L-TRYPTOPHAN,GuideToPharmacology,1,inhibitor
FKBP1AP4,MIVAVOTINIB,GuideToPharmacology,1,inhibitor
BDNF,LEVONORGESTREL,GuideToPharmacology,1,agonist
ALDH2,ZOTEPINE,GuideToPharmacology,1,inhibitor
SLC25A6,CDPPB,GuideToPharmacology,1,modulator
BTD,AMILORIDE,GuideToPharmacology,1,blocker
GALR2,GALP(3-32) (HUMAN),GuideToPharmacology,1,agonist
DRD5P2,GNF-5837,GuideToPharmacology,1,inhibitor
APOA4,PRRP-(24-31) (HUMAN),GuideToPharmacology,1,agonist
SERPINA3,5-HYDROXYTRYPTAMINE,GuideToPharmacology,1,agonist
DPYS,PACRITINIB,GuideToPharmacology,1,inhibitor
CD24P1,(R)-NFPS,GuideToPharmacology,1,inhibitor
EPHA8,COMPOUND 7 [PMID: 22464456],GuideToPharmacology,1,inhibitor
FMO5,JNJ-67569762,GuideToPharmacology,1,inhibitor
A12M3,ZOTEPINE,GuideToPharmacology,1,inhibitor
GNAI2,NIRAPARIB,GuideToPharmacology,1,inhibitor
KCNT2,BA2+,GuideToPharmacology,1,blocker
EIF4EP1,SORAFENIB,GuideToPharmacology,1,inhibitor
GRK3,PAMP-20,GuideToPharmacology,1,agonist
AANAT,NNC 11-1585,GuideToPharmacology,1,agonist
ACTBP2,CCL2,GuideToPharmacology,1,agonist
ALOX12P2,J20 (GALANIN ANALOGUE),GuideToPharmacology,1,agonist
SLC29A1,CDK/CRK INHIBITOR,GuideToPharmacology,1,inhibitor
GPC4,COMPOUND 31 [PMID: 22902653],GuideToPharmacology,1,inhibitor
ARR3,[3H]MUSCIMOL,GuideToPharmacology,1,agonist
NUDT2,ENADOLINE,GuideToPharmacology,1,agonist
EPS15,XILIERTINIB,GuideToPharmacology,1,inhibitor
XIAP,[ILE5]PTHRP-(1-36) (HUMAN),GuideToPharmacology,1,agonist
ABAT,NECA,GuideToPharmacology,1,agonist
DXO,NERATINIB,GuideToPharmacology,1,inhibitor
ACAT2,"[D-TYR6,&BETA;-ALA11,N-ME-ALA13,NLE14]BOMBESIN-(6-14)",GuideToPharmacology,1,agonist
FRV1,SKI II,GuideToPharmacology,1,inhibitor
BCHEL1,AGN193109,GuideToPharmacology,1,inhibitor
NAT1,PF-04995274,GuideToPharmacology,1,agonist
ENG,DS21360717,GuideToPharmacology,1,inhibitor
GNRHR,[GLN8]GNRH,GuideToPharmacology,1,agonist
ERCC8,TRYPTOPHAN,GuideToPharmacology,1,inhibitor
MS4A2,COMPOUND 19A [PMID: 30503936],GuideToPharmacology,1,inhibitor
AQP2,BIM 23060,GuideToPharmacology,1,agonist
A1BG,ZOTEPINE,GuideToPharmacology,1,inhibitor
A1BG,[3H]WAY100635,GuideToPharmacology,1,inhibitor
A2M,RIZATRIPTAN BENZOATE,GuideToPharmacology,1,agonist
A2M,RU 24969,GuideToPharmacology,1,agonist
A12M1,1-NAPHTHYLPIPERAZINE,GuideToPharmacology,1,inhibitor
A12M3,VER-3323,GuideToPharmacology,1,agonist
A12M3,SB 242084,GuideToPharmacology,1,inhibitor
A12M4,METERGOLINE,GuideToPharmacology,1,inhibitor
HTR2C,SARPOGRELATE,GuideToPharmacology,1,inhibitor
HTR2C,SB 216641,GuideToPharmacology,1,agonist
HTR2C,RS-102221,GuideToPharmacology,1,inhibitor
HTR2C,IDALOPIRDINE,GuideToPharmacology,1,inhibitor
NAT1,TD-8954,GuideToPharmacology,1,agonist
NATP,EMDT,GuideToPharmacology,1,agonist
NAT2,METERGOLINE,GuideToPharmacology,1,inhibitor
NATP,WAY-208466,GuideToPharmacology,1,agonist
NATP,SB399885,GuideToPharmacology,1,inhibitor
GSS,PFKFB3 KINASE INHIBITOR 69,GuideToPharmacology,1,inhibitor
ADAM10,COMPOUND 25 [PMID: 18068976],GuideToPharmacology,1,inhibitor
DNM2,MOMELOTINIB,GuideToPharmacology,1,inhibitor
TRDMT1,VACTOSERTIB,GuideToPharmacology,1,inhibitor
CNN1,TOFA,GuideToPharmacology,1,inhibitor
ADAM10,GI254023X,GuideToPharmacology,1,inhibitor
HBEGF,ZOTIZALKIB,GuideToPharmacology,1,inhibitor
HELLS,ORLISTAT,GuideToPharmacology,1,inhibitor
GNA12,AK198,GuideToPharmacology,1,inhibitor
HBEGF,COMPOUND 5G [PMID: 20483621],GuideToPharmacology,1,inhibitor
GNA12,ZENARESTAT,GuideToPharmacology,1,inhibitor
ABCF1,PRAZOSIN,GuideToPharmacology,1,inhibitor
ABCF1,ALFUZOSIN,GuideToPharmacology,1,inhibitor
ABCA4,RS-17053,GuideToPharmacology,1,inhibitor
ABCA4,INDORAMIN,GuideToPharmacology,1,inhibitor
ABCA4,DOXAZOSIN MESYLATE,GuideToPharmacology,1,inhibitor
ABL1,LOFEXIDINE,GuideToPharmacology,1,agonist
AOC1,ZOTEPINE,GuideToPharmacology,1,inhibitor
ABL2,TOLAZOLINE,GuideToPharmacology,1,inhibitor
BEVI,ENZALUTAMIDE,GuideToPharmacology,1,inhibitor
BEVI,ANDARINE,GuideToPharmacology,1,agonist
CYP2C9,COMPOUND 9 [PMID: 1738140],GuideToPharmacology,1,inhibitor
ABAT,SCH442416,GuideToPharmacology,1,inhibitor
ABCA1,ETRUMADENANT,GuideToPharmacology,1,inhibitor
ABCA3,MRS1754,GuideToPharmacology,1,inhibitor
EEF1D,AMG-900,GuideToPharmacology,1,inhibitor
ACADM,"[SAR1,ILE8]ANG-II",GuideToPharmacology,1,inhibitor
ACADM,LY301875,GuideToPharmacology,1,inhibitor
EEF1D,CDK2 INHIBITOR IV,GuideToPharmacology,1,inhibitor
ACAT1,PHYLLOLITORIN,GuideToPharmacology,1,agonist
ACAT1,BOMBESIN,GuideToPharmacology,1,agonist
CSRP2,CCG258747,GuideToPharmacology,1,inhibitor
FMO5,AM-6494,GuideToPharmacology,1,inhibitor
ABO,LEVOSALBUTAMOL,GuideToPharmacology,1,agonist
ABO,SOTALOL,GuideToPharmacology,1,inhibitor
ABO,[125I]ICYP,GuideToPharmacology,1,inhibitor
EFNA2,CHIR-265,GuideToPharmacology,1,inhibitor
EFNA1,ACALABRUTINIB,GuideToPharmacology,1,inhibitor
EFNA4,COMPOUND 4D [PMID: 21851057],GuideToPharmacology,1,inhibitor
EFNA3,COMPOUND 38 [PMID: 24000170],GuideToPharmacology,1,inhibitor
EFNA4,XY-06-007,GuideToPharmacology,1,inhibitor
BRD7,BI-9564,GuideToPharmacology,1,inhibitor
EFNB2,REMIBRUTINIB,GuideToPharmacology,1,inhibitor
ASIC1,LYS-KALLIDIN,GuideToPharmacology,1,agonist
BDKRB2,FR191413,GuideToPharmacology,1,agonist
ASIC1,B-9958,GuideToPharmacology,1,inhibitor
BDKRB2,[125I]HPP-HOE140,GuideToPharmacology,1,inhibitor
EFNB3,COMPOUND 2-3-2 [PMID: 24900824],GuideToPharmacology,1,inhibitor
EFNB3,COMPOUND 2-1-1 [PMID: 24900824],GuideToPharmacology,1,inhibitor
EFNB3,COMPOUND 2-3-1 [PMID: 24900824],GuideToPharmacology,1,inhibitor
BDKRB2,NPC-567,GuideToPharmacology,1,inhibitor
ACACB,PMX205,GuideToPharmacology,1,inhibitor
ACACB,"EU-DTPA-[SER27, NLE70]HC5A",GuideToPharmacology,1,agonist
ACACA,SB290157,GuideToPharmacology,1,inhibitor
C1QBP,CACCINH-A01,GuideToPharmacology,1,blocker
DBIL3,ISATIN SULFONAMIDE 34 [PMID: 11384246],GuideToPharmacology,1,inhibitor
ATP6V1E1,CALCISEPTINE,GuideToPharmacology,1,blocker
ATP6AP1,TTA-A2,GuideToPharmacology,1,blocker
FOS,LHVS,GuideToPharmacology,1,inhibitor
ACRV1,DRONABINOL,GuideToPharmacology,1,agonist
ACTA2,GSK COMPOUND 34,GuideToPharmacology,1,inhibitor
ACTB,MET-CK&BETA;7,GuideToPharmacology,1,inhibitor
CCR4,VMIP-III,GuideToPharmacology,1,agonist
ACTBP2,[125I]CCL3 (HUMAN),GuideToPharmacology,1,agonist
EGR3,COMPOUND 2 [PMID: 22560567],GuideToPharmacology,1,inhibitor
CFTR,UCCF-029,GuideToPharmacology,1,activator
CFTR,UCCF-339,GuideToPharmacology,1,activator
CFTR,CAPSAICIN,GuideToPharmacology,1,activator
CFTR,NS004,GuideToPharmacology,1,activator
EIF4A1,PURVALANOL A,GuideToPharmacology,1,inhibitor
EIF4A1,BMS-265246,GuideToPharmacology,1,inhibitor
EIF4A1,DINACICLIB,GuideToPharmacology,1,inhibitor
CDK4,SU9516,GuideToPharmacology,1,inhibitor
EIF4A1,THAL-SNS-032,GuideToPharmacology,1,inhibitor
EIF4E,(2R)-2-({9-(1-METHYLETHYL)-6-[(4-PYRIDIN-2-YLBENZYL)AMINO]-9H-PURIN-2-YL}AMINO)BUTAN-1-OL,GuideToPharmacology,1,inhibitor
EIF4E,SU9516,GuideToPharmacology,1,inhibitor
EIF4EBP2,CDK2 INHIBITOR IV,GuideToPharmacology,1,inhibitor
EIF4EBP2,SU9516,GuideToPharmacology,1,inhibitor
EIF4EBP2,BS-194,GuideToPharmacology,1,inhibitor
EIF4G1,"(7S)-2-(2-AMINOPYRIMIDIN-4-YL)-7-(2-FLUOROETHYL)-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE",GuideToPharmacology,1,inhibitor
EIF4G1,RIVICICLIB,GuideToPharmacology,1,inhibitor
CPD,ENDOXIFEN,GuideToPharmacology,1,inhibitor
EIF4G1,VORUCICLIB,GuideToPharmacology,1,inhibitor
CORD4,COMPOUND 39A [PMID: 15634016],GuideToPharmacology,1,inhibitor
COX5B,BERBERINE,GuideToPharmacology,1,inhibitor
CLDN7,LIAROZOLE,GuideToPharmacology,1,inhibitor
GLRB,CADONILIMAB,GuideToPharmacology,1,antibody
AMPD1,[3H]LTC4,GuideToPharmacology,1,agonist
CCNH,QUISQUALIC ACID,GuideToPharmacology,1,inhibitor
CD8B2,VANOXERINE,GuideToPharmacology,1,inhibitor
CD8B2,NOMIFENSINE,GuideToPharmacology,1,inhibitor
APAF1,SCH221510,GuideToPharmacology,1,agonist
APAF1,CTAP,GuideToPharmacology,1,inhibitor
APAF1,NALOXONE HYDROCHLORIDE,GuideToPharmacology,1,inhibitor
DHODH,FARUDODSTAT,GuideToPharmacology,1,inhibitor
CRIP1,RHC80267,GuideToPharmacology,1,inhibitor
ABCD1,LOXAPINE,GuideToPharmacology,1,inhibitor
ALDH1A1,FLUPENTHIXOL,GuideToPharmacology,1,inhibitor
ALDH1A1,NEMONAPRIDE,GuideToPharmacology,1,inhibitor
ALDH2,PROCHLORPERAZINE,GuideToPharmacology,1,inhibitor
ALDH2,ROTIGOTINE,GuideToPharmacology,1,agonist
ALDH3A1,ROTIGOTINE,GuideToPharmacology,1,agonist
ALDH2,U101958,GuideToPharmacology,1,inhibitor
ALDH3A1,SPIPERONE,GuideToPharmacology,1,inhibitor
CXCR3,IOX1,GuideToPharmacology,1,inhibitor
FRZB,MAK683,GuideToPharmacology,1,modulator
DSC3,COMPOUND 66 [PMID: 19788238],GuideToPharmacology,1,inhibitor
DSC1,COMPOUND 66 [PMID: 19788238],GuideToPharmacology,1,inhibitor
DXO,POZIOTINIB,GuideToPharmacology,1,inhibitor
DXO,MAVELERTINIB,GuideToPharmacology,1,inhibitor
DXO,OSIMERTINIB,GuideToPharmacology,1,inhibitor
DXO,RALIMETINIB,GuideToPharmacology,1,inhibitor
DXO,JBJ-04-125-02,GuideToPharmacology,1,inhibitor
DXO,XILIERTINIB,GuideToPharmacology,1,inhibitor
DXO,PP-121,GuideToPharmacology,1,inhibitor
CRMP1,(S)-ARN2508,GuideToPharmacology,1,inhibitor
CRP,ASP8477,GuideToPharmacology,1,inhibitor
FYN,HM50316,GuideToPharmacology,1,inhibitor
H2BC5,AFM13,GuideToPharmacology,1,antibody
FFAR3,ACETATE,GuideToPharmacology,1,agonist
DPYSL2,INFIGRATINIB,GuideToPharmacology,1,inhibitor
DPYSL2,BLU-9931,GuideToPharmacology,1,inhibitor
DPYSL3,INFIGRATINIB,GuideToPharmacology,1,inhibitor
DRD1,LINIFANIB,GuideToPharmacology,1,inhibitor
DRD1,BRIVANIB,GuideToPharmacology,1,inhibitor
DPYS,BMS-690514,GuideToPharmacology,1,inhibitor
DPYS,FLT-3 INHIBITOR III,GuideToPharmacology,1,inhibitor
DRD3,CHMFL-KIT-64,GuideToPharmacology,1,inhibitor
DPYS,SORAFENIB,GuideToPharmacology,1,inhibitor
DRD3,RIPK1 INHIBITOR 22B,GuideToPharmacology,1,inhibitor
ALDH3B2,T20(DP178),GuideToPharmacology,1,agonist
ALDH3A2,ANNEXIN I-(2-26),GuideToPharmacology,1,agonist
ENO2,ACALABRUTINIB,GuideToPharmacology,1,inhibitor
ENO1P1,BOSUTINIB,GuideToPharmacology,1,inhibitor
ENO2,BOSUTINIB,GuideToPharmacology,1,inhibitor
GABRA1,FLUMAZENIL,GuideToPharmacology,1,modulator
GABRA1,TRIAZOLAM,GuideToPharmacology,1,modulator
ARNT,MRK016,GuideToPharmacology,1,modulator
GABRA1,ALPRAZOLAM,GuideToPharmacology,1,modulator
BDM,ABBV-3373,GuideToPharmacology,1,agonist
BDM,FLUOCINONIDE,GuideToPharmacology,1,agonist
ASS1P10,"5,7-DICHLOROKYNURENIC ACID",GuideToPharmacology,1,inhibitor
ASS1P6,[3H]SYM2081,GuideToPharmacology,1,agonist
GRIK3,[3H]SYM2081,GuideToPharmacology,1,agonist
GRIN2B,AMANTADINE HYDROCHLORIDE,GuideToPharmacology,1,blocker
GNRHR,TEVERELIX,GuideToPharmacology,1,inhibitor
GNRHR,"5-(N,N-HEXAMETHYLENE)-AMILORIDE",GuideToPharmacology,1,modulator
DLX3,DENDROASPIS NATRIURETIC PEPTIDE,GuideToPharmacology,1,agonist
DLX6,PLECANATIDE,GuideToPharmacology,1,agonist
PHOX2A,CILOBRADINE,GuideToPharmacology,1,blocker
ARL2,CILOBRADINE,GuideToPharmacology,1,blocker
AOAH,COMPOUND 6O [PMID: 19524438],GuideToPharmacology,1,agonist
GDF2,GIVINOSTAT,GuideToPharmacology,1,inhibitor
GDF2,VALPROIC ACID,GuideToPharmacology,1,inhibitor
GDF2,KA1010,GuideToPharmacology,1,inhibitor
HDAC4,QUISINOSTAT,GuideToPharmacology,1,inhibitor
GARS1,PRACINOSTAT,GuideToPharmacology,1,inhibitor
HDAC4,TMP269,GuideToPharmacology,1,inhibitor
HDAC4,MARTINOSTAT,GuideToPharmacology,1,inhibitor
GARS1,RGFP966,GuideToPharmacology,1,inhibitor
GART,MARTINOSTAT,GuideToPharmacology,1,inhibitor
GDF9,QUISINOSTAT,GuideToPharmacology,1,inhibitor
AMD1,9-OH-RISPERIDONE,GuideToPharmacology,1,inhibitor
AMD1,AZELASTINE,GuideToPharmacology,1,inhibitor
GAS2,TMP269,GuideToPharmacology,1,inhibitor
AMD1,CIPROXIFAN,GuideToPharmacology,1,inhibitor
AMD1,MIZOLASTINE,GuideToPharmacology,1,inhibitor
AMD1,CYCLIZINE,GuideToPharmacology,1,inhibitor
AMD1P2,AMTHAMINE,GuideToPharmacology,1,agonist
AMD1,PYRILAMINE,GuideToPharmacology,1,inhibitor
AMD1,ZOTEPINE,GuideToPharmacology,1,inhibitor
AMELX,2-(3-BROMOPHENYL)HISTAMINE,GuideToPharmacology,1,agonist
PRDM1,ROSUVASTATIN,GuideToPharmacology,1,inhibitor
PRDM1,MEVASTATIN,GuideToPharmacology,1,inhibitor
GPR32,RVD1-ME,GuideToPharmacology,1,agonist
ADARB1,PROSAPTIDE,GuideToPharmacology,1,agonist
ACTG1P10,DIPHENYLENEIODONIUM CHLORIDE,GuideToPharmacology,1,agonist
ADD3,LAURIC ACID,GuideToPharmacology,1,agonist
ADCY3,O-1602,GuideToPharmacology,1,agonist
ADCY3,"COMPOUND 3A [BADOLATO ET AL., 2019]",GuideToPharmacology,1,agonist
NOS2,NIL,GuideToPharmacology,1,inhibitor
GATA3,MERIMEPODIB,GuideToPharmacology,1,inhibitor
NAAA,ARN19702,GuideToPharmacology,1,inhibitor
ITPR1,ADENOSINE TRIPHOSPHATE,GuideToPharmacology,1,activator
FOXL2,L-TRP-TRP-TRP,GuideToPharmacology,1,agonist
FOXL2,N-(2-OXOTETRAHYDROFURAN-3-YL)OCTANAMIDE,GuideToPharmacology,1,agonist
FOXL2,SANTONIN,GuideToPharmacology,1,agonist
FOXL2,NOBILETIN,GuideToPharmacology,1,agonist
EPHB3,LASW1393,GuideToPharmacology,1,inhibitor
EPHB3,CEP-33779,GuideToPharmacology,1,inhibitor
EPHB3,COMPOUND 1D [PMID: 21493067],GuideToPharmacology,1,inhibitor
NUDT2,DAMGO,GuideToPharmacology,1,agonist
NUDT2,PROBE 1.1 [PMID: 24187130],GuideToPharmacology,1,agonist
NUDT2,ENADOLINE,GuideToPharmacology,1,agonist
NUDT2,SR16835,GuideToPharmacology,1,agonist
NUDT2,DYNORPHIN B,GuideToPharmacology,1,agonist
NUDT2,NALTRIBEN,GuideToPharmacology,1,inhibitor
DRD2,LINIFANIB,GuideToPharmacology,1,inhibitor
DRD2,LAZERTINIB,GuideToPharmacology,1,inhibitor
DRD2,CP-547632,GuideToPharmacology,1,inhibitor
DPT,CRENOLANIB,GuideToPharmacology,1,inhibitor
ATP5ME,HALOTHANE,GuideToPharmacology,1,activator
ARF4P1,NS004,GuideToPharmacology,1,activator
ARG1,RA-2,GuideToPharmacology,1,inhibitor
BAD,HALOFANTRINE,GuideToPharmacology,1,blocker
AZGP1,NC00075159,GuideToPharmacology,1,activator
AZGP1,RETIGABINE DERIVATIVE 10G,GuideToPharmacology,1,activator
KCNQ5,RETIGABINE DERIVATIVE 10G,GuideToPharmacology,1,activator
FRA10D,COMPOUND 1 [PMID: 22533316],GuideToPharmacology,1,inhibitor
GSK3B,RELATLIMAB,GuideToPharmacology,1,antibody
EPHX2,XILIERTINIB,GuideToPharmacology,1,inhibitor
CNTFR,CARBIDOPA ANHYDROUS,GuideToPharmacology,1,inhibitor
GRM3,LIVMONIPLIMAB,GuideToPharmacology,1,antibody
STX2,COMPOUND 35 [PMID: 22902653],GuideToPharmacology,1,inhibitor
CRHR2,DG-051,GuideToPharmacology,1,inhibitor
BAK1P2,COMPOUND 17L [PMID: 26288691],GuideToPharmacology,1,inhibitor
CLN8,COMPOUND 31 [PMID: 22902653],GuideToPharmacology,1,inhibitor
BIN1,CPX,GuideToPharmacology,1,agonist
AMPD3,BMS-986278,GuideToPharmacology,1,inhibitor
GEM,RN-1,GuideToPharmacology,1,inhibitor
GLI3,ANACARDIC ACID,GuideToPharmacology,1,inhibitor
KDM5A,KDM5 INHIBITOR N71,GuideToPharmacology,1,inhibitor
AMY2B,MQ1,GuideToPharmacology,1,modulator
ANCR,AFAMELANOTIDE,GuideToPharmacology,1,agonist
ANK1,AFAMELANOTIDE,GuideToPharmacology,1,agonist
DRD4,GLESATINIB,GuideToPharmacology,1,inhibitor
ANPEP,THIIC,GuideToPharmacology,1,modulator
NR2F6,COBIMETINIB,GuideToPharmacology,1,modulator
CTNS,COMPOUND 25C [PMID: 36649216],GuideToPharmacology,1,inhibitor
CTNS,BOS172722,GuideToPharmacology,1,inhibitor
AADAC,NNC 11-1585,GuideToPharmacology,1,agonist
AADAC,G&OUML; 7874,GuideToPharmacology,1,modulator
AADAC,PILOCARPINE HYDROCHLORIDE,GuideToPharmacology,1,agonist
AADAC,CARBAMOYLCHOLINE,GuideToPharmacology,1,agonist
AADAC,HEXAHYDROSILADIFENIDOL,GuideToPharmacology,1,inhibitor
AAMP,CARBAMOYLCHOLINE,GuideToPharmacology,1,agonist
AAMP,IPRATROPIUM CATION,GuideToPharmacology,1,inhibitor
AANAT,"WIN 62,577",GuideToPharmacology,1,modulator
AARS1,CARBAMOYLCHOLINE,GuideToPharmacology,1,agonist
AARS1,NNC 11-1585,GuideToPharmacology,1,agonist
AANAT,TRIPITRAMINE,GuideToPharmacology,1,inhibitor
AARS1,VU0467154,GuideToPharmacology,1,modulator
AARS1,THIOCHROME,GuideToPharmacology,1,modulator
AAVS1,SCOPOLAMINE,GuideToPharmacology,1,inhibitor
AAVS1,REVEFENACIN,GuideToPharmacology,1,inhibitor
ANK2,AAE-M-PBP-AMINE,GuideToPharmacology,1,agonist
APOF,SR16835,GuideToPharmacology,1,agonist
APOF,BW373U86,GuideToPharmacology,1,agonist
APOF,ELUXADOLINE,GuideToPharmacology,1,agonist
APOF,SCH221510,GuideToPharmacology,1,agonist
APOF,UFP-505,GuideToPharmacology,1,agonist
APOF,LOPERAMIDE,GuideToPharmacology,1,agonist
GNG5P1,AZD5904,GuideToPharmacology,1,inhibitor
MYLK4,COMPOUND 17 [PMID: 36111834],GuideToPharmacology,1,inhibitor
CD70,CHLOROTHIAZIDE,GuideToPharmacology,1,inhibitor
DUSP5,COMPOUND 25 [PMID: 17935989],GuideToPharmacology,1,inhibitor
GZMA,NSC 780521,GuideToPharmacology,1,inhibitor
NKX3-2,HUWENTOXIN IV,GuideToPharmacology,1,inhibitor
BBS2,SAXITOXIN,GuideToPharmacology,1,blocker
BBS2,ATX-II,GuideToPharmacology,1,inhibitor
ATF4,A-867744,GuideToPharmacology,1,modulator
AQP4,SAREDUTANT,GuideToPharmacology,1,inhibitor
AQP5,SB 218795,GuideToPharmacology,1,inhibitor
AQP5,SAREDUTANT,GuideToPharmacology,1,inhibitor
APBA1,RO64-6198,GuideToPharmacology,1,agonist
ANXA1,BIBP3226,GuideToPharmacology,1,inhibitor
GRK6P1,KML110,GuideToPharmacology,1,inhibitor
HOXC@,COMPOUND 15A [PMID: 36642961],GuideToPharmacology,1,inhibitor
CDK5,DECYNIUM 22,GuideToPharmacology,1,inhibitor
HK3,THIAMET-G,GuideToPharmacology,1,inhibitor
ARAF,"L-368,930",GuideToPharmacology,1,inhibitor
APBB2,PFIZER COMPOUND 11 [PMID:18445527],GuideToPharmacology,1,inhibitor
APC,ADENOSINE TRIPHOSPHATE,GuideToPharmacology,1,agonist
APLP2,PCA 4248,GuideToPharmacology,1,inhibitor
ADCYAP1R1,PACAP-38,GuideToPharmacology,1,agonist
CDK11B,LYS[Z(NO2)]-LYS[Z(NO2)],GuideToPharmacology,1,inhibitor
SLC15A2,LYS[Z(NO2)]-LYS[Z(NO2)],GuideToPharmacology,1,inhibitor
BCKDHA,GW409544,GuideToPharmacology,1,agonist
CCND1,L-764406,GuideToPharmacology,1,agonist
CCND1,MESALAMINE,GuideToPharmacology,1,agonist
F5,AS-252424,GuideToPharmacology,1,inhibitor
F5,LENIOLISIB,GuideToPharmacology,1,inhibitor
F5,DUVELISIB,GuideToPharmacology,1,inhibitor
F5,COMPOUND 52 [PMID: 28541707],GuideToPharmacology,1,inhibitor
F5,PF-04691502,GuideToPharmacology,1,inhibitor
F5,RV1729,GuideToPharmacology,1,inhibitor
PIK3CB,AZD6482,GuideToPharmacology,1,inhibitor
PIK3CB,TGX-221,GuideToPharmacology,1,inhibitor
PIK3CB,VS-5584,GuideToPharmacology,1,inhibitor
F7R,COMPOUND 52 [PMID: 28541707],GuideToPharmacology,1,inhibitor
F7,TENALISIB,GuideToPharmacology,1,inhibitor
F7R,AS-252424,GuideToPharmacology,1,inhibitor
F7,TGX-221,GuideToPharmacology,1,inhibitor
F7R,ACALISIB,GuideToPharmacology,1,inhibitor
F7R,AZD-8186,GuideToPharmacology,1,inhibitor
COL9A2,MILRINONE,GuideToPharmacology,1,inhibitor
COL8A1,LENRISPODUN,GuideToPharmacology,1,inhibitor
EZH1,(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE,GuideToPharmacology,1,inhibitor
GPR34,COMPOUND 17 [PMID: 36111834],GuideToPharmacology,1,inhibitor
F10,AZD1208,GuideToPharmacology,1,inhibitor
HMBS,GNF-1331,GuideToPharmacology,1,inhibitor
FABP1,XY-06-007,GuideToPharmacology,1,inhibitor
BDNF,FLUTICASONE,GuideToPharmacology,1,agonist
BDNF,BUDESONIDE,GuideToPharmacology,1,agonist
PCSK5,FURIN INHIBITOR PEPTIDE,GuideToPharmacology,1,inhibitor
CLTC,INDOMETHACIN,GuideToPharmacology,1,inhibitor
XIAP,PTHRP-(1-20)/TIP-(23-39) (HUMAN),GuideToPharmacology,1,agonist
ERCC8,5-HYDROXYTRYPTAMINE,GuideToPharmacology,1,inhibitor
XIAP,"[ILE5,TRP23]PTHRP-(3-36) (HUMAN)",GuideToPharmacology,1,agonist
H1-2,MITAPIVAT,GuideToPharmacology,1,modulator
FAH,EXARAFENIB,GuideToPharmacology,1,inhibitor
NIPSNAP2,CLOFARABINE,GuideToPharmacology,1,inhibitor
DYT7,7-BIA,GuideToPharmacology,1,inhibitor
AMT,VPC44116,GuideToPharmacology,1,inhibitor
RYR3,ADENOSINE TRIPHOSPHATE,GuideToPharmacology,1,activator
AMT,SEW2871,GuideToPharmacology,1,agonist
AMY1B,COMPOUND 43 [PMID: 26751273],GuideToPharmacology,1,agonist
CASP7,TGN4,GuideToPharmacology,1,modulator
STK10,BOSUTINIB,GuideToPharmacology,1,inhibitor
CD9,"PAROXETINE HYDROCHLORIDE, HEMIHYDRATE",GuideToPharmacology,1,inhibitor
CYBA,GSK650394,GuideToPharmacology,1,inhibitor
CD9,SIBUTRAMINE,GuideToPharmacology,1,inhibitor
CARS1,DESLANOSIDE,GuideToPharmacology,1,inhibitor
CD3E,EMPAGLIFLOZIN,GuideToPharmacology,1,inhibitor
BLVRB,COMPOUND 4G [PMID: 17709461],GuideToPharmacology,1,inhibitor
MS4A2,ACALABRUTINIB,GuideToPharmacology,1,inhibitor
FASLG,BIM 23060,GuideToPharmacology,1,agonist
FAS,BIM 23627,GuideToPharmacology,1,inhibitor
AQP2,"[111IN,90Y]DOTA-LAN",GuideToPharmacology,1,agonist
AQP7,OCTOPAMINE,GuideToPharmacology,1,agonist
AQP7,[3H]TYRAMINE,GuideToPharmacology,1,agonist
TESK2,COMPOUND 35 [PMID: 22902653],GuideToPharmacology,1,inhibitor
BCGF1,VK-2809,GuideToPharmacology,1,agonist
TLR4,GSK1795091,GuideToPharmacology,1,agonist
ATP1B1P1,PF-4840154,GuideToPharmacology,1,activator
ATP2A2,GSK2833503A,GuideToPharmacology,1,blocker
ATP5BL2,AMILORIDE,GuideToPharmacology,1,blocker
TRPV5,OXOGLAUCINE,GuideToPharmacology,1,inhibitor
GCF1,VINBLASTINE,GuideToPharmacology,1,inhibitor
BCL7A,LITHOCHOLIC ACID,GuideToPharmacology,1,agonist
CDH13,DEUTETRABENAZINE,GuideToPharmacology,1,inhibitor
BCL7A,INECALCITOL,GuideToPharmacology,1,agonist
ARCN1,N-STEARYL-[NLE17]VIP,GuideToPharmacology,1,agonist
ARCN2,[125I]PACAP-27,GuideToPharmacology,1,agonist
GCK,DICUMAROL,GuideToPharmacology,1,inhibitor
GCK,ALITRETINOIN,GuideToPharmacology,1,inhibitor
ARCN2,PACAP-27,GuideToPharmacology,1,agonist
ANXA2P3,"[LEU31,PRO34]NPY",GuideToPharmacology,1,agonist
APBB1,SELTOREXANT,GuideToPharmacology,1,inhibitor
AAMP,G&OUML; 7874,GuideToPharmacology,1,modulator
DUSP2,DDR1/2 INHIBITOR 5N,GuideToPharmacology,1,inhibitor
ALDH3A1,SCH-23390,GuideToPharmacology,1,inhibitor
BIRC2,2MESAMP,GuideToPharmacology,1,inhibitor
AADAC,[3H]IPEROXO,GuideToPharmacology,1,agonist
A1BG,S-15535,GuideToPharmacology,1,agonist
ANXA3,C2-NPY (PIG),GuideToPharmacology,1,agonist
AMY1B,VPC44116,GuideToPharmacology,1,inhibitor
FEN1,SR8185,GuideToPharmacology,1,inhibitor
EN1,NERATINIB,GuideToPharmacology,1,inhibitor
FKBP2,M-2698,GuideToPharmacology,1,inhibitor
AANAT,VU0119498,GuideToPharmacology,1,modulator
EXTL2,PF-3758309,GuideToPharmacology,1,inhibitor
CD34,YM-244769,GuideToPharmacology,1,inhibitor
ABCA4,NS-49,GuideToPharmacology,1,agonist
COL12A1,CDP840,GuideToPharmacology,1,inhibitor
APAF1,TIPP&PSI;,GuideToPharmacology,1,inhibitor
CTNNB1,MAPK13-IN-1,GuideToPharmacology,1,inhibitor
CTSO,OSU-03012,GuideToPharmacology,1,inhibitor
A12M2,[3H]LY334370,GuideToPharmacology,1,agonist
ATP4A,HALOTHANE,GuideToPharmacology,1,blocker
CMA1,COMPOUND 7F [PMID: 29191554],GuideToPharmacology,1,inhibitor
AQP8,U46619,GuideToPharmacology,1,agonist
F5,TENALISIB,GuideToPharmacology,1,inhibitor
ANXA2P3,"[LEU31,PRO34]PYY (HUMAN)",GuideToPharmacology,1,agonist
AADAC,ALEXA-488-TELENZEPINE,GuideToPharmacology,1,inhibitor
CTNNA1,RAVOXERTINIB,GuideToPharmacology,1,inhibitor
ABCB7,INDORAMIN,GuideToPharmacology,1,inhibitor
GLC3B,I-BRD9,GuideToPharmacology,1,inhibitor
EML1,CIRTUVIVINT,GuideToPharmacology,1,inhibitor
GARS1,KA1010,GuideToPharmacology,1,inhibitor
ARL2,CS+,GuideToPharmacology,1,blocker
DRD2,PP-121,GuideToPharmacology,1,inhibitor
ANPEP,JNJ-46281222,GuideToPharmacology,1,modulator
EPHB2,IZENCITINIB,GuideToPharmacology,1,inhibitor
NUDT2,COMPOUND 3 [PMID: 23134120],GuideToPharmacology,1,agonist
SERPINC1,SUCCINYLCHOLINE,GuideToPharmacology,1,agonist
GAPDHL17,KA1010,GuideToPharmacology,1,inhibitor
ARL3,IVABRADINE,GuideToPharmacology,1,blocker
BDKRB2,FR190997,GuideToPharmacology,1,agonist
BDM,BUDESONIDE,GuideToPharmacology,1,agonist
GALR2,M871,GuideToPharmacology,1,inhibitor
TMEM258,CD2+,GuideToPharmacology,1,blocker
DPT,BPR1R024,GuideToPharmacology,1,inhibitor
GRN,ANTI-ILT7 ANTIBODY,GuideToPharmacology,1,antibody
ASS1P10,[3H]CGP39653,GuideToPharmacology,1,inhibitor
SLC29A1,GSK-3BETA INHIBITOR I,GuideToPharmacology,1,inhibitor
ELF2,PF-4800567,GuideToPharmacology,1,inhibitor
ACVRL1,FARNESYL DIPHOSPHATE,GuideToPharmacology,1,inhibitor
DAG1,UAMC00039,GuideToPharmacology,1,inhibitor
KLK3,MINIMISED INSL5 ANALOGUE 7,GuideToPharmacology,1,agonist
ABCD2,OLEIC ACID,GuideToPharmacology,1,agonist
ALDH1A1,COMPOUND 3 [PMID: 23134120],GuideToPharmacology,1,agonist
ABCA4,DAPIPRAZOLE,GuideToPharmacology,1,inhibitor
APBB2,A2P5P,GuideToPharmacology,1,inhibitor
FRA6B,CHF-5074,GuideToPharmacology,1,inhibitor
GMPR,RITUXIMAB,GuideToPharmacology,1,antibody
DRD4,GOLVATINIB,GuideToPharmacology,1,inhibitor
CSTP1,HU7691,GuideToPharmacology,1,inhibitor
ABCF1,NIGULDIPINE,GuideToPharmacology,1,inhibitor
ELF2,PF-670462,GuideToPharmacology,1,inhibitor
APOF,OXYCODEGOL,GuideToPharmacology,1,agonist
NMUR2,COMPOUND NRA 4 [PMID: 25262941],GuideToPharmacology,1,agonist
SERPINA3,SB269970,GuideToPharmacology,1,inhibitor
ARL2,IVABRADINE,GuideToPharmacology,1,blocker
GAPDHP60,GEMTUZUMAB OZOGAMICIN,GuideToPharmacology,1,antibody
GNA11,PXS-4681A,GuideToPharmacology,1,inhibitor
EGR4,ALSTERPAULLONE 2-CYANOETHYL,GuideToPharmacology,1,inhibitor
NATP,GR 127935,GuideToPharmacology,1,agonist
CNR2,PEPCAN-12,GuideToPharmacology,1,modulator
HRH3,A331440,GuideToPharmacology,1,inhibitor
PRKD3,BPKDI,GuideToPharmacology,1,inhibitor
EPHB2,PEFICITINIB,GuideToPharmacology,1,inhibitor
EMX1,CDK2 INHIBITOR IV,GuideToPharmacology,1,inhibitor
ALDH3B2,FMET-ILE-PHE-LEU,GuideToPharmacology,1,agonist
APEX1,PSB-0739,GuideToPharmacology,1,inhibitor
ABAT,SCH 58261,GuideToPharmacology,1,inhibitor
CPT1B,NAPROXCINOD,GuideToPharmacology,1,inhibitor
GRIK5,X-165,GuideToPharmacology,1,inhibitor
ELF3,COMPOUND 33 [PMID: 19364658],GuideToPharmacology,1,inhibitor
ABCD1,RISPERIDONE,GuideToPharmacology,1,inhibitor
ANXA2,NPS(1-4)NH2,GuideToPharmacology,1,agonist
GPR18,FORODESINE,GuideToPharmacology,1,inhibitor
AQP1,BIM 23627,GuideToPharmacology,1,inhibitor
TRPM8,DRONABINOL,GuideToPharmacology,1,blocker
GDF2,QUISINOSTAT,GuideToPharmacology,1,inhibitor
GDF9,SS-208,GuideToPharmacology,1,inhibitor
NR4A2,COMPOUND 108 [PMID: 37918435],GuideToPharmacology,1,agonist
CXCR3,IOX2,GuideToPharmacology,1,inhibitor
NUDT2,HYDROMORPHONE HYDROCHLORIDE,GuideToPharmacology,1,agonist
ASS1P5,ACET,GuideToPharmacology,1,inhibitor
DRG2,DDR1/2 INHIBITOR 5N,GuideToPharmacology,1,inhibitor
APRT,135PAM1,GuideToPharmacology,1,modulator
GLUD1,COMPOUND 13B [PMID: 19101153],GuideToPharmacology,1,modulator
A1BG,FLUPAROXAN,GuideToPharmacology,1,agonist
APBA2,SB-408124,GuideToPharmacology,1,inhibitor
AANAT,ALCURONIUM,GuideToPharmacology,1,modulator
GNRHR,ABARELIX,GuideToPharmacology,1,inhibitor
LONP1,COMPOUND 12D [PMID: 33821636],GuideToPharmacology,1,inhibitor
ACADSB,COMPOUND 40 [PMID: 34982553],GuideToPharmacology,1,agonist
DPYSL2,SORAFENIB,GuideToPharmacology,1,inhibitor
SLC29A1,VORUCICLIB,GuideToPharmacology,1,inhibitor
EPHB2,MOMELOTINIB,GuideToPharmacology,1,inhibitor
ALCAM,ROTIGOTINE,GuideToPharmacology,1,agonist
AMELX,JNJ 7777120,GuideToPharmacology,1,inhibitor
EPHB2,CEE321,GuideToPharmacology,1,inhibitor
LHCGR,LUTROPIN ALFA,GuideToPharmacology,1,agonist
DXO,PP1,GuideToPharmacology,1,inhibitor
GART,TUBASTATIN A,GuideToPharmacology,1,inhibitor
MSTN,QUISINOSTAT,GuideToPharmacology,1,inhibitor
APEX1,AZD1283,GuideToPharmacology,1,inhibitor
FRA9D,ML323,GuideToPharmacology,1,inhibitor
A12M1,METHYLERGONOVINE,GuideToPharmacology,1,inhibitor
A12M3,RELENOPRIDE,GuideToPharmacology,1,agonist
A12M3,ORG 12962,GuideToPharmacology,1,agonist
A12M3,BRL-15572,GuideToPharmacology,1,agonist
A12M3,LY215840,GuideToPharmacology,1,inhibitor
A12M3,GLEMANSERIN,GuideToPharmacology,1,inhibitor
A12M3,THIORIDAZINE,GuideToPharmacology,1,inhibitor
A12M4,[125I]DOI,GuideToPharmacology,1,agonist
A12M4,BRL-15572,GuideToPharmacology,1,agonist
A12M4,[3H]8-OH-DPAT,GuideToPharmacology,1,agonist
A12M3,PIMAVANSERIN,GuideToPharmacology,1,inhibitor
A12M4,LORCASERIN,GuideToPharmacology,1,agonist
HTR2C,GLEMANSERIN,GuideToPharmacology,1,inhibitor
HTR2C,CAPESEROD,GuideToPharmacology,1,agonist
NATP,BRL-15572,GuideToPharmacology,1,agonist
NATP,MIANSERIN,GuideToPharmacology,1,inhibitor
SERPINA3,CAPESEROD,GuideToPharmacology,1,agonist
ABCG2,COMPOUND 14 [PMID: 30925062],GuideToPharmacology,1,inhibitor
CA9,ZOSUQUIDAR,GuideToPharmacology,1,inhibitor
DNM2,ZILURGISERTIB,GuideToPharmacology,1,inhibitor
DNM2,FIDRISERTIB,GuideToPharmacology,1,inhibitor
CSTP1,AKT INHIBITOR VIII,GuideToPharmacology,1,modulator
FKBP2,AKT INHIBITOR VIII,GuideToPharmacology,1,modulator
HBEGF,IRUPLINALKIB,GuideToPharmacology,1,inhibitor
HBEGF,ALECTINIB,GuideToPharmacology,1,inhibitor
CXCL1,ABX-1431,GuideToPharmacology,1,inhibitor
ABCF1,[125I]HEAT (BE2254),GuideToPharmacology,1,inhibitor
ABCF1,MIANSERIN,GuideToPharmacology,1,inhibitor
ABCA4,OXYMETAZOLINE HYDROCHLORIDE,GuideToPharmacology,1,agonist
AOC1,GUANABENZ,GuideToPharmacology,1,agonist
AOC1,RAUWOLSCINE,GuideToPharmacology,1,inhibitor
AOC1,ROXINDOLE,GuideToPharmacology,1,inhibitor
ABL2,JP1302,GuideToPharmacology,1,inhibitor
ABL2,RX821002,GuideToPharmacology,1,inhibitor
BEVI,MIFEPRISTONE,GuideToPharmacology,1,inhibitor
GNA11,PHENELZINE,GuideToPharmacology,1,inhibitor
ACADM,"N,N`-BIS-ALKYL BUTYLIMMIDAZOLE 12B",GuideToPharmacology,1,inhibitor
GNG11,SM-337,GuideToPharmacology,1,inhibitor
ACAT2,LITORIN,GuideToPharmacology,1,agonist
ASIC2,"[D-TYR6,APA-4CL11,PHE13,NLE14]BOMBESIN-(6-14)",GuideToPharmacology,1,agonist
FMO5,COMPOUND 12 [PMID:28626832],GuideToPharmacology,1,inhibitor
FMO5,OXAZINE 89,GuideToPharmacology,1,inhibitor
FMO5,UMIBECESTAT,GuideToPharmacology,1,inhibitor
ABO,NORADRENALINE,GuideToPharmacology,1,agonist
ABR,MIRABEGRON,GuideToPharmacology,1,agonist
ABR,FENOTEROL,GuideToPharmacology,1,agonist
AMH,15S-HETE,GuideToPharmacology,1,agonist
DNMT1,COMPOUND 13R [PMID: 23639540],GuideToPharmacology,1,inhibitor
EFNA1,IBRUTINIB,GuideToPharmacology,1,inhibitor
EFNA2,TOVORAFENIB,GuideToPharmacology,1,inhibitor
BRD3,MS363,GuideToPharmacology,1,inhibitor
GLC1C,MS363,GuideToPharmacology,1,inhibitor
EFNB2,FENEBRUTINIB,GuideToPharmacology,1,inhibitor
EFNB2,VECABRUTINIB,GuideToPharmacology,1,inhibitor
EFNB2,PRN694,GuideToPharmacology,1,inhibitor
CD27,CINROMIDE,GuideToPharmacology,1,inhibitor
ACADL,C5A HEXAPEPTIDE ANALOGUE,GuideToPharmacology,1,agonist
EGR2,COMPOUND 26 [PMID: 34543009],GuideToPharmacology,1,inhibitor
GAPDH,HISTAMINE,GuideToPharmacology,1,activator
EGFR,STO609,GuideToPharmacology,1,inhibitor
CASP3,PAC1,GuideToPharmacology,1,activator
CYP2A7P1,SILMITASERTIB,GuideToPharmacology,1,inhibitor
DAZ1,URACIL 20,GuideToPharmacology,1,inhibitor
CACNA1D,(-)-(S)-BAYK8644,GuideToPharmacology,1,activator
FNZ,COMPOUND 1 [PMID: 10498202],GuideToPharmacology,1,inhibitor
FOSB,ODANACATIB,GuideToPharmacology,1,inhibitor
CBR1,WEDELOLACTONE,GuideToPharmacology,1,inhibitor
RHOG,PGF1&ALPHA;,GuideToPharmacology,1,activator
ACRV1,COMPOUND 70 [PMID: 26161824],GuideToPharmacology,1,inhibitor
ACTBP7,BI-6901,GuideToPharmacology,1,inhibitor
ACTA2,RS-102895,GuideToPharmacology,1,inhibitor
ACTBP2,CCL14,GuideToPharmacology,1,agonist
ACTB,SB328437,GuideToPharmacology,1,inhibitor
CPT2,RESVERATROL,GuideToPharmacology,1,inhibitor
CPT2,FLURBIPROFEN,GuideToPharmacology,1,inhibitor
CPT1B,SC-236,GuideToPharmacology,1,inhibitor
C4B,CARBENOXOLONE,GuideToPharmacology,1,inhibitor
C4BPA,CARBENOXOLONE,GuideToPharmacology,1,inhibitor
C2,CARBENOXOLONE,GuideToPharmacology,1,inhibitor
OSGIN2,CARBENOXOLONE,GuideToPharmacology,1,inhibitor
C8G,CARBENOXOLONE,GuideToPharmacology,1,inhibitor
ACTBP8,MINI-TYRRS,GuideToPharmacology,1,agonist
ACTBP9,VCXCL1,GuideToPharmacology,1,agonist
ACTC1,CXCL9,GuideToPharmacology,1,agonist
ACTG1,CXCL122 (DIMER),GuideToPharmacology,1,agonist
EGR4,7-HYDROXYSTAUROSPORINE,GuideToPharmacology,1,inhibitor
EIF4A1,TAGTOCICLIB,GuideToPharmacology,1,inhibitor
EIF4B,ZOTIRACICLIB,GuideToPharmacology,1,inhibitor
EIF4A1,ZOTIRACICLIB,GuideToPharmacology,1,inhibitor
CDK4,CDK4 INHIBITOR,GuideToPharmacology,1,inhibitor
EIF4E,RO3306,GuideToPharmacology,1,inhibitor
EIF4EBP2,SY-5609,GuideToPharmacology,1,inhibitor
EIF4EP1,CCT251545,GuideToPharmacology,1,inhibitor
CPD,AMINOGLUTETHIMIDE,GuideToPharmacology,1,inhibitor
CPB2,LEVOKETOCONAZOLE,GuideToPharmacology,1,inhibitor
EIF4G1,NVP-2,GuideToPharmacology,1,inhibitor
CPD,LETROZOLE,GuideToPharmacology,1,inhibitor
CPB2,YXG-158,GuideToPharmacology,1,inhibitor
CPB1,METYRAPONE,GuideToPharmacology,1,inhibitor
COX6A1,EFAVIRENZ,GuideToPharmacology,1,inhibitor
COX5BP3,COMPOUND 4 [PMID: 16495056],GuideToPharmacology,1,inhibitor
AMHR2,VERLUKAST,GuideToPharmacology,1,inhibitor
EBF1,SC-67655,GuideToPharmacology,1,agonist
HPE1,COMPOUND 13 [PMID: 37465299],GuideToPharmacology,1,inhibitor
APAF1,ADL5747,GuideToPharmacology,1,agonist
APAF1,NFP,GuideToPharmacology,1,inhibitor
DHFR,ICLAPRIM,GuideToPharmacology,1,inhibitor
CRIP1,DO34,GuideToPharmacology,1,inhibitor
FPGS,1G244,GuideToPharmacology,1,inhibitor
ALDH1A1,ROPINIROLE,GuideToPharmacology,1,agonist
ALDH1A1,VILAZODONE HYDROCHLORIDE,GuideToPharmacology,1,agonist
CXCR3,COMPOUND 6EE [PMID: 22364528],GuideToPharmacology,1,inhibitor
NPBWR2,COMPOUND 6EE [PMID: 22364528],GuideToPharmacology,1,inhibitor
DAXX,S136492,GuideToPharmacology,1,inhibitor
DSC3,RIPK3 INHIBITOR 18,GuideToPharmacology,1,inhibitor
DXO,EAI045,GuideToPharmacology,1,modulator
DXO,PD 158780,GuideToPharmacology,1,inhibitor
DXO,TESEVATINIB,GuideToPharmacology,1,inhibitor
DXO,IBRUTINIB,GuideToPharmacology,1,inhibitor
CRMP1,CAY10499,GuideToPharmacology,1,inhibitor
FZD2,COMPOUND 13 [PMID: 17502136],GuideToPharmacology,1,inhibitor
ABCD2,SETOGEPRAM,GuideToPharmacology,1,agonist
FGR,APITOLISIB,GuideToPharmacology,1,inhibitor
ALDOA,TRANS-2-METHYLCROTONIC ACID,GuideToPharmacology,1,agonist
DPYSL3,ALOFANIB,GuideToPharmacology,1,modulator
DPYSL2,SUNITINIB,GuideToPharmacology,1,inhibitor
CREBBP,ML355,GuideToPharmacology,1,inhibitor
A1BG,ULOTARONT,GuideToPharmacology,1,agonist
A1BG,[3H]NLX-112,GuideToPharmacology,1,agonist
A1BG,FLESINOXAN,GuideToPharmacology,1,agonist
A1BG,LY344864,GuideToPharmacology,1,agonist
A1BG,FG-5893,GuideToPharmacology,1,agonist
DPYSL2,PRN1371,GuideToPharmacology,1,inhibitor
A1BG,S-15535,GuideToPharmacology,1,agonist
A1BG,GR 127935,GuideToPharmacology,1,agonist
A2M,METHYSERGIDE,GuideToPharmacology,1,inhibitor
A2M,SB 649915,GuideToPharmacology,1,inhibitor
A2MP1,2-METHYL-5-HT,GuideToPharmacology,1,agonist
A2M,RITANSERIN,GuideToPharmacology,1,inhibitor
A2MP1,GR 127935,GuideToPharmacology,1,agonist
A2MP1,GR 127935,GuideToPharmacology,1,inhibitor
SLC26A3,COMPOUND 29 [PMID: 36356320],GuideToPharmacology,1,inhibitor
DRD1,DORSOMORPHIN,GuideToPharmacology,1,inhibitor
DPYS,KW-2449,GuideToPharmacology,1,inhibitor
DRD3,FORETINIB,GuideToPharmacology,1,inhibitor
DPYS,TUSPETINIB,GuideToPharmacology,1,inhibitor
A12M1,BRL-54443,GuideToPharmacology,1,agonist
A12M3,SPIRAMIDE,GuideToPharmacology,1,inhibitor
A12M3,METHYSERGIDE,GuideToPharmacology,1,inhibitor
A12M3,RITANSERIN,GuideToPharmacology,1,inhibitor
A12M4,M-CHLOROPHENYLPIPERAZINE,GuideToPharmacology,1,agonist
A12M4,PIBOSEROD,GuideToPharmacology,1,inhibitor
DPYS,SUNITINIB,GuideToPharmacology,1,inhibitor
A12M4,1-NAPHTHYLPIPERAZINE,GuideToPharmacology,1,inhibitor
HTR2C,CGS-12066,GuideToPharmacology,1,agonist
HTR2C,QUINPIROLE,GuideToPharmacology,1,agonist
HTR2C,SPIPERONE,GuideToPharmacology,1,inhibitor
DRD3,COMPOUND 38K [PMID: 34351741],GuideToPharmacology,1,inhibitor
NAT1,GR 113808,GuideToPharmacology,1,inhibitor
HTR2C,LOXAPINE,GuideToPharmacology,1,inhibitor
SERPINA3,METHYSERGIDE,GuideToPharmacology,1,inhibitor
SERPINA3,EMDT,GuideToPharmacology,1,agonist
SERPINA3,METERGOLINE,GuideToPharmacology,1,inhibitor
ABL1,DASATINIB ANHYDROUS,GuideToPharmacology,1,inhibitor
DPYS,ZOTIRACICLIB,GuideToPharmacology,1,inhibitor
DDR1,PAK-104P,GuideToPharmacology,1,inhibitor
ACTG1P8,CXCL12&ALPHA;,GuideToPharmacology,1,agonist
DRD3,PAZOPANIB,GuideToPharmacology,1,inhibitor
CSTF3,MIRANSERTIB,GuideToPharmacology,1,modulator
CSTF3,MIRANSERTIB,GuideToPharmacology,1,inhibitor
DRD3,TESEVATINIB,GuideToPharmacology,1,inhibitor
DDX10,GI254023X,GuideToPharmacology,1,inhibitor
CSTF3,COMPOUND E22 [PMID: 31298542],GuideToPharmacology,1,inhibitor
FKBP2,UPROSERTIB,GuideToPharmacology,1,inhibitor
CSTP1,MIRANSERTIB,GuideToPharmacology,1,modulator
CSTP1,MIRANSERTIB,GuideToPharmacology,1,inhibitor
CSTF3,HU7691,GuideToPharmacology,1,inhibitor
DRD3,TIVOZANIB,GuideToPharmacology,1,inhibitor
FKBP2,IPATASERTIB,GuideToPharmacology,1,inhibitor
CSTP1,IPATASERTIB,GuideToPharmacology,1,inhibitor
ABCB7,RS-17053,GuideToPharmacology,1,inhibitor
ABCB7,RITANSERIN,GuideToPharmacology,1,inhibitor
ACADSB,COMPOUND 39 [PMID: 34982553],GuideToPharmacology,1,agonist
BST2,AMILORIDE,GuideToPharmacology,1,blocker
DRD3,VEGF RECEPTOR TYROSINE KINASE INHIBITOR III,GuideToPharmacology,1,inhibitor
BTC,AMILORIDE,GuideToPharmacology,1,blocker
ABAT,PD81723,GuideToPharmacology,1,modulator
ABAT,PICLIDENOSON,GuideToPharmacology,1,agonist
ABAT,BAY 60-6583,GuideToPharmacology,1,agonist
ABAT,HEMADO,GuideToPharmacology,1,agonist
ABCA1,HEMADO,GuideToPharmacology,1,agonist
ABCA1,SCH 58261,GuideToPharmacology,1,inhibitor
ALDH3B2,[3H]FMET-LEU-PHE,GuideToPharmacology,1,agonist
ABCA2,(R)-PIA,GuideToPharmacology,1,agonist
ABCA2,HEMADO,GuideToPharmacology,1,agonist
ABCA2,MRS1523,GuideToPharmacology,1,inhibitor
ABCA3,KF26777,GuideToPharmacology,1,inhibitor
GLB1,COMPOUND 23 [PMID: 31398032],GuideToPharmacology,1,inhibitor
GPC3,AZ13824374,GuideToPharmacology,1,inhibitor
ATR,TUVUSERTIB,GuideToPharmacology,1,inhibitor
ALDH3B2,GROUP E 1682-2106 [PMID:16118363],GuideToPharmacology,1,inhibitor
EEF1G,COMPOUND 38 [PMID: 20817473],GuideToPharmacology,1,inhibitor
EEF1G,AMG-900,GuideToPharmacology,1,inhibitor
EEF1D,ZM447439,GuideToPharmacology,1,inhibitor
ALDH9A1,SERUM AMYLOID A,GuideToPharmacology,1,agonist
EEF2,"(3Z)-N,N-DIMETHYL-2-OXO-3-(4,5,6,7-TETRAHYDRO-1H-INDOL-2-YLMETHYLIDENE)-2,3-DIHYDRO-1H-INDOLE-5-SULFONAMIDE",GuideToPharmacology,1,inhibitor
GRIK5,EXAMPLE 1.11 [WO2014139978],GuideToPharmacology,1,inhibitor
AXL,NINGETINIB,GuideToPharmacology,1,inhibitor
EEF1G,XMD-12,GuideToPharmacology,1,inhibitor
ACAT2,BANTAG-1,GuideToPharmacology,1,inhibitor
ACAT2,PHYLLOLITORIN,GuideToPharmacology,1,agonist
ALDH9A1,AMYLOID &BETA;,GuideToPharmacology,1,agonist
ASIC2,D-NAL-CYS-TYR-D-TRP-LYS-VAL-CYS-NAL-NH2,GuideToPharmacology,1,inhibitor
FMO5,LY3202626,GuideToPharmacology,1,inhibitor
FMO5,COMPOUND 9 [PMID: 26937601],GuideToPharmacology,1,inhibitor
FMOD,EXAMPLE 41 [WO2012028563],GuideToPharmacology,1,inhibitor
ALDH9A1,ANNEXIN I,GuideToPharmacology,1,agonist
ABR,PROPAFENONE,GuideToPharmacology,1,inhibitor
ACAA1,CIMATEROL,GuideToPharmacology,1,agonist
ABR,ALPRENOLOL,GuideToPharmacology,1,inhibitor
ABR,[125I]ICYP,GuideToPharmacology,1,inhibitor
EEGV1,ACALABRUTINIB,GuideToPharmacology,1,inhibitor
ALDH9A1,ACT-389949,GuideToPharmacology,1,agonist
EFNA2,LY3009120,GuideToPharmacology,1,inhibitor
EFNA2,SORAFENIB,GuideToPharmacology,1,inhibitor
GLC1B,COMPOUND 7 [PMID: 25719566],GuideToPharmacology,1,inhibitor
EFNA2,LIFIRAFENIB,GuideToPharmacology,1,inhibitor
CA4,TOPIRAMATE,GuideToPharmacology,1,inhibitor
APOC2,TAFLUPROST ACID,GuideToPharmacology,1,agonist
GAPDH,INDISULAM,GuideToPharmacology,1,inhibitor
UBE2K,HISTIDINE,GuideToPharmacology,1,activator
GAPDH,TOPIRAMATE,GuideToPharmacology,1,inhibitor
GLUD1P3,ZONISAMIDE,GuideToPharmacology,1,inhibitor
ACP5,CINACALCET,GuideToPharmacology,1,modulator
DBIP2,ISATIN SULFONAMIDE 34 [PMID: 11384246],GuideToPharmacology,1,inhibitor
ACP5,2-METHYL-3-PHENETHYL-3H-PYRIMIDIN-4-ONE,GuideToPharmacology,1,inhibitor
APOC2,BIMATOPROST,GuideToPharmacology,1,agonist
ATP6V0A1,ACT-709478,GuideToPharmacology,1,blocker
ATP6V0A1,TTA-A2,GuideToPharmacology,1,blocker
FNZ,&BETA;-SECRETASE INHIBITOR IV,GuideToPharmacology,1,inhibitor
ACRV1,BAY-593074,GuideToPharmacology,1,agonist
RND3,NNC55-0396,GuideToPharmacology,1,blocker
GABRA1,ZN2+,GuideToPharmacology,1,modulator
RHOG,NNC55-0396,GuideToPharmacology,1,blocker
RHOG,MIBEFRADIL,GuideToPharmacology,1,blocker
CNR2,JWH-018,GuideToPharmacology,1,agonist
CCKAR,GW-5823,GuideToPharmacology,1,agonist
CCKBR,DESULFATED GASTRIN-34,GuideToPharmacology,1,agonist
CCKBR,LORGLUMIDE,GuideToPharmacology,1,inhibitor
CCKBR,DEVAZEPIDE,GuideToPharmacology,1,inhibitor
CCKBR,[125I]-BDZ2,GuideToPharmacology,1,inhibitor
ARNT,CGS8216,GuideToPharmacology,1,agonist
ACTA1,BX 471,GuideToPharmacology,1,inhibitor
CCR4,GSK2239633A,GuideToPharmacology,1,inhibitor
ARNT,ISONIPECOTIC ACID,GuideToPharmacology,1,agonist
ALOX12P2,M1152,GuideToPharmacology,1,agonist
ALOX12P2,GALANIN(7-29) (PIG),GuideToPharmacology,1,agonist
ACTBP2,[3H]ANCRIVIROC,GuideToPharmacology,1,inhibitor
ACTBP2,TAK-779,GuideToPharmacology,1,inhibitor
GALR2,M242,GuideToPharmacology,1,agonist
ACTBP4,[125I]CCL19 (HUMAN),GuideToPharmacology,1,agonist
GNG4,MOXETUMOMAB PASUDOTOX,GuideToPharmacology,1,antibody
EGR3,COMPOUND 1 [PMID: 24793884],GuideToPharmacology,1,inhibitor
ALOX12P2,SPEXIN-1,GuideToPharmacology,1,agonist
CTSB,(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE,GuideToPharmacology,1,inhibitor
GALR2,C7,GuideToPharmacology,1,inhibitor
GLE1,NVS-1,GuideToPharmacology,1,inhibitor
CXCR5,DIGERANYL BISPHOSPHONATE,GuideToPharmacology,1,inhibitor
ELANE,CIRTUVIVINT,GuideToPharmacology,1,inhibitor
CELA1,COMPOUND 2 [PMID: 22560567],GuideToPharmacology,1,inhibitor
ELAVL2,MW01,GuideToPharmacology,1,inhibitor
BDM,DESOXIMETASONE,GuideToPharmacology,1,agonist
BUB1,DIPHENYLAMINE-2-CARBOXYLIC ACID,GuideToPharmacology,1,blocker
HPGD,MK-8262,GuideToPharmacology,1,inhibitor
BTS1,CD2+,GuideToPharmacology,1,blocker
FRA1C,DUP-714,GuideToPharmacology,1,inhibitor
CNA1,MS023,GuideToPharmacology,1,inhibitor
BDM,DEXAMETHASONE,GuideToPharmacology,1,agonist
FRA1E,COMPOUND 57 [PMID: 20121197],GuideToPharmacology,1,inhibitor
DPYD,BPR1R024,GuideToPharmacology,1,inhibitor
DPYD,PEXIDARTINIB,GuideToPharmacology,1,inhibitor
CPT1B,NAPROXEN SODIUM,GuideToPharmacology,1,inhibitor
FN1,COMPOUND 28 [PMID: 16460935],GuideToPharmacology,1,inhibitor
ALAS2,[125I]ASTRESSIN,GuideToPharmacology,1,inhibitor
CPT2,VALDECOXIB,GuideToPharmacology,1,inhibitor
ALB,UROCORTIN 1,GuideToPharmacology,1,agonist
GPR27,ELOTUZUMAB,GuideToPharmacology,1,antibody
HOXB6,COMPOUND 27 [PMID: 36449304],GuideToPharmacology,1,inhibitor
EGR4,(2R)-2-({9-(1-METHYLETHYL)-6-[(4-PYRIDIN-2-YLBENZYL)AMINO]-9H-PURIN-2-YL}AMINO)BUTAN-1-OL,GuideToPharmacology,1,inhibitor
EGR4,KINASE INHIBITOR 2 [PMID: 30199702],GuideToPharmacology,1,inhibitor
AMHR2,SR2640,GuideToPharmacology,1,inhibitor
DAPK1,BEGELOMAB,GuideToPharmacology,1,antibody
DAPK1,OMARIGLIPTIN,GuideToPharmacology,1,inhibitor
ELK4,COMPOUND 5G [PMID: 20483621],GuideToPharmacology,1,inhibitor
ELK4,DCLK1-IN-1,GuideToPharmacology,1,inhibitor
APOBEC1,INDOMETHACIN,GuideToPharmacology,1,agonist
APOB,"L-888,291",GuideToPharmacology,1,agonist
APOB,BWA868C,GuideToPharmacology,1,inhibitor
APOBEC1,15(S)-15-METHYL-PGD2,GuideToPharmacology,1,agonist
APOB,"L-644,698",GuideToPharmacology,1,agonist
APOB,VIDUPIPRANT,GuideToPharmacology,1,inhibitor
ABCD1,QUINPIROLE,GuideToPharmacology,1,agonist
ABCD1,HS665,GuideToPharmacology,1,agonist
ABCD1,COMPOUND 3 [PMID: 23134120],GuideToPharmacology,1,agonist
ABCD1,7-TRANS-OH-PIPAT,GuideToPharmacology,1,agonist
ALDH1A1,[3H]PD128907,GuideToPharmacology,1,agonist
ASS1P10,[3H]CGP61594,GuideToPharmacology,1,inhibitor
ABCD1,(+)-SCH-23390,GuideToPharmacology,1,inhibitor
ABCD1,NAFADOTRIDE,GuideToPharmacology,1,inhibitor
ALDH1A1,ROTIGOTINE,GuideToPharmacology,1,agonist
ABCD1,EGIS-11150,GuideToPharmacology,1,inhibitor
ALDH1A1,RISPERIDONE,GuideToPharmacology,1,inhibitor
ALDH2,NEMONAPRIDE,GuideToPharmacology,1,inhibitor
ALDH2,PF-592379,GuideToPharmacology,1,agonist
ALDH2,LOXAPINE,GuideToPharmacology,1,inhibitor
ASS1P10,GLYCINE,GuideToPharmacology,1,agonist
GLI1,PLUMBAGIN,GuideToPharmacology,1,inhibitor
EMP1,KINASE INHIBITOR 2 [PMID: 30199702],GuideToPharmacology,1,inhibitor
ASS1P10,GLYCINE,GuideToPharmacology,1,agonist
DSP,COMPOUND 66 [PMID: 19788238],GuideToPharmacology,1,inhibitor
ASS1P5,[3H]UBP310,GuideToPharmacology,1,inhibitor
EPYC,COMPOUND 66 [PMID: 19788238],GuideToPharmacology,1,inhibitor
EZH2,TAZEMETOSTAT,GuideToPharmacology,1,inhibitor
APOBER1,SC-19220,GuideToPharmacology,1,inhibitor
AQP8,DINOPROSTONE,GuideToPharmacology,1,agonist
GRIN2B,GV196771A,GuideToPharmacology,1,inhibitor
APOC1P1,U46619,GuideToPharmacology,1,agonist
EN1,POZIOTINIB,GuideToPharmacology,1,inhibitor
ERBB4,XILIERTINIB,GuideToPharmacology,1,inhibitor
ERBB4,BMS-599626,GuideToPharmacology,1,inhibitor
ERBB4,ACALABRUTINIB,GuideToPharmacology,1,inhibitor
GNRHR,DESLORELIN,GuideToPharmacology,1,agonist
BCYRN1P2,TIBOLONE,GuideToPharmacology,1,agonist
BCYRN1P2,STANOZOLOL,GuideToPharmacology,1,agonist
BDKRB2,GSK5182,GuideToPharmacology,1,agonist
GNRHR,CMPD-1,GuideToPharmacology,1,modulator
ADGRE1,RIPK1 INHIBITOR 22B,GuideToPharmacology,1,inhibitor
ALDH1A3,"[125I][ALA1,3,11,15]ET-1",GuideToPharmacology,1,agonist
GNRHR,CMPD-1,GuideToPharmacology,1,inhibitor
CTTN,GSK2656157,GuideToPharmacology,1,inhibitor
BCL5,COMPOUND 25 [PMID: 32687365],GuideToPharmacology,1,agonist
BLVRA,NE58043,GuideToPharmacology,1,inhibitor
ALDH3B1,TAMOXIFEN,GuideToPharmacology,1,agonist
ARNT,[3H]GABAZINE,GuideToPharmacology,1,inhibitor
BMAL1,FLUNITRAZEPAM,GuideToPharmacology,1,modulator
BMAL1,ALPRAZOLAM,GuideToPharmacology,1,modulator
ARRB1,[3H]MUSCIMOL,GuideToPharmacology,1,agonist
ARRB1,COMPOUND 20 [PMID: 35584373],GuideToPharmacology,1,modulator
ARRB1,TETRAHYDRODEOXYCORTICOSTERONE,GuideToPharmacology,1,modulator
ARRB2,TETRAHYDRODEOXYCORTICOSTERONE,GuideToPharmacology,1,modulator
ARRB2,PIPERIDINE-4-SULPHONIC ACID,GuideToPharmacology,1,agonist
ARRB2,BICUCULLINE,GuideToPharmacology,1,inhibitor
ACP3,ARGININE,GuideToPharmacology,1,agonist
ARRB2,FLUMAZENIL,GuideToPharmacology,1,modulator
ARSF,DS2,GuideToPharmacology,1,agonist
ARVCF,(&PLUSMN;)-CIS-2-CAMP,GuideToPharmacology,1,agonist
ALOX12P1,[125I][TYR26]GALANIN (PIG),GuideToPharmacology,1,agonist
ALOX12P1,GALP(3-32) (HUMAN),GuideToPharmacology,1,agonist
ALOX12P1,"[N-ME,DES-SAR]GAL-B2",GuideToPharmacology,1,agonist
ANXA13,ACIFRAN,GuideToPharmacology,1,agonist
ALOX12P1,SCH 202596,GuideToPharmacology,1,inhibitor
CXCR5,COMPOUND 19 [PMID: 18800762],GuideToPharmacology,1,inhibitor
ALOX15,PF-6870961,GuideToPharmacology,1,inhibitor
ALOX15,MACIMORELIN,GuideToPharmacology,1,agonist
ASS1,IDRA-21,GuideToPharmacology,1,modulator
ANXA13,BUTYRIC ACID,GuideToPharmacology,1,agonist
GRIA3,IDRA-21,GuideToPharmacology,1,modulator
GRIN2C,RETASPIMYCIN HYDROCHLORIDE,GuideToPharmacology,1,inhibitor
CBS,COMPOUND 30 [PMID: 22468970],GuideToPharmacology,1,modulator
BDM,ZK216348,GuideToPharmacology,1,agonist
GRIN2A,TCN-201,GuideToPharmacology,1,modulator
ASS1P14,[3H]CGP39653,GuideToPharmacology,1,inhibitor
GRIN2C,[3H]CGP39653,GuideToPharmacology,1,inhibitor
GLRA1,PREGNENOLONE SULPHATE,GuideToPharmacology,1,inhibitor
ARVD4,"(12E,20Z,18S)-8-HYDROXYVARIABILIN",GuideToPharmacology,1,inhibitor
ARL2,ZATEBRADINE,GuideToPharmacology,1,blocker
SLC29A1,SB 216763,GuideToPharmacology,1,inhibitor
SLC29A1,ALSTERPAULLONE 2-CYANOETHYL,GuideToPharmacology,1,inhibitor
SLC29A1,LITHIUM CARBONATE,GuideToPharmacology,1,inhibitor
ENSA,VORUCICLIB,GuideToPharmacology,1,inhibitor
GNRHR,[SER8]GNRH,GuideToPharmacology,1,agonist
AOAH,"5-METHYL-5-(5-METHYLTHIOPHEN-3-YL)-4-OXO-4,5-DIHYDROFURAN-2-CARBOXYLIC ACID",GuideToPharmacology,1,agonist
ARL3,ZATEBRADINE,GuideToPharmacology,1,blocker
ENUR1,GUANYLYL CYCLASE-ACTIVATING PROTEIN 1,GuideToPharmacology,1,activator
PHOX2A,CS+,GuideToPharmacology,1,blocker
ENUR2,PP-121,GuideToPharmacology,1,inhibitor
GDF2,ROMIDEPSIN,GuideToPharmacology,1,inhibitor
GAPDHL17,QUISINOSTAT,GuideToPharmacology,1,inhibitor
GAPDHP1,ACY-738,GuideToPharmacology,1,inhibitor
GAPDHP1,GIVINOSTAT,GuideToPharmacology,1,inhibitor
AMELX,JNJ 7777120,GuideToPharmacology,1,inhibitor
AMELX,CCL16,GuideToPharmacology,1,agonist
GDF2,VORINOSTAT,GuideToPharmacology,1,inhibitor
PRDM1,COMPOUND 4I [PMID: 2296036],GuideToPharmacology,1,inhibitor
ACTN4,7&BETA;-HYDROXYCHOLESTEROL,GuideToPharmacology,1,agonist
ACTN4,7&ALPHA;-HYDROXYCHOLESTEROL,GuideToPharmacology,1,agonist
GARS1,SUPRASTAT,GuideToPharmacology,1,inhibitor
ADH6,NCRW0105-E06,GuideToPharmacology,1,inhibitor
ACTN2,ADENOSINE TRIPHOSPHATE,GuideToPharmacology,1,agonist
HDAC4,PANOBINOSTAT,GuideToPharmacology,1,inhibitor
ADH6,TRYPTOPHAN,GuideToPharmacology,1,agonist
ADCY3,CP55940,GuideToPharmacology,1,agonist
GDF9,CUDC-101,GuideToPharmacology,1,inhibitor
GPR61,COMPOUND 1 [PMID: 37741852],GuideToPharmacology,1,agonist
ADD3,3-HYDROXY CAPRIC ACID,GuideToPharmacology,1,agonist
EPHA8,BMS-509744,GuideToPharmacology,1,inhibitor
ADRA2A,AR234960,GuideToPharmacology,1,agonist
ADRA1A,R-SPONDIN-4,GuideToPharmacology,1,agonist
DPH1,MECASERMIN,GuideToPharmacology,1,agonist
DPH1,GSK-1838705A,GuideToPharmacology,1,inhibitor
DPEP1,NVP-TAE 226,GuideToPharmacology,1,inhibitor
EPHA7,IRAK4 INHIBITOR RAC-45 [PMID: 18501603],GuideToPharmacology,1,inhibitor
APOC3,AFP-07,GuideToPharmacology,1,agonist
IL7R,OSE-127,GuideToPharmacology,1,antibody
BRCA2,VANILLIN,GuideToPharmacology,1,agonist
BRDT,DAPSONE,GuideToPharmacology,1,agonist
TAS2R46,GROSHEIMIN,GuideToPharmacology,1,agonist
TAS2R46,L-TRP-TRP-TRP,GuideToPharmacology,1,agonist
EPHB1,FEDRATINIB,GuideToPharmacology,1,inhibitor
EPHB2,UPADACITINIB,GuideToPharmacology,1,inhibitor
FRA2E,COMPOUND 4D [PMID: 25489658],GuideToPharmacology,1,inhibitor
DRD2,AEE788,GuideToPharmacology,1,inhibitor
NUDT2,NALMEFENE,GuideToPharmacology,1,inhibitor
DRD2,BRIVANIB,GuideToPharmacology,1,inhibitor
DRD2,PAMUFETINIB,GuideToPharmacology,1,inhibitor
DRD2,SORAFENIB,GuideToPharmacology,1,inhibitor
GPM6B,SOTORASIB,GuideToPharmacology,1,inhibitor
GPM6B,BI-0474,GuideToPharmacology,1,inhibitor
DPT,SOTULETINIB,GuideToPharmacology,1,inhibitor
GPM6B,FULZERASIB,GuideToPharmacology,1,inhibitor
ARG2,ASP-0819,GuideToPharmacology,1,activator
RHOA,QUINIDINE,GuideToPharmacology,1,blocker
ASMT,NORTRIPTYLINE,GuideToPharmacology,1,blocker
ASPA,CS+,GuideToPharmacology,1,blocker
BAAT,QUINIDINE,GuideToPharmacology,1,blocker
KCNT1,LOXAPINE,GuideToPharmacology,1,activator
TPH2,RODATRISTAT,GuideToPharmacology,1,inhibitor
EPS15,"(3Z)-N,N-DIMETHYL-2-OXO-3-(4,5,6,7-TETRAHYDRO-1H-INDOL-2-YLMETHYLIDENE)-2,3-DIHYDRO-1H-INDOLE-5-SULFONAMIDE",GuideToPharmacology,1,inhibitor
DRD5,MERESTINIB,GuideToPharmacology,1,inhibitor
KDM5C,GSK-J4,GuideToPharmacology,1,inhibitor
GPR31,CCT365623,GuideToPharmacology,1,inhibitor
KMT5A,CDK4 INHIBITOR III,GuideToPharmacology,1,inhibitor
ERVT4,COMPOUND 16 [PMID: 18945615],GuideToPharmacology,1,inhibitor
GGTL1,KDM5 INHIBITOR N71,GuideToPharmacology,1,inhibitor
AMY2B,"[125I]MCH (HUMAN, MOUSE, RAT)",GuideToPharmacology,1,agonist
ANGPT2,CORTICOTROPIN,GuideToPharmacology,1,agonist
ANK1,MT-II,GuideToPharmacology,1,agonist
ANK1,AC-C[CYS-GLU-HIS-D-PHE-ARG-TRP-D-CYS]-PRO-PRO-LYS-ASP-NH2,GuideToPharmacology,1,inhibitor
ETFB,WORTMANNIN,GuideToPharmacology,1,inhibitor
ETFB,SAPANISERTIB,GuideToPharmacology,1,inhibitor
ETFB,NEOLYMPHOSTIN A,GuideToPharmacology,1,inhibitor
DRD4,CAPMATINIB,GuideToPharmacology,1,inhibitor
DTNA,RIPK1 INHIBITOR 22B,GuideToPharmacology,1,inhibitor
DRD4,COMPOUND 19A [PMID: 30503936],GuideToPharmacology,1,inhibitor
HNRNPA2B1,STC-15,GuideToPharmacology,1,inhibitor
ANOP1,A-841720,GuideToPharmacology,1,modulator
ANOP1,A-794278,GuideToPharmacology,1,modulator
SLC25A6,GSK2210875,GuideToPharmacology,1,modulator
SLC25A6,LSN2463359,GuideToPharmacology,1,modulator
ANTP2,L-CCG-I,GuideToPharmacology,1,agonist
GRM6,LY379268,GuideToPharmacology,1,agonist
SLC25A6,CPPZ,GuideToPharmacology,1,modulator
SLC25A6,VU0404251,GuideToPharmacology,1,modulator
ANTP2,VU6012962,GuideToPharmacology,1,modulator
ANTP2,&ALPHA;-METHYLSERINE-O-PHOSPHATE,GuideToPharmacology,1,inhibitor
NR3C2,AZD-9977,GuideToPharmacology,1,inhibitor
CTNNA1P1,JNK-IN-8,GuideToPharmacology,1,inhibitor
MAPK13,MAPK13-IN-1,GuideToPharmacology,1,inhibitor
CTNNB1,ACUMAPIMOD,GuideToPharmacology,1,inhibitor
CTNNA1P1,COMPOUND 25C [PMID: 36649216],GuideToPharmacology,1,inhibitor
CTNNA1P1,JNK INHIBITOR 9L,GuideToPharmacology,1,inhibitor
ERVT3,AX15836,GuideToPharmacology,1,inhibitor
CTNNB1,PF-670462,GuideToPharmacology,1,inhibitor
ERPL1,5Z-7-OXOZEAENOL,GuideToPharmacology,1,inhibitor
DCR,APRATASTAT,GuideToPharmacology,1,inhibitor
ERV1,COMPOUND 5I [PMID: 36542759],GuideToPharmacology,1,inhibitor
ANTP4,MOTILIN-(2-22) (HUMAN),GuideToPharmacology,1,agonist
CDC5L,BAY-8002,GuideToPharmacology,1,inhibitor
FSHMD1B,RASAGILINE,GuideToPharmacology,1,inhibitor
AADAC,METHYLFURMETHIDE,GuideToPharmacology,1,agonist
AADAC,IPRATROPIUM CATION,GuideToPharmacology,1,inhibitor
AADAC,SCOPOLAMINE,GuideToPharmacology,1,inhibitor
ANK3,5-HEAT,GuideToPharmacology,1,inhibitor
APOF,SAMIDORPHAN,GuideToPharmacology,1,inhibitor
APOF,NALOXONE HYDROCHLORIDE,GuideToPharmacology,1,inhibitor
APOF,ETONITAZENE,GuideToPharmacology,1,agonist
APOF,PAREGORIC,GuideToPharmacology,1,agonist
EVPL,COMPOUND 25 [PMID: 17935989],GuideToPharmacology,1,inhibitor
DLX5,M372049,GuideToPharmacology,1,inhibitor
DRD5P1,GNF-5837,GuideToPharmacology,1,inhibitor
NOS1,TILARGININE,GuideToPharmacology,1,inhibitor
ATHS,NICOTINE POLACRILEX,GuideToPharmacology,1,inhibitor
DRD5P2,DDR1/2 INHIBITOR 5N,GuideToPharmacology,1,inhibitor
DAP,KELATORPHAN,GuideToPharmacology,1,inhibitor
DRD5P2,RIPK1 INHIBITOR 22B,GuideToPharmacology,1,inhibitor
CHRNA3,A-867744,GuideToPharmacology,1,blocker
ATF4,PNU-120596,GuideToPharmacology,1,modulator
ATF4P1,NICOTINE POLACRILEX,GuideToPharmacology,1,inhibitor
AQP3,L760735,GuideToPharmacology,1,inhibitor
AQP3,ZD6021,GuideToPharmacology,1,inhibitor
AQP4,[&BETA;ALA8]NEUROKININ A-(4-10),GuideToPharmacology,1,agonist
GPR37,BRONTICTUZUMAB,GuideToPharmacology,1,antibody
AMPD2,5-(6-CHLORO-2-HEXYL-1H-INDOL-1-YL)-5-OXO-VALERIC ACID,GuideToPharmacology,1,inhibitor
APBB1,FIRAZOREXTON,GuideToPharmacology,1,agonist
APBB1,T-516,GuideToPharmacology,1,agonist
EXT3,PF-3758309,GuideToPharmacology,1,inhibitor
APBB1,[3H]CP-1,GuideToPharmacology,1,inhibitor
ATP1A3,ADENOSINE TRIPHOSPHATE,GuideToPharmacology,1,agonist
ATP1A3,L-&BETA;&GAMMA;-MEATP,GuideToPharmacology,1,agonist
ATP1B1,BAY-1797,GuideToPharmacology,1,inhibitor
BIRC3,MRS2690,GuideToPharmacology,1,agonist
APBB2,ADENOSINE TRIPHOSPHATE,GuideToPharmacology,1,agonist
APBB2,ADENOSINE TRIPHOSPHATE,GuideToPharmacology,1,inhibitor
APC,PSB-416,GuideToPharmacology,1,inhibitor
APOE,AC264613,GuideToPharmacology,1,agonist
GPX3,COMPOUND 14B [PMID: 25742366],GuideToPharmacology,1,inhibitor
F7,IC-87114,GuideToPharmacology,1,inhibitor
F7R,RV1729,GuideToPharmacology,1,inhibitor
COL11A2,CDP840,GuideToPharmacology,1,inhibitor
COL12A1,BPN14770,GuideToPharmacology,1,modulator
F11,COMPOUND 1A [PMID: 24900749],GuideToPharmacology,1,inhibitor
F10,PIM447,GuideToPharmacology,1,inhibitor
F9,VORUCICLIB,GuideToPharmacology,1,inhibitor
APOA2,PROKINETICIN-1,GuideToPharmacology,1,agonist
FRA4E,DUP-714,GuideToPharmacology,1,inhibitor
DPP6,BPR1R024,GuideToPharmacology,1,inhibitor
DPP4,MASITINIB,GuideToPharmacology,1,inhibitor
DPP4,CRENOLANIB,GuideToPharmacology,1,inhibitor
DPP4,COMPOUND 8I [PMID: 22765894],GuideToPharmacology,1,inhibitor
DPP6,PDGF RECEPTOR TYROSINE KINASE INHIBITOR III,GuideToPharmacology,1,inhibitor
GNAI2,LERZEPARIB,GuideToPharmacology,1,inhibitor
CNC2,MS023,GuideToPharmacology,1,inhibitor
GART,SUPRASTAT,GuideToPharmacology,1,inhibitor
FRA6A,AZAPRO-3,GuideToPharmacology,1,inhibitor
CTAA1,BISINDOLYLMALEIMIDE IV,GuideToPharmacology,1,inhibitor
GOLGA1,WORTMANNIN,GuideToPharmacology,1,inhibitor
PRKG1,IPATASERTIB,GuideToPharmacology,1,inhibitor
GAS2,ROMIDEPSIN,GuideToPharmacology,1,inhibitor
FABP7,CRT 0066101,GuideToPharmacology,1,inhibitor
GOLGA1,PI-103,GuideToPharmacology,1,inhibitor
ACSL3,ALOISINE,GuideToPharmacology,1,inhibitor
CTSW,COMPOUND 32 [PMID: 20471253],GuideToPharmacology,1,inhibitor
GDF9,ROMIDEPSIN,GuideToPharmacology,1,inhibitor
GTF3C2,COMPOUND 182 [PMID: 37500611],GuideToPharmacology,1,inhibitor
FAP,RIPK1 INHIBITOR 22B,GuideToPharmacology,1,inhibitor
BCHE,TAMIBAROTENE,GuideToPharmacology,1,agonist
GAS1,SUPRASTAT,GuideToPharmacology,1,inhibitor
FRA7F,ALISKIREN,GuideToPharmacology,1,inhibitor
HCN2,AGN194204,GuideToPharmacology,1,agonist
GAS1,PANOBINOSTAT,GuideToPharmacology,1,inhibitor
RXRG,ALITRETINOIN,GuideToPharmacology,1,agonist
HCN2,PA451,GuideToPharmacology,1,inhibitor
HCN2,PA452,GuideToPharmacology,1,inhibitor
CTPS1,BELUMOSUDIL,GuideToPharmacology,1,inhibitor
GAS2,PANOBINOSTAT,GuideToPharmacology,1,inhibitor
BCL2,SR9011,GuideToPharmacology,1,agonist
APPL1,NANOLUC-INSL3,GuideToPharmacology,1,agonist
APRT,MINIMISED RELAXIN-3 ANALOGUE 2,GuideToPharmacology,1,agonist
KLK3,COMPOUND 4 [PMID: 30824200],GuideToPharmacology,1,agonist
AMD1P2,CLOBENPROPIT,GuideToPharmacology,1,inhibitor
APRT,R3 B1-22R,GuideToPharmacology,1,inhibitor
KLK3,COMPOUND 7A [PMID: 33730669],GuideToPharmacology,1,agonist
KLK3,RELAXIN-3 (B CHAIN),GuideToPharmacology,1,agonist
KLK3,HINSL5: A8-21 (T15K),GuideToPharmacology,1,agonist
SIGMAR1,NE-100,GuideToPharmacology,1,inhibitor
SIRT2,AGK2,GuideToPharmacology,1,inhibitor
HRH3,IMETIT,GuideToPharmacology,1,agonist
CRYBB2P1,COMPOUND 12E [PMID: 18605714],GuideToPharmacology,1,inhibitor
FAS,"CYCLO(7-12) DES-AA1,2,5-[GLU7,D-TRP8,IAMP9,M-I-TYR11,HHLYS12]SRIF",GuideToPharmacology,1,agonist
FCGR1BP,COMPOUND 25 [PMID: 17935989],GuideToPharmacology,1,inhibitor
HRH3,(R)-&ALPHA;-METHYLHISTAMINE,GuideToPharmacology,1,agonist
FASLG,BIM 23027,GuideToPharmacology,1,agonist
FASLG,BIM 23627,GuideToPharmacology,1,inhibitor
FASLG,[125I]CGP 23996,GuideToPharmacology,1,agonist
AQP1,BIM 23295,GuideToPharmacology,1,agonist
HRH3,HISTAMINE,GuideToPharmacology,1,agonist
AQP2,PRL-2915,GuideToPharmacology,1,inhibitor
AQP7,[3H]TYRAMINE,GuideToPharmacology,1,agonist
AQP7,LEVAMFETAMINE,GuideToPharmacology,1,agonist
ECM2,COMPOUND 8I [PMID: 22765894],GuideToPharmacology,1,inhibitor
HRH3,VUF 8328,GuideToPharmacology,1,agonist
MPL,HETROMBOPAG,GuideToPharmacology,1,agonist
THRB,LIOTHYRONINE,GuideToPharmacology,1,agonist
HRH3,ENERISANT,GuideToPharmacology,1,inhibitor
HNRNPH3,SUCUNAMOSTAT,GuideToPharmacology,1,inhibitor
DNMT3A,COMPOUND 13D [PMID: 23639540],GuideToPharmacology,1,inhibitor
ATP2A2,CLEMIZOLE,GuideToPharmacology,1,blocker
ATP1B1P1,GDC-6599,GuideToPharmacology,1,inhibitor
GMFA,GLYCYRRHETINIC ACID,GuideToPharmacology,1,inhibitor
ATP1B1P1,DRONABINOL,GuideToPharmacology,1,activator
ATP2B2,20-HETE,GuideToPharmacology,1,activator
ATP2B3,AMILORIDE,GuideToPharmacology,1,blocker
ATP2B4,PREGNENOLONE SULPHATE,GuideToPharmacology,1,activator
ATP4A,2-APB,GuideToPharmacology,1,inhibitor
TRPM5,COMPOUND 39 [PMID: 36402081],GuideToPharmacology,1,activator
PRDM1,COMPOUND 2T [PMID: 2296036],GuideToPharmacology,1,inhibitor
ATP5F1BP1,CAPSAICIN,GuideToPharmacology,1,activator
FGFR4,BOS172722,GuideToPharmacology,1,inhibitor
TYK2,FEDRATINIB,GuideToPharmacology,1,inhibitor
ADAM10,KYNURENIC ACID,GuideToPharmacology,1,agonist
CDKN2C,DOTINURAD,GuideToPharmacology,1,inhibitor
GUSB,RITONAVIR,GuideToPharmacology,1,inhibitor
BCL7A,TACALCITOL,GuideToPharmacology,1,agonist
ARCN1,"[ALA11,22,28]VIP",GuideToPharmacology,1,agonist
AQP9,ARGIPRESTOCIN,GuideToPharmacology,1,agonist
ARCN1,N-STEARYL-[NLE17] NEUROTENSIN-(6-11)/VIP-(7-28),GuideToPharmacology,1,inhibitor
XCR1,PF-06840003,GuideToPharmacology,1,inhibitor
AQP9,NELIVAPTAN,GuideToPharmacology,1,inhibitor
AR,"[3H]AVP (HUMAN, MOUSE, RAT)",GuideToPharmacology,1,agonist
ABCC6,OPC-51803,GuideToPharmacology,1,agonist
ABCC6,D[D-PAL2]AVP,GuideToPharmacology,1,agonist
ABCC6,ARGIPRESTOCIN,GuideToPharmacology,1,agonist
ABCC6,"[3H]AVP (HUMAN, MOUSE, RAT)",GuideToPharmacology,1,agonist
FKBP1AP3,REBASTINIB,GuideToPharmacology,1,inhibitor
FKBP1AP4,ALOISINE,GuideToPharmacology,1,inhibitor
XCR1,NECROSTATIN-1,GuideToPharmacology,1,inhibitor
GRK2,BOVINE ADRENAL MEDULLA PEPTIDE 8-22,GuideToPharmacology,1,agonist
AEBP1,JTE-013,GuideToPharmacology,1,inhibitor
MYRF,IP3,GuideToPharmacology,1,activator
BNC1,NE21650,GuideToPharmacology,1,inhibitor
BOK,CUCURBITACIN B,GuideToPharmacology,1,agonist
GRB2,VORASIDENIB,GuideToPharmacology,1,inhibitor
EPHB3,DELGOCITINIB,GuideToPharmacology,1,inhibitor
EPHB3,CERDULATINIB,GuideToPharmacology,1,inhibitor
NUDT2,(-)-BREMAZOCINE,GuideToPharmacology,1,agonist
DRD2,ACRIZANIB,GuideToPharmacology,1,inhibitor
DRD2,RG-1530,GuideToPharmacology,1,inhibitor
DPT,GTP-14564,GuideToPharmacology,1,inhibitor
GPM6B,ASP2453,GuideToPharmacology,1,inhibitor
ATP5MC1,RILUZOLE,GuideToPharmacology,1,activator
ATP5PB,ANANDAMIDE,GuideToPharmacology,1,blocker
ARF6,NS8593,GuideToPharmacology,1,inhibitor
ARF6,NS309,GuideToPharmacology,1,activator
KCNJ8,GLYBURIDE,GuideToPharmacology,1,inhibitor
ATP7A,HELATX1,GuideToPharmacology,1,blocker
KIF1A,RY785,GuideToPharmacology,1,inhibitor
AQP8,ONO-AE1-329,GuideToPharmacology,1,agonist
KCNQ3,EZOGABINE,GuideToPharmacology,1,activator
AZF2,ICA-27243,GuideToPharmacology,1,activator
CTSV,A-674563,GuideToPharmacology,1,inhibitor
ACTBP5,VMIP-I,GuideToPharmacology,1,agonist
CTSV,K-252A,GuideToPharmacology,1,inhibitor
FRA10D,COMPOUND 9 [PMID: 22533316],GuideToPharmacology,1,inhibitor
SLC26A3,BLU-9931,GuideToPharmacology,1,inhibitor
CTSV,STAUROSPORINE,GuideToPharmacology,1,inhibitor
LATS2,SUNITINIB,GuideToPharmacology,1,inhibitor
ANOP1,AIDA,GuideToPharmacology,1,inhibitor
DRD2,COMPOUND 8I [PMID: 22765894],GuideToPharmacology,1,inhibitor
AAVS1,NNC 11-1585,GuideToPharmacology,1,agonist
EPHX2,7-HYDROXYSTAUROSPORINE,GuideToPharmacology,1,inhibitor
EPS8,HG-10-102-01,GuideToPharmacology,1,inhibitor
ALAS2,CRA1000,GuideToPharmacology,1,inhibitor
CLN8,COMPOUND 14 [PMID: 19831390],GuideToPharmacology,1,inhibitor
CRH,ACIVICIN,GuideToPharmacology,1,inhibitor
ABCA3,ST-1535,GuideToPharmacology,1,inhibitor
MMP7,SL422,GuideToPharmacology,1,inhibitor
DTNB,GILTERITINIB,GuideToPharmacology,1,inhibitor
AAMP,TROPICAMIDE,GuideToPharmacology,1,inhibitor
EPS15,BOSUTINIB,GuideToPharmacology,1,inhibitor
CRHR2,ACEBILUSTAT,GuideToPharmacology,1,inhibitor
CRHR2,LYS006,GuideToPharmacology,1,inhibitor
BCL3,TO-901317,GuideToPharmacology,1,agonist
BIN1,DIOCTANOYLGLYCEROL PYROPHOSPHATE,GuideToPharmacology,1,agonist
BIN1,DIOCTANOYLGLYCEROL PYROPHOSPHATE,GuideToPharmacology,1,inhibitor
AMPD3,MIANSERIN,GuideToPharmacology,1,inhibitor
AMPH,LPA,GuideToPharmacology,1,agonist
BIN1,DODECYLPHOSPHATE,GuideToPharmacology,1,inhibitor
EPAS1,COMPOUND 5B [PMID: 24900464],GuideToPharmacology,1,inhibitor
ALDH7A1,PRU-10,GuideToPharmacology,1,inhibitor
AP2B1,LPA,GuideToPharmacology,1,agonist
GFER,DAMINOZIDE,GuideToPharmacology,1,inhibitor
DPT,COMPOUND 19A [PMID: 30503936],GuideToPharmacology,1,inhibitor
ADH1A,FARNESYL DIPHOSPHATE,GuideToPharmacology,1,agonist
ABCA4,SKF 105854,GuideToPharmacology,1,inhibitor
BIRC5,COMPOUND III [PMID: 24080463],GuideToPharmacology,1,inhibitor
ARRB2,[3H]MUSCIMOL,GuideToPharmacology,1,agonist
DAPK1,TALABOSTAT,GuideToPharmacology,1,inhibitor
A12M3,EGIS-11150,GuideToPharmacology,1,inhibitor
GDNF,MG149,GuideToPharmacology,1,inhibitor
GPR31,SIMTUZUMAB,GuideToPharmacology,1,inhibitor
BDKRB2,NPC 17731,GuideToPharmacology,1,inhibitor
ESRRG,TOMIVOSERTIB,GuideToPharmacology,1,inhibitor
H1-0,SETANAXIB,GuideToPharmacology,1,inhibitor
ASS1P5,KAINIC ACID,GuideToPharmacology,1,agonist
AMY2B,ATC0175,GuideToPharmacology,1,inhibitor
XCR1,AMG-1,GuideToPharmacology,1,inhibitor
AMY2B,S38151,GuideToPharmacology,1,inhibitor
EFNB2,PTD10,GuideToPharmacology,1,inhibitor
AAMP,ALEXA-488-TELENZEPINE,GuideToPharmacology,1,inhibitor
ANGPT1,[D-TRP8]&GAMMA;-MSH,GuideToPharmacology,1,agonist
CNR2,BAY-593074,GuideToPharmacology,1,agonist
ABCD1,ROTIGOTINE,GuideToPharmacology,1,agonist
GRIN2C,AMANTADINE HYDROCHLORIDE,GuideToPharmacology,1,blocker
A12M2,BRL-54443,GuideToPharmacology,1,agonist
CACNA1F,ISRADIPINE,GuideToPharmacology,1,inhibitor
APOBER1,CICAPROST,GuideToPharmacology,1,agonist
DRD4,MERESTINIB,GuideToPharmacology,1,inhibitor
GLUD1P3,HISTIDINE,GuideToPharmacology,1,activator
DRD4,COMPOUND R-16 [PMID: 21967808],GuideToPharmacology,1,inhibitor
DRD4,FORETINIB,GuideToPharmacology,1,inhibitor
AADAC,"WIN 62,577",GuideToPharmacology,1,modulator
ANOP1,FTIDC,GuideToPharmacology,1,modulator
CTRB1,CORTISTATIN A,GuideToPharmacology,1,inhibitor
A2MP1,9-OH-RISPERIDONE,GuideToPharmacology,1,inhibitor
ACADM,"[SAR1,GLY4,GLY8]ANG-II",GuideToPharmacology,1,inhibitor
FNTBL1,POSTSTATIN,GuideToPharmacology,1,inhibitor
TYK2,UPADACITINIB,GuideToPharmacology,1,inhibitor
FUSE,COMPOUND 31 [PMID: 24809814],GuideToPharmacology,1,inhibitor
ANOP1,JNJ16259685,GuideToPharmacology,1,modulator
ANPEP,3-MPPTS,GuideToPharmacology,1,modulator
ANPEP,JNJ-42153605,GuideToPharmacology,1,modulator
SLC25A4,LY395756,GuideToPharmacology,1,inhibitor
CTNS,TANZISERTIB,GuideToPharmacology,1,inhibitor
CTNS,YL5084,GuideToPharmacology,1,inhibitor
A12M3,RISPERIDONE,GuideToPharmacology,1,inhibitor
ERBB3,COMPOUND 11 [PMID: 26431428],GuideToPharmacology,1,inhibitor
AAMP,VINCAMINE,GuideToPharmacology,1,modulator
DAPK3,ENALAPRILAT ANHYDROUS,GuideToPharmacology,1,inhibitor
APAF1,ETONITAZENE,GuideToPharmacology,1,agonist
MAP2K1,MEK INHIBITOR II,GuideToPharmacology,1,inhibitor
MAP2K1,AVUTOMETINIB,GuideToPharmacology,1,inhibitor
AADAC,NNC 11-1314,GuideToPharmacology,1,agonist
ALOX12P1,GALANIN(2-29) (PIG),GuideToPharmacology,1,agonist
GRM8,VU0422288,GuideToPharmacology,1,modulator
AAVS1,HEXAHYDROSILADIFENIDOL,GuideToPharmacology,1,inhibitor
ATP4B,ADP,GuideToPharmacology,1,inhibitor
PTGES,COMPOUND 44 [PMID: 19748780],GuideToPharmacology,1,inhibitor
CTNNB1,AZD7624,GuideToPharmacology,1,inhibitor
AQP3,TAK-637,GuideToPharmacology,1,inhibitor
GM2A,ZIMBERELIMAB,GuideToPharmacology,1,antibody
AADAC,MUSCARINIC TOXIN 7,GuideToPharmacology,1,modulator
AAMP,[3H]OXOTREMORINE-M,GuideToPharmacology,1,agonist
STX2,COMPOUND 31 [PMID: 22902653],GuideToPharmacology,1,inhibitor
FGB,COMPOUND 25C [PMID: 36649216],GuideToPharmacology,1,inhibitor
AADAC,TIOTROPIUM,GuideToPharmacology,1,inhibitor
APOF,DSLET,GuideToPharmacology,1,agonist
AAMP,W-84,GuideToPharmacology,1,modulator
A1BG,PIRIBEDIL,GuideToPharmacology,1,agonist
AAMP,BIPERIDEN,GuideToPharmacology,1,inhibitor
AAMP,WDUO3,GuideToPharmacology,1,modulator
AAMP,TIOTROPIUM,GuideToPharmacology,1,inhibitor
FRA2B,COMPOUND 33 [PMID: 19908842],GuideToPharmacology,1,inhibitor
ATP5F1BP1,RESINIFERATOXIN,GuideToPharmacology,1,activator
AANAT,HIMBACINE,GuideToPharmacology,1,inhibitor
AANAT,BIPERIDEN,GuideToPharmacology,1,inhibitor
HTR2C,PERPHENAZINE,GuideToPharmacology,1,inhibitor
AANAT,MILAMELINE,GuideToPharmacology,1,agonist
ABCA2,AS16,GuideToPharmacology,1,inhibitor
ACAT2,BOMBESIN,GuideToPharmacology,1,agonist
APAF1,NALTRIBEN,GuideToPharmacology,1,inhibitor
GABRA1,BICUCULLINE,GuideToPharmacology,1,inhibitor
A1BG,SB 272183,GuideToPharmacology,1,inhibitor
A2MP1,1-NAPHTHYLPIPERAZINE,GuideToPharmacology,1,agonist
CDK4,PURVALANOL A,GuideToPharmacology,1,inhibitor
FASN,ORLISTAT,GuideToPharmacology,1,inhibitor
AANAT,TIOTROPIUM,GuideToPharmacology,1,inhibitor
AARS1,NNC 11-1314,GuideToPharmacology,1,agonist
HTR2C,S33084,GuideToPharmacology,1,inhibitor
DR1,ASP5878,GuideToPharmacology,1,inhibitor
FRA6B,BEGACESTAT,GuideToPharmacology,1,inhibitor
AARS1,ARECAIDINE PROPARGYL ESTER,GuideToPharmacology,1,agonist
APAF1,HYDROMORPHONE HYDROCHLORIDE,GuideToPharmacology,1,agonist
APOB,AH6809,GuideToPharmacology,1,inhibitor
ALCAM,5-HYDROXYTRYPTAMINE,GuideToPharmacology,1,agonist
EMX2,COMPOUND A127 [WO2013110309],GuideToPharmacology,1,inhibitor
CTNNA2,BOS172722,GuideToPharmacology,1,inhibitor
KLK3,[125I]RELAXIN-3-B/INSL5 A CHIMERA,GuideToPharmacology,1,agonist
AANAT,UMECLIDINIUM BROMIDE,GuideToPharmacology,1,inhibitor
AARS1,MUSCARINIC TOXIN 3,GuideToPharmacology,1,modulator
CA14,METHAZOLAMIDE,GuideToPharmacology,1,inhibitor
HDAC4,KA1010,GuideToPharmacology,1,inhibitor
EPHB1,IZENCITINIB,GuideToPharmacology,1,inhibitor
ACAT1,[125I][TYR4]BOMBESIN,GuideToPharmacology,1,agonist
FRA1G,MI-1148,GuideToPharmacology,1,inhibitor
CD24P2,BITOPERTIN,GuideToPharmacology,1,inhibitor
AARS1,MUSCARINIC TOXIN 3,GuideToPharmacology,1,inhibitor
AARS1,KT 5720,GuideToPharmacology,1,modulator
GYPE,PIXATIMOD,GuideToPharmacology,1,inhibitor
AAVS1,NNC 11-1314,GuideToPharmacology,1,agonist
E11S,URELUMAB,GuideToPharmacology,1,antibody
AAVS1,BIPERIDEN,GuideToPharmacology,1,inhibitor
AAVS1,AMITRIPTYLINE HYDROCHLORIDE,GuideToPharmacology,1,inhibitor
ANK2,UCM 724,GuideToPharmacology,1,inhibitor
ANK2,S26284,GuideToPharmacology,1,agonist
CCR10,"L-739,750",GuideToPharmacology,1,inhibitor
BIN1,CPY,GuideToPharmacology,1,agonist
APOF,2F-MT-45,GuideToPharmacology,1,agonist
APCS,GUANOSINE-5'-TRIPHOSPHATE,GuideToPharmacology,1,agonist
RIPK2,OD36,GuideToPharmacology,1,inhibitor
BCKDHA,LY-510929,GuideToPharmacology,1,agonist
APOF,ADL5747,GuideToPharmacology,1,agonist
APOF,ICI-199441,GuideToPharmacology,1,agonist
APOF,GSK1521498,GuideToPharmacology,1,inhibitor
ABL1,ATIPAMEZOLE,GuideToPharmacology,1,inhibitor
BDKRB2,BRADYZIDE,GuideToPharmacology,1,inhibitor
ASS1P14,"5,7-DICHLOROKYNURENIC ACID",GuideToPharmacology,1,inhibitor
APLP2,2-O-ETHYL-PAF C-16,GuideToPharmacology,1,agonist
APOF,LEVORPHANOL,GuideToPharmacology,1,agonist
APOF,HYDROCODONE,GuideToPharmacology,1,agonist
GAS8-AS1,GD3+,GuideToPharmacology,1,blocker
ABAT,KF26777,GuideToPharmacology,1,inhibitor
CPT1B,MECLOFENAMATE,GuideToPharmacology,1,inhibitor
GAS1,GIVINOSTAT,GuideToPharmacology,1,inhibitor
BBS1,PROTOXIN II,GuideToPharmacology,1,inhibitor
BAK1,GNE-131,GuideToPharmacology,1,inhibitor
BBS2,VERATRIDINE,GuideToPharmacology,1,activator
ADH1A,N-ARACHIDONOYLGLYCINE,GuideToPharmacology,1,agonist
SCN9A,VIXOTRIGINE,GuideToPharmacology,1,blocker
FAH,VEMURAFENIB,GuideToPharmacology,1,inhibitor
SCN9A,XEN907,GuideToPharmacology,1,blocker
BBS4,FUNAPIDE,GuideToPharmacology,1,inhibitor
HLCS,LARGE PROLINE-RICH PROTEIN BAG6,GuideToPharmacology,1,activator
ATF4,AZD0328,GuideToPharmacology,1,agonist
ETV3,COMPOUND 31 [PMID: 20936789],GuideToPharmacology,1,inhibitor
AQP5,FK 224,GuideToPharmacology,1,inhibitor
NMUR2,R-PSOP,GuideToPharmacology,1,inhibitor
SLCO1A2,RIFAMPIN,GuideToPharmacology,1,inhibitor
SLCO1B1,RIFAMYCIN SV,GuideToPharmacology,1,inhibitor
ARAF,"D(CH2)5[TYR(ME)2,THR4,PHE(3125I,4N3)-NH29]OVT",GuideToPharmacology,1,inhibitor
ARAF,"DESGLYNH2-D(CH2)5[TYR(ME)2,THR4,ORN8]OT",GuideToPharmacology,1,inhibitor
ARAF,LIT-001,GuideToPharmacology,1,agonist
APBB2,ADENOSINE-3'-5'-BISPHOSPHATE,GuideToPharmacology,1,inhibitor
APBB2,PPADS,GuideToPharmacology,1,inhibitor
AIRE,URIDINE 5'-TRIPHOSPHATE,GuideToPharmacology,1,agonist
APLP2,FOROPAFANT,GuideToPharmacology,1,inhibitor
APOE,I-287,GuideToPharmacology,1,modulator
BCKDHA,CIPROFIBRATE,GuideToPharmacology,1,agonist
BCKDHA,PIRINIXIC ACID,GuideToPharmacology,1,agonist
CCND1,GW9578,GuideToPharmacology,1,agonist
FTH1P2,P6949,GuideToPharmacology,1,inhibitor
F5,APITOLISIB,GuideToPharmacology,1,inhibitor
F5,PUQUITINIB,GuideToPharmacology,1,inhibitor
F5,GEDATOLISIB,GuideToPharmacology,1,inhibitor
F5,IZORLISIB,GuideToPharmacology,1,inhibitor
PIK3CB,OMIPALISIB,GuideToPharmacology,1,inhibitor
COL19A1,MARDEPODECT,GuideToPharmacology,1,inhibitor
GPR34P,BAY-091,GuideToPharmacology,1,inhibitor
F9,SGI-1776,GuideToPharmacology,1,inhibitor
GNAI2,AZ1366,GuideToPharmacology,1,inhibitor
GM2A,PENPULIMAB,GuideToPharmacology,1,antibody
SLC36A2,"&ALPHA;-METHYL-D,L-TRYPTOPHAN",GuideToPharmacology,1,inhibitor
XIAP,PTHRP-(1-21)/PTH-(22-34) (HUMAN),GuideToPharmacology,1,agonist
XIAP,"[ALA1,12,AIB3,GLN10,HARG11,TRP14,ARG19]PTH-(1-21)-NH2 (HUMAN)",GuideToPharmacology,1,agonist
APOA4,PRRP-31,GuideToPharmacology,1,agonist
XIAP,TIP39-(3-39) (HUMAN/BOVINE),GuideToPharmacology,1,inhibitor
XIAP,TIP39,GuideToPharmacology,1,inhibitor
XIAP,[TYR34]PTH-(1-34) (HUMAN),GuideToPharmacology,1,agonist
BIRC5,PTHRP-(1-21)/PTH-(22-34) (HUMAN),GuideToPharmacology,1,inhibitor
BIRC5,"[ILE5,TRP23]PTHRP-(2-36) (HUMAN)",GuideToPharmacology,1,agonist
H1-2,COMPOUND 16 [PMID: 31977207],GuideToPharmacology,1,activator
FRA7E,COMPOUND 3 [PMID: 17942791],GuideToPharmacology,1,inhibitor
BAK1P1,GSK2981278,GuideToPharmacology,1,agonist
BCL2L2,ALL-TRANS-4-OXO-RETINOIC ACID,GuideToPharmacology,1,inhibitor
FANCG,COMPOUND 27 [PMID: 24900635],GuideToPharmacology,1,inhibitor
CTRB1,SOVESUDIL,GuideToPharmacology,1,inhibitor
APPL1,[33P]RELAXIN (HUMAN),GuideToPharmacology,1,agonist
APPL1,INSL3 B CHAIN DIMER ANALOGUE 8,GuideToPharmacology,1,inhibitor
AMY1A,JTE-013,GuideToPharmacology,1,inhibitor
AMY1A,OZANIMOD,GuideToPharmacology,1,agonist
FAUNA@,HG-9-91-01,GuideToPharmacology,1,inhibitor
SPTLC3,MYRIOCIN,GuideToPharmacology,1,inhibitor
FCGR3A,AT-9283,GuideToPharmacology,1,inhibitor
STK4,CERDULATINIB,GuideToPharmacology,1,inhibitor
CYLC1,COMPOUND 74 [PMID: 24793884],GuideToPharmacology,1,inhibitor
CD9,LEVOMILNACIPRAN,GuideToPharmacology,1,inhibitor
CYB561,COMPOUND 14N [PMID: 25589934],GuideToPharmacology,1,inhibitor
CHRNA3,LIFASTUZUMAB VEDOTIN,GuideToPharmacology,1,antibody
CD3D,MIZAGLIFLOZIN,GuideToPharmacology,1,inhibitor
BLVRB,COMPOUND 3 [PMID: 19191557],GuideToPharmacology,1,inhibitor
BLVRB,"COMPOUND 1 [OVERHAND ET AL., 1997]",GuideToPharmacology,1,inhibitor
BLVRB,E5700,GuideToPharmacology,1,inhibitor
BLVRB,1-ALLYL-2-[3-(ISOPROPYLAMINO)PROPOXY]-9H-XANTHEN-9-ONE,GuideToPharmacology,1,inhibitor
FASLG,BOC-ATE,GuideToPharmacology,1,agonist
FAS,BIM 23454,GuideToPharmacology,1,inhibitor
FASLG,DC 23-60,GuideToPharmacology,1,agonist
AQP1,[125I]TYR10-CST14,GuideToPharmacology,1,agonist
AQP2,[111IN]DOTA-BOC-ATE,GuideToPharmacology,1,agonist
HLA-DMA,NVP鈥怲NKS656,GuideToPharmacology,1,inhibitor
HLA-DMB,AZ1366,GuideToPharmacology,1,inhibitor
BCGF1,SOBETIROME,GuideToPharmacology,1,agonist
SARDH,GSK2245035,GuideToPharmacology,1,agonist
H2AZ1,JAK3 INHIBITOR IV,GuideToPharmacology,1,inhibitor
ATP1B1P1,JT010,GuideToPharmacology,1,activator
ATP1B1P1,AURANOFIN,GuideToPharmacology,1,activator
ATP2B2,OPTOBI-1,GuideToPharmacology,1,activator
ATP2B1,PICO145,GuideToPharmacology,1,blocker
TRPM8,SCUTELLAREIN,GuideToPharmacology,1,blocker
MCOLN2,ESTRADIOL 3-METHYL ETHER,GuideToPharmacology,1,inhibitor
ATP5F1C,ISOPENTENYL PYROPHOSPHATE,GuideToPharmacology,1,blocker
ATP5F1C,ASPIRIN-TRIGGERED RESOLVIN D1,GuideToPharmacology,1,blocker
ATP5BL2,TRANILAST,GuideToPharmacology,1,blocker
FGFR4,COMPOUND 27F [PMID: 25625617],GuideToPharmacology,1,inhibitor
UTS2R,[PEN5]U-(4-11) (HUMAN),GuideToPharmacology,1,agonist
CDH15,VESAMICOL,GuideToPharmacology,1,inhibitor
ARCN1,"[LYS15,ARG16,LEU27]VIP-(1-7)/GRF-(8-27)-NH2",GuideToPharmacology,1,agonist
ANXA3,NPY-(22-36) (PIG),GuideToPharmacology,1,agonist
ANXA5,"[ALA31,AIB32]NPY (PIG)",GuideToPharmacology,1,agonist
BCAT2,H+,GuideToPharmacology,1,agonist
ANXA3,NPY-(3-36) (PIG),GuideToPharmacology,1,agonist
A1BG,RISPERIDONE,GuideToPharmacology,1,inhibitor
A1BG,RITANSERIN,GuideToPharmacology,1,inhibitor
A2M,SB 216641,GuideToPharmacology,1,agonist
A12M1,RISPERIDONE,GuideToPharmacology,1,inhibitor
A12M2,GR 127935,GuideToPharmacology,1,agonist
A12M3,BROLAMFETAMINE,GuideToPharmacology,1,agonist
A12M2,METERGOLINE,GuideToPharmacology,1,inhibitor
A12M3,RU 24969,GuideToPharmacology,1,agonist
A12M3,FLIBANSERIN,GuideToPharmacology,1,inhibitor
HTR2C,SDZ SER-082,GuideToPharmacology,1,inhibitor
NAT1,RS 100235,GuideToPharmacology,1,inhibitor
NAT1,GR 125487,GuideToPharmacology,1,inhibitor
NATP,IDALOPIRDINE,GuideToPharmacology,1,inhibitor
NATP,METHYSERGIDE,GuideToPharmacology,1,inhibitor
NATP,ZOTEPINE,GuideToPharmacology,1,inhibitor
ACVR1C,SB-431542,GuideToPharmacology,1,inhibitor
HBEGF,FICONALKIB,GuideToPharmacology,1,inhibitor
ABCF1,RISPERIDONE,GuideToPharmacology,1,inhibitor
ABCF1,(+)-CYCLAZOSIN,GuideToPharmacology,1,inhibitor
ABCF1,RITANSERIN,GuideToPharmacology,1,inhibitor
ABCF1,SPIPERONE,GuideToPharmacology,1,inhibitor
ABCF1,INDORAMIN,GuideToPharmacology,1,inhibitor
ABCA4,CLONIDINE HYDROCHLORIDE,GuideToPharmacology,1,agonist
ABCA4,NIGULDIPINE,GuideToPharmacology,1,inhibitor
ABCA4,RISPERIDONE,GuideToPharmacology,1,inhibitor
ABCA4,ALFUZOSIN,GuideToPharmacology,1,inhibitor
ABL1,[3H]MK-912,GuideToPharmacology,1,inhibitor
ABL1,TIZANIDINE HYDROCHLORIDE,GuideToPharmacology,1,agonist
ABL1,"5-(N,N-HEXAMETHYLENE)-AMILORIDE",GuideToPharmacology,1,modulator
AOC1,[3H]MK-912,GuideToPharmacology,1,inhibitor
AOC1,DEXMEDETOMIDINE HYDROCHLORIDE,GuideToPharmacology,1,agonist
AOC1,PRAZOSIN,GuideToPharmacology,1,inhibitor
ABL2,[3H]MK-912,GuideToPharmacology,1,inhibitor
ABL2,RACEPINEPHRINE,GuideToPharmacology,1,agonist
ABL2,NAPHAZOLINE,GuideToPharmacology,1,agonist
BEVI,GALETERONE,GuideToPharmacology,1,inhibitor
GNA11,TIMOLUMAB,GuideToPharmacology,1,antibody
DAPK3,PERINDOPRIL,GuideToPharmacology,1,inhibitor
DAPK3,IMIDAPRILAT,GuideToPharmacology,1,inhibitor
ABCA1,"(R,S)-PHPNECA",GuideToPharmacology,1,agonist
ABCA3,"(R,S)-PHPNECA",GuideToPharmacology,1,agonist
ABCA3,MRS1220,GuideToPharmacology,1,inhibitor
EEF1D,ALISERTIB,GuideToPharmacology,1,inhibitor
ACADS,CGP42112,GuideToPharmacology,1,agonist
EEF1D,N-{3-[(4-{[3-(TRIFLUOROMETHYL)PHENYL]AMINO}PYRIMIDIN-2-YL)AMINO]PHENYL}CYCLOPROPANECARBOXAMIDE,GuideToPharmacology,1,inhibitor
ACADM,CANDESARTAN CILEXETIL,GuideToPharmacology,1,inhibitor
GNG11,BV-6,GuideToPharmacology,1,inhibitor
ACAT1,D-NAL-CYS-TYR-D-TRP-LYS-VAL-CYS-NAL-NH2,GuideToPharmacology,1,inhibitor
GPR21,OBATOCLAX,GuideToPharmacology,1,inhibitor
ASIC2,"[D-TYR6,(R)-APA11,PHE13,NLE14]BOMBESIN-(6-14)",GuideToPharmacology,1,agonist
GPR22,AZD4320,GuideToPharmacology,1,inhibitor
ABO,CIMATEROL,GuideToPharmacology,1,agonist
ABR,ISOPROTERENOL,GuideToPharmacology,1,agonist
DNMT3B,COMPOUND 13D [PMID: 23639540],GuideToPharmacology,1,inhibitor
EFNA3,SIM1,GuideToPharmacology,1,inhibitor
EFNA4,COLCHICINE,GuideToPharmacology,1,inhibitor
EFNA4,COMPOUND 9 [PMID: 23517011],GuideToPharmacology,1,inhibitor
EFNA4,N-METHYL-2-PYRROLIDONE,GuideToPharmacology,1,inhibitor
GLC3B,BI-9564,GuideToPharmacology,1,inhibitor
EFNB2,CNX-774,GuideToPharmacology,1,inhibitor
EFNB2,RN486,GuideToPharmacology,1,inhibitor
ASIC1,MET-LYS-BRADYKININ,GuideToPharmacology,1,agonist
ASIC1,B-10356,GuideToPharmacology,1,inhibitor
ASIC1,SSR240612,GuideToPharmacology,1,inhibitor
BDKRB2,NG291,GuideToPharmacology,1,agonist
ASIC1,NPC 17731,GuideToPharmacology,1,inhibitor
BDKRB2,MET-LYS-BRADYKININ,GuideToPharmacology,1,agonist
ACADL,"EU-DTPA-[SER27, NLE70]HC5A",GuideToPharmacology,1,agonist
ACACA,COMPOUND 4 [PMID: 25259874],GuideToPharmacology,1,inhibitor
C1QBP,MIBEFRADIL,GuideToPharmacology,1,blocker
CYP2A7P1,COMPOUND 2C [PMID: 22115617],GuideToPharmacology,1,inhibitor
ACP5,TECALCET,GuideToPharmacology,1,modulator
ATP6V1E1,ISRADIPINE,GuideToPharmacology,1,inhibitor
CACNA1D,ISRADIPINE,GuideToPharmacology,1,inhibitor
CACNA1D,ISRADIPINE,GuideToPharmacology,1,inhibitor
ATP6V1E1,ISRADIPINE,GuideToPharmacology,1,inhibitor
ATP6AP1,ACT-709478,GuideToPharmacology,1,blocker
RND3,MIBEFRADIL,GuideToPharmacology,1,blocker
CCKBR,Z-360,GuideToPharmacology,1,inhibitor
ACTB,CCL18,GuideToPharmacology,1,inhibitor
ACTB,YM-355179,GuideToPharmacology,1,inhibitor
ACTBP2,CCL16,GuideToPharmacology,1,agonist
EGR3,"(7S)-2-(2-AMINOPYRIMIDIN-4-YL)-7-(2-FLUOROETHYL)-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE",GuideToPharmacology,1,inhibitor
ACTC1,KALLSTROEMIN D,GuideToPharmacology,1,inhibitor
CDK19,JH-VIII-49,GuideToPharmacology,1,inhibitor
EIF4A1,FADRACICLIB,GuideToPharmacology,1,inhibitor
CDK4,BSJ-03-123,GuideToPharmacology,1,inhibitor
EIF4E,KINASE INHIBITOR 2 [PMID: 30199702],GuideToPharmacology,1,inhibitor
EIF4E,PURVALANOL A,GuideToPharmacology,1,inhibitor
EIF4E,(S)-CR8,GuideToPharmacology,1,inhibitor
EIF4EP1,JH-VIII-49,GuideToPharmacology,1,inhibitor
EIF4G1,DINACICLIB,GuideToPharmacology,1,inhibitor
EIF4EBP2,CDK/CRK INHIBITOR,GuideToPharmacology,1,inhibitor
EIF4EBP2,THAL-SNS-032,GuideToPharmacology,1,inhibitor
CPD,TESTOLACTONE,GuideToPharmacology,1,inhibitor
EIF5,URMC-099,GuideToPharmacology,1,inhibitor
CPB2,GALETERONE,GuideToPharmacology,1,inhibitor
CPA2,MITOTANE,GuideToPharmacology,1,inhibitor
EIF4G1,THAL-SNS-032,GuideToPharmacology,1,inhibitor
CLDN3,LUNACALCIPOL,GuideToPharmacology,1,inhibitor
GLRB,IPILIMUMAB,GuideToPharmacology,1,antibody
ELK3,URMC-099,GuideToPharmacology,1,inhibitor
HPE1,YT47R,GuideToPharmacology,1,inhibitor
APAF1,BW373U86,GuideToPharmacology,1,agonist
APAF1,NALDEMEDINE,GuideToPharmacology,1,inhibitor
APAF1,[3H]DPDPE,GuideToPharmacology,1,agonist
APAF1,NALMEFENE,GuideToPharmacology,1,agonist
CRIP1,ORLISTAT,GuideToPharmacology,1,inhibitor
DHODH,DSM421,GuideToPharmacology,1,inhibitor
ABCD1,ML321,GuideToPharmacology,1,inhibitor
ABCD1,PERPHENAZINE,GuideToPharmacology,1,inhibitor
ALDH1A1,PF-592379,GuideToPharmacology,1,agonist
ALDH1A1,7-TRANS-OH-PIPAT,GuideToPharmacology,1,agonist
ALDH1A1,R-VK4-40,GuideToPharmacology,1,inhibitor
ALDH2,PIRIBEDIL,GuideToPharmacology,1,inhibitor
ALDH2,[125I]L750667,GuideToPharmacology,1,inhibitor
ALDH1A1,SPIPERONE,GuideToPharmacology,1,inhibitor
ALDH3A1,N-PROPYLNORAPOMORPHINE,GuideToPharmacology,1,agonist
EMD,VORUCICLIB,GuideToPharmacology,1,inhibitor
MARK2,COMPOUND 5B [PMID: 24900464],GuideToPharmacology,1,inhibitor
DARS1,DAGLUTRIL,GuideToPharmacology,1,inhibitor
NOS3,TILARGININE,GuideToPharmacology,1,inhibitor
FPR2,POSTSTATIN,GuideToPharmacology,1,inhibitor
DRP2,COMPOUND 66 [PMID: 19788238],GuideToPharmacology,1,inhibitor
EZH2,EPZ011989,GuideToPharmacology,1,inhibitor
DSG1,DDR1/2 INHIBITOR 5N,GuideToPharmacology,1,inhibitor
DXO,NAZARTINIB,GuideToPharmacology,1,inhibitor
DXO,PD166285,GuideToPharmacology,1,inhibitor
DXO,MS39,GuideToPharmacology,1,inhibitor
DXO,PKI166,GuideToPharmacology,1,inhibitor
CRMP1,JNJ-42165279,GuideToPharmacology,1,inhibitor
ENO1,LORLATINIB,GuideToPharmacology,1,inhibitor
ADH4,GRIFOLIC ACID METHYL ETHER,GuideToPharmacology,1,agonist
FFAR3,ISOBUTYRIC ACID,GuideToPharmacology,1,agonist
ALDOA,ISOBUTYRIC ACID,GuideToPharmacology,1,agonist
HNMT,COMPOUND 19B [PMID: 37058391],GuideToPharmacology,1,inhibitor
DRD1,COMPOUND 8I [PMID: 22765894],GuideToPharmacology,1,inhibitor
DPYS,AC710,GuideToPharmacology,1,inhibitor
DPYS,COMPOUND 8I [PMID: 22765894],GuideToPharmacology,1,inhibitor
DPYS,MERESTINIB,GuideToPharmacology,1,inhibitor
ALDH3B2,ANNEXIN I-(2-26),GuideToPharmacology,1,agonist
ALDH3B2,BVT173187,GuideToPharmacology,1,inhibitor
ALDH3B2,MET-MET-TRP-LEU-LEU,GuideToPharmacology,1,agonist
ALDH9A1,ANNEXIN I-(2-26),GuideToPharmacology,1,agonist
ALDH9A1,PRP106-126,GuideToPharmacology,1,agonist
FZD7,VANTICTUMAB,GuideToPharmacology,1,antibody
FZD7,F7H,GuideToPharmacology,1,inhibitor
ALDRL2,VANTICTUMAB,GuideToPharmacology,1,antibody
GABRA1,TETRAHYDRODEOXYCORTICOSTERONE,GuideToPharmacology,1,modulator
ARNT,&ALPHA;5IA,GuideToPharmacology,1,modulator
ARNT,PIPERIDINE-4-SULPHONIC ACID,GuideToPharmacology,1,agonist
ARNT,RO15-4513,GuideToPharmacology,1,modulator
GALR2,GALANIN(1-15),GuideToPharmacology,1,agonist
GALR2,GAL-B2-C18,GuideToPharmacology,1,agonist
ALOX12P1,"DITHIIPIN-1,1,4,4-TETROXIDE ANALOGUE 7",GuideToPharmacology,1,inhibitor
GALR2,"DITHIIPIN-1,1,4,4-TETROXIDE ANALOGUE 7",GuideToPharmacology,1,inhibitor
GRIA3,ANIRACETAM,GuideToPharmacology,1,modulator
GRIN2B,[3H]CGP39653,GuideToPharmacology,1,inhibitor
GRIN2B,"5,7-DICHLOROKYNURENIC ACID",GuideToPharmacology,1,inhibitor
CD24P2,OPIRANSERIN,GuideToPharmacology,1,inhibitor
GNRHR,HISTERELIN,GuideToPharmacology,1,agonist
GNRHR,"[125I]GNRH I (HUMAN, MOUSE, RAT)",GuideToPharmacology,1,agonist
GNRHR,[125I]CETRORELIX,GuideToPharmacology,1,inhibitor
ALDH3B1,ESTRADIOL VALERATE,GuideToPharmacology,1,agonist
ACADVL,COMPOUND 77A [PMID: 37639383],GuideToPharmacology,1,agonist
GNRHR,DEGARELIX,GuideToPharmacology,1,inhibitor
ACADVL,LITHOCHOLIC ACID,GuideToPharmacology,1,agonist
GNRHR,SUFUGOLIX,GuideToPharmacology,1,inhibitor
ANXA13,MK 6892,GuideToPharmacology,1,agonist
ARL3,EC18,GuideToPharmacology,1,blocker
GDF2,PRACINOSTAT,GuideToPharmacology,1,inhibitor
MSTN,MARTINOSTAT,GuideToPharmacology,1,inhibitor
GARS1,TACEDINALINE,GuideToPharmacology,1,inhibitor
GARS1,QUISINOSTAT,GuideToPharmacology,1,inhibitor
MSTN,GIVINOSTAT,GuideToPharmacology,1,inhibitor
GARS1,GIVINOSTAT,GuideToPharmacology,1,inhibitor
HDAC4,GIVINOSTAT,GuideToPharmacology,1,inhibitor
MSTN,PRACINOSTAT,GuideToPharmacology,1,inhibitor
GART,TUBACIN,GuideToPharmacology,1,inhibitor
MSTN,SS-208,GuideToPharmacology,1,inhibitor
GART,QUISINOSTAT,GuideToPharmacology,1,inhibitor
GART,SS-208,GuideToPharmacology,1,inhibitor
GART,GIVINOSTAT,GuideToPharmacology,1,inhibitor
GART,COMPOUND 16 [PMID: 20947351],GuideToPharmacology,1,inhibitor
GART,SANTACRUZAMATE A,GuideToPharmacology,1,inhibitor
GDF9,TMP269,GuideToPharmacology,1,inhibitor
GAS2,QUISINOSTAT,GuideToPharmacology,1,inhibitor
GDF9,GIVINOSTAT,GuideToPharmacology,1,inhibitor
GAS1,SS-208,GuideToPharmacology,1,inhibitor
GAS1,QUISINOSTAT,GuideToPharmacology,1,inhibitor
AMD1,2-(3-BROMOPHENYL)HISTAMINE,GuideToPharmacology,1,agonist
AMD1,METHYLHISTAPRODIFEN,GuideToPharmacology,1,agonist
AMD1,EPINASTINE,GuideToPharmacology,1,inhibitor
AMD1,PERPHENAZINE,GuideToPharmacology,1,inhibitor
AMD1P2,TIOTIDINE,GuideToPharmacology,1,inhibitor
AMD1P2,CIPROXIFAN,GuideToPharmacology,1,inhibitor
AMELX,2-METHYLHISTAMINE,GuideToPharmacology,1,agonist
HRH3,METHIMEPIP,GuideToPharmacology,1,agonist
ADD3,2-HYDROXYLAURIC ACID,GuideToPharmacology,1,agonist
ADRA2C,BETA-ALANINE,GuideToPharmacology,1,agonist
XCR1,COMPOUND 8U [PMID: 31999451],GuideToPharmacology,1,inhibitor
ITPR1,PIP2,GuideToPharmacology,1,inhibitor
GPX1P2,IVOSIDENIB,GuideToPharmacology,1,inhibitor
FOXL2,TRIBUTYRIN,GuideToPharmacology,1,agonist
EPHB3,LAZERTINIB,GuideToPharmacology,1,inhibitor
EPHB3,COMPOUND 8L [PMID: 36053746],GuideToPharmacology,1,inhibitor
NUDT2,SCH221510,GuideToPharmacology,1,agonist
NUDT2,PAREGORIC,GuideToPharmacology,1,agonist
DRD2,GOLVATINIB,GuideToPharmacology,1,inhibitor
DPT,AC710,GuideToPharmacology,1,inhibitor
DPT,SORAFENIB,GuideToPharmacology,1,inhibitor
ATP5MC2,QUINIDINE,GuideToPharmacology,1,blocker
ATP6V1B1,BA2+,GuideToPharmacology,1,blocker
GRIK1-AS2,QUINIDINE,GuideToPharmacology,1,blocker
BAD,ERGTX-1,GuideToPharmacology,1,blocker
AZGP1,PIP2,GuideToPharmacology,1,activator
AZF1,"3S,4R-293B",GuideToPharmacology,1,blocker
LATS2,MIDOSTAURIN,GuideToPharmacology,1,inhibitor
FRA10D,COMPOUND 3 [PMID: 22533316],GuideToPharmacology,1,inhibitor
EPHX2,PEXIDARTINIB,GuideToPharmacology,1,inhibitor
LTC4S,COMPOUND 39 [PMID: 23623673],GuideToPharmacology,1,inhibitor
STX2,ZAK INHIBITOR 6P,GuideToPharmacology,1,inhibitor
CRHR2,KELATORPHAN,GuideToPharmacology,1,inhibitor
EPHX2,DORSOMORPHIN,GuideToPharmacology,1,inhibitor
BGN,COMPOUND 6N [PMID: 31419141],GuideToPharmacology,1,agonist
BCL3,27-HYDROXYCHOLESTEROL,GuideToPharmacology,1,agonist
AMPH,CPY,GuideToPharmacology,1,agonist
BIN1,FARNESYL DIPHOSPHATE,GuideToPharmacology,1,inhibitor
GFRA2,KDM5 INHIBITOR N71,GuideToPharmacology,1,inhibitor
APEH,NADIDE,GuideToPharmacology,1,agonist
GFRA2,COMPOUND 6A [PMID: 18942826],GuideToPharmacology,1,inhibitor
AMY2B,"[PHE13,TYR19]MCH",GuideToPharmacology,1,agonist
ESAT,GALAPAGOS MAPKAPK5 INHIBITOR D,GuideToPharmacology,1,inhibitor
ANCR,CORTICOTROPIN,GuideToPharmacology,1,agonist
MCHR1,AZD5991,GuideToPharmacology,1,inhibitor
AMYP1,"[AVA9,10,AVA14,15]-AC-HMCH6-16-NH2",GuideToPharmacology,1,inhibitor
AMY2B,T-226296,GuideToPharmacology,1,inhibitor
ANOP1,COMPOUND 2F [PMID: 17532216],GuideToPharmacology,1,modulator
ANOP1,COMPOUND 23E [PMID: 17929793],GuideToPharmacology,1,modulator
FASLG,BIM 23052,GuideToPharmacology,1,agonist
ANPEP,L-CCG-I,GuideToPharmacology,1,agonist
MAP2K1,COBIMETINIB,GuideToPharmacology,1,modulator
MAP2K1,MEK INHIBITOR I,GuideToPharmacology,1,inhibitor
PTGES,COMPOUND 39 [PMID: 23623673],GuideToPharmacology,1,inhibitor
AADAC,4-DAMP,GuideToPharmacology,1,inhibitor
AADAC,TRIPITRAMINE,GuideToPharmacology,1,inhibitor
AAMP,DUO3,GuideToPharmacology,1,modulator
AAMP,"WIN 62,577",GuideToPharmacology,1,modulator
AAMP,LEVETIMIDE,GuideToPharmacology,1,inhibitor
AANAT,HEXOCYCLIUM,GuideToPharmacology,1,inhibitor
AARS1,METHYLFURMETHIDE,GuideToPharmacology,1,agonist
AARS1,[3H]IPEROXO,GuideToPharmacology,1,agonist
AARS1,OXOTREMORINE-M,GuideToPharmacology,1,agonist
AARS1,HEXOCYCLIUM,GuideToPharmacology,1,inhibitor
AARS1,G&OUML; 7874,GuideToPharmacology,1,modulator
AARS1,VINCAMINE,GuideToPharmacology,1,modulator
AARS1,"WIN 62,577",GuideToPharmacology,1,modulator
AARS1,SOLIFENACIN,GuideToPharmacology,1,inhibitor
AAVS1,TRIPITRAMINE,GuideToPharmacology,1,inhibitor
AAVS1,N-BENZYL BRUCINE,GuideToPharmacology,1,modulator
ANK2,5-HEAT,GuideToPharmacology,1,agonist
APOF,HS665,GuideToPharmacology,1,agonist
APOF,DAMGO,GuideToPharmacology,1,agonist
APOF,COMPOUND 3 [PMID: 23134120],GuideToPharmacology,1,agonist
APOF,HYDROMORPHONE HYDROCHLORIDE,GuideToPharmacology,1,agonist
H1-0,NSC 780521,GuideToPharmacology,1,inhibitor
GNG5P1,COMPOUND 28 [PMID: 28671460],GuideToPharmacology,1,inhibitor
GNG5P1,PF-06282999,GuideToPharmacology,1,inhibitor
NKX3-2,ATX-II,GuideToPharmacology,1,inhibitor
BARD1,PF鈥?6526290,GuideToPharmacology,1,inhibitor
BBS1,ATX-II,GuideToPharmacology,1,inhibitor
SLC13A5,COMPOUND 7 [PMID: 37428122],GuideToPharmacology,1,inhibitor
SCN9A,CD2+,GuideToPharmacology,1,blocker
SCN9A,SAXITOXIN,GuideToPharmacology,1,blocker
CD8B,MAPROTILINE,GuideToPharmacology,1,inhibitor
ATF4,ATRACURIUM,GuideToPharmacology,1,inhibitor
AQP3,PHYSALAEMIN,GuideToPharmacology,1,agonist
AQP3,"L-703,606",GuideToPharmacology,1,inhibitor
AQP4,MEN10627,GuideToPharmacology,1,inhibitor
DNAH9,NT-0796,GuideToPharmacology,1,inhibitor
APBA1,AT-403,GuideToPharmacology,1,agonist
APBA1,MCOPPB,GuideToPharmacology,1,agonist
APBA1,N/OFQ-(1-13)-NH2,GuideToPharmacology,1,agonist
NMUR1,PEG40-NMU,GuideToPharmacology,1,agonist
GIPR,COMPOUND 15A [PMID: 36642961],GuideToPharmacology,1,inhibitor
NUAK1,WZ4003,GuideToPharmacology,1,inhibitor
ARAF,"[3H]AVP (HUMAN, MOUSE, RAT)",GuideToPharmacology,1,agonist
ADCYAP1R1,"[ALA11,22,28]VIP",GuideToPharmacology,1,agonist
CDK11B,LYS[Z(NO2)]-PRO,GuideToPharmacology,1,inhibitor
BCKDHA,GW7647,GuideToPharmacology,1,agonist
BCKDHB,COMPOUND 25 [PMID: 32687365],GuideToPharmacology,1,agonist
BCKDHB,GW0742X,GuideToPharmacology,1,agonist
CCND1,BADGE,GuideToPharmacology,1,agonist
CCND1,BADGE,GuideToPharmacology,1,inhibitor
CCND1,PAT5A,GuideToPharmacology,1,agonist
PIK3CB,AZD-8186,GuideToPharmacology,1,inhibitor
PIK3CB,ACALISIB,GuideToPharmacology,1,inhibitor
PIK3CB,DUVELISIB,GuideToPharmacology,1,inhibitor
F7,ACALISIB,GuideToPharmacology,1,inhibitor
PIK3CB,TENALISIB,GuideToPharmacology,1,inhibitor
PIK3CB,PP-121,GuideToPharmacology,1,inhibitor
F7R,BGT-226,GuideToPharmacology,1,inhibitor
COL12A1,MK-0359,GuideToPharmacology,1,inhibitor
COL12A1,DIFAMILAST,GuideToPharmacology,1,inhibitor
F11,PIM447,GuideToPharmacology,1,inhibitor
FFAR1,ME0328,GuideToPharmacology,1,inhibitor
GNAI2,PJ34,GuideToPharmacology,1,inhibitor
NBEAP1,PHENOBARBITAL,GuideToPharmacology,1,agonist
NBEAP1,LITHOCHOLIC ACID,GuideToPharmacology,1,agonist
FRA3A,FURIN INHIBITOR PEPTIDE,GuideToPharmacology,1,inhibitor
FXN,POSTSTATIN,GuideToPharmacology,1,inhibitor
GM2A,DOSTARLIMAB,GuideToPharmacology,1,antibody
HPX,MICROCYSTIN-LR,GuideToPharmacology,1,inhibitor
PPP1CA,OKADAIC ACID,GuideToPharmacology,1,inhibitor
APLP1,QRFP43,GuideToPharmacology,1,agonist
H1-3,MITAPIVAT,GuideToPharmacology,1,modulator
FAH,LY3009120,GuideToPharmacology,1,inhibitor
FAH,BELVARAFENIB,GuideToPharmacology,1,inhibitor
TEX28,COMPOUND E22 [PMID: 31298542],GuideToPharmacology,1,inhibitor
NIPSNAP2,HYDROXYUREA,GuideToPharmacology,1,inhibitor
PTPRD,7-BIA,GuideToPharmacology,1,inhibitor
APP,RELAXIN,GuideToPharmacology,1,agonist
APRT,NANOLUC R3/I5 CHIMERA,GuideToPharmacology,1,agonist
APPL1,RELAXIN,GuideToPharmacology,1,agonist
APRT,B1-27,GuideToPharmacology,1,agonist
APRT,COMPOUND 4 [PMID: 30824200],GuideToPharmacology,1,agonist
AMY1C,PHYTOSPHINGOSINE 1-PHOSPHATE,GuideToPharmacology,1,agonist
FAUNA@,BOSUTINIB,GuideToPharmacology,1,inhibitor
AMY2A,VPC44116,GuideToPharmacology,1,agonist
AMY2A,FINGOLIMOD,GuideToPharmacology,1,agonist
STK4,BOSUTINIB,GuideToPharmacology,1,inhibitor
FCGRT,BOSUTINIB,GuideToPharmacology,1,inhibitor
CD9,ATOMOXETINE HYDROCHLORIDE,GuideToPharmacology,1,inhibitor
CD9,VORTIOXETINE HYDROBROMIDE,GuideToPharmacology,1,inhibitor
CD9,ZOTEPINE,GuideToPharmacology,1,inhibitor
FASLG,DEMOTATE 2,GuideToPharmacology,1,agonist
FASLG,"L-054,522",GuideToPharmacology,1,agonist
AQP2,OCTREOTIDE ACETATE,GuideToPharmacology,1,agonist
AQP1,CST-17,GuideToPharmacology,1,agonist
FRA8A,COMPOUND 4D [PMID: 25489658],GuideToPharmacology,1,inhibitor
HLA-DMA,COMPOUND 21 [PMID: 34141085],GuideToPharmacology,1,inhibitor
TLE5,METHYLMALONIC ACID,GuideToPharmacology,1,agonist
ECM2,MERESTINIB,GuideToPharmacology,1,inhibitor
ECM2,LINIFANIB,GuideToPharmacology,1,inhibitor
NR2E1,BMS493,GuideToPharmacology,1,agonist
FRA8C,I-432,GuideToPharmacology,1,inhibitor
FRA8E,EXAMPLE 8 [WO1999033801A1],GuideToPharmacology,1,inhibitor
ATP1B1P1,OMEGA-CHLOROACETOPHENONE,GuideToPharmacology,1,activator
ATP2B2,GSK1702934A,GuideToPharmacology,1,activator
ATP5A2,NALTRIBEN,GuideToPharmacology,1,activator
MCOLN2,"PHOSPHATIDYL (3,5) INOSITOL BISPHOSPHATE",GuideToPharmacology,1,activator
ATP5F1A,2-APB,GuideToPharmacology,1,activator
ATP5F1BP1,NADA,GuideToPharmacology,1,blocker
FPR3,EDOXABAN,GuideToPharmacology,1,inhibitor
ATP5F1BP1,SB452533,GuideToPharmacology,1,blocker
FGR,BOSUTINIB,GuideToPharmacology,1,inhibitor
GCF1,ERIBULIN MESYLATE,GuideToPharmacology,1,inhibitor
GCF1,COLCHICINE,GuideToPharmacology,1,inhibitor
TYK2,IZENCITINIB,GuideToPharmacology,1,inhibitor
CDKN2C,VERINURAD,GuideToPharmacology,1,inhibitor
UTS2R,AC-7954,GuideToPharmacology,1,agonist
USP5,VIALININ A,GuideToPharmacology,1,inhibitor
UTS2R,FL104,GuideToPharmacology,1,agonist
UTS2R,JNJ-39319202,GuideToPharmacology,1,inhibitor
ANXA5,"[LEU31,PRO34]NPY (PIG)",GuideToPharmacology,1,agonist
ANXA4,TERT-BUTYLPHENOXYCYCLOHEXANOL,GuideToPharmacology,1,modulator
FPR1,TOMINOSTAT,GuideToPharmacology,1,inhibitor
CTPS1,RIPASUDIL,GuideToPharmacology,1,inhibitor
CREB1,PF-04191834,GuideToPharmacology,1,inhibitor
GRIK3,DYSIHERBAINE,GuideToPharmacology,1,agonist
GAS1,SZUH280,GuideToPharmacology,1,inhibitor
DRD2,SULFATINIB,GuideToPharmacology,1,inhibitor
BAD,BEKM-1,GuideToPharmacology,1,blocker
ASLP1,PIP2,GuideToPharmacology,1,activator
AARS1,AE9C90CB,GuideToPharmacology,1,inhibitor
BCGF1,LIOTHYRONINE,GuideToPharmacology,1,agonist
ALDH1A3,SARAFOTOXIN S6C,GuideToPharmacology,1,agonist
ARNT,FLUNITRAZEPAM,GuideToPharmacology,1,modulator
ALOX15,GHRP-6,GuideToPharmacology,1,agonist
XIAP,"[ILE5,TRP23]PTHRP-(4-36) (HUMAN)",GuideToPharmacology,1,agonist
CACNA1H,TTA-A2,GuideToPharmacology,1,blocker
SARDH,COMPOUND 10A [PMID: 31283223],GuideToPharmacology,1,inhibitor
CCND1,CIGLITAZONE,GuideToPharmacology,1,agonist
ATP1B1P1,BENZOQUINONE,GuideToPharmacology,1,activator
HTR2C,ORG 12962,GuideToPharmacology,1,agonist
EFNA4,COMPOUND 11H [PMID: 29808961],GuideToPharmacology,1,inhibitor
DPYSL2,PAZOPANIB,GuideToPharmacology,1,inhibitor
CCN2,STAUROSPORINE,GuideToPharmacology,1,inhibitor
CRBN,SJ995973,GuideToPharmacology,1,inhibitor
A2MP1,OXYMETAZOLINE HYDROCHLORIDE,GuideToPharmacology,1,agonist
FNTBL1,LHVS,GuideToPharmacology,1,inhibitor
GRM8,VU0155094,GuideToPharmacology,1,modulator
ITPR1,IP3,GuideToPharmacology,1,activator
A12M4,SPIPERONE,GuideToPharmacology,1,inhibitor
GAPDHP1,VORINOSTAT,GuideToPharmacology,1,inhibitor
NAAA,F215,GuideToPharmacology,1,inhibitor
CRMP1,SA-57,GuideToPharmacology,1,inhibitor
ABAT,MRS1754,GuideToPharmacology,1,inhibitor
DRG2,NIK INHIBITOR 12F,GuideToPharmacology,1,inhibitor
AMPD1,COMPOUND 15B [PMID: 31811124],GuideToPharmacology,1,inhibitor
ANTP4,OHM-11526,GuideToPharmacology,1,inhibitor
AQP9,SRX246,GuideToPharmacology,1,inhibitor
SLC25A4,COMPOUND 3 [PMID: 21105727],GuideToPharmacology,1,modulator
COL4A1,FD6,GuideToPharmacology,1,activator
ACTA2,TEIJIN-LEAD_CMP_5,GuideToPharmacology,1,inhibitor
AMY1A,COMPOUND 43 [PMID: 26751273],GuideToPharmacology,1,agonist
FASLG,"[111IN,90Y]DOTA-LAN",GuideToPharmacology,1,agonist
BLVRB,COMPOUND 15A [PMID: 22464687],GuideToPharmacology,1,inhibitor
FAU,BOSUTINIB,GuideToPharmacology,1,inhibitor
APOB,U46619,GuideToPharmacology,1,agonist
AMYP1,"[PHE13,TYR19]MCH",GuideToPharmacology,1,agonist
ETV2,COMPOUND 25 [PMID: 17935989],GuideToPharmacology,1,inhibitor
APOC4,ONO-8711,GuideToPharmacology,1,inhibitor
SLC25A6,VU0409551,GuideToPharmacology,1,modulator
APAF1,AR-M1000390,GuideToPharmacology,1,agonist
RCAN1,DDR1/2 INHIBITOR 5N,GuideToPharmacology,1,inhibitor
DPT,COMPOUND 8I [PMID: 22765894],GuideToPharmacology,1,inhibitor
ACRV1,JWH-018,GuideToPharmacology,1,agonist
A2M,9-OH-RISPERIDONE,GuideToPharmacology,1,inhibitor
ATF4,[3H]&ALPHA;-BUNGAROTOXIN,GuideToPharmacology,1,inhibitor
ASS1P5,8-DEOXY-NEODYSIHERBAINE,GuideToPharmacology,1,agonist
A1BG,5-HYDROXYTRYPTAMINE,GuideToPharmacology,1,agonist
HDC,FMH,GuideToPharmacology,1,inhibitor
HBEGF,GSK-1838705A,GuideToPharmacology,1,inhibitor
ARR3,[3H]GABAZINE,GuideToPharmacology,1,inhibitor
EXTL1,PF-3758309,GuideToPharmacology,1,inhibitor
GRIN1,ULEVOSTINAG,GuideToPharmacology,1,agonist
EMD,COMPOUND 3B [PMID: 23454515],GuideToPharmacology,1,inhibitor
AOC1,CLONIDINE HYDROCHLORIDE,GuideToPharmacology,1,agonist
ASIC2,[125I]BANTAG-1,GuideToPharmacology,1,inhibitor
EGR4,CDK1 INHIBITOR,GuideToPharmacology,1,inhibitor
DPYS,CRENOLANIB,GuideToPharmacology,1,inhibitor
ARNT,[3H]MUSCIMOL,GuideToPharmacology,1,agonist
GRIN2A,(+)-HA966,GuideToPharmacology,1,agonist
DLX3,ANANTIN,GuideToPharmacology,1,inhibitor
DPH1,COMPOUND 19A [PMID: 30503936],GuideToPharmacology,1,inhibitor
ATP5F1E,HALOTHANE,GuideToPharmacology,1,activator
PTK2B,COMPOUND 1D [PMID: 21493067],GuideToPharmacology,1,inhibitor
DRG2,RIPK1 INHIBITOR 22B,GuideToPharmacology,1,inhibitor
COL9A2,IBUDILAST,GuideToPharmacology,1,inhibitor
GNG10,BV-6,GuideToPharmacology,1,inhibitor
CD24P1,SSR-103800,GuideToPharmacology,1,inhibitor
CCR4,ZELNECIRNON,GuideToPharmacology,1,inhibitor
DPYS,MIDOSTAURIN,GuideToPharmacology,1,inhibitor
F7R,NEOLYMPHOSTIN A,GuideToPharmacology,1,inhibitor
ABL1,DDR1/2 INHIBITOR 5N,GuideToPharmacology,1,inhibitor
ERVK2,COMPOUND 5I [PMID: 36542759],GuideToPharmacology,1,inhibitor
GAPDHP1,TACEDINALINE,GuideToPharmacology,1,inhibitor
A12M4,VER-3323,GuideToPharmacology,1,agonist
CPT2,MECLOFENAMATE,GuideToPharmacology,1,inhibitor
F7,PI-103,GuideToPharmacology,1,inhibitor
ABR,METAPROTERENOL,GuideToPharmacology,1,agonist
CACNA1H,ACT-709478,GuideToPharmacology,1,blocker
ABAT,MRE 2029F20,GuideToPharmacology,1,inhibitor
ABCA3,MRS8054,GuideToPharmacology,1,modulator
CDK4,BSJ-03-204,GuideToPharmacology,1,inhibitor
ERBB3,DARIZMETINIB,GuideToPharmacology,1,inhibitor
TYK2,ZASOCITINIB,GuideToPharmacology,1,inhibitor
A12M3,SB 243213,GuideToPharmacology,1,inhibitor
BDM,MIRICORILANT,GuideToPharmacology,1,inhibitor
APPL1,RELAXIN-1,GuideToPharmacology,1,agonist
APC,URIDINE 5'-TRIPHOSPHATE,GuideToPharmacology,1,agonist
BDNF,TANAPROGET,GuideToPharmacology,1,agonist
ANXA2P1,AVA5,GuideToPharmacology,1,agonist
APOC3,U46619,GuideToPharmacology,1,agonist
ACTBP3,BETA-DEFENSIN 4A,GuideToPharmacology,1,agonist
BSG,N-PHENYLTHIOUREA,GuideToPharmacology,1,agonist
CLN8,COMPOUND 35 [PMID: 22902653],GuideToPharmacology,1,inhibitor
HMAA,GLYCYRRHETINIC ACID,GuideToPharmacology,1,inhibitor
GPC3,COMPOUND 60 [PMID: 26155854],GuideToPharmacology,1,inhibitor
EML1,(S)-CR8,GuideToPharmacology,1,inhibitor
ACTL5,CVN424,GuideToPharmacology,1,agonist
EPHB1,MOMELOTINIB,GuideToPharmacology,1,inhibitor
ALOX15,JMV3008,GuideToPharmacology,1,inhibitor
EPHB2,CEP-33779,GuideToPharmacology,1,inhibitor
FPR3,DX-9065A,GuideToPharmacology,1,inhibitor
DXO,LIFIRAFENIB,GuideToPharmacology,1,inhibitor
ATP5PB,BA2+,GuideToPharmacology,1,blocker
ARCN2,N-STEARYL-[NLE17] NEUROTENSIN-(6-11)/VIP-(7-28),GuideToPharmacology,1,inhibitor
TMEM258,ZN2+,GuideToPharmacology,1,blocker
A2MP1,[3H]ELETRIPTAN,GuideToPharmacology,1,agonist
APOH,UDM-001651,GuideToPharmacology,1,inhibitor
FOXA3,BJP-06-005-3,GuideToPharmacology,1,inhibitor
F9,CX-6258,GuideToPharmacology,1,inhibitor
A2MP1,SB 272183,GuideToPharmacology,1,inhibitor
GABRA1,CLONAZEPAM,GuideToPharmacology,1,modulator
ACTBP9,[125I]CXCL5 (HUMAN),GuideToPharmacology,1,agonist
ABCA2,XCC,GuideToPharmacology,1,inhibitor
NPFFR1,EFWSLAAPQRF-NH2,GuideToPharmacology,1,agonist
ADCY3,CID1792197,GuideToPharmacology,1,agonist
HTR2C,RITANSERIN,GuideToPharmacology,1,inhibitor
ANK3,UCM 765,GuideToPharmacology,1,agonist
CCND1,L-796449,GuideToPharmacology,1,agonist
ATP2A3,2-APB,GuideToPharmacology,1,blocker
HBEGF,LORLATINIB,GuideToPharmacology,1,inhibitor
GPR21,AZD4320,GuideToPharmacology,1,inhibitor
MS4A3,(R/S) EF-1500,GuideToPharmacology,1,inhibitor
BMAL1,[3H]MUSCIMOL,GuideToPharmacology,1,agonist
BCHEL3,TAZAROTENE,GuideToPharmacology,1,agonist
ARF5,TROPICAMIDE,GuideToPharmacology,1,blocker
DAPK1,SAXAGLIPTIN ANHYDROUS,GuideToPharmacology,1,inhibitor
GAPDHP1,SUPRASTAT,GuideToPharmacology,1,inhibitor
AQP8,BGC201531,GuideToPharmacology,1,inhibitor
ATP1B1P1,TCS 5861528,GuideToPharmacology,1,inhibitor
BUB1B,3-PHENYL-CPP,GuideToPharmacology,1,blocker
AKR1B1P2,CARBAMAZEPINE,GuideToPharmacology,1,modulator
GM2A,TISLELIZUMAB,GuideToPharmacology,1,antibody
GRIN2B,UBP141,GuideToPharmacology,1,inhibitor
ARG1,TROPICAMIDE,GuideToPharmacology,1,blocker
ARSF,PICROTOXIN,GuideToPharmacology,1,blocker
CTNNB1,PAMAPIMOD,GuideToPharmacology,1,inhibitor
ACTBP4,[125I]CCL21 (HUMAN),GuideToPharmacology,1,agonist
ABCD2,GW1100,GuideToPharmacology,1,inhibitor
E11S,BT7480,GuideToPharmacology,1,agonist
CSN1S1,I3MT-3,GuideToPharmacology,1,inhibitor
A1BG,QUINPIROLE,GuideToPharmacology,1,agonist
A1BG,1-NAPHTHYLPIPERAZINE,GuideToPharmacology,1,agonist
A1BG,NAFADOTRIDE,GuideToPharmacology,1,agonist
A1BG,7-METHOXY-1-NAPHTHYLPIPERAZINE,GuideToPharmacology,1,agonist
ABAT,PSB-11,GuideToPharmacology,1,inhibitor
ABAT,MRS1523,GuideToPharmacology,1,inhibitor
ABAT,XANTHINE AMINE CONGENER,GuideToPharmacology,1,inhibitor
ABCA1,2-HEXYNYL-NECA,GuideToPharmacology,1,agonist
ABCA1,PICLIDENOSON,GuideToPharmacology,1,agonist
ABCA1,MRE 2029F20,GuideToPharmacology,1,inhibitor
ABCA1,MRS1754,GuideToPharmacology,1,inhibitor
ABCA2,AS74,GuideToPharmacology,1,inhibitor
ABCA2,SCH 58261,GuideToPharmacology,1,inhibitor
ABCA2,OSIP339391,GuideToPharmacology,1,inhibitor
ABCA3,BAY 60-6583,GuideToPharmacology,1,agonist
ABCA3,PICLIDENOSON,GuideToPharmacology,1,agonist
EEF1B2P2,AZD1390,GuideToPharmacology,1,inhibitor
EEF1D,MK-5108,GuideToPharmacology,1,inhibitor
EEF1G,HESPERADIN,GuideToPharmacology,1,inhibitor
EEF2,COMPOUND 38 [PMID: 20817473],GuideToPharmacology,1,inhibitor
AXL,COMPOUND 19A [PMID: 30503936],GuideToPharmacology,1,inhibitor
AMPD2,5-OXO-ETE,GuideToPharmacology,1,agonist
ACAT2,D-NAL-CYS-TYR-D-TRP-LYS-VAL-CYS-NAL-NH2,GuideToPharmacology,1,inhibitor
ACAT2,PD 176252,GuideToPharmacology,1,inhibitor
ACAT2,NEUROMEDIN C,GuideToPharmacology,1,agonist
ACAT2,"[(3-PH-PR6), HIS7,D-ALA11,D-PRO13,&PSI;13-14),PHE14]BOMBESIN-(6-14)",GuideToPharmacology,1,inhibitor
FMOD,AM-6494,GuideToPharmacology,1,inhibitor
FMO5,ATABECESTAT,GuideToPharmacology,1,inhibitor
ABO,BETAXOLOL,GuideToPharmacology,1,inhibitor
ABR,BETAXOLOL,GuideToPharmacology,1,inhibitor
ABR,SOTALOL,GuideToPharmacology,1,inhibitor
ACAA1,[125I]ICYP,GuideToPharmacology,1,agonist
EFNA2,BELVARAFENIB,GuideToPharmacology,1,inhibitor
LGR6,R-SPONDIN-1,GuideToPharmacology,1,agonist
ADAM3A,COMPOUND 1B [PMID: 18078750],GuideToPharmacology,1,inhibitor
CA14,HISTIDINE,GuideToPharmacology,1,activator
GAPDH,METHOCARBAMOL,GuideToPharmacology,1,inhibitor
GLUD1P3,INDISULAM,GuideToPharmacology,1,inhibitor
ELF2,SR-4133,GuideToPharmacology,1,inhibitor
ACP5,TRYPTOPHAN,GuideToPharmacology,1,modulator
FOLH1,GRASSYSTATIN A,GuideToPharmacology,1,inhibitor
FOLH1,COMPOUND 2 [PMID: 8410973],GuideToPharmacology,1,inhibitor
AQP5,KASSININ,GuideToPharmacology,1,agonist
CACNA1H,MIBEFRADIL,GuideToPharmacology,1,blocker
ACRV1,CP55940,GuideToPharmacology,1,agonist
CNR2,JWH-133,GuideToPharmacology,1,agonist
CCKAR,"[125I]DTYR-GLY-[(NLE28,31)CCK-26-33",GuideToPharmacology,1,agonist
ALDH1A1,CARIPRAZINE,GuideToPharmacology,1,agonist
ALDH1A1,BP 897,GuideToPharmacology,1,agonist
ALDH1A1,PG01037,GuideToPharmacology,1,inhibitor
ALDH2,SONEPIPRAZOLE,GuideToPharmacology,1,inhibitor
ALDH2,L741742,GuideToPharmacology,1,inhibitor
ALDH2,QUINPIROLE,GuideToPharmacology,1,agonist
ALDH3A1,5-HYDROXYTRYPTAMINE,GuideToPharmacology,1,agonist
CCR3,MUPADOLIMAB,GuideToPharmacology,1,antibody
EMP1,COMPOUND 1A [PMID: 24900749],GuideToPharmacology,1,inhibitor
DXO,BMS-599626,GuideToPharmacology,1,inhibitor
DXO,BMS-690514,GuideToPharmacology,1,inhibitor
APOBER1,U46619,GuideToPharmacology,1,agonist
GTF2IP1,EC5026,GuideToPharmacology,1,inhibitor
APOC1,DINOPROSTONE,GuideToPharmacology,1,agonist
APOC1P1,CICAPROST,GuideToPharmacology,1,agonist
APOC1,AH13205,GuideToPharmacology,1,agonist
APOC1,U46619,GuideToPharmacology,1,agonist
APOC1,TG11-77,GuideToPharmacology,1,inhibitor
AQP8,BERAPROST,GuideToPharmacology,1,agonist
APOC1P1,DG-041,GuideToPharmacology,1,inhibitor
BCYRN1P2,RALOXIFENE HYDROCHLORIDE,GuideToPharmacology,1,agonist
BCYRN1P2,RALOXIFENE HYDROCHLORIDE,GuideToPharmacology,1,inhibitor
BCYRN1P2,HEXESTROL,GuideToPharmacology,1,inhibitor
BCYRN1P2,GSK5182,GuideToPharmacology,1,inhibitor
BDH1,1-CYCLOHEXYL-N-{[1-(4-METHYLPHENYL)-1H-INDOL-3-YL]METHYL}METHANAMINE,GuideToPharmacology,1,inhibitor
ALDH1B1,SARAFOTOXIN S6B,GuideToPharmacology,1,agonist
ESR2,RALOXIFENE HYDROCHLORIDE,GuideToPharmacology,1,inhibitor
GCNT2,UNC0642,GuideToPharmacology,1,inhibitor
OPN1MW,BRD9539,GuideToPharmacology,1,inhibitor
OPN1MW,UNC0642,GuideToPharmacology,1,inhibitor
ANOP1,CPCCOET,GuideToPharmacology,1,modulator
BCL5,BMS-986339,GuideToPharmacology,1,agonist
BLVRA,DIPHOSPHORIC ACID,GuideToPharmacology,1,inhibitor
ARNT,DARIGABAT,GuideToPharmacology,1,modulator
ARNT,TETRAHYDRODEOXYCORTICOSTERONE,GuideToPharmacology,1,modulator
ARR3,RO15-4513,GuideToPharmacology,1,modulator
ARR3,FLUMAZENIL,GuideToPharmacology,1,modulator
BMAL1,[3H]GABAZINE,GuideToPharmacology,1,inhibitor
BMAL1,CLONAZEPAM,GuideToPharmacology,1,modulator
ARRB1,RO15-4513,GuideToPharmacology,1,modulator
ARRB1,&ALPHA;5IA,GuideToPharmacology,1,modulator
ARRB1,MRK016,GuideToPharmacology,1,modulator
ARRB1,BICUCULLINE,GuideToPharmacology,1,inhibitor
ART4,(&PLUSMN;)-CIS-2-CAMP,GuideToPharmacology,1,agonist
ALOX5,CGP 47656,GuideToPharmacology,1,agonist
ALOX12P1,M871,GuideToPharmacology,1,inhibitor
ALOX15,ABBOTT 14C,GuideToPharmacology,1,inhibitor
ALOX15,BIM 28163,GuideToPharmacology,1,inhibitor
ALOX15,LIVER ENRICHED ANTIMICROBIAL PEPTIDE 2,GuideToPharmacology,1,inhibitor
ASPH,TEZAMPANEL ANHYDROUS,GuideToPharmacology,1,inhibitor
ALPP,GLUCAGON-LIKE PEPTIDE 2-(3-33),GuideToPharmacology,1,agonist
ALPL,AVEXITIDE,GuideToPharmacology,1,inhibitor
GRIA3,CYCLOTHIAZIDE,GuideToPharmacology,1,modulator
ASS1,4鈥怋CCA,GuideToPharmacology,1,inhibitor
ASS1P2,ANIRACETAM,GuideToPharmacology,1,modulator
ASS1P2,IDRA-21,GuideToPharmacology,1,modulator
BOK,5-METHOXYPSORALEN,GuideToPharmacology,1,agonist
GRIA3,ATPO,GuideToPharmacology,1,inhibitor
BDM,FLUOROMETHOLONE,GuideToPharmacology,1,agonist
BDM,BETAMETHASONE,GuideToPharmacology,1,agonist
BDM,RU28362,GuideToPharmacology,1,agonist
ASS1P5,[3H]SYM2081,GuideToPharmacology,1,agonist
GNRHR,DORZAGLIATIN,GuideToPharmacology,1,modulator
GRIN2A,AMANTADINE HYDROCHLORIDE,GuideToPharmacology,1,blocker
GRIN2A,"5,7-DICHLOROKYNURENIC ACID",GuideToPharmacology,1,inhibitor
GLRA1,DRONABINOL,GuideToPharmacology,1,modulator
ARVD4,DRONABINOL,GuideToPharmacology,1,modulator
SLC29A1,"COMPOUND 2F [JIANG ET AL., 2018]",GuideToPharmacology,1,inhibitor
SLC29A1,"(7S)-2-(2-AMINOPYRIMIDIN-4-YL)-7-(2-FLUOROETHYL)-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE",GuideToPharmacology,1,inhibitor
ARL3,CS+,GuideToPharmacology,1,blocker
GDF2,MARTINOSTAT,GuideToPharmacology,1,inhibitor
GDF2,SS-208,GuideToPharmacology,1,inhibitor
GDF2,TUBASTATIN A,GuideToPharmacology,1,inhibitor
GAPDHP1,MOCETINOSTAT,GuideToPharmacology,1,inhibitor
GAPDHP1,KA1010,GuideToPharmacology,1,inhibitor
AMELX,METHIMEPIP,GuideToPharmacology,1,agonist
AMELX,H4 ANTAGONIST 48,GuideToPharmacology,1,inhibitor
ADH1C,PSN632408,GuideToPharmacology,1,agonist
ADH1C,OLEOYL-LYSOPHOSPHATIDYLCHOLINE,GuideToPharmacology,1,agonist
ACTN2,LTC4,GuideToPharmacology,1,agonist
ACTN3,O-1602,GuideToPharmacology,1,agonist
ACTN2,ASN06917370,GuideToPharmacology,1,agonist
ACTN3,N-ARACHIDONOYLGLYCINE,GuideToPharmacology,1,agonist
PLIN2,COMPOUND 2 [PMID: 24793972],GuideToPharmacology,1,agonist
ADRA1B,R-SPONDIN-4,GuideToPharmacology,1,agonist
APOF,CTAP,GuideToPharmacology,1,inhibitor
APOF,NALTRIBEN,GuideToPharmacology,1,inhibitor
CD8B,ATOMOXETINE HYDROCHLORIDE,GuideToPharmacology,1,inhibitor
CD8B,DEXTROAMPHETAMINE SULFATE,GuideToPharmacology,1,inhibitor
CD8B,N-DESALKYLQUETIAPINE,GuideToPharmacology,1,inhibitor
CD8B,DULOXETINE HYDROCHLORIDE,GuideToPharmacology,1,inhibitor
DRD5P1,RIPK1 INHIBITOR 22B,GuideToPharmacology,1,inhibitor
ALCAM,UCM-1306,GuideToPharmacology,1,modulator
CD8B,ZOTEPINE,GuideToPharmacology,1,inhibitor
DRD5P1,LAROTRECTINIB,GuideToPharmacology,1,inhibitor
DRG2,TALETRECTINIB,GuideToPharmacology,1,inhibitor
DRG2,GNF-5837,GuideToPharmacology,1,inhibitor
SERPINC1,ATRACURIUM,GuideToPharmacology,1,inhibitor
ATD,ATRACURIUM,GuideToPharmacology,1,inhibitor
ATD,RIVANICLINE,GuideToPharmacology,1,agonist
BIN1,LPA,GuideToPharmacology,1,agonist
ETV3,COMPOUND 2 [PMID: 21627121],GuideToPharmacology,1,inhibitor
CD8B,PHENELZINE,GuideToPharmacology,1,inhibitor
AQP4,[PHE(ME)7]NEUROKININ B,GuideToPharmacology,1,agonist
AQP3,SAREDUTANT,GuideToPharmacology,1,inhibitor
AQP3,RP67580,GuideToPharmacology,1,inhibitor
NMUR2,COMPOUND 6B [PMID: 24999562],GuideToPharmacology,1,agonist
NMUR2,PEG40-NMU,GuideToPharmacology,1,agonist
APBA1,[F/G]N/OFQ-(1-13)-NH2,GuideToPharmacology,1,agonist
ANXA1,COMPOUND 46 [PMID: 25268943],GuideToPharmacology,1,inhibitor
APBA2,EMPA,GuideToPharmacology,1,inhibitor
APBB1,MK-1064,GuideToPharmacology,1,inhibitor
APBA2,SELTOREXANT,GuideToPharmacology,1,inhibitor
APBB1,EMPA,GuideToPharmacology,1,inhibitor
APBB1,ACT-462206,GuideToPharmacology,1,inhibitor
APBB1,SB-408124,GuideToPharmacology,1,inhibitor
ATP1A3,MRS 2219,GuideToPharmacology,1,modulator
BIRC3,MRS2802,GuideToPharmacology,1,agonist
APEX1,AP4A,GuideToPharmacology,1,inhibitor
APEX1,COMPOUND 4 [PMID: 23083103],GuideToPharmacology,1,inhibitor
APEX1,R-138727,GuideToPharmacology,1,inhibitor
APEX1,2MESAMP,GuideToPharmacology,1,inhibitor
APC,AP4A,GuideToPharmacology,1,agonist
AIRE,MRS2957,GuideToPharmacology,1,agonist
APPL1,CYCLIC INSL3 B-CHAIN ANALOGUE 6,GuideToPharmacology,1,inhibitor
APPL1,RELAXIN,GuideToPharmacology,1,agonist
KLK3,&DELTA;R3/I5,GuideToPharmacology,1,agonist
AMT,RP-001,GuideToPharmacology,1,agonist
CD9,PROTRIPTYLINE,GuideToPharmacology,1,inhibitor
FBLN2,BOSUTINIB,GuideToPharmacology,1,inhibitor
EFNB2,SUNVOZERTINIB,GuideToPharmacology,1,inhibitor
GTF2I,IL-37,GuideToPharmacology,1,agonist
SIGMAR1,BLARCAMESINE,GuideToPharmacology,1,agonist
CD3D,EMPAGLIFLOZIN,GuideToPharmacology,1,inhibitor
CD44,SC-435,GuideToPharmacology,1,inhibitor
FDX1,GUSACITINIB,GuideToPharmacology,1,inhibitor
FCER1A,MP-A08,GuideToPharmacology,1,inhibitor
FCAR,SKI II,GuideToPharmacology,1,inhibitor
FCER1A,PF-543,GuideToPharmacology,1,inhibitor
CRYGA,COMPOUND 12E [PMID: 18605714],GuideToPharmacology,1,inhibitor
FDX1,COMPOUND 7 [PMID: 22464456],GuideToPharmacology,1,inhibitor
FCAR,PF-543,GuideToPharmacology,1,inhibitor
MS4A2,PD166285,GuideToPharmacology,1,inhibitor
F7R,COMPOUND 41 [PMID: 31855425],GuideToPharmacology,1,inhibitor
FASLG,SEGLITIDE,GuideToPharmacology,1,agonist
SHROOM2,BIM 23627,GuideToPharmacology,1,inhibitor
SHROOM2,[L-TYR8]CYN 154806,GuideToPharmacology,1,inhibitor
TLE5,"CIS-1,2-CYCLOPROPANEDICARBOXYLIC ACID",GuideToPharmacology,1,agonist
ECM2,COMPOUND 5 [PMID: 17618114],GuideToPharmacology,1,inhibitor
THRB,NH-3,GuideToPharmacology,1,inhibitor
ARHGAP1,CD2+,GuideToPharmacology,1,blocker
APOC4,RAMATROBAN,GuideToPharmacology,1,inhibitor
DNMT3A,SD-208,GuideToPharmacology,1,inhibitor
GTF2IP1,GSK2256294,GuideToPharmacology,1,inhibitor
FRA8C,CAMOSTAT,GuideToPharmacology,1,inhibitor
ATP1B1P1,NICOTINE POLACRILEX,GuideToPharmacology,1,activator
ATP2A3,CLEMIZOLE,GuideToPharmacology,1,blocker
ATP2A2,2-APB,GuideToPharmacology,1,blocker
ATP2A2,GSK1702934A,GuideToPharmacology,1,activator
ATP3,2-APB,GuideToPharmacology,1,blocker
ATP5F1BP1,PIPERINE,GuideToPharmacology,1,activator
TRPV4,HC067047,GuideToPharmacology,1,blocker
TSHR,[125I]TSH (HUMAN),GuideToPharmacology,1,agonist
FGD1,XILIERTINIB,GuideToPharmacology,1,inhibitor
FGF1,BOSUTINIB,GuideToPharmacology,1,inhibitor
HOXA13,COMPOUND 61 [PMID: 36221183],GuideToPharmacology,1,inhibitor
BCL7A,DOXERCALCIFEROL,GuideToPharmacology,1,agonist
BCL7A,SEOCALCITOL,GuideToPharmacology,1,agonist
ARCN2,PG 97-269,GuideToPharmacology,1,inhibitor
AQP9,[VAL4]AVP,GuideToPharmacology,1,agonist
AQP9,LS-192629,GuideToPharmacology,1,inhibitor
AR,D[D-PHE2]AVP,GuideToPharmacology,1,agonist
AR,ARGIPRESTOCIN,GuideToPharmacology,1,agonist
AQP9,[125I]3-N3-PHPA-LVA,GuideToPharmacology,1,inhibitor
AR,D[LEU4]LVP,GuideToPharmacology,1,agonist
ABCC6,D[D-PHE2]AVP,GuideToPharmacology,1,agonist
ABCC6,"D(CH2)5[D-TYR(ET)2,VAL4,TYR-NH29]AVP",GuideToPharmacology,1,inhibitor
ANXA4,"[LEU31,PRO34]NPY",GuideToPharmacology,1,agonist
CRABP1,TFC007,GuideToPharmacology,1,inhibitor
BCL9,MECLIZINE,GuideToPharmacology,1,inhibitor
APBA1,UFP-101,GuideToPharmacology,1,inhibitor
DAPK3,PERINDOPRILAT,GuideToPharmacology,1,inhibitor
GAS1,BUTYRIC ACID,GuideToPharmacology,1,inhibitor
ARF6,CYPPA,GuideToPharmacology,1,activator
EPHB3,ACALABRUTINIB,GuideToPharmacology,1,inhibitor
ANK2,4P-PDOT,GuideToPharmacology,1,inhibitor
DPP6,SORAFENIB,GuideToPharmacology,1,inhibitor
CDK19,SORAFENIB,GuideToPharmacology,1,inhibitor
ARL1,CS+,GuideToPharmacology,1,blocker
EPHB1,PF-956980,GuideToPharmacology,1,inhibitor
ARVD4,ZN2+,GuideToPharmacology,1,modulator
GFPT1,IOX1,GuideToPharmacology,1,inhibitor
APBA2,MK-1064,GuideToPharmacology,1,inhibitor
DAGLA,ADENOSINE TRIPHOSPHATE,GuideToPharmacology,1,activator
MS4A2,"(3Z)-N,N-DIMETHYL-2-OXO-3-(4,5,6,7-TETRAHYDRO-1H-INDOL-2-YLMETHYLIDENE)-2,3-DIHYDRO-1H-INDOLE-5-SULFONAMIDE",GuideToPharmacology,1,inhibitor
BDM,FLUTICASONE,GuideToPharmacology,1,agonist
MAP2K1,TRAMETINIB DIMETHYL SULFOXIDE,GuideToPharmacology,1,inhibitor
A12M1,ZOTEPINE,GuideToPharmacology,1,inhibitor
FMO5,COMPOUND 16 [PMID: 23412139],GuideToPharmacology,1,inhibitor
ABCA1,MRS1191,GuideToPharmacology,1,inhibitor
ABCA2,SCH442416,GuideToPharmacology,1,inhibitor
ATP6V1E1,MIBEFRADIL,GuideToPharmacology,1,blocker
ALDH1A1,S33084,GuideToPharmacology,1,inhibitor
PIK3CB,PI-103,GuideToPharmacology,1,inhibitor
ABCA3,2-HEXYNYL-NECA,GuideToPharmacology,1,agonist
F7R,SAPANISERTIB,GuideToPharmacology,1,inhibitor
F7,BIMIRALISIB,GuideToPharmacology,1,inhibitor
ABCD1,MLS1547,GuideToPharmacology,1,agonist
EIF4G1,FADRACICLIB,GuideToPharmacology,1,inhibitor
FCN2,COMPOUND 25 [PMID: 17935989],GuideToPharmacology,1,inhibitor
CSTF3,M-2698,GuideToPharmacology,1,inhibitor
GSTP1P1,TAPINAROF,GuideToPharmacology,1,agonist
ACAA1,CGP 20712A,GuideToPharmacology,1,inhibitor
ACADSB,ALX40-4C,GuideToPharmacology,1,inhibitor
NATP,5-HYDROXYTRYPTAMINE,GuideToPharmacology,1,agonist
FRA17A,PRALIDOXIME CATION,GuideToPharmacology,1,inhibitor
EGR4,ASNUCICLIB,GuideToPharmacology,1,inhibitor
GALR2,GALANIN(1-10),GuideToPharmacology,1,agonist
ASIP,VU0810464,GuideToPharmacology,1,activator
AMPD2,5-OXO-C20:3,GuideToPharmacology,1,agonist
A12M1,LY344864,GuideToPharmacology,1,agonist
APBA1,SCH221510,GuideToPharmacology,1,agonist
GPC4,COMPOUND 35 [PMID: 22902653],GuideToPharmacology,1,inhibitor
DRD5,COMPOUND 8I [PMID: 22765894],GuideToPharmacology,1,inhibitor
ADD3,PSB-1584,GuideToPharmacology,1,agonist
ATP2B2,GSK2833503A,GuideToPharmacology,1,blocker
ERAP2,COMPOUND 17 [PMID: 23916253],GuideToPharmacology,1,inhibitor
PIK3CB,WORTMANNIN,GuideToPharmacology,1,inhibitor
AXL,COMPOUND 8I [PMID: 22765894],GuideToPharmacology,1,inhibitor
ERF,URMC-099,GuideToPharmacology,1,inhibitor
ALDH1A3,IRL 2500,GuideToPharmacology,1,inhibitor
BAD,APETX-1,GuideToPharmacology,1,inhibitor
BCL2,SR9009,GuideToPharmacology,1,agonist
ALOX12P1,GALNON,GuideToPharmacology,1,agonist
DLX6,E. COLI HEAT-STABLE ENTEROTOXIN (STA),GuideToPharmacology,1,agonist
AQP1,PRL-2915,GuideToPharmacology,1,inhibitor
ACSL1,NVP-TAE 226,GuideToPharmacology,1,inhibitor
CSTP1,(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE,GuideToPharmacology,1,inhibitor
FASLG,OCTREOTIDE ACETATE,GuideToPharmacology,1,agonist
H2AX,SELINEXOR,GuideToPharmacology,1,inhibitor
ATP2B1,GALANGIN,GuideToPharmacology,1,blocker
A12M1,EMDT,GuideToPharmacology,1,agonist
APOF,PL017,GuideToPharmacology,1,agonist
AADAC,ACETYLCHOLINE,GuideToPharmacology,1,agonist
APEH,NF157,GuideToPharmacology,1,inhibitor
TRPM8,CANNABIDIOL,GuideToPharmacology,1,blocker
ALDH9A1,RVD1-ME,GuideToPharmacology,1,agonist
POLR3D,AZITHROMYCIN,GuideToPharmacology,1,agonist
FCGR1A,URMC-099,GuideToPharmacology,1,inhibitor
AOAH,2-HYDROXYOCTANOIC ACID,GuideToPharmacology,1,agonist
CA9,BIRICODAR,GuideToPharmacology,1,inhibitor
DLX4,COMPOUND C10 [PMID: 24297249],GuideToPharmacology,1,inhibitor
ABCA2,BAY 60-6583,GuideToPharmacology,1,agonist
NR3C2,HYDROCORTISONE BUTYRATE,GuideToPharmacology,1,agonist
CTBS,Y27632,GuideToPharmacology,1,inhibitor
MPPED2,ADENOPHOSTIN A,GuideToPharmacology,1,activator
A12M1,GR 127935,GuideToPharmacology,1,agonist
DPYSL2,COMPOUND 8I [PMID: 22765894],GuideToPharmacology,1,inhibitor
BAD,CISAPRIDE,GuideToPharmacology,1,blocker
UTS2R,[125I]U-II (HUMAN),GuideToPharmacology,1,agonist
A1BG,ROBALZOTAN,GuideToPharmacology,1,inhibitor
EEF1D,XMD-12,GuideToPharmacology,1,inhibitor
ACTA1,MLN-3897,GuideToPharmacology,1,inhibitor
ALDH7A1P4,QUINIDINE,GuideToPharmacology,1,blocker
SERPINA3,SPIPERONE,GuideToPharmacology,1,inhibitor
GATM,OFATUMUMAB,GuideToPharmacology,1,antibody
A2MP1,SB 649915,GuideToPharmacology,1,inhibitor
GALNT3,GSK-264220A,GuideToPharmacology,1,inhibitor
SHROOM2,VAPREOTIDE,GuideToPharmacology,1,agonist
A12M2,RIZATRIPTAN BENZOATE,GuideToPharmacology,1,agonist
BTC,CD2+,GuideToPharmacology,1,blocker
ATP6V0A1,6-PRENYLNARINGENIN,GuideToPharmacology,1,blocker
ATF4P1,[3H]METHYLLYCACONITINE,GuideToPharmacology,1,inhibitor
SIGMAR1,EST64454,GuideToPharmacology,1,inhibitor
DXO,PF-670462,GuideToPharmacology,1,inhibitor
EN1,EGFR/ERBB-2 INHIBITOR,GuideToPharmacology,1,inhibitor
ARNT,ALPRAZOLAM,GuideToPharmacology,1,modulator
EEF1B2,EXARAFENIB,GuideToPharmacology,1,inhibitor
ERBB4,POZIOTINIB,GuideToPharmacology,1,inhibitor
APEX1,ADP,GuideToPharmacology,1,agonist
EMD,AZ191,GuideToPharmacology,1,inhibitor
AMELX,CIPROXIFAN,GuideToPharmacology,1,inhibitor
DPP6,AC710,GuideToPharmacology,1,inhibitor
ACKR4,CCL25,GuideToPharmacology,1,agonist
A12M3,KETANSERIN,GuideToPharmacology,1,inhibitor
GALT,GR148672X,GuideToPharmacology,1,inhibitor
DPT,COMPOUND 7K [PMID: 23521020],GuideToPharmacology,1,inhibitor
GABRA1,ZOLPIDEM TARTRATE,GuideToPharmacology,1,modulator
PDE5A,IBUDILAST,GuideToPharmacology,1,inhibitor
TRPV4,4&ALPHA;-PDD,GuideToPharmacology,1,activator
EPHX2,COMPOUND 30 [PMID: 17280833],GuideToPharmacology,1,inhibitor
ABCA3,MRE 3008F20,GuideToPharmacology,1,inhibitor
ACVR1,ADROPIN,GuideToPharmacology,1,agonist
NMUR1,NEUROMEDIN U-25,GuideToPharmacology,1,agonist
FRA5D,CAMOSTAT,GuideToPharmacology,1,inhibitor
ACADM,OLMESARTAN MEDOXOMIL,GuideToPharmacology,1,inhibitor
CD14,CI-966,GuideToPharmacology,1,inhibitor
GP1BA,CCG-63802,GuideToPharmacology,1,inhibitor
EFNA3,COMPOUND 36 [PMID: 24000170],GuideToPharmacology,1,inhibitor
GGCX,IOX1,GuideToPharmacology,1,inhibitor
ABCA3,AB-MECA,GuideToPharmacology,1,agonist
BCHEL3,BMS493,GuideToPharmacology,1,inhibitor
FRA1A,FXIA INHIBITOR 3F,GuideToPharmacology,1,inhibitor
FIM1,AZENOSERTIB,GuideToPharmacology,1,inhibitor
CTPS1,CORTISTATIN A,GuideToPharmacology,1,inhibitor
AOC1,RACEPINEPHRINE,GuideToPharmacology,1,agonist
DBP,APRATASTAT,GuideToPharmacology,1,inhibitor
GALR2,GALANIN(2-29) (PIG),GuideToPharmacology,1,agonist
ANXA13,MK 0354,GuideToPharmacology,1,agonist
DOCK3,TGF&BETA;3,GuideToPharmacology,1,agonist
A12M2,QUETIAPINE FUMARATE,GuideToPharmacology,1,agonist
ADCY2,COMPOUND 7A [PMID: 24884590],GuideToPharmacology,1,agonist
GTF2IP1,BI-1935,GuideToPharmacology,1,inhibitor
AAMP,OXOTREMORINE,GuideToPharmacology,1,agonist
AAMP,PILOCARPINE HYDROCHLORIDE,GuideToPharmacology,1,agonist
AAVS1,HEXOCYCLIUM,GuideToPharmacology,1,inhibitor
APOB,BUTAPROST (FREE ACID FORM),GuideToPharmacology,1,agonist
ANCR,[125I]NDP-MSH,GuideToPharmacology,1,agonist
HTR2C,SB 206553,GuideToPharmacology,1,inhibitor
NAT2,VORTIOXETINE HYDROBROMIDE,GuideToPharmacology,1,inhibitor
EEF1G,BARASERTIB-HQPA,GuideToPharmacology,1,inhibitor
ABCD1,R-VK4-40,GuideToPharmacology,1,inhibitor
ATP5F1E,ISOFLURANE,GuideToPharmacology,1,activator
ASGR2,CS+,GuideToPharmacology,1,blocker
AARS1,TRIPITRAMINE,GuideToPharmacology,1,inhibitor
PLD1,FIPI,GuideToPharmacology,1,inhibitor
PKD2L1,HCL,GuideToPharmacology,1,activator
GMPR,MEZAGITAMAB,GuideToPharmacology,1,antibody
APOC1P1,ENPROSTIL,GuideToPharmacology,1,agonist
CARS1,DIGITOXIN,GuideToPharmacology,1,inhibitor
ANOP1,COMPOUND 27 [PMID: 20346665],GuideToPharmacology,1,modulator
GABRA1,[3H]GABAZINE,GuideToPharmacology,1,inhibitor
EPHB3,MIVAVOTINIB,GuideToPharmacology,1,inhibitor
ANGPT2,AFAMELANOTIDE,GuideToPharmacology,1,agonist
TNFRSF13C,IANALUMAB,GuideToPharmacology,1,antibody
GABRR3,PIPERIDINE-4-SULPHONIC ACID,GuideToPharmacology,1,inhibitor
BAK1P2,DESMOSTEROL,GuideToPharmacology,1,agonist
BST2,JNJ-67869386,GuideToPharmacology,1,blocker
STX2,SR7826,GuideToPharmacology,1,inhibitor
F5,PI-103,GuideToPharmacology,1,inhibitor
APOC2,ENPROSTIL,GuideToPharmacology,1,agonist
ACP5,AXT914,GuideToPharmacology,1,modulator
CD47,MAGROLIMAB,GuideToPharmacology,1,antibody
DXO,JAK3 INHIBITOR II,GuideToPharmacology,1,inhibitor
DR1,LY2874455,GuideToPharmacology,1,inhibitor
GABRA1,[18F]FLUOROETHYLFLUMAZENIL,GuideToPharmacology,1,modulator
GART,CUDC-101,GuideToPharmacology,1,inhibitor
APOC3,EPOPROSTENOL,GuideToPharmacology,1,agonist
ACADSB,ML221,GuideToPharmacology,1,inhibitor
PRMT5,GSK591,GuideToPharmacology,1,inhibitor
CTNNB1,NEFLAMAPIMOD,GuideToPharmacology,1,inhibitor
ABCA2,VIPADENANT,GuideToPharmacology,1,inhibitor
DRD4,COMPOUND 27 [PMID: 21123062],GuideToPharmacology,1,inhibitor
GMFB,TAFASITAMAB,GuideToPharmacology,1,antibody
ACADSB,CMF-019,GuideToPharmacology,1,agonist
GOLGA1,DNA-PK INHIBITOR V,GuideToPharmacology,1,inhibitor
TYK2,DELGOCITINIB,GuideToPharmacology,1,inhibitor
ACTL5,EXAMPLE 494 [WO2014028479] PARENT MOLECULE,GuideToPharmacology,1,agonist
AIRE,MRS4162-BODIPY CONJUGATE,GuideToPharmacology,1,agonist
COL10A1,YM976,GuideToPharmacology,1,inhibitor
CYP11B1,COMPOUND 35 [PMID: 24157366],GuideToPharmacology,1,inhibitor
CTPS1,Y27632,GuideToPharmacology,1,inhibitor
AMD1,ST-1006,GuideToPharmacology,1,agonist
ABCC6,"D(CH2)5[TYR(ME)2,THR4]OVT",GuideToPharmacology,1,inhibitor
CSTF3,A-674563,GuideToPharmacology,1,inhibitor
ATF6B,PD-146176,GuideToPharmacology,1,inhibitor
CTSO,BX-912,GuideToPharmacology,1,inhibitor
A1BG,NLX-101,GuideToPharmacology,1,agonist
A1BG,EMDT,GuideToPharmacology,1,agonist
A1BG,BMY-14802,GuideToPharmacology,1,agonist
A1BG,P-MPPI,GuideToPharmacology,1,inhibitor
A1BG,(S)-FLUROCARAZOLOL,GuideToPharmacology,1,inhibitor
A1BG,SB 649915,GuideToPharmacology,1,inhibitor
A2M,CGS-12066,GuideToPharmacology,1,agonist
A2MP1,CGS-12066,GuideToPharmacology,1,agonist
A2MP1,AVITRIPTAN,GuideToPharmacology,1,agonist
A2MP1,SB 216641,GuideToPharmacology,1,agonist
A2MP1,METERGOLINE,GuideToPharmacology,1,inhibitor
A2MP1,S33084,GuideToPharmacology,1,inhibitor
A12M1,DOI,GuideToPharmacology,1,agonist
A12M3,SARPOGRELATE,GuideToPharmacology,1,inhibitor
A12M3,S33084,GuideToPharmacology,1,inhibitor
A12M3,SPIPERONE,GuideToPharmacology,1,inhibitor
A12M3,PERPHENAZINE,GuideToPharmacology,1,inhibitor
A12M3,SDZ SER-082,GuideToPharmacology,1,inhibitor
A12M4,BROLAMFETAMINE,GuideToPharmacology,1,agonist
A12M4,SB 206553,GuideToPharmacology,1,inhibitor
A12M4,SPIRAMIDE,GuideToPharmacology,1,inhibitor
A12M4,METHYSERGIDE,GuideToPharmacology,1,agonist
HTR2C,LY344864,GuideToPharmacology,1,agonist
HTR2C,BROLAMFETAMINE,GuideToPharmacology,1,agonist
A12M4,[3H]MESULERGINE,GuideToPharmacology,1,inhibitor
HTR2C,RO 60-0175,GuideToPharmacology,1,agonist
HTR2C,RU 24969,GuideToPharmacology,1,agonist
HTR2C,VER-3323,GuideToPharmacology,1,agonist
HTR2C,DULOXETINE HYDROCHLORIDE,GuideToPharmacology,1,inhibitor
HTR2C,SB 215505,GuideToPharmacology,1,inhibitor
NAT1,MOSAPRIDE,GuideToPharmacology,1,agonist
NATP,SB 271046,GuideToPharmacology,1,inhibitor
NATP,LOXAPINE,GuideToPharmacology,1,inhibitor
FRA17A,GALANTAMINE,GuideToPharmacology,1,inhibitor
FRA17A,DONEPEZIL,GuideToPharmacology,1,inhibitor
ABL1,PP-121,GuideToPharmacology,1,inhibitor
FRA17A,"COMPOUND 2F [JIANG ET AL., 2018]",GuideToPharmacology,1,inhibitor
DEFB4A,INCB3619,GuideToPharmacology,1,inhibitor
ABCB7,SPIPERONE,GuideToPharmacology,1,inhibitor
ABCB7,NORTRIPTYLINE,GuideToPharmacology,1,inhibitor
ABCB7,(+)-CYCLAZOSIN,GuideToPharmacology,1,inhibitor
ABCB7,PIRIBEDIL,GuideToPharmacology,1,inhibitor
ABAT,2-HEXYNYL-NECA,GuideToPharmacology,1,agonist
ABAT,"(R,S)-PHPNECA",GuideToPharmacology,1,agonist
ABCA1,BAY 60-6583,GuideToPharmacology,1,agonist
ABCA1,(R)-PIA,GuideToPharmacology,1,agonist
ABCA1,KF26777,GuideToPharmacology,1,inhibitor
ABCA1,XANTHINE AMINE CONGENER,GuideToPharmacology,1,inhibitor
ABCA1,ST-1535,GuideToPharmacology,1,inhibitor
ABCA1,MRS1523,GuideToPharmacology,1,inhibitor
ABCA3,2-PHENYLETHYLYL-ADENOSINE DERIVATIVE,GuideToPharmacology,1,agonist
ABCA2,KF26777,GuideToPharmacology,1,inhibitor
ABCA2,MRS1754,GuideToPharmacology,1,inhibitor
ABCA2,ST-1535,GuideToPharmacology,1,inhibitor
ABCA2,PSB603,GuideToPharmacology,1,inhibitor
ABCA2,XANTHINE AMINE CONGENER,GuideToPharmacology,1,inhibitor
ABCA3,CGS 21680,GuideToPharmacology,1,agonist
ACADM,ANGIOTENSIN A,GuideToPharmacology,1,agonist
EEF1D,MLN-8054,GuideToPharmacology,1,inhibitor
EEF1D,GSK2334470,GuideToPharmacology,1,inhibitor
EEF1G,ZM447439,GuideToPharmacology,1,inhibitor
EEF1G,MK-5108,GuideToPharmacology,1,inhibitor
GRIK5,BIO-32546,GuideToPharmacology,1,inhibitor
AXL,BEMCENTINIB,GuideToPharmacology,1,inhibitor
AXL,RIPK1 INHIBITOR 22B,GuideToPharmacology,1,inhibitor
EEF1G,"(3Z)-N,N-DIMETHYL-2-OXO-3-(4,5,6,7-TETRAHYDRO-1H-INDOL-2-YLMETHYLIDENE)-2,3-DIHYDRO-1H-INDOLE-5-SULFONAMIDE",GuideToPharmacology,1,inhibitor
EEF1G,MLN-8054,GuideToPharmacology,1,inhibitor
ACAT2,"D-NAL,CYS,TYR,D-TRP,ORN,VAL,CYS,NAL-NH2",GuideToPharmacology,1,inhibitor
ACAT2,[125I][TYR4]BOMBESIN,GuideToPharmacology,1,agonist
ACAT2,NEUROMEDIN B,GuideToPharmacology,1,agonist
ACAT2,"[D-TPI6, LEU13 &PSI;(CH2NH)-LEU14]BOMBESIN-(6-14)",GuideToPharmacology,1,inhibitor
ACAT1,"D-NAL,CYS,TYR,D-TRP,ORN,VAL,CYS,NAL-NH2",GuideToPharmacology,1,inhibitor
GPR22,OBATOCLAX,GuideToPharmacology,1,inhibitor
FMO5,VERUBECESTAT,GuideToPharmacology,1,inhibitor
FMOD,ATABECESTAT,GuideToPharmacology,1,inhibitor
FMO5,LANABECESTAT,GuideToPharmacology,1,inhibitor
ABO,PROPAFENONE,GuideToPharmacology,1,inhibitor
ABR,SALMETEROL,GuideToPharmacology,1,agonist
ACAA1,ISOPROTERENOL,GuideToPharmacology,1,agonist
GAPDH,METHAZOLAMIDE,GuideToPharmacology,1,inhibitor
GLUD1P3,TOPIRAMATE,GuideToPharmacology,1,inhibitor
GLUD1P3,METHAZOLAMIDE,GuideToPharmacology,1,inhibitor
ACP5,EVOCALCET,GuideToPharmacology,1,modulator
FNTBL1,Z-ARG-LEU-VAL-AGLY-ILE-VAL-OME,GuideToPharmacology,1,inhibitor
ATP6AP1,MIBEFRADIL,GuideToPharmacology,1,blocker
RHOC,MIBEFRADIL,GuideToPharmacology,1,blocker
FOLR3,CITRUSININE II,GuideToPharmacology,1,inhibitor
CNR2,CANNABINOR,GuideToPharmacology,1,agonist
CCKBR,LY-288513,GuideToPharmacology,1,inhibitor
CCKBR,DESULFATED CHOLECYSTOKININ-8,GuideToPharmacology,1,agonist
ACTA1,CCL5,GuideToPharmacology,1,agonist
ACTA2,CCL2,GuideToPharmacology,1,agonist
ACTB,RO320-2947/001,GuideToPharmacology,1,inhibitor
ACTBP2,CCL5,GuideToPharmacology,1,agonist
GATM,RITUXIMAB,GuideToPharmacology,1,antibody
H1-6,OTLERTUZUMAB,GuideToPharmacology,1,antibody
GAPDHP60,LINTUZUMAB,GuideToPharmacology,1,antibody
ELAVL2,KINASE INHIBITOR 2 [PMID: 30199702],GuideToPharmacology,1,inhibitor
EIF5AP3,RABUSERTIB,GuideToPharmacology,1,inhibitor
EIF5AP3,ISOGRANULATIMIDE,GuideToPharmacology,1,inhibitor
CLCN4,CD2+,GuideToPharmacology,1,blocker
FRA1C,DESIRUDIN,GuideToPharmacology,1,inhibitor
F8,DROTRECOGIN ALFA,GuideToPharmacology,1,inhibitor
FPR3,JTV-803,GuideToPharmacology,1,inhibitor
TLX1,SOTEVTAMAB,GuideToPharmacology,1,antibody
DPYD,AZD6495,GuideToPharmacology,1,inhibitor
DPYD,AMG820,GuideToPharmacology,1,antibody
DPYD,LINIFANIB,GuideToPharmacology,1,inhibitor
CPT2,"COMPOUND 9 [KUMAR ET AL., 2019]",GuideToPharmacology,1,inhibitor
ACHE,HUMAN CALCITONIN,GuideToPharmacology,1,agonist
ALB,UROTENSIN 1 (FISH),GuideToPharmacology,1,agonist
HOXB5,COMPOUND 27 [PMID: 36449304],GuideToPharmacology,1,inhibitor
ACTBP9,CXCL5,GuideToPharmacology,1,agonist
ACTBP9,NAVARIXIN,GuideToPharmacology,1,inhibitor
ACTG1,CXCL12&ALPHA;,GuideToPharmacology,1,agonist
ACTG1,BALIXAFORTIDE,GuideToPharmacology,1,inhibitor
EGR4,BMS-265246,GuideToPharmacology,1,inhibitor
EGR4,(S)-CR8,GuideToPharmacology,1,inhibitor
COX11,OZAGREL,GuideToPharmacology,1,inhibitor
COX11,PICOTAMIDE,GuideToPharmacology,1,inhibitor
COX6A1P1,RITONAVIR,GuideToPharmacology,1,inhibitor
DUSP1,CHMFL-KIT-64,GuideToPharmacology,1,inhibitor
FPR1,COMPOUND 9 [PMID: 20718420],GuideToPharmacology,1,inhibitor
FPR1,TALABOSTAT,GuideToPharmacology,1,inhibitor
GBX2,MITOXANTRONE,GuideToPharmacology,1,inhibitor
DUSP1,MERESTINIB,GuideToPharmacology,1,inhibitor
APOB,RS 93520,GuideToPharmacology,1,agonist
APOB,BW 245C,GuideToPharmacology,1,agonist
APOBEC1,U46619,GuideToPharmacology,1,agonist
ALCAM,SPIPERONE,GuideToPharmacology,1,inhibitor
ABCD1,ZOTEPINE,GuideToPharmacology,1,inhibitor
ALDH1A1,LOXAPINE,GuideToPharmacology,1,inhibitor
ALDH1A1,ZOTEPINE,GuideToPharmacology,1,inhibitor
GLI1,TTK21,GuideToPharmacology,1,activator
EMP1,COMPOUND 3B [PMID: 23454515],GuideToPharmacology,1,inhibitor
CCR3,COMPOUND 15 [PMID: 32045236],GuideToPharmacology,1,inhibitor
GLI1,ANACARDIC ACID,GuideToPharmacology,1,inhibitor
DXO,COMPOUND 19A [PMID: 30503936],GuideToPharmacology,1,inhibitor
DXO,AG 490,GuideToPharmacology,1,inhibitor
APOBER1,DINOPROSTONE,GuideToPharmacology,1,agonist
APOBER1,ENPROSTIL,GuideToPharmacology,1,agonist
APOC1P1,BERAPROST,GuideToPharmacology,1,agonist
APOBER1,SC-51089,GuideToPharmacology,1,inhibitor
APOC1P1,DINOPROSTONE,GuideToPharmacology,1,agonist
EN1,BMS-690514,GuideToPharmacology,1,inhibitor
AQP8,TG11-77,GuideToPharmacology,1,inhibitor
EN1,MM-111,GuideToPharmacology,1,antibody
EN1,AEE788,GuideToPharmacology,1,inhibitor
DPAGT1,MM-111,GuideToPharmacology,1,antibody
EN1,ZONGERTINIB,GuideToPharmacology,1,inhibitor
BCYRN1P2,LSZ102,GuideToPharmacology,1,inhibitor
ALDH1B1,"[125I]ET-1 (HUMAN, MOUSE, RAT)",GuideToPharmacology,1,agonist
BDKRB1,DY131,GuideToPharmacology,1,agonist
BDH1,XCT790,GuideToPharmacology,1,inhibitor
ALDH1B1,[125I]SARAFOTOXIN S6B,GuideToPharmacology,1,agonist
ESR2,PHTPP,GuideToPharmacology,1,inhibitor
ALDH1A3,"[125I]ET-1 (HUMAN, MOUSE, RAT)",GuideToPharmacology,1,agonist
ALDH1A3,BQ 3020,GuideToPharmacology,1,agonist
BLVRA,ZOLEDRONIC ACID ANHYDROUS,GuideToPharmacology,1,inhibitor
CRMP1,EXAMPLE 13 [WO2009109743],GuideToPharmacology,1,inhibitor
BLVRA,RISEDRONIC ACID,GuideToPharmacology,1,inhibitor
ARNT,DIAZEPAM,GuideToPharmacology,1,modulator
ARNT,CLONAZEPAM,GuideToPharmacology,1,modulator
ARNT,TRIAZOLAM,GuideToPharmacology,1,modulator
ARNT,AZD7325,GuideToPharmacology,1,modulator
BMAL1,&ALPHA;5IA,GuideToPharmacology,1,modulator
ARNT,BICUCULLINE,GuideToPharmacology,1,inhibitor
ARR3,PIPERIDINE-4-SULPHONIC ACID,GuideToPharmacology,1,agonist
ARR3,TETRAHYDRODEOXYCORTICOSTERONE,GuideToPharmacology,1,modulator
BMAL1,FLUMAZENIL,GuideToPharmacology,1,modulator
BMAL1,ZOLPIDEM TARTRATE,GuideToPharmacology,1,modulator
ARR3,BICUCULLINE,GuideToPharmacology,1,inhibitor
BMAL1,BICUCULLINE,GuideToPharmacology,1,inhibitor
BMAL1,DIAZEPAM,GuideToPharmacology,1,modulator
ARRB1,FLUNITRAZEPAM,GuideToPharmacology,1,modulator
ARRB1,[3H]GABAZINE,GuideToPharmacology,1,inhibitor
ARRB1,PIPERIDINE-4-SULPHONIC ACID,GuideToPharmacology,1,agonist
ARRB2,RO15-4513,GuideToPharmacology,1,modulator
ARRB2,LAU463,GuideToPharmacology,1,modulator
ART4,PIPERIDINE-4-SULPHONIC ACID,GuideToPharmacology,1,inhibitor
ALOX12P1,GALANIN(1-15),GuideToPharmacology,1,agonist
ALOX12P1,GAL-B2-C18,GuideToPharmacology,1,agonist
GALR2,GAL-B2-C14,GuideToPharmacology,1,agonist
ALOX12P1,GALANIN(2-29) (RAT/MOUSE),GuideToPharmacology,1,agonist
GALR2,GALANIN(3-29) (RAT/MOUSE),GuideToPharmacology,1,agonist
CXCR5,BPH-252,GuideToPharmacology,1,inhibitor
ALPL,EXENDIN-3,GuideToPharmacology,1,agonist
ALPL,LIXISENATIDE,GuideToPharmacology,1,agonist
ALOX15,"[D-ARG1,D-PHE5,D-TRP7,9,LEU11]SUBSTANCE P",GuideToPharmacology,1,inhibitor
ALPP,GLP-2 ANALOGUE 10,GuideToPharmacology,1,agonist
ASPH,CYCLOTHIAZIDE,GuideToPharmacology,1,modulator
ASS1,ANIRACETAM,GuideToPharmacology,1,modulator
ASPH,IDRA-21,GuideToPharmacology,1,modulator
ASPH,S18986,GuideToPharmacology,1,modulator
ASS1,TEZAMPANEL ANHYDROUS,GuideToPharmacology,1,inhibitor
GRIA3,S18986,GuideToPharmacology,1,modulator
ASS1P2,TEZAMPANEL ANHYDROUS,GuideToPharmacology,1,inhibitor
ASS1P5,"2,4-EPI-NEODYSIHERBAINE",GuideToPharmacology,1,inhibitor
MNX1,C1-27,GuideToPharmacology,1,inhibitor
SERPINA3,FLUPERLAPINE,GuideToPharmacology,1,inhibitor
GAPDHP71,GLUTATHIONE DISULFIDE,GuideToPharmacology,1,inhibitor
GLRA1,COLCHICINE,GuideToPharmacology,1,inhibitor
ARVD3,"5,7-DICHLOROKYNURENIC ACID",GuideToPharmacology,1,inhibitor
ARVD3,PREGNENOLONE SULPHATE,GuideToPharmacology,1,inhibitor
ENSA,CHIR-98014,GuideToPharmacology,1,inhibitor
ARVD3,CYANOTRIPHENYLBORATE,GuideToPharmacology,1,blocker
ASAH1,GINKGOLIDE X,GuideToPharmacology,1,inhibitor
SLC29A1,AZD1080,GuideToPharmacology,1,inhibitor
SLC29A1,ISOGRANULATIMIDE,GuideToPharmacology,1,inhibitor
SLC25A5,LSP4-2022,GuideToPharmacology,1,agonist
CD24P1,GLYT1 INHIBITOR 51B,GuideToPharmacology,1,inhibitor
ANXA11,COMPOUND 2 [PMID: 24486398],GuideToPharmacology,1,agonist
ANXA13,ACIPIMOX,GuideToPharmacology,1,agonist
ARL3,CILOBRADINE,GuideToPharmacology,1,blocker
AOAH,D-KYNURENINE,GuideToPharmacology,1,agonist
ARL1,IVABRADINE,GuideToPharmacology,1,blocker
LRRC32,KA1010,GuideToPharmacology,1,inhibitor
GARS1,ACY-738,GuideToPharmacology,1,inhibitor
AMELX,(R)-&ALPHA;-METHYLHISTAMINE,GuideToPharmacology,1,agonist
AMELX,IMPROGAN,GuideToPharmacology,1,agonist
ADH1C,JNJ-38431055,GuideToPharmacology,1,agonist
ADH1C,COMPOUND 29A [PMID: 21444206],GuideToPharmacology,1,agonist
ADH1C,COMPOUND 42 [PMID: 22545772],GuideToPharmacology,1,agonist
ACTN4,"7&ALPHA;,25-DIHYDROXYCHOLESTEROL",GuideToPharmacology,1,agonist
GPR32,[3H]RESOLVIN D1,GuideToPharmacology,1,agonist
ACTN4,27-HYDROXYCHOLESTEROL,GuideToPharmacology,1,agonist
ADD3,PSB-17365,GuideToPharmacology,1,agonist
ADCY8,POMC (141-162),GuideToPharmacology,1,agonist
LGR6,R-SPONDIN-2,GuideToPharmacology,1,agonist
LGR6,R-SPONDIN-1,GuideToPharmacology,1,agonist
LGR6,R-SPONDIN-4,GuideToPharmacology,1,agonist
XCR1,EPACADOSTAT,GuideToPharmacology,1,inhibitor
NCAN,LITHIUM CARBONATE,GuideToPharmacology,1,inhibitor
DPH1,BMS-754807,GuideToPharmacology,1,inhibitor
FRA12D,LIFITEGRAST,GuideToPharmacology,1,inhibitor
FRA11H,ETROLIZUMAB,GuideToPharmacology,1,antibody
FRA12D,ROVELIZUMAB,GuideToPharmacology,1,antibody
DCC,ILOMASTAT,GuideToPharmacology,1,inhibitor
FRA11F,VALATEGRAST,GuideToPharmacology,1,inhibitor
FRA13D,ROVELIZUMAB,GuideToPharmacology,1,antibody
DPEP1,GSK-1838705A,GuideToPharmacology,1,inhibitor
IL31RA,NEMOLIZUMAB,GuideToPharmacology,1,antibody
EPHA1,COMPOUND 22 [PMID: 21823616],GuideToPharmacology,1,inhibitor
APOC3,SELEXIPAG,GuideToPharmacology,1,agonist
GPX1P2,LY3410738,GuideToPharmacology,1,inhibitor
BPI,VANILLIN,GuideToPharmacology,1,agonist
BMPR2,L-TRP-TRP-TRP,GuideToPharmacology,1,agonist
BPI,RITANSERIN,GuideToPharmacology,1,agonist
POLR3D,L-TRP-TRP-TRP,GuideToPharmacology,1,agonist
POLR3D,COLCHICINE,GuideToPharmacology,1,agonist
BNIP2,GRANDININ,GuideToPharmacology,1,agonist
EPHB2,COMPOUND 8L [PMID: 36053746],GuideToPharmacology,1,inhibitor
EPHB2,AC430,GuideToPharmacology,1,inhibitor
EPHB2,COMPOUND 1D [PMID: 21493067],GuideToPharmacology,1,inhibitor
EPHB1,PEFICITINIB,GuideToPharmacology,1,inhibitor
EPHB2,FEDRATINIB,GuideToPharmacology,1,inhibitor
EPHB2,LASW1393,GuideToPharmacology,1,inhibitor
FRA2C,COMPOUND 4D [PMID: 25489658],GuideToPharmacology,1,inhibitor
FRA2D,COMPOUND 32 [PMID: 31675166],GuideToPharmacology,1,inhibitor
NUDT2,BW373U86,GuideToPharmacology,1,agonist
NUDT2,HS665,GuideToPharmacology,1,agonist
NUDT2,BUPRENORPHINE,GuideToPharmacology,1,inhibitor
NUDT2,&BETA;-FNA,GuideToPharmacology,1,inhibitor
DRD2,PRALSETINIB,GuideToPharmacology,1,inhibitor
DRD2,3-[(3-(2-CARBOXYETHYL)-4-METHYLPYRROL-2-YL)METHYLENE]-2-INDOLINONE,GuideToPharmacology,1,inhibitor
ATP6V1A,HALOTHANE,GuideToPharmacology,1,inhibitor
ATP5MC2,HALOTHANE,GuideToPharmacology,1,activator
ARF5,BICUCULLINE,GuideToPharmacology,1,blocker
RHOA,NS004,GuideToPharmacology,1,activator
ADGRB2,CS+,GuideToPharmacology,1,blocker
ALDH7A1P2,PROPAFENONE,GuideToPharmacology,1,blocker
LTB4R,TPT-004,GuideToPharmacology,1,inhibitor
GGTL2,IOX1,GuideToPharmacology,1,inhibitor
HIVEP2,CCT365623,GuideToPharmacology,1,inhibitor
DRD5,COMPOUND 19A [PMID: 30503936],GuideToPharmacology,1,inhibitor
KDM5A,GSK-J1,GuideToPharmacology,1,inhibitor
ANK1,CORTICOTROPIN,GuideToPharmacology,1,agonist
DRD4,COMPOUND 8I [PMID: 22765894],GuideToPharmacology,1,inhibitor
DRD4,AM7,GuideToPharmacology,1,inhibitor
DRD4,COMPOUND 16 [PMID: 18945615],GuideToPharmacology,1,inhibitor
SLC25A4,L-CCG-I,GuideToPharmacology,1,agonist
ABCD1,BREXPIPRAZOLE,GuideToPharmacology,1,agonist
ANPEP,CYPPTS,GuideToPharmacology,1,modulator
GRM6,L-CCG-I,GuideToPharmacology,1,agonist
SLC25A6,[3H]CTEP,GuideToPharmacology,1,modulator
SLC25A6,VU-1545,GuideToPharmacology,1,modulator
GRM8,L-CCG-I,GuideToPharmacology,1,agonist
ANTP2,MCCG,GuideToPharmacology,1,inhibitor
CEBPB,CTPI-2,GuideToPharmacology,1,inhibitor
NR3C2,SPIRONOLACTONE,GuideToPharmacology,1,inhibitor
CEBPB,"1,2,3-BENZENETRICARBOXYLIC ACID",GuideToPharmacology,1,inhibitor
NR3C2,DESOXYCORTICOSTERONE,GuideToPharmacology,1,agonist
CTNNB1,COMPOUND 4E [PMID: 35546685],GuideToPharmacology,1,inhibitor
CTNNA1P1,J30-8,GuideToPharmacology,1,inhibitor
CTNNA1P1,JNK INHIBITOR VIII,GuideToPharmacology,1,inhibitor
CTNND1,PH-797804,GuideToPharmacology,1,inhibitor
CTNNA1P1,BOS172722,GuideToPharmacology,1,inhibitor
MAPK3,"5-(2-PHENYLPYRAZOLO[1,5-A]PYRIDIN-3-YL)-1H-PYRAZOLO[3,4-C]PYRIDAZIN-3-AMINE",GuideToPharmacology,1,inhibitor
ESA4,BS-194,GuideToPharmacology,1,inhibitor
CTNNA2,JNK-IN-8,GuideToPharmacology,1,inhibitor
CTNNA2,COMPOUND 25C [PMID: 36649216],GuideToPharmacology,1,inhibitor
CTNNB1,PP1,GuideToPharmacology,1,inhibitor
CTNNA2,JNK INHIBITOR VIII,GuideToPharmacology,1,inhibitor
MAP3K9,URMC-099,GuideToPharmacology,1,inhibitor
MAP3K9,P505-15,GuideToPharmacology,1,inhibitor
ERVT1,RIPK1 INHIBITOR 22B,GuideToPharmacology,1,inhibitor
ERPL2,TPL2 KINASE INHIBITOR,GuideToPharmacology,1,inhibitor
DCR,SL422,GuideToPharmacology,1,inhibitor
DCK,COMPOUND 1A [PMID: 15055993],GuideToPharmacology,1,inhibitor
DCK,SL422,GuideToPharmacology,1,inhibitor
ANTP4,MOTILIN-(1-19) (HUMAN),GuideToPharmacology,1,agonist
AADAC,THIOCHROME,GuideToPharmacology,1,modulator
AADAC,T440,GuideToPharmacology,1,modulator
AADAC,VU0119498,GuideToPharmacology,1,modulator
AAMP,NNC 11-1607,GuideToPharmacology,1,agonist
AAMP,NNC 11-1585,GuideToPharmacology,1,agonist
AAMP,OXOTREMORINE-M,GuideToPharmacology,1,agonist
AAMP,MEPENZOLATE,GuideToPharmacology,1,inhibitor
AAMP,TRIPITRAMINE,GuideToPharmacology,1,inhibitor
ANK3,2-[125I]MELATONIN,GuideToPharmacology,1,agonist
ANK3,S24014,GuideToPharmacology,1,agonist
APOF,ISOTONITAZENE,GuideToPharmacology,1,agonist
APOF,NALDEMEDINE,GuideToPharmacology,1,inhibitor
APOF,NALMEFENE,GuideToPharmacology,1,inhibitor
CD8B,SIBUTRAMINE,GuideToPharmacology,1,inhibitor
DRD5P1,COMPOUND 1D [PMID: 21493067],GuideToPharmacology,1,inhibitor
DRD5P2,TALETRECTINIB,GuideToPharmacology,1,inhibitor
DRD5P1,ZURLETRECTINIB,GuideToPharmacology,1,inhibitor
DRG2,PEXIDARTINIB,GuideToPharmacology,1,inhibitor
DAP,DAGLUTRIL,GuideToPharmacology,1,inhibitor
CHRNA3,NICOTINE POLACRILEX,GuideToPharmacology,1,agonist
ETV4,COMPOUND 25 [PMID: 17935989],GuideToPharmacology,1,inhibitor
AQP4,GR 159897,GuideToPharmacology,1,inhibitor
AQP3,SERLOPITANT,GuideToPharmacology,1,inhibitor
AQP4,"[125I]NKA (HUMAN, MOUSE, RAT)",GuideToPharmacology,1,agonist
GPR37,IMR-1,GuideToPharmacology,1,inhibitor
ANXA2P1,NEUROPEPTIDE W-30,GuideToPharmacology,1,agonist
ANXA1,EFWSLAAPQRF-NH2,GuideToPharmacology,1,agonist
AMPD2,S鈥怸048,GuideToPharmacology,1,inhibitor
APBA2,ACT-462206,GuideToPharmacology,1,inhibitor
APBA2,[3H]-TCS 1102,GuideToPharmacology,1,inhibitor
APBB1,[3H]-TCS 1102,GuideToPharmacology,1,inhibitor
ATP1A3,NF023,GuideToPharmacology,1,inhibitor
EXTL3,PF-3758309,GuideToPharmacology,1,inhibitor
ATP12A,PSB-10211,GuideToPharmacology,1,inhibitor
ATP1A4,ELIAPIXANT,GuideToPharmacology,1,inhibitor
APEH,ADP,GuideToPharmacology,1,agonist
ATP1B3P1,A839977,GuideToPharmacology,1,inhibitor
ATP1B3P1,A740003,GuideToPharmacology,1,inhibitor
ATP1B3P1,ITH15004,GuideToPharmacology,1,inhibitor
BIRC2,ADP,GuideToPharmacology,1,agonist
BIRC2,AP4A,GuideToPharmacology,1,inhibitor
APC,DENUFOSOL,GuideToPharmacology,1,agonist
APBB2,"2',3'-DIDEOXYADENOSINE TRIPHOSPHATE",GuideToPharmacology,1,agonist
ADCYAP1R1,[125I]PACAP-27,GuideToPharmacology,1,agonist
ADCYAP1R1,PACAP-27,GuideToPharmacology,1,agonist
APOE,2-FUROYL-LIGRLO-AMIDE,GuideToPharmacology,1,agonist
PRF1,COMPOUND 16 [PMID: 31525966],GuideToPharmacology,1,inhibitor
GPX2,CL-AMIDINE,GuideToPharmacology,1,inhibitor
FOXA3,AG-122018,GuideToPharmacology,1,inhibitor
GPX2,COMPOUND 14B [PMID: 25742366],GuideToPharmacology,1,inhibitor
F7,RV1729,GuideToPharmacology,1,inhibitor
F2R,WORTMANNIN,GuideToPharmacology,1,inhibitor
F7R,WORTMANNIN,GuideToPharmacology,1,inhibitor
COL10A1,CDP840,GuideToPharmacology,1,inhibitor
COL10A1,MK-0359,GuideToPharmacology,1,inhibitor
COL11A2,IBUDILAST,GuideToPharmacology,1,inhibitor
PDE5A,MILRINONE,GuideToPharmacology,1,inhibitor
F11,CX-6258,GuideToPharmacology,1,inhibitor
F9,AZD1208,GuideToPharmacology,1,inhibitor
CHKB,DECYNIUM 22,GuideToPharmacology,1,inhibitor
CHKB,QUINIDINE,GuideToPharmacology,1,inhibitor
DPP4,AC710,GuideToPharmacology,1,inhibitor
DPP6,MASITINIB,GuideToPharmacology,1,inhibitor
DPP6,COMPOUND 8I [PMID: 22765894],GuideToPharmacology,1,inhibitor
DPP6,CRENOLANIB,GuideToPharmacology,1,inhibitor
CSE1L,PIP2,GuideToPharmacology,1,activator
CSE1L,OLEIC ACID,GuideToPharmacology,1,activator
FABP1,MLN0905,GuideToPharmacology,1,inhibitor
GM2A,SINTILIMAB,GuideToPharmacology,1,antibody
FRA3D,FURIN INHIBITOR PEPTIDE,GuideToPharmacology,1,inhibitor
CSTB,H-89,GuideToPharmacology,1,inhibitor
GOLGA1,NU-7441,GuideToPharmacology,1,inhibitor
FABP7,BPKDI,GuideToPharmacology,1,inhibitor
PRKD3,CRT 0066101,GuideToPharmacology,1,inhibitor
GOLGA1,COMPOUND 82 [PMID: 21332118],GuideToPharmacology,1,inhibitor
ACSL3,CONTELTINIB,GuideToPharmacology,1,inhibitor
HOXA6,MIGOPROTAFIB,GuideToPharmacology,1,modulator
GOLGA2,COMPOUND V [PMID: 29351497],GuideToPharmacology,1,inhibitor
BCHEL1,ALITRETINOIN,GuideToPharmacology,1,agonist
GP1BA,"(5Z)-5-[(5-BROMOTHIOPHEN-2-YL)METHYLIDENE]-1-METHYL-2-SULFANYLIDENE-1,3-DIAZINANE-4,6-DIONE",GuideToPharmacology,1,inhibitor
BCHEL1,TAZAROTENE,GuideToPharmacology,1,agonist
BCHEL1,BMS641,GuideToPharmacology,1,agonist
BCHE,AGN193109,GuideToPharmacology,1,inhibitor
BCHEL3,TAMIBAROTENE,GuideToPharmacology,1,agonist
HCN2,"COMPOUND 28 [HEITEL ET AL., 2019]",GuideToPharmacology,1,agonist
HCN2,FLUOROBEXAROTENE,GuideToPharmacology,1,agonist
BCL2A1,SR9011,GuideToPharmacology,1,agonist
PTK2B,VEPAFESTINIB,GuideToPharmacology,1,inhibitor
APRT,EUROPIUM-LABELLED R3(B1-22R),GuideToPharmacology,1,inhibitor
KLK3,NANOLUC R3/I5 CHIMERA,GuideToPharmacology,1,agonist
RYR2,ADENOSINE TRIPHOSPHATE,GuideToPharmacology,1,activator
KLK3,MINIMISED RELAXIN-3 ANALOGUE 2,GuideToPharmacology,1,agonist
CD9,DULOXETINE HYDROCHLORIDE,GuideToPharmacology,1,inhibitor
FBLN2,DASATINIB ANHYDROUS,GuideToPharmacology,1,inhibitor
GYPB,TTI-101,GuideToPharmacology,1,inhibitor
GK2,AKK(THIOAC)LM21,GuideToPharmacology,1,inhibitor
CD44,ODEVIXIBAT,GuideToPharmacology,1,inhibitor
CRYGB,COMPOUND 12E [PMID: 18605714],GuideToPharmacology,1,inhibitor
FCER1A,OPAGANIB,GuideToPharmacology,1,inhibitor
FCER1A,SKI II,GuideToPharmacology,1,inhibitor
CRYBB3,COMPOUND 12E [PMID: 18605714],GuideToPharmacology,1,inhibitor
MS4A2,PP-121,GuideToPharmacology,1,inhibitor
FAS,CST-17,GuideToPharmacology,1,agonist
FAS,[L-TYR8]CYN 154806,GuideToPharmacology,1,inhibitor
FASLG,[111IN]DOTA-NOC-ATE,GuideToPharmacology,1,agonist
FASLG,DOTA-JR11,GuideToPharmacology,1,inhibitor
AQP1,J-2156,GuideToPharmacology,1,agonist
SHROOM2,[111IN]DOTA-NOC-ATE,GuideToPharmacology,1,agonist
SHROOM2,SEGLITIDE,GuideToPharmacology,1,agonist
SHROOM2,CST-17,GuideToPharmacology,1,agonist
AQP2,BIM 23627,GuideToPharmacology,1,inhibitor
AQP2,[L-TYR8]CYN 154806,GuideToPharmacology,1,inhibitor
HLA-DMA,RK-287107,GuideToPharmacology,1,inhibitor
FRA7G,COMPOUND 8E [PMID: 23044371],GuideToPharmacology,1,inhibitor
HLA-DMB,COMPOUND 21 [PMID: 34141085],GuideToPharmacology,1,inhibitor
AQP7,ULOTARONT,GuideToPharmacology,1,agonist
AQP7,2-PHENYL-PROPYLAMINE,GuideToPharmacology,1,agonist
BCGF1,NH-3,GuideToPharmacology,1,inhibitor
NR2E1,COMPOUND 10 [PMID: 34989568],GuideToPharmacology,1,agonist
ARHGAP4,UM-9,GuideToPharmacology,1,inhibitor
APOC4,U46619,GuideToPharmacology,1,agonist
APOC4,DALTROBAN,GuideToPharmacology,1,inhibitor
APOC4,U46619,GuideToPharmacology,1,agonist
ARHGAP4,"PHOSPHATIDYL (3,5) INOSITOL BISPHOSPHATE",GuideToPharmacology,1,activator
FGB,COMPOUND 21K [PMID: 34985886],GuideToPharmacology,1,inhibitor
TLX2,LEPUNAFUSP ALFA,GuideToPharmacology,1,antibody
FXYD2,2-APB,GuideToPharmacology,1,blocker
ATP2A3,(-)-ENGLERIN A,GuideToPharmacology,1,activator
ATP3,PIP2,GuideToPharmacology,1,activator
ATP2B2,CLEMIZOLE,GuideToPharmacology,1,blocker
ATP4B,PIP2,GuideToPharmacology,1,activator
ATP4B,COMPOUND 5 [PMID: 29579323],GuideToPharmacology,1,blocker
ATP4B,COMPOUND 5 [PMID: 29579323],GuideToPharmacology,1,inhibitor
ATP4A,TROGLITAZONE,GuideToPharmacology,1,blocker
ATP4B,ADENOSINE MONOPHOSPHATE,GuideToPharmacology,1,inhibitor
ATP4A,PREGNENOLONE SULPHATE,GuideToPharmacology,1,activator
ATP4B,ADENOSINE TRIPHOSPHATE,GuideToPharmacology,1,blocker
ATP4B,ADENOSINE TRIPHOSPHATE,GuideToPharmacology,1,inhibitor
ATP5F1BP1,ZUCAPSAICIN,GuideToPharmacology,1,activator
MCOLN3,ML SA1,GuideToPharmacology,1,activator
MCOLN2,PRU-10,GuideToPharmacology,1,inhibitor
PKD2L1,CITRIC ACID,GuideToPharmacology,1,activator
MCOLN3,"PHOSPHATIDYL (3,5) INOSITOL BISPHOSPHATE",GuideToPharmacology,1,activator
TRPV6,CD2+,GuideToPharmacology,1,blocker
TRPV6,2-APB,GuideToPharmacology,1,activator
FGFR4,COMPOUND 34H [PMID: 27055065],GuideToPharmacology,1,inhibitor
TYK2,TYK2 INHIBITOR 14L,GuideToPharmacology,1,inhibitor
TYK2,PF-956980,GuideToPharmacology,1,inhibitor
ARCN1,[125I]PACAP-27,GuideToPharmacology,1,agonist
ABCC6,[VAL4]AVP,GuideToPharmacology,1,agonist
FKBP1A,PP1,GuideToPharmacology,1,inhibitor
GNG10,BIRINAPANT,GuideToPharmacology,1,inhibitor
ABCC6,[3H]SR 121463A,GuideToPharmacology,1,inhibitor
ABCC6,NELIVAPTAN,GuideToPharmacology,1,inhibitor
ANXA2P3,BIBP3226,GuideToPharmacology,1,inhibitor
ANXA3,"[LEU31,PRO34]NPY (PIG)",GuideToPharmacology,1,agonist
ANXA3,NPY-(26-36) (PIG),GuideToPharmacology,1,agonist
GM2A,PROLGOLIMAB,GuideToPharmacology,1,antibody
GBE1,FONDAPARINUX,GuideToPharmacology,1,activator
TYK2,TOFACITINIB,GuideToPharmacology,1,inhibitor
A12M4,QUINPIROLE,GuideToPharmacology,1,agonist
ASS1P6,KAINIC ACID,GuideToPharmacology,1,agonist
CCR10,FTI 276,GuideToPharmacology,1,inhibitor
ADCY9,CCL5,GuideToPharmacology,1,agonist
ACACB,CHIPS,GuideToPharmacology,1,inhibitor
DAPK3,SPIRAPRILAT,GuideToPharmacology,1,inhibitor
EPHX2,"(3Z)-N,N-DIMETHYL-2-OXO-3-(4,5,6,7-TETRAHYDRO-1H-INDOL-2-YLMETHYLIDENE)-2,3-DIHYDRO-1H-INDOLE-5-SULFONAMIDE",GuideToPharmacology,1,inhibitor
FGR,ACALABRUTINIB,GuideToPharmacology,1,inhibitor
ACTA2,CCL16,GuideToPharmacology,1,agonist
ASS1P5,IODO-WILLARDIINE,GuideToPharmacology,1,agonist
DBT,SB-3CT,GuideToPharmacology,1,inhibitor
EIF4EP1,CORTISTATIN A,GuideToPharmacology,1,inhibitor
ANXA3,[125I]PYY,GuideToPharmacology,1,agonist
ACADS,COMPOUND 21 [PMID: 22802221],GuideToPharmacology,1,agonist
APOBEC1,"L-888,607",GuideToPharmacology,1,agonist
ABO,ISOPROTERENOL,GuideToPharmacology,1,agonist
HPCA,COMPOUND 61 [PMID: 36221183],GuideToPharmacology,1,inhibitor
ABR,CIMATEROL,GuideToPharmacology,1,agonist
F5,DROTRECOGIN ALFA,GuideToPharmacology,1,inhibitor
CCND1,GW409544,GuideToPharmacology,1,agonist
AMELX,N-[3H]METHYLHISTAMINE,GuideToPharmacology,1,agonist
A1BG,VORTIOXETINE HYDROBROMIDE,GuideToPharmacology,1,agonist
ABCA2,PICLIDENOSON,GuideToPharmacology,1,agonist
EZH2,SKLB-03220,GuideToPharmacology,1,inhibitor
EIF4EBP1,CDK/CRK INHIBITOR,GuideToPharmacology,1,inhibitor
AANAT,THIOCHROME,GuideToPharmacology,1,modulator
ASPH,ANIRACETAM,GuideToPharmacology,1,modulator
DUSP5,COMPOUND 1D [PMID: 21493067],GuideToPharmacology,1,inhibitor
CDH13,[3H]TBZOH,GuideToPharmacology,1,inhibitor
AMELY,KISSPEPTIN-10,GuideToPharmacology,1,agonist
DXO,LAZERTINIB,GuideToPharmacology,1,inhibitor
GNRHR,BUSERELIN,GuideToPharmacology,1,agonist
CTNNB1,RALIMETINIB,GuideToPharmacology,1,inhibitor
EIF4G1,SU9516,GuideToPharmacology,1,inhibitor
COX5BP1,12-IMIDAZOLYL-1-DODECANOL,GuideToPharmacology,1,inhibitor
ANTP4,KOS1326,GuideToPharmacology,1,agonist
OPN1SW,"COMPOUND 28 [HEITEL ET AL., 2019]",GuideToPharmacology,1,agonist
ASPH,ATPO,GuideToPharmacology,1,inhibitor
EPHB3,MOMELOTINIB,GuideToPharmacology,1,inhibitor
ANPEP,COMPOUND 3 [PMID: 21105727],GuideToPharmacology,1,modulator
DAPK3,ZOFENOPRIL,GuideToPharmacology,1,inhibitor
EFNA3,COMPOUND 4D [PMID: 21851057],GuideToPharmacology,1,inhibitor
ARVD3,GINKGOLIDE X,GuideToPharmacology,1,inhibitor
SLC15A2,LYS[Z(NO2)]-PRO,GuideToPharmacology,1,inhibitor
BIRC3,PPTN,GuideToPharmacology,1,inhibitor
ACTN4,"7&ALPHA;,27-DIHYDROXYCHOLESTEROL",GuideToPharmacology,1,agonist
ATP5ME,GI鈥?30159,GuideToPharmacology,1,activator
F9,PIM447,GuideToPharmacology,1,inhibitor
EIF4E,VORUCICLIB,GuideToPharmacology,1,inhibitor
ECM2,ALTIRATINIB,GuideToPharmacology,1,inhibitor
CFTR,COMPOUND 16D [PMID: 36573286],GuideToPharmacology,1,activator
BDKRB2,DEUCRICTIBANT,GuideToPharmacology,1,inhibitor
CLTC,SULFASALAZINE,GuideToPharmacology,1,inhibitor
AR,[VAL4]AVP,GuideToPharmacology,1,agonist
NR2F6,VORUCICLIB,GuideToPharmacology,1,inhibitor
DNMT3A,VACTOSERTIB,GuideToPharmacology,1,inhibitor
A2M,GR 127935,GuideToPharmacology,1,agonist
A2M,GR 127935,GuideToPharmacology,1,inhibitor
CA4,METHAZOLAMIDE,GuideToPharmacology,1,inhibitor
ARG2,SKA-111,GuideToPharmacology,1,activator
SERPINA3,RISPERIDONE,GuideToPharmacology,1,inhibitor
APCS,ADENOSINE TRIPHOSPHATE,GuideToPharmacology,1,agonist
APCS,ADENOSINE TRIPHOSPHATE,GuideToPharmacology,1,inhibitor
ALCAM,A68930,GuideToPharmacology,1,agonist
APOC1P1,AH6809,GuideToPharmacology,1,inhibitor
AAMP,N-BENZYL BRUCINE,GuideToPharmacology,1,modulator
APLP2,SCH 37370,GuideToPharmacology,1,inhibitor
ATP4B,MECLOFENAMATE,GuideToPharmacology,1,blocker
DTYMK,COMPOUND R-16 [PMID: 21967808],GuideToPharmacology,1,inhibitor
NATP,RISPERIDONE,GuideToPharmacology,1,inhibitor
ASIC2,COMPOUND 22E [PMID: 20167483],GuideToPharmacology,1,agonist
ACTBP4,CCL21,GuideToPharmacology,1,agonist
ACTB,RO330-0802/001,GuideToPharmacology,1,inhibitor
ESAT,COMPOUND 16 [PMID: 18945615],GuideToPharmacology,1,inhibitor
BLVRA,COMPOUND 5E [PMID: 17975902],GuideToPharmacology,1,inhibitor
APRT,RELAXIN,GuideToPharmacology,1,agonist
MSTN,KA1010,GuideToPharmacology,1,inhibitor
AADAC,N-BENZYL BRUCINE,GuideToPharmacology,1,modulator
BRCA2,L-TRP-TRP-TRP,GuideToPharmacology,1,agonist
A2M,METERGOLINE,GuideToPharmacology,1,inhibitor
ARVD3,COLCHICINE,GuideToPharmacology,1,inhibitor
AIRE,ADP,GuideToPharmacology,1,agonist
FECH,"(7S)-2-(2-AMINOPYRIMIDIN-4-YL)-7-(2-FLUOROETHYL)-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE",GuideToPharmacology,1,inhibitor
BIRC3,MRS4478,GuideToPharmacology,1,inhibitor
DUSP2,SORAFENIB,GuideToPharmacology,1,inhibitor
AMD1,RISPERIDONE,GuideToPharmacology,1,inhibitor
ABCB7,DOXAZOSIN MESYLATE,GuideToPharmacology,1,inhibitor
DAP,COMPOUND 1B [PMID: 18078750],GuideToPharmacology,1,inhibitor
CSTF3,IPATASERTIB,GuideToPharmacology,1,inhibitor
DHFR,DIFLUNISAL,GuideToPharmacology,1,inhibitor
DXO,ZORIFERTINIB,GuideToPharmacology,1,inhibitor
HDC,AMA,GuideToPharmacology,1,inhibitor
GPX1P2,AGI-5198,GuideToPharmacology,1,inhibitor
APOE,2-FUROYL-LIGRL[N-(ALEXA FLUOR 594)-O]-NH2,GuideToPharmacology,1,agonist
GCF1,IXABEPILONE,GuideToPharmacology,1,inhibitor
CD9,NORTRIPTYLINE,GuideToPharmacology,1,inhibitor
ACTG1P9,CHEMERIN C-TERMINAL PEPTIDE,GuideToPharmacology,1,agonist
A2M,(S)-FLUROCARAZOLOL,GuideToPharmacology,1,inhibitor
A2M,[3H]ELETRIPTAN,GuideToPharmacology,1,agonist
A12M2,5-HYDROXYTRYPTAMINE,GuideToPharmacology,1,agonist
A12M2,2-METHYL-5-HT,GuideToPharmacology,1,agonist
A12M1,M-CHLOROPHENYLPIPERAZINE,GuideToPharmacology,1,agonist
A12M2,RISPERIDONE,GuideToPharmacology,1,inhibitor
A12M3,5-HYDROXYTRYPTAMINE,GuideToPharmacology,1,agonist
A12M2,METHYSERGIDE,GuideToPharmacology,1,inhibitor
A12M3,QUINPIROLE,GuideToPharmacology,1,agonist
A12M3,CGS-12066,GuideToPharmacology,1,agonist
A12M3,DULOXETINE HYDROCHLORIDE,GuideToPharmacology,1,inhibitor
A12M3,LY86057,GuideToPharmacology,1,inhibitor
A12M4,RITANSERIN,GuideToPharmacology,1,inhibitor
A12M4,S33084,GuideToPharmacology,1,inhibitor
A12M4,PIRIBEDIL,GuideToPharmacology,1,inhibitor
HTR2C,METHYSERGIDE,GuideToPharmacology,1,inhibitor
NAT1,SB 204070,GuideToPharmacology,1,inhibitor
NAT2,METHYSERGIDE,GuideToPharmacology,1,inhibitor
NAT2,RU 24969,GuideToPharmacology,1,agonist
NATP,VORTIOXETINE HYDROBROMIDE,GuideToPharmacology,1,inhibitor
SERPINA3,[3H]5-HT,GuideToPharmacology,1,agonist
DNCM,COMPOUND 13D [PMID: 23639540],GuideToPharmacology,1,inhibitor
TRDMT1,COMPOUND 13D [PMID: 23639540],GuideToPharmacology,1,inhibitor
GAPDHP69,MIGALASTAT,GuideToPharmacology,1,inhibitor
HBEGF,AZD3463,GuideToPharmacology,1,inhibitor
CXCL1,WWL70,GuideToPharmacology,1,inhibitor
ABCB7,PRAZOSIN,GuideToPharmacology,1,inhibitor
ABCA4,RITANSERIN,GuideToPharmacology,1,inhibitor
ABL1,CLONIDINE HYDROCHLORIDE,GuideToPharmacology,1,agonist
ABL1,GUANFACINE HYDROCHLORIDE,GuideToPharmacology,1,agonist
ABL1,DEXMEDETOMIDINE HYDROCHLORIDE,GuideToPharmacology,1,agonist
ABL1,MOXONIDINE,GuideToPharmacology,1,agonist
AOC1,TOLAZOLINE,GuideToPharmacology,1,inhibitor
AOC1,ATIPAMEZOLE,GuideToPharmacology,1,inhibitor
AOC1,LOFEXIDINE,GuideToPharmacology,1,agonist
ABL2,LOFEXIDINE,GuideToPharmacology,1,agonist
ABL2,PIRIBEDIL,GuideToPharmacology,1,inhibitor
BEVI,APALUTAMIDE,GuideToPharmacology,1,inhibitor
BEVI,NILUTAMIDE,GuideToPharmacology,1,inhibitor
BEVI,DAROLUTAMIDE,GuideToPharmacology,1,inhibitor
BEVI,METHYLTESTOSTERONE,GuideToPharmacology,1,agonist
GNA11,MOFEGILINE,GuideToPharmacology,1,inhibitor
ACADSB,APELIN-17,GuideToPharmacology,1,agonist
ABAT,[3H]DPCPX,GuideToPharmacology,1,inhibitor
ABCA3,MRS1191,GuideToPharmacology,1,inhibitor
ABCA3,SCH442416,GuideToPharmacology,1,inhibitor
ABCA3,SCH 58261,GuideToPharmacology,1,inhibitor
GPC3,COMPOUND 23 [PMID: 31398032],GuideToPharmacology,1,inhibitor
EEF1D,COMPOUND 38 [PMID: 20817473],GuideToPharmacology,1,inhibitor
GNG11,BIRINAPANT,GuideToPharmacology,1,inhibitor
AXL,UNC4203,GuideToPharmacology,1,inhibitor
GTF2A1,FX1,GuideToPharmacology,1,inhibitor
CSRP2P1,COMPOUND 101 [PMID: 21596927],GuideToPharmacology,1,inhibitor
ABO,CGP 20712A,GuideToPharmacology,1,inhibitor
AMFR,[3H]CGS23131,GuideToPharmacology,1,inhibitor
EEGV1,ZAK INHIBITOR 6P,GuideToPharmacology,1,inhibitor
AMH,LTB4,GuideToPharmacology,1,agonist
DNMT1,COMPOUND 13D [PMID: 23639540],GuideToPharmacology,1,inhibitor
EFNA2,DABRAFENIB,GuideToPharmacology,1,inhibitor
EFNA2,REGORAFENIB,GuideToPharmacology,1,inhibitor
EFNA4,COMPOUND 36 [PMID: 24000170],GuideToPharmacology,1,inhibitor
EFNA4,COMPOUND 38 [PMID: 24000170],GuideToPharmacology,1,inhibitor
EFNA4,ISOXAZOLE AZEPINE COMPOUND 3,GuideToPharmacology,1,inhibitor
ASIC1,"[LEU9,DES-ARG10]KALLIDIN",GuideToPharmacology,1,inhibitor
ACADL,C5A DES-ARG,GuideToPharmacology,1,agonist
ACACB,ACPHE-ORN-PRO-D-CHA-TRP-ARG,GuideToPharmacology,1,inhibitor
ACACA,FLPLAR,GuideToPharmacology,1,agonist
ACACA,AC-RHYPLWR,GuideToPharmacology,1,agonist
ACACB,[125I]C5A (HUMAN),GuideToPharmacology,1,agonist
ACACA,COMPOUND 21 [PMID: 25259874],GuideToPharmacology,1,agonist
MEGF6,BOSUTINIB,GuideToPharmacology,1,inhibitor
C1QBP,SITS,GuideToPharmacology,1,blocker
DBN1,GRASSYSTATIN A,GuideToPharmacology,1,inhibitor
CYP2A7,COMPOUND 2C [PMID: 22115617],GuideToPharmacology,1,inhibitor
ATP6V1C1,SZ(+)-(S)-202-791,GuideToPharmacology,1,activator
ATP6V0B,TROX-1,GuideToPharmacology,1,inhibitor
ATP6V1C1,ISRADIPINE,GuideToPharmacology,1,inhibitor
ATP6V1E1,NISOLDIPINE,GuideToPharmacology,1,inhibitor
FNZ,GRASSYSTATIN A,GuideToPharmacology,1,inhibitor
RHOB,NNC55-0396,GuideToPharmacology,1,blocker
RHOB,MIBEFRADIL,GuideToPharmacology,1,blocker
FOLR2,COMPOUND 1B [PMID: 16290936],GuideToPharmacology,1,inhibitor
ACRV1,AM6545,GuideToPharmacology,1,inhibitor
ACTA1,CCL18,GuideToPharmacology,1,inhibitor
ACTB,CCL5,GuideToPharmacology,1,agonist
ACTB,CCL2,GuideToPharmacology,1,agonist
ACTBP2,R5-HIV-1 GP120,GuideToPharmacology,1,agonist
ACTBP2,[125I]CCL4 (HUMAN),GuideToPharmacology,1,agonist
ELANE,LORECIVIVINT,GuideToPharmacology,1,inhibitor
CFTR,CFTRINH-172,GuideToPharmacology,1,blocker
CFTR,GATX1,GuideToPharmacology,1,blocker
CPT2,INDOMETHACIN,GuideToPharmacology,1,inhibitor
CPT2,NAPROXCINOD,GuideToPharmacology,1,inhibitor
CPT2,COMPOUND 10 [PMID: 34279934],GuideToPharmacology,1,inhibitor
ACTBP8,CYTOKINE DOMAIN OF TYROSYL TRNA SYNTHETASE,GuideToPharmacology,1,agonist
ACTC1,NBI-74330,GuideToPharmacology,1,inhibitor
ACTG1P2,JMS-17-2,GuideToPharmacology,1,inhibitor
HMS1,PF鈥?6928215,GuideToPharmacology,1,inhibitor
EGR4,THAL-SNS-032,GuideToPharmacology,1,inhibitor
EGR4,RIVICICLIB,GuideToPharmacology,1,inhibitor
EGR4,BS-194,GuideToPharmacology,1,inhibitor
EIF4A1,ALOISINE,GuideToPharmacology,1,inhibitor
CDK4,CDK4 INHIBITOR III,GuideToPharmacology,1,inhibitor
CDK4,RIVICICLIB,GuideToPharmacology,1,inhibitor
CDK4,CDK2 INHIBITOR IV,GuideToPharmacology,1,inhibitor
EIF4EBP1,BSJ-03-204,GuideToPharmacology,1,inhibitor
EIF4EBP1,BSJ-03-123,GuideToPharmacology,1,inhibitor
EIF4EP1,VORUCICLIB,GuideToPharmacology,1,inhibitor
EIF4G1,BS-194,GuideToPharmacology,1,inhibitor
CPA3,OSILODROSTAT,GuideToPharmacology,1,inhibitor
CPD,EXEMESTANE,GuideToPharmacology,1,inhibitor
CLDN3,CTA091,GuideToPharmacology,1,inhibitor
CYP2B6,THIOTEPA,GuideToPharmacology,1,inhibitor
CPN1,CTA091,GuideToPharmacology,1,inhibitor
CD8B2,ATOMOXETINE HYDROCHLORIDE,GuideToPharmacology,1,inhibitor
CD8B2,[3H]GBR12935,GuideToPharmacology,1,inhibitor
GZMB,SETANAXIB,GuideToPharmacology,1,inhibitor
AMPD1,LTC4,GuideToPharmacology,1,agonist
APAF1,OXYCODEGOL,GuideToPharmacology,1,agonist
CD8B2,SOLRIAMFETOL,GuideToPharmacology,1,inhibitor
CD8B2,[3H]WIN35428,GuideToPharmacology,1,inhibitor
APAF1,&BETA;-FNA,GuideToPharmacology,1,inhibitor
APAF1,PAREGORIC,GuideToPharmacology,1,agonist
APAF1,UFP-505,GuideToPharmacology,1,inhibitor
FPGS,COMPOUND 9 [PMID: 20718420],GuideToPharmacology,1,inhibitor
ALDH1A1,PROCHLORPERAZINE,GuideToPharmacology,1,inhibitor
ALDH1A1,NGB 2904,GuideToPharmacology,1,inhibitor
ALDH2,SPIPERONE,GuideToPharmacology,1,inhibitor
EML1,LORECIVIVINT,GuideToPharmacology,1,inhibitor
CYP2D7BP,COMPOUND 17 [PMID: 23916253],GuideToPharmacology,1,inhibitor
EZH2,COMPOUND 15A [PMID: 36642961],GuideToPharmacology,1,inhibitor
TSC22D3,DDR1/2 INHIBITOR 5N,GuideToPharmacology,1,inhibitor
DSC2,COMPOUND 66 [PMID: 19788238],GuideToPharmacology,1,inhibitor
RCAN1,COMPOUND 66 [PMID: 19788238],GuideToPharmacology,1,inhibitor
BLVRA,NE11808,GuideToPharmacology,1,inhibitor
ADH4,OLEIC ACID,GuideToPharmacology,1,agonist
FFAR3,FHQC,GuideToPharmacology,1,modulator
ADH4,COMPOUND A [PMID 24997608],GuideToPharmacology,1,agonist
DPYSL2,SULFATINIB,GuideToPharmacology,1,inhibitor
DPYSL2,PD166285,GuideToPharmacology,1,inhibitor
DR1,BLU-9931,GuideToPharmacology,1,inhibitor
DPYSL3,RESIGRATINIB,GuideToPharmacology,1,inhibitor
DR1,INFIGRATINIB,GuideToPharmacology,1,inhibitor
SLC26A3,INFIGRATINIB,GuideToPharmacology,1,inhibitor
ONECUT1,SAFIT2,GuideToPharmacology,1,inhibitor
DRD1,COMPOUND 25 [PMID: 17935989],GuideToPharmacology,1,inhibitor
SLC26A3,IRPAGRATINIB,GuideToPharmacology,1,inhibitor
DRD3,COMPOUND 8I [PMID: 22765894],GuideToPharmacology,1,inhibitor
DRD3,LINIFANIB,GuideToPharmacology,1,inhibitor
DPYS,PEXIDARTINIB,GuideToPharmacology,1,inhibitor
DPYS,LINIFANIB,GuideToPharmacology,1,inhibitor
ALDH9A1,T21/DP107,GuideToPharmacology,1,agonist
ALDH9A1,PSM&ALPHA;3,GuideToPharmacology,1,agonist
APOC2,"L-888,607",GuideToPharmacology,1,agonist
ALDH9A1,WRWWWW,GuideToPharmacology,1,inhibitor
ALDH3A2,WRWWWW,GuideToPharmacology,1,inhibitor
ALDOB,VANTICTUMAB,GuideToPharmacology,1,antibody
GABRA1,PIPERIDINE-4-SULPHONIC ACID,GuideToPharmacology,1,agonist
ALDOC,VANTICTUMAB,GuideToPharmacology,1,antibody
FZD6,WNT-3A,GuideToPharmacology,1,agonist
ENO2,PP1,GuideToPharmacology,1,inhibitor
GABRA1,MRK016,GuideToPharmacology,1,modulator
GABRA1,DIAZEPAM,GuideToPharmacology,1,modulator
ALOX12P1,M35,GuideToPharmacology,1,inhibitor
GALR2,GALP(1-32) (HUMAN),GuideToPharmacology,1,agonist
GALR2,GALANIN(10-29) (RAT/MOUSE),GuideToPharmacology,1,agonist
GALR2,QU-SPX,GuideToPharmacology,1,agonist
GALR2,M35,GuideToPharmacology,1,inhibitor
GALR2,M32,GuideToPharmacology,1,inhibitor
ALOX12P2,M35,GuideToPharmacology,1,inhibitor
CD14,(R/S) EF-1500,GuideToPharmacology,1,inhibitor
ASS1,ATPO,GuideToPharmacology,1,inhibitor
ASS1,S18986,GuideToPharmacology,1,modulator
ALPG,"L-168,049",GuideToPharmacology,1,inhibitor
ASS1P6,"2,4-EPI-NEODYSIHERBAINE",GuideToPharmacology,1,inhibitor
ASS1P8,KAINIC ACID,GuideToPharmacology,1,agonist
ASS1P10,(+)-HA966,GuideToPharmacology,1,agonist
ASS1P9,DYSIHERBAINE,GuideToPharmacology,1,agonist
ASS1P9,[3H]SYM2081,GuideToPharmacology,1,agonist
ASS1P10,COMPOUND 8 [PMID: 17562362},GuideToPharmacology,1,inhibitor
GRIN2C,"5,7-DICHLOROKYNURENIC ACID",GuideToPharmacology,1,inhibitor
CD24P1,PF-03463275,GuideToPharmacology,1,inhibitor
CSF2RA,GM-CSF,GuideToPharmacology,1,agonist
DLX4,"[SER11](N-CNP,C-ANP)PBNP2-15",GuideToPharmacology,1,inhibitor
ACP3,"ORNITHINE, (L)-ISOMER",GuideToPharmacology,1,agonist
DHFR,PEGFILGRASTIM-JMDB,GuideToPharmacology,1,agonist
DHFR,LENOGRASTIM,GuideToPharmacology,1,agonist
DHFRP3,GROWTH HORMONE 2,GuideToPharmacology,1,agonist
ANXA13,COMPOUND 8F [PMID: 20615702],GuideToPharmacology,1,agonist
ARL1,CILOBRADINE,GuideToPharmacology,1,blocker
GDF2,TACEDINALINE,GuideToPharmacology,1,inhibitor
GDF2,ACY-738,GuideToPharmacology,1,inhibitor
GAPDHL17,PRACINOSTAT,GuideToPharmacology,1,inhibitor
HDAC4,SANTACRUZAMATE A,GuideToPharmacology,1,inhibitor
GARS1,MOCETINOSTAT,GuideToPharmacology,1,inhibitor
GART,KA1010,GuideToPharmacology,1,inhibitor
GAS2,KA1010,GuideToPharmacology,1,inhibitor
GAS2,GIVINOSTAT,GuideToPharmacology,1,inhibitor
AMD1,UR-PG55B,GuideToPharmacology,1,agonist
AMD1,LOXAPINE,GuideToPharmacology,1,inhibitor
AMD1,CETIRIZINE HYDROCHLORIDE,GuideToPharmacology,1,inhibitor
HRH3,(R)-&ALPHA;-METHYLHISTAMINE,GuideToPharmacology,1,agonist
BIK,(S)-3-HYDROXY-3-METHYLGLUTARYL-COA,GuideToPharmacology,1,inhibitor
PRDM1,COMPOUND 2D [PMID: 2153213],GuideToPharmacology,1,inhibitor
PRDM1,"COMPOUND 3 [DREYER ET AL., 1991]",GuideToPharmacology,1,inhibitor
PRDM1,FLUVASTATIN,GuideToPharmacology,1,inhibitor
HINT1,COMPOUND 24 [PMID: 31343176],GuideToPharmacology,1,inhibitor
ADH1C,1-PALMITOYL-LYSOPHOSPHATIDYLCHOLINE,GuideToPharmacology,1,agonist
ADCY3,MSMB (91-114),GuideToPharmacology,1,agonist
NOS2,TILARGININE,GuideToPharmacology,1,inhibitor
XCR1,BETA-CARBOLINE,GuideToPharmacology,1,inhibitor
GRB2,LY3410738,GuideToPharmacology,1,inhibitor
FOXL2,PARTHENOLIDE,GuideToPharmacology,1,agonist
EPHB3,FEDRATINIB,GuideToPharmacology,1,inhibitor
EPHB3,CEE321,GuideToPharmacology,1,inhibitor
EPHB3,IZENCITINIB,GuideToPharmacology,1,inhibitor
EPHB3,JAK3 INHIBITOR 34,GuideToPharmacology,1,inhibitor
NUDT2,ETONITAZENE,GuideToPharmacology,1,agonist
NUDT2,&ALPHA;-NEOENDORPHIN,GuideToPharmacology,1,agonist
NUDT2,MP1104,GuideToPharmacology,1,agonist
DRD2,BX-912,GuideToPharmacology,1,inhibitor
DRD2,CANLITINIB,GuideToPharmacology,1,inhibitor
DRD2,GLESATINIB,GuideToPharmacology,1,inhibitor
DPT,CHMFL-KIT-64,GuideToPharmacology,1,inhibitor
DPT,STEM CELL FACTOR,GuideToPharmacology,1,agonist
DPT,PEXIDARTINIB,GuideToPharmacology,1,inhibitor
ATP6V1B1,QUINIDINE,GuideToPharmacology,1,blocker
ARF5,UCL1848,GuideToPharmacology,1,blocker
ASIP,BA2+,GuideToPharmacology,1,blocker
KCNJ5,PIP2,GuideToPharmacology,1,activator
ASPA,BA2+,GuideToPharmacology,1,blocker
BAD,VU0405601,GuideToPharmacology,1,activator
ALDH7A1P2,QUINIDINE,GuideToPharmacology,1,blocker
AZF2,QO-58,GuideToPharmacology,1,activator
AZF2,FLUPIRTINE,GuideToPharmacology,1,activator
FRA10D,COMPOUND 6 [PMID: 22533316],GuideToPharmacology,1,inhibitor
CTSV,MIDOSTAURIN,GuideToPharmacology,1,inhibitor
CTSV,PF-3758309,GuideToPharmacology,1,inhibitor
GRB7,GSK180,GuideToPharmacology,1,inhibitor
EPHX2,DDR1/2 INHIBITOR 5N,GuideToPharmacology,1,inhibitor
EPHX2,ACALABRUTINIB,GuideToPharmacology,1,inhibitor
EPHX2,WH-4-023,GuideToPharmacology,1,inhibitor
EPHX2,PP1,GuideToPharmacology,1,inhibitor
LNPEP,COMPOUND 17 [PMID: 23916253],GuideToPharmacology,1,inhibitor
STX2,VORUCICLIB,GuideToPharmacology,1,inhibitor
LHCGR,[125I]CHORIONIC GONADOTROPIN (HUMAN),GuideToPharmacology,1,agonist
EPS8,URMC-099,GuideToPharmacology,1,inhibitor
BAK1P2,27-HYDROXYCHOLESTEROL,GuideToPharmacology,1,agonist
CLN8,ZAK INHIBITOR 6P,GuideToPharmacology,1,inhibitor
AMPD3,ONO-7300243,GuideToPharmacology,1,inhibitor
AMPD3,ANTI-BRP-LPA,GuideToPharmacology,1,inhibitor
AMPH,FARNESYL DIPHOSPHATE,GuideToPharmacology,1,agonist
GGTL1,GSK-J1,GuideToPharmacology,1,inhibitor
GGTA1,GSK-J1,GuideToPharmacology,1,inhibitor
ERVT4,COMPOUND 33 [PMID: 19364658],GuideToPharmacology,1,inhibitor
ANCR,MT-II,GuideToPharmacology,1,agonist
MCHR1,OBATOCLAX,GuideToPharmacology,1,inhibitor
DRD4,PAMUFETINIB,GuideToPharmacology,1,inhibitor
ANOP1,VU0469650,GuideToPharmacology,1,modulator
ANPEP,"[3H]2,2,2-TEMPS",GuideToPharmacology,1,modulator
MAP2K1,BINIMETINIB,GuideToPharmacology,1,modulator
ERBB3,MEK INHIBITOR I,GuideToPharmacology,1,inhibitor
ERBB2,MEK INHIBITOR I,GuideToPharmacology,1,inhibitor
CTNS,JNK INHIBITOR VIII,GuideToPharmacology,1,inhibitor
NR2F6,BINIMETINIB,GuideToPharmacology,1,modulator
AADAC,OXOTREMORINE,GuideToPharmacology,1,agonist
AADAC,ALCURONIUM,GuideToPharmacology,1,modulator
AADAC,MK-7622,GuideToPharmacology,1,modulator
AAMP,METHYLFURMETHIDE,GuideToPharmacology,1,agonist
AAMP,C7/3-PHTH,GuideToPharmacology,1,modulator
AAMP,REVEFENACIN,GuideToPharmacology,1,inhibitor
AANAT,NNC 11-1607,GuideToPharmacology,1,agonist
AANAT,G&OUML; 7874,GuideToPharmacology,1,modulator
AANAT,MEPENZOLATE,GuideToPharmacology,1,inhibitor
AANAT,N-BENZYL BRUCINE,GuideToPharmacology,1,modulator
AANAT,AE9C90CB,GuideToPharmacology,1,inhibitor
AANAT,VINCAMINE,GuideToPharmacology,1,modulator
AANAT,OXOTREMORINE,GuideToPharmacology,1,agonist
AANAT,IPRATROPIUM CATION,GuideToPharmacology,1,inhibitor
AANAT,HEXAHYDROSILADIFENIDOL,GuideToPharmacology,1,inhibitor
AARS1,NNC 11-1607,GuideToPharmacology,1,agonist
AANAT,SCOPOLAMINE,GuideToPharmacology,1,inhibitor
AARS1,ACETYLCHOLINE,GuideToPharmacology,1,agonist
AARS1,MEPENZOLATE,GuideToPharmacology,1,inhibitor
AARS1,PILOCARPINE HYDROCHLORIDE,GuideToPharmacology,1,agonist
AAVS1,CARBAMOYLCHOLINE,GuideToPharmacology,1,agonist
AAVS1,[3H]IPEROXO,GuideToPharmacology,1,agonist
AAVS1,PILOCARPINE HYDROCHLORIDE,GuideToPharmacology,1,agonist
AARS1,REVEFENACIN,GuideToPharmacology,1,inhibitor
AAVS1,4-DAMP,GuideToPharmacology,1,inhibitor
AAVS1,ML380,GuideToPharmacology,1,modulator
AAVS1,N-CHLOROMETHYL-BRUCINE,GuideToPharmacology,1,modulator
ANK3,[125I]S70254,GuideToPharmacology,1,agonist
APOF,DYNORPHIN B,GuideToPharmacology,1,agonist
APOF,CODEINE ANHYDROUS,GuideToPharmacology,1,agonist
CD70,CYCLOTHIAZIDE,GuideToPharmacology,1,inhibitor
GZMA,SETANAXIB,GuideToPharmacology,1,inhibitor
GAS8-AS1,CD2+,GuideToPharmacology,1,blocker
BAX,ATX-II,GuideToPharmacology,1,inhibitor
BARD1,SAXITOXIN,GuideToPharmacology,1,blocker
BARD1,ATX-II,GuideToPharmacology,1,inhibitor
SLC13A5,PF-06761281,GuideToPharmacology,1,inhibitor
SCN9A,PF鈥?6526290,GuideToPharmacology,1,inhibitor
CD8B,NISOXETINE,GuideToPharmacology,1,inhibitor
CD8B,PROTRIPTYLINE,GuideToPharmacology,1,inhibitor
ATF4,BNC375,GuideToPharmacology,1,modulator
AQP3,NEUROPEPTIDE-&GAMMA;,GuideToPharmacology,1,agonist
AQP4,ZM 253270,GuideToPharmacology,1,inhibitor
AQP4,ZM-274773,GuideToPharmacology,1,inhibitor
NR4A2,"COMPOUND 29 [VIETOR, ET AL., 2023]",GuideToPharmacology,1,agonist
SLCO1A2,NARINGIN,GuideToPharmacology,1,inhibitor
CDK4,CLONIDINE HYDROCHLORIDE,GuideToPharmacology,1,inhibitor
APBB2,MRS2298,GuideToPharmacology,1,inhibitor
APBB2,ADP,GuideToPharmacology,1,agonist
APCS,PSB-16133,GuideToPharmacology,1,inhibitor
AIRE,RP-5-OME-UDP&ALPHA;B,GuideToPharmacology,1,agonist
APLP2,APAFANT,GuideToPharmacology,1,inhibitor
APLP2,ABT-491,GuideToPharmacology,1,inhibitor
ADCYAP1R1,M65,GuideToPharmacology,1,inhibitor
APOD,ATOPAXAR,GuideToPharmacology,1,inhibitor
APOE,SLIGRL-NH2,GuideToPharmacology,1,agonist
APOE,I-191,GuideToPharmacology,1,inhibitor
FOXA3,AG-17724,GuideToPharmacology,1,inhibitor
BCKDHB,L-796449,GuideToPharmacology,1,agonist
F5,ACALISIB,GuideToPharmacology,1,inhibitor
F3,COMPOUND 82 [PMID: 21332118],GuideToPharmacology,1,inhibitor
F5,AZD6482,GuideToPharmacology,1,inhibitor
F5,BIMIRALISIB,GuideToPharmacology,1,inhibitor
F5,AZD-8186,GuideToPharmacology,1,inhibitor
F5,BGT-226,GuideToPharmacology,1,inhibitor
F5,PP-121,GuideToPharmacology,1,inhibitor
F5,SAPANISERTIB,GuideToPharmacology,1,inhibitor
PIK3CB,BIMIRALISIB,GuideToPharmacology,1,inhibitor
PIK3CB,BGT-226,GuideToPharmacology,1,inhibitor
PIK3CB,BAY-8400,GuideToPharmacology,1,inhibitor
F7,VS-5584,GuideToPharmacology,1,inhibitor
F7,STK16-IN-1,GuideToPharmacology,1,inhibitor
F7R,DUVELISIB,GuideToPharmacology,1,inhibitor
F2RL2,PI-103,GuideToPharmacology,1,inhibitor
COL8A2,VINPOCETINE,GuideToPharmacology,1,inhibitor
COL10A1,IBUDILAST,GuideToPharmacology,1,inhibitor
COL11A2,MK-0359,GuideToPharmacology,1,inhibitor
GNAI2,ME0328,GuideToPharmacology,1,inhibitor
FRA6B,ELND006,GuideToPharmacology,1,inhibitor
BDNF,ULIPRISTAL ACETATE,GuideToPharmacology,1,agonist
BDNF,ULIPRISTAL ACETATE,GuideToPharmacology,1,inhibitor
ACSL3,NVP-TAE 226,GuideToPharmacology,1,inhibitor
BIRC5,[PHE23]PTH-(1-34) (HUMAN),GuideToPharmacology,1,agonist
APLP1,[125I]QRFP43 (HUMAN),GuideToPharmacology,1,agonist
BCL2L1,SR1001,GuideToPharmacology,1,agonist
FANCG,PN10,GuideToPharmacology,1,inhibitor
GBA1LP,HYDROXYUREA,GuideToPharmacology,1,inhibitor
GBA1LP,CLOFARABINE,GuideToPharmacology,1,inhibitor
TEX28,GSK-1838705A,GuideToPharmacology,1,inhibitor
APP,A(4-24)(B7-24)H2,GuideToPharmacology,1,agonist
APP,RELAXIN,GuideToPharmacology,1,agonist
APP,LY3540378,GuideToPharmacology,1,agonist
APP,RELAXIN-1,GuideToPharmacology,1,agonist
AMT,BMS-986104 DERIVATIVE 24,GuideToPharmacology,1,agonist
AMY1C,COMPOUND 43 [PMID: 26751273],GuideToPharmacology,1,agonist
AMY2A,COMPOUND 43 [PMID: 26751273],GuideToPharmacology,1,agonist
FAUNA@,DASATINIB ANHYDROUS,GuideToPharmacology,1,inhibitor
NIM1K,"(7S)-2-(2-AMINOPYRIMIDIN-4-YL)-7-(2-FLUOROETHYL)-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE",GuideToPharmacology,1,inhibitor
STK10,DDR1/2 INHIBITOR 5N,GuideToPharmacology,1,inhibitor
CYB561,PO-322,GuideToPharmacology,1,inhibitor
CD38,AMILORIDE,GuideToPharmacology,1,inhibitor
MS4A2,BOSUTINIB,GuideToPharmacology,1,inhibitor
BLVRB,COMPOUND 3F [PMID: 12238936],GuideToPharmacology,1,inhibitor
FDX1,SYK INHIBITOR II,GuideToPharmacology,1,inhibitor
BLVRB,COMPOUND 19 [PMID: 19191557],GuideToPharmacology,1,inhibitor
FOXG1,COMPOUND R-16 [PMID: 21967808],GuideToPharmacology,1,inhibitor
AQP7,DEXTROAMPHETAMINE SULFATE,GuideToPharmacology,1,agonist
BCGF1,TIRATRICOL,GuideToPharmacology,1,agonist
ARHGAP1,"PHOSPHATIDYL (3,5) INOSITOL BISPHOSPHATE",GuideToPharmacology,1,activator
ATP1B1P1,O3,GuideToPharmacology,1,activator
ATP1B1P1,ARTEPILLIN C,GuideToPharmacology,1,activator
ATP1B1P1,CD2+,GuideToPharmacology,1,activator
ALDH7A1,ML SA1,GuideToPharmacology,1,activator
ATP5F1BP1,2-APB,GuideToPharmacology,1,blocker
ATP5F1BP1,A-1165442,GuideToPharmacology,1,blocker
ATP5F1BP1,JNJ17203212,GuideToPharmacology,1,blocker
ATP5F1C,CITRUSININE II,GuideToPharmacology,1,blocker
FGFR4,RO3280,GuideToPharmacology,1,inhibitor
GCF1,CABAZITAXEL,GuideToPharmacology,1,inhibitor
SLC26A2,UNC4203,GuideToPharmacology,1,inhibitor
TYK2,LASW1393,GuideToPharmacology,1,inhibitor
HOXC6,BAY-805,GuideToPharmacology,1,inhibitor
ARCN2,PACAP-38,GuideToPharmacology,1,agonist
ARCN1,PHV,GuideToPharmacology,1,agonist
AQP9,OPC-51803,GuideToPharmacology,1,agonist
AQP9,D[D-PAL2]AVP,GuideToPharmacology,1,inhibitor
ARCN1,PG 97-269,GuideToPharmacology,1,inhibitor
AADAC,SOLIFENACIN,GuideToPharmacology,1,inhibitor
F3,VPS34-IN-1,GuideToPharmacology,1,inhibitor
CRYGC,COMPOUND 12E [PMID: 18605714],GuideToPharmacology,1,inhibitor
ATP5F1AP2,CD2+,GuideToPharmacology,1,blocker
ANGPT1,MT-II,GuideToPharmacology,1,agonist
MAP2K1,RO-4987655,GuideToPharmacology,1,inhibitor
AQP2,[111IN]DOTA-NOC-ATE,GuideToPharmacology,1,agonist
ARHGAP4,TPC2-A1-P,GuideToPharmacology,1,activator
EIF4A1,MK-8776,GuideToPharmacology,1,inhibitor
MARK2,COMPOUND 3B [PMID: 23454515],GuideToPharmacology,1,inhibitor
GM2A,CADONILIMAB,GuideToPharmacology,1,antibody
MCOLN3,PRU-10,GuideToPharmacology,1,inhibitor
ATR,BAY-8400,GuideToPharmacology,1,inhibitor
SELP,BIMOSIAMOSE,GuideToPharmacology,1,inhibitor
DTYMK,MERESTINIB,GuideToPharmacology,1,inhibitor
ACTBP2,MLN-3897,GuideToPharmacology,1,inhibitor
APCS,DENUFOSOL,GuideToPharmacology,1,agonist
ALOX12P1,M32,GuideToPharmacology,1,inhibitor
SLC25A6,PTEB,GuideToPharmacology,1,modulator
AOC1,GUANFACINE HYDROCHLORIDE,GuideToPharmacology,1,agonist
GAPDH,HISTIDINE,GuideToPharmacology,1,activator
NOS1,COMPOUND 14J [PMID: 27050842],GuideToPharmacology,1,inhibitor
NUDT2,SAMIDORPHAN,GuideToPharmacology,1,inhibitor
ACTL4,GPR4 ANTAGONIST 3B,GuideToPharmacology,1,inhibitor
ACTG1P2,[125I]CX3CL1 (HUMAN),GuideToPharmacology,1,agonist
NAT1,DAU 6285,GuideToPharmacology,1,inhibitor
FRA8A,I-432,GuideToPharmacology,1,inhibitor
AMPD3,CPX,GuideToPharmacology,1,agonist
FDX1,LAZERTINIB,GuideToPharmacology,1,inhibitor
FKBP5,ZAK INHIBITOR 6P,GuideToPharmacology,1,inhibitor
APOBEC1,RAMATROBAN,GuideToPharmacology,1,inhibitor
COL9A3,MILRINONE,GuideToPharmacology,1,inhibitor
ABCD1,FLUPENTHIXOL,GuideToPharmacology,1,inhibitor
AARS1,N-BENZYL BRUCINE,GuideToPharmacology,1,modulator
ATF4,PSAB-OFP,GuideToPharmacology,1,agonist
ABCA4,SPIPERONE,GuideToPharmacology,1,inhibitor
ARCN1,MAXADILAN,GuideToPharmacology,1,agonist
ANXA3,"PYY-(13-36) (MOUSE, RAT, PIG)",GuideToPharmacology,1,agonist
CRKL,JNJ-42226314,GuideToPharmacology,1,inhibitor
XIAP,PCO-371,GuideToPharmacology,1,agonist
NR3C2,BUDESONIDE,GuideToPharmacology,1,agonist
APAF1,BMS-986187,GuideToPharmacology,1,modulator
BEVI,MIBOLERONE,GuideToPharmacology,1,agonist
EIF4G1,KINASE INHIBITOR 2 [PMID: 30199702],GuideToPharmacology,1,inhibitor
APAF1,SAMIDORPHAN,GuideToPharmacology,1,inhibitor
CPT2,NAPROXEN SODIUM,GuideToPharmacology,1,inhibitor
A2M,VORTIOXETINE HYDROBROMIDE,GuideToPharmacology,1,agonist
FOXL2,VANILLIN,GuideToPharmacology,1,agonist
CRYZP1,COMPOUND 12E [PMID: 18605714],GuideToPharmacology,1,inhibitor
CCKBR,PD-135158,GuideToPharmacology,1,inhibitor
DPT,MASITINIB,GuideToPharmacology,1,inhibitor
F7R,BIMIRALISIB,GuideToPharmacology,1,inhibitor
GOLGA2,COMPOUND IV [PMID: 29351497],GuideToPharmacology,1,inhibitor
GGT3P,COMPOUND 6A [PMID: 18942826],GuideToPharmacology,1,inhibitor
ETFB,BIMIRALISIB,GuideToPharmacology,1,inhibitor
AANAT,PILOCARPINE HYDROCHLORIDE,GuideToPharmacology,1,agonist
CDK18,COMPOUND 77 [PMID: 24793884],GuideToPharmacology,1,inhibitor
EPHB2,TYK2 INHIBITOR 14L,GuideToPharmacology,1,inhibitor
ACAT1,PD 176252,GuideToPharmacology,1,inhibitor
ASIC1,COMPOUND 12 [PMID: 12723943],GuideToPharmacology,1,inhibitor
ELK3,DAPK INHIBITOR 13,GuideToPharmacology,1,inhibitor
DPYSL2,BRIVANIB,GuideToPharmacology,1,inhibitor
ALOX12P2,GALANIN(2-29) (PIG),GuideToPharmacology,1,agonist
ASS1P8,DYSIHERBAINE,GuideToPharmacology,1,agonist
AQP6,METRH,GuideToPharmacology,1,agonist
FPR1,COMPOUND 42 [PMID: 37721854],GuideToPharmacology,1,inhibitor
GLRA1,CYANOTRIPHENYLBORATE,GuideToPharmacology,1,blocker
CHRNA3,&ALPHA;-CONOTOXIN PNIA,GuideToPharmacology,1,inhibitor
BCHEL1,AC261066,GuideToPharmacology,1,agonist
EFNA2,EXARAFENIB,GuideToPharmacology,1,inhibitor
BAK1,SAXITOXIN,GuideToPharmacology,1,blocker
A2M,SB 272183,GuideToPharmacology,1,inhibitor
AAVS1,ACETYLCHOLINE,GuideToPharmacology,1,agonist
CTRB1,BELUMOSUDIL,GuideToPharmacology,1,inhibitor
FCAR,MP-A08,GuideToPharmacology,1,inhibitor
CPT2,(S)-ARN2508,GuideToPharmacology,1,inhibitor
CPN2,CTA091,GuideToPharmacology,1,inhibitor
AADAC,REVEFENACIN,GuideToPharmacology,1,inhibitor
ATF4,4BP-TQS,GuideToPharmacology,1,agonist
CD3D,CANAGLIFLOZIN,GuideToPharmacology,1,inhibitor
DPYD,AC710,GuideToPharmacology,1,inhibitor
BMAL1,TRIAZOLAM,GuideToPharmacology,1,modulator
ARCN2,"[ALA11,22,28]VIP",GuideToPharmacology,1,agonist
CDK19,CORTISTATIN A,GuideToPharmacology,1,inhibitor
GAPDHP1,QUISINOSTAT,GuideToPharmacology,1,inhibitor
CD8B,NOMIFENSINE,GuideToPharmacology,1,inhibitor
CD3E,CANAGLIFLOZIN,GuideToPharmacology,1,inhibitor
A12M2,LY344864,GuideToPharmacology,1,agonist
EIF4EP1,COMPOUND 1 [PMID: 24793884],GuideToPharmacology,1,inhibitor
ARRB2,[3H]GABAZINE,GuideToPharmacology,1,inhibitor
ACTN3,DRONABINOL,GuideToPharmacology,1,agonist
ADAR,PROSAPTIDE,GuideToPharmacology,1,agonist
AANAT,SOLIFENACIN,GuideToPharmacology,1,inhibitor
COL9A1,MILRINONE,GuideToPharmacology,1,inhibitor
EPHB1,LASW1393,GuideToPharmacology,1,inhibitor
EPHB2,PACRITINIB,GuideToPharmacology,1,inhibitor
MAPK13,COMPOUND 4E [PMID: 35546685],GuideToPharmacology,1,inhibitor
BCHEL3,ALITRETINOIN,GuideToPharmacology,1,agonist
CCKBR,GW-5823,GuideToPharmacology,1,inhibitor
BMAL1,PIPERIDINE-4-SULPHONIC ACID,GuideToPharmacology,1,agonist
COL11A1,IBUDILAST,GuideToPharmacology,1,inhibitor
FGR,COMPOUND 7 [PMID: 22464456],GuideToPharmacology,1,inhibitor
HBEGF,COMPOUND 5N [PMID: 20483621],GuideToPharmacology,1,inhibitor
DPYD,PIMICOTINIB,GuideToPharmacology,1,inhibitor
CD9,[3H]PAROXETINE,GuideToPharmacology,1,inhibitor
AMT,CYM5442,GuideToPharmacology,1,agonist
CHEK2,ISOGRANULATIMIDE,GuideToPharmacology,1,inhibitor
CRMP1,BIA 10-2474,GuideToPharmacology,1,inhibitor
ALDH3B2,SPINORPHIN,GuideToPharmacology,1,inhibitor
AARS1,IPRATROPIUM CATION,GuideToPharmacology,1,inhibitor
CXADR,COMPOUND E22 [PMID: 31298542],GuideToPharmacology,1,inhibitor
ADH6,PHENYLALANINE,GuideToPharmacology,1,agonist
ATHS,[3H]METHYLLYCACONITINE,GuideToPharmacology,1,inhibitor
ABCA1,SCH442416,GuideToPharmacology,1,inhibitor
DPYS,MIVAVOTINIB,GuideToPharmacology,1,inhibitor
ETFB,PF-04691502,GuideToPharmacology,1,inhibitor
FIM1,PD166285,GuideToPharmacology,1,inhibitor
A12M3,GR 127935,GuideToPharmacology,1,agonist
AQP2,SEGLITIDE,GuideToPharmacology,1,agonist
CYP2B6,SIBUTRAMINE,GuideToPharmacology,1,inhibitor
FRA1C,XIMELAGATRAN,GuideToPharmacology,1,inhibitor
ERBB4,AEE788,GuideToPharmacology,1,inhibitor
ESR2,LASOFOXIFENE,GuideToPharmacology,1,agonist
DCK,SB-3CT,GuideToPharmacology,1,inhibitor
CTSO,GSK2334470,GuideToPharmacology,1,inhibitor
A1BG,FLIBANSERIN,GuideToPharmacology,1,agonist
A1BG,RU 24969,GuideToPharmacology,1,agonist
A1BG,[3H]LY334370,GuideToPharmacology,1,agonist
A1BG,RIZATRIPTAN BENZOATE,GuideToPharmacology,1,agonist
A1BG,9-OH-RISPERIDONE,GuideToPharmacology,1,inhibitor
A1BG,SPIPERONE,GuideToPharmacology,1,inhibitor
A2M,AVITRIPTAN,GuideToPharmacology,1,agonist
A1BG,P-[18F]MPPF,GuideToPharmacology,1,inhibitor
A2M,1-NAPHTHYLPIPERAZINE,GuideToPharmacology,1,agonist
A1BG,PIZOTYLINE,GuideToPharmacology,1,inhibitor
A2M,2-METHYL-5-HT,GuideToPharmacology,1,agonist
A2M,5-HYDROXYTRYPTAMINE,GuideToPharmacology,1,agonist
A2MP1,EMDT,GuideToPharmacology,1,agonist
A2M,ZOTEPINE,GuideToPharmacology,1,inhibitor
A2MP1,M-CHLOROPHENYLPIPERAZINE,GuideToPharmacology,1,inhibitor
A2MP1,[3H]5-HT,GuideToPharmacology,1,agonist
A12M1,RIZATRIPTAN BENZOATE,GuideToPharmacology,1,agonist
A12M1,2-METHYL-5-HT,GuideToPharmacology,1,agonist
A12M1,ERGONOVINE,GuideToPharmacology,1,agonist
A12M3,RS-102221,GuideToPharmacology,1,inhibitor
A12M4,RU 24969,GuideToPharmacology,1,agonist
A12M4,SARPOGRELATE,GuideToPharmacology,1,inhibitor
A12M4,SDZ SER-082,GuideToPharmacology,1,inhibitor
A12M4,RS-102221,GuideToPharmacology,1,inhibitor
HTR2C,DOI,GuideToPharmacology,1,agonist
HTR2C,5-HYDROXYTRYPTAMINE,GuideToPharmacology,1,agonist
HTR2C,GR 127935,GuideToPharmacology,1,agonist
HTR2C,SB 242084,GuideToPharmacology,1,inhibitor
NAT1,5-HYDROXYTRYPTAMINE,GuideToPharmacology,1,agonist
HTR2C,METERGOLINE,GuideToPharmacology,1,inhibitor
HTR2C,RISPERIDONE,GuideToPharmacology,1,inhibitor
NAT2,EMDT,GuideToPharmacology,1,agonist
NAT2,RITANSERIN,GuideToPharmacology,1,inhibitor
NATP,METERGOLINE,GuideToPharmacology,1,inhibitor
NATP,RITANSERIN,GuideToPharmacology,1,inhibitor
SERPINA3,1-NAPHTHYLPIPERAZINE,GuideToPharmacology,1,agonist
SERPINA3,VORTIOXETINE HYDROBROMIDE,GuideToPharmacology,1,inhibitor
SERPINA3,RITANSERIN,GuideToPharmacology,1,inhibitor
CREB1,HONOKIOL,GuideToPharmacology,1,inhibitor
SERPINA3,SB 258719,GuideToPharmacology,1,inhibitor
ABL1,BOSUTINIB,GuideToPharmacology,1,inhibitor
ABL1,GNF-5,GuideToPharmacology,1,inhibitor
ABL1,REBASTINIB,GuideToPharmacology,1,inhibitor
ABL1,ZAK INHIBITOR 6P,GuideToPharmacology,1,inhibitor
DDX6,INCB3619,GuideToPharmacology,1,inhibitor
AGTRL2,BECLOMETHASONE DIPROPIONATE,GuideToPharmacology,1,agonist
CSTF3,UPROSERTIB,GuideToPharmacology,1,inhibitor
FKBP2,MIRANSERTIB,GuideToPharmacology,1,modulator
FKBP2,MIRANSERTIB,GuideToPharmacology,1,inhibitor
CSTP1,COMPOUND E22 [PMID: 31298542],GuideToPharmacology,1,inhibitor
CSTP1,UPROSERTIB,GuideToPharmacology,1,inhibitor
ACE2,DX600,GuideToPharmacology,1,inhibitor
ACADSB,MM07,GuideToPharmacology,1,agonist
BTD,AGMATINE,GuideToPharmacology,1,activator
ABAT,(R)-PIA,GuideToPharmacology,1,agonist
ABAT,MRS1191,GuideToPharmacology,1,inhibitor
ABCA1,NECA,GuideToPharmacology,1,agonist
ABCA1,CGS 21680,GuideToPharmacology,1,agonist
ABCA1,AB-MECA,GuideToPharmacology,1,agonist
ABCA1,NECA,GuideToPharmacology,1,agonist
ABCA1,PSB-11,GuideToPharmacology,1,inhibitor
ABCA2,DEPX,GuideToPharmacology,1,inhibitor
ABCA2,NECA,GuideToPharmacology,1,agonist
ABCA2,2-HEXYNYL-NECA,GuideToPharmacology,1,agonist
ABCA2,CGS 21680,GuideToPharmacology,1,agonist
ABCA2,[125I]ABOPX,GuideToPharmacology,1,inhibitor
ABCA2,MRE 2029F20,GuideToPharmacology,1,inhibitor
ABCA3,HEMADO,GuideToPharmacology,1,agonist
ABCA2,MRS1191,GuideToPharmacology,1,inhibitor
ABCA2,MRS1220,GuideToPharmacology,1,inhibitor
ABCA2,[3H]DPCPX,GuideToPharmacology,1,inhibitor
ABCA3,APNEA,GuideToPharmacology,1,agonist
ABCA3,XANTHINE AMINE CONGENER,GuideToPharmacology,1,inhibitor
EEF1B2P2,BAY-8400,GuideToPharmacology,1,inhibitor
EEF1G,GSK2334470,GuideToPharmacology,1,inhibitor
EEF1G,CDK2 INHIBITOR IV,GuideToPharmacology,1,inhibitor
AXL,CANLITINIB,GuideToPharmacology,1,inhibitor
EEF2,AMG-900,GuideToPharmacology,1,inhibitor
AXL,MERESTINIB,GuideToPharmacology,1,inhibitor
FMOD,&BETA;-SECRETASE INHIBITOR IV,GuideToPharmacology,1,inhibitor
FMO5,AMG-8718,GuideToPharmacology,1,inhibitor
FMO5,COMPOUND 13 [PMID: 23412139],GuideToPharmacology,1,inhibitor
ABR,RACTOPAMINE,GuideToPharmacology,1,agonist
ACAA1,VIBEGRON,GuideToPharmacology,1,agonist
ACAA1,L 755507,GuideToPharmacology,1,agonist
ACAA1,RACEPINEPHRINE,GuideToPharmacology,1,agonist
AMFR,RO5101576,GuideToPharmacology,1,inhibitor
GRIA4,COMPOUND 27 [PMID: 26938474],GuideToPharmacology,1,inhibitor
EFNA2,VEMURAFENIB,GuideToPharmacology,1,inhibitor
GAPDH,ZONISAMIDE,GuideToPharmacology,1,inhibitor
GAPDH,GALLIC ACID,GuideToPharmacology,1,inhibitor
ACP5,COMPOUND 18C [PMID:19143533],GuideToPharmacology,1,modulator
FNZ,COMPOUND 33 [PMID: 32003991],GuideToPharmacology,1,inhibitor
CACNA1H,EFONIDIPINE,GuideToPharmacology,1,blocker
ACRV1,ORG27569,GuideToPharmacology,1,modulator
CNR2,CP55940,GuideToPharmacology,1,agonist
CNR2,DRONABINOL,GuideToPharmacology,1,agonist
CNR2,"L-759,656",GuideToPharmacology,1,agonist
CCKBR,A-71378,GuideToPharmacology,1,agonist
CCKBR,"[125I]DTYR-GLY-[(NLE28,31)CCK-26-33",GuideToPharmacology,1,agonist
ACTBP5,VMCC-I,GuideToPharmacology,1,inhibitor
ACTBP2,GSK2239633A,GuideToPharmacology,1,inhibitor
SERPINB1,CIRTUVIVINT,GuideToPharmacology,1,inhibitor
EIF5AP3,CCT245737,GuideToPharmacology,1,inhibitor
EIF5AP3,MK-8776,GuideToPharmacology,1,inhibitor
CHEK2,CCT241533,GuideToPharmacology,1,inhibitor
EIF5AP3,COMPOUND 25 [PMID: 17935989],GuideToPharmacology,1,inhibitor
BUB1,CD2+,GuideToPharmacology,1,blocker
FRA1D,COMPOUND 1 [PMID: 16650987],GuideToPharmacology,1,inhibitor
DPYD,COMPOUND 29 [PMID: 31934767],GuideToPharmacology,1,inhibitor
DPYD,CRENOLANIB,GuideToPharmacology,1,inhibitor
CPT1B,(S)-ARN2508,GuideToPharmacology,1,inhibitor
ALAS2,"[125I]TYR0-CRF (HUMAN, RAT, MOUSE)",GuideToPharmacology,1,agonist
ACHE,DAVALINTIDE,GuideToPharmacology,1,agonist
ELAVL1,PP1,GuideToPharmacology,1,inhibitor
ACHE,[125I]CT (HUMAN),GuideToPharmacology,1,agonist
ACTBP8,[125I]MINI-TYRRS,GuideToPharmacology,1,agonist
ACTG1,CXCL12&EPSILON;,GuideToPharmacology,1,agonist
ACTC1,CXCL12&ALPHA;,GuideToPharmacology,1,agonist
ACTG1,[125I]CXCL12&BETA; (HUMAN),GuideToPharmacology,1,agonist
EGR4,SU9516,GuideToPharmacology,1,inhibitor
CDK19,LINIFANIB,GuideToPharmacology,1,inhibitor
COX10,COMPOUND 7 [PMID: 32302132],GuideToPharmacology,1,inhibitor
COX11,CAMONAGREL,GuideToPharmacology,1,inhibitor
AMHR2,MONTELUKAST SODIUM,GuideToPharmacology,1,inhibitor
AMHR2,LTC4,GuideToPharmacology,1,agonist
COX11,COMPOUND 10A [PMID: 1447738],GuideToPharmacology,1,inhibitor
FPGS,COMPOUND 42 [PMID: 37721854],GuideToPharmacology,1,inhibitor
FPGS,TALABOSTAT,GuideToPharmacology,1,inhibitor
DUSP1,COMPOUND 7K [PMID: 23521020],GuideToPharmacology,1,inhibitor
DUSP1,RIPK1 INHIBITOR 22B,GuideToPharmacology,1,inhibitor
GCNT1,EPZ004777,GuideToPharmacology,1,inhibitor
GBX2,ETOPOSIDE,GuideToPharmacology,1,inhibitor
APOBEC1,"L-888,291",GuideToPharmacology,1,agonist
APOB,SQ-27986,GuideToPharmacology,1,agonist
APOBEC1,VIDUPIPRANT,GuideToPharmacology,1,inhibitor
ALCAM,PROCHLORPERAZINE,GuideToPharmacology,1,inhibitor
ALCAM,N-PROPYLNORAPOMORPHINE,GuideToPharmacology,1,agonist
ABCD1,(-)-N-PORPHYNORAPOMORPHINE,GuideToPharmacology,1,agonist
ABCD1,PIRIBEDIL,GuideToPharmacology,1,agonist
ALDH1A1,PIRIBEDIL,GuideToPharmacology,1,agonist
ALDH1A1,NAFADOTRIDE,GuideToPharmacology,1,inhibitor
ALDH1A1,(-)-N-PORPHYNORAPOMORPHINE,GuideToPharmacology,1,agonist
ATN1,DDR1/2 INHIBITOR 5N,GuideToPharmacology,1,inhibitor
DXO,COMPOUND 56 [PMID: 8568816],GuideToPharmacology,1,inhibitor
DXO,ACALABRUTINIB,GuideToPharmacology,1,inhibitor
DXO,"C34 [ZHU ET AL., 2023]",GuideToPharmacology,1,inhibitor
DXO,CETUXIMAB,GuideToPharmacology,1,antibody
GTF2IP1,DIFLAPOLIN,GuideToPharmacology,1,inhibitor
APOBER1,AH6809,GuideToPharmacology,1,inhibitor
APOC1,AH6809,GuideToPharmacology,1,inhibitor
APOBER1,ONO-8711,GuideToPharmacology,1,inhibitor
APOC1,TG4-155,GuideToPharmacology,1,inhibitor
AQP8,ENPROSTIL,GuideToPharmacology,1,agonist
EN1,ACALABRUTINIB,GuideToPharmacology,1,inhibitor
EN1,BMS-599626,GuideToPharmacology,1,inhibitor
AQP8,GRAPIPRANT,GuideToPharmacology,1,inhibitor
EN1,TUXOBERTINIB,GuideToPharmacology,1,inhibitor
BCYRN1P2,METHYL-PIPERIDINO-PYRAZOLE,GuideToPharmacology,1,inhibitor
BCYRN1P2,LASOFOXIFENE,GuideToPharmacology,1,agonist
BCYRN1P2,ERD-308,GuideToPharmacology,1,inhibitor
ALDH1B1,[125I]PD151242,GuideToPharmacology,1,inhibitor
ALDH1B1,DARUSENTAN,GuideToPharmacology,1,inhibitor
BDKRB2,DY131,GuideToPharmacology,1,agonist
H2AX,ELTANEXOR,GuideToPharmacology,1,inhibitor
CBLN1,(R)-AS-1,GuideToPharmacology,1,modulator
CBLN1,DIHYDROKAINATE,GuideToPharmacology,1,inhibitor
ARNT,FLUMAZENIL,GuideToPharmacology,1,modulator
ARNT,ZOLPIDEM TARTRATE,GuideToPharmacology,1,modulator
BMAL1,MRK016,GuideToPharmacology,1,modulator
BMAL1,RO15-4513,GuideToPharmacology,1,modulator
BMAL1,AZD7325,GuideToPharmacology,1,modulator
ARRB1,ALPRAZOLAM,GuideToPharmacology,1,modulator
ARRB1,FLUMAZENIL,GuideToPharmacology,1,modulator
ARRB1,TRIAZOLAM,GuideToPharmacology,1,modulator
ARRB2,AMILORIDE,GuideToPharmacology,1,modulator
GABRR3,(&PLUSMN;)-CIS-2-CAMP,GuideToPharmacology,1,agonist
ARVCF,PIPERIDINE-4-SULPHONIC ACID,GuideToPharmacology,1,inhibitor
ALOX12P1,J20 (GALANIN ANALOGUE),GuideToPharmacology,1,agonist
ALOX12P1,GALP(1-32) (HUMAN),GuideToPharmacology,1,agonist
ALOX12P2,M32,GuideToPharmacology,1,inhibitor
ALOX15B,TESAMORELIN,GuideToPharmacology,1,agonist
ALPI,HUMAN GIP(3-30)NH2,GuideToPharmacology,1,inhibitor
ALPL,EXENATIDE,GuideToPharmacology,1,agonist
ALPL,WB4-24,GuideToPharmacology,1,agonist
ALOX15,LENOMORELIN,GuideToPharmacology,1,agonist
ALOX15B,JI-38,GuideToPharmacology,1,agonist
ASS1,CYCLOTHIAZIDE,GuideToPharmacology,1,modulator
GRIA3,TEZAMPANEL ANHYDROUS,GuideToPharmacology,1,inhibitor
GRIN2A,[3H]CGP39653,GuideToPharmacology,1,inhibitor
ARVD3,DRONABINOL,GuideToPharmacology,1,modulator
ENSA,SB 216763,GuideToPharmacology,1,inhibitor
ENSA,AZD1080,GuideToPharmacology,1,inhibitor
CD24P1,BITOPERTIN,GuideToPharmacology,1,inhibitor
SLC29A1,COMPOUND 2 [PMID: 22560567],GuideToPharmacology,1,inhibitor
SLC29A1,COMPOUND 5B [PMID: 24900464],GuideToPharmacology,1,inhibitor
SLC29A1,BX-912,GuideToPharmacology,1,inhibitor
SLC29A1,AZD2858,GuideToPharmacology,1,inhibitor
SLC29A1,CHIR-98014,GuideToPharmacology,1,inhibitor
GNRHR,"[HIS5,D-TYR6]GNRH",GuideToPharmacology,1,agonist
DLX6,UROGUANYLIN,GuideToPharmacology,1,agonist
ARL3,MEL57A,GuideToPharmacology,1,blocker
GDF2,MOCETINOSTAT,GuideToPharmacology,1,inhibitor
LRRC32,SS-208,GuideToPharmacology,1,inhibitor
ADH5,NOX-6-7,GuideToPharmacology,1,agonist
ADH6,LP-471756,GuideToPharmacology,1,inhibitor
ACTN2,ASN02563583,GuideToPharmacology,1,agonist
ADD3,EMBELIN,GuideToPharmacology,1,agonist
EPHA8,ACALABRUTINIB,GuideToPharmacology,1,inhibitor
PLIN2,RTI-122,GuideToPharmacology,1,agonist
ADRA2A,AR244555,GuideToPharmacology,1,inhibitor
XCR1,LW106,GuideToPharmacology,1,inhibitor
FRA11F,CAROTEGRAST METHYL,GuideToPharmacology,1,inhibitor
DFNB13,IL-3,GuideToPharmacology,1,agonist
IL15RA,IL-15,GuideToPharmacology,1,agonist
DFNB14,BENRALIZUMAB,GuideToPharmacology,1,antibody
EPHA5,COMPOUND R-16 [PMID: 21967808],GuideToPharmacology,1,inhibitor
ITPR1,ADENOPHOSTIN A,GuideToPharmacology,1,activator
APOC3,BERAPROST,GuideToPharmacology,1,agonist
FOXL2,SILYBIN,GuideToPharmacology,1,agonist
BRCA2,(&PLUSMN;)-EQUOL,GuideToPharmacology,1,agonist
TAS2R46,COLCHICINE,GuideToPharmacology,1,agonist
EPHB1,JAK3 INHIBITOR 34,GuideToPharmacology,1,inhibitor
BNIP3L,OFLOXACIN,GuideToPharmacology,1,agonist
EPHB1,CEE321,GuideToPharmacology,1,inhibitor
EPHB1,PACRITINIB,GuideToPharmacology,1,inhibitor
EPHB2,DECERNOTINIB,GuideToPharmacology,1,inhibitor
EPHB2,ITACNOSERTIB,GuideToPharmacology,1,inhibitor
EPHB2,PF-956980,GuideToPharmacology,1,inhibitor
EPHB2,JAK3 INHIBITOR 34,GuideToPharmacology,1,inhibitor
FRA2F,COMPOUND 32 [PMID: 31675166],GuideToPharmacology,1,inhibitor
EPHB3,UPADACITINIB,GuideToPharmacology,1,inhibitor
FRA2B,COMPOUND 32 [PMID: 31675166],GuideToPharmacology,1,inhibitor
GPR42,COMPOUND 4D [PMID: 25489658],GuideToPharmacology,1,inhibitor
NUDT2,NALOXONE HYDROCHLORIDE,GuideToPharmacology,1,inhibitor
DRD2,INFIGRATINIB,GuideToPharmacology,1,inhibitor
DRD2,BMS-690514,GuideToPharmacology,1,inhibitor
DRD2,COMPOUND 19A [PMID: 30503936],GuideToPharmacology,1,inhibitor
DRD2,PEGDINETANIB,GuideToPharmacology,1,inhibitor
DRD2,PEXIDARTINIB,GuideToPharmacology,1,inhibitor
DRD2,VEGF RECEPTOR 2 KINASE INHIBITOR IV,GuideToPharmacology,1,inhibitor
DRD2,REGORAFENIB,GuideToPharmacology,1,inhibitor
AMELY,KISSPEPTIN-54,GuideToPharmacology,1,agonist
ATP6V1B1,ISOFLURANE,GuideToPharmacology,1,activator
ATP5MC2P1,HALOTHANE,GuideToPharmacology,1,activator
ARF4P1,NS11021,GuideToPharmacology,1,activator
ASGR2,BA2+,GuideToPharmacology,1,blocker
ASGR1,BA2+,GuideToPharmacology,1,blocker
ASGR1,CS+,GuideToPharmacology,1,blocker
KCNJ8,CROMAKALIM,GuideToPharmacology,1,activator
KCNT1,QUINIDINE,GuideToPharmacology,1,blocker
BAG1,ERGTX-1,GuideToPharmacology,1,inhibitor
ATR,BA2+,GuideToPharmacology,1,blocker
TPH2,TPT-004,GuideToPharmacology,1,inhibitor
LTB4R,RODATRISTAT,GuideToPharmacology,1,inhibitor
ACVRL1,[1-BROMO-(3S)-HYDROX-4-(PALMITOYLOXY)BUTYL]PHOSPHATE,GuideToPharmacology,1,inhibitor
GLI3,PLUMBAGIN,GuideToPharmacology,1,inhibitor
KDM5C,IOX2,GuideToPharmacology,1,inhibitor
GGTA1,KDOAM25,GuideToPharmacology,1,inhibitor
AMY2B,COMPOUND 2 [PMID: 11375253],GuideToPharmacology,1,agonist
ETFB,STK16-IN-1,GuideToPharmacology,1,inhibitor
ETFB,TORIN 1,GuideToPharmacology,1,inhibitor
ETFB,RIDAFOROLIMUS,GuideToPharmacology,1,inhibitor
ETFB,COMPOUND 82 [PMID: 21332118],GuideToPharmacology,1,inhibitor
DRD4,ALTIRATINIB,GuideToPharmacology,1,inhibitor
DRD4,EMIBETUZUMAB,GuideToPharmacology,1,antibody
DTNA,MERESTINIB,GuideToPharmacology,1,inhibitor
ANPEP,BIPHENYLINDANONE A,GuideToPharmacology,1,modulator
SLC25A6,"3,3'-DIFLUOROBENZALDAZINE",GuideToPharmacology,1,modulator
SLC25A6,CPPHA,GuideToPharmacology,1,modulator
SLC25A6,ADX-47273,GuideToPharmacology,1,modulator
ANTP2,PPG,GuideToPharmacology,1,agonist
CTNNA1,ERK INHIBITOR III,GuideToPharmacology,1,inhibitor
NR3C2,FLUTICASONE,GuideToPharmacology,1,agonist
CTNNA1,"5-(2-PHENYLPYRAZOLO[1,5-A]PYRIDIN-3-YL)-1H-PYRAZOLO[3,4-C]PYRIDAZIN-3-AMINE",GuideToPharmacology,1,inhibitor
CTNND1,TAK-715,GuideToPharmacology,1,inhibitor
CTNNB1,NDPPC,GuideToPharmacology,1,inhibitor
CTNNB1,LOSMAPIMOD,GuideToPharmacology,1,inhibitor
CTNNB1,SB202190,GuideToPharmacology,1,inhibitor
ERVT3,DCLK1-IN-1,GuideToPharmacology,1,inhibitor
CTNNB1,PH-797804,GuideToPharmacology,1,inhibitor
CTNNA2,JNK INHIBITOR 9L,GuideToPharmacology,1,inhibitor
ERCC2,COBIMETINIB,GuideToPharmacology,1,modulator
DCTD,COMPOUND 10 [PMID: 18790648],GuideToPharmacology,1,inhibitor
MMP16,SL422,GuideToPharmacology,1,inhibitor
DCTN1,SL422,GuideToPharmacology,1,inhibitor
DBT,TILUDRONIC ACID,GuideToPharmacology,1,inhibitor
ECI1,SL422,GuideToPharmacology,1,inhibitor
ANTP4,AZITHROMYCIN,GuideToPharmacology,1,agonist
SEPTIN7,COMPOUND 18N [PMID: 34382802],GuideToPharmacology,1,inhibitor
ANTP4,DS-3801B FREE BASE,GuideToPharmacology,1,agonist
AADAC,OXOTREMORINE-M,GuideToPharmacology,1,agonist
AADAC,NNC 11-1607,GuideToPharmacology,1,agonist
AADAC,VINCAMINE,GuideToPharmacology,1,modulator
AAMP,N-CHLOROMETHYL-BRUCINE,GuideToPharmacology,1,modulator
AAMP,ALCURONIUM,GuideToPharmacology,1,modulator
AAMP,4-DAMP,GuideToPharmacology,1,inhibitor
AAMP,SOLIFENACIN,GuideToPharmacology,1,inhibitor
AANAT,CARBAMOYLCHOLINE,GuideToPharmacology,1,agonist
ANK2,UCM 549,GuideToPharmacology,1,inhibitor
ANK3,UCM 549,GuideToPharmacology,1,inhibitor
APOF,BUPRENORPHINE,GuideToPharmacology,1,agonist
CD8B,REBOXETINE,GuideToPharmacology,1,inhibitor
CD8B,SOLRIAMFETOL,GuideToPharmacology,1,inhibitor
DRD5P1,DDR1/2 INHIBITOR 5N,GuideToPharmacology,1,inhibitor
DRD5P1,TALETRECTINIB,GuideToPharmacology,1,inhibitor
ATD,NICOTINE POLACRILEX,GuideToPharmacology,1,agonist
ATF3,&ALPHA;-CONOTOXIN PIA,GuideToPharmacology,1,inhibitor
ATD,A-867744,GuideToPharmacology,1,blocker
ATF1,&ALPHA;-CONOTOXIN PNIA,GuideToPharmacology,1,inhibitor
ANXA2P2,NEUROPEPTIDE W-30,GuideToPharmacology,1,agonist
APBA1,N/OFQ-NH2,GuideToPharmacology,1,agonist
APBA1,PEPTIDE III-BTD,GuideToPharmacology,1,inhibitor
ANXA2P1,AVA3,GuideToPharmacology,1,agonist
NPFFR1,COMPOUND 46 [PMID: 25268943],GuideToPharmacology,1,inhibitor
NPFFR1,BIBP3226,GuideToPharmacology,1,inhibitor
APBA2,FIRAZOREXTON,GuideToPharmacology,1,agonist
AMPD2,5-OXO-ETE,GuideToPharmacology,1,agonist
AP1B1,ALPHA-KETOGLUTARIC ACID,GuideToPharmacology,1,agonist
APBA2,SB-674042,GuideToPharmacology,1,inhibitor
EXT3,IPA-3,GuideToPharmacology,1,inhibitor
APBB1,TCS-OX2-29,GuideToPharmacology,1,inhibitor
EYA1,PF-3758309,GuideToPharmacology,1,inhibitor
ATP1A3,TNP-ATP,GuideToPharmacology,1,inhibitor
ATP1A4,AF-906,GuideToPharmacology,1,inhibitor
ATP1B1,"PAROXETINE HYDROCHLORIDE, HEMIHYDRATE",GuideToPharmacology,1,inhibitor
ATP1B1,ADENOSINE TRIPHOSPHATE,GuideToPharmacology,1,agonist
ATP1A4,ADENOSINE TRIPHOSPHATE,GuideToPharmacology,1,agonist
ATP1B3P1,AZ11645373,GuideToPharmacology,1,modulator
APEH,ADENOSINE TRIPHOSPHATE,GuideToPharmacology,1,agonist
ATP1B3P1,POLYMYXIN B SULFATE,GuideToPharmacology,1,modulator
ATP1B3P1,ADENOSINE TRIPHOSPHATE,GuideToPharmacology,1,agonist
BIRC2,[33P]2MESADP,GuideToPharmacology,1,agonist
APBB2,GLAXOSMITHKLINE COMPOUND 6I [PMID:18926700],GuideToPharmacology,1,inhibitor
APBB2,AP5A,GuideToPharmacology,1,agonist
APC,UTP&GAMMA;S,GuideToPharmacology,1,agonist
ADCYAP1R1,N-STEARYL-[NLE17] NEUROTENSIN-(6-11)/VIP-(7-28),GuideToPharmacology,1,inhibitor
GALNT2,ORLISTAT,GuideToPharmacology,1,inhibitor
APOE,AZ2429,GuideToPharmacology,1,agonist
APOE,AC-55541,GuideToPharmacology,1,agonist
APOE,P2PAL18S,GuideToPharmacology,1,inhibitor
F7,COMPOUND 52 [PMID: 28541707],GuideToPharmacology,1,inhibitor
F7,COMPOUND 82 [PMID: 21332118],GuideToPharmacology,1,inhibitor
F7,PP-121,GuideToPharmacology,1,inhibitor
F7,NEOLYMPHOSTIN A,GuideToPharmacology,1,inhibitor
F7,LENIOLISIB,GuideToPharmacology,1,inhibitor
F7R,PI-103,GuideToPharmacology,1,inhibitor
F7R,STK16-IN-1,GuideToPharmacology,1,inhibitor
COL11A1,CDP840,GuideToPharmacology,1,inhibitor
COL11A1,MK-0359,GuideToPharmacology,1,inhibitor
F11,AZD1208,GuideToPharmacology,1,inhibitor
F9,COMPOUND 28 [PMID: 30624936],GuideToPharmacology,1,inhibitor
DPP4,CHMFL-KIT-64,GuideToPharmacology,1,inhibitor
DPP4,BPR1R024,GuideToPharmacology,1,inhibitor
MAPK14,COMPOUND 37 [PMID: 29193967],GuideToPharmacology,1,inhibitor
FRA5B,APROTININ,GuideToPharmacology,1,inhibitor
APOA2,TRIAZINE COMPOUND PC1,GuideToPharmacology,1,inhibitor
DPP6,CHMFL-KIT-64,GuideToPharmacology,1,inhibitor
CSE1L,FIPI,GuideToPharmacology,1,inhibitor
FRA3C,FURIN INHIBITOR PEPTIDE,GuideToPharmacology,1,inhibitor
PRMT1,MS023,GuideToPharmacology,1,inhibitor
CMTX3,MS023,GuideToPharmacology,1,inhibitor
CTAA1,CGP53353,GuideToPharmacology,1,inhibitor
GOLGA1,PP-121,GuideToPharmacology,1,inhibitor
HPX,OKADAIC ACID,GuideToPharmacology,1,inhibitor
HOXA6,BATOPROTAFIB,GuideToPharmacology,1,inhibitor
RIPK2,ZAK INHIBITOR 6P,GuideToPharmacology,1,inhibitor
GP1BA,"(5E)-1-(4-FLUOROPHENYL)-5-[(5-METHYLTHIOPHEN-2-YL)METHYLIDENE]-2-SULFANYLIDENE-1,3-DIAZINANE-4,6-DIONE",GuideToPharmacology,1,inhibitor
GOLGA2,CELASTROL,GuideToPharmacology,1,inhibitor
BCHEL1,TAMIBAROTENE,GuideToPharmacology,1,agonist
BCHE,TAZAROTENE,GuideToPharmacology,1,agonist
BCHEL1,BMS493,GuideToPharmacology,1,inhibitor
GRM1,ELEZANUMAB,GuideToPharmacology,1,antibody
BCHE,BMS493,GuideToPharmacology,1,inhibitor
CTPS1,COMPOUND 33 [PMID: 19364658],GuideToPharmacology,1,inhibitor
PTK2B,SORAFENIB,GuideToPharmacology,1,inhibitor
PTK2B,LINIFANIB,GuideToPharmacology,1,inhibitor
APRT,RELAXIN-3 (B CHAIN),GuideToPharmacology,1,agonist
APRT,RLX-33,GuideToPharmacology,1,inhibitor
KLK3,DC591053,GuideToPharmacology,1,agonist
KLK3,[125I]INSL5 (HUMAN),GuideToPharmacology,1,agonist
KLK3,ANALOGUE 13: B7-24,GuideToPharmacology,1,agonist
AMT,COMPOUND 43 [PMID: 26751273],GuideToPharmacology,1,agonist
GKP4,LLY-507,GuideToPharmacology,1,inhibitor
GJA8,(R)-PFI-2,GuideToPharmacology,1,inhibitor
CYB561,GSK650394,GuideToPharmacology,1,inhibitor
GYPB,SD-36,GuideToPharmacology,1,inhibitor
GYPB,COMPOUND 8U [PMID: 31999451],GuideToPharmacology,1,inhibitor
CEBPA,CGP-37157,GuideToPharmacology,1,inhibitor
PLA2G10,COMPOUND 12E [PMID: 18605714],GuideToPharmacology,1,inhibitor
FCAR,COMPOUND 55 [PMID: 30889352],GuideToPharmacology,1,inhibitor
MS4A2,DASATINIB ANHYDROUS,GuideToPharmacology,1,inhibitor
MS4A2,WH-4-023,GuideToPharmacology,1,inhibitor
FAS,[125I]CGP 23996,GuideToPharmacology,1,agonist
FAS,"L-797,591",GuideToPharmacology,1,agonist
FASLG,VAPREOTIDE,GuideToPharmacology,1,agonist
SHROOM2,OCTREOTIDE ACETATE,GuideToPharmacology,1,agonist
SHROOM2,"[111IN,90Y]DOTA-LAN",GuideToPharmacology,1,agonist
SHROOM2,PRL-2915,GuideToPharmacology,1,inhibitor
SHROOM2,[125I]CGP 23996,GuideToPharmacology,1,agonist
AQP1,[L-TYR8]CYN 154806,GuideToPharmacology,1,inhibitor
AQP2,[125I]CGP 23996,GuideToPharmacology,1,agonist
TLE5,CIS-EPOXYSUCCINIC ACID,GuideToPharmacology,1,agonist
TEC,ACALABRUTINIB,GuideToPharmacology,1,inhibitor
FECH,COMPOUND 1 [PMID: 24793884],GuideToPharmacology,1,inhibitor
HLA-DMB,RK-287107,GuideToPharmacology,1,inhibitor
ECM2,DDR1/2 INHIBITOR 5N,GuideToPharmacology,1,inhibitor
GCGR,PEMETREXED DISODIUM,GuideToPharmacology,1,inhibitor
DNM1,AGATOLIMOD,GuideToPharmacology,1,agonist
THRB,TIRATRICOL,GuideToPharmacology,1,agonist
APOC4,ONO-3708,GuideToPharmacology,1,inhibitor
DNMT3A,SB-431542,GuideToPharmacology,1,inhibitor
ATP1B1P1,METHYLGLYOXAL,GuideToPharmacology,1,activator
ATP2A3,M084,GuideToPharmacology,1,blocker
ATP1B1P1,HC030031,GuideToPharmacology,1,inhibitor
ATP2A2,PYR10,GuideToPharmacology,1,blocker
ATP2A3,ML204,GuideToPharmacology,1,blocker
ATP2B3,2-APB,GuideToPharmacology,1,blocker
ATP2B2,PYRAZOLO-PYRIMIDINE 14A [PMID: 29859875],GuideToPharmacology,1,blocker
ATP2B2,2-APB,GuideToPharmacology,1,blocker
ATP4A,CIM0216,GuideToPharmacology,1,activator
ATP4A,MAPROTILINE,GuideToPharmacology,1,blocker
PKD2L1,AMILORIDE,GuideToPharmacology,1,blocker
TSHR,COMPOUND 8B [PMID: 22408719],GuideToPharmacology,1,agonist
TRPV6,GSK3527497,GuideToPharmacology,1,inhibitor
TYK2,PEFICITINIB,GuideToPharmacology,1,inhibitor
TYK2,CEE321,GuideToPharmacology,1,inhibitor
TYK2,MOMELOTINIB,GuideToPharmacology,1,inhibitor
TYK2,JAK3 INHIBITOR 34,GuideToPharmacology,1,inhibitor
FH,COMPOUND R-16 [PMID: 21967808],GuideToPharmacology,1,inhibitor
UTS2R,UROTENSIN II-RELATED PEPTIDE,GuideToPharmacology,1,agonist
CDH12,CLODRONIC ACID,GuideToPharmacology,1,inhibitor
BCL7A,2MD,GuideToPharmacology,1,agonist
ARCN2,N-STEARYL-[NLE17]VIP,GuideToPharmacology,1,agonist
AQP9,"[3H]AVP (HUMAN, MOUSE, RAT)",GuideToPharmacology,1,agonist
AR,D[D-PAL2]AVP,GuideToPharmacology,1,agonist
AR,NELIVAPTAN,GuideToPharmacology,1,inhibitor
ABCC6,[PHE3]OT,GuideToPharmacology,1,agonist
FKBP1B,COMPOUND 25 [PMID: 17935989],GuideToPharmacology,1,inhibitor
ANXA3,"[LEU31,PRO34]NPY",GuideToPharmacology,1,agonist
ANXA3,"[LEU31,PRO34]PYY (HUMAN)",GuideToPharmacology,1,agonist
CYP4A11,APSTATIN,GuideToPharmacology,1,inhibitor
FKBP1AP3,"(3Z)-N,N-DIMETHYL-2-OXO-3-(4,5,6,7-TETRAHYDRO-1H-INDOL-2-YLMETHYLIDENE)-2,3-DIHYDRO-1H-INDOLE-5-SULFONAMIDE",GuideToPharmacology,1,inhibitor
FKBP1AP4,SYK INHIBITOR II,GuideToPharmacology,1,inhibitor
NATP,SB258585,GuideToPharmacology,1,inhibitor
GNA12,TOLRESTAT,GuideToPharmacology,1,inhibitor
ABAT,ST-1535,GuideToPharmacology,1,inhibitor
ESR2,AC-186,GuideToPharmacology,1,agonist
ELF1,PF-670462,GuideToPharmacology,1,inhibitor
RHOC,NNC55-0396,GuideToPharmacology,1,blocker
ALDH1A1,HS665,GuideToPharmacology,1,agonist
DXO,GEFITINIB,GuideToPharmacology,1,inhibitor
DDX10,APRATASTAT,GuideToPharmacology,1,inhibitor
ACAT1,NEUROMEDIN B,GuideToPharmacology,1,agonist
ATR,VE-821,GuideToPharmacology,1,inhibitor
AARS1,N-CHLOROMETHYL-BRUCINE,GuideToPharmacology,1,modulator
AMHR2,COMPOUND 15B [PMID: 31811124],GuideToPharmacology,1,inhibitor
DRD4,NINGETINIB,GuideToPharmacology,1,inhibitor
DTX1,TALETRECTINIB,GuideToPharmacology,1,inhibitor
GRIN2B,(+)-HA966,GuideToPharmacology,1,agonist
DLX3,[125I]ANP (HUMAN),GuideToPharmacology,1,agonist
ALOX15,EXAMORELIN,GuideToPharmacology,1,agonist
ACTA1,[125I]CCL3 (HUMAN),GuideToPharmacology,1,agonist
BRCA2,EPIGALLOCATECHIN,GuideToPharmacology,1,agonist
KMT5A,NAHUOIC ACID A,GuideToPharmacology,1,inhibitor
CD8B2,DEXTROAMPHETAMINE SULFATE,GuideToPharmacology,1,inhibitor
A12M4,SB 215505,GuideToPharmacology,1,inhibitor
APOA4,PRRP-20,GuideToPharmacology,1,agonist
FMO5,&BETA;-SECRETASE INHIBITOR IV,GuideToPharmacology,1,inhibitor
ALDH7A1,"PHOSPHATIDYL (3,5) INOSITOL BISPHOSPHATE",GuideToPharmacology,1,activator
ARCN1,PACAP-27,GuideToPharmacology,1,agonist
AOC1,MOXONIDINE,GuideToPharmacology,1,agonist
CTNNA1,EDAXETERKIB,GuideToPharmacology,1,inhibitor
THRB,VK-2809,GuideToPharmacology,1,agonist
GOLGA2,PSEUDOCHELERYTHRINE,GuideToPharmacology,1,inhibitor
BAK1P1,SR1001,GuideToPharmacology,1,agonist
AQP2,VAPREOTIDE,GuideToPharmacology,1,agonist
CD8B,NORTRIPTYLINE,GuideToPharmacology,1,inhibitor
DXO,AEE788,GuideToPharmacology,1,inhibitor
ALOX12P1,GALANIN(3-29) (RAT/MOUSE),GuideToPharmacology,1,agonist
ABCA3,MRS1523,GuideToPharmacology,1,inhibitor
EIF4A1,AZD5438,GuideToPharmacology,1,inhibitor
CCND1,TROGLITAZONE,GuideToPharmacology,1,agonist
AAVS1,NNC 11-1607,GuideToPharmacology,1,agonist
A12M4,5-HYDROXYTRYPTAMINE,GuideToPharmacology,1,agonist
AMT,FINGOLIMOD,GuideToPharmacology,1,agonist
ATP1A4,TNP-ATP,GuideToPharmacology,1,inhibitor
GPR20,AZELIRAGON,GuideToPharmacology,1,inhibitor
HTR2C,M-CHLOROPHENYLPIPERAZINE,GuideToPharmacology,1,agonist
ALPG,CROTEDUMAB,GuideToPharmacology,1,antibody
PAK4,PF-3758309,GuideToPharmacology,1,inhibitor
F5,WORTMANNIN,GuideToPharmacology,1,inhibitor
GNG7,AZD4877,GuideToPharmacology,1,inhibitor
FBN1,RN486,GuideToPharmacology,1,inhibitor
ATP5PF,HALOTHANE,GuideToPharmacology,1,inhibitor
CHRNA3,COMPOUND 15 [PMID: 35034442],GuideToPharmacology,1,inhibitor
ANGPT1,CORTICOTROPIN,GuideToPharmacology,1,agonist
GPI,PF-04620110,GuideToPharmacology,1,inhibitor
GNAI2,AZD9574,GuideToPharmacology,1,inhibitor
GNRHR,ITURELIX,GuideToPharmacology,1,inhibitor
ASIC1,T-KININ,GuideToPharmacology,1,agonist
CRMP1,JNJ40355003,GuideToPharmacology,1,inhibitor
ANK3,TASIMELTEON,GuideToPharmacology,1,agonist
FRA1G,FURIN INHIBITOR PEPTIDE,GuideToPharmacology,1,inhibitor
AARS1,ALCURONIUM,GuideToPharmacology,1,modulator
CHRNA3,ATRACURIUM,GuideToPharmacology,1,inhibitor
APBB1,SB-674042,GuideToPharmacology,1,inhibitor
ACADSB,APELIN-13,GuideToPharmacology,1,agonist
EEF2,MK-5108,GuideToPharmacology,1,inhibitor
EIF4G1,AZD5438,GuideToPharmacology,1,inhibitor
CD8B2,SIBUTRAMINE,GuideToPharmacology,1,inhibitor
ANXA5,"PYY-(13-36) (MOUSE, RAT, PIG)",GuideToPharmacology,1,agonist
DXO,ZONGERTINIB,GuideToPharmacology,1,inhibitor
ETFB,VS-5584,GuideToPharmacology,1,inhibitor
DXO,EGFR/ERBB-2 INHIBITOR,GuideToPharmacology,1,inhibitor
FGR,P505-15,GuideToPharmacology,1,inhibitor
CD40LG,DEXPROPRANOLOL,GuideToPharmacology,1,inhibitor
FCER1A,COMPOUND 55 [PMID: 30889352],GuideToPharmacology,1,inhibitor
FRA4A,EVOLOCUMAB,GuideToPharmacology,1,antibody
CTRB1,COMPOUND 32 [PMID: 20471253],GuideToPharmacology,1,inhibitor
ABCB7,NAPHAZOLINE,GuideToPharmacology,1,agonist
ASS1P2,CYCLOTHIAZIDE,GuideToPharmacology,1,modulator
EPHX2,ZAK INHIBITOR 6P,GuideToPharmacology,1,inhibitor
SHROOM2,[125I]TYR7-SST3-ODN-8,GuideToPharmacology,1,agonist
ADGRB1,BA2+,GuideToPharmacology,1,blocker
ANK2,TASIMELTEON,GuideToPharmacology,1,agonist
BCL2A1,SR9009,GuideToPharmacology,1,agonist
CYP2A7,COMPOUND 1A [PMID: 24900749],GuideToPharmacology,1,inhibitor
GGTL1,GSK-J4,GuideToPharmacology,1,inhibitor
PPP1CA,MICROCYSTIN-LR,GuideToPharmacology,1,inhibitor
AQP2,CST-17,GuideToPharmacology,1,agonist
CSRP2,COMPOUND 101 [PMID: 21596927],GuideToPharmacology,1,inhibitor
ASS1P14,AMANTADINE HYDROCHLORIDE,GuideToPharmacology,1,blocker
ASAH1,PREGNENOLONE SULPHATE,GuideToPharmacology,1,inhibitor
A12M3,METERGOLINE,GuideToPharmacology,1,inhibitor
ABO,ACEBUTOLOL,GuideToPharmacology,1,inhibitor
DSG3,COMPOUND 66 [PMID: 19788238],GuideToPharmacology,1,inhibitor
APBB2,BMS COMPOUND 4C,GuideToPharmacology,1,inhibitor
GSS,PFK15,GuideToPharmacology,1,inhibitor
ABCA3,(R)-PIA,GuideToPharmacology,1,agonist
ALOX12P1,GAL-B2-C14,GuideToPharmacology,1,agonist
GGTA1,GSK-J4,GuideToPharmacology,1,inhibitor
AADAC,[11C]BUTYLTHIO-TZTP,GuideToPharmacology,1,agonist
ATP1A4,SPINORPHIN,GuideToPharmacology,1,modulator
AARS1,4-DAMP,GuideToPharmacology,1,inhibitor
PTPRB,COMPOUND 13E [PMID: 16759857],GuideToPharmacology,1,inhibitor
APOC4,SQ-29548,GuideToPharmacology,1,inhibitor
A2M,CP94253,GuideToPharmacology,1,agonist
A2M,(R)-FLUROCARAZOLOL,GuideToPharmacology,1,inhibitor
A12M1,METHYSERGIDE,GuideToPharmacology,1,inhibitor
A12M1,9-OH-RISPERIDONE,GuideToPharmacology,1,inhibitor
A12M2,DOI,GuideToPharmacology,1,agonist
A12M1,METERGOLINE,GuideToPharmacology,1,inhibitor
A12M3,LY344864,GuideToPharmacology,1,agonist
A12M3,N-1-ISOPROPYL-5-MEOT,GuideToPharmacology,1,agonist
A12M2,1-NAPHTHYLPIPERAZINE,GuideToPharmacology,1,inhibitor
A12M3,M-CHLOROPHENYLPIPERAZINE,GuideToPharmacology,1,agonist
A12M3,SB 216641,GuideToPharmacology,1,agonist
A12M3,RO 60-0175,GuideToPharmacology,1,agonist
A12M3,9-OH-RISPERIDONE,GuideToPharmacology,1,inhibitor
A12M3,SB 206553,GuideToPharmacology,1,inhibitor
A12M4,CGS-12066,GuideToPharmacology,1,agonist
A12M4,RO 60-0175,GuideToPharmacology,1,agonist
A12M4,DOI,GuideToPharmacology,1,agonist
A12M4,GR 127935,GuideToPharmacology,1,agonist
A12M4,LY344864,GuideToPharmacology,1,agonist
A12M3,LOXAPINE,GuideToPharmacology,1,inhibitor
HTR2C,SPIRAMIDE,GuideToPharmacology,1,inhibitor
HTR2C,[3H]MESULERGINE,GuideToPharmacology,1,inhibitor
NAT1,CISAPRIDE,GuideToPharmacology,1,agonist
NAT1,PIBOSEROD,GuideToPharmacology,1,inhibitor
NAT2,5-HYDROXYTRYPTAMINE,GuideToPharmacology,1,agonist
NATP,RU 24969,GuideToPharmacology,1,agonist
NATP,DULOXETINE HYDROCHLORIDE,GuideToPharmacology,1,inhibitor
NATP,PERPHENAZINE,GuideToPharmacology,1,inhibitor
SERPINA3,EGIS-11150,GuideToPharmacology,1,inhibitor
CREB1,5-LOX ACTIVATING PROTEIN,GuideToPharmacology,1,activator
SERPINA3,ZOTEPINE,GuideToPharmacology,1,inhibitor
FRA17A,NEOSTIGMINE,GuideToPharmacology,1,inhibitor
ACKR4,CCL21,GuideToPharmacology,1,agonist
DNM2,ITACNOSERTIB,GuideToPharmacology,1,inhibitor
DNM2,COMPOUND 13D [PMID: 23639540],GuideToPharmacology,1,inhibitor
ABCF1,DOXAZOSIN MESYLATE,GuideToPharmacology,1,inhibitor
ABCF1,NS-49,GuideToPharmacology,1,agonist
ABCA4,(+)-CYCLAZOSIN,GuideToPharmacology,1,inhibitor
ABCA4,PRAZOSIN,GuideToPharmacology,1,inhibitor
ABL1,PIRIBEDIL,GuideToPharmacology,1,inhibitor
ABL1,PRAZOSIN,GuideToPharmacology,1,inhibitor
ABL1,RISPERIDONE,GuideToPharmacology,1,inhibitor
ABL1,NAPHAZOLINE,GuideToPharmacology,1,agonist
AOC1,TIZANIDINE HYDROCHLORIDE,GuideToPharmacology,1,agonist
ABL1,TOLAZOLINE,GuideToPharmacology,1,inhibitor
ABL2,GUANFACINE HYDROCHLORIDE,GuideToPharmacology,1,agonist
ABL2,PRAZOSIN,GuideToPharmacology,1,inhibitor
ABL2,MOXONIDINE,GuideToPharmacology,1,agonist
ABL2,EGIS-11150,GuideToPharmacology,1,inhibitor
ABL2,ATIPAMEZOLE,GuideToPharmacology,1,inhibitor
ABL2,DEXMEDETOMIDINE HYDROCHLORIDE,GuideToPharmacology,1,agonist
ABL2,CLONIDINE HYDROCHLORIDE,GuideToPharmacology,1,agonist
BEVI,GSK2881078,GuideToPharmacology,1,agonist
ABCA3,NECA,GuideToPharmacology,1,agonist
ABCA3,NECA,GuideToPharmacology,1,agonist
ABCA3,PSB-11,GuideToPharmacology,1,inhibitor
ABCA3,MRS1067,GuideToPharmacology,1,inhibitor
ABCA3,MRE 2029F20,GuideToPharmacology,1,inhibitor
ABCA3,[3H]PSB-11,GuideToPharmacology,1,inhibitor
ACADM,VALSARTAN,GuideToPharmacology,1,inhibitor
EEF1D,COMPOUND 16 [PMID: 18945615],GuideToPharmacology,1,inhibitor
ACADS,ANGIOTENSIN A,GuideToPharmacology,1,agonist
ACAT1,BANTAG-1,GuideToPharmacology,1,inhibitor
ASIC2,BANTAG-1,GuideToPharmacology,1,inhibitor
GTF2A1,JNJ-65234637,GuideToPharmacology,1,inhibitor
FMO5,ELENBECESTAT,GuideToPharmacology,1,inhibitor
FMO5,AZD3839,GuideToPharmacology,1,inhibitor
FMOD,VERUBECESTAT,GuideToPharmacology,1,inhibitor
ABO,RACEPINEPHRINE,GuideToPharmacology,1,agonist
AMFR,LTB4,GuideToPharmacology,1,agonist
BRD3,COMPOUND 36 [PMID: 24000170],GuideToPharmacology,1,inhibitor
BRD3,COMPOUND 38 [PMID: 24000170],GuideToPharmacology,1,inhibitor
EFNB1,"(3Z)-N,N-DIMETHYL-2-OXO-3-(4,5,6,7-TETRAHYDRO-1H-INDOL-2-YLMETHYLIDENE)-2,3-DIHYDRO-1H-INDOLE-5-SULFONAMIDE",GuideToPharmacology,1,inhibitor
EFNA4,FEDRATINIB,GuideToPharmacology,1,inhibitor
EFNB2,ACALABRUTINIB,GuideToPharmacology,1,inhibitor
EFNB2,ORELABRUTINIB,GuideToPharmacology,1,inhibitor
EFNB2,ELSUBRUTINIB,GuideToPharmacology,1,inhibitor
ASIC1,B-9858,GuideToPharmacology,1,inhibitor
EFNB3,COMPOUND 2-13-1 [PMID: 24900824],GuideToPharmacology,1,inhibitor
BDKRB2,[125I][TYR8]BRADYKININ,GuideToPharmacology,1,agonist
ACACB,DF2593A,GuideToPharmacology,1,inhibitor
ACACB,C5A DES-ARG,GuideToPharmacology,1,agonist
ACACB,C089,GuideToPharmacology,1,inhibitor
ACACB,BM221,GuideToPharmacology,1,agonist
CYP2C19,BOSUTINIB,GuideToPharmacology,1,inhibitor
ACADL,CHIPS-(28-149),GuideToPharmacology,1,inhibitor
ACADL,[125I]C5A (HUMAN),GuideToPharmacology,1,agonist
ELF3,VORUCICLIB,GuideToPharmacology,1,inhibitor
ELF1,PF-4800567,GuideToPharmacology,1,inhibitor
ATP6V1E1,SZ(+)-(S)-202-791,GuideToPharmacology,1,activator
ATP6V1G2,CD2+,GuideToPharmacology,1,blocker
ATP6V0A1,MIBEFRADIL,GuideToPharmacology,1,blocker
CTSH,COMPOUND 1B [PMID: 16290936],GuideToPharmacology,1,inhibitor
ACRV1,PEPCAN-12,GuideToPharmacology,1,modulator
ACTA2,ILACIRNON,GuideToPharmacology,1,inhibitor
ACTA2,TAK-779,GuideToPharmacology,1,inhibitor
EGR3,COMPOUND 77 [PMID: 24793884],GuideToPharmacology,1,inhibitor
CFTR,SULFONAMIDE-01,GuideToPharmacology,1,activator
CPT2,CARPROFEN,GuideToPharmacology,1,inhibitor
ALAS2,"CP-316,311",GuideToPharmacology,1,inhibitor
ALAS2,UROCORTIN 1,GuideToPharmacology,1,agonist
ACTC1,CCL5,GuideToPharmacology,1,agonist
ACTBP9,DANIRIXIN,GuideToPharmacology,1,inhibitor
ACTBP9,NSC 157449,GuideToPharmacology,1,inhibitor
ACTBP9,[125I]CXCL1 (HUMAN),GuideToPharmacology,1,agonist
EIF4A1,SU9516,GuideToPharmacology,1,inhibitor
EIF4A1,CDK4 INHIBITOR III,GuideToPharmacology,1,inhibitor
EIF4A1,CDK2 INHIBITOR IV,GuideToPharmacology,1,inhibitor
EIF4A1,BS-194,GuideToPharmacology,1,inhibitor
EIF4A1,BX-912,GuideToPharmacology,1,inhibitor
EIF4A1,"(7S)-2-(2-AMINOPYRIMIDIN-4-YL)-7-(2-FLUOROETHYL)-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE",GuideToPharmacology,1,inhibitor
EIF4A1,KINASE INHIBITOR 2 [PMID: 30199702],GuideToPharmacology,1,inhibitor
EIF4E,BS-194,GuideToPharmacology,1,inhibitor
EIF4EBP1,VORUCICLIB,GuideToPharmacology,1,inhibitor
CDK4,VORUCICLIB,GuideToPharmacology,1,inhibitor
EIF4E,DINACICLIB,GuideToPharmacology,1,inhibitor
EIF4E,CDK2 INHIBITOR IV,GuideToPharmacology,1,inhibitor
EIF4EP1,LINIFANIB,GuideToPharmacology,1,inhibitor
CPB1,OSILODROSTAT,GuideToPharmacology,1,inhibitor
CLDN7,TALAROZOLE,GuideToPharmacology,1,inhibitor
CD8B2,DEXMETHYLPHENIDATE,GuideToPharmacology,1,inhibitor
GZMB,NSC 780521,GuideToPharmacology,1,inhibitor
FRV1,RBM2-1B,GuideToPharmacology,1,inhibitor
APAF1,DSLET,GuideToPharmacology,1,agonist
APAF1,DYNORPHIN B,GuideToPharmacology,1,agonist
DHFR,PEMETREXED DISODIUM,GuideToPharmacology,1,inhibitor
CRIP2,ORLISTAT,GuideToPharmacology,1,inhibitor
CRIP2,RHC80267,GuideToPharmacology,1,inhibitor
CXCL2,SLR14,GuideToPharmacology,1,agonist
ABCD1,PROCHLORPERAZINE,GuideToPharmacology,1,inhibitor
ALDH1A1,QUINPIROLE,GuideToPharmacology,1,agonist
ALDH3A1,A68930,GuideToPharmacology,1,agonist
EML1,COMPOUND 3B [PMID: 23454515],GuideToPharmacology,1,inhibitor
GZMH,NSC 780521,GuideToPharmacology,1,inhibitor
EML1,COMPOUND 2-2C [PMID: 32003560],GuideToPharmacology,1,inhibitor
TSC22D3,COMPOUND 66 [PMID: 19788238],GuideToPharmacology,1,inhibitor
ATN1,COMPOUND 66 [PMID: 19788238],GuideToPharmacology,1,inhibitor
DSG1,COMPOUND 66 [PMID: 19788238],GuideToPharmacology,1,inhibitor
CCR10,TIPIFARNIB,GuideToPharmacology,1,inhibitor
CRMP1,MM-433593,GuideToPharmacology,1,inhibitor
CRMP1,ASP8477,GuideToPharmacology,1,inhibitor
ENG,RO3280,GuideToPharmacology,1,inhibitor
ALDOA,ACETATE,GuideToPharmacology,1,agonist
FRA1F,COMPOUND 9 [PMID: 20718420],GuideToPharmacology,1,inhibitor
DR1,COMPOUND 1D [PMID: 21493067],GuideToPharmacology,1,inhibitor
DPYSL3,BLU-9931,GuideToPharmacology,1,inhibitor
ONECUT1,COMPOUND 19B [PMID: 37058391],GuideToPharmacology,1,inhibitor
DPYS,FLT-3 INHIBITOR,GuideToPharmacology,1,inhibitor
DRD1,PEXIDARTINIB,GuideToPharmacology,1,inhibitor
DPYS,URMC-099,GuideToPharmacology,1,inhibitor
DPYS,UNC4203,GuideToPharmacology,1,inhibitor
DRD3,COMPOUND 25C [PMID: 36649216],GuideToPharmacology,1,inhibitor
DPYS,TTT-3002,GuideToPharmacology,1,inhibitor
ALDH3B2,AG-09/1,GuideToPharmacology,1,agonist
DGKA,COMPOUND 8D [PMID: 15027864],GuideToPharmacology,1,inhibitor
ALDH3B2,FMET-ILE-VAL-ILE-LEU,GuideToPharmacology,1,agonist
ALDH3B2,SULFINPYRAZONE,GuideToPharmacology,1,inhibitor
ALDH9A1,ASPIRIN TRIGGERED LIPOXIN A4,GuideToPharmacology,1,agonist
APOC2,U46619,GuideToPharmacology,1,agonist
FZD6,WNT-5A,GuideToPharmacology,1,agonist
AKR1B1P2,VANTICTUMAB,GuideToPharmacology,1,antibody
GABRA1,[3H]MUSCIMOL,GuideToPharmacology,1,agonist
GABRA1,&ALPHA;5IA,GuideToPharmacology,1,modulator
GABRA1,RO15-4513,GuideToPharmacology,1,modulator
GABRA1,FLUNITRAZEPAM,GuideToPharmacology,1,modulator
GABRA1,ZOLPIDEM TARTRATE,GuideToPharmacology,1,modulator
GALR2,J20 (GALANIN ANALOGUE),GuideToPharmacology,1,agonist
GALR2,[125I][TYR26]GALANIN (PIG),GuideToPharmacology,1,agonist
GALR2,GALANIN(2-29) (RAT/MOUSE),GuideToPharmacology,1,agonist
ALOX12P2,[125I][TYR26]GALANIN (PIG),GuideToPharmacology,1,agonist
GALR2,"[N-ME,DES-SAR]GAL-B2",GuideToPharmacology,1,agonist
ALOX12P2,M871,GuideToPharmacology,1,inhibitor
BDM,DIFLORASONE DIACETATE,GuideToPharmacology,1,agonist
BDM,DESOXYCORTICOSTERONE,GuideToPharmacology,1,agonist
BDM,BI 653048,GuideToPharmacology,1,agonist
ASS1P2,S18986,GuideToPharmacology,1,modulator
ASS1P2,ATPO,GuideToPharmacology,1,inhibitor
BDM,BECLOMETHASONE DIPROPIONATE,GuideToPharmacology,1,agonist
ASS1P5,MSVIII-19,GuideToPharmacology,1,inhibitor
ASS1P8,[3H]SYM2081,GuideToPharmacology,1,agonist
ASS1P9,KAINIC ACID,GuideToPharmacology,1,agonist
GNRHR,[D-LYS6]GNRH-II,GuideToPharmacology,1,agonist
GNRHR,NBI-42902,GuideToPharmacology,1,inhibitor
ALDH3B1,RALOXIFENE HYDROCHLORIDE,GuideToPharmacology,1,agonist
GNRHR,NBI-42902,GuideToPharmacology,1,inhibitor
ACADVL,OLEANOLIC ACID,GuideToPharmacology,1,agonist
DLX3,"[ASU7,23']&BETA;-ANP-(7-28)",GuideToPharmacology,1,inhibitor
GAPDHP1,MARTINOSTAT,GuideToPharmacology,1,inhibitor
GAPDHP1,SANTACRUZAMATE A,GuideToPharmacology,1,inhibitor
GARS1,MARTINOSTAT,GuideToPharmacology,1,inhibitor
MSTN,TMP269,GuideToPharmacology,1,inhibitor
GART,ACY-738,GuideToPharmacology,1,inhibitor
GDF9,KA1010,GuideToPharmacology,1,inhibitor
GAS1,TUBASTATIN A,GuideToPharmacology,1,inhibitor
GAS1,KA1010,GuideToPharmacology,1,inhibitor
AMD1,BU-E 47,GuideToPharmacology,1,inhibitor
EPAS1,COMPOUND 1A [PMID: 24900749],GuideToPharmacology,1,inhibitor
AMD1,2-(3-CHLOROPHENYL)HISTAMINE,GuideToPharmacology,1,agonist
HRH3,N-[3H]METHYLHISTAMINE,GuideToPharmacology,1,agonist
HRH3,CIPROXIFAN,GuideToPharmacology,1,inhibitor
HRH3,PROXYFAN,GuideToPharmacology,1,agonist
HRH3,PROXYFAN,GuideToPharmacology,1,inhibitor
ADCY3,DRONABINOL,GuideToPharmacology,1,agonist
ADCY3,GSK494581A,GuideToPharmacology,1,agonist
ADD3,PSB-16434,GuideToPharmacology,1,agonist
NOS2,PIMAGEDINE,GuideToPharmacology,1,inhibitor
STOM,SR8185,GuideToPharmacology,1,inhibitor
FOXL2,(&PLUSMN;)-EQUOL,GuideToPharmacology,1,agonist
FOXL2,ERIODICTYOL CHALCONE,GuideToPharmacology,1,agonist
EPHB3,PACRITINIB,GuideToPharmacology,1,inhibitor
EPHB3,DECERNOTINIB,GuideToPharmacology,1,inhibitor
DRD2,MIVAVOTINIB,GuideToPharmacology,1,inhibitor
DRD2,NINGETINIB,GuideToPharmacology,1,inhibitor
AMELY,KISSPEPTIN-9,GuideToPharmacology,1,agonist
ATP5F1E,GI鈥?30159,GuideToPharmacology,1,activator
ARF6,UCL1848,GuideToPharmacology,1,blocker
BAD,PD-307243,GuideToPharmacology,1,activator
BAD,ZORIFERTINIB,GuideToPharmacology,1,inhibitor
AZF1,HMR-1556,GuideToPharmacology,1,blocker
AZF2,PIP2,GuideToPharmacology,1,activator
GRB7,GSK065,GuideToPharmacology,1,inhibitor
EPS8,BOS172722,GuideToPharmacology,1,inhibitor
EPHX2,NEOLYMPHOSTIN A,GuideToPharmacology,1,inhibitor
EPHX2,COMPOUND 7 [PMID: 22464456],GuideToPharmacology,1,inhibitor
EPS8,DCLK1-IN-1,GuideToPharmacology,1,inhibitor
EPS8,XMD-12,GuideToPharmacology,1,inhibitor
EPS8,PF-06454589,GuideToPharmacology,1,inhibitor
EPS8,TTT-3002,GuideToPharmacology,1,inhibitor
AMPD3,CPY,GuideToPharmacology,1,agonist
BCL3,DESMOSTEROL,GuideToPharmacology,1,agonist
AMPH,CPX,GuideToPharmacology,1,agonist
AMPD3,ONO-9780307,GuideToPharmacology,1,inhibitor
EPS15,ACALABRUTINIB,GuideToPharmacology,1,inhibitor
GFER,IOX2,GuideToPharmacology,1,inhibitor
GEM,TAK-418,GuideToPharmacology,1,inhibitor
GGTA1,KDM5 INHIBITOR N71,GuideToPharmacology,1,inhibitor
ERVT4,"(10R)-10-METHYL-3-(6-METHYLPYRIDIN-3-YL)-9,10,11,12-TETRAHYDRO-8H-[1,4]DIAZEPINO[5',6':4,5]THIENO[3,2-F]QUINOLIN-8-ONE",GuideToPharmacology,1,inhibitor
AMY2B,"[3H]MCH (HUMAN, MOUSE, RAT)",GuideToPharmacology,1,agonist
AMY2B,"4-ARYLPHTHALAZIN-1(2H)-3,4-DI-F",GuideToPharmacology,1,inhibitor
AMY2B,"[125I][PHE13,TYR19]MCH",GuideToPharmacology,1,agonist
AMY2B,"[AVA9,10,AVA14,15]-AC-HMCH6-16-NH2",GuideToPharmacology,1,inhibitor
AMY2B,[125I]S36057,GuideToPharmacology,1,inhibitor
ANPEP,MNI-136,GuideToPharmacology,1,modulator
ANOP1,COMPOUND 23I [PMID: 17929793],GuideToPharmacology,1,modulator
NR2F6,TRAMETINIB DIMETHYL SULFOXIDE,GuideToPharmacology,1,inhibitor
CTNS,JNK-IN-8,GuideToPharmacology,1,inhibitor
ERCC3,URMC-099,GuideToPharmacology,1,inhibitor
AADAC,(&PLUSMN;)YM796,GuideToPharmacology,1,agonist
AAMP,ACETYLCHOLINE,GuideToPharmacology,1,agonist
AAMP,[3H]IPEROXO,GuideToPharmacology,1,agonist
AAMP,THIOCHROME,GuideToPharmacology,1,modulator
AAMP,AE9C90CB,GuideToPharmacology,1,inhibitor
AAMP,HEXOCYCLIUM,GuideToPharmacology,1,inhibitor
AAMP,SCOPOLAMINE,GuideToPharmacology,1,inhibitor
AANAT,ACETYLCHOLINE,GuideToPharmacology,1,agonist
AANAT,[3H]IPEROXO,GuideToPharmacology,1,agonist
AANAT,N-CHLOROMETHYL-BRUCINE,GuideToPharmacology,1,modulator
AANAT,4-DAMP,GuideToPharmacology,1,inhibitor
AARS1,OXOTREMORINE,GuideToPharmacology,1,agonist
AANAT,TROPICAMIDE,GuideToPharmacology,1,inhibitor
AARS1,HEXAHYDROSILADIFENIDOL,GuideToPharmacology,1,inhibitor
AARS1,[3H]QNB,GuideToPharmacology,1,inhibitor
AARS1,SCOPOLAMINE,GuideToPharmacology,1,inhibitor
AARS1,TROPICAMIDE,GuideToPharmacology,1,inhibitor
AAVS1,VU0119498,GuideToPharmacology,1,modulator
AAVS1,IPRATROPIUM CATION,GuideToPharmacology,1,inhibitor
AAVS1,AE9C90CB,GuideToPharmacology,1,inhibitor
AAVS1,SOLIFENACIN,GuideToPharmacology,1,inhibitor
ANK2,S24014,GuideToPharmacology,1,agonist
AAVS1,TROPICAMIDE,GuideToPharmacology,1,inhibitor
ANK2,AZD7325,GuideToPharmacology,1,inhibitor
APOF,EG-1-230,GuideToPharmacology,1,agonist
APOF,MT-45,GuideToPharmacology,1,agonist
BAK1,ATX-II,GuideToPharmacology,1,inhibitor
GZMM,SETANAXIB,GuideToPharmacology,1,inhibitor
ATF4,JNJ1930942,GuideToPharmacology,1,modulator
ATF4,&ALPHA;-CONOTOXIN IMI,GuideToPharmacology,1,inhibitor
AQP5,[PHE(ME)7]NEUROKININ B,GuideToPharmacology,1,agonist
AQP5,[PRO7]NEUROKININ B,GuideToPharmacology,1,agonist
APBA1,SR16835,GuideToPharmacology,1,agonist
NMUR2,NEUROMEDIN U-25,GuideToPharmacology,1,agonist
HCL2,ML385,GuideToPharmacology,1,inhibitor
GHSR,COMPOUND 26 [PMID: 21733693],GuideToPharmacology,1,inhibitor
ARAF,ARGIPRESTOCIN,GuideToPharmacology,1,agonist
ARAF,LS-192629,GuideToPharmacology,1,inhibitor
ARAF,"[MPA1,D-TYR(ET)2,D-TIC7,AIB9]OT",GuideToPharmacology,1,inhibitor
ARAF,NELIVAPTAN,GuideToPharmacology,1,inhibitor
ARAF,"L-365,209",GuideToPharmacology,1,inhibitor
APBB2,BMS COMPOUND 16 [PMID:23368907],GuideToPharmacology,1,modulator
APCS,(N)METHANOCARBA-UTP,GuideToPharmacology,1,agonist
ADCYAP1R1,MAXADILAN,GuideToPharmacology,1,agonist
ADCYAP1R1,PG 97-269,GuideToPharmacology,1,inhibitor
APLP2,BN 50739,GuideToPharmacology,1,inhibitor
FOXA3,COMPOUND 20 [PMID: 25091930],GuideToPharmacology,1,inhibitor
BCKDHB,GW2433,GuideToPharmacology,1,agonist
BCKDHB,GSK0660,GuideToPharmacology,1,inhibitor
CCND1,LY-510929,GuideToPharmacology,1,agonist
CCND1,INDOMETHACIN,GuideToPharmacology,1,agonist
F3,COMPOUND 5 [PMID: 34779204],GuideToPharmacology,1,inhibitor
F5,NEOLYMPHOSTIN A,GuideToPharmacology,1,inhibitor
PIK3CB,COMPOUND 82 [PMID: 21332118],GuideToPharmacology,1,inhibitor
F5,VS-5584,GuideToPharmacology,1,inhibitor
PIK3CB,NEOLYMPHOSTIN A,GuideToPharmacology,1,inhibitor
F7,AZD-8186,GuideToPharmacology,1,inhibitor
F7,WORTMANNIN,GuideToPharmacology,1,inhibitor
F7R,AZD6482,GuideToPharmacology,1,inhibitor
F7R,COMPOUND 82 [PMID: 21332118],GuideToPharmacology,1,inhibitor
COL7A1,VINPOCETINE,GuideToPharmacology,1,inhibitor
F13A3,ISA-2011B,GuideToPharmacology,1,inhibitor
COL10A1,LENRISPODUN,GuideToPharmacology,1,inhibitor
COL13A1,BRL50481,GuideToPharmacology,1,inhibitor
GNAI2P1,AZD9574,GuideToPharmacology,1,inhibitor
HMBS,WNT-C59,GuideToPharmacology,1,inhibitor
NBEAP1,"5&BETA;-CHOLESTANE-3&ALPHA;,7&ALPHA;,12&ALPHA;-TRIOL",GuideToPharmacology,1,agonist
FRA6B,AZ4800,GuideToPharmacology,1,inhibitor
NBEAP1,SCHISANDRIN A,GuideToPharmacology,1,agonist
FRA4A,MK-0616,GuideToPharmacology,1,inhibitor
ACSL1,NARMAFOTINIB,GuideToPharmacology,1,inhibitor
ACSL1,CONTELTINIB,GuideToPharmacology,1,inhibitor
XIAP,[PHE23]PTH-(1-34) (HUMAN),GuideToPharmacology,1,agonist
BIRC5,"[ILE5,TRP23]PTHRP-(3-36) (HUMAN)",GuideToPharmacology,1,agonist
BIRC5,"[ILE5,TRP23]PTHRP-(4-36) (HUMAN)",GuideToPharmacology,1,agonist
FAH,SORAFENIB,GuideToPharmacology,1,inhibitor
BAK1P1,"COMPOUND 25 [ZHANG ET AL., 2020]",GuideToPharmacology,1,modulator
TEX28,COMPOUND 33 [PMID: 19364658],GuideToPharmacology,1,inhibitor
DVL1,ILLUDALIC ACID,GuideToPharmacology,1,inhibitor
CXADR,M-2698,GuideToPharmacology,1,inhibitor
APRT,DOTA/EU RELAXIN-3,GuideToPharmacology,1,agonist
APRT,[125I]RELAXIN-3-B/INSL5 A CHIMERA,GuideToPharmacology,1,agonist
APPL1,A(4-24)(B7-24)H2,GuideToPharmacology,1,inhibitor
AMY1B,CYM-5541,GuideToPharmacology,1,modulator
AMY1B,CYM-5541,GuideToPharmacology,1,agonist
AMY1C,CYM-50308,GuideToPharmacology,1,agonist
FAU,DASATINIB ANHYDROUS,GuideToPharmacology,1,inhibitor
HOXA3,UPROLESELAN,GuideToPharmacology,1,inhibitor
STK4,IHMT-MST1-58,GuideToPharmacology,1,inhibitor
FCGR2B,STK16-IN-1,GuideToPharmacology,1,inhibitor
ALOX12,TALADEGIB,GuideToPharmacology,1,inhibitor
FDX1,P505-15,GuideToPharmacology,1,inhibitor
BLVRB,NB-598,GuideToPharmacology,1,inhibitor
BLVRB,COMPOUND 32 [PMID: 19191557],GuideToPharmacology,1,inhibitor
FASLG,GA-DOTA-NOC,GuideToPharmacology,1,agonist
FASLG,CST-17,GuideToPharmacology,1,agonist
FASLG,[L-TYR8]CYN 154806,GuideToPharmacology,1,inhibitor
AQP1,"H-C[CYS-PHE-LAGL(N&BETA;ME,BENZOYL)-TRP-LYS-THR-PHE-CYS]-OH",GuideToPharmacology,1,agonist
AQP1,[125I]CGP 23996,GuideToPharmacology,1,agonist
AQP7,RALMITARONT,GuideToPharmacology,1,agonist
TESK2,COMPOUND 31 [PMID: 22902653],GuideToPharmacology,1,inhibitor
FGF2,SORAFENIB,GuideToPharmacology,1,inhibitor
DOCK3,COMPOUND 13D [PMID: 23639540],GuideToPharmacology,1,inhibitor
ATP2B1,ML204,GuideToPharmacology,1,blocker
ATP2B1,CLEMIZOLE,GuideToPharmacology,1,blocker
ATP2B1,M084,GuideToPharmacology,1,blocker
ATP2B1,2-APB,GuideToPharmacology,1,blocker
MCOLN2,ML SA1,GuideToPharmacology,1,activator
TRPM8,NADA,GuideToPharmacology,1,blocker
ATP5F1BP1,AZD1386,GuideToPharmacology,1,inhibitor
ATP5F1BP1,SB705498,GuideToPharmacology,1,blocker
FGFR4,EMPESERTIB,GuideToPharmacology,1,inhibitor
CDKN2C,SULFINPYRAZONE,GuideToPharmacology,1,inhibitor
FRA9D,COMPOUND 61 [PMID: 36221183],GuideToPharmacology,1,inhibitor
UTS2R,TOLYACETYL-C[DCYS-APA-DTRP-ORN-VAL-CYS]-HIS-AMIDE,GuideToPharmacology,1,inhibitor
CDH13,[125I]7-AZIDO-8-IODOKETANSERINE,GuideToPharmacology,1,inhibitor
ARCN2,PHV,GuideToPharmacology,1,agonist
ARCN1,PACAP-38,GuideToPharmacology,1,agonist
ARCN2,PHM,GuideToPharmacology,1,agonist
AQP9,D[D-PHE2]AVP,GuideToPharmacology,1,agonist
AQP9,"D(CH2)5[D-TYR(ET)2,VAL4,TYR-NH29]AVP",GuideToPharmacology,1,inhibitor
ANXA2P3,SR120819A,GuideToPharmacology,1,inhibitor
ANXA5,"[LEU31,PRO34]PYY (HUMAN)",GuideToPharmacology,1,agonist
A1BG,IPSAPIRONE,GuideToPharmacology,1,agonist
A1BG,SB 216641,GuideToPharmacology,1,agonist
A1BG,(R)-FLUROCARAZOLOL,GuideToPharmacology,1,inhibitor
A2M,7-METHOXY-1-NAPHTHYLPIPERAZINE,GuideToPharmacology,1,agonist
A2M,LY344864,GuideToPharmacology,1,agonist
A2MP1,LY344864,GuideToPharmacology,1,agonist
A2MP1,7-METHOXY-1-NAPHTHYLPIPERAZINE,GuideToPharmacology,1,agonist
A2M,S33084,GuideToPharmacology,1,inhibitor
A2M,RISPERIDONE,GuideToPharmacology,1,inhibitor
A2MP1,5-HYDROXYTRYPTAMINE,GuideToPharmacology,1,agonist
A2MP1,METHYSERGIDE,GuideToPharmacology,1,inhibitor
A2MP1,RU 24969,GuideToPharmacology,1,agonist
A2MP1,RIZATRIPTAN BENZOATE,GuideToPharmacology,1,agonist
A2MP1,RISPERIDONE,GuideToPharmacology,1,inhibitor
A2MP1,ZOTEPINE,GuideToPharmacology,1,inhibitor
A2MP1,RITANSERIN,GuideToPharmacology,1,inhibitor
A2MP1,SPIPERONE,GuideToPharmacology,1,inhibitor
A12M1,5-HYDROXYTRYPTAMINE,GuideToPharmacology,1,agonist
A12M3,[18F]ALTANSERIN,GuideToPharmacology,1,inhibitor
A12M3,SB 215505,GuideToPharmacology,1,inhibitor
A12M4,(-)-NORFENFLURAMINE,GuideToPharmacology,1,agonist
A12M4,SB 216641,GuideToPharmacology,1,agonist
A12M4,SB 242084,GuideToPharmacology,1,inhibitor
HTR2C,FR260010,GuideToPharmacology,1,inhibitor
HTR2C,ZOTEPINE,GuideToPharmacology,1,inhibitor
SERPINA3,LY344864,GuideToPharmacology,1,agonist
SERPINA3,PERPHENAZINE,GuideToPharmacology,1,inhibitor
PLK3,TOFA,GuideToPharmacology,1,inhibitor
CSTF3,(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE,GuideToPharmacology,1,inhibitor
FKBP2,(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE,GuideToPharmacology,1,inhibitor
RBMXP1,RALOXIFENE HYDROCHLORIDE,GuideToPharmacology,1,inhibitor
FKBP2,COMPOUND E22 [PMID: 31298542],GuideToPharmacology,1,inhibitor
ABCB7,RISPERIDONE,GuideToPharmacology,1,inhibitor
ABCB7,NIGULDIPINE,GuideToPharmacology,1,inhibitor
ABCB7,ALFUZOSIN,GuideToPharmacology,1,inhibitor
ABCB7,NS-49,GuideToPharmacology,1,agonist
ACE2,XNT [PMID: 18391097],GuideToPharmacology,1,activator
EEF1B2,LY3009120,GuideToPharmacology,1,inhibitor
ACADSB,APELIN-36,GuideToPharmacology,1,agonist
ACADSB,COMPOUND 1 [PMID: 25241924],GuideToPharmacology,1,agonist
EEF1B2,LIFIRAFENIB,GuideToPharmacology,1,inhibitor
ACADSB,ELABELA/TODDLER-21,GuideToPharmacology,1,agonist
BST2,PI-THERAPHOTOXIN-HM3A,GuideToPharmacology,1,blocker
ABAT,CGS 21680,GuideToPharmacology,1,agonist
ACTBP4,CCL21B,GuideToPharmacology,1,agonist
E4F1,AFM13,GuideToPharmacology,1,antibody
CELA1,MW01,GuideToPharmacology,1,inhibitor
ACTG1P7,CHEMERIN C-TERMINAL PEPTIDE,GuideToPharmacology,1,agonist
EIF5AP3,COMPOUND 33 [PMID: 19364658],GuideToPharmacology,1,inhibitor
CHEK2,CHK2 INHIBITOR II,GuideToPharmacology,1,inhibitor
ACTG1P9,OSTN (81-102),GuideToPharmacology,1,agonist
EIF5AP3,CCT241533,GuideToPharmacology,1,inhibitor
EIF5AP3,BX-912,GuideToPharmacology,1,inhibitor
CHEK2,CCT245737,GuideToPharmacology,1,inhibitor
CD2,HEMICHOLINIUM-3,GuideToPharmacology,1,inhibitor
CLNS1AP1,HEMICHOLINIUM-3,GuideToPharmacology,1,inhibitor
DPYD,CHMFL-KIT-64,GuideToPharmacology,1,inhibitor
DPYD,SOTULETINIB,GuideToPharmacology,1,inhibitor
CHUK,PHA-408,GuideToPharmacology,1,inhibitor
CPT1B,INDOMETHACIN,GuideToPharmacology,1,inhibitor
GLG1,TTK21,GuideToPharmacology,1,activator
ALAS2,SSR125543A,GuideToPharmacology,1,inhibitor
ALAS2,UROTENSIN 1 (FISH),GuideToPharmacology,1,agonist
ACHE,PRAMLINTIDE,GuideToPharmacology,1,agonist
ALB,UROCORTIN 3,GuideToPharmacology,1,agonist
ALB,[125I]ASTRESSIN,GuideToPharmacology,1,inhibitor
DTX1,LORLATINIB,GuideToPharmacology,1,inhibitor
ACTBP8,NAVARIXIN,GuideToPharmacology,1,inhibitor
ACTBP9,CXCL3,GuideToPharmacology,1,agonist
EGR4,AZD5438,GuideToPharmacology,1,inhibitor
EGR4,CDK2 INHIBITOR IV,GuideToPharmacology,1,inhibitor
EGR4,"(7S)-2-(2-AMINOPYRIMIDIN-4-YL)-7-(2-FLUOROETHYL)-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE",GuideToPharmacology,1,inhibitor
EGR4,VORUCICLIB,GuideToPharmacology,1,inhibitor
EGR4,DINACICLIB,GuideToPharmacology,1,inhibitor
CDK19,PEXIDARTINIB,GuideToPharmacology,1,inhibitor
COX6A1,RITONAVIR,GuideToPharmacology,1,inhibitor
DAPK1,COMPOUND 9 [PMID: 20718420],GuideToPharmacology,1,inhibitor
DAPK1,LINAGLIPTIN,GuideToPharmacology,1,inhibitor
DAPK1,ANAGLIPTIN,GuideToPharmacology,1,inhibitor
DAPK1,ALOGLIPTIN,GuideToPharmacology,1,inhibitor
BLMH,6-FLUOROMEVALONATE PYROPHOSPHATE,GuideToPharmacology,1,inhibitor
ELNL1,COMPOUND 5N [PMID: 20483621],GuideToPharmacology,1,inhibitor
ELN,DCLK1-IN-1,GuideToPharmacology,1,inhibitor
GBX2,DOXORUBICIN HYDROCHLORIDE,GuideToPharmacology,1,inhibitor
HOXD1,OLEANOLIC ACID,GuideToPharmacology,1,inhibitor
APOB,TG11-77,GuideToPharmacology,1,inhibitor
ALCAM,SKF-82958,GuideToPharmacology,1,agonist
ABCD1,CARIPRAZINE,GuideToPharmacology,1,agonist
ALCAM,SCH-23390,GuideToPharmacology,1,inhibitor
GRK3,(R)-ZINC-3573,GuideToPharmacology,1,agonist
DMTN,PHA-408,GuideToPharmacology,1,inhibitor
DPH1,AZD3463,GuideToPharmacology,1,inhibitor
DPH1,NVP-TAE 226,GuideToPharmacology,1,inhibitor
APOC3,CICAPROST,GuideToPharmacology,1,agonist
BMPR2,L-PHE-PHE-PHE,GuideToPharmacology,1,agonist
BRCA2,DATISCETIN,GuideToPharmacology,1,agonist
ZFP36L2,GROSHEIMIN,GuideToPharmacology,1,agonist
EPHB1,DECERNOTINIB,GuideToPharmacology,1,inhibitor
EPHB1,COMPOUND 8L [PMID: 36053746],GuideToPharmacology,1,inhibitor
BNIP3,PARTHENOLIDE,GuideToPharmacology,1,agonist
BNIP3L,PROCAINAMIDE,GuideToPharmacology,1,agonist
EPHB1,UPADACITINIB,GuideToPharmacology,1,inhibitor
EPHB2,GUSACITINIB,GuideToPharmacology,1,inhibitor
EPHB3,PEFICITINIB,GuideToPharmacology,1,inhibitor
EPHB3,PF-956980,GuideToPharmacology,1,inhibitor
FRA2G,BEROTRALSTAT,GuideToPharmacology,1,inhibitor
DRD2,ALTIRATINIB,GuideToPharmacology,1,inhibitor
DPT,LINIFANIB,GuideToPharmacology,1,inhibitor
GPM6B,COMPOUND 25 [PMID: 32023060],GuideToPharmacology,1,inhibitor
ATP5PB,HALOTHANE,GuideToPharmacology,1,activator
ARF4P1,SLOTOXIN,GuideToPharmacology,1,blocker
ASCL1,MK-8153,GuideToPharmacology,1,blocker
ARG2,CHLORZOXAZONE,GuideToPharmacology,1,activator
ALDH7A1P2,RESINIFERATOXIN,GuideToPharmacology,1,blocker
CCND3,KYT-0353,GuideToPharmacology,1,inhibitor
GLI3,N-(3-AMINOPROPYL)-2-NITROBENZENAMINE,GuideToPharmacology,1,inhibitor
GUCY1B1,JNJ-67856633,GuideToPharmacology,1,inhibitor
KDM5C,GSK-J1,GuideToPharmacology,1,inhibitor
GGTL2,GSK-J4,GuideToPharmacology,1,inhibitor
GGTL2,GSK-J1,GuideToPharmacology,1,inhibitor
ANGPT2,MT-II,GuideToPharmacology,1,agonist
ANGPT1,AFAMELANOTIDE,GuideToPharmacology,1,agonist
ANGPT1,&GAMMA;-MSH,GuideToPharmacology,1,agonist
ETFB,PP-121,GuideToPharmacology,1,inhibitor
ETFB,PI-103,GuideToPharmacology,1,inhibitor
ETFB,VISTUSERTIB,GuideToPharmacology,1,inhibitor
ETFB,EVEROLIMUS,GuideToPharmacology,1,inhibitor
CYP2J2,M8891,GuideToPharmacology,1,inhibitor
DTNA,UNC4203,GuideToPharmacology,1,inhibitor
SLC25A6,DIPRAGLURANT,GuideToPharmacology,1,modulator
SLC25A6,COMPOUND 10 [PMID: 15482908],GuideToPharmacology,1,modulator
CTNNA1,RINETERKIB,GuideToPharmacology,1,inhibitor
CENPE,BONGKREK ACID,GuideToPharmacology,1,inhibitor
CTNND2,COMPOUND 4E [PMID: 35546685],GuideToPharmacology,1,inhibitor
CTNND1,COMPOUND 4E [PMID: 35546685],GuideToPharmacology,1,inhibitor
CTNND1,RALIMETINIB,GuideToPharmacology,1,inhibitor
CTNNB1,TAK-715,GuideToPharmacology,1,inhibitor
MAPK3,RAVOXERTINIB,GuideToPharmacology,1,inhibitor
ERG,COMPOUND 5N [PMID: 20483621],GuideToPharmacology,1,inhibitor
EYA4,URMC-099,GuideToPharmacology,1,inhibitor
ERCM1,COMPOUND 1 [PMID: 24793884],GuideToPharmacology,1,inhibitor
ERVT1,BOSUTINIB,GuideToPharmacology,1,inhibitor
DCR,[18F]FMBP,GuideToPharmacology,1,inhibitor
CRKL,SA-57,GuideToPharmacology,1,inhibitor
CRKL,COMPOUND 4F [PMID: 34328319],GuideToPharmacology,1,inhibitor
CDC6,BAY-8002,GuideToPharmacology,1,inhibitor
ANTP4,ME67,GuideToPharmacology,1,agonist
AADAC,N-CHLOROMETHYL-BRUCINE,GuideToPharmacology,1,modulator
ANK3,4P-PDOT,GuideToPharmacology,1,inhibitor
ANK3,DH97,GuideToPharmacology,1,inhibitor
APOH,RAG8,GuideToPharmacology,1,inhibitor
APOE,GB88,GuideToPharmacology,1,inhibitor
GPX3,CL-AMIDINE,GuideToPharmacology,1,inhibitor
F7,DUVELISIB,GuideToPharmacology,1,inhibitor
F7,SAPANISERTIB,GuideToPharmacology,1,inhibitor
F2L,PHENYLARSINE OXIDE,GuideToPharmacology,1,inhibitor
F7R,TENALISIB,GuideToPharmacology,1,inhibitor
F7R,PP-121,GuideToPharmacology,1,inhibitor
F7R,VS-5584,GuideToPharmacology,1,inhibitor
F2R,COMPOUND 22 [WO2019141694A1],GuideToPharmacology,1,inhibitor
F2L,WORTMANNIN,GuideToPharmacology,1,inhibitor
COL15A1,BRL50481,GuideToPharmacology,1,inhibitor
F9,COMPOUND 2 [PMID: 22560567],GuideToPharmacology,1,inhibitor
F9,CX-5011,GuideToPharmacology,1,inhibitor
F10,CX-6258,GuideToPharmacology,1,inhibitor
F10,COMPOUND 28 [PMID: 30624936],GuideToPharmacology,1,inhibitor
APOA1,TRIAZINE COMPOUND PC1,GuideToPharmacology,1,inhibitor
APOA1,PROKINETICIN-1,GuideToPharmacology,1,agonist
MAPK14,(S)-23 [PMID: 27933945],GuideToPharmacology,1,inhibitor
DPP6,LINIFANIB,GuideToPharmacology,1,inhibitor
DPP4,PP-121,GuideToPharmacology,1,inhibitor
DPP6,PD166285,GuideToPharmacology,1,inhibitor
FABP1,RO3280,GuideToPharmacology,1,inhibitor
DPP6,3-[(3-(2-CARBOXYETHYL)-4-METHYLPYRROL-2-YL)METHYLENE]-2-INDOLINONE,GuideToPharmacology,1,inhibitor
GNAI2P1,NIRAPARIB,GuideToPharmacology,1,inhibitor
PRMT5,MRTX1719,GuideToPharmacology,1,inhibitor
CNGA1,MS023,GuideToPharmacology,1,inhibitor
GOLGA1,BAY-8400,GuideToPharmacology,1,inhibitor
CTLA4,COMPOUND 32 [PMID: 20471253],GuideToPharmacology,1,inhibitor
CTF1,CRT 0066101,GuideToPharmacology,1,inhibitor
CTF1,BPKDI,GuideToPharmacology,1,inhibitor
FABP4,PD166285,GuideToPharmacology,1,inhibitor
HOXC8,JMS-053,GuideToPharmacology,1,inhibitor
GP1BA,"(4Z)-1-(3-FLUOROPHENYL)-4-(2-OXO-1H-INDOL-3-YLIDENE)PYRAZOLIDINE-3,5-DIONE",GuideToPharmacology,1,inhibitor
FANCG,RIPK1 INHIBITOR 22B,GuideToPharmacology,1,inhibitor
GOLGA2,COMPOUND II [PMID: 29351497],GuideToPharmacology,1,inhibitor
RIPK2,PN10,GuideToPharmacology,1,inhibitor
FRA7F,SITOKIREN,GuideToPharmacology,1,inhibitor
BCHE,ALITRETINOIN,GuideToPharmacology,1,agonist
HCN2,ALITRETINOIN,GuideToPharmacology,1,agonist
RXRG,"COMPOUND 28 [HEITEL ET AL., 2019]",GuideToPharmacology,1,agonist
BCHEL3,AGN193109,GuideToPharmacology,1,inhibitor
CTPS1,COMPOUND E22 [PMID: 31298542],GuideToPharmacology,1,inhibitor
PTK2B,PRALSETINIB,GuideToPharmacology,1,inhibitor
ABCA1,CGS 15943,GuideToPharmacology,1,inhibitor
ABCD1,[3H]PD128907,GuideToPharmacology,1,agonist
AQP8,MB-28767,GuideToPharmacology,1,agonist
ACTB,[3H]BANYU (I),GuideToPharmacology,1,inhibitor
ALS3,FSH DEGLYCOSYLATED &ALPHA;/&BETA;,GuideToPharmacology,1,inhibitor
ARSF,TRACAZOLATE,GuideToPharmacology,1,agonist
A1BG,[11C]WAY100635,GuideToPharmacology,1,inhibitor
EEF2,GSK1070916,GuideToPharmacology,1,inhibitor
GCLC,GSK852,GuideToPharmacology,1,inhibitor
BUB1,NPPB,GuideToPharmacology,1,blocker
FPGS,VILDAGLIPTIN,GuideToPharmacology,1,inhibitor
ALDH1A1,[3H]NEMONAPRIDE,GuideToPharmacology,1,inhibitor
GAPDHP1,ENTINOSTAT,GuideToPharmacology,1,inhibitor
MPPED2,DECAVANADATE,GuideToPharmacology,1,inhibitor
FCAR,SLM6071469,GuideToPharmacology,1,inhibitor
ABCA3,MRS928,GuideToPharmacology,1,inhibitor
APAF1,DIHYDROMORPHINE,GuideToPharmacology,1,agonist
ALCAM,SKF-83959,GuideToPharmacology,1,agonist
TRPV6,ACETALDEHYDE,GuideToPharmacology,1,activator
AAMP,VINBURNINE,GuideToPharmacology,1,modulator
SERPINA3,HALOPERIDOL DECANOATE,GuideToPharmacology,1,inhibitor
EFNA4,COMPOUND 3 [PMID: 25408830],GuideToPharmacology,1,inhibitor
GARS1,RICOLINOSTAT,GuideToPharmacology,1,inhibitor
DST,DENATONIUM,GuideToPharmacology,1,agonist
A12M3,PSILOCIN,GuideToPharmacology,1,agonist
FASLG,NC 4-28B,GuideToPharmacology,1,agonist
GRIN2B,(RS)-(TETRAZOL-5-YL)GLYCINE,GuideToPharmacology,1,agonist
BLVRA,INCADRONIC ACID,GuideToPharmacology,1,inhibitor
CTF1,KB-NB142-70,GuideToPharmacology,1,inhibitor
GART,DROXINOSTAT,GuideToPharmacology,1,inhibitor
A12M3,"L-741,626",GuideToPharmacology,1,inhibitor
PIK3CB,COMPOUND 2Q [PMID: 30986068],GuideToPharmacology,1,inhibitor
COL8A2,CALMODULIN,GuideToPharmacology,1,activator
GLG1,I-CBP112,GuideToPharmacology,1,inhibitor
C3AR1,OCTANOL,GuideToPharmacology,1,inhibitor
A12M3,[11C]VOLINANSERIN,GuideToPharmacology,1,inhibitor
TRPM5,FLUFENAMIC ACID,GuideToPharmacology,1,blocker
BCGF1,RESMETIROM,GuideToPharmacology,1,agonist
AMELX,4-METHYLHISTAMINE,GuideToPharmacology,1,agonist
TAS2R46,DENATONIUM,GuideToPharmacology,1,agonist
CSHL1,PROPARGYLGLYCINE,GuideToPharmacology,1,inhibitor
ALDH1B1,[3H]BQ123,GuideToPharmacology,1,inhibitor
AARS1,PENTYLTHIO-TZTP,GuideToPharmacology,1,agonist
C6,CA2+,GuideToPharmacology,1,inhibitor
EZH2,JQEZ5,GuideToPharmacology,1,inhibitor
TLE5,COMPOUND 7E [PMID: 21571530],GuideToPharmacology,1,inhibitor
FRA17A,ECOTHIOPATE,GuideToPharmacology,1,inhibitor
ANOP1,LY367385,GuideToPharmacology,1,inhibitor
ABCD1,TRIFLUOPERAZINE,GuideToPharmacology,1,inhibitor
AADAC,PENTYLTHIO-TZTP,GuideToPharmacology,1,agonist
ABL1,LISURIDE,GuideToPharmacology,1,inhibitor
BAK1P2,GW3965,GuideToPharmacology,1,agonist
MPL,LUSUTROMBOPAG,GuideToPharmacology,1,agonist
SLC26A3,FISOGATINIB,GuideToPharmacology,1,inhibitor
ARRB1,BREXANOLONE,GuideToPharmacology,1,modulator
DRD5P1,CEP-11981,GuideToPharmacology,1,inhibitor
CHEK2,COMPOUND 25B [PMID: 22564207],GuideToPharmacology,1,inhibitor
STOM,MRT67307,GuideToPharmacology,1,inhibitor
EPHA3,BELIZATINIB,GuideToPharmacology,1,inhibitor
ANPEP,COMPOUND 2 [PMID: 21105727],GuideToPharmacology,1,modulator
ANGPT1,HS024,GuideToPharmacology,1,inhibitor
ABL1,PERGOLIDE,GuideToPharmacology,1,agonist
ABCA2,MRE 3008F20,GuideToPharmacology,1,inhibitor
EIF4E,1-AZAKENPAULLONE,GuideToPharmacology,1,inhibitor
DPP4,NINTEDANIB ESYLATE,GuideToPharmacology,1,inhibitor
FXYD2,LA3+,GuideToPharmacology,1,blocker
ALDH1A1,PROMAZINE,GuideToPharmacology,1,inhibitor
BAK1,TETRODOTOXIN,GuideToPharmacology,1,blocker
CD8B,DESIPRAMINE,GuideToPharmacology,1,inhibitor
DPT,KI-20227,GuideToPharmacology,1,inhibitor
KEAP1,NRF2 PEPTIDE [PMID: 23647822],GuideToPharmacology,1,inhibitor
SLC25A6,COMPOUND 13 [PMID: 15686941],GuideToPharmacology,1,modulator
NR2F6,BI-847325,GuideToPharmacology,1,inhibitor
CD9,DESIPRAMINE,GuideToPharmacology,1,inhibitor
ATP6AP1,SUVECALTAMIDE,GuideToPharmacology,1,blocker
XIAP,"[ILE5,TRP23]PTHRP-(5-36)",GuideToPharmacology,1,inhibitor
ANXA3,JNJ-5207787,GuideToPharmacology,1,inhibitor
APOC1,TG7-171,GuideToPharmacology,1,inhibitor
ASPH,JORO SPIDER TOXIN,GuideToPharmacology,1,blocker
ANOP1,MK-5435,GuideToPharmacology,1,modulator
AQP9,"D(CH2)5[TYR(ME)2,THR4,PHE(3I,4N3)-NH29]OVT",GuideToPharmacology,1,inhibitor
EGR4,RGB-286638,GuideToPharmacology,1,inhibitor
A12M3,FLUPHENAZINE HYDROCHLORIDE,GuideToPharmacology,1,inhibitor
AMELY,[125I]KISSPEPTIN-10 (HUMAN),GuideToPharmacology,1,agonist
ARAF,ARGIPRESSIN,GuideToPharmacology,1,agonist
DPP6,HENATINIB,GuideToPharmacology,1,inhibitor
GRB10,LM10,GuideToPharmacology,1,inhibitor
ATP4B,AMP-PNP,GuideToPharmacology,1,inhibitor
APOB,TG6-129,GuideToPharmacology,1,inhibitor
GNRHR,ELAGOLIX,GuideToPharmacology,1,inhibitor
AQP3,VESTIPITANT,GuideToPharmacology,1,inhibitor
CDKN2B,CEPHALOTHIN,GuideToPharmacology,1,inhibitor
ABCA3,VUF8504,GuideToPharmacology,1,inhibitor
DRD3,DOVITINIB,GuideToPharmacology,1,inhibitor
EFNA1,JNJ-64264681,GuideToPharmacology,1,inhibitor
A1BG,[3H]WAY100635,GuideToPharmacology,1,inhibitor
A2M,ALNIDITAN,GuideToPharmacology,1,agonist
A2M,ZOLMITRIPTAN,GuideToPharmacology,1,agonist
A12M1,5-MEO-DMT,GuideToPharmacology,1,agonist
A12M2,ZOLMITRIPTAN,GuideToPharmacology,1,agonist
A12M2,TRYPTAMINE,GuideToPharmacology,1,agonist
A12M3,5-MEOT,GuideToPharmacology,1,agonist
A12M3,PINDOLOL,GuideToPharmacology,1,agonist
A12M3,PINDOLOL,GuideToPharmacology,1,inhibitor
A12M3,AL-37350A,GuideToPharmacology,1,agonist
A12M3,N-1-ISOPROPYLTRYPTAMINE,GuideToPharmacology,1,agonist
A12M3,S 16924,GuideToPharmacology,1,agonist
A12M4,ERGOTAMINE,GuideToPharmacology,1,agonist
A12M4,QUIPAZINE,GuideToPharmacology,1,agonist
HTR2C,PERGOLIDE,GuideToPharmacology,1,agonist
HTR2C,ERGOTAMINE,GuideToPharmacology,1,agonist
HTR2C,SB 224289,GuideToPharmacology,1,inhibitor
NATP,DIMETHYLTRYPTAMINE,GuideToPharmacology,1,agonist
NATP,METITEPINE,GuideToPharmacology,1,inhibitor
ABCG2,CYCLOSPORINE,GuideToPharmacology,1,inhibitor
DNM2,ML347,GuideToPharmacology,1,inhibitor
ACTG1P8,CXCL11,GuideToPharmacology,1,agonist
HBEGF,ENSARTINIB,GuideToPharmacology,1,inhibitor
GAPDHP69,DUVOGLUSTAT,GuideToPharmacology,1,inhibitor
ABCF1,A-119637,GuideToPharmacology,1,inhibitor
ABCF1,A61603,GuideToPharmacology,1,agonist
ABCA4,LABETALOL,GuideToPharmacology,1,inhibitor
AOC1,CHLORPROMAZINE,GuideToPharmacology,1,inhibitor
AOC1,YOHIMBINE,GuideToPharmacology,1,inhibitor
BEVI,METRIBOLONE,GuideToPharmacology,1,agonist
DAPK3,CILAZAPRIL,GuideToPharmacology,1,inhibitor
ABAT,FK-453,GuideToPharmacology,1,inhibitor
ABCA1,APNEA,GuideToPharmacology,1,agonist
ABCA1,CYCLOPENTYLADENOSINE,GuideToPharmacology,1,agonist
ABCA3,MRS1093,GuideToPharmacology,1,inhibitor
ACADS,ANGIOTENSIN III,GuideToPharmacology,1,agonist
ACADS,COMPOUND 2 [PMID: 28379944],GuideToPharmacology,1,inhibitor
EEF1D,COMPOUND 10 [PMID: 19402633],GuideToPharmacology,1,inhibitor
GNG11,GDC-0152,GuideToPharmacology,1,inhibitor
FMO5,COMPOUND 3L [PMID: 30637955],GuideToPharmacology,1,inhibitor
ABO,DENOPAMINE,GuideToPharmacology,1,agonist
ABO,CARAZOLOL,GuideToPharmacology,1,inhibitor
ABR,CLENBUTEROL,GuideToPharmacology,1,agonist
EEGV1,CEP-11981,GuideToPharmacology,1,inhibitor
AMFR,20-HYDROXY-LTB4,GuideToPharmacology,1,agonist
DNMT1,COMPOUND 13A [PMID: 23639540],GuideToPharmacology,1,inhibitor
EFNA3,GSK852,GuideToPharmacology,1,inhibitor
BRD3,APABETALONE,GuideToPharmacology,1,inhibitor
EFNA3,GW841819X,GuideToPharmacology,1,inhibitor
EFNA4,COMPOUND 1 [PMID: 25408830],GuideToPharmacology,1,inhibitor
EFNA4,MS417,GuideToPharmacology,1,inhibitor
EFNA4,GW841819X,GuideToPharmacology,1,inhibitor
BRD7,TP-472,GuideToPharmacology,1,inhibitor
EFNB2,COMPOUND 36 [PMID: 21958547],GuideToPharmacology,1,inhibitor
EFNB2,EXAMPLE A225 [WO2012170976A2],GuideToPharmacology,1,inhibitor
EFNB2,CHMFL-BTK-11,GuideToPharmacology,1,inhibitor
ASIC1,"[DES-PHE9,DES-ARG10]KALLIDIN",GuideToPharmacology,1,agonist
ASIC1,JMV1431,GuideToPharmacology,1,inhibitor
ASIC1,NVP-SAA164,GuideToPharmacology,1,inhibitor
ASIC1,"[D-LYS1,DES-ARG10]KALLIDIN",GuideToPharmacology,1,agonist
ASIC1,[DES-ARG10]ICATIBANT,GuideToPharmacology,1,inhibitor
BDKRB2,ANATIBANT,GuideToPharmacology,1,inhibitor
ACACB,NDT9513727,GuideToPharmacology,1,agonist
ACACB,LACTOMEDIN 1,GuideToPharmacology,1,agonist
ACACA,E7,GuideToPharmacology,1,agonist
GAPDH,DICHLORPHENAMIDE,GuideToPharmacology,1,inhibitor
CA4,DICHLORPHENAMIDE,GuideToPharmacology,1,inhibitor
CACNA1F,BAYK 8644,GuideToPharmacology,1,activator
ATP6V1G2,NI2+,GuideToPharmacology,1,blocker
FOLR2,CALPEPTIN,GuideToPharmacology,1,inhibitor
FOS,PETESICATIB,GuideToPharmacology,1,inhibitor
ACTA2,BMS-681,GuideToPharmacology,1,inhibitor
ACTBP2,FLU-CCL3,GuideToPharmacology,1,agonist
CELA1,ML315,GuideToPharmacology,1,inhibitor
CELA1,MW05,GuideToPharmacology,1,inhibitor
FRA22A,NVP 231,GuideToPharmacology,1,inhibitor
C1R,FLUFENAMIC ACID,GuideToPharmacology,1,inhibitor
GJB1,FLUFENAMIC ACID,GuideToPharmacology,1,inhibitor
C4BPAP2,CA2+,GuideToPharmacology,1,inhibitor
GJB1,OCTANOL,GuideToPharmacology,1,inhibitor
C6,OCTANOL,GuideToPharmacology,1,inhibitor
C5AR1,CA2+,GuideToPharmacology,1,inhibitor
ACTC1,ACT-777991,GuideToPharmacology,1,inhibitor
EIF4A1,COMPOUND 3 [PMID: 19097791],GuideToPharmacology,1,inhibitor
EIF4A1,PURVALANOL B,GuideToPharmacology,1,inhibitor
CDK4,FASCAPLYSIN,GuideToPharmacology,1,inhibitor
CDK4,ULECACICLIB,GuideToPharmacology,1,inhibitor
CDK4,PURVALANOL B,GuideToPharmacology,1,inhibitor
CDK4,BMS-387032,GuideToPharmacology,1,inhibitor
EIF4E,MILCICLIB,GuideToPharmacology,1,inhibitor
EIF4EBP1,TANUXICICLIB,GuideToPharmacology,1,inhibitor
EIF4EBP1,ULECACICLIB,GuideToPharmacology,1,inhibitor
EIF4E,PURVALANOL B,GuideToPharmacology,1,inhibitor
EIF4EBP2,THZ1,GuideToPharmacology,1,inhibitor
EIF4EBP2,MILCICLIB,GuideToPharmacology,1,inhibitor
EIF4EP1,"COMPOUND 20 [BERGERON ET AL., 2016]",GuideToPharmacology,1,inhibitor
EIF4G1,BMS-387032,GuideToPharmacology,1,inhibitor
ENO3,BARICITINIB,GuideToPharmacology,1,inhibitor
COX5B,AJMALICINE,GuideToPharmacology,1,inhibitor
CYP1B1,CHRYSIN,GuideToPharmacology,1,inhibitor
MAP3K8,VOXELOTOR,GuideToPharmacology,1,inhibitor
AMPD1,LTE4,GuideToPharmacology,1,agonist
CD8B2,MAZINDOL,GuideToPharmacology,1,inhibitor
APAF1,UFP-512,GuideToPharmacology,1,agonist
CD8B2,METHYLPHENIDATE HYDROCHLORIDE,GuideToPharmacology,1,inhibitor
APAF1,[D-ALA2]DELTORPHIN II,GuideToPharmacology,1,agonist
APAF1,AT-076,GuideToPharmacology,1,inhibitor
FPR1,ICED-2,GuideToPharmacology,1,inhibitor
ALDH1A1,PIMOZIDE,GuideToPharmacology,1,inhibitor
ALDH1A1,PEROSPIRONE,GuideToPharmacology,1,inhibitor
ALDH3A1,HALOPERIDOL DECANOATE,GuideToPharmacology,1,inhibitor
NPBWR2,ROXADUSTAT,GuideToPharmacology,1,inhibitor
NOS3,L-NNA,GuideToPharmacology,1,inhibitor
ERAP2,COMPOUND 2G [PMID: 27390066],GuideToPharmacology,1,inhibitor
DARS1,PD159790,GuideToPharmacology,1,inhibitor
EZH2,TULMIMETOSTAT,GuideToPharmacology,1,inhibitor
DXO,BI-4142,GuideToPharmacology,1,inhibitor
BLVRA,PAMIDRONATE,GuideToPharmacology,1,inhibitor
DPYSL2,CATEQUENTINIB,GuideToPharmacology,1,inhibitor
DPYSL2,ROGARATINIB,GuideToPharmacology,1,inhibitor
DPYSL2,"COMPOUND 7 [NGUYEN ET AL., 2023]",GuideToPharmacology,1,inhibitor
DPYSL2,TOCERANIB,GuideToPharmacology,1,inhibitor
SLC26A3,"COMPOUND 7 [NGUYEN ET AL., 2023]",GuideToPharmacology,1,inhibitor
DR1,ROGARATINIB,GuideToPharmacology,1,inhibitor
DR1,NINTEDANIB ESYLATE,GuideToPharmacology,1,inhibitor
SLC26A3,FUTIBATINIB,GuideToPharmacology,1,inhibitor
DRD1,CATEQUENTINIB,GuideToPharmacology,1,inhibitor
DRD1,DOVITINIB,GuideToPharmacology,1,inhibitor
ONECUT1,SAFIT1,GuideToPharmacology,1,inhibitor
DPYS,COMPOUND 18E [PMID: 31670517],GuideToPharmacology,1,inhibitor
DRD3,ILORASERTIB,GuideToPharmacology,1,inhibitor
ALDH3B2,COMPOUND R-(-)-5F [PMID: 22607879],GuideToPharmacology,1,agonist
ALDH3B2,FMET-ILE-VAL-THR-LEU-PHE,GuideToPharmacology,1,agonist
DRD3,NINTEDANIB ESYLATE,GuideToPharmacology,1,inhibitor
ALDH3B2,CYCLOSPORINE,GuideToPharmacology,1,inhibitor
ALDH9A1,QUIN-C1,GuideToPharmacology,1,agonist
ALDH9A1,ATLA2,GuideToPharmacology,1,agonist
ALDH9A1,LXA4,GuideToPharmacology,1,agonist
ALS3,UROFOLLITROPIN,GuideToPharmacology,1,agonist
FZD7,SRI37892,GuideToPharmacology,1,inhibitor
GABRA1,RO4938581,GuideToPharmacology,1,modulator
ARNT,ZK93423,GuideToPharmacology,1,agonist
ARNT,TP003,GuideToPharmacology,1,modulator
GABRA1,GANAXOLONE,GuideToPharmacology,1,modulator
GABRA1,RO19-4603,GuideToPharmacology,1,modulator
GABRA1,[35S]TBPS,GuideToPharmacology,1,blocker
GALR2,GAL-B2-DPEG24,GuideToPharmacology,1,agonist
GALR2,M617,GuideToPharmacology,1,agonist
GALR2,M40,GuideToPharmacology,1,inhibitor
ALOX12P2,M1151,GuideToPharmacology,1,agonist
CXCR5,BPH-742,GuideToPharmacology,1,inhibitor
BDM,TRIAMCINOLONE,GuideToPharmacology,1,agonist
ASS1P6,CONCANAVALIN A,GuideToPharmacology,1,modulator
ASS1P5,NS3763,GuideToPharmacology,1,inhibitor
GRIN2B,SELFOTEL,GuideToPharmacology,1,inhibitor
GRIN2B,KETAMINE HYDROCHLORIDE,GuideToPharmacology,1,blocker
GNRHR,GNRH I,GuideToPharmacology,1,agonist
ACADVL,COMPOUND 15 [PMID: 25411721],GuideToPharmacology,1,agonist
GNRHR,D-23487,GuideToPharmacology,1,inhibitor
GNRHR,FD-1,GuideToPharmacology,1,modulator
GNRHR,FD-1,GuideToPharmacology,1,inhibitor
ACP3,SERINE,GuideToPharmacology,1,agonist
SLC25A10,BALANOL,GuideToPharmacology,1,inhibitor
CST2,BALANOL,GuideToPharmacology,1,inhibitor
ENUR1,GUANYLYL CYCLASE-ACTIVATING PROTEIN 2,GuideToPharmacology,1,activator
GRIN2B,GRP94 INHIBITOR 54,GuideToPharmacology,1,inhibitor
GAPDHL17,COMPOUND 30 [PMID: 37057760],GuideToPharmacology,1,inhibitor
GDF2,ENTINOSTAT,GuideToPharmacology,1,inhibitor
GARS1,DROXINOSTAT,GuideToPharmacology,1,inhibitor
GART,NEXTURASTAT A,GuideToPharmacology,1,inhibitor
AMD1,CHLORPROTHIXENE,GuideToPharmacology,1,inhibitor
AMD1,2-(3-IODOPHENYL)HISTAMINE,GuideToPharmacology,1,agonist
AMD1,CLEMASTINE,GuideToPharmacology,1,inhibitor
AMD1,DESLORATADINE,GuideToPharmacology,1,inhibitor
AMD1P2,BURIMAMIDE,GuideToPharmacology,1,agonist
AMD1P2,IMPROMIDINE,GuideToPharmacology,1,agonist
AMD1P2,ARPROMIDINE,GuideToPharmacology,1,agonist
HRH3,A-317920,GuideToPharmacology,1,inhibitor
HRH3,FUB 349,GuideToPharmacology,1,inhibitor
PRDM1,"COMPOUND 2 [DREYER ET AL., 1991]",GuideToPharmacology,1,inhibitor
ADAM10,BUMETANIDE,GuideToPharmacology,1,agonist
ADAM8,LYSOPHOSPHATIDYLSERINE,GuideToPharmacology,1,agonist
GRK3,GPR15L,GuideToPharmacology,1,agonist
STOM,BX-795,GuideToPharmacology,1,inhibitor
CSNK1D,"COMPOUND 5 [NOBLE ET AL., 1992]",GuideToPharmacology,1,inhibitor
MPPED2,CA2+,GuideToPharmacology,1,activator
MYRF,DECAVANADATE,GuideToPharmacology,1,inhibitor
FOXL2,HOMOERIODICTYOL,GuideToPharmacology,1,agonist
MYRF,CA2+,GuideToPharmacology,1,activator
EPHB3,GDC-0214,GuideToPharmacology,1,inhibitor
EPHB3,COMPOUND 19A [PMID: 24359159],GuideToPharmacology,1,inhibitor
NUDT2,U69593,GuideToPharmacology,1,agonist
NUDT2,DYNORPHIN A,GuideToPharmacology,1,agonist
NUDT2,SALVINORIN A,GuideToPharmacology,1,agonist
DRD2,FAMITINIB,GuideToPharmacology,1,inhibitor
DRD2,ILORASERTIB,GuideToPharmacology,1,inhibitor
DRD2,BX-795,GuideToPharmacology,1,inhibitor
DRD2,CATEQUENTINIB,GuideToPharmacology,1,inhibitor
DPT,CHMFL-KIT-8140,GuideToPharmacology,1,inhibitor
DPT,"COMPOUND 6LI [CHAN ET AL., 2022]",GuideToPharmacology,1,inhibitor
DPT,FAMITINIB,GuideToPharmacology,1,inhibitor
ATP5F1E,ARACHIDONIC ACID,GuideToPharmacology,1,activator
ARF4P1,RIMTUZALCAP,GuideToPharmacology,1,modulator
ARF5,CM-TPMF,GuideToPharmacology,1,activator
ARG1,CA2+,GuideToPharmacology,1,activator
BAAT,E4031,GuideToPharmacology,1,blocker
BAD,KB-130015,GuideToPharmacology,1,activator
ATP7B,CORREOLIDE,GuideToPharmacology,1,blocker
EPHX2,CCT196969,GuideToPharmacology,1,inhibitor
EPS8,GNE-0877,GuideToPharmacology,1,inhibitor
FRA2H,COMPOUND 7U [PMID: 24775305],GuideToPharmacology,1,inhibitor
CNTFR,3-HYDROXYBENZYLHYDRAZINE,GuideToPharmacology,1,inhibitor
EPS8,NIK SMI1,GuideToPharmacology,1,inhibitor
BCL3,ACETYL-PODOCARPIC DIMER,GuideToPharmacology,1,agonist
BIN1,2-OLEOYL-LPA,GuideToPharmacology,1,agonist
AMPH,2-OLEOYL-LPA,GuideToPharmacology,1,agonist
EPS15,COMPOUND 36 [PMID: 21958547],GuideToPharmacology,1,inhibitor
GUCY1B1,COMPOUND 20C [PMID: 34181850],GuideToPharmacology,1,inhibitor
MELK,OTSSP167,GuideToPharmacology,1,inhibitor
ESRRG,TINODASERTIB,GuideToPharmacology,1,inhibitor
ANG,ASIP [90-132 (L89Y)],GuideToPharmacology,1,inhibitor
AMYP1,AC-HMCH-(6-16)-NH2,GuideToPharmacology,1,agonist
ANOP1,CFMMC,GuideToPharmacology,1,modulator
ANOP1,[11C]MMTP,GuideToPharmacology,1,modulator
ANOP1,[3H]R214127,GuideToPharmacology,1,modulator
SLC25A4,"(2R,3R)-APDC",GuideToPharmacology,1,agonist
ANPEP,JNJ-40068782,GuideToPharmacology,1,modulator
MAP2K1,SELUMETINIB,GuideToPharmacology,1,modulator
MAP3K5,MSC2032964A,GuideToPharmacology,1,inhibitor
AADAC,BQCA,GuideToPharmacology,1,modulator
AAMP,LY2033298,GuideToPharmacology,1,modulator
AANAT,METHOCTRAMINE,GuideToPharmacology,1,inhibitor
AARS1,ACLIDINIUM,GuideToPharmacology,1,inhibitor
AARS1,MCN-A-343,GuideToPharmacology,1,agonist
AARS1,LY2033298,GuideToPharmacology,1,modulator
AARS1,LITHOCHOLYLCHOLINE,GuideToPharmacology,1,inhibitor
AARS1,TOLTERODINE,GuideToPharmacology,1,inhibitor
AAVS1,PIRENZEPINE,GuideToPharmacology,1,inhibitor
AAVS1,METHOCTRAMINE,GuideToPharmacology,1,inhibitor
AAVS1,STRYCHNINE,GuideToPharmacology,1,modulator
AAVS1,UH-AH 37,GuideToPharmacology,1,inhibitor
ANK2,"2-METHOXY-&ALPHA;,&BETA;-DIDEHYDRO-AGOMELATINE",GuideToPharmacology,1,agonist
ANK2,UCM1341,GuideToPharmacology,1,agonist
APOF,DYNORPHIN A,GuideToPharmacology,1,agonist
APOF,UFP-512,GuideToPharmacology,1,agonist
GZMM,GKT136901,GuideToPharmacology,1,inhibitor
GZMA,GKT136901,GuideToPharmacology,1,inhibitor
BAX,TETRODOTOXIN,GuideToPharmacology,1,blocker
NKX3-2,RELUTRIGINE,GuideToPharmacology,1,inhibitor
BBS1,RELUTRIGINE,GuideToPharmacology,1,inhibitor
BARD1,TETRODOTOXIN,GuideToPharmacology,1,blocker
BBS4,PF-04885614,GuideToPharmacology,1,inhibitor
SCN9A,BATRACHOTOXIN,GuideToPharmacology,1,activator
SCN9A,PYRROLOPYRIMIDINE 48 [PMID: 22318156],GuideToPharmacology,1,blocker
BBS2,RELUTRIGINE,GuideToPharmacology,1,inhibitor
ATD,HEXAMETHONIUM,GuideToPharmacology,1,blocker
ATF4,PHA-543613,GuideToPharmacology,1,agonist
ATF4P1,STRYCHNINE,GuideToPharmacology,1,inhibitor
AQP5,PD157672,GuideToPharmacology,1,inhibitor
NMUR2,[125I]NEUROMEDIN U-25 (HUMAN),GuideToPharmacology,1,agonist
NMUR2,NEUROMEDIN U-25,GuideToPharmacology,1,agonist
SLCO1B1,INDOCYANINE GREEN ACID FORM,GuideToPharmacology,1,inhibitor
SLCO2B1,SILDENAFIL,GuideToPharmacology,1,inhibitor
SLCO1B3,SILDENAFIL,GuideToPharmacology,1,inhibitor
ARAF,"L-366,682",GuideToPharmacology,1,inhibitor
ARAF,"[MPA1,D-TYR(ET)2,D-TIC7]OT",GuideToPharmacology,1,inhibitor
AIRE,MRS2567,GuideToPharmacology,1,inhibitor
APLP2,BEPAFANT,GuideToPharmacology,1,inhibitor
ADCYAP1R1,RO 25-1553,GuideToPharmacology,1,agonist
APOE,ISOX-CHA-CHG-ALA-ARG-DPR(4FB)-NH2,GuideToPharmacology,1,agonist
BCKDHB,LANIFIBRANOR,GuideToPharmacology,1,agonist
CCND1,"15-DEOXY-&DELTA;-12,14-PROSTAGLANDIN J2",GuideToPharmacology,1,agonist
CCND1,FMOC-L-LEUCINE,GuideToPharmacology,1,agonist
F5,COMPOUND 12B [PMID: 31465220],GuideToPharmacology,1,inhibitor
F5,DACTOLISIB,GuideToPharmacology,1,inhibitor
F5,ECF309,GuideToPharmacology,1,inhibitor
F5,COMPOUND 7 [PMID: 31955578],GuideToPharmacology,1,inhibitor
PIK3CB,INAVOLISIB,GuideToPharmacology,1,inhibitor
PIK3CB,FIMEPINOSTAT,GuideToPharmacology,1,inhibitor
F5,STX-478,GuideToPharmacology,1,inhibitor
PIK3CB,SAMOTOLISIB,GuideToPharmacology,1,inhibitor
PIK3CB,NEMIRALISIB,GuideToPharmacology,1,inhibitor
PIK3CB,ZSTK474,GuideToPharmacology,1,inhibitor
F7R,COMPOUND 15A [PMID: 32069401],GuideToPharmacology,1,inhibitor
F7R,BERZOSERTIB,GuideToPharmacology,1,inhibitor
F7R,ALPELISIB,GuideToPharmacology,1,inhibitor
F7R,COMPOUND 2Q [PMID: 30986068],GuideToPharmacology,1,inhibitor
COMP,BC11-38,GuideToPharmacology,1,inhibitor
COL8A2,SCH51866,GuideToPharmacology,1,inhibitor
COL9A1,BAY607550,GuideToPharmacology,1,inhibitor
COL7A1,SCH51866,GuideToPharmacology,1,inhibitor
COL9A3,CILOSTAZOL,GuideToPharmacology,1,inhibitor
COL9A2,ENSIFENTRINE,GuideToPharmacology,1,inhibitor
COL16A1,PF-04957325,GuideToPharmacology,1,inhibitor
PDE5A,SCH51866,GuideToPharmacology,1,inhibitor
PDE9A,SCH51866,GuideToPharmacology,1,inhibitor
GNAI2P1,OLAPARIB,GuideToPharmacology,1,inhibitor
NBEAP1,(+)-S20,GuideToPharmacology,1,agonist
NBEAP1,PACLITAXEL,GuideToPharmacology,1,agonist
GM2A,NIVOLUMAB,GuideToPharmacology,1,antibody
APOA4,[125I]PRRP-20 (HUMAN),GuideToPharmacology,1,agonist
APOA4,PRRP-31,GuideToPharmacology,1,agonist
XIAP,"[125I][NLE8,21,TYR34]PTH-(1-34)-NH2 (RAT)",GuideToPharmacology,1,agonist
XIAP,TERIPARATIDE,GuideToPharmacology,1,agonist
BIRC5,"[D-TRP12,TYR34]PTH-(7-34) (BOVINE)",GuideToPharmacology,1,inhibitor
BIRC5,PTHRP-(1-34) (HUMAN),GuideToPharmacology,1,agonist
BIRC5,"[ILE5,TRP23]PTHRP-(5-36)",GuideToPharmacology,1,inhibitor
PDK3,VER-246608,GuideToPharmacology,1,inhibitor
BAK1P1,"COMPOUND 14 [SCHNUTE ET AL., 2023]",GuideToPharmacology,1,agonist
CTRB1,NETARSUDIL,GuideToPharmacology,1,inhibitor
APRT,H3 AC-B10-27(13-17 HC),GuideToPharmacology,1,agonist
AMT,VPC03090-P,GuideToPharmacology,1,inhibitor
AMT,BMS-986104 DERIVATIVE 12,GuideToPharmacology,1,agonist
AMT,ST-2191,GuideToPharmacology,1,agonist
AMY1B,VPC03090-P,GuideToPharmacology,1,inhibitor
AMY1C,PONESIMOD,GuideToPharmacology,1,agonist
AMY2A,COMPOUND 15 [PMID: 33738061],GuideToPharmacology,1,inhibitor
FAU,ARN-3236,GuideToPharmacology,1,inhibitor
AMY2A,SIPONIMOD,GuideToPharmacology,1,agonist
SELP,RIVIPANSEL,GuideToPharmacology,1,inhibitor
CD9,AMOXAPINE,GuideToPharmacology,1,inhibitor
FCN1,CEP-11981,GuideToPharmacology,1,inhibitor
GBE1,HEPARIN,GuideToPharmacology,1,activator
FRA5F,BPTI-K15R/R17G,GuideToPharmacology,1,inhibitor
GABPB1,PB-28,GuideToPharmacology,1,agonist
CD3E,ERTUGLIFLOZIN,GuideToPharmacology,1,inhibitor
BLVRB,COMPOUND 8 [PMID: 19191557],GuideToPharmacology,1,inhibitor
BLVRB,COMPOUND 14 [PMID: 19191557],GuideToPharmacology,1,inhibitor
FASLG,NC 8-12,GuideToPharmacology,1,agonist
FASLG,PASIREOTIDE,GuideToPharmacology,1,agonist
FAS,[D-TYR8]CYN 154806,GuideToPharmacology,1,inhibitor
FASLG,IN-NODAGATOC,GuideToPharmacology,1,agonist
AQP2,DES-AA5-[D-TRP8]SRIF,GuideToPharmacology,1,agonist
AQP2,VELDOREOTIDE,GuideToPharmacology,1,agonist
AQP1,[D-TYR8]CYN 154806,GuideToPharmacology,1,inhibitor
AQP2,"[111IN,90Y]DOTA-NOC",GuideToPharmacology,1,agonist
GLP1R,GNE-064,GuideToPharmacology,1,inhibitor
TEC,JNJ-64264681,GuideToPharmacology,1,inhibitor
HLA-DMB,OM-1700,GuideToPharmacology,1,inhibitor
TLR2,TOMARALIMAB,GuideToPharmacology,1,antibody
DMP1,COMPOUND 15 [PMID: 35450354],GuideToPharmacology,1,inhibitor
TLR2,DIPROVOCIM-1,GuideToPharmacology,1,agonist
FRA8C,N-0385,GuideToPharmacology,1,inhibitor
ATP1B1P1,POLYGODIAL,GuideToPharmacology,1,activator
ATP2A2,LA3+,GuideToPharmacology,1,blocker
ATP2B1,DAIDZEIN,GuideToPharmacology,1,activator
ATP2B1,FLUFENAMIC ACID,GuideToPharmacology,1,blocker
ATP2B2,OAG,GuideToPharmacology,1,activator
ATP2B2,ARACHIDONIC ACID,GuideToPharmacology,1,activator
ATP4A,PRIMIDONE,GuideToPharmacology,1,blocker
TRPM8,RACEMENTHOL,GuideToPharmacology,1,activator
ATP5F1BP1,AMG517,GuideToPharmacology,1,blocker
ATP5F1BP1,[3H]A778317,GuideToPharmacology,1,blocker
ATP5F1BP1,A425619,GuideToPharmacology,1,blocker
ATP5BL2,LA3+,GuideToPharmacology,1,blocker
TRPV4,VILDAGLIPTIN,GuideToPharmacology,1,activator
SLC26A2,COMPOUND 21 [PMID: 23312943],GuideToPharmacology,1,inhibitor
UTS2R,HIMB1636-MMAE,GuideToPharmacology,1,antibody
FHIT,SBP-7455,GuideToPharmacology,1,inhibitor
FRA9D,KSQ-4279,GuideToPharmacology,1,inhibitor
FHL1,COMPOUND 15 [PMID: 24900237],GuideToPharmacology,1,inhibitor
ARCN2,[ARG16]CHICKEN SECRETIN,GuideToPharmacology,1,agonist
ARCN1,SECRETIN,GuideToPharmacology,1,agonist
ARCN2,VIP,GuideToPharmacology,1,agonist
ANXA4,PANCREATIC POLYPEPTIDE,GuideToPharmacology,1,agonist
A12M3,CYAMEMAZINE,GuideToPharmacology,1,inhibitor
DPH1,GSK1511931,GuideToPharmacology,1,inhibitor
CD8B,TOLUDESVENLAFAXINE,GuideToPharmacology,1,inhibitor
CD24P1,[3H]N-METHYL-SSR504734,GuideToPharmacology,1,inhibitor
COL12A1,CBS-3595,GuideToPharmacology,1,inhibitor
AANAT,ML381,GuideToPharmacology,1,inhibitor
CPA3,"(2S,4S)-KETOCONAZOLE",GuideToPharmacology,1,inhibitor
AAMP,ACECLIDINE,GuideToPharmacology,1,agonist
CPT2,PEPTIDE 30 [PMID: 27019010],GuideToPharmacology,1,inhibitor
F7R,INAVOLISIB,GuideToPharmacology,1,inhibitor
ABCA1,METRIFUDIL,GuideToPharmacology,1,agonist
SHROOM2,DES-AA5-[D-TRP8]SRIF,GuideToPharmacology,1,agonist
C1QBP,DIDS,GuideToPharmacology,1,blocker
ALOX12P1,GAL-B2-C8,GuideToPharmacology,1,agonist
DMWD,MESO-DAP,GuideToPharmacology,1,agonist
BAD,NS1643,GuideToPharmacology,1,activator
COD2,COMPOUND 10H [PMID: 20832306],GuideToPharmacology,1,inhibitor
GLO1,GNE-064,GuideToPharmacology,1,inhibitor
AAVS1,HEXAHYDRODIFENIDOL,GuideToPharmacology,1,inhibitor
A2M,LISURIDE,GuideToPharmacology,1,agonist
STOM,GSK8612,GuideToPharmacology,1,inhibitor
APRT,R3/I5,GuideToPharmacology,1,agonist
SLC29A1,AR-AO-14418,GuideToPharmacology,1,inhibitor
AMD1,PIMOZIDE,GuideToPharmacology,1,inhibitor
AAMP,CY3B-TELENZEPINE,GuideToPharmacology,1,inhibitor
F7,TASELISIB,GuideToPharmacology,1,inhibitor
MAP2K1,MAP855,GuideToPharmacology,1,inhibitor
FRA11F,ZAURATEGRAST,GuideToPharmacology,1,inhibitor
TAS2R46,STRYCHNINE,GuideToPharmacology,1,agonist
HTR2C,(R)-DOI,GuideToPharmacology,1,agonist
BEVI,PF0998425,GuideToPharmacology,1,inhibitor
C4A,OCTANOL,GuideToPharmacology,1,inhibitor
ANK2,6-CL-MLT,GuideToPharmacology,1,agonist
SLCO2B1,GEMFIBROZIL,GuideToPharmacology,1,inhibitor
ALDH1B1,SITAXENTAN,GuideToPharmacology,1,inhibitor
AQP8,ER819762,GuideToPharmacology,1,inhibitor
SERPINA3,YOHIMBINE,GuideToPharmacology,1,inhibitor
GUSM,BSAB (CD89-CD20),GuideToPharmacology,1,antibody
SLC25A6,COMPOUND 10 [PMID: 15482906],GuideToPharmacology,1,modulator
DRD1,NINTEDANIB ESYLATE,GuideToPharmacology,1,inhibitor
ALOX12P1,M617,GuideToPharmacology,1,agonist
CTSV,BI-847325,GuideToPharmacology,1,inhibitor
CHI3L2,NBTGR,GuideToPharmacology,1,inhibitor
EPHB2,AZD1480,GuideToPharmacology,1,inhibitor
ANPEP,4-APPES,GuideToPharmacology,1,modulator
ARCN1,PG 99-465,GuideToPharmacology,1,agonist
ARCN1,PG 99-465,GuideToPharmacology,1,inhibitor
EEF1B2P2,CP466722,GuideToPharmacology,1,inhibitor
A12M3,BW723C86,GuideToPharmacology,1,agonist
ALB,ANTISAUVAGINE,GuideToPharmacology,1,inhibitor
APOB,PGJ2,GuideToPharmacology,1,agonist
ADH1C,COMPOUND 36 [PMID: 21273063],GuideToPharmacology,1,agonist
EPHB3,COMPOUND 25AP [PMID: 37796543],GuideToPharmacology,1,inhibitor
GRK3,SUBSTANCE P,GuideToPharmacology,1,agonist
AMD1,LORATADINE,GuideToPharmacology,1,inhibitor
ATP2A2,BTP2,GuideToPharmacology,1,blocker
APOBER1,SC-51322,GuideToPharmacology,1,inhibitor
APC,MRS2698,GuideToPharmacology,1,agonist
EN1,SELATINIB,GuideToPharmacology,1,inhibitor
CCR3,&ALPHA;&BETA;-METHYLENEADP,GuideToPharmacology,1,inhibitor
SLC26A3,ROBLITINIB,GuideToPharmacology,1,inhibitor
CD8A,PHLORIZIN,GuideToPharmacology,1,inhibitor
ANTP4,ME4,GuideToPharmacology,1,agonist
ABAT,CGS 15943,GuideToPharmacology,1,inhibitor
ACADS,NOVOKININ,GuideToPharmacology,1,agonist
CTNND1,DORAMAPIMOD,GuideToPharmacology,1,inhibitor
ETFB,SAMOTOLISIB,GuideToPharmacology,1,inhibitor
ABO,DOBUTAMINE,GuideToPharmacology,1,agonist
AQP3,OSANETANT,GuideToPharmacology,1,inhibitor
NAT1,ZACOPRIDE,GuideToPharmacology,1,agonist
GLC3B,TP-472,GuideToPharmacology,1,inhibitor
BMAL1,RO4938581,GuideToPharmacology,1,modulator
ITPR1,XESTOSPONGIN C,GuideToPharmacology,1,inhibitor
HTR2C,SB 204741,GuideToPharmacology,1,inhibitor
EEF1G,ILORASERTIB,GuideToPharmacology,1,inhibitor
ACACB,BM213,GuideToPharmacology,1,agonist
A2MP1,YOHIMBINE,GuideToPharmacology,1,inhibitor
ABL2,YOHIMBINE,GuideToPharmacology,1,inhibitor
GNG11,LCL161,GuideToPharmacology,1,inhibitor
CCND1,L-165461,GuideToPharmacology,1,agonist
ABCD1,LISURIDE,GuideToPharmacology,1,agonist
NUDT2,ETHYLKETOCYCLAZOCINE,GuideToPharmacology,1,agonist
ATP5F1C,OSTHOLE,GuideToPharmacology,1,blocker
ATP1B1P1,RACEMENTHOL,GuideToPharmacology,1,activator
ABCA3,MRS1088,GuideToPharmacology,1,inhibitor
EFNB2,COMPOUND 38 [PMID: 24915291],GuideToPharmacology,1,inhibitor
CPT2,ASPIRIN,GuideToPharmacology,1,inhibitor
SLC29A1,CDK1/5 INHIBITOR,GuideToPharmacology,1,inhibitor
NUDT2,AT-076,GuideToPharmacology,1,inhibitor
AZGP1,PYRITHIONE ZINC,GuideToPharmacology,1,activator
UTS2R,UROLININ,GuideToPharmacology,1,agonist
APBA1,AC-RYYRWK-NH2,GuideToPharmacology,1,agonist
SHROOM2,BIM 23030,GuideToPharmacology,1,agonist
FAP,TAK-632,GuideToPharmacology,1,inhibitor
ACACB,"L-156,602",GuideToPharmacology,1,inhibitor
C2,FLUFENAMIC ACID,GuideToPharmacology,1,inhibitor
DRD2,KI-20227,GuideToPharmacology,1,inhibitor
TRPV4,AM404,GuideToPharmacology,1,inhibitor
GTF2IP1,PF750,GuideToPharmacology,1,inhibitor
GGTL2,COMPOUND 3 [PMID: 29633584],GuideToPharmacology,1,inhibitor
SLC25A4,COMPOUND 2 [PMID: 21105727],GuideToPharmacology,1,modulator
MAP3K5,SELONSERTIB,GuideToPharmacology,1,inhibitor
BCKDHA,LY-465608,GuideToPharmacology,1,agonist
AMD1P2,CONESSINE,GuideToPharmacology,1,inhibitor
HCN2,LG-100268,GuideToPharmacology,1,agonist
C1QBP,NPPB,GuideToPharmacology,1,blocker
ACTG1P6,CCL19,GuideToPharmacology,1,agonist
ACP3,LYSINE,GuideToPharmacology,1,agonist
HRH3,(S)-&ALPHA;-METHYLHISTAMINE,GuideToPharmacology,1,agonist
NOS1,L-NNA,GuideToPharmacology,1,inhibitor
ABR,CARAZOLOL,GuideToPharmacology,1,inhibitor
BCYRN1P2,OSPEMIFENE,GuideToPharmacology,1,inhibitor
BIRC3,MRS2905,GuideToPharmacology,1,agonist
FRA5A,UPAMOSTAT,GuideToPharmacology,1,inhibitor
ALDH3A1,SCH-23390,GuideToPharmacology,1,inhibitor
CD7,PHLORIZIN,GuideToPharmacology,1,inhibitor
ABR,LABETALOL,GuideToPharmacology,1,inhibitor
ETFB,SERABELISIB,GuideToPharmacology,1,inhibitor
GALR2,SNAP 37889,GuideToPharmacology,1,inhibitor
C4B,FLUFENAMIC ACID,GuideToPharmacology,1,inhibitor
A1BG,LYSERGIDE,GuideToPharmacology,1,agonist
CTBP2,COMPOUND 41 [PMID: 25000588],GuideToPharmacology,1,inhibitor
FRA16E,VIGABATRIN,GuideToPharmacology,1,inhibitor
A1BG,[3H]8-OH-DPAT,GuideToPharmacology,1,agonist
A2M,ASENAPINE,GuideToPharmacology,1,agonist
A2M,[3H]8-OH-DPAT,GuideToPharmacology,1,agonist
A2M,SB236057,GuideToPharmacology,1,inhibitor
A2MP1,[3H]8-OH-DPAT,GuideToPharmacology,1,agonist
A2MP1,ALNIDITAN,GuideToPharmacology,1,agonist
A2MP1,BRL-15572,GuideToPharmacology,1,agonist
A2MP1,OLANZAPINE,GuideToPharmacology,1,agonist
A12M1,ASENAPINE,GuideToPharmacology,1,agonist
A12M3,SERGOLEXOLE,GuideToPharmacology,1,inhibitor
A12M4,LY53857,GuideToPharmacology,1,inhibitor
A12M4,MIANSERIN,GuideToPharmacology,1,inhibitor
A12M4,SB 243213,GuideToPharmacology,1,inhibitor
HTR2C,LORCASERIN,GuideToPharmacology,1,agonist
HTR2C,ORG-37684,GuideToPharmacology,1,agonist
HTR2C,SB 221284,GuideToPharmacology,1,inhibitor
HTR2C,MESULERGINE,GuideToPharmacology,1,inhibitor
HTR2C,OLANZAPINE,GuideToPharmacology,1,inhibitor
NAT2,[3H]8-OH-DPAT,GuideToPharmacology,1,agonist
NATP,CAPESEROD,GuideToPharmacology,1,agonist
NATP,OLANZAPINE,GuideToPharmacology,1,inhibitor
NATP,MESULERGINE,GuideToPharmacology,1,inhibitor
CACNA1S,BIRICODAR,GuideToPharmacology,1,inhibitor
ABL1,KW-2449,GuideToPharmacology,1,inhibitor
DNM2,BMS-986260,GuideToPharmacology,1,inhibitor
DDX10,ILOMASTAT,GuideToPharmacology,1,inhibitor
FKBP2,NTQ1062,GuideToPharmacology,1,inhibitor
GANC,PRUNETIN,GuideToPharmacology,1,inhibitor
FKBP2,AFURESERTIB,GuideToPharmacology,1,inhibitor
ACADSB,BMS-986224,GuideToPharmacology,1,agonist
ACE2,BCY15291,GuideToPharmacology,1,inhibitor
DAPK3,BENAZEPRILAT,GuideToPharmacology,1,inhibitor
BTN1A1,HG2+,GuideToPharmacology,1,inhibitor
BTF3P1,HG2+,GuideToPharmacology,1,activator
ABCC2,A1P,GuideToPharmacology,1,inhibitor
BST2,H+,GuideToPharmacology,1,activator
ABAT,CPFPX,GuideToPharmacology,1,inhibitor
ABAT,2-CHLOROADENOSINE,GuideToPharmacology,1,agonist
ABAT,BINODENOSON,GuideToPharmacology,1,agonist
ABAT,MRS7469,GuideToPharmacology,1,agonist
ABAT,ADENOSINE,GuideToPharmacology,1,agonist
ABAT,L-97-1,GuideToPharmacology,1,inhibitor
ABCA1,MRS1066,GuideToPharmacology,1,inhibitor
ABCA1,"4-{2-[(7-AMINO-2-FURAN-2-YL[1,2,4]TRIAZOLO[1,5-A][1,3,5]TRIAZIN-5-YL)AMINO]ETHYL}PHENOL",GuideToPharmacology,1,inhibitor
ABCA2,2-CHLOROADENOSINE,GuideToPharmacology,1,agonist
ABCA2,AB-NECA,GuideToPharmacology,1,agonist
ABCA2,REGADENOSON ANHYDROUS,GuideToPharmacology,1,agonist
ABCA2,BINODENOSON,GuideToPharmacology,1,agonist
ABCA3,ADENOSINE,GuideToPharmacology,1,agonist
ABCA2,MSX-2,GuideToPharmacology,1,inhibitor
ABCA3,I-ABA,GuideToPharmacology,1,agonist
ABCA3,CVT-6883,GuideToPharmacology,1,inhibitor
ABCA3,"4-{2-[(7-AMINO-2-FURAN-2-YL[1,2,4]TRIAZOLO[1,5-A][1,3,5]TRIAZIN-5-YL)AMINO]ETHYL}PHENOL",GuideToPharmacology,1,inhibitor
EEF1D,VIC 1911,GuideToPharmacology,1,inhibitor
EEF1D,SNS-314,GuideToPharmacology,1,inhibitor
AXL,ADRIXETINIB,GuideToPharmacology,1,inhibitor
AXL,GILTERITINIB,GuideToPharmacology,1,inhibitor
ACAT1,MK-5046,GuideToPharmacology,1,agonist
ACAT2,GASTRIN-RELEASING PEPTIDE,GuideToPharmacology,1,agonist
ACAT2,[D-PHE6]BOMBESIN(6-13)METHYL ESTER,GuideToPharmacology,1,inhibitor
FMO5,COMPOUND J [PMID: 21907142],GuideToPharmacology,1,inhibitor
FMOD,UMIBECESTAT,GuideToPharmacology,1,inhibitor
ABO,T-0509,GuideToPharmacology,1,agonist
FMOD,COMPOUND 6 [PMID: 34553947],GuideToPharmacology,1,inhibitor
ABO,MIRABEGRON,GuideToPharmacology,1,agonist
ABR,PROCATEROL,GuideToPharmacology,1,agonist
ABR,ICI 118551,GuideToPharmacology,1,inhibitor
ABR,NADOLOL,GuideToPharmacology,1,inhibitor
ABR,CGP 12177,GuideToPharmacology,1,inhibitor
EEGV1,COMPOUND 31 [PMID: 24915291],GuideToPharmacology,1,inhibitor
EEGV1,IBRUTINIB,GuideToPharmacology,1,inhibitor
EFNA1,PRN694,GuideToPharmacology,1,inhibitor
EFNA2,AGERAFENIB,GuideToPharmacology,1,inhibitor
EFNA3,BIC1,GuideToPharmacology,1,inhibitor
UBE2K,HISTAMINE,GuideToPharmacology,1,activator
HCK,COMPOUND 5B  [PMID: 31287314],GuideToPharmacology,1,inhibitor
ATP6V1C1,(-)-(S)-BAYK8644,GuideToPharmacology,1,activator
DBH,M826,GuideToPharmacology,1,inhibitor
CACNA1H,Z944,GuideToPharmacology,1,blocker
ACRV1,ANANDAMIDE,GuideToPharmacology,1,agonist
ACRV1,OLORINAB,GuideToPharmacology,1,agonist
RHOG,ALPROSTADIL,GuideToPharmacology,1,activator
ACRV1,OTENABANT,GuideToPharmacology,1,inhibitor
ACRV1,LY320135,GuideToPharmacology,1,inhibitor
CNR2,AZD1940,GuideToPharmacology,1,agonist
ACRV1,PF-514273,GuideToPharmacology,1,inhibitor
CCKBR,[125I]GASTRIN,GuideToPharmacology,1,agonist
CCKAR,GLAXO-11P,GuideToPharmacology,1,agonist
ACTBP2,LERONLIMAB,GuideToPharmacology,1,antibody
ACTBP2,TAK-220,GuideToPharmacology,1,inhibitor
CEACAM5,LABETUZUMAB,GuideToPharmacology,1,antibody
GPR17,MILATUZUMAB,GuideToPharmacology,1,antibody
CD52,ALEMTUZUMAB,GuideToPharmacology,1,antibody
ACTG1P9,CHEMERIN,GuideToPharmacology,1,agonist
ACTG1P7,S-26D [PMID: 37883692],GuideToPharmacology,1,inhibitor
EIF5AP3,7-HYDROXYSTAUROSPORINE,GuideToPharmacology,1,inhibitor
ACTG1P7,[3H]RESOLVIN E1,GuideToPharmacology,1,agonist
CHEK2,CDK INHIBITOR 4.35,GuideToPharmacology,1,inhibitor
BUB1,OMEPRAZOLE,GuideToPharmacology,1,activator
BUB1,ZN2+,GuideToPharmacology,1,blocker
FPR3,APIXABAN,GuideToPharmacology,1,inhibitor
DPYD,ELZOVANTINIB,GuideToPharmacology,1,inhibitor
DPYD,CERDULATINIB,GuideToPharmacology,1,inhibitor
CPT1B,MELOXICAM,GuideToPharmacology,1,inhibitor
CPT2,MELOXICAM,GuideToPharmacology,1,inhibitor
DTX1,REPOTRECTINIB,GuideToPharmacology,1,inhibitor
C1R,CARBENOXOLONE,GuideToPharmacology,1,inhibitor
ACTC1,[125I]CXCL11 (HUMAN),GuideToPharmacology,1,agonist
ACTG1,ISOTHIOUREA-1A,GuideToPharmacology,1,inhibitor
ACTG1,T134,GuideToPharmacology,1,inhibitor
CPT1A,COMPOUND 10 [PMID: 31663733],GuideToPharmacology,1,inhibitor
CP,COMPOUND 7P [PMID: 7861416],GuideToPharmacology,1,inhibitor
CPT1A,AZALANSTAT,GuideToPharmacology,1,inhibitor
DHODH,TERIFLUNOMIDE,GuideToPharmacology,1,inhibitor
DAPK1,SITAGLIPTIN,GuideToPharmacology,1,inhibitor
DAPK1,COMPOUND 1 [XIAO ET AL. 2014],GuideToPharmacology,1,inhibitor
GCNT1,BROMO-DEAZA-SAH,GuideToPharmacology,1,inhibitor
ELN,XMD8-92,GuideToPharmacology,1,inhibitor
DNMT1,BROMO-DEAZA-SAH,GuideToPharmacology,1,inhibitor
DMPK,RKI-1447,GuideToPharmacology,1,inhibitor
APOBEC1,"15-DEOXY-&DELTA;12,14-PGJ2",GuideToPharmacology,1,agonist
APOB,PGD2,GuideToPharmacology,1,agonist
APOB,PGD2,GuideToPharmacology,1,agonist
APOBEC1,AM-461,GuideToPharmacology,1,inhibitor
APOB,ILOPROST,GuideToPharmacology,1,agonist
ABCD1,UNC9975,GuideToPharmacology,1,agonist
ALCAM,THIORIDAZINE,GuideToPharmacology,1,inhibitor
EML1,COMPOUND 17 [PMID: 23642479],GuideToPharmacology,1,inhibitor
EML1,HARMINE,GuideToPharmacology,1,inhibitor
EML1,"ETHYL 3-[(E)-2-AMINO-1-CYANOETHENYL]-6,7-DICHLORO-1-METHYL-1H-INDOLE-2-CARBOXYLATE",GuideToPharmacology,1,inhibitor
EMD,HARMINE,GuideToPharmacology,1,inhibitor
DXO,FALNIDAMOL,GuideToPharmacology,1,inhibitor
DXO,VANDETANIB,GuideToPharmacology,1,inhibitor
APOBER1,ALPROSTADIL,GuideToPharmacology,1,agonist
APOBER1,DINOPROST,GuideToPharmacology,1,agonist
GTF2IP1,SWE101,GuideToPharmacology,1,inhibitor
APOC1,OMIDENEPAG,GuideToPharmacology,1,agonist
APOC1,MISOPROSTOL,GuideToPharmacology,1,agonist
APOC1P1,ILOPROST,GuideToPharmacology,1,agonist
APOC1P1,MISOPROSTOL,GuideToPharmacology,1,agonist
APOC1P1,MISOPROSTOL,GuideToPharmacology,1,agonist
AQP8,ILOPROST,GuideToPharmacology,1,agonist
AQP8,"L-161,982 (EP4A)",GuideToPharmacology,1,agonist
AQP8,17-PHENYL-&OMEGA;-TRINOR-PGE2,GuideToPharmacology,1,agonist
EN1,CUDC-101,GuideToPharmacology,1,inhibitor
EN1,DACOMITINIB ANHYDROUS,GuideToPharmacology,1,inhibitor
BCYRN1P2,IMLUNESTRANT,GuideToPharmacology,1,inhibitor
ALDH1A3,RES7011,GuideToPharmacology,1,inhibitor
ADGRE1,COMPOUND 27 [PMID: 19854648],GuideToPharmacology,1,inhibitor
ARNT,PICROTOXIN,GuideToPharmacology,1,blocker
BMAL1,ISONIPECOTIC ACID,GuideToPharmacology,1,agonist
ARR3,PICROTOXIN,GuideToPharmacology,1,blocker
ARR3,ZN2+,GuideToPharmacology,1,modulator
ARRB1,ISONIPECOTIC ACID,GuideToPharmacology,1,agonist
ARRB1,CGS8216,GuideToPharmacology,1,agonist
ATF6B,ML351,GuideToPharmacology,1,inhibitor
A1BG,(+)-BUTACLAMOL,GuideToPharmacology,1,inhibitor
A1BG,"GR 218,231",GuideToPharmacology,1,inhibitor
A1BG,MPDT,GuideToPharmacology,1,inhibitor
A1BG,S 16924,GuideToPharmacology,1,agonist
A1BG,PINDOLOL,GuideToPharmacology,1,inhibitor
A1BG,NAN 190,GuideToPharmacology,1,inhibitor
A1BG,HALOPERIDOL DECANOATE,GuideToPharmacology,1,inhibitor
A1BG,ZOLMITRIPTAN,GuideToPharmacology,1,agonist
A1BG,YOHIMBINE,GuideToPharmacology,1,inhibitor
A1BG,REC 15/3079,GuideToPharmacology,1,inhibitor
A1BG,PROPRANOLOL HYDROCHLORIDE,GuideToPharmacology,1,inhibitor
A2MP1,SUMATRIPTAN,GuideToPharmacology,1,agonist
A2MP1,TFMPP,GuideToPharmacology,1,agonist
A2MP1,BUFOTENINE,GuideToPharmacology,1,inhibitor
A2MP1,HALOPERIDOL DECANOATE,GuideToPharmacology,1,inhibitor
A12M3,MESORIDAZINE,GuideToPharmacology,1,inhibitor
A12M4,NORFLUOXETINE,GuideToPharmacology,1,inhibitor
HTR2C,5-MEOT,GuideToPharmacology,1,agonist
HTR2C,TFMPP,GuideToPharmacology,1,agonist
HTR2C,TRYPTAMINE,GuideToPharmacology,1,agonist
HTR2C,WAY-163909,GuideToPharmacology,1,agonist
NATP,ERGOTAMINE,GuideToPharmacology,1,agonist
NATP,MPDT,GuideToPharmacology,1,inhibitor
NATP,TIOSPIRONE,GuideToPharmacology,1,inhibitor
SERPINA3,CHLORPROMAZINE,GuideToPharmacology,1,inhibitor
ABL1,ECF506,GuideToPharmacology,1,inhibitor
ABL1,PD173955,GuideToPharmacology,1,inhibitor
ABL1,SARACATINIB,GuideToPharmacology,1,inhibitor
ABL1,RISVODETINIB,GuideToPharmacology,1,inhibitor
HDGF,KH7,GuideToPharmacology,1,inhibitor
CSTF3,MK-2206,GuideToPharmacology,1,modulator
TIMM8A,ALDUMASTAT,GuideToPharmacology,1,inhibitor
DEFB4A,IK-862,GuideToPharmacology,1,inhibitor
CBR3,BENZYLCYSTEINE,GuideToPharmacology,1,inhibitor
ABCB7,PHENTOLAMINE,GuideToPharmacology,1,inhibitor
BTD,DICLOFENAC SODIUM,GuideToPharmacology,1,blocker
ABAT,5-CL-5-DEOXY-(&PLUSMN;)-ENBA,GuideToPharmacology,1,agonist
ABAT,AS70,GuideToPharmacology,1,inhibitor
ABAT,WRC-0571,GuideToPharmacology,1,inhibitor
ABCA1,LUF5981,GuideToPharmacology,1,inhibitor
ABCA1,SCH 58261,GuideToPharmacology,1,inhibitor
ABCA3,MRS5151,GuideToPharmacology,1,agonist
ABCA3,LUF5981,GuideToPharmacology,1,inhibitor
ABCA3,LUF6096,GuideToPharmacology,1,modulator
ACLY,NDI-091143,GuideToPharmacology,1,inhibitor
ACADM,5-BUTYL-METHYL IMMIDAZOLE CARBOXYLATE 30,GuideToPharmacology,1,inhibitor
EEF1B2P2,LARTESERTIB,GuideToPharmacology,1,inhibitor
ABCC8,CHLORPROPAMIDE,GuideToPharmacology,1,inhibitor
EEF1D,GSK143,GuideToPharmacology,1,inhibitor
EEF1G,GSK1070916,GuideToPharmacology,1,inhibitor
EEF1D,TOZASERTIB,GuideToPharmacology,1,inhibitor
AXL,BELIZATINIB,GuideToPharmacology,1,inhibitor
ACAT2,[PHE13]BOMBESIN,GuideToPharmacology,1,agonist
ASIC2,MK-7725,GuideToPharmacology,1,agonist
ABR,BRL 37344,GuideToPharmacology,1,agonist
ACAA1,CARAZOLOL,GuideToPharmacology,1,agonist
ACAA1,SOLABEGRON,GuideToPharmacology,1,agonist
ACAA1,AMIBEGRON,GuideToPharmacology,1,agonist
ABR,CICLOPROLOL,GuideToPharmacology,1,inhibitor
EEGV1,WZ4002,GuideToPharmacology,1,inhibitor
AMFR,BIIL 260,GuideToPharmacology,1,inhibitor
GLC1D,BAY-299,GuideToPharmacology,1,inhibitor
GLC1B,BAZ2-ICR,GuideToPharmacology,1,inhibitor
HCK,COMPOUND 5A [PMID: 31287314],GuideToPharmacology,1,inhibitor
HIP1,COMPOUND 5A [PMID: 31287314],GuideToPharmacology,1,inhibitor
ATP6V0A1,SUVECALTAMIDE,GuideToPharmacology,1,blocker
CACNA1H,SUVECALTAMIDE,GuideToPharmacology,1,blocker
CACNA1H,PIMOZIDE,GuideToPharmacology,1,blocker
RHOB,DINOPROSTONE,GuideToPharmacology,1,activator
ACRV1,GAT100,GuideToPharmacology,1,modulator
RHOG,DINOPROSTONE,GuideToPharmacology,1,activator
CNR2,COMPOUND C2 [PMID: 29990428],GuideToPharmacology,1,modulator
CCKAR,JNJ-17156516,GuideToPharmacology,1,inhibitor
CCKAR,LINTITRIPT,GuideToPharmacology,1,inhibitor
CNR2,SR144528,GuideToPharmacology,1,inhibitor
ACTA2,HIV-TAT,GuideToPharmacology,1,agonist
ACTA2,[125I]CCL2 (HUMAN),GuideToPharmacology,1,agonist
ACTA2,VCCL4,GuideToPharmacology,1,agonist
ACTBP3,CCL20-SEAP(HIS)6,GuideToPharmacology,1,agonist
ACTBP5,CCL1,GuideToPharmacology,1,agonist
ACTBP2,VMIP-II,GuideToPharmacology,1,inhibitor
ACTBP2,VICRIVIROC,GuideToPharmacology,1,inhibitor
GLRA2,ZWB67,GuideToPharmacology,1,antibody
ELANE,ML315,GuideToPharmacology,1,inhibitor
ELAVL2,MW05,GuideToPharmacology,1,inhibitor
EIF5AP3,COMPOUND 25 [PMID: 20855207],GuideToPharmacology,1,inhibitor
BTS1,S-(-)CPP,GuideToPharmacology,1,blocker
CLCN3,PHLORETIN,GuideToPharmacology,1,blocker
BVR1,DIDS,GuideToPharmacology,1,blocker
CNA1,BIIB021,GuideToPharmacology,1,inhibitor
FPR3,RIVAROXABAN,GuideToPharmacology,1,inhibitor
FRA1C,ARGATROBAN,GuideToPharmacology,1,inhibitor
FRA1E,EMICIZUMAB,GuideToPharmacology,1,antibody
CNA1,MS049,GuideToPharmacology,1,inhibitor
CNA1,COMPOUND 17F [PMID: 19632837],GuideToPharmacology,1,inhibitor
DPYD,EMACTUZUMAB,GuideToPharmacology,1,antibody
CPT1B,ASPIRIN,GuideToPharmacology,1,inhibitor
BCL9,"5&BETA;-PREGNANE-3,20-DIONE",GuideToPharmacology,1,agonist
ALB,"[125I]UROCORTIN 1 (MOUSE, RAT)",GuideToPharmacology,1,agonist
ALB,K31440,GuideToPharmacology,1,inhibitor
DTX1,ZIDESAMTINIB,GuideToPharmacology,1,inhibitor
ACTC1,CCL19,GuideToPharmacology,1,agonist
ACTBP9,CXCL6,GuideToPharmacology,1,agonist
EGR4,BMS-387032,GuideToPharmacology,1,inhibitor
EGR4,TANUXICICLIB,GuideToPharmacology,1,inhibitor
DAPK1,VILDAGLIPTIN,GuideToPharmacology,1,inhibitor
HOXD@,ART812,GuideToPharmacology,1,inhibitor
GCNT1,"COMPOUND 13 [CHEN ET AL., 2016]",GuideToPharmacology,1,inhibitor
GCNT1,SGC0946,GuideToPharmacology,1,inhibitor
APOB,S-5751,GuideToPharmacology,1,inhibitor
ALCAM,FLUPHENAZINE HYDROCHLORIDE,GuideToPharmacology,1,inhibitor
ALCAM,LISURIDE,GuideToPharmacology,1,agonist
ABCD1,SB269652,GuideToPharmacology,1,modulator
ABCD1,SULPIRIDE,GuideToPharmacology,1,inhibitor
ABCD1,PEROSPIRONE,GuideToPharmacology,1,inhibitor
ALDH1A1,CHLORPROTHIXENE,GuideToPharmacology,1,inhibitor
ALDH1A1,[3H]PD128907,GuideToPharmacology,1,agonist
ALDH1A1,FLUPENTHIXOL,GuideToPharmacology,1,inhibitor
ALDH2,SULPIRIDE,GuideToPharmacology,1,inhibitor
ALDH3A1,BETA-ERGOCRIPTINE,GuideToPharmacology,1,agonist
GLI1,GARCINOL,GuideToPharmacology,1,inhibitor
GRB14,PERENOSTOBART,GuideToPharmacology,1,antibody
EZH2,GSK126,GuideToPharmacology,1,inhibitor
DXO,EGFR/ERBB-2/ERBB-4 INHIBITOR,GuideToPharmacology,1,inhibitor
DXO,COMPOUND 6G [PMID: 30633509],GuideToPharmacology,1,inhibitor
DXO,DOVITINIB,GuideToPharmacology,1,inhibitor
DXO,ROCILETINIB,GuideToPharmacology,1,inhibitor
APOBER1,ZK118182,GuideToPharmacology,1,agonist
APOBER1,GW848687X,GuideToPharmacology,1,inhibitor
APOC1,MB-28767,GuideToPharmacology,1,agonist
AQP8,TREPROSTINIL,GuideToPharmacology,1,agonist
AQP8,DINOPROSTONE,GuideToPharmacology,1,agonist
APOC1P1,TREPROSTINIL,GuideToPharmacology,1,agonist
APOC1P1,SC-51322,GuideToPharmacology,1,inhibitor
AQP8,CR6086,GuideToPharmacology,1,inhibitor
EN1,CANERTINIB,GuideToPharmacology,1,inhibitor
EN1,SAPITINIB,GuideToPharmacology,1,inhibitor
AQP8,EVATANEPAG,GuideToPharmacology,1,inhibitor
ERBB4,WZ4002,GuideToPharmacology,1,inhibitor
ERBB4,EGFR/ERBB-2/ERBB-4 INHIBITOR,GuideToPharmacology,1,inhibitor
ESR2,ESTRONE,GuideToPharmacology,1,agonist
ESR2,AFIMOXIFENE,GuideToPharmacology,1,inhibitor
OPN1MW,UNC0321,GuideToPharmacology,1,inhibitor
ALDH1A3,SOVATELTIDE,GuideToPharmacology,1,agonist
GCNT2,A-366,GuideToPharmacology,1,inhibitor
EMX1,INDIRUBIN DERIVATIVE E804,GuideToPharmacology,1,inhibitor
BCL5,HPG1860,GuideToPharmacology,1,agonist
ARNT,RO4938581,GuideToPharmacology,1,modulator
BMAL1,[35S]TBPS,GuideToPharmacology,1,blocker
ARR3,BREXANOLONE,GuideToPharmacology,1,modulator
ARR3,CENOBAMATE,GuideToPharmacology,1,modulator
ARRB1,DMCM,GuideToPharmacology,1,modulator
STS,ETAZOLATE HYDROCHLORIDE,GuideToPharmacology,1,modulator
ARVCF,5-ME-IAA,GuideToPharmacology,1,agonist
ALOX12P1,GALANIN,GuideToPharmacology,1,agonist
ALOX12P1,GALANIN(2-30) (HUMAN),GuideToPharmacology,1,agonist
ALOX12P1,[125I][TYR26]GALANIN (HUMAN),GuideToPharmacology,1,agonist
ALOX12P1,M40,GuideToPharmacology,1,inhibitor
GALR2,GAL-B5,GuideToPharmacology,1,agonist
CD14,(S)-EF-1520,GuideToPharmacology,1,inhibitor
CXCR5,GERANYLGERANYL DIPHOSPHATE,GuideToPharmacology,1,inhibitor
ASPH,LY503430,GuideToPharmacology,1,modulator
ASS1,CX546,GuideToPharmacology,1,modulator
ASS1P2,LY404187,GuideToPharmacology,1,modulator
BDM,AZD-5423,GuideToPharmacology,1,inhibitor
ASS1P5,ATPA,GuideToPharmacology,1,agonist
BDM,TRIAMCINOLONE,GuideToPharmacology,1,agonist
GNRHR,AZD1656,GuideToPharmacology,1,activator
GRIN2A,[3H]CPP,GuideToPharmacology,1,inhibitor
GRIN2A,(RS)-(TETRAZOL-5-YL)GLYCINE,GuideToPharmacology,1,agonist
ASS1P14,CGP37849,GuideToPharmacology,1,inhibitor
GRIN2C,KETAMINE HYDROCHLORIDE,GuideToPharmacology,1,blocker
GLRA1,HU-210,GuideToPharmacology,1,modulator
ARVD3,CU2+,GuideToPharmacology,1,modulator
GLRA1,CU2+,GuideToPharmacology,1,modulator
ARVD3,HU-210,GuideToPharmacology,1,inhibitor
SLC29A1,TWS119,GuideToPharmacology,1,inhibitor
SLC29A1,N-(5-METHYL-1H-PYRAZOL-3-YL)-2-PHENYLQUINAZOLIN-4-AMINE,GuideToPharmacology,1,inhibitor
CSF2RA,MAVRILIMUMAB,GuideToPharmacology,1,antibody
AOAH,(S)-3-PHENYLLACTIC ACID,GuideToPharmacology,1,agonist
ANXA13,COMPOUND 1Q  [PMID: 18029181],GuideToPharmacology,1,agonist
AOAH,3-HYDROXYOCTANOIC ACID,GuideToPharmacology,1,agonist
ENUR2,COMPOUND 2 [PMID: 15546730],GuideToPharmacology,1,inhibitor
GDF2,COMPOUND 25AP [PMID: 37796543],GuideToPharmacology,1,inhibitor
GARS1,COMPOUND 30 [PMID: 37057760],GuideToPharmacology,1,inhibitor
LRRC32,FIMEPINOSTAT,GuideToPharmacology,1,inhibitor
AMELX,TOREFORANT,GuideToPharmacology,1,inhibitor
AMELX,N-ETHYLHISTAMINE,GuideToPharmacology,1,agonist
ADH1C,COMPOUND 36J [PMID: 21536438],GuideToPharmacology,1,agonist
ADH1C,AS1907417,GuideToPharmacology,1,agonist
ADH1C,AR231453,GuideToPharmacology,1,agonist
PARP1P2,LYSOPHOSPHATIDYLSERINE,GuideToPharmacology,1,agonist
AK1,LEVODOPA,GuideToPharmacology,1,agonist
PLIN2,RTI-13951-33,GuideToPharmacology,1,agonist
GRK2,GPR15L,GuideToPharmacology,1,agonist
GATA3,THIOGUANINE,GuideToPharmacology,1,inhibitor
FRA13A,GSK3008348,GuideToPharmacology,1,inhibitor
FRA11F,FIRATEGRAST,GuideToPharmacology,1,inhibitor
ITPR1,CAFFEINE,GuideToPharmacology,1,inhibitor
FOXL2,FLUFENAMIC ACID,GuideToPharmacology,1,agonist
BRCA2,THEAFLAVIN,GuideToPharmacology,1,agonist
BRAFPS1,SAKURANETIN,GuideToPharmacology,1,inhibitor
BSG,PROBENECID,GuideToPharmacology,1,inhibitor
BRCA2,PHLORETIN,GuideToPharmacology,1,agonist
ZFP36L2,CYCLAMATE,GuideToPharmacology,1,inhibitor
ZFP36L2,SACCHARIN,GuideToPharmacology,1,agonist
ZFP36L2,LACTUCOPICRIN,GuideToPharmacology,1,agonist
EPHB1,DEUCRAVACITINIB,GuideToPharmacology,1,modulator
EPHB1,COMPOUND 13AC [PMID: 33256400],GuideToPharmacology,1,inhibitor
EPHB1,NEZULCITINIB,GuideToPharmacology,1,inhibitor
EPHB2,COMPOUND 18E [PMID: 31670517],GuideToPharmacology,1,inhibitor
EPHB2,COMPOUND 19A [PMID: 24359159],GuideToPharmacology,1,inhibitor
EPHB2,COMPOUND 30 [PMID: 37057760],GuideToPharmacology,1,inhibitor
EPHB1,ROPSACITINIB,GuideToPharmacology,1,inhibitor
FRA2G,MILVEXIAN,GuideToPharmacology,1,inhibitor
NUDT2,ALVIMOPAN ANHYDROUS,GuideToPharmacology,1,inhibitor
CD68,BUMETANIDE,GuideToPharmacology,1,inhibitor
DRD2,RAMUCIRUMAB,GuideToPharmacology,1,antibody
DRD2,BIBF-1202,GuideToPharmacology,1,inhibitor
ATP5F1E,NORFLUOXETINE,GuideToPharmacology,1,inhibitor
ASGR1,ARACHIDONIC ACID,GuideToPharmacology,1,activator
BAD,LUF7244,GuideToPharmacology,1,modulator
BAD,IBUTILIDE,GuideToPharmacology,1,blocker
BAD,DISOPYRAMIDE,GuideToPharmacology,1,blocker
BAG1,NS1643,GuideToPharmacology,1,activator
ATRX,"3-BICYCLO[2.2.1]HEPT-2-YL-BENZENE-1,2-DIOL",GuideToPharmacology,1,blocker
AVPR1A,DALFAMPRIDINE,GuideToPharmacology,1,blocker
KIF1A,DALFAMPRIDINE,GuideToPharmacology,1,blocker
ATR,DALFAMPRIDINE,GuideToPharmacology,1,blocker
CMM,3-IODOTYROSINE,GuideToPharmacology,1,inhibitor
GATA6,MIGLITOL,GuideToPharmacology,1,inhibitor
ANGPT2,[125I]SHU9119,GuideToPharmacology,1,inhibitor
ETFB,BERZOSERTIB,GuideToPharmacology,1,inhibitor
HLA-H,NAVTEMADLIN,GuideToPharmacology,1,inhibitor
ETFB,COMPOUND 12B [PMID: 31465220],GuideToPharmacology,1,inhibitor
DRD4,D6808,GuideToPharmacology,1,inhibitor
BLK,DIMETHYLALLYL DIPHOSPHATE,GuideToPharmacology,1,inhibitor
SLC25A5,VU0364770,GuideToPharmacology,1,modulator
SLC25A5,VU0092145,GuideToPharmacology,1,modulator
ANTP2,DEXFOSFOSERINE,GuideToPharmacology,1,agonist
ANTP2,AMN082,GuideToPharmacology,1,modulator
CTNNB1,DORAMAPIMOD,GuideToPharmacology,1,inhibitor
CTNNB1,DILMAPIMOD,GuideToPharmacology,1,inhibitor
CTNNB1,VX-702,GuideToPharmacology,1,inhibitor
ERVT3,BAY-885,GuideToPharmacology,1,inhibitor
ERPL1,RGB-286638,GuideToPharmacology,1,inhibitor
ERCC6,NIK SMI1,GuideToPharmacology,1,inhibitor
CRKL,COMPOUND 36 [PMID: 32429662],GuideToPharmacology,1,inhibitor
CRKL,JJKK 048,GuideToPharmacology,1,inhibitor
FSHMD1A,CLORGILINE,GuideToPharmacology,1,inhibitor
AADAC,DICYCLOMINE HYDROCHLORIDE,GuideToPharmacology,1,inhibitor
ANK3,S20928,GuideToPharmacology,1,inhibitor
ANK3,[125I]DIV880,GuideToPharmacology,1,agonist
ANK3,6-CL-MLT,GuideToPharmacology,1,agonist
ANK3,RAMELTEON,GuideToPharmacology,1,agonist
APOF,NALTREXONE,GuideToPharmacology,1,inhibitor
CD8B,LOFEPRAMINE,GuideToPharmacology,1,inhibitor
CD8B,AMOXAPINE,GuideToPharmacology,1,inhibitor
HOXB4,COMPOUND 22 [PMID: 30457869],GuideToPharmacology,1,inhibitor
BFSP1,COMPOUND 111 [PMID: 37918435],GuideToPharmacology,1,agonist
ATF4,PHA-709829,GuideToPharmacology,1,agonist
AQP4,SUBSTANCE P,GuideToPharmacology,1,agonist
APBA1,SCH486757,GuideToPharmacology,1,agonist
APBA1,AT-076,GuideToPharmacology,1,inhibitor
ANXA7,JMV2004,GuideToPharmacology,1,agonist
ANXA1,[3H]EYF,GuideToPharmacology,1,agonist
APBA2,NAG 26,GuideToPharmacology,1,agonist
AMPD2,5-OXO-20-HETE,GuideToPharmacology,1,agonist
AMPD2,5-OXO-15-HETE,GuideToPharmacology,1,agonist
APBB1,JNJ-10397049,GuideToPharmacology,1,inhibitor
APBB1,LEMBOREXANT,GuideToPharmacology,1,inhibitor
PAK4,AMG28,GuideToPharmacology,1,inhibitor
ATP1B3P1,AZ10606120,GuideToPharmacology,1,modulator
ATP1B3P1,AZ10606120,GuideToPharmacology,1,inhibitor
ATP1B3P1,COMPOUND 16I [PMID: 31525963],GuideToPharmacology,1,inhibitor
ATP1B3P1,CLEMASTINE,GuideToPharmacology,1,modulator
ATP1B3P1,KN62,GuideToPharmacology,1,modulator
ATP1B3P1,DECAVANADATE,GuideToPharmacology,1,inhibitor
BIRC2,REACTIVE BLUE-2,GuideToPharmacology,1,inhibitor
APEX1,COMPOUND 58L [PMID: 30843696],GuideToPharmacology,1,inhibitor
APBB2,2-CHLOROADENOSINE-5-TRIPHOSPHATE,GuideToPharmacology,1,inhibitor
AIRE,5BRUTP,GuideToPharmacology,1,agonist
AIRE,URIDINE-5'-DIPHOSPHATE,GuideToPharmacology,1,agonist
ADCYAP1R1,[ARG16]CHICKEN SECRETIN,GuideToPharmacology,1,agonist
APOE,2-FUROYL-LIGRL[N[3H]PROPIONYL]-O-NH2,GuideToPharmacology,1,agonist
APOE,[3H]2-FUROYL-LIGRL-NH2,GuideToPharmacology,1,agonist
APOH,YD-3,GuideToPharmacology,1,inhibitor
F7,FIMEPINOSTAT,GuideToPharmacology,1,inhibitor
F7,PIK-75,GuideToPharmacology,1,inhibitor
F7R,ECF309,GuideToPharmacology,1,inhibitor
F7R,PIK-75,GuideToPharmacology,1,inhibitor
F7R,PILARALISIB,GuideToPharmacology,1,inhibitor
BLM,(R)-5-DIPHOSPHOMEVALONATE,GuideToPharmacology,1,inhibitor
F11,COMPOUND 14K [PMID: 21982499],GuideToPharmacology,1,inhibitor
CHKB,DESIPRAMINE,GuideToPharmacology,1,inhibitor
DPP6,DOVITINIB,GuideToPharmacology,1,inhibitor
DPP4,ILORASERTIB,GuideToPharmacology,1,inhibitor
DPP4,COMPOUND 8H [PMID: 21561767],GuideToPharmacology,1,inhibitor
DPP6,ORANTINIB,GuideToPharmacology,1,inhibitor
FRA4A,"SBC-115,337",GuideToPharmacology,1,inhibitor
CNGA1,MS049,GuideToPharmacology,1,inhibitor
CNC2,MS049,GuideToPharmacology,1,inhibitor
PSMB8,ONX-0914,GuideToPharmacology,1,inhibitor
GTF3C2,CHLOROGENIC ACID,GuideToPharmacology,1,inhibitor
FANCG,TAK-632,GuideToPharmacology,1,inhibitor
FANCG,SZM679,GuideToPharmacology,1,inhibitor
FAP,AZD-5423,GuideToPharmacology,1,inhibitor
GP1BA,CCG-63808,GuideToPharmacology,1,inhibitor
PTK2B,COMPOUND 8H [PMID: 21561767],GuideToPharmacology,1,inhibitor
BCHEL3,"3-FLUORO-4-{[(2R)-2-HYDROXY-2-(5,5,8,8-TETRAMETHYL-5,6,7,8-TETRAHYDRO-2-NAPHTHALENYL)ACETYL]AMINO}BENZOIC ACID",GuideToPharmacology,1,agonist
BCHEL3,PALOVAROTENE,GuideToPharmacology,1,agonist
PTK2B,SELPERCATINIB,GuideToPharmacology,1,inhibitor
CTPS1,FASUDIL,GuideToPharmacology,1,inhibitor
CTPS1,ROCK INHIBITOR 3,GuideToPharmacology,1,inhibitor
PTK2B,RESENCATINIB,GuideToPharmacology,1,inhibitor
TEX28,GSK429286A,GuideToPharmacology,1,inhibitor
DAGLA,CA2+,GuideToPharmacology,1,activator
DAGLA,CA2+,GuideToPharmacology,1,inhibitor
RYR2,CAFFEINE,GuideToPharmacology,1,activator
KLK3,INSL5,GuideToPharmacology,1,agonist
KLK3,MINIMISED RELAXIN-3 ANALOGUE 3,GuideToPharmacology,1,inhibitor
AMT,AMISELIMOD PHOSPHATE,GuideToPharmacology,1,agonist
FCER1A,SLM6071469,GuideToPharmacology,1,inhibitor
FDX1,GSK143,GuideToPharmacology,1,inhibitor
CRYBB3,KH064,GuideToPharmacology,1,inhibitor
FAS,"DES-ALA1,2,5-[D-TRP8,IAMP9]SRIF",GuideToPharmacology,1,agonist
FASLG,"[111IN,90Y]DOTA-OC",GuideToPharmacology,1,agonist
HLA-DMA,MC2050,GuideToPharmacology,1,inhibitor
FEN1,MRT67307,GuideToPharmacology,1,inhibitor
TEC,COMPOUND 38 [PMID: 24915291],GuideToPharmacology,1,inhibitor
HLA-DMB,MC2050,GuideToPharmacology,1,inhibitor
BCGF1,RT3,GuideToPharmacology,1,agonist
MPL,AVATROMBOPAG,GuideToPharmacology,1,agonist
TLR4,LPS,GuideToPharmacology,1,agonist
APOC4,IFETROBAN,GuideToPharmacology,1,inhibitor
APOC4,[125I]BOP,GuideToPharmacology,1,agonist
APOC4,KW-3635,GuideToPharmacology,1,inhibitor
ATP2A2,GSK417651A,GuideToPharmacology,1,blocker
ATP2A3,HC-070,GuideToPharmacology,1,blocker
ATP2A2,KB-R7943,GuideToPharmacology,1,blocker
ATP2A2,SAR7334,GuideToPharmacology,1,blocker
ATP3,CA2+,GuideToPharmacology,1,activator
ATP2B2,GSK417651A,GuideToPharmacology,1,blocker
ATP2B2,LA3+,GuideToPharmacology,1,blocker
ATP2B3,SH045,GuideToPharmacology,1,blocker
ATP2B2,SH045,GuideToPharmacology,1,blocker
ATP4A,LA3+,GuideToPharmacology,1,blocker
ATP4B,9-PHENANTHROL,GuideToPharmacology,1,blocker
ATP4B,CA2+,GuideToPharmacology,1,activator
ATP4A,EPIPREGNANOLONE SULPHATE,GuideToPharmacology,1,activator
ATP5F1AP2,NI2+,GuideToPharmacology,1,blocker
ATP5F1AP2,CA2+,GuideToPharmacology,1,activator
MCOLN2,PRU-12,GuideToPharmacology,1,inhibitor
GRB10,NAVOXIMOD,GuideToPharmacology,1,inhibitor
TRPV6,LA3+,GuideToPharmacology,1,blocker
TYK2,COMPOUND 30 [PMID: 37057760],GuideToPharmacology,1,inhibitor
BCL7A,PARICALCITOL,GuideToPharmacology,1,agonist
CDH12P2,TETRABENAZINE,GuideToPharmacology,1,inhibitor
AR,"D(CH2)5[D-ILE2,ILE4,ALA-NH2]AVP",GuideToPharmacology,1,inhibitor
ABCC6,DESMOPRESSIN,GuideToPharmacology,1,agonist
NPBWR1,COMPOUND 41 [PMID: 35436124],GuideToPharmacology,1,inhibitor
ABCC6,OPC-21268,GuideToPharmacology,1,inhibitor
ABCC6,LIXIVAPTAN,GuideToPharmacology,1,inhibitor
ANXA5,PANCREATIC POLYPEPTIDE,GuideToPharmacology,1,agonist
BCAT2,TTFB,GuideToPharmacology,1,modulator
ABCA4,TAMSULOSIN HYDROCHLORIDE,GuideToPharmacology,1,inhibitor
ASIC2,COMPOUND 21B [PMID: 12723954],GuideToPharmacology,1,agonist
ACAA1,PROPRANOLOL HYDROCHLORIDE,GuideToPharmacology,1,inhibitor
A12M4,[3H]RAUWOLSCINE,GuideToPharmacology,1,inhibitor
ASS1,GYKI53655,GuideToPharmacology,1,inhibitor
BCL3,IMB-808,GuideToPharmacology,1,agonist
ABL1,BRIMONIDINE,GuideToPharmacology,1,agonist
ABCA3,FLAVANONE,GuideToPharmacology,1,inhibitor
A12M4,TRYPTAMINE,GuideToPharmacology,1,agonist
ACTA2,VMIP-II,GuideToPharmacology,1,inhibitor
BMAL1,TP003,GuideToPharmacology,1,modulator
GRIN2C,L701324,GuideToPharmacology,1,inhibitor
DPP4,DOVITINIB,GuideToPharmacology,1,inhibitor
AZF1,ML277,GuideToPharmacology,1,activator
ABAT,CAPADENOSON,GuideToPharmacology,1,agonist
DNMT1,GSK3685032,GuideToPharmacology,1,inhibitor
ACADSB,[125I]APELIN-13,GuideToPharmacology,1,agonist
COL8A1,SCH51866,GuideToPharmacology,1,inhibitor
ABCD1,ETICLOPRIDE,GuideToPharmacology,1,inhibitor
ESR2,BISPHENOL A,GuideToPharmacology,1,agonist
AMD1,PIPAMPERONE,GuideToPharmacology,1,inhibitor
SHROOM2,PASIREOTIDE,GuideToPharmacology,1,agonist
ARG2,CHARYBDOTOXIN-GLU32 ANALOG,GuideToPharmacology,1,blocker
FRA8C,MM3122,GuideToPharmacology,1,inhibitor
COX6A1,VOXELOTOR,GuideToPharmacology,1,inhibitor
EN1,BI-4142,GuideToPharmacology,1,inhibitor
KIF1A,GXTX-1E,GuideToPharmacology,1,inhibitor
CTNNA1P1,BRIMAPITIDE,GuideToPharmacology,1,inhibitor
A12M3,(+)-LSD,GuideToPharmacology,1,agonist
ADH1C,2-OLEOYL GLYCEROL,GuideToPharmacology,1,agonist
BAD,E4031,GuideToPharmacology,1,blocker
ATN1,COMPOUND 8H [PMID: 21561767],GuideToPharmacology,1,inhibitor
CTNNB1,CBS-3595,GuideToPharmacology,1,inhibitor
GRIN2A,SAGE-718,GuideToPharmacology,1,modulator
ABL1,COMPOUND 24 [PMID: 23441572],GuideToPharmacology,1,inhibitor
SHROOM2,NC 8-12,GuideToPharmacology,1,agonist
BCKDHA,REGLITAZAR,GuideToPharmacology,1,agonist
TYK2,NEZULCITINIB,GuideToPharmacology,1,inhibitor
CCND1,AD5075,GuideToPharmacology,1,agonist
ARSD,PICROTOXIN,GuideToPharmacology,1,blocker
CD9,SERTRALINE HYDROCHLORIDE,GuideToPharmacology,1,inhibitor
ATP5BL2,SET2,GuideToPharmacology,1,blocker
EGR4,1-AZAKENPAULLONE,GuideToPharmacology,1,inhibitor
MS4A3,(S)-EF-1520,GuideToPharmacology,1,inhibitor
ACTA1,CCL8,GuideToPharmacology,1,agonist
LATS2,LESTAURTINIB,GuideToPharmacology,1,inhibitor
AAMP,PENTYLTHIO-TZTP,GuideToPharmacology,1,agonist
ATP2B1,CHLORPROMAZINE,GuideToPharmacology,1,blocker
AMYP1,ATC0065,GuideToPharmacology,1,inhibitor
F7,ZSTK474,GuideToPharmacology,1,inhibitor
ALDH2,ETICLOPRIDE,GuideToPharmacology,1,inhibitor
ITGA9,BOP,GuideToPharmacology,1,inhibitor
TIMM8A,COMPOUND 15C [PMID: 21536437],GuideToPharmacology,1,inhibitor
C1QBP,CA2+,GuideToPharmacology,1,activator
ATP1B1P1,ACETALDEHYDE,GuideToPharmacology,1,activator
CSRP2P1,BALANOL,GuideToPharmacology,1,inhibitor
DPYS,ILORASERTIB,GuideToPharmacology,1,inhibitor
GPR183,TRAIL,GuideToPharmacology,1,agonist
GM2A,SPARTALIZUMAB,GuideToPharmacology,1,antibody
ART1,PICROTOXIN,GuideToPharmacology,1,blocker
ALDH1B1,FR139317,GuideToPharmacology,1,inhibitor
APPL1,RELAXIN,GuideToPharmacology,1,agonist
ALDH1A1,[3H]7-OH-DPAT,GuideToPharmacology,1,agonist
CCR4,COMPOUND 31 [PMID: 31259550],GuideToPharmacology,1,inhibitor
ABCD2,COMPOUND 4 [PMID: 27074625],GuideToPharmacology,1,agonist
COX11,DAZOXIBEN,GuideToPharmacology,1,inhibitor
ARRB2,ZN2+,GuideToPharmacology,1,modulator
DRD4,ONARTUZUMAB,GuideToPharmacology,1,antibody
CCND1,NETOGLITAZONE,GuideToPharmacology,1,agonist
HRH3,INCB-38579,GuideToPharmacology,1,inhibitor
ASNSP2,MINOXIDIL,GuideToPharmacology,1,activator
HOXD10,PF-06835919,GuideToPharmacology,1,inhibitor
TRPM8,5-BENZYLOXYTRYPTAMINE,GuideToPharmacology,1,blocker
ARVCF,TRANS-3-ACPBPA,GuideToPharmacology,1,inhibitor
EEF1B2P2,KU-55933,GuideToPharmacology,1,inhibitor
CPA2,"(2S,4S)-KETOCONAZOLE",GuideToPharmacology,1,inhibitor
BDH1,DAIDZEIN,GuideToPharmacology,1,agonist
ALOX12P1,GALANIN(7-29) (PIG),GuideToPharmacology,1,agonist
ALOX12P1,GAL-B2-C12,GuideToPharmacology,1,agonist
A2MP1,MPDT,GuideToPharmacology,1,inhibitor
A12M1,DONITRIPTAN,GuideToPharmacology,1,agonist
EFNA4,XD14,GuideToPharmacology,1,inhibitor
ASS1P2,ARGIOTOXIN,GuideToPharmacology,1,blocker
ATP5F1BP1,CAMPHOR OIL,GuideToPharmacology,1,activator
GALR2,M1152,GuideToPharmacology,1,agonist
CXCR5,BPH-675,GuideToPharmacology,1,inhibitor
CACNA1H,NI2+,GuideToPharmacology,1,blocker
COX5B,COMPOUND 46C [PMID: 29350534],GuideToPharmacology,1,inhibitor
EPHB3,AZD1480,GuideToPharmacology,1,inhibitor
ALOX15,[35S]IBUTAMOREN,GuideToPharmacology,1,agonist
ABCA3,LAS38096,GuideToPharmacology,1,inhibitor
ALPI,HUMAN GIP(1-30)NH2,GuideToPharmacology,1,agonist
ALPL,[125I]GLP-1-(7-36)-AMIDE,GuideToPharmacology,1,agonist
ASS1P2,[3H]AMPA,GuideToPharmacology,1,agonist
BDM,HYDROCORTISONE BUTYRATE,GuideToPharmacology,1,agonist
BDM,MOMETASONE,GuideToPharmacology,1,agonist
BDM,DAGROCORAT,GuideToPharmacology,1,agonist
OSGIN2,CA2+,GuideToPharmacology,1,inhibitor
APOF,MEPERIDINE HYDROCHLORIDE,GuideToPharmacology,1,agonist
BDM,MIFEPRISTONE,GuideToPharmacology,1,inhibitor
BDM,AZD9567,GuideToPharmacology,1,agonist
GRIN2A,GV196771A,GuideToPharmacology,1,inhibitor
GRIN2A,ASPARTIC ACID,GuideToPharmacology,1,agonist
ACACA,FLTCHAAR,GuideToPharmacology,1,inhibitor
GRIN2A,CGP37849,GuideToPharmacology,1,inhibitor
ASS1P14,GLYCINE,GuideToPharmacology,1,agonist
ABR,PINDOLOL,GuideToPharmacology,1,agonist
ABR,PINDOLOL,GuideToPharmacology,1,inhibitor
GRIN2C,N1-DANSYL-SPERMINE,GuideToPharmacology,1,blocker
AQP8,MRE-269,GuideToPharmacology,1,agonist
AQP5,OSANETANT,GuideToPharmacology,1,inhibitor
ASS1P14,GLYCINE,GuideToPharmacology,1,agonist
GRIN2C,[3H]CGP61594,GuideToPharmacology,1,inhibitor
GLRA1,ZN2+,GuideToPharmacology,1,modulator
HOXD13,ML162,GuideToPharmacology,1,inhibitor
NAT1,SB 207710,GuideToPharmacology,1,inhibitor
MNX1,COMPOUND 25 [PMID: 32105470],GuideToPharmacology,1,inhibitor
ARVD4,PICROTOXIN,GuideToPharmacology,1,blocker
ASAH1,TROPISETRON,GuideToPharmacology,1,inhibitor
ASAH1,PICROTIN,GuideToPharmacology,1,blocker
SLC29A1,LY2090314,GuideToPharmacology,1,inhibitor
A2M,5-(NONYLOXY)-TRYPTAMINE,GuideToPharmacology,1,agonist
A12M4,YOHIMBINE,GuideToPharmacology,1,inhibitor
APEH,REACTIVE BLUE-2,GuideToPharmacology,1,inhibitor
DNMT3A,LDN-214117,GuideToPharmacology,1,inhibitor
SLC29A1,GNF4877,GuideToPharmacology,1,inhibitor
SLC25A6,COMPOUND 30 [PMID: 21757343],GuideToPharmacology,1,modulator
SLC29A1,COMPOUND 4-3 [PMID: 34027661],GuideToPharmacology,1,inhibitor
ANXA13,CINNAMIC ACID,GuideToPharmacology,1,agonist
FAUNA@,TILPISERTIB,GuideToPharmacology,1,inhibitor
FAS,"L-817,818",GuideToPharmacology,1,agonist
TLE5,(S)-CHLOROSUCCINIC ACID,GuideToPharmacology,1,agonist
ARL2,ZD7288,GuideToPharmacology,1,blocker
GSTA3,SABATOLIMAB,GuideToPharmacology,1,antibody
AOAH,ACIFRAN,GuideToPharmacology,1,agonist
ENUR2,IBRUTINIB,GuideToPharmacology,1,inhibitor
CDK4,AT-7519,GuideToPharmacology,1,inhibitor
EIF4EP1,"COMPOUND 51 [MALLINGER ET AL., 2016]",GuideToPharmacology,1,inhibitor
AMPD1,BAYU9773,GuideToPharmacology,1,agonist
AMPD1,BAYU9773,GuideToPharmacology,1,inhibitor
GDF2,SUPRASTAT,GuideToPharmacology,1,inhibitor
EMP2,LEUCETTINE L41,GuideToPharmacology,1,inhibitor
AMELX,VUF 8430,GuideToPharmacology,1,agonist
AMELX,HISTAMINE,GuideToPharmacology,1,agonist
AMELX,IMETIT,GuideToPharmacology,1,agonist
GEM,TRANYLCYPROMINE,GuideToPharmacology,1,inhibitor
AR,DESMOPRESSIN,GuideToPharmacology,1,agonist
ADH1C,LYSOPHOSPHATIDYLETHANOLAMINE,GuideToPharmacology,1,agonist
EFNB2,DD-03-171,GuideToPharmacology,1,inhibitor
ADH1C,COMPOUND 1 [PMID: 21273063],GuideToPharmacology,1,agonist
ADH6,NCRW0005-F05,GuideToPharmacology,1,inhibitor
AQP3,NEUROKININ B,GuideToPharmacology,1,agonist
EGR4,CDK1/5 INHIBITOR,GuideToPharmacology,1,inhibitor
EIF4A1,BMS-387032,GuideToPharmacology,1,inhibitor
GABRA1,ZK93423,GuideToPharmacology,1,agonist
ADAM10,ZAPRINAST,GuideToPharmacology,1,agonist
ADRA2A,AR291903,GuideToPharmacology,1,inhibitor
ADD3,PBI-4547,GuideToPharmacology,1,inhibitor
DMTN,BI605906,GuideToPharmacology,1,inhibitor
NAAA,CCP,GuideToPharmacology,1,inhibitor
DPH1,INSULIN-LIKE GROWTH FACTOR 2,GuideToPharmacology,1,agonist
FRA13A,BEXOTEGRAST,GuideToPharmacology,1,inhibitor
EPHA3,TAKINIB,GuideToPharmacology,1,inhibitor
DFNB5,DUPILUMAB,GuideToPharmacology,1,antibody
EPHA7,PF-06426779,GuideToPharmacology,1,inhibitor
ITGB6,COMPOUND 7 [PMID: 31381331],GuideToPharmacology,1,inhibitor
FRA16C,COMPOUND 7 [PMID: 31381331],GuideToPharmacology,1,inhibitor
APOC3,EP 157,GuideToPharmacology,1,agonist
DST,DIPHENIDOL,GuideToPharmacology,1,agonist
BRAFPS1,GIV3727,GuideToPharmacology,1,inhibitor
BRDT,GIV3727,GuideToPharmacology,1,inhibitor
BNIP1,"1,10-PHENANTHROLINE",GuideToPharmacology,1,agonist
EPHB2,AT-9283,GuideToPharmacology,1,inhibitor
EPHB2,LORPUCITINIB,GuideToPharmacology,1,inhibitor
EPHB2,RUXOLITINIB,GuideToPharmacology,1,inhibitor
NUDT2,HYDROCODONE,GuideToPharmacology,1,agonist
EPHB3,PRN694,GuideToPharmacology,1,inhibitor
CD72,DIOA,GuideToPharmacology,1,inhibitor
DRD2,VEGFA,GuideToPharmacology,1,agonist
DRD2,LENVATINIB,GuideToPharmacology,1,inhibitor
DPT,VIMSELTINIB,GuideToPharmacology,1,inhibitor
ARG1,NS8593,GuideToPharmacology,1,inhibitor
ASGR1,SPERMIDINE,GuideToPharmacology,1,blocker
ASGR1,ZN2+,GuideToPharmacology,1,blocker
KCNJ5,NA+,GuideToPharmacology,1,activator
ATP5PO,MARGATOXIN,GuideToPharmacology,1,blocker
BAD,GINSENOSIDE RG3,GuideToPharmacology,1,activator
GGT7,DAMINOZIDE,GuideToPharmacology,1,inhibitor
ANK1,SHU9119,GuideToPharmacology,1,agonist
ANGPT2,SHU9119,GuideToPharmacology,1,inhibitor
HLA-H,MILADEMETAN,GuideToPharmacology,1,inhibitor
ETFB,GEDATOLISIB,GuideToPharmacology,1,inhibitor
ETFB,PAXALISIB,GuideToPharmacology,1,inhibitor
ETFB,OMIPALISIB,GuideToPharmacology,1,inhibitor
DRD4,CRIZOTINIB,GuideToPharmacology,1,inhibitor
DRD4,DALMELITINIB,GuideToPharmacology,1,inhibitor
BLK,ISOPENTENYL PYROPHOSPHATE,GuideToPharmacology,1,inhibitor
ANOP1,CFMTI,GuideToPharmacology,1,modulator
ANPEP,AZD8529,GuideToPharmacology,1,modulator
SLC25A5,VU0155041,GuideToPharmacology,1,modulator
SLC25A5,MPEP,GuideToPharmacology,1,modulator
SLC25A5,COMPOUND 11 [PMID: 20638279],GuideToPharmacology,1,modulator
ANTP2,GLUTAMIC ACID,GuideToPharmacology,1,agonist
NR3C2,BENZODROCORTISONE,GuideToPharmacology,1,agonist
ANTP2,XAP044,GuideToPharmacology,1,modulator
GRM8,LY341495,GuideToPharmacology,1,inhibitor
ESB3,7-HYDROXYSTAUROSPORINE,GuideToPharmacology,1,inhibitor
H4F3,"NITROFURANTOIN, MACROCRYSTALS",GuideToPharmacology,1,inhibitor
CTNNA1,SCH772984,GuideToPharmacology,1,inhibitor
ESRRB,PF-03715455,GuideToPharmacology,1,inhibitor
NR3C2,PREDNISOLONE,GuideToPharmacology,1,agonist
NR3C2,DEXAMETHASONE,GuideToPharmacology,1,agonist
CTNNB1,AZD6703,GuideToPharmacology,1,inhibitor
CTNNA1P1,PAMAPIMOD,GuideToPharmacology,1,inhibitor
CTNNA1P1,SP600125,GuideToPharmacology,1,inhibitor
CTNND1,PAMAPIMOD,GuideToPharmacology,1,inhibitor
CTNNA2,SP600125,GuideToPharmacology,1,inhibitor
CTNNB1,SB220025,GuideToPharmacology,1,inhibitor
ERPL1,COMPOUND 12 [PMID: 27448772],GuideToPharmacology,1,inhibitor
EYA4,CEP-1347,GuideToPharmacology,1,inhibitor
ERCC2,COMPOUND 11 [PMID: 26431428],GuideToPharmacology,1,inhibitor
ERCC3,COMPOUND 8 [PMID: 24044867],GuideToPharmacology,1,inhibitor
ERCC4,COMPOUND 11 [PMID: 26431428],GuideToPharmacology,1,inhibitor
DBP,ILOMASTAT,GuideToPharmacology,1,inhibitor
ERPL1,TAKINIB,GuideToPharmacology,1,inhibitor
ACE,ILOMASTAT,GuideToPharmacology,1,inhibitor
GADD45AP1,ILOMASTAT,GuideToPharmacology,1,inhibitor
ECI1,DOXYCYCLINE ANHYDROUS,GuideToPharmacology,1,inhibitor
FSHMD1A,LINEZOLID,GuideToPharmacology,1,inhibitor
CRKL,MJN110,GuideToPharmacology,1,inhibitor
DCK,ILOMASTAT,GuideToPharmacology,1,inhibitor
ANTP4,ME36,GuideToPharmacology,1,agonist
PTGES,COMPOUND 30 [PMID: 15953724],GuideToPharmacology,1,inhibitor
AADAC,K-252A,GuideToPharmacology,1,modulator
AADAC,DROXIDOPA,GuideToPharmacology,1,inhibitor
AADAC,AFDX384,GuideToPharmacology,1,inhibitor
AAMP,BRUCINE N-OXIDE,GuideToPharmacology,1,modulator
AAMP,AFDX384,GuideToPharmacology,1,inhibitor
AAMP,DEXETIMIDE,GuideToPharmacology,1,inhibitor
AAMP,MUSCARINIC TOXIN 3,GuideToPharmacology,1,inhibitor
AANAT,NNC 11-1314,GuideToPharmacology,1,agonist
ANK3,[125I]SD6,GuideToPharmacology,1,agonist
ANK3,AGOMELATINE,GuideToPharmacology,1,agonist
APOF,NALORPHINE,GuideToPharmacology,1,inhibitor
APOF,[LEU]ENKEPHALIN,GuideToPharmacology,1,agonist
APOF,ETORPHINE,GuideToPharmacology,1,agonist
HMAB,"COMPOUND 5 [STECULA ET AL., 2020]",GuideToPharmacology,1,inhibitor
CD8B,AMITRIPTYLINE HYDROCHLORIDE,GuideToPharmacology,1,inhibitor
DRD5P1,PALTIMATRECTINIB,GuideToPharmacology,1,inhibitor
NOS1,3-BROMO-7NI,GuideToPharmacology,1,inhibitor
DRD5P1,CZS-241,GuideToPharmacology,1,inhibitor
ATHS,MUSCARINE,GuideToPharmacology,1,inhibitor
DRG2,REPOTRECTINIB,GuideToPharmacology,1,inhibitor
ATHS,&ALPHA;-CONOTOXIN RGIA,GuideToPharmacology,1,inhibitor
DRG2,AZD1332,GuideToPharmacology,1,inhibitor
ATD,TC-2559,GuideToPharmacology,1,agonist
CHRNA3,&ALPHA;-CONOTOXIN TXIA,GuideToPharmacology,1,inhibitor
SERPINC1,GALLAMINE TRIETHIODIDE,GuideToPharmacology,1,blocker
ATF4,PNU-282987,GuideToPharmacology,1,agonist
ATF3,&ALPHA;-CONOTOXIN MII,GuideToPharmacology,1,inhibitor
ATD,SUVN-911,GuideToPharmacology,1,inhibitor
ATF4,MECAMYLAMINE,GuideToPharmacology,1,blocker
ATD,MECAMYLAMINE,GuideToPharmacology,1,blocker
AQP3,NEUROKININ A,GuideToPharmacology,1,agonist
APBA1,[3H]LEU-N/OFQ,GuideToPharmacology,1,agonist
NPFFR1,NEUROPEPTIDE FF,GuideToPharmacology,1,agonist
APBA1,[3H]N/OFQ,GuideToPharmacology,1,agonist
ANXA2P1,[125I][TYR11]DES-BR-NPB-23,GuideToPharmacology,1,agonist
ANXA1,[125I]NPFF,GuideToPharmacology,1,agonist
ANXA2,NCGC 84,GuideToPharmacology,1,inhibitor
ANXA6,JMV458,GuideToPharmacology,1,agonist
APBA2,DARIDOREXANT,GuideToPharmacology,1,inhibitor
APBA2,COMPOUND 11 [PMID: 15261275],GuideToPharmacology,1,inhibitor
APBB1,HTL6641,GuideToPharmacology,1,inhibitor
APBB1,JH112,GuideToPharmacology,1,inhibitor
APBB1,DANAVOREXTON,GuideToPharmacology,1,agonist
EXT3,IL-94,GuideToPharmacology,1,inhibitor
ATP1B1,5-BDBD,GuideToPharmacology,1,inhibitor
A2M,SUMATRIPTAN,GuideToPharmacology,1,agonist
A2M,DONITRIPTAN,GuideToPharmacology,1,agonist
A2MP1,SB 224289,GuideToPharmacology,1,inhibitor
A12M1,ZOLMITRIPTAN,GuideToPharmacology,1,agonist
A12M1,YOHIMBINE,GuideToPharmacology,1,inhibitor
A12M2,NAN 190,GuideToPharmacology,1,agonist
A12M2,YOHIMBINE,GuideToPharmacology,1,inhibitor
A12M3,DONITRIPTAN,GuideToPharmacology,1,agonist
A12M3,TRYPTAMINE,GuideToPharmacology,1,agonist
A12M3,(+)-BUTACLAMOL,GuideToPharmacology,1,inhibitor
A12M3,BF-1,GuideToPharmacology,1,inhibitor
A12M4,(+)-LSD,GuideToPharmacology,1,agonist
A12M4,AL-37350A,GuideToPharmacology,1,agonist
HTR2C,TRIFLUOPERAZINE,GuideToPharmacology,1,inhibitor
NAT1,RS 39604,GuideToPharmacology,1,inhibitor
HTR2C,TIOSPIRONE,GuideToPharmacology,1,inhibitor
NAT1,[3H]GR 113808,GuideToPharmacology,1,inhibitor
NATP,ICI 169369,GuideToPharmacology,1,inhibitor
SERPINA3,[3H]5-CT,GuideToPharmacology,1,agonist
SERPINA3,5-MEOT,GuideToPharmacology,1,agonist
ABL1,COMPOUND 8H [PMID: 21561767],GuideToPharmacology,1,inhibitor
ABL1,PHENTOLAMINE,GuideToPharmacology,1,agonist
ABL1,PHENTOLAMINE,GuideToPharmacology,1,inhibitor
ABL1,RX821002,GuideToPharmacology,1,inhibitor
ABL1,YOHIMBINE,GuideToPharmacology,1,inhibitor
AOC1,RX821002,GuideToPharmacology,1,inhibitor
BEVI,FLUTAMIDE,GuideToPharmacology,1,inhibitor
BEVI,JNJ-63576253,GuideToPharmacology,1,inhibitor
BEVI,ETHYLESTRENOL,GuideToPharmacology,1,agonist
BEVI,BISPHENOL A,GuideToPharmacology,1,inhibitor
ACADSB,APELIN RECEPTOR EARLY ENDOGENOUS LIGAND,GuideToPharmacology,1,agonist
ABAT,DERENOFYLLINE,GuideToPharmacology,1,inhibitor
ABCA3,PSB603,GuideToPharmacology,1,inhibitor
ABCA3,PSB-10,GuideToPharmacology,1,inhibitor
ACADS,CGP42112,GuideToPharmacology,1,agonist
EEF1D,COMPOUND 25 [PMID: 20855207],GuideToPharmacology,1,inhibitor
ACADM,IRBESARTAN,GuideToPharmacology,1,inhibitor
ACADM,LY303336,GuideToPharmacology,1,inhibitor
ACADM,EXP3174,GuideToPharmacology,1,inhibitor
ACAT1,[LEU8]-PHYLLOLITORIN,GuideToPharmacology,1,agonist
GNGT1,GDC-0152,GuideToPharmacology,1,inhibitor
AXL,ZANZALINTINIB,GuideToPharmacology,1,inhibitor
GNG11,XEVINAPANT,GuideToPharmacology,1,inhibitor
ABO,CARVEDILOL,GuideToPharmacology,1,inhibitor
ABO,BRL 37344,GuideToPharmacology,1,agonist
ABO,LABETALOL,GuideToPharmacology,1,inhibitor
AMFR,ETALOCIB,GuideToPharmacology,1,inhibitor
BMP2K,BARICITINIB,GuideToPharmacology,1,inhibitor
DNMT3B,COMPOUND 13A [PMID: 23639540],GuideToPharmacology,1,inhibitor
GLC1B,COMPOUND 1 [PMID: 25719566],GuideToPharmacology,1,inhibitor
BRD3,GW841819X,GuideToPharmacology,1,inhibitor
EFNA3,XD14,GuideToPharmacology,1,inhibitor
BRD3,XD14,GuideToPharmacology,1,inhibitor
EFNA3,LY-294002,GuideToPharmacology,1,inhibitor
ATP1B3P1,A804598,GuideToPharmacology,1,inhibitor
BRD7,LP99,GuideToPharmacology,1,inhibitor
EFNB2,BIIB068,GuideToPharmacology,1,inhibitor
BIRC2,MRS2211,GuideToPharmacology,1,inhibitor
EFNB2,JNJ-64264681,GuideToPharmacology,1,inhibitor
EFNB2,COMPOUND 25 [PMID: 31260299],GuideToPharmacology,1,inhibitor
EFNB2,WZ4002,GuideToPharmacology,1,inhibitor
EFNB2,SOFNOBRUTINIB,GuideToPharmacology,1,inhibitor
ASIC1,R-954,GuideToPharmacology,1,inhibitor
ASIC1,NG29,GuideToPharmacology,1,agonist
FRA20A,PYRIDOSTIGMINE,GuideToPharmacology,1,inhibitor
BIRC3,&ALPHA;.&BETA;-METHYLENE-2-THIO-UDP,GuideToPharmacology,1,agonist
BDKRB2,B-9430,GuideToPharmacology,1,inhibitor
C1QBP,ANI9,GuideToPharmacology,1,inhibitor
C1QBP,FLUFENAMIC ACID,GuideToPharmacology,1,blocker
CYP2C8,COMPOUND 27 [PMID: 18337095],GuideToPharmacology,1,inhibitor
CASP3,PETCM,GuideToPharmacology,1,activator
APLP2,CV-3988,GuideToPharmacology,1,inhibitor
ACTB,CXCL11,GuideToPharmacology,1,inhibitor
ACTB,CCL8,GuideToPharmacology,1,agonist
ACTB,CCL26,GuideToPharmacology,1,agonist
ACTB,GW766994,GuideToPharmacology,1,inhibitor
ACTBP2,CCL8,GuideToPharmacology,1,agonist
ACTBP2,COMPOUND 39 [PMID: 31742400],GuideToPharmacology,1,modulator
C4A,CA2+,GuideToPharmacology,1,inhibitor
BCKDHA,AZD4619,GuideToPharmacology,1,agonist
C4BPB,FLUFENAMIC ACID,GuideToPharmacology,1,inhibitor
C2,CA2+,GuideToPharmacology,1,inhibitor
FOXA3,SULFOPIN,GuideToPharmacology,1,inhibitor
C8A,OCTANOL,GuideToPharmacology,1,inhibitor
C8G,OCTANOL,GuideToPharmacology,1,inhibitor
C5,CA2+,GuideToPharmacology,1,inhibitor
C8A,CA2+,GuideToPharmacology,1,inhibitor
ACTG1,CXCL12H25R (MONOMER),GuideToPharmacology,1,agonist
ACTBP9,AZD5069,GuideToPharmacology,1,inhibitor
ACTC1,[125I]CXCL10 (HUMAN),GuideToPharmacology,1,agonist
EIF4A1,AT-7519,GuideToPharmacology,1,inhibitor
F7,PI-3065,GuideToPharmacology,1,inhibitor
EIF4B,RGB-286638,GuideToPharmacology,1,inhibitor
EIF4EBP1,AT-7519,GuideToPharmacology,1,inhibitor
EIF4E,6-BROMOINDIRUBIN-3'-OXIME,GuideToPharmacology,1,inhibitor
EIF4G1,CDK12 INHIBITOR 2,GuideToPharmacology,1,inhibitor
EIF4EBP2,TRILACICLIB,GuideToPharmacology,1,inhibitor
F7,OMIPALISIB,GuideToPharmacology,1,inhibitor
EIF4EP1,CDK12 INHIBITOR 2,GuideToPharmacology,1,inhibitor
CPD,ANASTROZOLE,GuideToPharmacology,1,inhibitor
EIF4G1,RGB-286638,GuideToPharmacology,1,inhibitor
F7,PICTILISIB,GuideToPharmacology,1,inhibitor
CORT,"COMPOUND 51 [CROSIGNANI ET AL., 2011]",GuideToPharmacology,1,inhibitor
CORT,VOXELOTOR,GuideToPharmacology,1,inhibitor
MAP3K8,"COMPOUND 51 [CROSIGNANI ET AL., 2011]",GuideToPharmacology,1,inhibitor
AMPD1,COMPOUND 13E [PMID: 31811124],GuideToPharmacology,1,inhibitor
APAF1,MEPERIDINE HYDROCHLORIDE,GuideToPharmacology,1,agonist
APAF1,PN6047,GuideToPharmacology,1,agonist
HPE1,OICR-8268,GuideToPharmacology,1,inhibitor
APAF1,CEBRANOPADOL,GuideToPharmacology,1,agonist
APAF1,ETHYLKETOCYCLAZOCINE,GuideToPharmacology,1,agonist
APAF1,NALTREXONE,GuideToPharmacology,1,inhibitor
APAF1,(-)-CYCLAZOCINE,GuideToPharmacology,1,agonist
APAF1,NALTRIBEN,GuideToPharmacology,1,inhibitor
APAF1,QUADAZOCINE,GuideToPharmacology,1,inhibitor
ALDH1A1,PERGOLIDE,GuideToPharmacology,1,agonist
ALDH3A1,PERGOLIDE,GuideToPharmacology,1,agonist
ALDH2,TRIFLUOPERAZINE,GuideToPharmacology,1,inhibitor
F7,COMPOUND 41 [PMID: 31855425],GuideToPharmacology,1,inhibitor
PRLHR,MOLIDUSTAT,GuideToPharmacology,1,inhibitor
F7R,KU-0060648,GuideToPharmacology,1,inhibitor
HMGB2,PT2385,GuideToPharmacology,1,inhibitor
HMGB2,BELZUTIFAN,GuideToPharmacology,1,inhibitor
FPR2,COMPOUND 10L [PMID: 24556381],GuideToPharmacology,1,inhibitor
DSC1,COMPOUND 8H [PMID: 21561767],GuideToPharmacology,1,inhibitor
EZH2,CPI-1205,GuideToPharmacology,1,inhibitor
RCAN1,COMPOUND 8H [PMID: 21561767],GuideToPharmacology,1,inhibitor
DXO,AMIVANTAMAB,GuideToPharmacology,1,antibody
DXO,PELITINIB,GuideToPharmacology,1,inhibitor
BLVRA,ALENDRONATE SODIUM,GuideToPharmacology,1,inhibitor
ABCD2,TUG-905,GuideToPharmacology,1,agonist
ABCD2,COMPOUND B [PMID:18477808],GuideToPharmacology,1,agonist
ENG,COMPOUND 25B [PMID: 22564207],GuideToPharmacology,1,inhibitor
FCGRT,EFGARTIGIMOD ALFA,GuideToPharmacology,1,antibody
F7R,PICTILISIB,GuideToPharmacology,1,inhibitor
CHEK1,COMPOUND 1L [PMID: 16644217],GuideToPharmacology,1,inhibitor
ABCD2,AMG-837,GuideToPharmacology,1,agonist
ABCD2,LINOLENIC ACID,GuideToPharmacology,1,agonist
F7R,IZORLISIB,GuideToPharmacology,1,inhibitor
ENO1,COMPOUND 25B [PMID: 22564207],GuideToPharmacology,1,inhibitor
CRMP1,URB597,GuideToPharmacology,1,inhibitor
DPYSL2,DOVITINIB,GuideToPharmacology,1,inhibitor
FGR,ECF506,GuideToPharmacology,1,inhibitor
DPYSL2,ORANTINIB,GuideToPharmacology,1,inhibitor
DPYSL2,FUTIBATINIB,GuideToPharmacology,1,inhibitor
COL9A3,INAMRINONE,GuideToPharmacology,1,inhibitor
SLC26A3,FGF-19,GuideToPharmacology,1,agonist
DRD1,FRUQUINTINIB,GuideToPharmacology,1,inhibitor
GAPDHP67,ZOTAROLIMUS,GuideToPharmacology,1,inhibitor
DPYS,EDICOTINIB,GuideToPharmacology,1,inhibitor
DPYS,COMPOUND 13AC [PMID: 33256400],GuideToPharmacology,1,inhibitor
DRD3,ONATASERTIB,GuideToPharmacology,1,inhibitor
ALDH9A1,[3H]LXA4,GuideToPharmacology,1,agonist
ALDH9A1,CGEN-855A,GuideToPharmacology,1,agonist
ALDH9A1,FMET-LEU-PHE,GuideToPharmacology,1,agonist
ALDH9A1,ISOPROPYLUREIDO-FLFLF,GuideToPharmacology,1,inhibitor
APOC2,DINOPROSTONE,GuideToPharmacology,1,agonist
ALDH3A2,FMET-MET-TYR-ALA-LEU-PHE,GuideToPharmacology,1,agonist
ALDH3A2,HUMANIN,GuideToPharmacology,1,agonist
COL10A1,REVAMILAST,GuideToPharmacology,1,inhibitor
ALDH3A2,HP(2-20),GuideToPharmacology,1,agonist
FZD4,FZM1.8,GuideToPharmacology,1,modulator
GALR2,GAL-B2,GuideToPharmacology,1,agonist
GALR2,[125I][TYR26]GALANIN (HUMAN),GuideToPharmacology,1,agonist
ALOX12P2,GALANIN,GuideToPharmacology,1,agonist
F11,SGI-1776,GuideToPharmacology,1,inhibitor
CXCR5,"[1-HYDROXY-2-(1,1':3',1''-TERPHENYL-3-YLOXY)ETHANE-1,1-DIYL]BIS(PHOSPHONIC ACID)",GuideToPharmacology,1,inhibitor
ASS1,LY503430,GuideToPharmacology,1,modulator
ALPG,NNC 92-1687,GuideToPharmacology,1,inhibitor
BDM,CLOBETASOL PROPIONATE,GuideToPharmacology,1,agonist
ASS1P6,LY339434,GuideToPharmacology,1,agonist
GRIN2B,L701324,GuideToPharmacology,1,inhibitor
GRIN2C,(RS)-(TETRAZOL-5-YL)GLYCINE,GuideToPharmacology,1,agonist
F9,SILMITASERTIB,GuideToPharmacology,1,inhibitor
GNRHR,IN-3,GuideToPharmacology,1,inhibitor
DLX3,CENDERITIDE,GuideToPharmacology,1,agonist
DLX4,HS-142-1,GuideToPharmacology,1,inhibitor
DHFRP3,SOMATROPIN (RECOMBINANT DNA ORIGIN),GuideToPharmacology,1,agonist
ANXA13,NIACIN,GuideToPharmacology,1,agonist
ANXA13,COMPOUND 42 [PMID: 22420767],GuideToPharmacology,1,modulator
ENUR2,ECF506,GuideToPharmacology,1,inhibitor
GAPDHP1,BML-281,GuideToPharmacology,1,inhibitor
F11,COMPOUND 20 [PMID: 22136433],GuideToPharmacology,1,inhibitor
GART,FIMEPINOSTAT,GuideToPharmacology,1,inhibitor
GART,RICOLINOSTAT,GuideToPharmacology,1,inhibitor
GART,COMPOUND 25AP [PMID: 37796543],GuideToPharmacology,1,inhibitor
GART,BML-281,GuideToPharmacology,1,inhibitor
AMD1,CHLORPROMAZINE,GuideToPharmacology,1,inhibitor
AMD1,(S)-DIMETINDENE,GuideToPharmacology,1,inhibitor
AMD1,CONESSINE,GuideToPharmacology,1,inhibitor
HRH3,IMMETHRIDINE,GuideToPharmacology,1,agonist
AMD1,TRIPELENNAMINE,GuideToPharmacology,1,inhibitor
GSTM5P1,YODA1,GuideToPharmacology,1,activator
AMD1P2,MK-0249,GuideToPharmacology,1,inhibitor
AMD1,ABT-239,GuideToPharmacology,1,inhibitor
HRH3,GT2394,GuideToPharmacology,1,inhibitor
HRH3,COMPOUND 3A [PMID: 18606542],GuideToPharmacology,1,agonist
HRH3,JNJ-5207852,GuideToPharmacology,1,inhibitor
HRH3,[123I]IODOPROXYFAN,GuideToPharmacology,1,inhibitor
HRH3,CONESSINE,GuideToPharmacology,1,inhibitor
HRH3,IMPROMIDINE,GuideToPharmacology,1,agonist
HRH3,SUVN-G3031,GuideToPharmacology,1,agonist
PRDM1,"COMPOUND 9A [PATIL ET AL., 1989]",GuideToPharmacology,1,inhibitor
ADCY3,HU-210,GuideToPharmacology,1,agonist
ADCY3,2-ARACHIDONYL GLYCERYL ETHER,GuideToPharmacology,1,agonist
APOA2,PROKINETICIN-2,GuideToPharmacology,1,agonist
ADCY3,CHGB (511-532),GuideToPharmacology,1,agonist
DMTN,BMS-345541,GuideToPharmacology,1,modulator
DPH1,AG 1024,GuideToPharmacology,1,inhibitor
APOC3,MRE-269,GuideToPharmacology,1,agonist
BOK,HALOPERIDOL DECANOATE,GuideToPharmacology,1,agonist
EPHB3,COMPOUND 30 [PMID: 37057760],GuideToPharmacology,1,inhibitor
EPHB3,BARICITINIB,GuideToPharmacology,1,inhibitor
EPHB3,ABIVERTINIB,GuideToPharmacology,1,inhibitor
EPHB3,COMPOUND 2 [PMID: 15546730],GuideToPharmacology,1,inhibitor
FRA2D,DKFZ鈥?51,GuideToPharmacology,1,inhibitor
NUDT2,MEPERIDINE HYDROCHLORIDE,GuideToPharmacology,1,agonist
NUDT2,DYNORPHIN-(1-11),GuideToPharmacology,1,agonist
DRD2,DOVITINIB,GuideToPharmacology,1,inhibitor
DRD2,TELATINIB,GuideToPharmacology,1,inhibitor
DPT,AVAPRITINIB,GuideToPharmacology,1,inhibitor
DPT,DOVITINIB,GuideToPharmacology,1,inhibitor
GPM6B,BI-2493,GuideToPharmacology,1,inhibitor
ATP5PB,ARACHIDONIC ACID,GuideToPharmacology,1,blocker
ARF5,DEQUALINIUM,GuideToPharmacology,1,blocker
KCNT2,FLUFENAMIC ACID,GuideToPharmacology,1,activator
BAD,DOFETILIDE,GuideToPharmacology,1,blocker
BAD,ICA-105574,GuideToPharmacology,1,activator
BAD,PF-04885614,GuideToPharmacology,1,inhibitor
AZF1,"(3R,4S)-293B",GuideToPharmacology,1,blocker
AZF1,IKS124,GuideToPharmacology,1,blocker
AZGP1,ML213,GuideToPharmacology,1,activator
EPS8,EB-42486,GuideToPharmacology,1,inhibitor
LHCGR,HCG,GuideToPharmacology,1,agonist
STX2,LIMKI3,GuideToPharmacology,1,inhibitor
CLN8,LIMKI3,GuideToPharmacology,1,inhibitor
BGN,RJW100,GuideToPharmacology,1,agonist
BAK1P2,"24(S), 25-EPOXYCHOLESTEROL",GuideToPharmacology,1,agonist
AMPD3,UCM-05194,GuideToPharmacology,1,agonist
BAK1P2,ACETYL-PODOCARPIC DIMER,GuideToPharmacology,1,agonist
BCL3,GW3965,GuideToPharmacology,1,agonist
AMPD3,VPC32183,GuideToPharmacology,1,inhibitor
GEM,GSK-LSD1,GuideToPharmacology,1,inhibitor
GLI3,GARCINOL,GuideToPharmacology,1,inhibitor
AMY2B,P-GUANIDINOBENZOYL-MCH-(7-17),GuideToPharmacology,1,agonist
AMY2B,TETRALIN_UREA ANALOGUE (7O),GuideToPharmacology,1,inhibitor
ANCR,ASIP [90-132 (L89Y)],GuideToPharmacology,1,inhibitor
DRD4,TEPOTINIB,GuideToPharmacology,1,inhibitor
ANOP1,A-794282,GuideToPharmacology,1,modulator
ANOP1,LY456236,GuideToPharmacology,1,modulator
ANOP1,LY456066,GuideToPharmacology,1,modulator
ANOP1,(S)-4C3HPG,GuideToPharmacology,1,inhibitor
SLC25A5,"(R,S)-4-PPG",GuideToPharmacology,1,agonist
CTNS,JNK INHIBITOR IX,GuideToPharmacology,1,inhibitor
FRA5A,COMPOUND 4 [PMID: 18163548],GuideToPharmacology,1,inhibitor
AADAC,MCN-A-343,GuideToPharmacology,1,agonist
AADAC,PF-06767832,GuideToPharmacology,1,modulator
AADAC,ACLIDINIUM,GuideToPharmacology,1,inhibitor
AADAC,T鈥?95,GuideToPharmacology,1,modulator
AADAC,METHSCOPOLAMINE BROMIDE,GuideToPharmacology,1,inhibitor
AAMP,ACLIDINIUM,GuideToPharmacology,1,inhibitor
AAMP,(S)-DIMETINDENE,GuideToPharmacology,1,inhibitor
DPP6,SU-11652,GuideToPharmacology,1,inhibitor
AANAT,DICYCLOMINE HYDROCHLORIDE,GuideToPharmacology,1,inhibitor
AANAT,PENTYLTHIO-TZTP,GuideToPharmacology,1,agonist
AANAT,HEXAHYDRODIFENIDOL,GuideToPharmacology,1,inhibitor
AANAT,ACLIDINIUM,GuideToPharmacology,1,inhibitor
AANAT,(S)-DIMETINDENE,GuideToPharmacology,1,inhibitor
AARS1,PROPANTHELINE,GuideToPharmacology,1,inhibitor
AARS1,METHOCTRAMINE,GuideToPharmacology,1,inhibitor
AARS1,PCS1055,GuideToPharmacology,1,inhibitor
AAVS1,(S)-DIMETINDENE,GuideToPharmacology,1,inhibitor
ANK2,LUZINDOLE,GuideToPharmacology,1,inhibitor
ANK2,RAMELTEON,GuideToPharmacology,1,agonist
APOF,CEBRANOPADOL,GuideToPharmacology,1,agonist
DPP6,PDGF RECEPTOR TYROSINE KINASE INHIBITOR IV,GuideToPharmacology,1,inhibitor
APOF,DIHYDROMORPHINE,GuideToPharmacology,1,agonist
APOF,ZYKLOPHIN,GuideToPharmacology,1,inhibitor
MYLK,CALMODULIN,GuideToPharmacology,1,activator
FABP1,GW853606,GuideToPharmacology,1,inhibitor
BBS1,ACONITINE,GuideToPharmacology,1,activator
BBS4,BATRACHOTOXIN,GuideToPharmacology,1,activator
SCN9A,DS-1971A,GuideToPharmacology,1,inhibitor
BBS2,PF-04885614,GuideToPharmacology,1,inhibitor
CD8B,CITALOPRAM,GuideToPharmacology,1,inhibitor
AQP3,BEFETUPITANT,GuideToPharmacology,1,inhibitor
AQP4,YM44778,GuideToPharmacology,1,inhibitor
AQP4,NEUROKININ B,GuideToPharmacology,1,agonist
DNAH9,EMLENOFLAST,GuideToPharmacology,1,inhibitor
AQP5,FEZOLINETANT,GuideToPharmacology,1,inhibitor
CRY2,CCT129957,GuideToPharmacology,1,inhibitor
AQP5,SSR 146977,GuideToPharmacology,1,inhibitor
AQP5,OSANETANT,GuideToPharmacology,1,inhibitor
NMUR1,NEUROMEDIN U-25,GuideToPharmacology,1,agonist
APBA1,CEBRANOPADOL,GuideToPharmacology,1,agonist
DMWD,ML130,GuideToPharmacology,1,inhibitor
HCL2,OMAVELOXOLONE,GuideToPharmacology,1,activator
GTF2F2P1,CRAC CHANNEL INHIBITOR 5B [PMID: 26256403],GuideToPharmacology,1,blocker
SLCO1C1,[3H]TAUROCHOLIC ACID,GuideToPharmacology,1,inhibitor
SLCO1C1,PROBENECID,GuideToPharmacology,1,inhibitor
GNAI2P1,AZ1366,GuideToPharmacology,1,inhibitor
ARAF,CARBETOCIN,GuideToPharmacology,1,agonist
ARAF,"[THR4,GLY7]OT",GuideToPharmacology,1,agonist
ARAF,L023103,GuideToPharmacology,1,inhibitor
ARAF,"[MPA1,D-TYR(ET)2,D-TIC7,D-TIC9]OT",GuideToPharmacology,1,inhibitor
ARAF,DESMOPRESSIN,GuideToPharmacology,1,agonist
APC,4-THIO-UTP,GuideToPharmacology,1,agonist
APCS,MRS2927,GuideToPharmacology,1,agonist
APCS,2-AMINO-URIDINE-5'-MONOPHOSPHATE,GuideToPharmacology,1,agonist
AIRE,TIM-38,GuideToPharmacology,1,inhibitor
APOH,BMS-986141,GuideToPharmacology,1,inhibitor
PRMT5,CMP5 [PMID: 25742700],GuideToPharmacology,1,inhibitor
PPID,CYCLOSPORINE,GuideToPharmacology,1,inhibitor
BCKDHA,DRF 2519,GuideToPharmacology,1,agonist
BCKDHA,IMIGLITAZAR,GuideToPharmacology,1,agonist
FRA7B,ZETOMIPZOMIB,GuideToPharmacology,1,inhibitor
CCND1,SB-219994,GuideToPharmacology,1,agonist
CCND1,AD5075,GuideToPharmacology,1,agonist
CCND1,AD-5061,GuideToPharmacology,1,agonist
F5,COMPOUND 15A [PMID: 32069401],GuideToPharmacology,1,inhibitor
F5,AMG319,GuideToPharmacology,1,inhibitor
F5,PI 3-KG INHIBITOR II,GuideToPharmacology,1,inhibitor
F5,LY-294002,GuideToPharmacology,1,inhibitor
PIK3CB,ALPELISIB,GuideToPharmacology,1,inhibitor
PIK3CB,AMG319,GuideToPharmacology,1,inhibitor
PIK3CB,COMPOUND 20F [PMID: 28520415],GuideToPharmacology,1,inhibitor
F7,AZD8154,GuideToPharmacology,1,inhibitor
F7,COMPOUND 20F [PMID: 28520415],GuideToPharmacology,1,inhibitor
PIK3CB,PIK-75,GuideToPharmacology,1,inhibitor
F7,SERABELISIB,GuideToPharmacology,1,inhibitor
F7R,DACTOLISIB,GuideToPharmacology,1,inhibitor
CTAA1,7-HYDROXYSTAUROSPORINE,GuideToPharmacology,1,inhibitor
F7R,SERABELISIB,GuideToPharmacology,1,inhibitor
COL19A1,MK-8189,GuideToPharmacology,1,inhibitor
COL9A2,CILOSTAZOL,GuideToPharmacology,1,inhibitor
NBEAP1,LOVASTATIN,GuideToPharmacology,1,agonist
BDNF,ORG2058,GuideToPharmacology,1,agonist
BDNF,PROMEGESTONE,GuideToPharmacology,1,agonist
FXN,S 17092,GuideToPharmacology,1,inhibitor
NKX2-5,G&OUML; 6976,GuideToPharmacology,1,inhibitor
ERCC8,INDOLE-3-PROPIONIC ACID,GuideToPharmacology,1,inhibitor
BIRC5,"[ILE5,TRP23]PTHRP-(1-36) (HUMAN)",GuideToPharmacology,1,agonist
BIRC5,"[ILE5,TRP23,TYR36]PTHRP-(1-36)-NH2 (HUMAN)",GuideToPharmacology,1,agonist
XIAP,"[D-TRP12,TYR34]PTH-(7-34) (BOVINE)",GuideToPharmacology,1,inhibitor
BIRC5,[D-TRP12]PTH-(7-34) (BOVINE),GuideToPharmacology,1,inhibitor
XIAP,[TRP23]PTHRP-(1-36) (HUMAN),GuideToPharmacology,1,agonist
BIRC5,"[125I][NLE8,21,TYR34]PTH-(1-34)-NH2 (RAT)",GuideToPharmacology,1,agonist
APLP1,COMPOUND 25E [PMID: 25875054],GuideToPharmacology,1,inhibitor
FAH,TAK-632,GuideToPharmacology,1,inhibitor
FANCG,GSK963,GuideToPharmacology,1,inhibitor
CTAA1,ENZASTAURIN,GuideToPharmacology,1,inhibitor
GOLGA2,COMPOUND III [PMID: 29351497],GuideToPharmacology,1,inhibitor
APP,RELAXIN,GuideToPharmacology,1,agonist
CXADR,PF-4708671,GuideToPharmacology,1,inhibitor
AMT,PONESIMOD,GuideToPharmacology,1,agonist
AMY1C,SIPONIMOD,GuideToPharmacology,1,agonist
AMY1C,ETRASIMOD,GuideToPharmacology,1,agonist
AMY1B,SIPONIMOD,GuideToPharmacology,1,agonist
AMY1B,PONESIMOD,GuideToPharmacology,1,agonist
AMY2A,PONESIMOD,GuideToPharmacology,1,agonist
AMY2A,ETRASIMOD,GuideToPharmacology,1,agonist
CD9,CITALOPRAM,GuideToPharmacology,1,inhibitor
STK36,RO-0505124,GuideToPharmacology,1,inhibitor
CD9,DESVENLAFAXINE SUCCINATE,GuideToPharmacology,1,inhibitor
FRA5G,B3C,GuideToPharmacology,1,inhibitor
CD9,LOFEPRAMINE,GuideToPharmacology,1,inhibitor
CD3E,REMOGLIFLOZIN,GuideToPharmacology,1,inhibitor
CD3D,LICOGLIFLOZIN,GuideToPharmacology,1,inhibitor
FDX1,TAS05567,GuideToPharmacology,1,inhibitor
MS4A2,CCT196969,GuideToPharmacology,1,inhibitor
FDX1,SYK INHIBITOR,GuideToPharmacology,1,inhibitor
FASLG,"L-363,377",GuideToPharmacology,1,agonist
SHROOM2,CGP 23996,GuideToPharmacology,1,agonist
FEN1,GSK8612,GuideToPharmacology,1,inhibitor
TLE5,COMPOUND 31 [PMID: 29968758],GuideToPharmacology,1,agonist
FEN1,COMPOUND II [PMID: 21329883],GuideToPharmacology,1,inhibitor
FEN1,BAY-985,GuideToPharmacology,1,inhibitor
FEN1,BX-795,GuideToPharmacology,1,inhibitor
TEC,COMPOUND 25 [PMID: 31260299],GuideToPharmacology,1,inhibitor
1-Feb,AMG28,GuideToPharmacology,1,inhibitor
TLR3,POLY(I:C),GuideToPharmacology,1,agonist
DMP1,CU-CPT8M,GuideToPharmacology,1,inhibitor
ATP1B1P1,GDC-0334,GuideToPharmacology,1,blocker
ATP2B1,BTP2,GuideToPharmacology,1,blocker
TRPM5,APV206690A,GuideToPharmacology,1,modulator
ALDH7A1,ML-SA5,GuideToPharmacology,1,activator
ATP5F1C,ISOCHLOROGENIC ACID B,GuideToPharmacology,1,blocker
GCF1,DOCETAXEL ANHYDROUS,GuideToPharmacology,1,inhibitor
TYK2,BREPOCITINIB,GuideToPharmacology,1,inhibitor
TYK2,GDC-0214,GuideToPharmacology,1,inhibitor
UTS2R,UROTENSIN-II,GuideToPharmacology,1,agonist
BCL7A,3-KETO-LITHOCHOLIC ACID,GuideToPharmacology,1,agonist
AQP9,"D(CH2)5[TYR(ET)2,VAL4,DES-GLY9]AVP",GuideToPharmacology,1,inhibitor
GNG10,TOLINAPANT,GuideToPharmacology,1,inhibitor
ANXA3,NPY-(20-36) (PIG),GuideToPharmacology,1,agonist
ANXA3,NEUROPEPTIDE Y-(3-36),GuideToPharmacology,1,agonist
DLX3,HS-142-1,GuideToPharmacology,1,inhibitor
DRD2,COMPOUND T.14,GuideToPharmacology,1,inhibitor
ARF5,CA2+,GuideToPharmacology,1,activator
AANAT,MCN-A-343,GuideToPharmacology,1,agonist
APOBER1,TREPROSTINIL,GuideToPharmacology,1,agonist
ALDH9A1,V3 PEPTIDE,GuideToPharmacology,1,agonist
ECI1,MMP13 TRACER  [18F]5J,GuideToPharmacology,1,inhibitor
ADCYAP1R1,PG 99-465,GuideToPharmacology,1,agonist
COL19A1,PDE4 INHIBITOR 16,GuideToPharmacology,1,inhibitor
PIK3CB,COMPOUND 12B [PMID: 31465220],GuideToPharmacology,1,inhibitor
APBB2,MRS2500,GuideToPharmacology,1,inhibitor
FRA7E,CID16197121,GuideToPharmacology,1,inhibitor
CTH,G&OUML; 6983,GuideToPharmacology,1,inhibitor
TYK2,BMS-986202,GuideToPharmacology,1,inhibitor
A12M4,SB 224289,GuideToPharmacology,1,inhibitor
AMT,GSK-2018682,GuideToPharmacology,1,agonist
CTF1,G&OUML; 6976,GuideToPharmacology,1,inhibitor
HLA-F,SL-176,GuideToPharmacology,1,inhibitor
AAK1,BARICITINIB,GuideToPharmacology,1,inhibitor
APOF,DYNORPHIN-(1-11),GuideToPharmacology,1,agonist
ACSL4,COMPOUND 19A [PMID: 21855335],GuideToPharmacology,1,inhibitor
BIRC3,UDP-GLUCOSE,GuideToPharmacology,1,agonist
APOC1,TG6-129,GuideToPharmacology,1,inhibitor
AQP2,CGP 23996,GuideToPharmacology,1,agonist
FANCG,NECROSTATIN-1S,GuideToPharmacology,1,inhibitor
HCN2,METHOPRENE ACID,GuideToPharmacology,1,agonist
TYK2,"COMPOUND 29 [MOSLIN ET AL., 2017]",GuideToPharmacology,1,inhibitor
BCHEL3,MM 11253,GuideToPharmacology,1,inhibitor
C4B,CA2+,GuideToPharmacology,1,inhibitor
APOF,TAPENTADOL,GuideToPharmacology,1,agonist
ATP5F1A,CA2+,GuideToPharmacology,1,blocker
ABCA1,PRELADENANT,GuideToPharmacology,1,inhibitor
DMP1,SELGANTOLIMOD,GuideToPharmacology,1,agonist
CTPS1,HSD1590,GuideToPharmacology,1,inhibitor
AMH,CAY10583,GuideToPharmacology,1,agonist
PTK2B,RIVOCERANIB,GuideToPharmacology,1,inhibitor
CYP2B6,TICLOPIDINE,GuideToPharmacology,1,inhibitor
ABCC6,D[CHA4]AVP,GuideToPharmacology,1,agonist
CTPS1,COMPOUND 8 [PMID: 25898023],GuideToPharmacology,1,inhibitor
PTK2B,VANDETANIB,GuideToPharmacology,1,inhibitor
CD9,DOXEPIN HYDROCHLORIDE,GuideToPharmacology,1,inhibitor
GAS1,DROXINOSTAT,GuideToPharmacology,1,inhibitor
F7R,LY-294002,GuideToPharmacology,1,inhibitor
BCYRN1P2,COMPOUND 17B [PMID: 35286086],GuideToPharmacology,1,inhibitor
AQP5,ELEDOISIN,GuideToPharmacology,1,agonist
FGR,COMPOUND 9 [PMID: 26006010],GuideToPharmacology,1,inhibitor
FBLN2,HG-9-91-01,GuideToPharmacology,1,inhibitor
ASL,SCH-23390,GuideToPharmacology,1,inhibitor
A2MP1,PERGOLIDE,GuideToPharmacology,1,agonist
GLRA1,PMBA,GuideToPharmacology,1,inhibitor
APLP2,ABT-299,GuideToPharmacology,1,inhibitor
APBB2,2-CL-ADP(&ALPHA;-BH3),GuideToPharmacology,1,agonist
BRD3,I-BET151,GuideToPharmacology,1,inhibitor
FAS,SRIF-28,GuideToPharmacology,1,agonist
ABAT,PRELADENANT,GuideToPharmacology,1,inhibitor
FCER2,COMPOUND 13 [PMID: 15925511],GuideToPharmacology,1,inhibitor
SHROOM2,BOC-ATE,GuideToPharmacology,1,agonist
DXO,COMPOUND 38 [PMID: 24915291],GuideToPharmacology,1,inhibitor
FASLG,[125I]TYR10-CST14,GuideToPharmacology,1,agonist
CCR4,[125I]CCL17 (HUMAN),GuideToPharmacology,1,agonist
FASLG,ANALOG 31 [PMID:18543899],GuideToPharmacology,1,inhibitor
CCKAR,CCK-58,GuideToPharmacology,1,agonist
ALPG,BAY27-9955,GuideToPharmacology,1,inhibitor
SHROOM2,ACQ090,GuideToPharmacology,1,inhibitor
EGR4,SAMURACICLIB,GuideToPharmacology,1,inhibitor
A2M,METITEPINE,GuideToPharmacology,1,inhibitor
ELF5,COMPOUND 14K [PMID: 21982499],GuideToPharmacology,1,inhibitor
ACTG1P7,&ALPHA;-NETA,GuideToPharmacology,1,inhibitor
ATP1B1,NP-1815-PX,GuideToPharmacology,1,inhibitor
F3,SAR405,GuideToPharmacology,1,inhibitor
DPYD,KI-20227,GuideToPharmacology,1,inhibitor
EFNA1,COMPOUND 9 [PMID: 26006010],GuideToPharmacology,1,inhibitor
ENO1P1,ECF506,GuideToPharmacology,1,inhibitor
ABL2,PERGOLIDE,GuideToPharmacology,1,agonist
ABAT,PSB603,GuideToPharmacology,1,inhibitor
EEGV1,COMPOUND 38 [PMID: 24915291],GuideToPharmacology,1,inhibitor
ASS1P5,LY339434,GuideToPharmacology,1,agonist
A12M3,LISURIDE,GuideToPharmacology,1,agonist
HBEGF,COMPOUND 15 [PMID: 24900237],GuideToPharmacology,1,inhibitor
ASPH,[3H]AMPA,GuideToPharmacology,1,agonist
EPS15,ECF506,GuideToPharmacology,1,inhibitor
AMPD2,5-OXO-12-HETE,GuideToPharmacology,1,inhibitor
ABCB7,TAMSULOSIN HYDROCHLORIDE,GuideToPharmacology,1,inhibitor
ANXA7,LEVOCABASTINE,GuideToPharmacology,1,agonist
FNTAP2,MILVEXIAN,GuideToPharmacology,1,inhibitor
SLC31A2,CHRYSIN,GuideToPharmacology,1,inhibitor
DRD2,FRUQUINTINIB,GuideToPharmacology,1,inhibitor
BAK1,RELUTRIGINE,GuideToPharmacology,1,inhibitor
A12M3,ERGOTAMINE,GuideToPharmacology,1,agonist
GNAI2,COMPOUND 10B [PMID: 26222319],GuideToPharmacology,1,inhibitor
AQP2,LANREOTIDE ACETATE,GuideToPharmacology,1,agonist
AMD1,TRIFLUOPERAZINE,GuideToPharmacology,1,inhibitor
CTAA2,BALANOL,GuideToPharmacology,1,inhibitor
GAPDH,COMPOUND 5A [PMID: 31287314],GuideToPharmacology,1,inhibitor
SLC25A5,COMPOUND 1 [PMID: 22465637],GuideToPharmacology,1,modulator
A1BG,CYAMEMAZINE,GuideToPharmacology,1,inhibitor
AMD1,A-317920,GuideToPharmacology,1,inhibitor
EXTL1,FRAX597,GuideToPharmacology,1,inhibitor
BCKDHA,MK-0767,GuideToPharmacology,1,agonist
ATP2A2,NI2+,GuideToPharmacology,1,blocker
ABCC6,"D(CH2)5[D-ILE2,ILE4]AVP",GuideToPharmacology,1,inhibitor
APLP2,L659989,GuideToPharmacology,1,inhibitor
GRIN1,COMPOUND 40 [PMID: 33470814],GuideToPharmacology,1,agonist
AQP2,SRIF-28,GuideToPharmacology,1,agonist
A12M2,DONITRIPTAN,GuideToPharmacology,1,agonist
CD3D,ERTUGLIFLOZIN,GuideToPharmacology,1,inhibitor
GRIN1,DIABZI-4,GuideToPharmacology,1,agonist
TEC,IBRUTINIB,GuideToPharmacology,1,inhibitor
APOC4,AGN 191976,GuideToPharmacology,1,agonist
FRA8C,COMPOUND 5 [PMID: 21741839],GuideToPharmacology,1,inhibitor
NAT1,RS 67333,GuideToPharmacology,1,agonist
DNMT3A,ZILURGISERTIB,GuideToPharmacology,1,inhibitor
GRIN2A,ZWB67,GuideToPharmacology,1,antibody
RIPK2,SRC KINASE INHIBITOR I,GuideToPharmacology,1,inhibitor
DOCK3,LY2109761,GuideToPharmacology,1,inhibitor
ATP2A2,NORGESTIMATE,GuideToPharmacology,1,blocker
ATP3,OAADPR,GuideToPharmacology,1,activator
APCS,DEZAMIZUMAB,GuideToPharmacology,1,antibody
ATP3,ZN2+,GuideToPharmacology,1,blocker
TRPV4,CIMIFUGIN,GuideToPharmacology,1,inhibitor
ALDH3B2,I-BOC-MET-LEU-PHE,GuideToPharmacology,1,inhibitor
BCKDHA,LANIFIBRANOR,GuideToPharmacology,1,agonist
TRPV6,TETRAHYDROCANNABIVARIN,GuideToPharmacology,1,inhibitor
PDK2,VER-246608,GuideToPharmacology,1,inhibitor
CD9,CLOMIPRAMINE,GuideToPharmacology,1,inhibitor
TRPV6,SOR-C13,GuideToPharmacology,1,inhibitor
ABAT,CYCLOPENTYLADENOSINE,GuideToPharmacology,1,agonist
ESR2,BAZEDOXIFENE,GuideToPharmacology,1,inhibitor
TYK2,LORPUCITINIB,GuideToPharmacology,1,inhibitor
AARS1,PIRENZEPINE,GuideToPharmacology,1,inhibitor
CCND1,GW0072,GuideToPharmacology,1,agonist
F5,SAMOTOLISIB,GuideToPharmacology,1,inhibitor
FPR2,ALPHA 1-ANTITRYPSIN,GuideToPharmacology,1,inhibitor
GCK,PHENPROCOUMON,GuideToPharmacology,1,inhibitor
ACTA2,JNJ-27141491,GuideToPharmacology,1,modulator
FRA12D,BI-1950,GuideToPharmacology,1,inhibitor
SCN9A,TETRODOTOXIN,GuideToPharmacology,1,blocker
C2,OCTANOL,GuideToPharmacology,1,inhibitor
AQP9,ARGIPRESSIN,GuideToPharmacology,1,agonist
EFNA3,I-BET151,GuideToPharmacology,1,inhibitor
ALOX12P1,GALR3ANT,GuideToPharmacology,1,inhibitor
AQP9,DVDAVP,GuideToPharmacology,1,agonist
APOA2,PROKINETICIN-2&BETA;,GuideToPharmacology,1,agonist
AR,"D(CH2)5[TYR(ME)2,THR4]OVT",GuideToPharmacology,1,inhibitor
EEF2,ILORASERTIB,GuideToPharmacology,1,inhibitor
CDK4,MILCICLIB,GuideToPharmacology,1,inhibitor
AQP9,"[PHAA1,D-TYR(ME)2,ARG6,TYR-NH29]AVP",GuideToPharmacology,1,inhibitor
FASLG,"[125I][TYR3,THR8]OCTREOTIDE",GuideToPharmacology,1,agonist
ATP5F1C,FORSYTHOSIDE B,GuideToPharmacology,1,blocker
AQP9,"[PHAA1,D-TYR(ET)2,VAL4,LYS6,TYR-NH28,DES-GLY9]AVP",GuideToPharmacology,1,inhibitor
AQP9,"[TBAA1,D-TYR(ET)2,VAL4,LYS6,ARG-NH28,DES-GLY9]AVP",GuideToPharmacology,1,inhibitor
AQP9,YM 471,GuideToPharmacology,1,inhibitor
ABCA3,CAFFEINE,GuideToPharmacology,1,inhibitor
DOCK2,DEUCRAVACITINIB,GuideToPharmacology,1,inhibitor
EPHB2,OCLACITINIB,GuideToPharmacology,1,inhibitor
ERVT3,XMD17-109,GuideToPharmacology,1,inhibitor
AR,"[PHAA1,D-TYR2,VAL4,ARG6,ARG-NH29]AVP",GuideToPharmacology,1,inhibitor
FDX1,SYK INHIBITOR III,GuideToPharmacology,1,inhibitor
AR,"[PHAA1,D-TYR(ET)2,VAL4,LYS6,TYR-NH28,DES-GLY9]AVP",GuideToPharmacology,1,inhibitor
AR,YM 471,GuideToPharmacology,1,inhibitor
ACTG1P3,XCL1,GuideToPharmacology,1,agonist
C4BPA,CA2+,GuideToPharmacology,1,inhibitor
ACADM,"[SAR1,ALA8]ANG-II",GuideToPharmacology,1,inhibitor
GNG5P1,VERDIPERSTAT,GuideToPharmacology,1,inhibitor
ACTG1P3,[125I]XCL1 (HUMAN),GuideToPharmacology,1,agonist
ACTB,RO116-9132/238,GuideToPharmacology,1,inhibitor
CYB5A,COMPOUND 25B [PMID: 22564207],GuideToPharmacology,1,inhibitor
UTS2R,BIM 23127,GuideToPharmacology,1,inhibitor
GRIA3,ARGIOTOXIN,GuideToPharmacology,1,blocker
EIF4E,AT-7519,GuideToPharmacology,1,inhibitor
NPBWR2,DESIDUSTAT,GuideToPharmacology,1,inhibitor
A12M3,BROLAMFETAMINE,GuideToPharmacology,1,agonist
ACRV1,VCE-004.3,GuideToPharmacology,1,inhibitor
ANXA2P3,BIBO3304,GuideToPharmacology,1,inhibitor
ANXA3,PEPTIDE YY,GuideToPharmacology,1,agonist
CYP4A11,COMPOUND 6 [PMID: 10395480],GuideToPharmacology,1,inhibitor
ANXA3,NEUROPEPTIDE Y,GuideToPharmacology,1,agonist
ANXA3,"[125I]NPY (HUMAN, MOUSE, RAT)",GuideToPharmacology,1,agonist
FRA16E,4-ACRYLOYLPHENOL,GuideToPharmacology,1,inhibitor
A1BG,TANDOSPIRONE,GuideToPharmacology,1,agonist
ABCA1,COMPOUND 4G [PMID: 22220592],GuideToPharmacology,1,agonist
ABAT,DU172,GuideToPharmacology,1,inhibitor
ABAT,ISTRADEFYLLINE,GuideToPharmacology,1,inhibitor
ABCA1,SAKURANETIN,GuideToPharmacology,1,inhibitor
ABCA2,ALLOXAZINE,GuideToPharmacology,1,inhibitor
ABCA2,ISTRADEFYLLINE,GuideToPharmacology,1,inhibitor
ABCA2,OSIP339391,GuideToPharmacology,1,inhibitor
ABCA3,DERENOFYLLINE,GuideToPharmacology,1,inhibitor
ACADM,TRV023,GuideToPharmacology,1,agonist
ATR,BERZOSERTIB,GuideToPharmacology,1,inhibitor
AXL,"COMPOUND 6LI [CHAN ET AL., 2022]",GuideToPharmacology,1,inhibitor
ACAT1,PD 165929,GuideToPharmacology,1,inhibitor
ACAT1,"[D-PHE6, LEU13, CPA14,&PSI;13-14]BOMBESIN-(6-14)",GuideToPharmacology,1,inhibitor
ACAT2,[D-PHE6]BOMBESIN(6-13)PROPYLAMIDE,GuideToPharmacology,1,inhibitor
ACAT2,AC-GRP-(20-26)-METHYLESTER,GuideToPharmacology,1,inhibitor
ABO,NIHP,GuideToPharmacology,1,inhibitor
ABR,LK 204-545,GuideToPharmacology,1,inhibitor
EEGV1,COMPOUND 25 [PMID: 31260299],GuideToPharmacology,1,inhibitor
AMFR,CP105696,GuideToPharmacology,1,inhibitor
ACAA1,NEBIVOLOL HYDROCHLORIDE,GuideToPharmacology,1,inhibitor
MS4A3,(R)-EF-1520,GuideToPharmacology,1,inhibitor
DOCK2,COMPOUND 13A [PMID: 23639540],GuideToPharmacology,1,inhibitor
EFNA1,COMPOUND 38 [PMID: 24915291],GuideToPharmacology,1,inhibitor
AMH,12S-HETE,GuideToPharmacology,1,agonist
ACP5,CA2+,GuideToPharmacology,1,agonist
FOLR2,UAWJ9-36-3,GuideToPharmacology,1,inhibitor
RND3,DINOPROSTONE,GuideToPharmacology,1,activator
HOXD8,C7683,GuideToPharmacology,1,inhibitor
CNR2,AM2201,GuideToPharmacology,1,agonist
CNR2,SCH.336,GuideToPharmacology,1,agonist
CNR2,NABILONE,GuideToPharmacology,1,agonist
CNR2,BMS-202,GuideToPharmacology,1,agonist
CCKBR,GASTRIN-14,GuideToPharmacology,1,agonist
ALDH1A1,LISURIDE,GuideToPharmacology,1,agonist
ALDH1A1,ETICLOPRIDE,GuideToPharmacology,1,inhibitor
ALDH1A1,CHLORPROMAZINE,GuideToPharmacology,1,inhibitor
ALDH1A1,SULPIRIDE,GuideToPharmacology,1,inhibitor
ALDH2,LISURIDE,GuideToPharmacology,1,agonist
ALDH2,HALOPERIDOL DECANOATE,GuideToPharmacology,1,inhibitor
EML1,GNF2133,GuideToPharmacology,1,inhibitor
DXO,ABIVERTINIB,GuideToPharmacology,1,inhibitor
DXO,CANERTINIB,GuideToPharmacology,1,inhibitor
APOBER1,MB-28767,GuideToPharmacology,1,agonist
APOC1,DINOPROSTONE,GuideToPharmacology,1,agonist
APOC1P1,GR 63799,GuideToPharmacology,1,agonist
AQP8,MK-2894,GuideToPharmacology,1,inhibitor
ERBB4,COMPOUND 38 [PMID: 24915291],GuideToPharmacology,1,inhibitor
BCYRN1P2,CLOMIPHENE,GuideToPharmacology,1,inhibitor
ALDH1B1,ENDOTHELIN-1,GuideToPharmacology,1,agonist
ALDH1B1,ENDOTHELIN-2,GuideToPharmacology,1,agonist
ALDH1B1,AMBRISENTAN,GuideToPharmacology,1,inhibitor
ALDH1B1,EDONENTAN ANHYDROUS,GuideToPharmacology,1,inhibitor
DHCR24,CIBINETIDE,GuideToPharmacology,1,agonist
SLC1A1,L-&BETA;-BA,GuideToPharmacology,1,inhibitor
BMAL1,DMCM,GuideToPharmacology,1,modulator
BMAL1,BREXANOLONE,GuideToPharmacology,1,modulator
ARRB1,[35S]TBPS,GuideToPharmacology,1,blocker
ARRB1,L655708,GuideToPharmacology,1,modulator
ARRB2,PZ-II-029,GuideToPharmacology,1,modulator
ART4,5-ME-IAA,GuideToPharmacology,1,agonist
ALOX12P1,GALANIN,GuideToPharmacology,1,agonist
ALOX15,WFW-ISN-NH2,GuideToPharmacology,1,agonist
ALPL,TIRZEPATIDE,GuideToPharmacology,1,agonist
ALOX15,PF-05190457,GuideToPharmacology,1,inhibitor
ASPH,CX546,GuideToPharmacology,1,modulator
ASPH,GYKI53655,GuideToPharmacology,1,inhibitor
ASS1,[3H]AMPA,GuideToPharmacology,1,agonist
ALPL,LIRAGLUTIDE,GuideToPharmacology,1,agonist
ASS1P2,LY503430,GuideToPharmacology,1,modulator
ASS1P2,CX546,GuideToPharmacology,1,modulator
GRIA3,CX546,GuideToPharmacology,1,modulator
ALPG,"[125I]GLUCAGON (HUMAN, MOUSE, RAT)",GuideToPharmacology,1,agonist
BDM,ORG 214007-0,GuideToPharmacology,1,agonist
GRIN2A,[3H]L689560,GuideToPharmacology,1,inhibitor
ASS1P14,L701324,GuideToPharmacology,1,inhibitor
ASS1P14,(RS)-(TETRAZOL-5-YL)GLYCINE,GuideToPharmacology,1,agonist
GRIN2C,DEXTRORPHAN,GuideToPharmacology,1,blocker
GLRA1,BILOBALIDE,GuideToPharmacology,1,inhibitor
ASS1P14,PHENCYCLIDINE,GuideToPharmacology,1,blocker
GAD2,S-ALLYLGLYCINE,GuideToPharmacology,1,inhibitor
ARVD4,CU2+,GuideToPharmacology,1,modulator
GTF2B,CODRITUZUMAB,GuideToPharmacology,1,antibody
SLC29A1,RGB-286638,GuideToPharmacology,1,inhibitor
ANXA11,"3,5-DIHYDROXYBENZOIC ACID",GuideToPharmacology,1,agonist
AMELX,DIMAPRIT,GuideToPharmacology,1,agonist
AMELX,MK-0249,GuideToPharmacology,1,inhibitor
AMELX,N-&ALPHA;-METHYLHISTAMINE,GuideToPharmacology,1,agonist
AMELX,INCB-38579,GuideToPharmacology,1,inhibitor
AMELX,(S)-&ALPHA;-METHYLHISTAMINE,GuideToPharmacology,1,agonist
AMELX,IODOPHENPROPIT,GuideToPharmacology,1,inhibitor
PRDM1,COMPOUND 29 [PMID: 1527791],GuideToPharmacology,1,inhibitor
ADH1C,COMPOUND 3 [PMID: 21310611],GuideToPharmacology,1,agonist
ADH1C,(S)-N-OLEOYLTYROSINOL,GuideToPharmacology,1,agonist
ADH1C,AS1535907,GuideToPharmacology,1,agonist
ADH1C,1-OLEOYL GLYCEROL,GuideToPharmacology,1,agonist
ACTN2,ASN04450772,GuideToPharmacology,1,agonist
ADH6,ZELATRIAZIN (TAK-041),GuideToPharmacology,1,agonist
ADCY3,JWH015,GuideToPharmacology,1,agonist
ADAM10,CID2745687,GuideToPharmacology,1,inhibitor
ADD3,DL-175,GuideToPharmacology,1,agonist
ADD3,3-HYDROXYLAURIC ACID,GuideToPharmacology,1,agonist
ADRA2A,AR305352,GuideToPharmacology,1,inhibitor
XCR1,NAVOXIMOD,GuideToPharmacology,1,inhibitor
NOS2,L-NNA,GuideToPharmacology,1,inhibitor
APOF,CTOP,GuideToPharmacology,1,inhibitor
APOF,PENTAZOCINE,GuideToPharmacology,1,agonist
CFB,COMPOUND 111 [PMID: 37918435],GuideToPharmacology,1,agonist
ZFHX3,HEXAMETHONIUM,GuideToPharmacology,1,blocker
ATHS,STRYCHNINE,GuideToPharmacology,1,inhibitor
ZFHX3,CP-601927,GuideToPharmacology,1,agonist
ATD,NS9283,GuideToPharmacology,1,modulator
SERPINC1,[125I]&ALPHA;-BUNGAROTOXIN,GuideToPharmacology,1,inhibitor
ATF4,[125I]&ALPHA;-BUNGAROTOXIN,GuideToPharmacology,1,inhibitor
ATF4P1,[125I]&ALPHA;-BUNGAROTOXIN,GuideToPharmacology,1,inhibitor
AQP3,ELEDOISIN,GuideToPharmacology,1,agonist
AQP3,"[125I]SP (HUMAN, MOUSE, RAT)",GuideToPharmacology,1,agonist
AQP4,YM49598,GuideToPharmacology,1,inhibitor
AQP4,GR100679,GuideToPharmacology,1,inhibitor
AQP3,"[125I]L703,606",GuideToPharmacology,1,inhibitor
ANXA2P1,NEUROPEPTIDE W-23,GuideToPharmacology,1,agonist
GBA1,EZETIMIBE,GuideToPharmacology,1,inhibitor
ANXA6,JMV2004,GuideToPharmacology,1,agonist
APBA2,OREXIN-A,GuideToPharmacology,1,agonist
ARAF,"[125I]D(CH2)5[TYR(ME)2,THR4,ORN8,TYR-NH29]OVT",GuideToPharmacology,1,inhibitor
APBA2,COMPOUND 1 [PMID: 33547286],GuideToPharmacology,1,agonist
ARAF,RELCOVAPTAN,GuideToPharmacology,1,inhibitor
APBB1,[3H]T-516,GuideToPharmacology,1,agonist
APBA2,LSN2424100,GuideToPharmacology,1,inhibitor
APBA2,SUVOREXANT,GuideToPharmacology,1,inhibitor
EXTL1,PQA-18,GuideToPharmacology,1,inhibitor
ATP1A4,GEFAPIXANT,GuideToPharmacology,1,inhibitor
ATP12A,NF778,GuideToPharmacology,1,inhibitor
ATP1A3,IP5I,GuideToPharmacology,1,inhibitor
ATP1B1,PSB-12054,GuideToPharmacology,1,inhibitor
ATP1B1,NIMODIPINE,GuideToPharmacology,1,modulator
ATP1B3P1,GSK1482160,GuideToPharmacology,1,modulator
ATP1B3P1,GSK1482160,GuideToPharmacology,1,inhibitor
ATP1B3P1,JNJ-47965567,GuideToPharmacology,1,inhibitor
BIRC2,MRS2603,GuideToPharmacology,1,inhibitor
APC,2-THIOUTP,GuideToPharmacology,1,agonist
APLP2,PLATELET ACTIVATING FACTOR,GuideToPharmacology,1,agonist
ADCYAP1R1,VIP,GuideToPharmacology,1,agonist
APLP2,ENANTIO PAF C-16,GuideToPharmacology,1,agonist
APOE,TRANS-CINNAMOYL-LIGRLO [N-[3H]PROPIONYL]-NH2,GuideToPharmacology,1,agonist
APPL1,(DES 1-8) A-CHAIN INSL3 ANALOGUE,GuideToPharmacology,1,inhibitor
KLK3,INSL5 AMIDE (HUMAN),GuideToPharmacology,1,agonist
SIGMAR1,EST73502,GuideToPharmacology,1,inhibitor
CD40LG,PROPRANOLOL HYDROCHLORIDE,GuideToPharmacology,1,inhibitor
CDSN,PHLORETIN,GuideToPharmacology,1,inhibitor
FDX1,LANRAPLENIB,GuideToPharmacology,1,inhibitor
CRYBB2P1,COMPOUND 28XVII [PMID: 8809154],GuideToPharmacology,1,inhibitor
FAS,CGP 23996,GuideToPharmacology,1,agonist
FAS,NC 4-28B,GuideToPharmacology,1,agonist
FASLG,GA-KE88,GuideToPharmacology,1,agonist
SHROOM2,"[111IN,90Y]DOTA-NOC",GuideToPharmacology,1,agonist
SHROOM2,PRL-2970,GuideToPharmacology,1,inhibitor
SHROOM2,[D-TYR8]CYN 154806,GuideToPharmacology,1,inhibitor
GRIN1,SNX281,GuideToPharmacology,1,agonist
HLA-DMA,BASROPARIB,GuideToPharmacology,1,inhibitor
FDX1P1,BAY-299,GuideToPharmacology,1,inhibitor
GCGR,CAPECITABINE,GuideToPharmacology,1,inhibitor
SARDH,LOXORIBINE,GuideToPharmacology,1,agonist
APOC4,CARBOCYCLIC THROMBOXANE A2,GuideToPharmacology,1,agonist
APOC4,S-5751,GuideToPharmacology,1,inhibitor
APOC4,I-BOP,GuideToPharmacology,1,agonist
APOC4,MB-28767,GuideToPharmacology,1,agonist
ARHGAP4,SG-094,GuideToPharmacology,1,inhibitor
ATP1B1P1,CHLOROBENZYLIDENE MALONONITRILE,GuideToPharmacology,1,activator
ATP2B1,AC1903,GuideToPharmacology,1,blocker
ATP2B2,KB-R7943,GuideToPharmacology,1,blocker
ATP3,FLUFENAMIC ACID,GuideToPharmacology,1,blocker
ATP2B2,SAR7334,GuideToPharmacology,1,blocker
ATP3,GEA 3162,GuideToPharmacology,1,activator
ATP2B3,LARIXYL ACETATE,GuideToPharmacology,1,blocker
ATP4A,PIOGLITAZONE HYDROCHLORIDE,GuideToPharmacology,1,blocker
ATP4B,COMPOUND 6 [PMID: 29579323],GuideToPharmacology,1,blocker
ATP4B,COMPOUND 6 [PMID: 29579323],GuideToPharmacology,1,inhibitor
ATP4B,BTP2,GuideToPharmacology,1,activator
PKD2L1,BENZAMIL,GuideToPharmacology,1,blocker
PKD2L1,FLUFENAMIC ACID,GuideToPharmacology,1,blocker
MCOLN3,SN-2,GuideToPharmacology,1,activator
PKD2L1,CA2+,GuideToPharmacology,1,activator
ATP5F1C,COMPOUND 74A [PMID: 27077528],GuideToPharmacology,1,inhibitor
TRPV5,GENTAMICIN,GuideToPharmacology,1,inhibitor
TRPV4,GSK-BZ DERIVATIVE 2B,GuideToPharmacology,1,inhibitor
FGR,COMPOUND 38 [PMID: 24915291],GuideToPharmacology,1,inhibitor
TYK2,ROPSACITINIB,GuideToPharmacology,1,inhibitor
DTYMK,"COMPOUND 6LI [CHAN ET AL., 2022]",GuideToPharmacology,1,inhibitor
UTS2R,COMPOUND 1A [PMID: 18573659],GuideToPharmacology,1,inhibitor
CDH13,TETRABENAZINE,GuideToPharmacology,1,inhibitor
AR,D[CHA4]AVP,GuideToPharmacology,1,agonist
AR,ARGIPRESSIN,GuideToPharmacology,1,agonist
ABCC6,"D(CH2)5[TYR(ME)2,THR4,PHE(3I,4N3)-NH29]OVT",GuideToPharmacology,1,inhibitor
ABCC6,DAVP,GuideToPharmacology,1,agonist
ABCC6,VNA932,GuideToPharmacology,1,agonist
ABCC6,ARGIPRESSIN,GuideToPharmacology,1,agonist
ABCC6,"D(CH2)5[TYR(ET)2,VAL4,DES-GLY9]AVP",GuideToPharmacology,1,inhibitor
ABCC6,D[LEU4]AVP,GuideToPharmacology,1,agonist
GNG10,XEVINAPANT,GuideToPharmacology,1,inhibitor
ABCC6,RELCOVAPTAN,GuideToPharmacology,1,inhibitor
NPBWR1,OICR-9429,GuideToPharmacology,1,inhibitor
ANXA4,GR231118,GuideToPharmacology,1,agonist
FKBP5,KC-130,GuideToPharmacology,1,inhibitor
GRIN2B,SAGE-718,GuideToPharmacology,1,modulator
GALR2,M1151,GuideToPharmacology,1,agonist
ANOP1,COMPOUND 24 [PMID: 20346665],GuideToPharmacology,1,modulator
GNAI2,OLAPARIB,GuideToPharmacology,1,inhibitor
ANXA5,PANCREATIC POLYPEPTIDE,GuideToPharmacology,1,agonist
APPL1,A(9-26)INSL3,GuideToPharmacology,1,inhibitor
AQP9,DESMOPRESSIN,GuideToPharmacology,1,agonist
GALR2,GALANIN(3-30) (HUMAN),GuideToPharmacology,1,agonist
APOE,AC-98170,GuideToPharmacology,1,agonist
F7,LINPERLISIB,GuideToPharmacology,1,inhibitor
FCGR3A,BAY-985,GuideToPharmacology,1,inhibitor
AQP9,"[PHAA1,D-TYR(ET)2,LYS6,DES-GLY9]AVP",GuideToPharmacology,1,inhibitor
CD8B2,[3H]WIN35428,GuideToPharmacology,1,inhibitor
AMD1,PROMETHAZINE HYDROCHLORIDE,GuideToPharmacology,1,inhibitor
ARF4P1,IBERIOTOXIN,GuideToPharmacology,1,blocker
EPHB3,COMPOUND 18E [PMID: 31670517],GuideToPharmacology,1,inhibitor
TRPV4,NSC212069,GuideToPharmacology,1,blocker
DHODH,PEGINTERFERON ALFA-2B,GuideToPharmacology,1,agonist
DSC1,FIBATUZUMAB,GuideToPharmacology,1,antibody
DRD1,ILORASERTIB,GuideToPharmacology,1,inhibitor
F7R,AZD8154,GuideToPharmacology,1,inhibitor
BCHE,BMS753,GuideToPharmacology,1,agonist
CTRB1,ROCK INHIBITOR 3,GuideToPharmacology,1,inhibitor
ALOX12P2,GALANIN(2-11),GuideToPharmacology,1,agonist
GLC#,BAZ2-ICR,GuideToPharmacology,1,inhibitor
CAPN5,FLUFENAMIC ACID,GuideToPharmacology,1,inhibitor
ERCC6,COMPOUND 18 [PMID: 34212719],GuideToPharmacology,1,inhibitor
GRIN2B,SEMAPIMOD,GuideToPharmacology,1,inhibitor
ATP1B1,BX-430,GuideToPharmacology,1,inhibitor
F5,INAVOLISIB,GuideToPharmacology,1,inhibitor
EN1,COMPOUND 38 [PMID: 24915291],GuideToPharmacology,1,inhibitor
BAK1,BATRACHOTOXIN,GuideToPharmacology,1,activator
APLP2,ISRAPAFANT,GuideToPharmacology,1,inhibitor
ADH5,ONC212,GuideToPharmacology,1,agonist
ETFB,WYE-354,GuideToPharmacology,1,inhibitor
HRH3,IODOPROXYFAN,GuideToPharmacology,1,agonist
ANTP2,"(R,S)-4-PPG",GuideToPharmacology,1,agonist
APAF1,PENTAZOCINE,GuideToPharmacology,1,agonist
GRIN2A,PHENCYCLIDINE,GuideToPharmacology,1,blocker
EYA1,AMG28,GuideToPharmacology,1,inhibitor
FEN1,COMPOUND 17D [PMID: 23099093],GuideToPharmacology,1,inhibitor
ASIC1,B-9430,GuideToPharmacology,1,inhibitor
ARNT,BREXANOLONE,GuideToPharmacology,1,modulator
AQP9,D[CHA4]AVP,GuideToPharmacology,1,agonist
EPHB3,NEZULCITINIB,GuideToPharmacology,1,inhibitor
ECE1,BELANTAMAB MAFODOTIN-BLMF,GuideToPharmacology,1,antibody
DPYD,ILORASERTIB,GuideToPharmacology,1,inhibitor
DPP6,ILORASERTIB,GuideToPharmacology,1,inhibitor
AZF2,PYRITHIONE ZINC,GuideToPharmacology,1,activator
FBLN2,ARN-3236,GuideToPharmacology,1,inhibitor
APOF,4F-MT-45,GuideToPharmacology,1,agonist
ACTA2,CCL26,GuideToPharmacology,1,inhibitor
ALB,CORTICOTROPIN-RELEASING FACTOR,GuideToPharmacology,1,agonist
ABCA1,MRS1093,GuideToPharmacology,1,inhibitor
AIRE,REACTIVE BLUE-2,GuideToPharmacology,1,inhibitor
DRD5P1,D5261,GuideToPharmacology,1,modulator
ABL1,CHLORPROMAZINE,GuideToPharmacology,1,inhibitor
EIF4EBP2,SAMURACICLIB,GuideToPharmacology,1,inhibitor
STOM,BAY-985,GuideToPharmacology,1,inhibitor
GAS1,COMPOUND 25AP [PMID: 37796543],GuideToPharmacology,1,inhibitor
ODC1,APA,GuideToPharmacology,1,inhibitor
CNR2,VCE-004.3,GuideToPharmacology,1,agonist
CSH2,BENSERAZIDE,GuideToPharmacology,1,inhibitor
DRD2,CEP-11981,GuideToPharmacology,1,inhibitor
ACACA,YSFKPMPLAR,GuideToPharmacology,1,agonist
CD63,COMPOUND 6B [PMID: 22749870],GuideToPharmacology,1,inhibitor
DXO,TQB3804,GuideToPharmacology,1,inhibitor
ASIC1,[3H]LYS-[DES-ARG9]BK,GuideToPharmacology,1,agonist
GNRHR,CETRORELIX,GuideToPharmacology,1,inhibitor
BDKRB2,DIETHYLSTILBESTROL,GuideToPharmacology,1,inhibitor
ARNT,RO19-4603,GuideToPharmacology,1,modulator
AADAC,(S)-DIMETINDENE,GuideToPharmacology,1,inhibitor
GAPDH,SLC-0111,GuideToPharmacology,1,inhibitor
CDK4,CDK INHIBITOR 4.35,GuideToPharmacology,1,inhibitor
ARVCF,[3H]MUSCIMOL,GuideToPharmacology,1,agonist
HTR2C,MESORIDAZINE,GuideToPharmacology,1,inhibitor
CLDN7,COMPOUND 5 [PMID: 21838328],GuideToPharmacology,1,inhibitor
ASIC1,BRADYKININ,GuideToPharmacology,1,agonist
A12M4,METITEPINE,GuideToPharmacology,1,inhibitor
BRINP1,M826,GuideToPharmacology,1,inhibitor
AANAT,PROPANTHELINE,GuideToPharmacology,1,inhibitor
BDM,FLUNISOLIDE ANHYDROUS,GuideToPharmacology,1,agonist
ADH1C,N-OLEOYLETHANOLAMIDE,GuideToPharmacology,1,agonist
CELA1,COMPOUND 17 [PMID: 23642479],GuideToPharmacology,1,inhibitor
EEF1B2P2,BERZOSERTIB,GuideToPharmacology,1,inhibitor
EIF4A1,RGB-286638,GuideToPharmacology,1,inhibitor
ALOX12P2,GALANIN(D-TRP2) (PIG),GuideToPharmacology,1,agonist
EPHX2,ECF506,GuideToPharmacology,1,inhibitor
ABL2,[3H]RAUWOLSCINE,GuideToPharmacology,1,inhibitor
ACTG1P7,RESOLVIN E1,GuideToPharmacology,1,agonist
UTS2R,RCI-0879,GuideToPharmacology,1,inhibitor
DNMT1,SGI-1027,GuideToPharmacology,1,inhibitor
AMY1B,COMPOUND 26 [PMID: 16190743],GuideToPharmacology,1,agonist
ACTA2,COMPOUND 39 [PMID: 31742400],GuideToPharmacology,1,modulator
AMFR,SC-41930,GuideToPharmacology,1,inhibitor
HTR2C,AL-37350A,GuideToPharmacology,1,agonist
EPHB2,TOFACITINIB,GuideToPharmacology,1,inhibitor
F7,NVP-CLR457,GuideToPharmacology,1,inhibitor
APOC1,MISOPROSTOL,GuideToPharmacology,1,agonist
EPHB1,COMPOUND 18E [PMID: 31670517],GuideToPharmacology,1,inhibitor
ATP1B1P1,METHYL ISOCYANATE,GuideToPharmacology,1,activator
NPBWR2,VADADUSTAT,GuideToPharmacology,1,inhibitor
CSN2,GNF362,GuideToPharmacology,1,inhibitor
CD8B2,DESVENLAFAXINE SUCCINATE,GuideToPharmacology,1,inhibitor
H2AZ1,ZED1227,GuideToPharmacology,1,inhibitor
BMPR2,COHUMULONE,GuideToPharmacology,1,agonist
BAK1,CANGITOXIN II,GuideToPharmacology,1,inhibitor
ABCC2,COMPOUND 9 [PMID: 23472952],GuideToPharmacology,1,inhibitor
DAZ1,VRT-043198,GuideToPharmacology,1,inhibitor
GPI,AZD7687,GuideToPharmacology,1,inhibitor
ACADVL,BETULINIC ACID,GuideToPharmacology,1,agonist
DRD4,ENSARTINIB,GuideToPharmacology,1,inhibitor
F5,SERABELISIB,GuideToPharmacology,1,inhibitor
EEF1G,BX-795,GuideToPharmacology,1,inhibitor
GABRA1,BREXANOLONE,GuideToPharmacology,1,modulator
DPT,SUNITINIB,GuideToPharmacology,1,inhibitor
ABO,PINDOLOL,GuideToPharmacology,1,agonist
ABO,PINDOLOL,GuideToPharmacology,1,inhibitor
ANTP4,MOTILIN,GuideToPharmacology,1,agonist
ABCA2,BAY-545,GuideToPharmacology,1,inhibitor
ANXA2P3,[PRO34]PYY (HUMAN),GuideToPharmacology,1,agonist
EPHX2,BELIZATINIB,GuideToPharmacology,1,inhibitor
ANK2,MELATONIN,GuideToPharmacology,1,agonist
ARRB2,[35S]TBPS,GuideToPharmacology,1,blocker
AANAT,TOLTERODINE,GuideToPharmacology,1,inhibitor
ACAA1,PINDOLOL,GuideToPharmacology,1,inhibitor
TSPO,DIDS,GuideToPharmacology,1,blocker
DNAH9,NDT-19795,GuideToPharmacology,1,inhibitor
ALDH1A1,(+)-UH232,GuideToPharmacology,1,inhibitor
APOC1,TREPROSTINIL,GuideToPharmacology,1,agonist
A2M,TRYPTAMINE,GuideToPharmacology,1,agonist
ABCA1,LAS38096,GuideToPharmacology,1,inhibitor
APOB,ONO-AE3-237,GuideToPharmacology,1,inhibitor
DTNA,BELIZATINIB,GuideToPharmacology,1,inhibitor
APPL1,EUROPIUM-LABELLED INSL3,GuideToPharmacology,1,agonist
GNRHR,BMS-820132,GuideToPharmacology,1,activator
EPHB2,DELGOCITINIB,GuideToPharmacology,1,inhibitor
ADFN,DIOCTANOYLGLYCEROL PYROPHOSPHATE,GuideToPharmacology,1,inhibitor
CDH16,METHOTREXATE,GuideToPharmacology,1,inhibitor
BDNF,AZD9567,GuideToPharmacology,1,agonist
GLRA1,QUILIZUMAB,GuideToPharmacology,1,antibody
APOC4,BUTAPROST (FREE ACID FORM),GuideToPharmacology,1,agonist
A2MP1,ALMOTRIPTAN,GuideToPharmacology,1,agonist
ACACA,[125I]C3A (HUMAN),GuideToPharmacology,1,agonist
SERPINB1,"ETHYL 3-[(E)-2-AMINO-1-CYANOETHENYL]-6,7-DICHLORO-1-METHYL-1H-INDOLE-2-CARBOXYLATE",GuideToPharmacology,1,inhibitor
FRK,VOLOCIXIMAB,GuideToPharmacology,1,antibody
ABCA1,GR79236,GuideToPharmacology,1,agonist
EFNB3,BAY-320,GuideToPharmacology,1,inhibitor
CTSO,BX-795,GuideToPharmacology,1,inhibitor
CREBL2,MLS000536924,GuideToPharmacology,1,inhibitor
A1BG,DONITRIPTAN,GuideToPharmacology,1,agonist
A1BG,"GR 125,743",GuideToPharmacology,1,inhibitor
A1BG,RS-30199,GuideToPharmacology,1,modulator
A1BG,CHLORPROMAZINE,GuideToPharmacology,1,inhibitor
A1BG,PERGOLIDE,GuideToPharmacology,1,agonist
A1BG,PIPAMPERONE,GuideToPharmacology,1,inhibitor
A1BG,METITEPINE,GuideToPharmacology,1,inhibitor
A2M,[3H]N-METHYL-AZ10419369,GuideToPharmacology,1,agonist
BCL5,CHENODEOXYCHOLIC ACID,GuideToPharmacology,1,agonist
A2M,PERGOLIDE,GuideToPharmacology,1,agonist
A2MP1,DIMETHYLTRYPTAMINE,GuideToPharmacology,1,agonist
A2MP1,[3H]5-CT,GuideToPharmacology,1,agonist
A2MP1,DONITRIPTAN,GuideToPharmacology,1,agonist
A2MP1,ERGOTAMINE,GuideToPharmacology,1,agonist
A12M1,TFMPP,GuideToPharmacology,1,agonist
A12M3,CHLORPROMAZINE,GuideToPharmacology,1,inhibitor
A12M3,PIMOZIDE,GuideToPharmacology,1,inhibitor
A12M4,(+)-NORFENFLURAMINE,GuideToPharmacology,1,agonist
A12M4,BF-1,GuideToPharmacology,1,inhibitor
HTR2C,YM348,GuideToPharmacology,1,agonist
HTR2C,S 16924,GuideToPharmacology,1,agonist
HTR2C,LISURIDE,GuideToPharmacology,1,agonist
NAT2,ERGOTAMINE,GuideToPharmacology,1,inhibitor
NATP,FLUPHENAZINE HYDROCHLORIDE,GuideToPharmacology,1,inhibitor
NATP,LISURIDE,GuideToPharmacology,1,agonist
SERPINA3,CYAMEMAZINE,GuideToPharmacology,1,inhibitor
PLK3,CLESACOSTAT,GuideToPharmacology,1,inhibitor
FRA17A,PYRIDOSTIGMINE,GuideToPharmacology,1,inhibitor
ABL1,FLUMBATINIB,GuideToPharmacology,1,inhibitor
DDX10,IK-862,GuideToPharmacology,1,inhibitor
CCR2,ABT702,GuideToPharmacology,1,inhibitor
HDGF,LRE1,GuideToPharmacology,1,inhibitor
DES,COMPOUND 12C [PMID: 16516466],GuideToPharmacology,1,inhibitor
CSTP1,MS15,GuideToPharmacology,1,inhibitor
ABCB7,A-119637,GuideToPharmacology,1,inhibitor
ABCB7,5-METHYLURAPIDIL,GuideToPharmacology,1,inhibitor
AAK1,PILAVAPADIN,GuideToPharmacology,1,inhibitor
DAPK3,FOSINOPRIL,GuideToPharmacology,1,inhibitor
DAPK3,IMIDAPRIL,GuideToPharmacology,1,inhibitor
BST2,BENZAMIL,GuideToPharmacology,1,blocker
BST2,NS383,GuideToPharmacology,1,blocker
ABCA1,XANTHINE AMINE CONGENER,GuideToPharmacology,1,inhibitor
ABCA1,PSB-10,GuideToPharmacology,1,inhibitor
ABCA2,FK-453,GuideToPharmacology,1,inhibitor
ABCA2,CYCLOPENTYLADENOSINE,GuideToPharmacology,1,agonist
ABCA2,PSB603,GuideToPharmacology,1,inhibitor
ABCA3,CYCLOPENTYLADENOSINE,GuideToPharmacology,1,agonist
ABCA3,[125I]AB-MECA,GuideToPharmacology,1,agonist
ABCA3,ISTRADEFYLLINE,GuideToPharmacology,1,inhibitor
ABCA3,MRE 3008F20,GuideToPharmacology,1,agonist
ABCA3,MRE 3008F20,GuideToPharmacology,1,inhibitor
ACADM,"L-162,313",GuideToPharmacology,1,agonist
ACADM,ANGIOTENSIN III,GuideToPharmacology,1,agonist
ATR,CERALASERTIB,GuideToPharmacology,1,inhibitor
EEF1D,GSK1070916,GuideToPharmacology,1,inhibitor
EEF2,TOZASERTIB,GuideToPharmacology,1,inhibitor
FMO5,LY2886721,GuideToPharmacology,1,inhibitor
ABR,SOLABEGRON,GuideToPharmacology,1,agonist
ABO,PRACTOLOL,GuideToPharmacology,1,inhibitor
ACAA1,CL316243,GuideToPharmacology,1,agonist
ABR,NIHP,GuideToPharmacology,1,inhibitor
ABR,NEBIVOLOL HYDROCHLORIDE,GuideToPharmacology,1,inhibitor
EEGV1,COMPOUND 2 [PMID: 15546730],GuideToPharmacology,1,inhibitor
GLC1B,GSK2801,GuideToPharmacology,1,inhibitor
DBIP1,EMRICASAN,GuideToPharmacology,1,inhibitor
ACP5,CALINDOL,GuideToPharmacology,1,modulator
CTSC,BRENSOCATIB,GuideToPharmacology,1,inhibitor
FOLR3,CITIBRASINE,GuideToPharmacology,1,inhibitor
CNR2,ONTERNABEZ,GuideToPharmacology,1,agonist
CNR2,HU-210,GuideToPharmacology,1,agonist
CCKBR,GV150013,GuideToPharmacology,1,inhibitor
A2M,[3H]SUMATRIPTAN,GuideToPharmacology,1,agonist
CNR2,AM-630,GuideToPharmacology,1,inhibitor
ACTA1,FLU-CCL3,GuideToPharmacology,1,agonist
CCR4,AZD1678,GuideToPharmacology,1,inhibitor
ACTBP2,CCL4,GuideToPharmacology,1,agonist
SLC31A2,65PF,GuideToPharmacology,1,inhibitor
GLRA2,EPCORITAMAB,GuideToPharmacology,1,antibody
GATM,EPCORITAMAB,GuideToPharmacology,1,antibody
ELANE,MW05,GuideToPharmacology,1,inhibitor
ALDH1A1,ROXINDOLE,GuideToPharmacology,1,agonist
CDC42BPA,COMPOUND 11D [DOI: 10.1039/C0MD00194E],GuideToPharmacology,1,inhibitor
DRD5P1,GILTERITINIB,GuideToPharmacology,1,inhibitor
CEACAM5,LABETUZUMAB GOVITECAN,GuideToPharmacology,1,antibody
TSPO,NPPB,GuideToPharmacology,1,blocker
GRIN2A,ZOLBETUXIMAB,GuideToPharmacology,1,antibody
BYSL,DIDS,GuideToPharmacology,1,blocker
HOXA4,ELAFIN,GuideToPharmacology,1,inhibitor
ATF4P1,MUSCARINE,GuideToPharmacology,1,inhibitor
ARHGDIA,CYCLIC ADENOSINE MONOPHOSPHATE,GuideToPharmacology,1,activator
FPR3,EMICIZUMAB,GuideToPharmacology,1,antibody
FPR3,ZIFAXABAN,GuideToPharmacology,1,inhibitor
DPYD,ONATASERTIB,GuideToPharmacology,1,inhibitor
GPR19,DANICOPAN,GuideToPharmacology,1,inhibitor
CPT1B,GW406381,GuideToPharmacology,1,inhibitor
CPT1B,PEPTIDE 30 [PMID: 27019010],GuideToPharmacology,1,inhibitor
CPT2,DICLOFENAC SODIUM,GuideToPharmacology,1,inhibitor
ALAS2,CORTICOTROPIN-RELEASING FACTOR,GuideToPharmacology,1,agonist
ALAS2,&ALPHA;-HELICAL CRF,GuideToPharmacology,1,inhibitor
ALAS2,NBI27914,GuideToPharmacology,1,inhibitor
ACHE,ADRENOMEDULLIN 2/INTERMEDIN,GuideToPharmacology,1,agonist
ACHE,CT-(8-32) (SALMON),GuideToPharmacology,1,inhibitor
C3,FLUFENAMIC ACID,GuideToPharmacology,1,inhibitor
C3AR1,FLUFENAMIC ACID,GuideToPharmacology,1,inhibitor
MAPK14,ABX-1431,GuideToPharmacology,1,inhibitor
GJB1,CA2+,GuideToPharmacology,1,inhibitor
C5AR1,FLUFENAMIC ACID,GuideToPharmacology,1,inhibitor
C5AR1,OCTANOL,GuideToPharmacology,1,inhibitor
C8A,FLUFENAMIC ACID,GuideToPharmacology,1,inhibitor
OSGIN2,FLUFENAMIC ACID,GuideToPharmacology,1,inhibitor
CDK19,"COMPOUND 51 [MALLINGER ET AL., 2016]",GuideToPharmacology,1,inhibitor
COX6A1,AMG-337,GuideToPharmacology,1,inhibitor
CP,TRANYLCYPROMINE,GuideToPharmacology,1,inhibitor
CYP7A1,"(2S,4S)-KETOCONAZOLE",GuideToPharmacology,1,inhibitor
AMHR2,LTE4,GuideToPharmacology,1,agonist
BLMH,P'-GERANYL 2-FLUOROMEVALONATE 5-DIPHOSPHATE,GuideToPharmacology,1,inhibitor
DUSP2,COMPOUND 1 [PMID: 31477924],GuideToPharmacology,1,inhibitor
HOXD@,ART558,GuideToPharmacology,1,inhibitor
APOBEC1,"13,14-DIHYDRO-15-KETO-PGD2",GuideToPharmacology,1,agonist
APOB,ZK118182,GuideToPharmacology,1,agonist
ALCAM,ECOPIPAM HYDROCHLORIDE,GuideToPharmacology,1,inhibitor
ALCAM,FLUPENTHIXOL,GuideToPharmacology,1,inhibitor
ALCAM,PERGOLIDE,GuideToPharmacology,1,agonist
APOBEC1,AZD1981,GuideToPharmacology,1,inhibitor
ALCAM,HALOPERIDOL DECANOATE,GuideToPharmacology,1,inhibitor
ALCAM,MESORIDAZINE,GuideToPharmacology,1,inhibitor
ABCD1,CHLORPROMAZINE,GuideToPharmacology,1,inhibitor
ABCD1,[3H]7-OH-DPAT,GuideToPharmacology,1,agonist
ABCD1,MESORIDAZINE,GuideToPharmacology,1,inhibitor
ABCD1,CHLORPROTHIXENE,GuideToPharmacology,1,inhibitor
ABCD1,HALOPERIDOL DECANOATE,GuideToPharmacology,1,inhibitor
ALDH2,A412997,GuideToPharmacology,1,agonist
ALDH2,PERGOLIDE,GuideToPharmacology,1,agonist
DXO,PANITUMUMAB,GuideToPharmacology,1,antibody
APOBER1,DINOPROSTONE,GuideToPharmacology,1,agonist
APOC1,COMPOUND 1 [PMID: 20080612],GuideToPharmacology,1,modulator
APOC1,MRE-269,GuideToPharmacology,1,agonist
AQP8,TCS 2510,GuideToPharmacology,1,agonist
APOC1P1,DINOPROSTONE,GuideToPharmacology,1,agonist
EPHX2,IBRUTINIB,GuideToPharmacology,1,inhibitor
AQP8,CP734432,GuideToPharmacology,1,agonist
AQP8,KMN-159,GuideToPharmacology,1,agonist
AQP8,"13,14-DIHYDRO-PGE1",GuideToPharmacology,1,agonist
APOC1P1,"L-798,106",GuideToPharmacology,1,inhibitor
CHI3L2,DRAFLAZINE,GuideToPharmacology,1,inhibitor
CHI3L2,NITROBENZYLMERCAPTOPURINE RIBONUCLEOSIDE,GuideToPharmacology,1,inhibitor
CHI3L2,KF24345,GuideToPharmacology,1,inhibitor
AQP8,MF 498,GuideToPharmacology,1,inhibitor
AQP8,GW 627368,GuideToPharmacology,1,inhibitor
BCYRN1P2,DIETHYLSTILBESTROL,GuideToPharmacology,1,agonist
ERBB4,COMPOUND 9 [PMID: 26006010],GuideToPharmacology,1,inhibitor
DPAGT1,SAPITINIB,GuideToPharmacology,1,inhibitor
BCYRN1P2,BAZEDOXIFENE,GuideToPharmacology,1,inhibitor
BDKRB2,DAIDZEIN,GuideToPharmacology,1,agonist
BDKRB2,AFIMOXIFENE,GuideToPharmacology,1,agonist
ESR2,OSPEMIFENE,GuideToPharmacology,1,inhibitor
BDKRB1,DIETHYLSTILBESTROL,GuideToPharmacology,1,inhibitor
ALDH1B1,BMS-193884,GuideToPharmacology,1,inhibitor
ALDH1A3,BOSENTAN ANHYDROUS,GuideToPharmacology,1,inhibitor
ALDH1A3,[125I]BQ3020,GuideToPharmacology,1,agonist
ALDH1A3,A192621,GuideToPharmacology,1,inhibitor
ALDH1A3,BMS-193884,GuideToPharmacology,1,inhibitor
ALDH1A3,AMBRISENTAN,GuideToPharmacology,1,inhibitor
EMX2,COMPOUND 39 [PMID: 36127295],GuideToPharmacology,1,inhibitor
CRMP1,JNJ1661010,GuideToPharmacology,1,inhibitor
BLVRA,NE58027,GuideToPharmacology,1,inhibitor
BMAL1,ZK93423,GuideToPharmacology,1,agonist
ARNT,[35S]TBPS,GuideToPharmacology,1,blocker
ARRB1,[3H]L655708,GuideToPharmacology,1,modulator
GABRR3,5-ME-IAA,GuideToPharmacology,1,agonist
ALOX12P1,GAL-(K)4,GuideToPharmacology,1,agonist
ALOX12P1,M1151,GuideToPharmacology,1,agonist
ALOX12P1,GAL-B2-C10,GuideToPharmacology,1,agonist
GALR2,GALANIN(1-12),GuideToPharmacology,1,agonist
CXCR5,[2-(3-DIBENZOFURAN-4-YL-PHENYL)-1-HYDROXY-1-PHOSPHONO-ETHYL]-PHOSPHONIC ACID,GuideToPharmacology,1,inhibitor
ALOX15B,SERMORELIN,GuideToPharmacology,1,agonist
ALOX15,HM01,GuideToPharmacology,1,agonist
ALPI,TIRZEPATIDE,GuideToPharmacology,1,agonist
ALPL,GLUCAGON-LIKE PEPTIDE 1-(7-37),GuideToPharmacology,1,agonist
ALPL,BETP,GuideToPharmacology,1,modulator
ASPH,LY404187,GuideToPharmacology,1,modulator
ASS1,LY404187,GuideToPharmacology,1,modulator
BDM,ZK112993,GuideToPharmacology,1,inhibitor
GRIN2A,L701324,GuideToPharmacology,1,inhibitor
GRIN2A,SELFOTEL,GuideToPharmacology,1,inhibitor
ASS1P14,KETAMINE HYDROCHLORIDE,GuideToPharmacology,1,blocker
GLRA1,ONTERNABEZ,GuideToPharmacology,1,inhibitor
GLRA1,STRYCHNINE,GuideToPharmacology,1,inhibitor
GLRA1,STRYCHNINE,GuideToPharmacology,1,inhibitor
ARVD3,ONTERNABEZ,GuideToPharmacology,1,inhibitor
ARVD4,STRYCHNINE,GuideToPharmacology,1,inhibitor
ARVD3,BILOBALIDE,GuideToPharmacology,1,inhibitor
ARVD4,STRYCHNINE,GuideToPharmacology,1,inhibitor
SLC29A1,ALSTERPAULLONE,GuideToPharmacology,1,inhibitor
SLC29A1,1-AZAKENPAULLONE,GuideToPharmacology,1,inhibitor
CD24P1,GLYT1 INHIBITOR 27A,GuideToPharmacology,1,inhibitor
GDF2,BML-281,GuideToPharmacology,1,inhibitor
GDF2,RICOLINOSTAT,GuideToPharmacology,1,inhibitor
GAPDHP1,FIMEPINOSTAT,GuideToPharmacology,1,inhibitor
AMELX,BURIMAMIDE,GuideToPharmacology,1,inhibitor
AMELX,N-[3H]METHYLHISTAMINE,GuideToPharmacology,1,agonist
AMELX,THIOPERAMIDE,GuideToPharmacology,1,inhibitor
ADH5,9-HYDROXYOCTADECADIENOIC ACID,GuideToPharmacology,1,agonist
ACTN2,LTD4,GuideToPharmacology,1,agonist
ACTN2,URIDINE-5'-DIPHOSPHATE,GuideToPharmacology,1,agonist
ACTN1,GPR15L,GuideToPharmacology,1,agonist
ACTN2,ASN04885796,GuideToPharmacology,1,agonist
ADCY3,ML193,GuideToPharmacology,1,inhibitor
EPHA8,WZ4002,GuideToPharmacology,1,inhibitor
GRK3,COMPOUND 48/80,GuideToPharmacology,1,agonist
CRK,LEI-401,GuideToPharmacology,1,inhibitor
FRA13A,MK-0429,GuideToPharmacology,1,inhibitor
DPEP1,COMPOUND 15 [PMID: 24900237],GuideToPharmacology,1,inhibitor
EPHA7,EMAVUSERTIB,GuideToPharmacology,1,inhibitor
DHODH,IFN-&BETA;,GuideToPharmacology,1,agonist
DKC1,SPESOLIMAB,GuideToPharmacology,1,antibody
DFNB14,IL-5,GuideToPharmacology,1,agonist
ITPR1,CA2+,GuideToPharmacology,1,activator
BOK,DENATONIUM,GuideToPharmacology,1,agonist
BRCA2,THEAFLAVIN-3鈥?O-GALLATE,GuideToPharmacology,1,agonist
BRAFPS1,ARISTOLOCHIC ACID,GuideToPharmacology,1,agonist
BPGM,PROBENECID,GuideToPharmacology,1,inhibitor
EPHB1,JAK3 INHIBITOR 32,GuideToPharmacology,1,inhibitor
EPHB1,COMPOUND 19A [PMID: 24359159],GuideToPharmacology,1,inhibitor
EPHB1,GDC-0214,GuideToPharmacology,1,inhibitor
EPHB1,BMS-911543,GuideToPharmacology,1,inhibitor
EPHB1,OCLACITINIB,GuideToPharmacology,1,inhibitor
EPHB2,BIIB068,GuideToPharmacology,1,inhibitor
EPHB2,COMPOUND 13AC [PMID: 33256400],GuideToPharmacology,1,inhibitor
EPHB3,POSELTINIB,GuideToPharmacology,1,inhibitor
FRA2G,SEBETRALSTAT,GuideToPharmacology,1,inhibitor
NUDT2,CEBRANOPADOL,GuideToPharmacology,1,agonist
DRD2,ORANTINIB,GuideToPharmacology,1,inhibitor
DRD2,RESENCATINIB,GuideToPharmacology,1,inhibitor
AMELY,[D-TYR-14C]TAK-448,GuideToPharmacology,1,agonist
AMELY,4-FLUOROBENZOYL-FGLRW-NH2,GuideToPharmacology,1,agonist
DPT,HENATINIB,GuideToPharmacology,1,inhibitor
AMELY,[125I]KISSPEPTIN-54 (HUMAN),GuideToPharmacology,1,agonist
ARF4P1,CHARYBDOTOXIN,GuideToPharmacology,1,blocker
ATP5MC1,ARACHIDONIC ACID,GuideToPharmacology,1,activator
ARF6,CA2+,GuideToPharmacology,1,activator
KCNJ8,MINOXIDIL,GuideToPharmacology,1,activator
BAAT,MK-499,GuideToPharmacology,1,blocker
CPT1B,SWE101,GuideToPharmacology,1,inhibitor
ATRX,GXTX-1E,GuideToPharmacology,1,inhibitor
ATR,PIMOZIDE,GuideToPharmacology,1,blocker
BIN1,VPC32183,GuideToPharmacology,1,inhibitor
AMY2B,AC-HMCH-(6-16)-NH2,GuideToPharmacology,1,agonist
AMY2B,VARIANT MCH,GuideToPharmacology,1,agonist
ETFB,COMPOUND 15A [PMID: 32069401],GuideToPharmacology,1,inhibitor
ETFB,ONATASERTIB,GuideToPharmacology,1,inhibitor
ETFB,XL388,GuideToPharmacology,1,inhibitor
DTNA,METATINIB,GuideToPharmacology,1,inhibitor
FRA3C,PHENYLACETYL-ARG-VAL-ARG-4-AMIDINOBENZYLAMIDE,GuideToPharmacology,1,inhibitor
DRD4,AMIVANTAMAB,GuideToPharmacology,1,antibody
DRD4,AMG-337,GuideToPharmacology,1,inhibitor
DRD4,GUMARONTINIB,GuideToPharmacology,1,inhibitor
DRD4,PHA-665752,GuideToPharmacology,1,inhibitor
SLC25A5,L-AP4,GuideToPharmacology,1,agonist
SLC25A5,VU2957,GuideToPharmacology,1,modulator
SLC25A6,COMPOUND 18 [PMID: 21927650],GuideToPharmacology,1,modulator
SLC25A5,FOLIGLURAX,GuideToPharmacology,1,modulator
GRM6,L-AP4,GuideToPharmacology,1,agonist
GRM6,EGLUMEGAD,GuideToPharmacology,1,agonist
ANTP2,L-AP4,GuideToPharmacology,1,agonist
ERCC4,"COMPOUND 16D [TAO ET AL., 2009]",GuideToPharmacology,1,inhibitor
GRM8,D-AP4,GuideToPharmacology,1,agonist
GRM8,DEXFOSFOSERINE,GuideToPharmacology,1,agonist
ERVT3,BIX02189,GuideToPharmacology,1,inhibitor
ERPL1,COMPOUND 5 [PMID: 28038940],GuideToPharmacology,1,inhibitor
ERCM1,BIIB068,GuideToPharmacology,1,inhibitor
ERVK3,COMPOUND 26 [PMID: 24673130],GuideToPharmacology,1,inhibitor
MMP7,RS 39066,GuideToPharmacology,1,inhibitor
DBT,(R)-ND-336,GuideToPharmacology,1,inhibitor
CRKL,MAGLI 432,GuideToPharmacology,1,inhibitor
DCK,AZD1236,GuideToPharmacology,1,inhibitor
FSHMD1B,TRANYLCYPROMINE,GuideToPharmacology,1,inhibitor
ANTP4,"[NLEU13,GLU14]MOTILIN (HUMAN)",GuideToPharmacology,1,agonist
AADAC,STRYCHNINE,GuideToPharmacology,1,modulator
AAMP,PROPANTHELINE,GuideToPharmacology,1,inhibitor
AAMP,METHOCTRAMINE,GuideToPharmacology,1,inhibitor
AAMP,ML381,GuideToPharmacology,1,inhibitor
AAMP,LITHOCHOLYLCHOLINE,GuideToPharmacology,1,inhibitor
ANK3,LUZINDOLE,GuideToPharmacology,1,inhibitor
APOF,ALVIMOPAN ANHYDROUS,GuideToPharmacology,1,inhibitor
APOF,AT-076,GuideToPharmacology,1,inhibitor
CD8B,METHYLPHENIDATE HYDROCHLORIDE,GuideToPharmacology,1,inhibitor
CD8B,CLOMIPRAMINE,GuideToPharmacology,1,inhibitor
DRD5P1,GR-389988,GuideToPharmacology,1,inhibitor
NMUR2,NEUROMEDIN S-33,GuideToPharmacology,1,agonist
NMUR1,[125I]NEUROMEDIN U-25 (HUMAN),GuideToPharmacology,1,agonist
ANXA2P2,NEUROPEPTIDE W-23,GuideToPharmacology,1,agonist
ANXA2,SHA 68R,GuideToPharmacology,1,inhibitor
APBA2,CP-1,GuideToPharmacology,1,inhibitor
APBA2,"[ALA11, D-LEU15]OREXIN-B",GuideToPharmacology,1,agonist
APBB1,OREXIN-A,GuideToPharmacology,1,agonist
APBB1,OREXIN-B,GuideToPharmacology,1,agonist
APBA2,JNJ-10397049,GuideToPharmacology,1,inhibitor
APBB1,NAG 26,GuideToPharmacology,1,agonist
EXT3,FRAX597,GuideToPharmacology,1,inhibitor
EXTL3,AMG28,GuideToPharmacology,1,inhibitor
ATP1B1,PSB-12062,GuideToPharmacology,1,inhibitor
APEX1,TICAGRELOR,GuideToPharmacology,1,inhibitor
APEX1,ARL66096,GuideToPharmacology,1,inhibitor
APBB2,MRS2950,GuideToPharmacology,1,inhibitor
BIRC3,UDP N-ACETYL-GLUCOSAMINE,GuideToPharmacology,1,agonist
AIRE,UDP-&BETA;-S,GuideToPharmacology,1,agonist
F7,COMPOUND 2Q [PMID: 30986068],GuideToPharmacology,1,inhibitor
F7,ECF309,GuideToPharmacology,1,inhibitor
F7R,FIMEPINOSTAT,GuideToPharmacology,1,inhibitor
F7R,SAMOTOLISIB,GuideToPharmacology,1,inhibitor
F7R,NEMIRALISIB,GuideToPharmacology,1,inhibitor
COL8A1,CALMODULIN,GuideToPharmacology,1,activator
COL11A1,EXAMPLE 2 [WO2013026797A1],GuideToPharmacology,1,inhibitor
F11,UZANSERTIB,GuideToPharmacology,1,inhibitor
F9,LEUCETTINE L41,GuideToPharmacology,1,inhibitor
F9,UZANSERTIB,GuideToPharmacology,1,inhibitor
APOA2,TRIAZINE COMPOUND PC10,GuideToPharmacology,1,inhibitor
DPP4,TOCERANIB,GuideToPharmacology,1,inhibitor
PLD1,COMPOUND 69 [PMID: 19136975],GuideToPharmacology,1,inhibitor
FRA3C,MULTI-LEU (ML)-PEPTIDE,GuideToPharmacology,1,inhibitor
FRA6F,CARFILZOMIB,GuideToPharmacology,1,inhibitor
CMTX3,SGC707,GuideToPharmacology,1,modulator
CYP1A2,MT47-100,GuideToPharmacology,1,modulator
CTBS,BALANOL,GuideToPharmacology,1,inhibitor
CTAG1B,BALANOL,GuideToPharmacology,1,inhibitor
NKX2-5,BALANOL,GuideToPharmacology,1,inhibitor
CTAA1,BALANOL,GuideToPharmacology,1,inhibitor
GOLGA1,LARTESERTIB,GuideToPharmacology,1,inhibitor
CTF1,NIK SMI1,GuideToPharmacology,1,inhibitor
FAP,SZM679,GuideToPharmacology,1,inhibitor
RIPK2,RIPK2 INHIBITOR 8,GuideToPharmacology,1,inhibitor
GP1BA,CCG-4986,GuideToPharmacology,1,inhibitor
BCHEL1,RO 40-6055,GuideToPharmacology,1,agonist
BCHE,RO 40-6055,GuideToPharmacology,1,agonist
CTPS1,NETARSUDIL,GuideToPharmacology,1,inhibitor
APRT,MINIMISED RELAXIN-3 ANALOGUE 3,GuideToPharmacology,1,inhibitor
APRT,R3/I5- SMBIT,GuideToPharmacology,1,agonist
DAGLA,CAFFEINE,GuideToPharmacology,1,activator
AMT,COMPOUND 26 [PMID: 16190743],GuideToPharmacology,1,agonist
AMT,SIPONIMOD,GuideToPharmacology,1,agonist
AMT,CYM5181,GuideToPharmacology,1,agonist
SIGMAR1,BD-1063,GuideToPharmacology,1,inhibitor
GJB3,SELISISTAT,GuideToPharmacology,1,inhibitor
GJB3,COMPOUND 17 [PMID: 23570514],GuideToPharmacology,1,inhibitor
CD40LG,IRBESARTAN,GuideToPharmacology,1,inhibitor
FCER1A,COMPOUND 59 [PMID: 30889352],GuideToPharmacology,1,inhibitor
FDX1,ER-27319,GuideToPharmacology,1,inhibitor
CRYBB3,VARESPLADIB,GuideToPharmacology,1,inhibitor
MS4A2,SARACATINIB,GuideToPharmacology,1,inhibitor
FAS,"L-362,855",GuideToPharmacology,1,agonist
MS4A2,KX2-361,GuideToPharmacology,1,inhibitor
FASLG,[D-TYR8]CYN 154806,GuideToPharmacology,1,inhibitor
FASLG,ANALOG 30 [PMID:18543899],GuideToPharmacology,1,inhibitor
SHROOM2,"L-362,855",GuideToPharmacology,1,agonist
AQP1,VELDOREOTIDE,GuideToPharmacology,1,agonist
SHROOM2,"[111IN,90Y]DOTA-OC",GuideToPharmacology,1,agonist
SHROOM2,NC 4-28B,GuideToPharmacology,1,agonist
AQP1,"L-362,855",GuideToPharmacology,1,agonist
AQP2,BIM 23059,GuideToPharmacology,1,agonist
AQP2,BIM 23030,GuideToPharmacology,1,agonist
AQP2,PRL-2970,GuideToPharmacology,1,inhibitor
AQP2,[D-TYR8]CYN 154806,GuideToPharmacology,1,inhibitor
VCAN,EXAMPLE 15 [WO2015079413],GuideToPharmacology,1,inhibitor
TLR4,CRX-555,GuideToPharmacology,1,agonist
APOC4,I-SAP,GuideToPharmacology,1,inhibitor
ATP2A3,LA3+,GuideToPharmacology,1,activator
ATP2A3,LA3+,GuideToPharmacology,1,blocker
ATP2B2,LARIXYL ACETATE,GuideToPharmacology,1,blocker
ATP3,CADPR,GuideToPharmacology,1,activator
ATP4B,SPERMINE,GuideToPharmacology,1,blocker
MCOLN3,PRU-12,GuideToPharmacology,1,inhibitor
MCOLN3,EVP-21,GuideToPharmacology,1,activator
PKD2L1,LA3+,GuideToPharmacology,1,blocker
MCOLN3,SF-11,GuideToPharmacology,1,activator
ATP5F1BP1,6-IODO-NORDIHYDROCAPSAICIN,GuideToPharmacology,1,blocker
FRA8F,RWJ-56423,GuideToPharmacology,1,inhibitor
FGFR4,AZ3146,GuideToPharmacology,1,inhibitor
TRPV4,RN1734,GuideToPharmacology,1,blocker
TYK2,COMPOUND 13AC [PMID: 33256400],GuideToPharmacology,1,inhibitor
FRA9C,COMPOUND 6 [PMID: 17948018],GuideToPharmacology,1,inhibitor
ARCN2,SECRETIN,GuideToPharmacology,1,agonist
ARCN1,VIP,GuideToPharmacology,1,agonist
AQP9,BALOVAPTAN,GuideToPharmacology,1,inhibitor
AQP9,ATOSIBAN,GuideToPharmacology,1,inhibitor
AQP9,RELCOVAPTAN,GuideToPharmacology,1,inhibitor
AR,ATOSIBAN,GuideToPharmacology,1,inhibitor
AR,[3H]NELIVAPTAN,GuideToPharmacology,1,inhibitor
ABCC6,"D[PEN1,TYR(ME)2]AVP",GuideToPharmacology,1,inhibitor
FIM1,ADAVOSERTIB,GuideToPharmacology,1,inhibitor
ANXA3,NPY,GuideToPharmacology,1,agonist
FKBP1AP3,SARACATINIB,GuideToPharmacology,1,inhibitor
EEF1D,ILORASERTIB,GuideToPharmacology,1,inhibitor
GCLC,XD14,GuideToPharmacology,1,inhibitor
AOC1,[3H]RAUWOLSCINE,GuideToPharmacology,1,inhibitor
BBS2,BATRACHOTOXIN,GuideToPharmacology,1,activator
AQP3,TRADIPITANT,GuideToPharmacology,1,inhibitor
NATP,[3H]5-CT,GuideToPharmacology,1,agonist
CHKB,RHODAMINE123,GuideToPharmacology,1,inhibitor
ARRB1,RO4938581,GuideToPharmacology,1,modulator
SMPD1,WJYK50,GuideToPharmacology,1,inhibitor
ACAA1,CGP 12177,GuideToPharmacology,1,agonist
ACTG1,HIV-TAT,GuideToPharmacology,1,inhibitor
RHOB,PGF1&ALPHA;,GuideToPharmacology,1,activator
EEF1G,COMPOUND 25 [PMID: 20855207],GuideToPharmacology,1,inhibitor
ARSC2,PICROTOXIN,GuideToPharmacology,1,blocker
GLI4,PFI-3,GuideToPharmacology,1,inhibitor
BLVRA,NE10575,GuideToPharmacology,1,inhibitor
ANXA13,PARA-COUMARIC ACID,GuideToPharmacology,1,agonist
FOXA1,MK-7110,GuideToPharmacology,1,agonist
PRDM1,CERIVASTATIN,GuideToPharmacology,1,inhibitor
EFNB2,POSELTINIB,GuideToPharmacology,1,inhibitor
CNR2,2-ARACHIDONOYLGLYCEROL,GuideToPharmacology,1,agonist
AMD1P2,INCB-38579,GuideToPharmacology,1,inhibitor
PRMT1,AMI-1,GuideToPharmacology,1,inhibitor
ASS1P10,[3H]D-ASPARTIC ACID,GuideToPharmacology,1,agonist
ALDH9A1,HUMANIN,GuideToPharmacology,1,agonist
AAMP,TOLTERODINE,GuideToPharmacology,1,inhibitor
GLC3B,LP99,GuideToPharmacology,1,inhibitor
ARAF,ATOSIBAN,GuideToPharmacology,1,inhibitor
FANCG,RIPK3 INHIBITOR 42,GuideToPharmacology,1,inhibitor
FKBP2,MK-2206,GuideToPharmacology,1,modulator
ACADM,"[SAR1,ILE4,ILE8]ANG-II",GuideToPharmacology,1,inhibitor
ASS1P5,[3H]UBP310,GuideToPharmacology,1,inhibitor
APOC3,TREPROSTINIL,GuideToPharmacology,1,agonist
A1BG,TIOSPIRONE,GuideToPharmacology,1,inhibitor
ABO,CICLOPROLOL,GuideToPharmacology,1,inhibitor
ABR,ZINTEROL,GuideToPharmacology,1,agonist
GABRA1,DMCM,GuideToPharmacology,1,modulator
AMELY,[125I]KISSPEPTIN-13 (HUMAN),GuideToPharmacology,1,agonist
DTNB,BELIZATINIB,GuideToPharmacology,1,inhibitor
A2MP1,METITEPINE,GuideToPharmacology,1,inhibitor
FAS,PASIREOTIDE,GuideToPharmacology,1,agonist
APOC1P1,MB-28767,GuideToPharmacology,1,agonist
ABCC6,BALOVAPTAN,GuideToPharmacology,1,inhibitor
NAT2,[3H]5-CT,GuideToPharmacology,1,agonist
HLA-DRB6,EXAMPLE 265 [WO2019097515A1],GuideToPharmacology,1,inhibitor
CPT1B,DICLOFENAC SODIUM,GuideToPharmacology,1,inhibitor
A2M,PIPAMPERONE,GuideToPharmacology,1,inhibitor
GALR2,GAL-(K)4,GuideToPharmacology,1,agonist
ERVT1,NIK SMI1,GuideToPharmacology,1,inhibitor
ANXA6,THR10CONTULAKIN-G,GuideToPharmacology,1,agonist
APOF,BRORPHINE,GuideToPharmacology,1,agonist
ABCA1,MEFLOQUINE,GuideToPharmacology,1,inhibitor
DCN,MMP13 TRACER  [18F]5J,GuideToPharmacology,1,inhibitor
GPR32,RESOLVIN D1,GuideToPharmacology,1,agonist
ITPR1,DECAVANADATE,GuideToPharmacology,1,inhibitor
EPHB2,BARICITINIB,GuideToPharmacology,1,inhibitor
GRIA3,LY503430,GuideToPharmacology,1,modulator
ALOX12P2,GALANIN,GuideToPharmacology,1,agonist
GNG10,LCL161,GuideToPharmacology,1,inhibitor
ANXA1,[125I]EYF,GuideToPharmacology,1,agonist
GLUD1P5,CYCLOSPORINE,GuideToPharmacology,1,inhibitor
LTB4R,DEXFENFLURAMINE,GuideToPharmacology,1,inhibitor
CCKBR,[3H]GASTRIN,GuideToPharmacology,1,agonist
AQP3,SUBSTANCE P,GuideToPharmacology,1,agonist
RPS6KA6,COMPOUND 25B [PMID: 22564207],GuideToPharmacology,1,inhibitor
C3,CA2+,GuideToPharmacology,1,inhibitor
ASAH1,BILOBALIDE,GuideToPharmacology,1,inhibitor
BMAL1,ISOGUVACINE,GuideToPharmacology,1,agonist
KDM5A,PBIT,GuideToPharmacology,1,inhibitor
NKX3-2,PHENYTOIN SODIUM,GuideToPharmacology,1,blocker
XIAP,DS69910557,GuideToPharmacology,1,inhibitor
FASLG,BASS ANTAGONIST,GuideToPharmacology,1,inhibitor
A2MP1,TRYPTAMINE,GuideToPharmacology,1,agonist
FRA1C,DESIRUDIN,GuideToPharmacology,1,inhibitor
ELAVL3,D4476,GuideToPharmacology,1,inhibitor
C1QC,OCTANOL,GuideToPharmacology,1,inhibitor
APAF1,ZYKLOPHIN,GuideToPharmacology,1,inhibitor
MS4A2,COMPOUND 36 [PMID: 21958547],GuideToPharmacology,1,inhibitor
ALPL,[125I]EXENDIN-(9-39),GuideToPharmacology,1,inhibitor
A12M4,BALOVAPTAN,GuideToPharmacology,1,inhibitor
CMA1,TY-51469,GuideToPharmacology,1,inhibitor
GRIN2B,[3H]CPP,GuideToPharmacology,1,inhibitor
SCTR,VIP,GuideToPharmacology,1,agonist
SLC26A3,NINTEDANIB ESYLATE,GuideToPharmacology,1,inhibitor
ALDH3B2,T-BOC-MET-LEU-PHE,GuideToPharmacology,1,inhibitor
ALOX12P1,GALANIN(1-11),GuideToPharmacology,1,agonist
DCK,(R)-ND-336,GuideToPharmacology,1,inhibitor
ARAF,"L-368,228",GuideToPharmacology,1,inhibitor
DRD2,VEGF RECEPTOR TYROSINE KINASE INHIBITOR III,GuideToPharmacology,1,inhibitor
PIK3CB,SERABELISIB,GuideToPharmacology,1,inhibitor
BAK1P2,L-783483,GuideToPharmacology,1,agonist
ACAT2,GASTRIN RELEASING PEPTIDE(14-27) (HUMAN),GuideToPharmacology,1,agonist
GRB14,PSB-0963,GuideToPharmacology,1,inhibitor
EPHB3,OCLACITINIB,GuideToPharmacology,1,inhibitor
DPP6,TAK-632,GuideToPharmacology,1,inhibitor
GRIA3,[3H]AMPA,GuideToPharmacology,1,agonist
EXTL2,FRAX597,GuideToPharmacology,1,inhibitor
NR3C2,OCEDURENONE,GuideToPharmacology,1,inhibitor
ACP5,SPERMINE,GuideToPharmacology,1,agonist
F5,TASELISIB,GuideToPharmacology,1,inhibitor
TYK2,OCLACITINIB,GuideToPharmacology,1,inhibitor
CACNA1D,AZIDOPINE,GuideToPharmacology,1,inhibitor
EPHB2,LONDAMOCITINIB,GuideToPharmacology,1,inhibitor
C8B,CA2+,GuideToPharmacology,1,inhibitor
BCYRN1P2,ESTRIOL,GuideToPharmacology,1,agonist
ADCY3,O-ARACHIDONOYL ETHANOLAMINE,GuideToPharmacology,1,agonist
CD3D,SOTAGLIFLOZIN,GuideToPharmacology,1,inhibitor
FASLG,[67GA]NODAGA-[TYR3]OCTREOTIDE,GuideToPharmacology,1,agonist
AQP9,"D[PEN1,TYR(ME)2]AVP",GuideToPharmacology,1,inhibitor
AMD1,CHLORPHENIRAMINE POLISTIREX,GuideToPharmacology,1,inhibitor
BCKDHA,GEMFIBROZIL,GuideToPharmacology,1,agonist
A12M4,LISURIDE,GuideToPharmacology,1,inhibitor
ACADM,EPROSARTAN,GuideToPharmacology,1,inhibitor
FMO5,RO5508887,GuideToPharmacology,1,inhibitor
AIRE,UP3U,GuideToPharmacology,1,agonist
UTS2R,S6716,GuideToPharmacology,1,inhibitor
GYPB,LLL12,GuideToPharmacology,1,inhibitor
ABCA2,"4-{2-[(7-AMINO-2-FURAN-2-YL[1,2,4]TRIAZOLO[1,5-A][1,3,5]TRIAZIN-5-YL)AMINO]ETHYL}PHENOL",GuideToPharmacology,1,inhibitor
ACTBP6,[125I]CCL25 (HUMAN),GuideToPharmacology,1,agonist
AR,SATAVAPTAN,GuideToPharmacology,1,inhibitor
GAPDHL17,CUDC-101,GuideToPharmacology,1,inhibitor
PIK3CB,VULOLISIB,GuideToPharmacology,1,inhibitor
FRZB,A-395,GuideToPharmacology,1,inhibitor
ADD3,DECANOIC ACID,GuideToPharmacology,1,agonist
RYR2,PROCAINE,GuideToPharmacology,1,blocker
F5,OMIPALISIB,GuideToPharmacology,1,inhibitor
CTRB1,RKI-1447,GuideToPharmacology,1,inhibitor
ATP5F1BP1,H+,GuideToPharmacology,1,activator
A1BG,SB 714786,GuideToPharmacology,1,inhibitor
A12M2,ERGOTAMINE,GuideToPharmacology,1,agonist
A12M2,TFMPP,GuideToPharmacology,1,agonist
A12M2,SUMATRIPTAN,GuideToPharmacology,1,agonist
A12M3,PERGOLIDE,GuideToPharmacology,1,agonist
A12M2,METITEPINE,GuideToPharmacology,1,inhibitor
A12M3,QUIPAZINE,GuideToPharmacology,1,agonist
A12M4,BW723C86,GuideToPharmacology,1,agonist
A12M4,TFMPP,GuideToPharmacology,1,agonist
A12M4,(R)-DOI,GuideToPharmacology,1,agonist
HTR2C,CHLORPROMAZINE,GuideToPharmacology,1,inhibitor
NAT1,VELUSETRAG,GuideToPharmacology,1,agonist
NAT2,SUMATRIPTAN,GuideToPharmacology,1,agonist
NAT2,PROPRANOLOL HYDROCHLORIDE,GuideToPharmacology,1,inhibitor
SERPINA3,SUMATRIPTAN,GuideToPharmacology,1,inhibitor
SERPINA3,[3H]LSD,GuideToPharmacology,1,agonist
SERPINA3,TRYPTAMINE,GuideToPharmacology,1,agonist
SERPINA3,(+)-LSD,GuideToPharmacology,1,agonist
SERPINA3,FLUPHENAZINE HYDROCHLORIDE,GuideToPharmacology,1,inhibitor
DNCM,LDN-214117,GuideToPharmacology,1,inhibitor
ACKR4,CCL19,GuideToPharmacology,1,agonist
DNCM,COMPOUND 13A [PMID: 23639540],GuideToPharmacology,1,inhibitor
DNM2,COMPOUND 13A [PMID: 23639540],GuideToPharmacology,1,inhibitor
DNM2,LDN-214117,GuideToPharmacology,1,inhibitor
HBEGF,COMPOUND 5M [PMID: 20483621],GuideToPharmacology,1,inhibitor
ABCB7,A61603,GuideToPharmacology,1,agonist
ABCF1,PHENTOLAMINE,GuideToPharmacology,1,inhibitor
ABCF1,REC 15/2615,GuideToPharmacology,1,inhibitor
ABCF1,5-METHYLURAPIDIL,GuideToPharmacology,1,inhibitor
ABCA4,NAN 190,GuideToPharmacology,1,inhibitor
ABCA4,5-METHYLURAPIDIL,GuideToPharmacology,1,inhibitor
AOC1,PERGOLIDE,GuideToPharmacology,1,agonist
AOC1,LISURIDE,GuideToPharmacology,1,inhibitor
ABL2,PHENTOLAMINE,GuideToPharmacology,1,inhibitor
ABL2,CHLORPROMAZINE,GuideToPharmacology,1,inhibitor
ABL2,RX821002,GuideToPharmacology,1,inhibitor
BEVI,TESTOSTERONE PROPIONATE,GuideToPharmacology,1,agonist
BEVI,CYPROTERONE ACETATE,GuideToPharmacology,1,inhibitor
ABAT,LUF5981,GuideToPharmacology,1,inhibitor
ABCA1,FK-453,GuideToPharmacology,1,inhibitor
ABCA1,MRS5151,GuideToPharmacology,1,agonist
ABCA1,ISTRADEFYLLINE,GuideToPharmacology,1,inhibitor
ABCA3,FK-453,GuideToPharmacology,1,inhibitor
ABCA3,SAKURANETIN,GuideToPharmacology,1,inhibitor
ACADS,ANGIOTENSIN-(1-7),GuideToPharmacology,1,agonist
ACADM,COMPOUND 2 [PMID: 28379944],GuideToPharmacology,1,inhibitor
GNL1,GDC-0152,GuideToPharmacology,1,inhibitor
CD69,BUMETANIDE,GuideToPharmacology,1,inhibitor
GNG11,TOLINAPANT,GuideToPharmacology,1,inhibitor
CSRP2,BALANOL,GuideToPharmacology,1,inhibitor
HOXD3,BCL3 INHIBITOR JS6,GuideToPharmacology,1,inhibitor
ASIC2,COMPOUND A [PMID: 28324017],GuideToPharmacology,1,agonist
ABO,SOLABEGRON,GuideToPharmacology,1,agonist
FMOD,RO5508887,GuideToPharmacology,1,inhibitor
ABO,BISOPROLOL,GuideToPharmacology,1,inhibitor
ABO,ICI-89406,GuideToPharmacology,1,inhibitor
ABO,NEBIVOLOL HYDROCHLORIDE,GuideToPharmacology,1,inhibitor
EFNA4,COMPOUND 25AP [PMID: 37796543],GuideToPharmacology,1,inhibitor
EFNA4,LY-294002,GuideToPharmacology,1,inhibitor
EFNA4,I-BET151,GuideToPharmacology,1,inhibitor
GLC3B,BI-7273,GuideToPharmacology,1,inhibitor
EFNB2,BTK INHIBITOR 16 [PMID: 30122225],GuideToPharmacology,1,inhibitor
EFNB2,TOLEBRUTINIB,GuideToPharmacology,1,inhibitor
ASIC1,"AC-LYS-[MEALA6,LEU8,DES-ARG9]BRADYKININ",GuideToPharmacology,1,inhibitor
ASIC1,[3H]LYS-[LEU8][DES-ARG9]BK,GuideToPharmacology,1,inhibitor
ACACB,JPE1375,GuideToPharmacology,1,inhibitor
ACACB,YSFKPMPLAR,GuideToPharmacology,1,agonist
ELF1,D4476,GuideToPharmacology,1,inhibitor
CACNA1F,NIMODIPINE,GuideToPharmacology,1,inhibitor
ACTA2,SB-282241,GuideToPharmacology,1,inhibitor
ACTB,HIV-TAT,GuideToPharmacology,1,agonist
ACTBP2,BMS-681,GuideToPharmacology,1,inhibitor
CCR4,COMPOUND 8IC [PMID: 19081254],GuideToPharmacology,1,inhibitor
CCR4,MOGAMULIZUMAB,GuideToPharmacology,1,antibody
CFTR,APIGENIN,GuideToPharmacology,1,activator
CPT2,COMPOUND 12A [PMID: 29031075],GuideToPharmacology,1,inhibitor
C4BPB,CA2+,GuideToPharmacology,1,inhibitor
C4BPA,OCTANOL,GuideToPharmacology,1,inhibitor
C1R,OCTANOL,GuideToPharmacology,1,inhibitor
ACTBP8,CXCL6,GuideToPharmacology,1,agonist
C5,FLUFENAMIC ACID,GuideToPharmacology,1,inhibitor
ACTG1,[125I]CXCL12&ALPHA; (HUMAN),GuideToPharmacology,1,agonist
ACTG1,T22,GuideToPharmacology,1,inhibitor
ACTG1,COMPOUND 46C [PMID: 29350534],GuideToPharmacology,1,inhibitor
EGR4,6-BROMOINDIRUBIN-3'-OXIME,GuideToPharmacology,1,inhibitor
CDK13,CDK12 INHIBITOR 2,GuideToPharmacology,1,inhibitor
EIF4A1,ALVOCIDIB,GuideToPharmacology,1,inhibitor
EIF4A1,QR-6401,GuideToPharmacology,1,inhibitor
CD24P1,GSK931145,GuideToPharmacology,1,inhibitor
EIF4A1,TANUXICICLIB,GuideToPharmacology,1,inhibitor
EIF4A1,TRILACICLIB,GuideToPharmacology,1,inhibitor
CDK4,EBVACICLIB,GuideToPharmacology,1,inhibitor
CDK4,TANUXICICLIB,GuideToPharmacology,1,inhibitor
CDK4,ALVOCIDIB,GuideToPharmacology,1,inhibitor
CDK4,RO-0505124,GuideToPharmacology,1,inhibitor
EIF4EBP1,TRILACICLIB,GuideToPharmacology,1,inhibitor
EIF4EBP1,RGB-286638,GuideToPharmacology,1,inhibitor
EIF4E,RGB-286638,GuideToPharmacology,1,inhibitor
EIF4EBP1,DALPICICLIB,GuideToPharmacology,1,inhibitor
EIF4EBP2,LY3405105,GuideToPharmacology,1,inhibitor
EIF4EBP2,RGB-286638,GuideToPharmacology,1,inhibitor
CPD,"(2S,4S)-KETOCONAZOLE",GuideToPharmacology,1,inhibitor
AMD1P2,CIMETIDINE,GuideToPharmacology,1,inhibitor
COX6A1,COMPOUND 1A [PMID: 18573659],GuideToPharmacology,1,inhibitor
CLDN7,R116010,GuideToPharmacology,1,inhibitor
CORD4,COMPOUND 38A [PMID: 15634016],GuideToPharmacology,1,inhibitor
GZMB,GKT136901,GuideToPharmacology,1,inhibitor
CSH2,AMINOOXYACETIC ACID,GuideToPharmacology,1,inhibitor
CD8B2,[3H]GBR12935,GuideToPharmacology,1,inhibitor
THRB,SOBETIROME,GuideToPharmacology,1,agonist
APAF1,BILORPHIN,GuideToPharmacology,1,agonist
APAF1,[3H]DELTORPHIN II,GuideToPharmacology,1,agonist
GPI,COMPOUND 23N [PMID: 24900877],GuideToPharmacology,1,inhibitor
ALDH1A1,HALOPERIDOL DECANOATE,GuideToPharmacology,1,inhibitor
ALDH1A1,SB269652,GuideToPharmacology,1,modulator
ALDH2,CHLORPROMAZINE,GuideToPharmacology,1,inhibitor
ALDH3A1,FLUPENTHIXOL,GuideToPharmacology,1,inhibitor
ALDH3A1,CHLORPROMAZINE,GuideToPharmacology,1,inhibitor
MARK2,LEUCETTINE L41,GuideToPharmacology,1,inhibitor
EML1,ML315,GuideToPharmacology,1,inhibitor
GLI1,I-CBP112,GuideToPharmacology,1,inhibitor
FPR2,SIVELESTAT,GuideToPharmacology,1,inhibitor
NPBWR2,MOLIDUSTAT,GuideToPharmacology,1,inhibitor
DARS1,COMPOUND 22 [PMID: 19899765],GuideToPharmacology,1,inhibitor
DXO,WZ4002,GuideToPharmacology,1,inhibitor
DXO,TARLOXOTINIB,GuideToPharmacology,1,inhibitor
CRP,URB597,GuideToPharmacology,1,inhibitor
ADH4,LINOLENIC ACID,GuideToPharmacology,1,agonist
ALDOA,CPTB,GuideToPharmacology,1,agonist
ALDOA,TUG-2304,GuideToPharmacology,1,inhibitor
FGR,COMPOUND 2 [PMID: 15546730],GuideToPharmacology,1,inhibitor
DPYSL2,CEP-11981,GuideToPharmacology,1,inhibitor
DR1,DOVITINIB,GuideToPharmacology,1,inhibitor
DR1,FUTIBATINIB,GuideToPharmacology,1,inhibitor
DR1,TAK-632,GuideToPharmacology,1,inhibitor
DPYSL3,NINTEDANIB ESYLATE,GuideToPharmacology,1,inhibitor
DRD1,CEP-11981,GuideToPharmacology,1,inhibitor
DPYS,COMPOUND 25AP [PMID: 37796543],GuideToPharmacology,1,inhibitor
DPYS,BAY-985,GuideToPharmacology,1,inhibitor
DRD1,VATALANIB,GuideToPharmacology,1,inhibitor
DPYS,BELIZATINIB,GuideToPharmacology,1,inhibitor
DPYS,COMPOUND 7D [PMID: 29672049],GuideToPharmacology,1,inhibitor
ALDH3B2,FMET-MET-TYR-ALA-LEU-PHE,GuideToPharmacology,1,agonist
ALDH9A1,SHAAGTIDE,GuideToPharmacology,1,agonist
ALDH9A1,[125I-TYR]AC2-26,GuideToPharmacology,1,agonist
ALDH9A1,FMET-MET-TYR-ALA-LEU-PHE,GuideToPharmacology,1,agonist
APOC2,LATANOPROST,GuideToPharmacology,1,agonist
GABRA1,TP003,GuideToPharmacology,1,modulator
ENO2,COMPOUND 2 [PMID: 15546730],GuideToPharmacology,1,inhibitor
ARNT,DMCM,GuideToPharmacology,1,modulator
BMAL1,RO19-4603,GuideToPharmacology,1,modulator
GALR2,GALANIN(9-25) (RAT/MOUSE),GuideToPharmacology,1,agonist
GALR2,GALANIN(2-11),GuideToPharmacology,1,agonist
GALR2,GALANIN(1-20)  (HUMAN),GuideToPharmacology,1,agonist
GALR2,J18 (GALANIN ANALOGUE),GuideToPharmacology,1,agonist
ALOX12P2,M617,GuideToPharmacology,1,agonist
GALR2,GALANIN,GuideToPharmacology,1,agonist
GALR2,GALANIN(2-30) (HUMAN),GuideToPharmacology,1,agonist
GALR2,GALANIN,GuideToPharmacology,1,agonist
ALOX12P2,M40,GuideToPharmacology,1,inhibitor
CXCR5,COMPOUND 51 [PMID: 18800762],GuideToPharmacology,1,inhibitor
GUCY1A2,GRASP,GuideToPharmacology,1,inhibitor
ASS1P2,JORO SPIDER TOXIN,GuideToPharmacology,1,blocker
ALPG,HGCGR ANTAGONIST,GuideToPharmacology,1,inhibitor
GRIN2C,CGP37849,GuideToPharmacology,1,inhibitor
GRIN2B,[3H]L689560,GuideToPharmacology,1,inhibitor
CD24P1,ICLEPERTIN,GuideToPharmacology,1,inhibitor
ALDH3B1,AFIMOXIFENE,GuideToPharmacology,1,agonist
CSRP1,BALANOL,GuideToPharmacology,1,inhibitor
GDF2,FIMEPINOSTAT,GuideToPharmacology,1,inhibitor
GARS1,BML-281,GuideToPharmacology,1,inhibitor
GARS1,ENTINOSTAT,GuideToPharmacology,1,inhibitor
GARS1,FIMEPINOSTAT,GuideToPharmacology,1,inhibitor
GART,COMPOUND 30 [PMID: 37057760],GuideToPharmacology,1,inhibitor
GAS1,BML-281,GuideToPharmacology,1,inhibitor
GAS1,CITARINOSTAT,GuideToPharmacology,1,inhibitor
AMD1,HISTAPRODIFEN,GuideToPharmacology,1,agonist
AMD1,2-PYRIDYLETHYLAMINE,GuideToPharmacology,1,agonist
AMD1,2-(2-THIAZOLYL)ETHANAMINE,GuideToPharmacology,1,agonist
AMD1,CHLORPHENIRAMINE POLISTIREX,GuideToPharmacology,1,inhibitor
AMD1,CHLORPHENIRAMINE POLISTIREX,GuideToPharmacology,1,inhibitor
AMD1,INCB-38579,GuideToPharmacology,1,inhibitor
AMD1,(+)-CIS-H2-PAT,GuideToPharmacology,1,inhibitor
HRH3,IMPENTAMINE,GuideToPharmacology,1,agonist
HRH3,IMPENTAMINE,GuideToPharmacology,1,inhibitor
HRH3,ST-1505,GuideToPharmacology,1,inhibitor
HRH3,MK-0249,GuideToPharmacology,1,agonist
HRH3,MK-0249,GuideToPharmacology,1,inhibitor
HRH3,GSK-189254,GuideToPharmacology,1,agonist
GMFA,INCB13739,GuideToPharmacology,1,inhibitor
ADCY3,2-ARACHIDONOYLGLYCEROL,GuideToPharmacology,1,agonist
ADCY6,DIOLEOYLPHOSPHATIDIC ACID,GuideToPharmacology,1,agonist
GRB2,ENASIDENIB,GuideToPharmacology,1,inhibitor
EPHB3,BMS-911543,GuideToPharmacology,1,inhibitor
EPHB3,BREPOCITINIB,GuideToPharmacology,1,inhibitor
EPHB3,JAK3 INHIBITOR 32,GuideToPharmacology,1,inhibitor
NUDT2,(-)-CYCLAZOCINE,GuideToPharmacology,1,agonist
NUDT2,DIHYDROMORPHINE,GuideToPharmacology,1,agonist
NUDT2,UFP-512,GuideToPharmacology,1,agonist
NUDT2,QUADAZOCINE,GuideToPharmacology,1,inhibitor
DRD2,HENATINIB,GuideToPharmacology,1,inhibitor
AMELY,KISSPEPTIN-13,GuideToPharmacology,1,agonist
DRD2,VATALANIB,GuideToPharmacology,1,inhibitor
DPT,ILORASERTIB,GuideToPharmacology,1,inhibitor
BAD,NEMIRALISIB,GuideToPharmacology,1,inhibitor
ATP7B,CHARYBDOTOXIN,GuideToPharmacology,1,blocker
ATR,CHARYBDOTOXIN,GuideToPharmacology,1,blocker
AZF1,JNJ303,GuideToPharmacology,1,blocker
CTSV,NINTEDANIB ESYLATE,GuideToPharmacology,1,inhibitor
GPX7,OPICINUMAB,GuideToPharmacology,1,antibody
EPHX2,COMPOUND 36 [PMID: 21958547],GuideToPharmacology,1,inhibitor
EPHX2,SARACATINIB,GuideToPharmacology,1,inhibitor
AMPD3,2-OLEOYL-LPA,GuideToPharmacology,1,agonist
BCL3,"24(S), 25-EPOXYCHOLESTEROL",GuideToPharmacology,1,agonist
BIN1,H2L5186303,GuideToPharmacology,1,inhibitor
AMPD3,ONO-9910539,GuideToPharmacology,1,inhibitor
BIN1,ALKYL OMPT,GuideToPharmacology,1,agonist
AMPD3,ONO-3080573,GuideToPharmacology,1,inhibitor
AMY2B,S36077,GuideToPharmacology,1,agonist
ANCR,HS024,GuideToPharmacology,1,inhibitor
ANCR,MS05,GuideToPharmacology,1,agonist
ANGPT1,AP1189,GuideToPharmacology,1,agonist
ANOP1,COMPOUND 11Q [PMID: 19433355],GuideToPharmacology,1,modulator
BLK,FARNESYL THIODIPHOSPHATE,GuideToPharmacology,1,inhibitor
SLC25A4,EGLUMEGAD,GuideToPharmacology,1,agonist
SLC25A5,DEXFOSFOSERINE,GuideToPharmacology,1,agonist
MAP2K1,TAK-733,GuideToPharmacology,1,modulator
MAP2K1,MIRDAMETINIB,GuideToPharmacology,1,inhibitor
MAP2K1,BI-847325,GuideToPharmacology,1,inhibitor
AADAC,VINBURNINE,GuideToPharmacology,1,modulator
AADAC,TOLTERODINE,GuideToPharmacology,1,inhibitor
AADAC,PIRENZEPINE,GuideToPharmacology,1,inhibitor
AAMP,STRYCHNINE,GuideToPharmacology,1,modulator
AANAT,ACECLIDINE,GuideToPharmacology,1,agonist
EIF5AP3,CCT244747,GuideToPharmacology,1,inhibitor
AANAT,UH-AH 37,GuideToPharmacology,1,inhibitor
AARS1,ACECLIDINE,GuideToPharmacology,1,agonist
AANAT,METHSCOPOLAMINE BROMIDE,GuideToPharmacology,1,inhibitor
AARS1,VINBURNINE,GuideToPharmacology,1,modulator
AARS1,DICYCLOMINE HYDROCHLORIDE,GuideToPharmacology,1,inhibitor
AARS1,STRYCHNINE,GuideToPharmacology,1,modulator
AAVS1,MCN-A-343,GuideToPharmacology,1,agonist
AARS1,UH-AH 37,GuideToPharmacology,1,inhibitor
AAVS1,METHACHOLINE,GuideToPharmacology,1,agonist
AAVS1,LITHOCHOLYLCHOLINE,GuideToPharmacology,1,inhibitor
AAVS1,ML381,GuideToPharmacology,1,inhibitor
AAVS1,ML375,GuideToPharmacology,1,modulator
AAVS1,VU0238429,GuideToPharmacology,1,modulator
AAVS1,TOLTERODINE,GuideToPharmacology,1,inhibitor
ANK2,S20928,GuideToPharmacology,1,inhibitor
ANK2,CBOBNEA,GuideToPharmacology,1,agonist
CD70,METOLAZONE,GuideToPharmacology,1,inhibitor
GZMM,COMPOUND 87 [PMID: 20942471],GuideToPharmacology,1,inhibitor
BARD1,BATRACHOTOXIN,GuideToPharmacology,1,activator
SLC13A5,BI01383298,GuideToPharmacology,1,inhibitor
BBS2,ZANDATRIGINE,GuideToPharmacology,1,inhibitor
ATF4,&ALPHA;-CONOTOXIN ARIB,GuideToPharmacology,1,inhibitor
AQP5,SB 222200,GuideToPharmacology,1,inhibitor
NMUR1,[125I]NEUROMEDIN U-23 (RAT),GuideToPharmacology,1,agonist
SLCO1B1,GEMFIBROZIL,GuideToPharmacology,1,inhibitor
DNA2,ML130,GuideToPharmacology,1,inhibitor
SLCO1B1,CYCLOSPORINE,GuideToPharmacology,1,inhibitor
CDKN1B,CEPHALOTHIN,GuideToPharmacology,1,inhibitor
CDK9,PROBENECID,GuideToPharmacology,1,inhibitor
ARAF,BALOVAPTAN,GuideToPharmacology,1,inhibitor
ARAF,D[CHA4]AVP,GuideToPharmacology,1,agonist
ODC1,EFLORNITHINE,GuideToPharmacology,1,inhibitor
ARAF,"L-368,899",GuideToPharmacology,1,inhibitor
ARAF,"D(CH2)5[TYR(ME)2,THR4,PHE(3I,4N3)-NH29]OVT",GuideToPharmacology,1,inhibitor
APBB2,MRS2496,GuideToPharmacology,1,inhibitor
APC,REACTIVE BLUE-2,GuideToPharmacology,1,inhibitor
APOH,GYPGKF-NH2,GuideToPharmacology,1,agonist
BCKDHA,FENOFIBRATE MICRONIZED,GuideToPharmacology,1,agonist
CCND1,LANIFIBRANOR,GuideToPharmacology,1,agonist
BCKDHB,L-783483,GuideToPharmacology,1,agonist
CCND1,PIOGLITAZONE HYDROCHLORIDE,GuideToPharmacology,1,agonist
CCND1,GW1929,GuideToPharmacology,1,agonist
CCND1,MK-0767,GuideToPharmacology,1,agonist
CCND1,MRL24,GuideToPharmacology,1,agonist
CCND1,VCE-004.3,GuideToPharmacology,1,agonist
F5,AZD8154,GuideToPharmacology,1,inhibitor
F5,COMPOUND 22 [PMID: 24754609],GuideToPharmacology,1,inhibitor
CCND1,DICLOFENAC SODIUM,GuideToPharmacology,1,inhibitor
F5,PF-06843195,GuideToPharmacology,1,inhibitor
F5,NEMIRALISIB,GuideToPharmacology,1,inhibitor
PIK3CB,PILARALISIB,GuideToPharmacology,1,inhibitor
F7,COMPOUND 15A [PMID: 32069401],GuideToPharmacology,1,inhibitor
PIK3CB,LY-294002,GuideToPharmacology,1,inhibitor
F7,ALPELISIB,GuideToPharmacology,1,inhibitor
F7,INAVOLISIB,GuideToPharmacology,1,inhibitor
F7R,AMG319,GuideToPharmacology,1,inhibitor
F7R,COMPOUND 22 [PMID: 24754609],GuideToPharmacology,1,inhibitor
COL19A1,COMPOUND 27 [PMID: 22142545],GuideToPharmacology,1,inhibitor
HOXA11,COMPOUND 1 [PMID: 26055709],GuideToPharmacology,1,inhibitor
COL9A3,CILOSTAMIDE,GuideToPharmacology,1,inhibitor
COL9A2,CILOSTAMIDE,GuideToPharmacology,1,inhibitor
COPA,PDE4 INHIBITOR 16,GuideToPharmacology,1,inhibitor
COPA,SILDENAFIL,GuideToPharmacology,1,inhibitor
F10,UZANSERTIB,GuideToPharmacology,1,inhibitor
GLI4,GNE-064,GuideToPharmacology,1,inhibitor
GNAI2,"COMPOUND 9 [LIN ET AL., 2023]",GuideToPharmacology,1,inhibitor
GNAI2,RUCAPARIB,GuideToPharmacology,1,inhibitor
HMBS,GNF-6231,GuideToPharmacology,1,inhibitor
BDNF,ZK112993,GuideToPharmacology,1,inhibitor
XIAP,"[ALA1,12,AIB3,GLN10,HARG11,TRP14,ARG19]PTH-(1-28)-NH2 (HUMAN)",GuideToPharmacology,1,agonist
XIAP,"[ILE5,TRP23,TYR36]PTHRP-(1-36)-NH2 (HUMAN)",GuideToPharmacology,1,agonist
BIRC5,TERIPARATIDE,GuideToPharmacology,1,agonist
BIRC5,PTHRP-(1-36),GuideToPharmacology,1,agonist
BIRC5,[TRP23]PTHRP-(1-36) (HUMAN),GuideToPharmacology,1,agonist
FAH,CCT196969,GuideToPharmacology,1,inhibitor
PDK4,VER-246608,GuideToPharmacology,1,inhibitor
PANX3,FLUFENAMIC ACID,GuideToPharmacology,1,inhibitor
FAH,TINLORAFENIB,GuideToPharmacology,1,inhibitor
FANCG,6E11,GuideToPharmacology,1,inhibitor
COL6A3,ESI-09,GuideToPharmacology,1,inhibitor
RASGRP1,RASGRP ACTIVATOR 1,GuideToPharmacology,1,activator
COL6A2,ESI-09,GuideToPharmacology,1,inhibitor
CTRB1,COMPOUND 11D [DOI: 10.1039/C0MD00194E],GuideToPharmacology,1,inhibitor
GBA1LP,TAS1553,GuideToPharmacology,1,inhibitor
CYB5A,FMK,GuideToPharmacology,1,inhibitor
APP,[125I]RELAXIN (HUMAN),GuideToPharmacology,1,agonist
RYR2,CARVEDILOL,GuideToPharmacology,1,inhibitor
AMT,AUY954,GuideToPharmacology,1,agonist
FAUNA@,ARN-3236,GuideToPharmacology,1,inhibitor
AMY2A,GSK-2018682,GuideToPharmacology,1,agonist
GBE1,ENOXAPARIN SODIUM,GuideToPharmacology,1,activator
GKP4,BAY-598,GuideToPharmacology,1,inhibitor
CD3D,BEXAGLIFLOZIN,GuideToPharmacology,1,inhibitor
CD3E,IPRAGLIFLOZIN,GuideToPharmacology,1,inhibitor
CD3E,SOTAGLIFLOZIN,GuideToPharmacology,1,inhibitor
CD3E,TOFOGLIFLOZIN ANHYDROUS,GuideToPharmacology,1,inhibitor
CD3E,DAPAGLIFLOZIN PROPANEDIOL,GuideToPharmacology,1,inhibitor
MS4A2,COMPOUND 25 [PMID: 31260299],GuideToPharmacology,1,inhibitor
FASLG,BIM 23059,GuideToPharmacology,1,agonist
FASLG,CGP 23996,GuideToPharmacology,1,agonist
SHROOM2,"BN-81,644",GuideToPharmacology,1,agonist
AQP2,"L-362,855",GuideToPharmacology,1,agonist
FRA8A,N-0385,GuideToPharmacology,1,inhibitor
HLA-DMB,BASROPARIB,GuideToPharmacology,1,inhibitor
ECM2,CEP-11981,GuideToPharmacology,1,inhibitor
GPC5,AMG28,GuideToPharmacology,1,inhibitor
MPL,ELTROMBOPAG,GuideToPharmacology,1,agonist
THRB,RT3,GuideToPharmacology,1,agonist
FUT4,MITIPERSTAT,GuideToPharmacology,1,inhibitor
SARDH,ENPATORAN,GuideToPharmacology,1,inhibitor
DOCK3,COMPOUND 13A [PMID: 23639540],GuideToPharmacology,1,inhibitor
ATP1B1P1,DIBENZOXAZEPINE,GuideToPharmacology,1,activator
ATP1B1P1,NITROOLEIC ACID,GuideToPharmacology,1,activator
ATP1B1P1,AP18,GuideToPharmacology,1,blocker
ATP1B1P1,AP18,GuideToPharmacology,1,inhibitor
ATP2B2,OPTODARG,GuideToPharmacology,1,activator
ATP5F1BP1,SB366791,GuideToPharmacology,1,blocker
ATP5F1BP1,BCTC,GuideToPharmacology,1,blocker
ATP5BL2,LORATADINE,GuideToPharmacology,1,blocker
ATP5F1BP1,AMG 9810,GuideToPharmacology,1,blocker
FGFR4,MPI-0479605,GuideToPharmacology,1,inhibitor
GCF1,PACLITAXEL,GuideToPharmacology,1,inhibitor
ARCN2,PG 99-465,GuideToPharmacology,1,agonist
AQP9,D[LEU4]AVP,GuideToPharmacology,1,agonist
AQP9,L023103,GuideToPharmacology,1,inhibitor
ANXA4,PANCREATIC POLYPEPTIDE,GuideToPharmacology,1,agonist
ANXA5,PEPTIDE YY,GuideToPharmacology,1,agonist
ANXA3,[PRO34]PYY (HUMAN),GuideToPharmacology,1,agonist
EPHB2,JAK3 INHIBITOR 32,GuideToPharmacology,1,inhibitor
APBB2,PFIZER COMPOUND 67 [PMID:18445527],GuideToPharmacology,1,inhibitor
FABP1,VOLASERTIB,GuideToPharmacology,1,inhibitor
ATP4A,DICLOFENAC SODIUM,GuideToPharmacology,1,blocker
APC,AR-C118925XX,GuideToPharmacology,1,inhibitor
AR,RELCOVAPTAN,GuideToPharmacology,1,inhibitor
FCGRT,ROZANOLIXIZUMAB,GuideToPharmacology,1,antibody
ALOX12P1,GALANIN(1-19) (HUMAN),GuideToPharmacology,1,agonist
SLC29A1,KENPAULLONE,GuideToPharmacology,1,inhibitor
BIRC5,"[ILE5,TRP23]PTHRP-(5-36) (HUMAN)",GuideToPharmacology,1,agonist
ABCA2,CGS 15943,GuideToPharmacology,1,inhibitor
CD9,TOLUDESVENLAFAXINE,GuideToPharmacology,1,inhibitor
TYK2,"2-TERT-BUTYL-9-FLUORO-1,6-DIHYDROBENZO[H]IMIDAZO[4,5-F]ISOQUINOLIN-7-ONE",GuideToPharmacology,1,inhibitor
ECM2,COMPOUND 8H [PMID: 21561767],GuideToPharmacology,1,inhibitor
DXO,SELATINIB,GuideToPharmacology,1,inhibitor
ABL1,VAMOTINIB,GuideToPharmacology,1,inhibitor
FDX1,TAMATINIB,GuideToPharmacology,1,inhibitor
ASIP,ML297,GuideToPharmacology,1,activator
AQP3,IMNOPITANT,GuideToPharmacology,1,inhibitor
KLK3,INSL5-A13NR,GuideToPharmacology,1,inhibitor
EPHB1,AZD1480,GuideToPharmacology,1,inhibitor
CD3E,BEXAGLIFLOZIN,GuideToPharmacology,1,inhibitor
GNA12,ZOPOLRESTAT,GuideToPharmacology,1,inhibitor
ABCA3,APADENOSON,GuideToPharmacology,1,agonist
EIF4A1,"6-PHENYL[5H]PYRROLO[2,3-B]PYRAZINE",GuideToPharmacology,1,inhibitor
GNG5P1,MITIPERSTAT,GuideToPharmacology,1,inhibitor
GRIN2B,CGP37849,GuideToPharmacology,1,inhibitor
AQP1,"H-C[DCYS-PHE-LAGL(N&BETA;ME,BENZOYL)-DTRP-LYS-THR-PHE-CYS]-OH",GuideToPharmacology,1,agonist
GAPDHL17,BUFEXAMAC,GuideToPharmacology,1,inhibitor
APBB1,"[ALA11, D-LEU15]OREXIN-B",GuideToPharmacology,1,agonist
ANXA4,[PRO34]PYY (HUMAN),GuideToPharmacology,1,agonist
EPHA7,EDECESERTIB,GuideToPharmacology,1,inhibitor
HBEGF,COMPOUND 25B [PMID: 22564207],GuideToPharmacology,1,inhibitor
SIGMAR1,PENTAZOCINE,GuideToPharmacology,1,inhibitor
APOC2,[3H]PGF2&ALPHA;,GuideToPharmacology,1,agonist
APC,5BRUTP,GuideToPharmacology,1,agonist
ALOX12P2,M15,GuideToPharmacology,1,inhibitor
DRD5P2,CEP-11981,GuideToPharmacology,1,inhibitor
ALDH9A1,FMET-ILE-VAL-THR-LEU-PHE,GuideToPharmacology,1,agonist
MS4A2,SYK INHIBITOR III,GuideToPharmacology,1,inhibitor
AARS1,ML381,GuideToPharmacology,1,inhibitor
CDK4,INIXACICLIB,GuideToPharmacology,1,inhibitor
ALDH2,PEROSPIRONE,GuideToPharmacology,1,inhibitor
ACTA1,VMIP-II,GuideToPharmacology,1,inhibitor
STS,PICROTOXIN,GuideToPharmacology,1,blocker
ABO,CLENBUTEROL,GuideToPharmacology,1,agonist
GTF2IP1,COMPOUND G1 [PMID: 36689364],GuideToPharmacology,1,inhibitor
RYR3,CAFFEINE,GuideToPharmacology,1,activator
EEF1D,BI-847325,GuideToPharmacology,1,inhibitor
EPHB2,CERDULATINIB,GuideToPharmacology,1,inhibitor
ANOP1,COMPOUND 22 [PMID: 17276684],GuideToPharmacology,1,modulator
GSTA2,FELADILIMAB,GuideToPharmacology,1,antibody
F7R,TASELISIB,GuideToPharmacology,1,inhibitor
DRD2,DORSOMORPHIN,GuideToPharmacology,1,inhibitor
MAP2K1,GDC-0623,GuideToPharmacology,1,inhibitor
NR4A2,COMPOUND 111 [PMID: 37918435],GuideToPharmacology,1,agonist
GJB5,COMPOUND 17 [PMID: 23570514],GuideToPharmacology,1,inhibitor
A1BG,LISURIDE,GuideToPharmacology,1,agonist
CTNNA1P1,JNK INHIBITOR IX,GuideToPharmacology,1,inhibitor
GLC1D,NI-57,GuideToPharmacology,1,inhibitor
DPYSL3,"COMPOUND 7 [NGUYEN ET AL., 2023]",GuideToPharmacology,1,inhibitor
CHRNA3,HEXAMETHONIUM,GuideToPharmacology,1,blocker
ABAT,LUF5831,GuideToPharmacology,1,agonist
ACAT2,[LEU8]-PHYLLOLITORIN,GuideToPharmacology,1,agonist
GAPDHL17,FIMEPINOSTAT,GuideToPharmacology,1,inhibitor
APBB1,CP-1,GuideToPharmacology,1,inhibitor
GPR34,AMG28,GuideToPharmacology,1,inhibitor
ERPL1,CEP-11981,GuideToPharmacology,1,inhibitor
CCND1,LG100754,GuideToPharmacology,1,agonist
DNCM,ZILURGISERTIB,GuideToPharmacology,1,inhibitor
CAPN5,CA2+,GuideToPharmacology,1,inhibitor
ACTG1,CXCL12-(1-9),GuideToPharmacology,1,agonist
BLVRA,NE58062,GuideToPharmacology,1,inhibitor
ALDH3A1,FLUPHENAZINE HYDROCHLORIDE,GuideToPharmacology,1,inhibitor
RYR2,CA2+,GuideToPharmacology,1,activator
RYR2,CA2+,GuideToPharmacology,1,inhibitor
ACRV1,NABILONE,GuideToPharmacology,1,agonist
CAPN5,OCTANOL,GuideToPharmacology,1,inhibitor
CD8B,DESVENLAFAXINE SUCCINATE,GuideToPharmacology,1,inhibitor
F3,COMPOUND 12B [PMID: 31465220],GuideToPharmacology,1,inhibitor
AAVS1,ACECLIDINE,GuideToPharmacology,1,agonist
A2M,5-MEOT,GuideToPharmacology,1,agonist
EN1,EGFR/ERBB-2/ERBB-4 INHIBITOR,GuideToPharmacology,1,inhibitor
BPGM,PHENYL-&BETA;-D-GLUCOPYRANOSIDE,GuideToPharmacology,1,agonist
APBB1,LSN2424100,GuideToPharmacology,1,inhibitor
APBA2,MK-3697,GuideToPharmacology,1,inhibitor
FMO5,PF-06751979,GuideToPharmacology,1,inhibitor
AMHR2,LTD4,GuideToPharmacology,1,agonist
ACADVL,COMPOUND 11D [PMID: 34406006],GuideToPharmacology,1,agonist
F7,COMPOUND 7 [PMID: 31955578],GuideToPharmacology,1,inhibitor
AAVS1,ACLIDINIUM,GuideToPharmacology,1,inhibitor
AMY1C,COMPOUND 26 [PMID: 16190743],GuideToPharmacology,1,agonist
DPYSL2,NINTEDANIB ESYLATE,GuideToPharmacology,1,inhibitor
ASS1P2,[3H]AMPA,GuideToPharmacology,1,agonist
HRH3,BURIMAMIDE,GuideToPharmacology,1,inhibitor
BIN1,VPC12249,GuideToPharmacology,1,inhibitor
ALDH7A1P3,CHARYBDOTOXIN,GuideToPharmacology,1,blocker
NR3C2,ZK112993,GuideToPharmacology,1,inhibitor
DLX3,MUTANT ANP,GuideToPharmacology,1,agonist
GRIN2C,BIIB021,GuideToPharmacology,1,inhibitor
CSE1L,VU0364739,GuideToPharmacology,1,inhibitor
A12M2,METHYLERGONOVINE,GuideToPharmacology,1,inhibitor
CD28,LORATADINE,GuideToPharmacology,1,inhibitor
CNR2,TARANABANT,GuideToPharmacology,1,agonist
C7,CA2+,GuideToPharmacology,1,inhibitor
MMP16,ILOMASTAT,GuideToPharmacology,1,inhibitor
EIF4A1,MILCICLIB,GuideToPharmacology,1,inhibitor
CD8B2,CLOMIPRAMINE,GuideToPharmacology,1,inhibitor
F5,COMPOUND 2Q [PMID: 30986068],GuideToPharmacology,1,inhibitor
DPYS,COMPOUND 14K [PMID: 21982499],GuideToPharmacology,1,inhibitor
ABL2,LISURIDE,GuideToPharmacology,1,inhibitor
ASS1P14,[3H]CPP,GuideToPharmacology,1,inhibitor
MS4A2,N-(5-METHYL-1H-PYRAZOL-3-YL)-2-PHENYLQUINAZOLIN-4-AMINE,GuideToPharmacology,1,inhibitor
EIF4E,CDK INHIBITOR 4.35,GuideToPharmacology,1,inhibitor
APBB1,COMPOUND 11 [PMID: 15261275],GuideToPharmacology,1,inhibitor
NAT1,CAPESEROD,GuideToPharmacology,1,agonist
GAPDHP1,RICOLINOSTAT,GuideToPharmacology,1,inhibitor
ANPEP,OPIORPHIN,GuideToPharmacology,1,inhibitor
SLC25A6,SIB-1757,GuideToPharmacology,1,modulator
GDF2,NEXTURASTAT A,GuideToPharmacology,1,inhibitor
EPHA8,COMPOUND 25 [PMID: 31260299],GuideToPharmacology,1,inhibitor
BAAT,ICA-105574,GuideToPharmacology,1,inhibitor
ANXA2,[125I]TYR10NPS (HUMAN),GuideToPharmacology,1,agonist
DRD5P2,GR-389988,GuideToPharmacology,1,inhibitor
F5,PQR620,GuideToPharmacology,1,inhibitor
AMELX,[3H]PYRILAMINE,GuideToPharmacology,1,inhibitor
DNMT3A,LY2109761,GuideToPharmacology,1,inhibitor
APOC2,MB-28767,GuideToPharmacology,1,agonist
ABL2,RISVODETINIB,GuideToPharmacology,1,inhibitor
ABCF1,NAN 190,GuideToPharmacology,1,inhibitor
ABO,LK 204-545,GuideToPharmacology,1,inhibitor
ALDH3B2,FMET-LEU-PHE,GuideToPharmacology,1,agonist
ARVD4,ONTERNABEZ,GuideToPharmacology,1,inhibitor
DPT,RIPRETINIB,GuideToPharmacology,1,inhibitor
AAMP,HEXAHYDRODIFENIDOL,GuideToPharmacology,1,inhibitor
AMY1C,CYM-50358,GuideToPharmacology,1,inhibitor
NAT2,DONITRIPTAN,GuideToPharmacology,1,agonist
CHI3L2,TICAGRELOR,GuideToPharmacology,1,inhibitor
FSHMD1A,CR4056,GuideToPharmacology,1,inhibitor
EIF4EBP2,CDK12 INHIBITOR 2,GuideToPharmacology,1,inhibitor
ANXA5,"L-152,804",GuideToPharmacology,1,inhibitor
SERPINA3,AS-19,GuideToPharmacology,1,agonist
HBEGF,COMPOUND 8E [PMID: 24432909],GuideToPharmacology,1,inhibitor
GABRA1,CGS8216,GuideToPharmacology,1,agonist
ANXA13,"(+)-5-(5-BROMOTHIOPHEN-3-YL)-5-METHYL-4-OXO-4,5-DIHYDRO-FURAN-2-CARBOXYLIC ACID",GuideToPharmacology,1,agonist
GRIN2B,L689560,GuideToPharmacology,1,inhibitor
DRD4,ALECTINIB,GuideToPharmacology,1,inhibitor
AADAC,STAUROSPORINE,GuideToPharmacology,1,modulator
MPL,THROMBOPOIETIN,GuideToPharmacology,1,agonist
ANXA5,"NPY-(18-36) (HUMAN, PIG)",GuideToPharmacology,1,agonist
DPYD,IBCASERTIB,GuideToPharmacology,1,inhibitor
AQP8,L902688,GuideToPharmacology,1,agonist
ASS1P5,LY382884,GuideToPharmacology,1,inhibitor
APBA1,[(PF)PHE4]N/OFQ-(1-13)-NH2,GuideToPharmacology,1,agonist
BAK1P1,MRL-871,GuideToPharmacology,1,agonist
F7,SAR260301,GuideToPharmacology,1,inhibitor
CTSS,TOFACITINIB,GuideToPharmacology,1,inhibitor
ASS1P14,[3H]CGP61594,GuideToPharmacology,1,inhibitor
PHOX2A,ZATEBRADINE,GuideToPharmacology,1,blocker
ATF6B,PKUMDL_MH_1001,GuideToPharmacology,1,modulator
A1BG,[3H]8-OH-DPAT,GuideToPharmacology,1,agonist
A1BG,LY293284,GuideToPharmacology,1,agonist
A1BG,U92016A,GuideToPharmacology,1,agonist
A1BG,S-14506,GuideToPharmacology,1,agonist
A1BG,PIMOZIDE,GuideToPharmacology,1,inhibitor
A1BG,SDZ-216525,GuideToPharmacology,1,inhibitor
A2MP1,5-MEOT,GuideToPharmacology,1,agonist
A2MP1,ZOLMITRIPTAN,GuideToPharmacology,1,agonist
A2MP1,LISURIDE,GuideToPharmacology,1,agonist
A2MP1,ALNIDITAN,GuideToPharmacology,1,agonist
A2MP1,[3H]8-OH-DPAT,GuideToPharmacology,1,agonist
A12M1,TRYPTAMINE,GuideToPharmacology,1,agonist
A12M1,SUMATRIPTAN,GuideToPharmacology,1,agonist
A12M1,5-MEOT,GuideToPharmacology,1,agonist
A12M3,SB 224289,GuideToPharmacology,1,inhibitor
A12M3,TRIFLUOPERAZINE,GuideToPharmacology,1,inhibitor
A12M3,METITEPINE,GuideToPharmacology,1,inhibitor
A12M4,[3H]LSD,GuideToPharmacology,1,agonist
A12M4,HALOPERIDOL DECANOATE,GuideToPharmacology,1,inhibitor
HTR2C,5-MEO-DMT,GuideToPharmacology,1,agonist
HTR2C,(+)-LSD,GuideToPharmacology,1,agonist
NAT2,METITEPINE,GuideToPharmacology,1,inhibitor
NATP,DONITRIPTAN,GuideToPharmacology,1,agonist
NAT2,MPDT,GuideToPharmacology,1,inhibitor
NATP,AMOXAPINE,GuideToPharmacology,1,inhibitor
SERPINA3,METITEPINE,GuideToPharmacology,1,inhibitor
SERPINA3,MPDT,GuideToPharmacology,1,inhibitor
SERPINA3,E55888,GuideToPharmacology,1,agonist
CREB1,ZILEUTON,GuideToPharmacology,1,inhibitor
CA9,ENCEQUIDAR,GuideToPharmacology,1,inhibitor
DNCM,ML347,GuideToPharmacology,1,inhibitor
CCR2,A134974,GuideToPharmacology,1,inhibitor
DFFB,COMPOUND 15C [PMID: 21536437],GuideToPharmacology,1,inhibitor
COL1AR,FD1,GuideToPharmacology,1,activator
HDGF,TDI-11861,GuideToPharmacology,1,inhibitor
FRA17B,4-ACRYLOYLPHENOL,GuideToPharmacology,1,inhibitor
CSTF3,MS15,GuideToPharmacology,1,inhibitor
ABCB7,NAN 190,GuideToPharmacology,1,inhibitor
ABCB7,LISURIDE,GuideToPharmacology,1,inhibitor
DAPK3,LISINOPRIL ANHYDROUS,GuideToPharmacology,1,inhibitor
DAPK3,FASIDOTRIL,GuideToPharmacology,1,inhibitor
DAPK3,SPIRAPRIL,GuideToPharmacology,1,inhibitor
DAPK3,MOEXIPRIL,GuideToPharmacology,1,inhibitor
ACADSB,ML233,GuideToPharmacology,1,agonist
ACADSB,ELABELA/TODDLER-32,GuideToPharmacology,1,agonist
BTN1A1,PHLORETIN,GuideToPharmacology,1,inhibitor
ACADSB,MM54,GuideToPharmacology,1,inhibitor
GSTP1P1,TCDD,GuideToPharmacology,1,agonist
CMR1A,COMPOUND 9 [PMID: 23472952],GuideToPharmacology,1,inhibitor
BTD,ASPIRIN,GuideToPharmacology,1,blocker
ABAT,MRS5151,GuideToPharmacology,1,agonist
ABAT,PSB-10,GuideToPharmacology,1,inhibitor
ABAT,MEFLOQUINE,GuideToPharmacology,1,inhibitor
ABCA1,MRS1088,GuideToPharmacology,1,inhibitor
ABCA1,MRS1065,GuideToPharmacology,1,inhibitor
ABCA1,MRE 3008F20,GuideToPharmacology,1,inhibitor
ABCA1,MRS928,GuideToPharmacology,1,inhibitor
ABCA2,CAFFEINE,GuideToPharmacology,1,inhibitor
ABCA2,DERENOFYLLINE,GuideToPharmacology,1,inhibitor
ABCA2,AS70,GuideToPharmacology,1,inhibitor
ABCA2,LAS38096,GuideToPharmacology,1,inhibitor
ABCA2,LUF5981,GuideToPharmacology,1,inhibitor
ABCA2,PRELADENANT,GuideToPharmacology,1,inhibitor
ABCA3,CGS 15943,GuideToPharmacology,1,inhibitor
ABCA3,FLAVONE,GuideToPharmacology,1,inhibitor
ABCA3,DEXNIGULDIPINE,GuideToPharmacology,1,inhibitor
ABCA3,MPC-MECA,GuideToPharmacology,1,agonist
ATR,GARTISERTIB,GuideToPharmacology,1,inhibitor
EEF1B2P2,KU-60019,GuideToPharmacology,1,inhibitor
ATR,DACTOLISIB,GuideToPharmacology,1,inhibitor
EEF1G,COMPOUND 10 [PMID: 19402633],GuideToPharmacology,1,inhibitor
GRIK5,PF-8380,GuideToPharmacology,1,inhibitor
EEF1G,TAK-632,GuideToPharmacology,1,inhibitor
GRIK5,BI-2545,GuideToPharmacology,1,inhibitor
EEF1G,TOZASERTIB,GuideToPharmacology,1,inhibitor
EEF2,BI-847325,GuideToPharmacology,1,inhibitor
ACAT2,RANATENSIN,GuideToPharmacology,1,agonist
ACAT2,[125I]GRP (HUMAN),GuideToPharmacology,1,agonist
ACAT2,"[D-PHE6, LEU13, CPA14,&PSI;13-14]BOMBESIN-(6-14)",GuideToPharmacology,1,inhibitor
ACAT2,"[D-ARG1,D-TRP7,9,LEU11]SUBSTANCE P",GuideToPharmacology,1,inhibitor
FMOD,COMPOUND 3L [PMID: 30637955],GuideToPharmacology,1,inhibitor
FMOD,EXAMPLE 98 [WO2011020806],GuideToPharmacology,1,inhibitor
FMO5,AZ3971,GuideToPharmacology,1,inhibitor
ABO,PROPRANOLOL HYDROCHLORIDE,GuideToPharmacology,1,inhibitor
ABO,NDD-825,GuideToPharmacology,1,inhibitor
ABR,PROPRANOLOL HYDROCHLORIDE,GuideToPharmacology,1,inhibitor
ACAA1,BRL 37344,GuideToPharmacology,1,agonist
AMFR,U75302,GuideToPharmacology,1,inhibitor
AMFR,ONO-4057,GuideToPharmacology,1,inhibitor
EEGV1,JNJ-64264681,GuideToPharmacology,1,inhibitor
EFNA2,CCT196969,GuideToPharmacology,1,inhibitor
EFNA1,BMX-IN-1,GuideToPharmacology,1,inhibitor
DNMT1,ML347,GuideToPharmacology,1,inhibitor
EFNA2,TINLORAFENIB,GuideToPharmacology,1,inhibitor
EFNA2,TAK-632,GuideToPharmacology,1,inhibitor
GLC#,GSK2801,GuideToPharmacology,1,inhibitor
CA4,COMPOUND 5A [PMID: 31287314],GuideToPharmacology,1,inhibitor
ACP5,SB-423562,GuideToPharmacology,1,modulator
BRINP1,VRT-043198,GuideToPharmacology,1,inhibitor
ACP5,ATF936,GuideToPharmacology,1,modulator
FOLR2L,UAWJ9-36-3,GuideToPharmacology,1,inhibitor
FOLR2,RELACATIB,GuideToPharmacology,1,inhibitor
ACRV1,AM2201,GuideToPharmacology,1,agonist
CNR2,GW405833,GuideToPharmacology,1,agonist
ACRV1,TARANABANT,GuideToPharmacology,1,inhibitor
ACTA1,CCL4,GuideToPharmacology,1,inhibitor
ACTBP7,CCL28,GuideToPharmacology,1,agonist
ACTA1,[125I]CCL2 (HUMAN),GuideToPharmacology,1,agonist
HLA-DRB4,ATIBUCLIMAB,GuideToPharmacology,1,antibody
ACTBP2,[3H]MARAVIROC,GuideToPharmacology,1,inhibitor
ACTBP2,CENICRIVIROC,GuideToPharmacology,1,inhibitor
ACTBP5,CCL8,GuideToPharmacology,1,agonist
GMFB,INEBILIZUMAB,GuideToPharmacology,1,antibody
GATM,BSAB (CD89-CD20),GuideToPharmacology,1,antibody
ACTBP5,VMIP-II,GuideToPharmacology,1,inhibitor
ACTBP2,CCR5 ANTAGONIST 34,GuideToPharmacology,1,inhibitor
ACTBP4,CCL19,GuideToPharmacology,1,agonist
GATM,TOSITUMOMAB,GuideToPharmacology,1,antibody
GAPDHP60,VADASTUXIMAB TALIRINE,GuideToPharmacology,1,antibody
ELAVL2,ML315,GuideToPharmacology,1,inhibitor
EGR3,MONZOSERTIB,GuideToPharmacology,1,inhibitor
EIF5AP3,CHIR-124,GuideToPharmacology,1,inhibitor
BUB1,GATX2,GuideToPharmacology,1,blocker
HPGD,ANACETRAPIB,GuideToPharmacology,1,inhibitor
BUB1,ARACHIDONIC ACID,GuideToPharmacology,1,activator
ARHGAP6,DEQUALINIUM,GuideToPharmacology,1,blocker
CNA1,BMS PYRAZOLE INHIBITOR 7F,GuideToPharmacology,1,inhibitor
FPR3,ERIBAXABAN,GuideToPharmacology,1,inhibitor
DPYD,EDICOTINIB,GuideToPharmacology,1,inhibitor
DPYD,DOVITINIB,GuideToPharmacology,1,inhibitor
ALAS2,"[125I]UROCORTIN 1 (MOUSE, RAT)",GuideToPharmacology,1,agonist
C1QC,FLUFENAMIC ACID,GuideToPharmacology,1,inhibitor
C1QC,CA2+,GuideToPharmacology,1,inhibitor
ACHE,ADRENOMEDULLIN,GuideToPharmacology,1,agonist
C4B,OCTANOL,GuideToPharmacology,1,inhibitor
C4BPA,FLUFENAMIC ACID,GuideToPharmacology,1,inhibitor
C3AR1,CA2+,GuideToPharmacology,1,inhibitor
C7,FLUFENAMIC ACID,GuideToPharmacology,1,inhibitor
C6,FLUFENAMIC ACID,GuideToPharmacology,1,inhibitor
C8B,FLUFENAMIC ACID,GuideToPharmacology,1,inhibitor
C8G,CA2+,GuideToPharmacology,1,inhibitor
C7,OCTANOL,GuideToPharmacology,1,inhibitor
ACTBP9,CXCL8,GuideToPharmacology,1,agonist
ACTC1,CXCL11,GuideToPharmacology,1,agonist
ACTG1,VMIP-II,GuideToPharmacology,1,inhibitor
EGR4,MILCICLIB,GuideToPharmacology,1,inhibitor
CYP2C19,"COMPOUND 51 [CROSIGNANI ET AL., 2011]",GuideToPharmacology,1,inhibitor
AMHR2,LTD4,GuideToPharmacology,1,agonist
AMHR2,MK-571,GuideToPharmacology,1,inhibitor
AMHR2,BAYU9773,GuideToPharmacology,1,inhibitor
DUSP1,COMPOUND 1 [PMID: 31477924],GuideToPharmacology,1,inhibitor
FPR1,TENELIGLIPTIN,GuideToPharmacology,1,inhibitor
FPGS,ICED-2,GuideToPharmacology,1,inhibitor
DAPK1,TENELIGLIPTIN,GuideToPharmacology,1,inhibitor
APOB,TREPROSTINIL,GuideToPharmacology,1,agonist
APOB,DINOPROSTONE,GuideToPharmacology,1,agonist
APOB,[3H]BWA868C,GuideToPharmacology,1,inhibitor
APOBEC1,TIMAPIPRANT,GuideToPharmacology,1,inhibitor
APOBEC1,SETIPIPRANT,GuideToPharmacology,1,inhibitor
ALCAM,[125I]SCH23982,GuideToPharmacology,1,inhibitor
ABCD1,FLUPENTHIXOL,GuideToPharmacology,1,inhibitor
ALDH2,A-381393,GuideToPharmacology,1,inhibitor
ALDH2,[3H]WAY100635,GuideToPharmacology,1,agonist
CCR3,COMPOUND 49 [PMID: 36529947],GuideToPharmacology,1,inhibitor
DXO,FIRMONERTINIB,GuideToPharmacology,1,inhibitor
DXO,COMPOUND 17B [PMID: 35286086],GuideToPharmacology,1,inhibitor
DXO,BEFOTERTINIB,GuideToPharmacology,1,inhibitor
APOBER1,MF266-1,GuideToPharmacology,1,inhibitor
AQP8,11-DEOXY-PGE1,GuideToPharmacology,1,agonist
AQP8,CJ-042794,GuideToPharmacology,1,inhibitor
APOC1P1,ONO-AE-248,GuideToPharmacology,1,agonist
AQP8,TG6-129,GuideToPharmacology,1,inhibitor
BCYRN1P2,AFIMOXIFENE,GuideToPharmacology,1,agonist
BCYRN1P2,AFIMOXIFENE,GuideToPharmacology,1,inhibitor
BCYRN1P2,ESTRONE,GuideToPharmacology,1,agonist
ESR2,ESTRIOL,GuideToPharmacology,1,agonist
ESR2,DIETHYLSTILBESTROL,GuideToPharmacology,1,agonist
ESR2,HPTE,GuideToPharmacology,1,inhibitor
BCL5,GW4064,GuideToPharmacology,1,agonist
DHCR24,PEGINESATIDE,GuideToPharmacology,1,agonist
ARR3,[35S]TBPS,GuideToPharmacology,1,blocker
ARRB1,TP003,GuideToPharmacology,1,modulator
ARRB1,RO19-4603,GuideToPharmacology,1,modulator
ARRB1,ZK93423,GuideToPharmacology,1,agonist
ARRB2,BREXANOLONE,GuideToPharmacology,1,modulator
ARRB2,CENOBAMATE,GuideToPharmacology,1,modulator
ALOX12P1,GALANIN(2-11),GuideToPharmacology,1,agonist
ALOX12P1,GAL-B2,GuideToPharmacology,1,agonist
ALOX12P1,J18 (GALANIN ANALOGUE),GuideToPharmacology,1,agonist
ALOX12P1,GAL-B2-DPEG24,GuideToPharmacology,1,agonist
ALOX12P1,GAL-B5,GuideToPharmacology,1,agonist
GALR2,GAL-B2-C10,GuideToPharmacology,1,agonist
GALR2,GAL-B2-C8,GuideToPharmacology,1,agonist
CD14,(R)-EF-1520,GuideToPharmacology,1,inhibitor
ASPH,ARGIOTOXIN,GuideToPharmacology,1,blocker
ALPP,APRAGLUTIDE,GuideToPharmacology,1,agonist
ALPP,GLUCAGON-LIKE PEPTIDE 2,GuideToPharmacology,1,agonist
ASS1,ARGIOTOXIN,GuideToPharmacology,1,blocker
GRIA3,JORO SPIDER TOXIN,GuideToPharmacology,1,blocker
GRIA3,LY404187,GuideToPharmacology,1,modulator
ASS1P5,CONCANAVALIN A,GuideToPharmacology,1,modulator
ASS1P10,(RS)-(TETRAZOL-5-YL)GLYCINE,GuideToPharmacology,1,agonist
ASS1P10,[3H]CPP,GuideToPharmacology,1,inhibitor
GRIN2A,KETAMINE HYDROCHLORIDE,GuideToPharmacology,1,blocker
GRIN2C,[3H]L689560,GuideToPharmacology,1,inhibitor
GRIN2C,PHENCYCLIDINE,GuideToPharmacology,1,blocker
GRIN2C,[3H]CPP,GuideToPharmacology,1,inhibitor
GRIN2C,SELFOTEL,GuideToPharmacology,1,inhibitor
ASS1P14,SELFOTEL,GuideToPharmacology,1,inhibitor
CNTN1,S-ALLYLGLYCINE,GuideToPharmacology,1,inhibitor
ASS1P14,[3H]L689560,GuideToPharmacology,1,inhibitor
ARVD3,STRYCHNINE,GuideToPharmacology,1,inhibitor
ARVD4,HU-210,GuideToPharmacology,1,inhibitor
ARVD3,STRYCHNINE,GuideToPharmacology,1,inhibitor
ARVD3,PMBA,GuideToPharmacology,1,inhibitor
SLC29A1,BX-795,GuideToPharmacology,1,inhibitor
SLC29A1,INDIRUBIN-3'-MONOXIME,GuideToPharmacology,1,inhibitor
SLC29A1,ELRAGLUSIB,GuideToPharmacology,1,inhibitor
ANXA11,COMPOUND 2 [PMID: 31932225],GuideToPharmacology,1,agonist
AMELX,CONESSINE,GuideToPharmacology,1,inhibitor
AMELX,IMPROMIDINE,GuideToPharmacology,1,agonist
ADH1C,COMPOUND 20F [PMID: 21536438],GuideToPharmacology,1,agonist
ADH1C,SEA,GuideToPharmacology,1,agonist
ADH1C,COMPOUND 3J [PMID: 21444206],GuideToPharmacology,1,agonist
GPR32,LXA4,GuideToPharmacology,1,agonist
ADARB2,COMPOUND 1 [PMID: 24900608],GuideToPharmacology,1,agonist
ADAM8,YL-365,GuideToPharmacology,1,inhibitor
ADD3,6-N-OCTYLAMINOURACIL,GuideToPharmacology,1,agonist
ADCY8,OSTN (115-133),GuideToPharmacology,1,agonist
ADRA2A,CGEN-857,GuideToPharmacology,1,agonist
GATA3,RIBAVIRIN,GuideToPharmacology,1,inhibitor
STOM,AMLEXANOX,GuideToPharmacology,1,inhibitor
FRA11F,CAROTEGRAST,GuideToPharmacology,1,inhibitor
FRA12D,BIRT 377,GuideToPharmacology,1,inhibitor
FOXL2,LUPULONE,GuideToPharmacology,1,agonist
BRAFPS1,CYCLAMATE,GuideToPharmacology,1,inhibitor
BRAFPS1,SACCHARIN,GuideToPharmacology,1,agonist
TAS2R46,LACTUCOPICRIN,GuideToPharmacology,1,agonist
EPHB2,BMS-911543,GuideToPharmacology,1,inhibitor
EPHB2,BREPOCITINIB,GuideToPharmacology,1,inhibitor
EPHB2,NEZULCITINIB,GuideToPharmacology,1,inhibitor
EPHB2,ROPSACITINIB,GuideToPharmacology,1,inhibitor
EPHB2,RGB-286638,GuideToPharmacology,1,inhibitor
EPHB2,GDC-0214,GuideToPharmacology,1,inhibitor
NUDT2,ZYKLOPHIN,GuideToPharmacology,1,inhibitor
DPT,EDICOTINIB,GuideToPharmacology,1,inhibitor
DPT,PLX5622,GuideToPharmacology,1,inhibitor
ATP5ME,ARACHIDONIC ACID,GuideToPharmacology,1,activator
ASGR1,SPERMINE,GuideToPharmacology,1,blocker
ASGR1,SCH-23390,GuideToPharmacology,1,blocker
BAAT,HALOPERIDOL DECANOATE,GuideToPharmacology,1,blocker
AUH,SHK TOXIN,GuideToPharmacology,1,blocker
LTB4R,COMPOUND 23A [PMID: 33417443],GuideToPharmacology,1,inhibitor
ANGPT2,THIQ,GuideToPharmacology,1,agonist
ANK1,HS024,GuideToPharmacology,1,inhibitor
ETFB,DACTOLISIB,GuideToPharmacology,1,inhibitor
ETFB,COMPOUND 7 [PMID: 31955578],GuideToPharmacology,1,inhibitor
ETFB,ECF309,GuideToPharmacology,1,inhibitor
FRA2I,COMPOUND 7B [PMID: 17583500],GuideToPharmacology,1,inhibitor
GUK2,IMAPRELIMAB,GuideToPharmacology,1,antibody
DTNA,ZANZALINTINIB,GuideToPharmacology,1,inhibitor
SLC25A6,CTEP,GuideToPharmacology,1,modulator
SLC25A6,COMPOUND 16M [PMID: 19931453],GuideToPharmacology,1,modulator
GRM6,"(R,S)-4-PPG",GuideToPharmacology,1,agonist
GRM6,DEXFOSFOSERINE,GuideToPharmacology,1,agonist
GRM8,EGLUMEGAD,GuideToPharmacology,1,agonist
NR3C2,NIMODIPINE,GuideToPharmacology,1,inhibitor
CTNNA1,MK-8353,GuideToPharmacology,1,inhibitor
CTNNB1,ARRY-371797,GuideToPharmacology,1,inhibitor
ERBB4,BIX02189,GuideToPharmacology,1,inhibitor
ERCC4,GDC-0134,GuideToPharmacology,1,inhibitor
ERCC6,COMPOUND 31 [PMID: 23374866],GuideToPharmacology,1,inhibitor
ERCC6,AMG28,GuideToPharmacology,1,inhibitor
ERV3-1,BELIZATINIB,GuideToPharmacology,1,inhibitor
DCT,(R)-ND-336,GuideToPharmacology,1,inhibitor
CDC6,7ACC2,GuideToPharmacology,1,inhibitor
ANTP4,MOTILIN,GuideToPharmacology,1,agonist
ANTP4,EM-523,GuideToPharmacology,1,agonist
AADAC,ACECLIDINE,GuideToPharmacology,1,agonist
AAMP,PIRENZEPINE,GuideToPharmacology,1,inhibitor
ANK3,MELATONIN,GuideToPharmacology,1,agonist
ANK3,ISOAMYL-AGOMELATINE,GuideToPharmacology,1,agonist
APOF,(-)-CYCLAZOCINE,GuideToPharmacology,1,agonist
APOF,QUADAZOCINE,GuideToPharmacology,1,inhibitor
CYP2A13,CALMODULIN,GuideToPharmacology,1,activator
CD8B,MAZINDOL,GuideToPharmacology,1,inhibitor
CD8B,TAPENTADOL,GuideToPharmacology,1,inhibitor
NOS1,7NI,GuideToPharmacology,1,inhibitor
DRD5P1,ZIDESAMTINIB,GuideToPharmacology,1,inhibitor
DRG2,GR-389988,GuideToPharmacology,1,inhibitor
DAP,CANDOXATRIL,GuideToPharmacology,1,inhibitor
DAP,FASIDOTRIL,GuideToPharmacology,1,inhibitor
SERPINC1,WAGLERIN-1,GuideToPharmacology,1,inhibitor
SERPINC1,PANCURONIUM,GuideToPharmacology,1,inhibitor
CHRNA3,&ALPHA;-CONOTOXIN AUIB,GuideToPharmacology,1,inhibitor
ATF4,[3H]A-585539,GuideToPharmacology,1,agonist
AQP3,NEUROPEPTIDE K,GuideToPharmacology,1,agonist
NMUR1,CPN-223,GuideToPharmacology,1,agonist
NMUR2,[125I]NEUROMEDIN U-23 (RAT),GuideToPharmacology,1,agonist
NPFFR1,Y-RFRP-3,GuideToPharmacology,1,agonist
ANXA1,AC263093,GuideToPharmacology,1,agonist
APBA2,(R)-YNT-3708,GuideToPharmacology,1,agonist
APBA2,OREXIN-B,GuideToPharmacology,1,agonist
APBB1,(R)-YNT-3708,GuideToPharmacology,1,agonist
APBB1,COMPOUND 1 [PMID: 33547286],GuideToPharmacology,1,agonist
APBA2,LEMBOREXANT,GuideToPharmacology,1,inhibitor
APBB1,SUVOREXANT,GuideToPharmacology,1,inhibitor
APBB1,[3H]EMPA,GuideToPharmacology,1,inhibitor
PAK4,FRAX597,GuideToPharmacology,1,inhibitor
ATP1A4,RO3,GuideToPharmacology,1,inhibitor
ATP1B3P1,PF-04905428,GuideToPharmacology,1,inhibitor
APEX1,COMPOUND 4 [PMID: 22984835],GuideToPharmacology,1,inhibitor
APCS,N4-PHENYLETHOXYCYTIDINE-5'-TRIPHOSPHATE,GuideToPharmacology,1,agonist
APLP2,SCH 40338,GuideToPharmacology,1,inhibitor
F7,SAMOTOLISIB,GuideToPharmacology,1,inhibitor
F7,GSK2292767,GuideToPharmacology,1,inhibitor
F7,PARSACLISIB,GuideToPharmacology,1,inhibitor
F7,LY-294002,GuideToPharmacology,1,inhibitor
F7R,PI 3-KG INHIBITOR II,GuideToPharmacology,1,inhibitor
F7R,ZSTK474,GuideToPharmacology,1,inhibitor
COL10A1,ENSIFENTRINE,GuideToPharmacology,1,inhibitor
PDE5A,VARDENAFIL,GuideToPharmacology,1,inhibitor
PDE5A,T0156,GuideToPharmacology,1,inhibitor
APOA2,PKR-A,GuideToPharmacology,1,inhibitor
APOA1,PROKINETICIN-2&BETA;,GuideToPharmacology,1,agonist
APOA1,TRIAZINE COMPOUND PC10,GuideToPharmacology,1,inhibitor
DPP6,VATALANIB,GuideToPharmacology,1,inhibitor
FFAR1,OLAPARIB,GuideToPharmacology,1,inhibitor
GNAI2,CICLOPIROX,GuideToPharmacology,1,inhibitor
GNAI2P1,MC2050,GuideToPharmacology,1,inhibitor
CTBS,RASGRP ACTIVATOR 1,GuideToPharmacology,1,activator
CTH,BALANOL,GuideToPharmacology,1,inhibitor
GOLGA1,PIK-75,GuideToPharmacology,1,inhibitor
GOLGA1,PEPOSERTIB,GuideToPharmacology,1,inhibitor
GTF3C2,TRODUSQUEMINE,GuideToPharmacology,1,inhibitor
GTF3C2,HPN,GuideToPharmacology,1,inhibitor
HCN2,LG100754,GuideToPharmacology,1,inhibitor
BCHEL3,CD2665,GuideToPharmacology,1,inhibitor
CTPS1,GSK429286A,GuideToPharmacology,1,inhibitor
CYB5A,BIX 02565,GuideToPharmacology,1,inhibitor
APRT,WNN0109-C011,GuideToPharmacology,1,agonist
KLK3,WNN0109-C011,GuideToPharmacology,1,agonist
KLK3,EUROPIUM-LABELLED MOUSE INSL5,GuideToPharmacology,1,agonist
KLK3,R3/I5,GuideToPharmacology,1,agonist
AMT,ETRASIMOD,GuideToPharmacology,1,agonist
RYR3,CA2+,GuideToPharmacology,1,activator
RYR3,CA2+,GuideToPharmacology,1,inhibitor
AMT,ST-1505,GuideToPharmacology,1,agonist
SIRT2,COMPOUND 17 [PMID: 23570514],GuideToPharmacology,1,inhibitor
SIGMAR1,(+)-SKF 10.047,GuideToPharmacology,1,agonist
GJB3,SRT1720,GuideToPharmacology,1,activator
GK2,MDL-800,GuideToPharmacology,1,modulator
FBLN2,TILPISERTIB,GuideToPharmacology,1,inhibitor
CD40LG,CYCLOSPORINE,GuideToPharmacology,1,inhibitor
CD44,264W94,GuideToPharmacology,1,inhibitor
CD3D,DAPAGLIFLOZIN PROPANEDIOL,GuideToPharmacology,1,inhibitor
FCAR,COMPOUND 59 [PMID: 30889352],GuideToPharmacology,1,inhibitor
MS4A2,ECF506,GuideToPharmacology,1,inhibitor
FAS,"DES-AA1,2,5,12,13-[D-TRP8]SRIF",GuideToPharmacology,1,agonist
FAS,DES-AA5-[D-TRP8]SRIF,GuideToPharmacology,1,agonist
FASLG,"[111IN,90Y]DOTA-NOC",GuideToPharmacology,1,agonist
SHROOM2,BIM 23058,GuideToPharmacology,1,agonist
SHROOM2,SST3-ODN-8,GuideToPharmacology,1,inhibitor
AQP1,CGP 23996,GuideToPharmacology,1,agonist
AQP2,"L-817,818",GuideToPharmacology,1,agonist
AQP1,DES-AA5-[D-TRP8]SRIF,GuideToPharmacology,1,agonist
AQP2,"[111IN,90Y]DOTA-OC",GuideToPharmacology,1,agonist
GRIN1,STING AGONIST 2,GuideToPharmacology,1,agonist
FEN1,AMLEXANOX,GuideToPharmacology,1,inhibitor
TEC,COMPOUND 9 [PMID: 26006010],GuideToPharmacology,1,inhibitor
GCGR,RALTITREXED,GuideToPharmacology,1,inhibitor
THRB,RESMETIROM,GuideToPharmacology,1,agonist
TLR2,COMPOUND 13 [PMID: 23098072],GuideToPharmacology,1,agonist
APOC4,EP 171,GuideToPharmacology,1,agonist
APOC4,DINOPROSTONE,GuideToPharmacology,1,agonist
APOC4,VAPIPROST,GuideToPharmacology,1,inhibitor
APOC4,[125I]SQ-29548,GuideToPharmacology,1,inhibitor
DNMT3A,BIX02189,GuideToPharmacology,1,inhibitor
ATP1B1P1,OLEOCANTHAL,GuideToPharmacology,1,activator
ATP2A2,SH045,GuideToPharmacology,1,blocker
ATP2A2,OAG,GuideToPharmacology,1,activator
ATP1B1P1,URB597,GuideToPharmacology,1,activator
ATP3,ARACHIDONIC ACID,GuideToPharmacology,1,activator
ATP4B,LBA,GuideToPharmacology,1,blocker
ATP4B,DECAVANADATE,GuideToPharmacology,1,activator
ATP4A,PENTAFLUORO-TRITYL CLOTRIMAZOLE ANALOGUE 29A,GuideToPharmacology,1,activator
PKD2L1,MALIC ACID,GuideToPharmacology,1,activator
TRPV4,LA3+,GuideToPharmacology,1,blocker
TYK2,COMPOUND 25AP [PMID: 37796543],GuideToPharmacology,1,inhibitor
TYK2,BMS-911543,GuideToPharmacology,1,inhibitor
BCL7A,CALCITRIOL,GuideToPharmacology,1,agonist
GCK,WARFARIN,GuideToPharmacology,1,inhibitor
ARCN2,RO 25-1553,GuideToPharmacology,1,agonist
ARCN1,[125I]BAY 55-9837,GuideToPharmacology,1,agonist
AQP9,ARGIPRESSIN,GuideToPharmacology,1,agonist
AQP9,"[THR4,GLY7]OT",GuideToPharmacology,1,agonist
AQP9,OPC-21268,GuideToPharmacology,1,inhibitor
AR,D[LEU4]AVP,GuideToPharmacology,1,agonist
AR,"D(CH2)5[TYR(ET)2,VAL4,DES-GLY9]AVP",GuideToPharmacology,1,inhibitor
ABCC6,ATOSIBAN,GuideToPharmacology,1,inhibitor
ABCC6,"D(CH2)5[D-ILE2,ILE4,TYR-NH29]AVP",GuideToPharmacology,1,inhibitor
AR,"[PHAA1,D-TYR(ET)2,LYS6,DES-GLY9]AVP",GuideToPharmacology,1,inhibitor
ABCC6,"D(CH2)5[D-ILE2,ILE4,ALA-NH2]AVP",GuideToPharmacology,1,inhibitor
ABCC6,"[125I]D(CH2)5[D-TYR(ET)2,ILE4,TYR-NH29]AVP",GuideToPharmacology,1,inhibitor
ACTG1P3,XCL2,GuideToPharmacology,1,agonist
ABCC6,"[PHAA1,D-TYR(ET)2,LYS6,DES-GLY9]AVP",GuideToPharmacology,1,inhibitor
GNG10,GDC-0152,GuideToPharmacology,1,inhibitor
FKBP1AP3,ECF506,GuideToPharmacology,1,inhibitor
ANXA2P3,NPY,GuideToPharmacology,1,agonist
BCAT2,CU2+,GuideToPharmacology,1,agonist
BCAT2,CA2+,GuideToPharmacology,1,inhibitor
ABR,CARVEDILOL,GuideToPharmacology,1,inhibitor
BDKRB1,DAIDZEIN,GuideToPharmacology,1,agonist
DPYD,GR-389988,GuideToPharmacology,1,inhibitor
ERPL1,COMPOUND 17D [PMID: 23099093],GuideToPharmacology,1,inhibitor
APOC4,TERUTROBAN,GuideToPharmacology,1,inhibitor
C8B,OCTANOL,GuideToPharmacology,1,inhibitor
AMELY,[125I]KISSPEPTIN-14 (HUMAN),GuideToPharmacology,1,agonist
CRHR2,SC-22716,GuideToPharmacology,1,inhibitor
SLC25A5,VU0001171,GuideToPharmacology,1,modulator
PRDM1,COMPOUND 2C [PMID: 2153213],GuideToPharmacology,1,inhibitor
FOLR3,PETESICATIB,GuideToPharmacology,1,inhibitor
ATP2B1,CA2+,GuideToPharmacology,1,activator
GPR12,TULMIMETOSTAT,GuideToPharmacology,1,inhibitor
APBA1,COMPOUND 24 [PMID: 16451050],GuideToPharmacology,1,inhibitor
AMY2B,MELANIN-CONCENTRATING HORMONE,GuideToPharmacology,1,agonist
ACHE,[125I]CT (SALMON),GuideToPharmacology,1,agonist
ALOX12P2,SNAP 37889,GuideToPharmacology,1,inhibitor
GATM,OBINUTUZUMAB,GuideToPharmacology,1,antibody
GRIA3,GYKI53655,GuideToPharmacology,1,inhibitor
ARCN1,RO 25-1553,GuideToPharmacology,1,agonist
A12M4,NORFENFLURAMINE,GuideToPharmacology,1,agonist
CCKBR,CI-988,GuideToPharmacology,1,inhibitor
TRPM8,ELISMETREP,GuideToPharmacology,1,inhibitor
EEF1D,N-(5-METHYL-1H-PYRAZOL-3-YL)-2-PHENYLQUINAZOLIN-4-AMINE,GuideToPharmacology,1,inhibitor
CNN1,A-908292,GuideToPharmacology,1,inhibitor
ETFB,PQR620,GuideToPharmacology,1,inhibitor
OPN1MW,A-366,GuideToPharmacology,1,inhibitor
GNGT1,XEVINAPANT,GuideToPharmacology,1,inhibitor
ADH1C,COMPOUND 2 [PMID: 21939274],GuideToPharmacology,1,agonist
KCNT1,NICLOSAMIDE,GuideToPharmacology,1,activator
GRK6P1,MJN228,GuideToPharmacology,1,inhibitor
ARF5,GW542573X,GuideToPharmacology,1,activator
F7,PF-06843195,GuideToPharmacology,1,inhibitor
DPP6,FLUMBATINIB,GuideToPharmacology,1,inhibitor
AMY2A,VPC03090-P,GuideToPharmacology,1,agonist
TYK2,DEUCRAVACITINIB,GuideToPharmacology,1,modulator
ACTBP2,[125I]CCL8 (HUMAN),GuideToPharmacology,1,agonist
ARCN1,[ARG16]CHICKEN SECRETIN,GuideToPharmacology,1,agonist
AR,[3H]D[CHA4]AVP,GuideToPharmacology,1,agonist
NATP,[3H]LSD,GuideToPharmacology,1,agonist
EIF4EBP1,INIXACICLIB,GuideToPharmacology,1,inhibitor
EFNB2,COMPOUND 4G [PMID: 30893553],GuideToPharmacology,1,inhibitor
ACTN2,UDP-GLUCOSE,GuideToPharmacology,1,agonist
BPGM,BETA-GENTIOBIOSE,GuideToPharmacology,1,agonist
DRD5P1,MILCICLIB,GuideToPharmacology,1,inhibitor
C1S,CA2+,GuideToPharmacology,1,inhibitor
ANK3,(HYDROXYMETHYLPHENYL)AGOMELATINE,GuideToPharmacology,1,inhibitor
TYK2,BARICITINIB,GuideToPharmacology,1,inhibitor
KLK3,HINSL5: A8-21 (T9R),GuideToPharmacology,1,agonist
AQP2,PASIREOTIDE,GuideToPharmacology,1,agonist
APOC4,DOMITROBAN,GuideToPharmacology,1,inhibitor
APOBEC1,DINOPROSTONE,GuideToPharmacology,1,agonist
ATF4,METHYLLYCACONITINE,GuideToPharmacology,1,inhibitor
APBA1,SB 612111,GuideToPharmacology,1,inhibitor
ACRV1,SCH.336,GuideToPharmacology,1,agonist
ANXA13,MK 1903,GuideToPharmacology,1,agonist
TNFRSF17,BI6015,GuideToPharmacology,1,inhibitor
ANTP4,ERYTHROMYCIN,GuideToPharmacology,1,agonist
ASS1P2,GYKI53655,GuideToPharmacology,1,inhibitor
SIGMAR1,(RS)-PPCC,GuideToPharmacology,1,agonist
AR,"D[PEN1,TYR(ME)2]AVP",GuideToPharmacology,1,inhibitor
ASIC2,BAG-1,GuideToPharmacology,1,agonist
HTR2C,LYSERGIDE,GuideToPharmacology,1,agonist
ASS1P10,[3H]L689560,GuideToPharmacology,1,inhibitor
BAAT,DOFETILIDE,GuideToPharmacology,1,blocker
ARHGAP5,DEQUALINIUM,GuideToPharmacology,1,blocker
ALDH3A1,(+)-BUTACLAMOL,GuideToPharmacology,1,inhibitor
AR,"D(CH2)5[TYR(ME)2,THR4,PHE(3I,4N3)-NH29]OVT",GuideToPharmacology,1,inhibitor
ESR1,COMPOUND 17D [PMID: 23099093],GuideToPharmacology,1,inhibitor
BIRC3,URIDINE-5'-DIPHOSPHATE,GuideToPharmacology,1,agonist
SERPINA3,SB 207710,GuideToPharmacology,1,inhibitor
BCHE,BMS-189532,GuideToPharmacology,1,inhibitor
RPS6KA6,BAY-985,GuideToPharmacology,1,inhibitor
FECH,AMG28,GuideToPharmacology,1,inhibitor
ABCA1,CAFFEINE,GuideToPharmacology,1,inhibitor
CDK4,RGB-286638,GuideToPharmacology,1,inhibitor
ALDH3A1,LISURIDE,GuideToPharmacology,1,agonist
GAPDHL17,BML-281,GuideToPharmacology,1,inhibitor
FOXL2,ARISTOLOCHIC ACID,GuideToPharmacology,1,agonist
AMPH,H2L5186303,GuideToPharmacology,1,inhibitor
UTS2R,PALOSURAN,GuideToPharmacology,1,inhibitor
GPC3,COMPOUND 57 [PMID: 26155854],GuideToPharmacology,1,inhibitor
ACADS,PD123319,GuideToPharmacology,1,inhibitor
ALOX12,PATIDEGIB,GuideToPharmacology,1,inhibitor
ATP2B3,SAR7334,GuideToPharmacology,1,blocker
ACTA2,CCL8,GuideToPharmacology,1,agonist
FRA1D,PCI-27483,GuideToPharmacology,1,inhibitor
DPEP1,DOVITINIB,GuideToPharmacology,1,inhibitor
PDE5A,SILDENAFIL,GuideToPharmacology,1,inhibitor
ABCA1,PSB603,GuideToPharmacology,1,inhibitor
A2M,SB 714786,GuideToPharmacology,1,inhibitor
CSTP1,MK-2206,GuideToPharmacology,1,modulator
EFNA2,LUT014,GuideToPharmacology,1,inhibitor
NR2F6,REFAMETINIB,GuideToPharmacology,1,modulator
APRT,INSL5,GuideToPharmacology,1,inhibitor
2-Feb,AMG28,GuideToPharmacology,1,inhibitor
ALDH7A1,SF-22,GuideToPharmacology,1,activator
ATP2B1,HC-070,GuideToPharmacology,1,blocker
CFTR,NIMODIPINE,GuideToPharmacology,1,activator
AADAC,ML381,GuideToPharmacology,1,inhibitor
EPHB1,COMPOUND 30 [PMID: 37057760],GuideToPharmacology,1,inhibitor
PIK3CB,PF-06843195,GuideToPharmacology,1,inhibitor
ADAM10,2-OLEOYL-LPA,GuideToPharmacology,1,agonist
ADRA2A,AR234958,GuideToPharmacology,1,agonist
COL12A1,PDE4 INHIBITOR 16,GuideToPharmacology,1,inhibitor
ABCD1,[3H]NEMONAPRIDE,GuideToPharmacology,1,inhibitor
A2M,[3H]8-OH-DPAT,GuideToPharmacology,1,agonist
A2M,TFMPP,GuideToPharmacology,1,agonist
A12M2,5-MEO-DMT,GuideToPharmacology,1,agonist
A12M1,METITEPINE,GuideToPharmacology,1,inhibitor
A12M2,5-MEOT,GuideToPharmacology,1,agonist
A12M3,LYSERGIDE,GuideToPharmacology,1,agonist
A12M3,(R)-DOI,GuideToPharmacology,1,agonist
A12M3,BUFOTENINE,GuideToPharmacology,1,inhibitor
A12M3,TFMPP,GuideToPharmacology,1,agonist
A12M3,HALOPERIDOL DECANOATE,GuideToPharmacology,1,inhibitor
A12M4,PINDOLOL,GuideToPharmacology,1,agonist
A12M4,PINDOLOL,GuideToPharmacology,1,inhibitor
A12M4,PERGOLIDE,GuideToPharmacology,1,agonist
A12M4,S 16924,GuideToPharmacology,1,agonist
A12M4,LYSERGIDE,GuideToPharmacology,1,agonist
NATP,LYSERGIDE,GuideToPharmacology,1,agonist
NAT2,YOHIMBINE,GuideToPharmacology,1,inhibitor
NATP,5-MEOT,GuideToPharmacology,1,agonist
NATP,TFMPP,GuideToPharmacology,1,agonist
NATP,SUMATRIPTAN,GuideToPharmacology,1,inhibitor
ABL1,BO1,GuideToPharmacology,1,inhibitor
ABL2,COMPOUND 24 [PMID: 23441572],GuideToPharmacology,1,inhibitor
DNM2,"COMPOUND 7 [NGUYEN ET AL., 2023]",GuideToPharmacology,1,inhibitor
HBEGF,COMPOUND 17 [PMID: 34176264],GuideToPharmacology,1,inhibitor
HBEGF,BELIZATINIB,GuideToPharmacology,1,inhibitor
HBEGF,NVP-TAE684,GuideToPharmacology,1,inhibitor
GAPDHP69,MIGLITOL,GuideToPharmacology,1,inhibitor
ABCF1,TAMSULOSIN HYDROCHLORIDE,GuideToPharmacology,1,inhibitor
ABCA4,A-119637,GuideToPharmacology,1,inhibitor
ABCA4,PHENTOLAMINE,GuideToPharmacology,1,inhibitor
ABL1,[3H]RAUWOLSCINE,GuideToPharmacology,1,inhibitor
AOC1,PHENTOLAMINE,GuideToPharmacology,1,inhibitor
BEVI,MIBOLERONE,GuideToPharmacology,1,agonist
DAPK3,LISINOPRIL-TRYPTOPHAN,GuideToPharmacology,1,inhibitor
ACADSB,COMPOUND 15A,GuideToPharmacology,1,agonist
ABAT,MRE 3008F20,GuideToPharmacology,1,inhibitor
ABAT,LAS38096,GuideToPharmacology,1,inhibitor
ABCA1,DERENOFYLLINE,GuideToPharmacology,1,inhibitor
ABCA1,FLAVONE,GuideToPharmacology,1,inhibitor
ABCA1,CGS 24012,GuideToPharmacology,1,agonist
ABCA3,MRS1186,GuideToPharmacology,1,inhibitor
ABCA3,MRS1097,GuideToPharmacology,1,inhibitor
ABCA3,PRELADENANT,GuideToPharmacology,1,inhibitor
EEF1B2P2,A011,GuideToPharmacology,1,inhibitor
ACADS,OLODANRIGAN,GuideToPharmacology,1,inhibitor
ACAT1,GASTRIN RELEASING PEPTIDE(14-27) (HUMAN),GuideToPharmacology,1,agonist
HLA-DRB5,MEPLAZUMAB,GuideToPharmacology,1,antibody
ACAT1,RANATENSIN,GuideToPharmacology,1,agonist
FMOD,EXAMPLE 20 [WO2010128058],GuideToPharmacology,1,inhibitor
EEGV1,COMPOUND 9 [PMID: 26006010],GuideToPharmacology,1,inhibitor
ACAA1,CARVEDILOL,GuideToPharmacology,1,inhibitor
EEGV1,ECF506,GuideToPharmacology,1,inhibitor
BMP1,COMPOUND 2 [PMID: 11934595],GuideToPharmacology,1,inhibitor
DNMT1,LDN-214117,GuideToPharmacology,1,inhibitor
BMP2K,COMPOUND 5M [PMID: 20483621],GuideToPharmacology,1,inhibitor
EFNA3,APABETALONE,GuideToPharmacology,1,inhibitor
BRD3,LY-294002,GuideToPharmacology,1,inhibitor
EFNA4,APABETALONE,GuideToPharmacology,1,inhibitor
EFNA3,ET BROMODOMAIN INHIBITOR,GuideToPharmacology,1,inhibitor
EFNA4,DBET6,GuideToPharmacology,1,inhibitor
EFNA4,GSK852,GuideToPharmacology,1,inhibitor
EFNB2,ABIVERTINIB,GuideToPharmacology,1,inhibitor
EFNB2,PIRTOBRUTINIB,GuideToPharmacology,1,inhibitor
EFNB2,COMPOUND 9 [PMID: 26006010],GuideToPharmacology,1,inhibitor
BDKRB2,JMV1116,GuideToPharmacology,1,agonist
BDKRB2,KALLIDIN,GuideToPharmacology,1,agonist
ASIC1,KALLIDIN,GuideToPharmacology,1,agonist
ACACA,COMPOUND 17 [PMID: 24257095],GuideToPharmacology,1,agonist
BDKRB2,JMV1431,GuideToPharmacology,1,inhibitor
BDKRB2,"[PHE8,&PSI;(CH2-NH)ARG9]BK",GuideToPharmacology,1,agonist
CAPN1,CALPEPTIN,GuideToPharmacology,1,inhibitor
ACADL,C5APEP,GuideToPharmacology,1,agonist
CAPN1,UAWJ9-36-3,GuideToPharmacology,1,inhibitor
DBI,AC-VEID-CHO,GuideToPharmacology,1,inhibitor
ATP6V1C1,NIMODIPINE,GuideToPharmacology,1,inhibitor
CACNA1D,BAYK 8644,GuideToPharmacology,1,activator
ATP6AP1,PIMOZIDE,GuideToPharmacology,1,blocker
RHOB,HC-056456,GuideToPharmacology,1,blocker
RHOC,DINOPROSTONE,GuideToPharmacology,1,activator
ACRV1,BMS-202,GuideToPharmacology,1,agonist
ACRV1,HU-210,GuideToPharmacology,1,agonist
ACTBP7,CCL27,GuideToPharmacology,1,agonist
ACTA1,BMS-817399,GuideToPharmacology,1,inhibitor
ACTB,CCL28,GuideToPharmacology,1,agonist
ACTB,[125I]CCL11 (HUMAN),GuideToPharmacology,1,inhibitor
CFTR,FELODIPINE,GuideToPharmacology,1,activator
CPT2,GW406381,GuideToPharmacology,1,inhibitor
C3,OCTANOL,GuideToPharmacology,1,inhibitor
C4A,FLUFENAMIC ACID,GuideToPharmacology,1,inhibitor
C4BPB,OCTANOL,GuideToPharmacology,1,inhibitor
C4BPAP2,OCTANOL,GuideToPharmacology,1,inhibitor
C1S,OCTANOL,GuideToPharmacology,1,inhibitor
C8G,FLUFENAMIC ACID,GuideToPharmacology,1,inhibitor
ACTG1,ISOTHIOUREA-1T,GuideToPharmacology,1,inhibitor
EGR4,QR-6401,GuideToPharmacology,1,inhibitor
EIF4A1,SAMURACICLIB,GuideToPharmacology,1,inhibitor
EIF4A1,BX-795,GuideToPharmacology,1,inhibitor
EIF4A1,EBVACICLIB,GuideToPharmacology,1,inhibitor
CDK4,DALPICICLIB,GuideToPharmacology,1,inhibitor
CDK4,TRILACICLIB,GuideToPharmacology,1,inhibitor
EIF4E,CDK1/5 INHIBITOR,GuideToPharmacology,1,inhibitor
EIF4EBP1,EBVACICLIB,GuideToPharmacology,1,inhibitor
EIF4E,TANUXICICLIB,GuideToPharmacology,1,inhibitor
EIF4G1,AT-7519,GuideToPharmacology,1,inhibitor
EIF4EP1,JH-XI-10-02,GuideToPharmacology,1,inhibitor
EIF4G1,MILCICLIB,GuideToPharmacology,1,inhibitor
EIF4G1,TRILACICLIB,GuideToPharmacology,1,inhibitor
EIF4G1,SAMURACICLIB,GuideToPharmacology,1,inhibitor
AMPD1,LTD4,GuideToPharmacology,1,agonist
GLRB,TREMELIMUMAB,GuideToPharmacology,1,antibody
CSHL1,AMINOOXYACETIC ACID,GuideToPharmacology,1,inhibitor
AMPD1,LTD4,GuideToPharmacology,1,agonist
CD8B2,TOLUDESVENLAFAXINE,GuideToPharmacology,1,inhibitor
APAF1,[3H][D-ALA2]DELTORPHIN I,GuideToPharmacology,1,agonist
APAF1,&BETA;-ENDORPHIN,GuideToPharmacology,1,agonist
APAF1,DYNORPHIN A,GuideToPharmacology,1,agonist
APAF1,DPDPE,GuideToPharmacology,1,agonist
APAF1,DYNORPHIN-(1-11),GuideToPharmacology,1,agonist
APAF1,ALVIMOPAN ANHYDROUS,GuideToPharmacology,1,inhibitor
FPGS,TENELIGLIPTIN,GuideToPharmacology,1,inhibitor
FPR1,VILDAGLIPTIN,GuideToPharmacology,1,inhibitor
ABCD1,FLUPHENAZINE HYDROCHLORIDE,GuideToPharmacology,1,inhibitor
ABCD1,PIMOZIDE,GuideToPharmacology,1,inhibitor
ABCD1,"L-741,626",GuideToPharmacology,1,inhibitor
ABCD1,PROMAZINE,GuideToPharmacology,1,inhibitor
ALDH1A1,MESORIDAZINE,GuideToPharmacology,1,inhibitor
ALDH1A1,(+)-BUTACLAMOL,GuideToPharmacology,1,inhibitor
ALDH2,(+)-BUTACLAMOL,GuideToPharmacology,1,inhibitor
ALDH3A1,ECOPIPAM HYDROCHLORIDE,GuideToPharmacology,1,inhibitor
FRZB,AZ14117230,GuideToPharmacology,1,inhibitor
CYP2D7BP,COMPOUND 2G [PMID: 27390066],GuideToPharmacology,1,inhibitor
EZH2,EI1,GuideToPharmacology,1,inhibitor
DXO,SAPITINIB,GuideToPharmacology,1,inhibitor
DXO,ORANTINIB,GuideToPharmacology,1,inhibitor
CRMP1,PF750,GuideToPharmacology,1,inhibitor
CRP,JNJ1661010,GuideToPharmacology,1,inhibitor
ABCD2,DOCONEXENT,GuideToPharmacology,1,agonist
DPYSL2,COMPOUND 7R [PMID: 26080733],GuideToPharmacology,1,inhibitor
DR1,"COMPOUND 7 [NGUYEN ET AL., 2023]",GuideToPharmacology,1,inhibitor
DPYSL3,FUTIBATINIB,GuideToPharmacology,1,inhibitor
DPYS,"COMPOUND 6LI [CHAN ET AL., 2022]",GuideToPharmacology,1,inhibitor
DPYS,DOVITINIB,GuideToPharmacology,1,inhibitor
DRD3,CATEQUENTINIB,GuideToPharmacology,1,inhibitor
DPYS,RGB-286638,GuideToPharmacology,1,inhibitor
DPYS,LESTAURTINIB,GuideToPharmacology,1,inhibitor
DRD3,FRUQUINTINIB,GuideToPharmacology,1,inhibitor
DRD3,VATALANIB,GuideToPharmacology,1,inhibitor
ALDH9A1,SCK&BETA;8-1,GuideToPharmacology,1,agonist
ALDH9A1,UPAR FRAGMENT,GuideToPharmacology,1,agonist
ALDH9A1,COMPOUND R-(-)-5F [PMID: 22607879],GuideToPharmacology,1,agonist
ALDH9A1,HP(2-20),GuideToPharmacology,1,agonist
ALDH3A2,F2L-[125I]TYR,GuideToPharmacology,1,agonist
APOC2,BAY-6672,GuideToPharmacology,1,inhibitor
ENO2,COMPOUND 25 [PMID: 31260299],GuideToPharmacology,1,inhibitor
ENO2,ECF506,GuideToPharmacology,1,inhibitor
ALOX12P1,"2,3-DIHYDRO-1,4-DITHIIN-1,1,4,4-TETROXIDE",GuideToPharmacology,1,inhibitor
ALOX12P1,M15,GuideToPharmacology,1,inhibitor
GALR2,GALANIN(5-29) (RAT/MOUSE),GuideToPharmacology,1,agonist
GALR2,M15,GuideToPharmacology,1,inhibitor
ALOX12P2,J18 (GALANIN ANALOGUE),GuideToPharmacology,1,agonist
CXCR5,"(1-HYDROXY-1-PHOSPHONO-2-[1,1';4',1'']TERPHENYL-3-YL-ETHYL)-PHOSPHONIC ACID",GuideToPharmacology,1,inhibitor
CD14,TIAGABINE HYDROCHLORIDE,GuideToPharmacology,1,inhibitor
BDM,FLUOCINOLONE ACETONIDE,GuideToPharmacology,1,agonist
GRIN2B,PHENCYCLIDINE,GuideToPharmacology,1,blocker
CD24P2,ORG 25543,GuideToPharmacology,1,inhibitor
GNRHR,GNRH III,GuideToPharmacology,1,agonist
GNRHR,LINZAGOLIX,GuideToPharmacology,1,inhibitor
GNRHR,"[AC-D-2NAL1,D4CPA2,D-3PAL3,6,LEU8, D-ALA10]GNRH-II",GuideToPharmacology,1,inhibitor
GNRHR,MERIGOLIX,GuideToPharmacology,1,inhibitor
CST3,BALANOL,GuideToPharmacology,1,inhibitor
FRA1J,COMPOUND 20 [PMID:12127536],GuideToPharmacology,1,inhibitor
DLX4,CENDERITIDE,GuideToPharmacology,1,agonist
ANXA13,COMPOUND 21 [PMID: 21185185],GuideToPharmacology,1,agonist
GDF2,CITARINOSTAT,GuideToPharmacology,1,inhibitor
GARS1,CITARINOSTAT,GuideToPharmacology,1,inhibitor
GAPDHP1,CITARINOSTAT,GuideToPharmacology,1,inhibitor
GART,CITARINOSTAT,GuideToPharmacology,1,inhibitor
GART,COMPOUND 35M [PMID: 36073117],GuideToPharmacology,1,inhibitor
GART,KA2507,GuideToPharmacology,1,inhibitor
GAS2,ENTINOSTAT,GuideToPharmacology,1,inhibitor
GAS1,RICOLINOSTAT,GuideToPharmacology,1,inhibitor
AMD1,ARPROMIDINE,GuideToPharmacology,1,inhibitor
AMD1,MK-0249,GuideToPharmacology,1,inhibitor
AMD1,HALOPERIDOL DECANOATE,GuideToPharmacology,1,inhibitor
AMD1,IMPROMIDINE,GuideToPharmacology,1,inhibitor
AMD1,FLUPHENAZINE HYDROCHLORIDE,GuideToPharmacology,1,inhibitor
AMD1P2,ABT-239,GuideToPharmacology,1,inhibitor
HRH3,N-[3H]METHYLHISTAMINE,GuideToPharmacology,1,agonist
HRH3,IMBUTAMINE,GuideToPharmacology,1,agonist
HRH3,DIMAPRIT,GuideToPharmacology,1,agonist
HRH3,A-304121,GuideToPharmacology,1,inhibitor
HRH3,ABT-239,GuideToPharmacology,1,inhibitor
HRH3,VUF14738,GuideToPharmacology,1,inhibitor
HRH3,IODOPHENPROPIT,GuideToPharmacology,1,inhibitor
HRH3,THIOPERAMIDE,GuideToPharmacology,1,inhibitor
PRDM1,COMPOUND 18 [PMID: 8426367],GuideToPharmacology,1,inhibitor
PRDM1,LOVASTATIN,GuideToPharmacology,1,inhibitor
ADCY3,CID1172084,GuideToPharmacology,1,agonist
ADCY3,"CP55,667",GuideToPharmacology,1,inhibitor
IDO2,EXAMPLE 184 [WO2014186035],GuideToPharmacology,1,inhibitor
GATA2,THIOGUANINE,GuideToPharmacology,1,inhibitor
STOM,COMPOUND II [PMID: 21329883],GuideToPharmacology,1,inhibitor
STOM,COMPOUND 17D [PMID: 23099093],GuideToPharmacology,1,inhibitor
DMTN,IKK-2 INHIBITOR IV,GuideToPharmacology,1,inhibitor
EPHB3,COMPOUND 13AC [PMID: 33256400],GuideToPharmacology,1,inhibitor
NUDT2,PENTAZOCINE,GuideToPharmacology,1,agonist
NUDT2,&BETA;-ENDORPHIN,GuideToPharmacology,1,agonist
DPT,FLUMBATINIB,GuideToPharmacology,1,inhibitor
DPT,RISVODETINIB,GuideToPharmacology,1,inhibitor
GPM6B,DIVARASIB,GuideToPharmacology,1,inhibitor
ATP5ME,DOCONEXENT,GuideToPharmacology,1,activator
ATP6V1B2,NITRIC OXIDE,GuideToPharmacology,1,activator
ARF4P1,NS1643,GuideToPharmacology,1,activator
BAD,ROTTLERIN,GuideToPharmacology,1,activator
AZF1,PYRITHIONE ZINC,GuideToPharmacology,1,activator
GPR6,UNC1215,GuideToPharmacology,1,agonist
CTSV,LESTAURTINIB,GuideToPharmacology,1,inhibitor
KCNQ5,PYRITHIONE ZINC,GuideToPharmacology,1,activator
FRA10D,COMPOUND 4 [PMID: 22533316],GuideToPharmacology,1,inhibitor
EPHX2,COMPOUND 2 [PMID: 15546730],GuideToPharmacology,1,inhibitor
CNTFR,BENSERAZIDE,GuideToPharmacology,1,inhibitor
AMPD3,ALKYL OMPT,GuideToPharmacology,1,agonist
BCL3,PAXILLINE,GuideToPharmacology,1,agonist
BCL3,L-783483,GuideToPharmacology,1,agonist
BAK1P2,IMB-808,GuideToPharmacology,1,agonist
BIN1,OMPT,GuideToPharmacology,1,agonist
BIN1,&ALPHA;-FLUOROMETHYLENEPHOSPHONATE,GuideToPharmacology,1,agonist
MKNK2,TINODASERTIB,GuideToPharmacology,1,inhibitor
AMY2B,ATC0065,GuideToPharmacology,1,inhibitor
AMYP1,MELANIN-CONCENTRATING HORMONE,GuideToPharmacology,1,agonist
ANGPT1,PG-106,GuideToPharmacology,1,inhibitor
BLK,GERANYLGERANYL DIPHOSPHATE,GuideToPharmacology,1,inhibitor
ANPEP,EGLUMEGAD,GuideToPharmacology,1,agonist
ANPEP,"(2R,3R)-APDC",GuideToPharmacology,1,agonist
ANOP1,[18F]FITM,GuideToPharmacology,1,modulator
ANOP1,[18F]MK-1312,GuideToPharmacology,1,modulator
CTNS,RGB-286638,GuideToPharmacology,1,inhibitor
MAP2K1,REFAMETINIB,GuideToPharmacology,1,modulator
AADAC,LY593093,GuideToPharmacology,1,agonist
AADAC,BODIPY-PIRENZEPINE,GuideToPharmacology,1,inhibitor
AADAC,CY3B-TELENZEPINE,GuideToPharmacology,1,inhibitor
AADAC,PROPANTHELINE,GuideToPharmacology,1,inhibitor
AAMP,UH-AH 37,GuideToPharmacology,1,inhibitor
AANAT,LITHOCHOLYLCHOLINE,GuideToPharmacology,1,inhibitor
AANAT,VINBURNINE,GuideToPharmacology,1,modulator
AANAT,STRYCHNINE,GuideToPharmacology,1,modulator
AANAT,PIRENZEPINE,GuideToPharmacology,1,inhibitor
AARS1,HEXAHYDRODIFENIDOL,GuideToPharmacology,1,inhibitor
AARS1,(S)-DIMETINDENE,GuideToPharmacology,1,inhibitor
ANK3,UCM1341,GuideToPharmacology,1,agonist
APOF,BILORPHIN,GuideToPharmacology,1,agonist
APOF,ETHYLKETOCYCLAZOCINE,GuideToPharmacology,1,agonist
GAS8-AS1,CO2+,GuideToPharmacology,1,blocker
BBS1,LIDOCAINE,GuideToPharmacology,1,blocker
ATF4,A-582941,GuideToPharmacology,1,agonist
ATF3,HEXAMETHONIUM,GuideToPharmacology,1,blocker
AQP4,OSANETANT,GuideToPharmacology,1,inhibitor
AQP4,IBODUTANT,GuideToPharmacology,1,inhibitor
AQP5,NEUROKININ B,GuideToPharmacology,1,agonist
AQP5,SUBSTANCE P,GuideToPharmacology,1,agonist
AQP5,PD 161182,GuideToPharmacology,1,inhibitor
NMUR1,NEUROMEDIN S-33,GuideToPharmacology,1,agonist
ANXA2,RTI-118,GuideToPharmacology,1,inhibitor
ANXA1,Y-RFRP-3,GuideToPharmacology,1,agonist
NUAK1,COMPOUND 25B [PMID: 22564207],GuideToPharmacology,1,inhibitor
NUAK1,WZ4002,GuideToPharmacology,1,inhibitor
HMG1P,NUDT7-COV-1,GuideToPharmacology,1,inhibitor
SLCO1C1,DPDPE,GuideToPharmacology,1,inhibitor
SLCO1B3,CYCLOSPORINE,GuideToPharmacology,1,inhibitor
SLCO1B3,GEMFIBROZIL,GuideToPharmacology,1,inhibitor
ARAF,D[LEU4]AVP,GuideToPharmacology,1,agonist
CDK6,DISPROCYNIUM24,GuideToPharmacology,1,inhibitor
ARAF,OPC-21268,GuideToPharmacology,1,inhibitor
APBB2,MRS2365,GuideToPharmacology,1,agonist
APBB2,DATP&ALPHA;S,GuideToPharmacology,1,agonist
CCND1,REGLITAZAR,GuideToPharmacology,1,agonist
CCND1,NTZDPA,GuideToPharmacology,1,agonist
CCND1,LY-465608,GuideToPharmacology,1,agonist
CCND1,L-783483,GuideToPharmacology,1,agonist
F5,ALPELISIB,GuideToPharmacology,1,inhibitor
F3,PQR620,GuideToPharmacology,1,inhibitor
F5,PILARALISIB,GuideToPharmacology,1,inhibitor
F5,PIK-75,GuideToPharmacology,1,inhibitor
F5,FIMEPINOSTAT,GuideToPharmacology,1,inhibitor
F5,GSK1059615,GuideToPharmacology,1,inhibitor
PIK3CB,COMPOUND 15A [PMID: 32069401],GuideToPharmacology,1,inhibitor
F5,ZSTK474,GuideToPharmacology,1,inhibitor
PIK3CB,AZD8154,GuideToPharmacology,1,inhibitor
PIK3CB,TASELISIB,GuideToPharmacology,1,inhibitor
COL9A1,PF-05180999,GuideToPharmacology,1,inhibitor
HOXA11,COMPOUND 3 [PMID: 26055709],GuideToPharmacology,1,inhibitor
PDE5A,UDENAFIL,GuideToPharmacology,1,inhibitor
PDE5A,NITROSOPRODENAFIL,GuideToPharmacology,1,inhibitor
COL15A1,SCH51866,GuideToPharmacology,1,inhibitor
F10,COMPOUND 14K [PMID: 21982499],GuideToPharmacology,1,inhibitor
GNAI2,MC2050,GuideToPharmacology,1,inhibitor
GNAI2P1,COMPOUND 10B [PMID: 26222319],GuideToPharmacology,1,inhibitor
BDNF,19-Apr,GuideToPharmacology,1,inhibitor
NBEAP1,"5&BETA;-PREGNANE-3,20-DIONE",GuideToPharmacology,1,agonist
NBEAP1,3-KETO-LITHOCHOLIC ACID,GuideToPharmacology,1,agonist
HMBS,WNT-974,GuideToPharmacology,1,inhibitor
XIAP,[HIS5]PTH-(1-34) (HUMAN),GuideToPharmacology,1,agonist
XIAP,PTHRP-(1-36),GuideToPharmacology,1,agonist
XIAP,"[ILE5,TRP23]PTHRP-(1-36) (HUMAN)",GuideToPharmacology,1,agonist
XIAP,ABALOPARATIDE,GuideToPharmacology,1,agonist
BIRC5,[HIS5]PTH-(1-34) (HUMAN),GuideToPharmacology,1,agonist
C9,FLUFENAMIC ACID,GuideToPharmacology,1,inhibitor
PANX2,FLUFENAMIC ACID,GuideToPharmacology,1,inhibitor
GRM5,VER-246608,GuideToPharmacology,1,inhibitor
BCL2L1,CHOLESTEROL SULPHATE,GuideToPharmacology,1,agonist
BAK1P1,CINTIRORGON,GuideToPharmacology,1,agonist
CYB5P1,COMPOUND 25B [PMID: 22564207],GuideToPharmacology,1,inhibitor
APP,NANOLUCIFERASE-LABELLED RELAXIN,GuideToPharmacology,1,agonist
CXADR,GLXC-26326,GuideToPharmacology,1,inhibitor
APPL1,A(C10/15S)INSL3,GuideToPharmacology,1,inhibitor
APPL1,INSL3 B-CHAIN ANALOGUE,GuideToPharmacology,1,inhibitor
AMT,ICANBELIMOD,GuideToPharmacology,1,agonist
AMY1C,VPC03090-P,GuideToPharmacology,1,agonist
AMY1B,VPC12249,GuideToPharmacology,1,agonist
HOXB3,YTK-2205,GuideToPharmacology,1,agonist
AMY2A,AUY954,GuideToPharmacology,1,agonist
H3-3A,SPRI3,GuideToPharmacology,1,inhibitor
AMY2A,COMPOUND 26 [PMID: 16190743],GuideToPharmacology,1,agonist
SEMA4D,PEPINEMAB,GuideToPharmacology,1,antibody
SELP,CRIZANLIZUMAB,GuideToPharmacology,1,antibody
GKP4,AZ505,GuideToPharmacology,1,inhibitor
CD3E,LICOGLIFLOZIN,GuideToPharmacology,1,inhibitor
CD3D,IPRAGLIFLOZIN,GuideToPharmacology,1,inhibitor
CARS1,ACETYLDIGITOXIN,GuideToPharmacology,1,inhibitor
CD3D,REMOGLIFLOZIN,GuideToPharmacology,1,inhibitor
CD3D,TOFOGLIFLOZIN ANHYDROUS,GuideToPharmacology,1,inhibitor
SMPD1,COMPOUND 21B [PMID: 31944697],GuideToPharmacology,1,inhibitor
BLVRB,YM-75440,GuideToPharmacology,1,inhibitor
MS4A2,COMPOUND 2 [PMID: 15546730],GuideToPharmacology,1,inhibitor
FASLG,VELDOREOTIDE,GuideToPharmacology,1,agonist
FASLG,"L-362,855",GuideToPharmacology,1,agonist
FASLG,BIM 23030,GuideToPharmacology,1,agonist
BGLAP,RJW100,GuideToPharmacology,1,agonist
GLP1R,PFI-3,GuideToPharmacology,1,inhibitor
ATP1B1P1,"1,6-HEXAMETHYLENE DIISOCYANATE",GuideToPharmacology,1,activator
ATP1B1P1,NPPB,GuideToPharmacology,1,activator
ATP1B1P1,CU2+,GuideToPharmacology,1,activator
ATP2B1,GFB-8438,GuideToPharmacology,1,blocker
ATP2B1,KB-R7943,GuideToPharmacology,1,blocker
ATP2B1,LA3+,GuideToPharmacology,1,activator
TRPM8,LA3+,GuideToPharmacology,1,blocker
ALDH7A1,PRU-12,GuideToPharmacology,1,blocker
TRPM5,SPERMINE,GuideToPharmacology,1,blocker
ATP5F1BP1,CAPSAZEPINE,GuideToPharmacology,1,blocker
TRPV4,RN1747,GuideToPharmacology,1,activator
FGFR4,MPS1-IN-1,GuideToPharmacology,1,inhibitor
TYK2,JAK3 INHIBITOR 32,GuideToPharmacology,1,inhibitor
FRA9E,IU1,GuideToPharmacology,1,inhibitor
FH,SBP-7455,GuideToPharmacology,1,inhibitor
BCL7A,LEXACALCITOL,GuideToPharmacology,1,agonist
AQP9,SELEPRESSIN,GuideToPharmacology,1,agonist
AQP9,"D(CH2)5[D-ILE2,ILE4,ALA-NH2]AVP",GuideToPharmacology,1,inhibitor
ANXA3,PEPTIDE YY,GuideToPharmacology,1,agonist
A1BG,SUMATRIPTAN,GuideToPharmacology,1,agonist
A1BG,MESORIDAZINE,GuideToPharmacology,1,inhibitor
A1BG,BUSPIRONE,GuideToPharmacology,1,agonist
A1BG,ZALOSPIRONE,GuideToPharmacology,1,agonist
A2M,[11C]AZ10419369,GuideToPharmacology,1,agonist
A2M,YOHIMBINE,GuideToPharmacology,1,inhibitor
A2M,SB 224289,GuideToPharmacology,1,inhibitor
A2MP1,PIPAMPERONE,GuideToPharmacology,1,inhibitor
A2MP1,SB 714786,GuideToPharmacology,1,inhibitor
A12M1,ERGOTAMINE,GuideToPharmacology,1,agonist
A12M3,PIPAMPERONE,GuideToPharmacology,1,inhibitor
A12M4,"L-741,626",GuideToPharmacology,1,inhibitor
A12M4,SB 204741,GuideToPharmacology,1,inhibitor
HTR2C,QUIPAZINE,GuideToPharmacology,1,agonist
HTR2C,BW723C86,GuideToPharmacology,1,agonist
HTR2C,[3H]LSD,GuideToPharmacology,1,agonist
HTR2C,CYAMEMAZINE,GuideToPharmacology,1,inhibitor
NAT1,5-MEOT,GuideToPharmacology,1,agonist
HTR2C,METITEPINE,GuideToPharmacology,1,inhibitor
NAT1,RENZAPRIDE,GuideToPharmacology,1,agonist
NATP,CHLORPROMAZINE,GuideToPharmacology,1,inhibitor
CACNB2,SILDENAFIL,GuideToPharmacology,1,inhibitor
CNN1,CLESACOSTAT,GuideToPharmacology,1,inhibitor
CRABP2,"COMPOUND 1 [LOLLI ET AL., 2019]",GuideToPharmacology,1,inhibitor
CRABP2,TOLFENAMIC ACID,GuideToPharmacology,1,inhibitor
COL1A2,ST034307,GuideToPharmacology,1,inhibitor
CBR3,BENZYLSERINE,GuideToPharmacology,1,inhibitor
FKBP2,MS15,GuideToPharmacology,1,inhibitor
CSTF3,MILTEFOSINE,GuideToPharmacology,1,inhibitor
ABCB7,CLOMIPRAMINE,GuideToPharmacology,1,inhibitor
ABCB7,LABETALOL,GuideToPharmacology,1,inhibitor
ABCB7,CARVEDILOL,GuideToPharmacology,1,inhibitor
DAPK3,RXP-407,GuideToPharmacology,1,inhibitor
DAPK3,RAMIPRIL,GuideToPharmacology,1,inhibitor
ACADSB,CYCLO APELIN-12 (1-12),GuideToPharmacology,1,agonist
BTD,GMQ,GuideToPharmacology,1,activator
GSTP1P1,EZUTROMID,GuideToPharmacology,1,inhibitor
ABAT,CAFFEINE,GuideToPharmacology,1,inhibitor
BTD,NS383,GuideToPharmacology,1,blocker
CCKBR,L-740093,GuideToPharmacology,1,inhibitor
ACTA1,[125I]CCL8 (HUMAN),GuideToPharmacology,1,agonist
CCR4,CCL17,GuideToPharmacology,1,agonist
CCR4,CCL22,GuideToPharmacology,1,agonist
GLRA2,OTELIXIZUMAB,GuideToPharmacology,1,antibody
ACTG1P7,LC52-0332,GuideToPharmacology,1,inhibitor
EIF5AP3,BX-795,GuideToPharmacology,1,inhibitor
BUB1,LUBIPROSTONE,GuideToPharmacology,1,activator
HPGD,EVACETRAPIB,GuideToPharmacology,1,inhibitor
HPGD,DRL-17822,GuideToPharmacology,1,inhibitor
BUB1B,DIDS,GuideToPharmacology,1,blocker
FPR3,BETRIXABAN,GuideToPharmacology,1,inhibitor
FRA1A,MILVEXIAN,GuideToPharmacology,1,inhibitor
DPYD,IL-34,GuideToPharmacology,1,agonist
CPT1B,COMPOUND 12A [PMID: 29031075],GuideToPharmacology,1,inhibitor
CHUK,BMS-345541,GuideToPharmacology,1,modulator
CPT2,ETORICOXIB,GuideToPharmacology,1,inhibitor
ACHE,AMLINTIDE,GuideToPharmacology,1,agonist
C1R,CA2+,GuideToPharmacology,1,inhibitor
C1S,FLUFENAMIC ACID,GuideToPharmacology,1,inhibitor
C4BPAP2,FLUFENAMIC ACID,GuideToPharmacology,1,inhibitor
ACTBP8,AZD5069,GuideToPharmacology,1,inhibitor
OSGIN2,OCTANOL,GuideToPharmacology,1,inhibitor
ACTBP9,HIV-1 MATRIX PROTEIN P17,GuideToPharmacology,1,agonist
C5,OCTANOL,GuideToPharmacology,1,inhibitor
ACTBP8,CXCL8,GuideToPharmacology,1,agonist
ACTC1,DIOSCIN,GuideToPharmacology,1,inhibitor
EGR4,AT-7519,GuideToPharmacology,1,inhibitor
EGR4,ALSTERPAULLONE,GuideToPharmacology,1,inhibitor
EIF2S1,CDK12 INHIBITOR 2,GuideToPharmacology,1,inhibitor
AMHR2,COMPOUND 13E [PMID: 31811124],GuideToPharmacology,1,inhibitor
APOB,ASAPIPRANT,GuideToPharmacology,1,inhibitor
APOBEC1,"13,14-DIHYDRO-15-KETO-PGF2&ALPHA;",GuideToPharmacology,1,agonist
APOBEC1,PGJ2,GuideToPharmacology,1,agonist
APOBEC1,TM30089,GuideToPharmacology,1,inhibitor
ALCAM,CHLORPROMAZINE,GuideToPharmacology,1,inhibitor
ALCAM,(+)-BUTACLAMOL,GuideToPharmacology,1,inhibitor
APOBEC1,"COMPOUND 51 [CROSIGNANI ET AL., 2011]",GuideToPharmacology,1,inhibitor
ALCAM,SCH-23390,GuideToPharmacology,1,inhibitor
ABCD1,(+)-BUTACLAMOL,GuideToPharmacology,1,inhibitor
ABCD1,PERGOLIDE,GuideToPharmacology,1,agonist
ABCD1,(+)-UH232,GuideToPharmacology,1,inhibitor
GRK2,COMPOUND 16 [PMID: 31498617],GuideToPharmacology,1,agonist
NOS2,1400W,GuideToPharmacology,1,inhibitor
GATA2,RIBAVIRIN,GuideToPharmacology,1,inhibitor
CRK,BITHIONOL,GuideToPharmacology,1,inhibitor
FRA11F,NATALIZUMAB,GuideToPharmacology,1,antibody
FRA12D,EFALIZUMAB,GuideToPharmacology,1,antibody
DPH1,NVP-AEW541,GuideToPharmacology,1,inhibitor
DPH1,PQ401,GuideToPharmacology,1,inhibitor
IL2RA,BASILIXIMAB,GuideToPharmacology,1,antibody
EPHA7,IRAK4 INHIBITOR 4B [PMID: 18474425],GuideToPharmacology,1,inhibitor
APOC3,RO3244794,GuideToPharmacology,1,inhibitor
APOC3,FK-788,GuideToPharmacology,1,agonist
APOC3,TG6-129,GuideToPharmacology,1,inhibitor
FOXL2,PHLORETIN,GuideToPharmacology,1,agonist
BOK,STRYCHNINE,GuideToPharmacology,1,agonist
BRCA2,EPICATECHIN,GuideToPharmacology,1,agonist
BPI,CROMOGLYCATE,GuideToPharmacology,1,agonist
BPGM,SALICIN,GuideToPharmacology,1,agonist
BPGM,4-NITROPHENYL-&BETA;-D-MANNOPYRANOSIDE,GuideToPharmacology,1,agonist
BNIP2,MALVIDIN-3-GLUCOSIDE,GuideToPharmacology,1,agonist
POLR3D,STEVIOSIDE,GuideToPharmacology,1,agonist
ZFP36L2,"CYCLOLINOPEPTIDE 1-MSO,3-MET-CL6",GuideToPharmacology,1,agonist
ZFP36L2,ARISTOLOCHIC ACID,GuideToPharmacology,1,agonist
BNIP2,CROMOGLYCATE,GuideToPharmacology,1,agonist
EPHB1,COMPOUND 25AP [PMID: 37796543],GuideToPharmacology,1,inhibitor
BNIP3L,PIRENZEPINE,GuideToPharmacology,1,agonist
EPHB1,BARICITINIB,GuideToPharmacology,1,inhibitor
EPHB1,BREPOCITINIB,GuideToPharmacology,1,inhibitor
EPHB2,COMPOUND 11 [PMID: 35653642],GuideToPharmacology,1,inhibitor
EPHB2,COMPOUND 25AP [PMID: 37796543],GuideToPharmacology,1,inhibitor
NUDT2,BILORPHIN,GuideToPharmacology,1,agonist
NUDT2,NALTREXONE,GuideToPharmacology,1,inhibitor
DRD2,COMPOUND 13A [PMID: 23639540],GuideToPharmacology,1,inhibitor
DRD2,TOCERANIB,GuideToPharmacology,1,inhibitor
DRD2,NINTEDANIB ESYLATE,GuideToPharmacology,1,inhibitor
DRD2,VEGF RECEPTOR 2 KINASE INHIBITOR II,GuideToPharmacology,1,inhibitor
AMELY,KISSPEPTIN-28,GuideToPharmacology,1,agonist
ATP6V1B1,NITRIC OXIDE,GuideToPharmacology,1,activator
ATP6V0C,ARACHIDONIC ACID,GuideToPharmacology,1,inhibitor
ARF4P1,NS1619,GuideToPharmacology,1,activator
ARG1,DEQUALINIUM,GuideToPharmacology,1,blocker
RHOA,NS1619,GuideToPharmacology,1,activator
ASGR1,PUTRESCINE,GuideToPharmacology,1,blocker
ARG2,CA2+,GuideToPharmacology,1,activator
ARG2,CHARYBDOTOXIN,GuideToPharmacology,1,blocker
ASPA,DALFAMPRIDINE,GuideToPharmacology,1,blocker
ALDH7A1P2,DALFAMPRIDINE,GuideToPharmacology,1,blocker
EPS15,TOLIMIDONE,GuideToPharmacology,1,modulator
CR2,AT-56,GuideToPharmacology,1,inhibitor
KDM5C,PBIT,GuideToPharmacology,1,inhibitor
GGTA1,PBIT,GuideToPharmacology,1,inhibitor
AMY2B,AZ13483342,GuideToPharmacology,1,inhibitor
ANGPT1,[125I]SHU9119,GuideToPharmacology,1,inhibitor
ANGPT2,HS024,GuideToPharmacology,1,inhibitor
ETFB,TEMSIROLIMUS,GuideToPharmacology,1,inhibitor
DRD4,ZANZALINTINIB,GuideToPharmacology,1,inhibitor
ANOP1,A-850002,GuideToPharmacology,1,modulator
SLC25A6,COMPOUND 53 [PMID: 23434029],GuideToPharmacology,1,modulator
SLC25A6,[3H]M-MPEP,GuideToPharmacology,1,modulator
GRM8,"(R,S)-4-PPG",GuideToPharmacology,1,agonist
ANTP2,MSOPPE,GuideToPharmacology,1,inhibitor
GRM8,L-AP4,GuideToPharmacology,1,agonist
GRM8,L-AP4,GuideToPharmacology,1,agonist
NR3C2,FLUDROCORTISONE,GuideToPharmacology,1,agonist
NR3C2,EPLERENONE,GuideToPharmacology,1,inhibitor
MAPK13,DORAMAPIMOD,GuideToPharmacology,1,inhibitor
CTNND2,DORAMAPIMOD,GuideToPharmacology,1,inhibitor
CTNND1,VX-702,GuideToPharmacology,1,inhibitor
CTNNB1,BMS-582949,GuideToPharmacology,1,inhibitor
MAPK3,MK-8353,GuideToPharmacology,1,inhibitor
ERVK3,COMPOUND 21 [PMID: 23312943],GuideToPharmacology,1,inhibitor
ACE,COMPOUND 5  [PMID: 24900526],GuideToPharmacology,1,inhibitor
ACE,AZD1236,GuideToPharmacology,1,inhibitor
DCR,MMP13 TRACER  [18F]5J,GuideToPharmacology,1,inhibitor
FSHMD1A,TRANYLCYPROMINE,GuideToPharmacology,1,inhibitor
ANTP4,[LEU13]MOTILIN (HUMAN),GuideToPharmacology,1,agonist
ANTP4,"[PHE3,LEU13]MOTILIN (HUMAN)",GuideToPharmacology,1,agonist
ANTP4,"[D-BPA5,ILE13]MOTILIN (HUMAN)",GuideToPharmacology,1,agonist
AADAC,VU0486846,GuideToPharmacology,1,modulator
PTGES,FRILUGLANSTAT,GuideToPharmacology,1,inhibitor
AADAC,METHOCTRAMINE,GuideToPharmacology,1,inhibitor
AAMP,DICYCLOMINE HYDROCHLORIDE,GuideToPharmacology,1,inhibitor
AAMP,THRX160209,GuideToPharmacology,1,inhibitor
BCKDHA,AD-5061,GuideToPharmacology,1,agonist
F7,AMG319,GuideToPharmacology,1,inhibitor
F7,DACTOLISIB,GuideToPharmacology,1,inhibitor
F7,PILARALISIB,GuideToPharmacology,1,inhibitor
F7,NEMIRALISIB,GuideToPharmacology,1,inhibitor
COL7A1,CALMODULIN,GuideToPharmacology,1,activator
COL12A1,"COMPOUND 29 [MOSLIN ET AL., 2017]",GuideToPharmacology,1,inhibitor
COL11A1,CBS-3595,GuideToPharmacology,1,inhibitor
F9,COMPOUND 14K [PMID: 21982499],GuideToPharmacology,1,inhibitor
MAPK14,RILAPLADIB,GuideToPharmacology,1,inhibitor
DPP6,AGL 2043,GuideToPharmacology,1,inhibitor
DPP6,KI-20227,GuideToPharmacology,1,inhibitor
DPP6,FAMITINIB,GuideToPharmacology,1,inhibitor
DPP6,NINTEDANIB ESYLATE,GuideToPharmacology,1,inhibitor
CSE1L,COMPOUND 69 [PMID: 19136975],GuideToPharmacology,1,inhibitor
FRA4A,BOCOCIZUMAB,GuideToPharmacology,1,antibody
CYP1A1,MT47-100,GuideToPharmacology,1,activator
FRA6F,MG-132,GuideToPharmacology,1,inhibitor
CNC2,SGC6870,GuideToPharmacology,1,inhibitor
CTAG1B,ROTTLERIN,GuideToPharmacology,1,inhibitor
NKX2-5,RASGRP ACTIVATOR 1,GuideToPharmacology,1,activator
CTBP1,BALANOL,GuideToPharmacology,1,inhibitor
CTH,COMPOUND 3 [PMID: 19097791],GuideToPharmacology,1,inhibitor
CTH,ARACHIDONIC ACID,GuideToPharmacology,1,activator
FANCG,RIPA-56,GuideToPharmacology,1,inhibitor
FAP,RIPK3 INHIBITOR 42,GuideToPharmacology,1,inhibitor
OPN1SW,LG100754,GuideToPharmacology,1,inhibitor
PTK2B,CEP-11981,GuideToPharmacology,1,inhibitor
BCHEL3,RO 40-6055,GuideToPharmacology,1,agonist
PTK2B,TAMATINIB,GuideToPharmacology,1,inhibitor
CTRB1,FASUDIL,GuideToPharmacology,1,inhibitor
ABCB7,AMITRIPTYLINE HYDROCHLORIDE,GuideToPharmacology,1,inhibitor
APCS,MIRIDESAP,GuideToPharmacology,1,inhibitor
CYP4F2,SESAMIN,GuideToPharmacology,1,inhibitor
DXO,BI-4020,GuideToPharmacology,1,inhibitor
ACTN3,PSB-KD107,GuideToPharmacology,1,agonist
A1BG,ELETRIPTAN,GuideToPharmacology,1,agonist
ABL1,BAFETINIB,GuideToPharmacology,1,inhibitor
DPT,SU-11652,GuideToPharmacology,1,inhibitor
HLA-F,GSK2830371,GuideToPharmacology,1,modulator
NUDT2,NALORPHINE,GuideToPharmacology,1,agonist
HK3,MK-8719,GuideToPharmacology,1,inhibitor
ALDH3B2,GG-2P20,GuideToPharmacology,1,agonist
ARF6,TROPICAMIDE,GuideToPharmacology,1,blocker
NPEPPS,ANTAQ,GuideToPharmacology,1,inhibitor
ANK1,[125I]NDP-MSH,GuideToPharmacology,1,agonist
ABL1,RAUWOLSCINE,GuideToPharmacology,1,inhibitor
ACADSB,ELABELA/TODDLER-11,GuideToPharmacology,1,agonist
CDB2,COMPOUND 1A [PMID: 23597791],GuideToPharmacology,1,inhibitor
CHRNA3,[125I]EPIBATIDINE,GuideToPharmacology,1,agonist
CCR1,PENTOSTATIN,GuideToPharmacology,1,inhibitor
ATF4P1,&ALPHA;-CONOTOXIN RGIA,GuideToPharmacology,1,inhibitor
AMH,ZK-158252,GuideToPharmacology,1,inhibitor
ALCAM,A77636,GuideToPharmacology,1,agonist
HIVEP2,COMPOUND 21B [PMID: 31430136],GuideToPharmacology,1,inhibitor
ACACB,C5A,GuideToPharmacology,1,agonist
GPR21,VENETOCLAX,GuideToPharmacology,1,inhibitor
ADCY3,CID16020046,GuideToPharmacology,1,inhibitor
ATP7B,WP1066,GuideToPharmacology,1,blocker
RYR2,VK-II-86,GuideToPharmacology,1,inhibitor
AMY2B,MCH6-17,GuideToPharmacology,1,agonist
MAP3K8,COMPOUND 3 [PMID: 18255300],GuideToPharmacology,1,inhibitor
AMD1,[3H]PYRILAMINE,GuideToPharmacology,1,inhibitor
SLC25A6,GLUTAMIC ACID,GuideToPharmacology,1,agonist
AQP9,SATAVAPTAN,GuideToPharmacology,1,inhibitor
PIK3CB,SAR260301,GuideToPharmacology,1,inhibitor
BCHEL3,TRIFAROTENE,GuideToPharmacology,1,agonist
EFNA4,MIVEBRESIB,GuideToPharmacology,1,inhibitor
AMY1B,(S)-FTY720-PHOSPHATE,GuideToPharmacology,1,agonist
GABRR3,[3H]MUSCIMOL,GuideToPharmacology,1,agonist
AAVS1,MILAMELINE,GuideToPharmacology,1,agonist
APP,EUROPIUM-LABELLED RELAXIN,GuideToPharmacology,1,agonist
ADAM10,PAMOIC ACID,GuideToPharmacology,1,agonist
ATP1A3,NF449,GuideToPharmacology,1,inhibitor
C1QC,CARBENOXOLONE,GuideToPharmacology,1,inhibitor
A2MP1,ELETRIPTAN,GuideToPharmacology,1,agonist
SLC29A1,IM-12,GuideToPharmacology,1,inhibitor
ASS1,GYKI53784,GuideToPharmacology,1,inhibitor
AADAC,ML169,GuideToPharmacology,1,modulator
ABAT,(S)-PIA,GuideToPharmacology,1,agonist
ACTC1,DURAMYCIN,GuideToPharmacology,1,inhibitor
DRD4,OMO-1,GuideToPharmacology,1,inhibitor
GTF3C2,NC1,GuideToPharmacology,1,inhibitor
PIK3CB,PUQUITINIB,GuideToPharmacology,1,inhibitor
F11,GDC-0339,GuideToPharmacology,1,inhibitor
EIF4E,"6-PHENYL[5H]PYRROLO[2,3-B]PYRAZINE",GuideToPharmacology,1,inhibitor
DPT,PAZOPANIB,GuideToPharmacology,1,inhibitor
AMY2B,S36057,GuideToPharmacology,1,agonist
DRD4,TEREVALEFIM,GuideToPharmacology,1,activator
FRA6E,ZETOMIPZOMIB,GuideToPharmacology,1,inhibitor
GPX1P2,OLUTASIDENIB,GuideToPharmacology,1,inhibitor
CCR1,EHNA,GuideToPharmacology,1,inhibitor
CR1,COMPOUND 30 [PMID: 15953724],GuideToPharmacology,1,inhibitor
CPS1,SOTICLESTAT,GuideToPharmacology,1,inhibitor
AAVS1,UMECLIDINIUM BROMIDE,GuideToPharmacology,1,inhibitor
F7,IZORLISIB,GuideToPharmacology,1,inhibitor
APLP1,[125I]26RFA (HUMAN),GuideToPharmacology,1,agonist
AMY2B,GW803430,GuideToPharmacology,1,inhibitor
CTAA2,7-HYDROXYSTAUROSPORINE,GuideToPharmacology,1,inhibitor
BDNF,NORETHINDRONE,GuideToPharmacology,1,agonist
CPD,AZALANSTAT,GuideToPharmacology,1,inhibitor
GALR2,GALANIN(7-29) (PIG),GuideToPharmacology,1,agonist
GATA3,MYCOPHENOLATE,GuideToPharmacology,1,inhibitor
GDF9,PANOBINOSTAT,GuideToPharmacology,1,inhibitor
GYPB,STAT3 INHIBITOR 8Q,GuideToPharmacology,1,inhibitor
CNR2,"L-759,633",GuideToPharmacology,1,agonist
AMY2B,SB-568849,GuideToPharmacology,1,inhibitor
ANXA7,MECLINERTANT,GuideToPharmacology,1,agonist
A12M4,(+)-DOI,GuideToPharmacology,1,agonist
CD9,NEFAZODONE,GuideToPharmacology,1,inhibitor
A2MP1,RAUWOLSCINE,GuideToPharmacology,1,inhibitor
ZFP36L1,ANDROGRAPHOLIDE,GuideToPharmacology,1,agonist
CHRNA3,NS1738,GuideToPharmacology,1,blocker
ARAF,"L-371,257",GuideToPharmacology,1,inhibitor
ATP2B3,OPTOBI-1,GuideToPharmacology,1,activator
DRD2,SUNITINIB,GuideToPharmacology,1,inhibitor
ARF5,NS309,GuideToPharmacology,1,activator
A2M,OXYMETAZOLINE HYDROCHLORIDE,GuideToPharmacology,1,agonist
A2M,TERGURIDE,GuideToPharmacology,1,agonist
A12M1,RAUWOLSCINE,GuideToPharmacology,1,inhibitor
A12M2,&ALPHA;-METHYL-5-HT,GuideToPharmacology,1,agonist
A12M2,ELETRIPTAN,GuideToPharmacology,1,agonist
A12M3,(+)-DOI,GuideToPharmacology,1,agonist
A12M2,BRL-15572,GuideToPharmacology,1,agonist
A12M3,METHYLERGONOVINE,GuideToPharmacology,1,agonist
A12M3,H05,GuideToPharmacology,1,inhibitor
A12M3,LY314228,GuideToPharmacology,1,inhibitor
A12M3,CAPESEROD,GuideToPharmacology,1,agonist
A12M3,ASENAPINE,GuideToPharmacology,1,inhibitor
A12M3,EGIS-7625,GuideToPharmacology,1,inhibitor
A12M4,RELENOPRIDE,GuideToPharmacology,1,agonist
HTR2C,BRL-15572,GuideToPharmacology,1,agonist
HTR2C,AGOMELATINE,GuideToPharmacology,1,inhibitor
SERPINA3,SB269970,GuideToPharmacology,1,inhibitor
SERPINA3,SB656104,GuideToPharmacology,1,inhibitor
CA9,WS-898,GuideToPharmacology,1,inhibitor
ABCA1,PROBUCOL,GuideToPharmacology,1,inhibitor
CACNB2,COMPOUND 2 [PMID: 22380603],GuideToPharmacology,1,inhibitor
ABL1,OLVEREMBATINIB,GuideToPharmacology,1,inhibitor
FRA17A,PHYSOSTIGMINE,GuideToPharmacology,1,inhibitor
FKBP2,PIFUSERTIB,GuideToPharmacology,1,inhibitor
HBEGF,REPOTRECTINIB,GuideToPharmacology,1,inhibitor
ABCF1,CIRAZOLINE,GuideToPharmacology,1,agonist
ABCF1,RHO-TIA,GuideToPharmacology,1,inhibitor
ABCB7,TERGURIDE,GuideToPharmacology,1,inhibitor
ABCA4,CIRAZOLINE,GuideToPharmacology,1,agonist
ABCF1,PRAZOSIN,GuideToPharmacology,1,inhibitor
ABL1,MK-912,GuideToPharmacology,1,inhibitor
ABL1,TERGURIDE,GuideToPharmacology,1,inhibitor
ABL1,WB 4101,GuideToPharmacology,1,inhibitor
ABL2,RAUWOLSCINE,GuideToPharmacology,1,inhibitor
BEVI,ARD-69,GuideToPharmacology,1,inhibitor
BEVI,BICALUTAMIDE,GuideToPharmacology,1,inhibitor
DAPK3,CAPTOPRIL,GuideToPharmacology,1,inhibitor
ABAT,"4-{2-[(7-AMINO-2-FURAN-2-YL[1,2,4]TRIAZOLO[1,5-A][1,3,5]TRIAZIN-5-YL)AMINO]ETHYL}PHENOL",GuideToPharmacology,1,inhibitor
ABCA1,CPFPX,GuideToPharmacology,1,inhibitor
ABCA1,GS9667,GuideToPharmacology,1,agonist
CD24P3,"&ALPHA;-METHYL-D,L-TRYPTOPHAN",GuideToPharmacology,1,inhibitor
ABCA3,MRS1177,GuideToPharmacology,1,inhibitor
EEF1D,AT-9283,GuideToPharmacology,1,inhibitor
ACADM,SPARSENTAN,GuideToPharmacology,1,inhibitor
ACADS,COMPOUND 1 [PMID: 28379944],GuideToPharmacology,1,inhibitor
ACAT2,[LEU14]BOMBESIN,GuideToPharmacology,1,agonist
GPR22,ABT-737,GuideToPharmacology,1,inhibitor
ASIC2,ML-18,GuideToPharmacology,1,inhibitor
ASIC2,NMU (104-114),GuideToPharmacology,1,agonist
ASIC2,AC-PHE-TRP-ALA-HIS(&TAU;BZL)-NIP-GLY-ARG-NH2,GuideToPharmacology,1,agonist
FMO5,COMPOUND 6 [PMID: 34553947],GuideToPharmacology,1,inhibitor
ABO,FENOTEROL,GuideToPharmacology,1,agonist
ACAA1,ICI 118551,GuideToPharmacology,1,inhibitor
DNMT1,ZILURGISERTIB,GuideToPharmacology,1,inhibitor
EFNA2,PLX-4720,GuideToPharmacology,1,inhibitor
EFNA2,SZM594,GuideToPharmacology,1,inhibitor
EFNA3,ME BROMODOMAIN INHIBITOR,GuideToPharmacology,1,inhibitor
EFNA4,"COMPOUND 15 [HAY ET AL., 2013]",GuideToPharmacology,1,inhibitor
EFNA4,DUAL BRD4/PLK1 INHIBITOR 23,GuideToPharmacology,1,inhibitor
EFNB1,CCT244747,GuideToPharmacology,1,inhibitor
EFNA4,PFI-1,GuideToPharmacology,1,inhibitor
EFNB2,LUXEPTINIB,GuideToPharmacology,1,inhibitor
EFNB2,IBRUTINIB,GuideToPharmacology,1,inhibitor
ASIC1,R-715,GuideToPharmacology,1,inhibitor
BDKRB2,FR167344,GuideToPharmacology,1,inhibitor
ACACA,ALBUTENSIN A,GuideToPharmacology,1,agonist
ACACB,N-METHYL-PHE-LYS-PRO-D-CHA-TRP-D-ARG-CO2H,GuideToPharmacology,1,inhibitor
ACACB,W54011,GuideToPharmacology,1,inhibitor
ACACA,EU-DTPA-HC3A,GuideToPharmacology,1,agonist
ACACB,PMX53,GuideToPharmacology,1,inhibitor
FNL1,COMPOUND 19 [PMID: 8831774],GuideToPharmacology,1,inhibitor
CYP2B7P,STAUROSPORINE,GuideToPharmacology,1,inhibitor
GAPDH,COMPOUND 5B  [PMID: 31287314],GuideToPharmacology,1,inhibitor
C1QBP,NIFLUMIC ACID,GuideToPharmacology,1,blocker
ACADL,C5A,GuideToPharmacology,1,agonist
ELF2,UMBRALISIB,GuideToPharmacology,1,inhibitor
RHOC,PGF1&ALPHA;,GuideToPharmacology,1,activator
FOLR2L,KGP94,GuideToPharmacology,1,inhibitor
RHOB,ALPROSTADIL,GuideToPharmacology,1,activator
FOS,K777,GuideToPharmacology,1,inhibitor
ACRV1,MDMB-FUBINACA,GuideToPharmacology,1,agonist
ACRV1,AZD1940,GuideToPharmacology,1,agonist
ACTA1,[125I]CCL5 (HUMAN),GuideToPharmacology,1,agonist
ACTA2,MC148R,GuideToPharmacology,1,inhibitor
ACTA2,RS-504393,GuideToPharmacology,1,inhibitor
ACTA2,INCB3284,GuideToPharmacology,1,inhibitor
ACTB,CCL15,GuideToPharmacology,1,agonist
ACTB,[125I]CCL5 (HUMAN),GuideToPharmacology,1,agonist
ACTA2,RS-136270,GuideToPharmacology,1,inhibitor
ACTB,CCL11,GuideToPharmacology,1,agonist
ACTBP2,APLAVIROC,GuideToPharmacology,1,inhibitor
EGR3,XL413,GuideToPharmacology,1,inhibitor
CPT2,FK-881,GuideToPharmacology,1,inhibitor
CPT2,SWE101,GuideToPharmacology,1,inhibitor
CAPN5,CARBENOXOLONE,GuideToPharmacology,1,inhibitor
GJB1,CARBENOXOLONE,GuideToPharmacology,1,inhibitor
ACTBP9,ELUBRIXIN,GuideToPharmacology,1,inhibitor
ACTG2,CXCL13,GuideToPharmacology,1,agonist
ACTG1,ALX40-4C,GuideToPharmacology,1,agonist
ACTG1,CXCR4 ANTAGONIST 22,GuideToPharmacology,1,inhibitor
EGR4,CDK2 INHIBITOR III,GuideToPharmacology,1,inhibitor
EGR4,ZOTIRACICLIB,GuideToPharmacology,1,inhibitor
EGR4,K-00546,GuideToPharmacology,1,inhibitor
EGR4,CGP74514A,GuideToPharmacology,1,inhibitor
EIF4A1,SELICICLIB,GuideToPharmacology,1,inhibitor
EIF4A1,CDK INHIBITOR 4.35,GuideToPharmacology,1,inhibitor
EIF4A1,CDK4 INHIBITOR,GuideToPharmacology,1,inhibitor
EIF4A1,ASNUCICLIB,GuideToPharmacology,1,inhibitor
EIF4A1,CDK2 INHIBITOR III,GuideToPharmacology,1,inhibitor
CDK4,CIMPUCICLIB,GuideToPharmacology,1,inhibitor
EIF4EBP1,BSJ-04-132,GuideToPharmacology,1,inhibitor
EIF4E,CGP74514A,GuideToPharmacology,1,inhibitor
CPB1,BAXDROSTAT,GuideToPharmacology,1,inhibitor
EIF4G1,SY-5609,GuideToPharmacology,1,inhibitor
EIF4G1,SELICICLIB,GuideToPharmacology,1,inhibitor
CPA3,METYRAPONE,GuideToPharmacology,1,inhibitor
CORT,PHENELZINE,GuideToPharmacology,1,inhibitor
COX5B,TIQ-15,GuideToPharmacology,1,inhibitor
COX11,COMPOUND 7P [PMID: 7861416],GuideToPharmacology,1,inhibitor
GZMB,COMPOUND 7C [PMID: 22041175],GuideToPharmacology,1,inhibitor
AMPD1,PRANLUKAST,GuideToPharmacology,1,inhibitor
AMPD1,POBILUKAST,GuideToPharmacology,1,inhibitor
APAF1,TRAMADOL,GuideToPharmacology,1,agonist
APAF1,(-)-BREMAZOCINE,GuideToPharmacology,1,agonist
ELK3,SILMITASERTIB,GuideToPharmacology,1,inhibitor
CD8B2,PHENELZINE,GuideToPharmacology,1,inhibitor
APAF1,METHADONE HYDROCHLORIDE,GuideToPharmacology,1,agonist
CRIP2,LEI105,GuideToPharmacology,1,inhibitor
DHFR,METHOTREXATE,GuideToPharmacology,1,inhibitor
CRIP1,KT-109,GuideToPharmacology,1,inhibitor
HOXB1,PF-07202954,GuideToPharmacology,1,inhibitor
EML1,EPIGALLOCATECHIN-3-GALLATE,GuideToPharmacology,1,inhibitor
EML1,GNF4877,GuideToPharmacology,1,inhibitor
ALDH3A1,THIORIDAZINE,GuideToPharmacology,1,inhibitor
DAXX,COMPOUND 1 [PMID: 18507370],GuideToPharmacology,1,inhibitor
NOS3,GW274150,GuideToPharmacology,1,inhibitor
EPYC,TESEVATINIB,GuideToPharmacology,1,inhibitor
EZH2,PF-06821497,GuideToPharmacology,1,inhibitor
DSG1,RIPK3 INHIBITOR 18,GuideToPharmacology,1,inhibitor
ATN1,DORSOMORPHIN,GuideToPharmacology,1,inhibitor
DXO,NAQUOTINIB,GuideToPharmacology,1,inhibitor
DXO,REZIVERTINIB,GuideToPharmacology,1,inhibitor
DXO,MS154,GuideToPharmacology,1,inhibitor
BLVRA,NE21650,GuideToPharmacology,1,inhibitor
ABCD2,TUG-770,GuideToPharmacology,1,agonist
ALDOA,AMG7703,GuideToPharmacology,1,modulator
ADH4,GRIFOLIC ACID,GuideToPharmacology,1,agonist
ADH4,NCG21,GuideToPharmacology,1,agonist
DPYSL2,SU-14813,GuideToPharmacology,1,inhibitor
SLC26A3,ALDAFERMIN,GuideToPharmacology,1,agonist
SLC29A2,DM-CHX,GuideToPharmacology,1,inhibitor
SLC26A3,LY2874455,GuideToPharmacology,1,inhibitor
DRD1,PAZOPANIB,GuideToPharmacology,1,inhibitor
SLC26A3,PRN1371,GuideToPharmacology,1,inhibitor
DPYS,GILTERITINIB,GuideToPharmacology,1,inhibitor
DRD1,RG-1530,GuideToPharmacology,1,inhibitor
DPYS,G&OUML; 6976,GuideToPharmacology,1,inhibitor
DPYS,ENMD-2076,GuideToPharmacology,1,inhibitor
DPYS,COMPOUND 34F [PMID: 37535845],GuideToPharmacology,1,inhibitor
DPYS,RG-1530,GuideToPharmacology,1,inhibitor
DGKA,CAPROMAB PENDETIDE,GuideToPharmacology,1,antibody
DRD3,SUNITINIB,GuideToPharmacology,1,inhibitor
ALDH3B2,BMS-986235,GuideToPharmacology,1,agonist
ALDH9A1,1R-11,GuideToPharmacology,1,agonist
APOC2,ILOPROST,GuideToPharmacology,1,agonist
ENO2,PP2,GuideToPharmacology,1,inhibitor
GABRA1,ISONIPECOTIC ACID,GuideToPharmacology,1,agonist
ARNT,ZN2+,GuideToPharmacology,1,modulator
ALOX12P2,GALANIN-LIKE PEPTIDE,GuideToPharmacology,1,agonist
GALR2,SPEXIN-1,GuideToPharmacology,1,agonist
ALPG,NNC0640,GuideToPharmacology,1,modulator
ASS1P5,UBP302,GuideToPharmacology,1,inhibitor
GRIN2C,D-AP5,GuideToPharmacology,1,inhibitor
GRIN2B,S-DESCHLOROKETAMINE,GuideToPharmacology,1,inhibitor
GRIN2C,ASPARTIC ACID,GuideToPharmacology,1,agonist
GRIN2B,D-CCPENE,GuideToPharmacology,1,inhibitor
GRIN2C,CONANTOKIN-G,GuideToPharmacology,1,inhibitor
ASS1P14,[3H]D-ASPARTIC ACID,GuideToPharmacology,1,agonist
CD24P1,LY2365109,GuideToPharmacology,1,inhibitor
GNRHR,TRIPTORELIN,GuideToPharmacology,1,agonist
GNRHR,GNRH II,GuideToPharmacology,1,agonist
ALDH3B1,G15,GuideToPharmacology,1,inhibitor
ACADVL,INT-767,GuideToPharmacology,1,agonist
ACADVL,XYT528B,GuideToPharmacology,1,agonist
DLX6,LINACLOTIDE,GuideToPharmacology,1,agonist
DLX3,SANP,GuideToPharmacology,1,agonist
GRIN2C,SNX0723,GuideToPharmacology,1,inhibitor
AOAH,D-TRYPTOPHAN,GuideToPharmacology,1,agonist
AOAH,COMPOUND 5B [PMID: 17358052],GuideToPharmacology,1,agonist
GDF2,BUTYRIC ACID,GuideToPharmacology,1,inhibitor
GAPDHP1,ROMIDEPSIN,GuideToPharmacology,1,inhibitor
GARS1,PANOBINOSTAT,GuideToPharmacology,1,inhibitor
HDAC4,ROMIDEPSIN,GuideToPharmacology,1,inhibitor
GART,BUFEXAMAC,GuideToPharmacology,1,inhibitor
GART,VORINOSTAT,GuideToPharmacology,1,inhibitor
GART,ROMIDEPSIN,GuideToPharmacology,1,inhibitor
MSTN,ROMIDEPSIN,GuideToPharmacology,1,inhibitor
GAS2,VORINOSTAT,GuideToPharmacology,1,inhibitor
CRABP1,4-(BENZHYDRYLOXY)-1-[3-(1H-TETRAAZOL-5-YL)PROPYL]PIPERIDINE,GuideToPharmacology,1,inhibitor
AMD1,VILAZODONE HYDROCHLORIDE,GuideToPharmacology,1,agonist
CRAT,COMPOUND 3 [PMID: 21650226],GuideToPharmacology,1,inhibitor
AMD1,AMITRIPTYLINE HYDROCHLORIDE,GuideToPharmacology,1,inhibitor
AMD1,DOXEPIN HYDROCHLORIDE,GuideToPharmacology,1,inhibitor
AMD1,(-)-TRANS-H2-PAT,GuideToPharmacology,1,inhibitor
AMD1,DOXEPIN HYDROCHLORIDE,GuideToPharmacology,1,inhibitor
AMD1,DIPHENHYDRAMINE,GuideToPharmacology,1,inhibitor
AMD1,(&PLUSMN;)-TRANS-H2-PAT,GuideToPharmacology,1,inhibitor
AMD1,PYRILAMINE,GuideToPharmacology,1,inhibitor
AMD1P2,OXO-ARPROMIDINE,GuideToPharmacology,1,agonist
HRH3,ADRIFORANT,GuideToPharmacology,1,inhibitor
HTRA1,GALEGENIMAB,GuideToPharmacology,1,antibody
PRDM1,COMPOUND 1E [PMID: 2153213],GuideToPharmacology,1,inhibitor
ADAM10,COMPOUND 83 [PMID: 23888932],GuideToPharmacology,1,agonist
ADCY3,ANANDAMIDE,GuideToPharmacology,1,agonist
ADCY3,CID2440433,GuideToPharmacology,1,agonist
APOC3,[3H]ILOPROST,GuideToPharmacology,1,agonist
CSN3,GNF362,GuideToPharmacology,1,inhibitor
FOXL2,LUTEOLIN,GuideToPharmacology,1,agonist
EPHB3,LORPUCITINIB,GuideToPharmacology,1,inhibitor
NUDT2,METHADONE HYDROCHLORIDE,GuideToPharmacology,1,agonist
DRD2,TESEVATINIB,GuideToPharmacology,1,inhibitor
AMELY,PEPTIDE 234,GuideToPharmacology,1,inhibitor
GPM6B,LY3499446,GuideToPharmacology,1,inhibitor
ATP5MC2P1,ANANDAMIDE,GuideToPharmacology,1,inhibitor
ATP5PB,R-(+)-METHANANDAMIDE,GuideToPharmacology,1,blocker
ARF5,RILUZOLE,GuideToPharmacology,1,activator
ARG1,CYPPA,GuideToPharmacology,1,activator
KCNT2,CLOFILIUM,GuideToPharmacology,1,blocker
ALDH7A1P3,MAST CELL DEGRANULATING PEPTIDE,GuideToPharmacology,1,blocker
ATRX,RY785,GuideToPharmacology,1,inhibitor
AZF1,L735821,GuideToPharmacology,1,blocker
KCNQ5,FLINDOKALNER,GuideToPharmacology,1,activator
AZF2,FLINDOKALNER,GuideToPharmacology,1,activator
AZF1,NIFLUMIC ACID,GuideToPharmacology,1,activator
KCNQ5,EZOGABINE,GuideToPharmacology,1,activator
AZGP1,EZOGABINE,GuideToPharmacology,1,activator
FRA10D,COMPOUND 7 [PMID: 22533316],GuideToPharmacology,1,inhibitor
LATS2,STAUROSPORINE,GuideToPharmacology,1,inhibitor
EPHX2,LCK INHIBITOR,GuideToPharmacology,1,inhibitor
EPS8,PF-06447475,GuideToPharmacology,1,inhibitor
BAK1P2,24(S)-HYDROXYCHOLESTEROL,GuideToPharmacology,1,agonist
BCL3,24(S)-HYDROXYCHOLESTEROL,GuideToPharmacology,1,agonist
AMPH,GRI977143,GuideToPharmacology,1,agonist
AMPD3,SAR100842,GuideToPharmacology,1,inhibitor
EPS15,IBRUTINIB,GuideToPharmacology,1,inhibitor
EPS15,NG-25,GuideToPharmacology,1,inhibitor
AMY2B,COMPOUND 17 [PMID: 17125263],GuideToPharmacology,1,inhibitor
AMY2B,COMPOUND 4B [PMID: 19683441],GuideToPharmacology,1,inhibitor
ANPEP,MNI-135,GuideToPharmacology,1,modulator
ANOP1,VU0483605,GuideToPharmacology,1,modulator
ANPEP,JNJ-40411813,GuideToPharmacology,1,modulator
SLC25A5,FP0429,GuideToPharmacology,1,agonist
AADAC,ARECAIDINE PROPARGYL ESTER,GuideToPharmacology,1,agonist
AADAC,IPEROXO,GuideToPharmacology,1,agonist
AADAC,AC-42,GuideToPharmacology,1,modulator
AADAC,AC-42,GuideToPharmacology,1,agonist
AADAC,BENZOQUINAZOLINONE 12,GuideToPharmacology,1,modulator
AADAC,[3H]PIRENZEPINE,GuideToPharmacology,1,inhibitor
AAMP,AQ-RA 741,GuideToPharmacology,1,inhibitor
AANAT,ATROPINE,GuideToPharmacology,1,inhibitor
AANAT,MUSCARINIC TOXIN 3,GuideToPharmacology,1,inhibitor
AARS1,AFDX384,GuideToPharmacology,1,inhibitor
AARS1,GLYCOPYRRONIUM,GuideToPharmacology,1,inhibitor
AARS1,MILAMELINE,GuideToPharmacology,1,agonist
AAVS1,IPEROXO,GuideToPharmacology,1,agonist
AARS1,OXYPHENONIUM,GuideToPharmacology,1,inhibitor
AAVS1,GLYCOPYRRONIUM,GuideToPharmacology,1,inhibitor
AAVS1,AQ-RA 741,GuideToPharmacology,1,inhibitor
ANK2,[125I]SD6,GuideToPharmacology,1,agonist
ANK2,S24773,GuideToPharmacology,1,agonist
GZMM,COMPOUND 7C [PMID: 22041175],GuideToPharmacology,1,inhibitor
GZMA,COMPOUND 7C [PMID: 22041175],GuideToPharmacology,1,inhibitor
NKX3-2,GNE-131,GuideToPharmacology,1,inhibitor
BBS1,GS-458967,GuideToPharmacology,1,inhibitor
BAX,GNE-616,GuideToPharmacology,1,blocker
BBS1,ROPIVACAINE,GuideToPharmacology,1,blocker
BAX,MEXILETINE,GuideToPharmacology,1,blocker
BBS1,FUNAPIDE,GuideToPharmacology,1,inhibitor
NKX3-2,GNE-616,GuideToPharmacology,1,blocker
DLX5,CANF4-23,GuideToPharmacology,1,agonist
BBS4,PF-01247324,GuideToPharmacology,1,blocker
BBS2,GNE-616,GuideToPharmacology,1,blocker
SCN9A,FUNAPIDE,GuideToPharmacology,1,inhibitor
ATF4,BRADANICLINE,GuideToPharmacology,1,agonist
AQP3,SUBSTANCE P-(4-11),GuideToPharmacology,1,agonist
ETV3,GSK579289A,GuideToPharmacology,1,inhibitor
ATF4P1,[3H]&ALPHA;-BUNGAROTOXIN,GuideToPharmacology,1,inhibitor
AQP4,HEMOKININ 1,GuideToPharmacology,1,agonist
AQP3,[18F]SPA-RQ,GuideToPharmacology,1,inhibitor
DNAH9,GDC-2394,GuideToPharmacology,1,modulator
AQP5,GSK 172981,GuideToPharmacology,1,inhibitor
APBA1,(R)-RO65-6570,GuideToPharmacology,1,agonist
SLCO1B1,RIFAMPIN,GuideToPharmacology,1,inhibitor
SLCO1A2,RIFAMYCIN SV,GuideToPharmacology,1,inhibitor
SLCO1B3,RIFAMPIN,GuideToPharmacology,1,inhibitor
GTF2F2P1,CM4620,GuideToPharmacology,1,blocker
GTF2H1,CM4620,GuideToPharmacology,1,blocker
ARAF,ARGIPRESSIN,GuideToPharmacology,1,agonist
BIRC3,MRS4458,GuideToPharmacology,1,inhibitor
ADCYAP1R1,BAY 55-9837,GuideToPharmacology,1,agonist
APLP2,2-O-METHYL-PAF C-18,GuideToPharmacology,1,agonist
APLP2,RP-52770,GuideToPharmacology,1,inhibitor
ADCYAP1R1,"[LYS15,ARG16,LEU27]VIP-(1-7)/GRF-(8-27)-NH2",GuideToPharmacology,1,agonist
GLUD1P5,RENCOFILSTAT,GuideToPharmacology,1,inhibitor
BCKDHB,{4-[3-(4-ACETYL-3-HYDROXY-2-PROPYLPHENOXY)PROPOXY]PHENOXY}ACETIC ACID,GuideToPharmacology,1,agonist
BCKDHB,GW9578,GuideToPharmacology,1,agonist
BCKDHA,GW6471,GuideToPharmacology,1,inhibitor
BCKDHA,FARGLITAZAR,GuideToPharmacology,1,agonist
BCKDHA,GW9578,GuideToPharmacology,1,agonist
BCKDHA,EDAGLITAZONE,GuideToPharmacology,1,agonist
BCKDHA,CP-775146,GuideToPharmacology,1,agonist
CCND1,CHIGLITAZAR,GuideToPharmacology,1,agonist
CCND1,FARGLITAZAR,GuideToPharmacology,1,agonist
CCND1,RESVERATROL,GuideToPharmacology,1,inhibitor
F5,BUPARLISIB,GuideToPharmacology,1,inhibitor
FTH1P1,LY134046,GuideToPharmacology,1,inhibitor
GJA1P1,DAMINOZIDE,GuideToPharmacology,1,inhibitor
F5,PAXALISIB,GuideToPharmacology,1,inhibitor
F5,NVP-CLR457,GuideToPharmacology,1,inhibitor
F5,COPANLISIB,GuideToPharmacology,1,inhibitor
F5,SAR260301,GuideToPharmacology,1,inhibitor
PIK3CB,APITOLISIB,GuideToPharmacology,1,inhibitor
PIK3CB,IZORLISIB,GuideToPharmacology,1,inhibitor
F7,ROGINOLISIB,GuideToPharmacology,1,modulator
F7R,COPANLISIB,GuideToPharmacology,1,inhibitor
COL9A1,EHNA,GuideToPharmacology,1,inhibitor
F9,CX-5279,GuideToPharmacology,1,inhibitor
FABP3,ONVANSERTIB,GuideToPharmacology,1,inhibitor
FABP5,RG-1530,GuideToPharmacology,1,inhibitor
FABP2,ONVANSERTIB,GuideToPharmacology,1,inhibitor
BDNF,DYDROGESTERONE,GuideToPharmacology,1,agonist
NBEAP1,GARCINOIC ACID,GuideToPharmacology,1,agonist
PCSK5,PHENYLACETYL-ARG-VAL-ARG-4-AMIDINOBENZYLAMIDE,GuideToPharmacology,1,inhibitor
BDNF,ONAPRISTONE,GuideToPharmacology,1,inhibitor
APOA4,NEUROPEPTIDE Y,GuideToPharmacology,1,inhibitor
XIAP,"[ALA1,12,AIB3,GLN10,HARG11,TRP14,ARG19]PTH-(1-34)-NH2",GuideToPharmacology,1,agonist
GRM5,AZD7545,GuideToPharmacology,1,inhibitor
H1-2,DMAMCL,GuideToPharmacology,1,activator
FAH,AGERAFENIB,GuideToPharmacology,1,inhibitor
FAH,RIPK3 INHIBITOR 18,GuideToPharmacology,1,inhibitor
FAH,AVUTOMETINIB,GuideToPharmacology,1,inhibitor
BAK1P1,AZD0284,GuideToPharmacology,1,agonist
TEX28,DORSOMORPHIN,GuideToPharmacology,1,inhibitor
GBA1LP,GEMCITABINE,GuideToPharmacology,1,inhibitor
PTPRB,RAZUPROTAFIB,GuideToPharmacology,1,inhibitor
RPS6KA6,AT-9283,GuideToPharmacology,1,inhibitor
APP,(B7-33)H2,GuideToPharmacology,1,agonist
APP,[33P]RELAXIN (HUMAN),GuideToPharmacology,1,agonist
CTSLP8,COMPOUND 27 [PMID: 21123062],GuideToPharmacology,1,inhibitor
CD9,PHENELZINE,GuideToPharmacology,1,inhibitor
CYBA,COMPOUND 14N [PMID: 25589934],GuideToPharmacology,1,inhibitor
GABPB1,SM 21,GuideToPharmacology,1,inhibitor
CARS1,DIGOXIN,GuideToPharmacology,1,inhibitor
FDX1,APITOLISIB,GuideToPharmacology,1,inhibitor
BLVRB,J-104123,GuideToPharmacology,1,inhibitor
BLVRB,SQ-109,GuideToPharmacology,1,inhibitor
FASLG,"L-779,976",GuideToPharmacology,1,agonist
FASLG,BIM 23034,GuideToPharmacology,1,agonist
AQP2,BIM 23052,GuideToPharmacology,1,agonist
AQP1,BIM 23454,GuideToPharmacology,1,inhibitor
AQP2,NOC-ATE,GuideToPharmacology,1,agonist
FEN1,MPI-0485520,GuideToPharmacology,1,inhibitor
TLE5,COMPOUND 5G [PMID: 21571530],GuideToPharmacology,1,inhibitor
TEC,COMPOUND 31 [PMID: 24915291],GuideToPharmacology,1,inhibitor
FUT4,PROPYLTHIOURACIL,GuideToPharmacology,1,inhibitor
DNMT3A,BMS-986260,GuideToPharmacology,1,inhibitor
ALDH7A1,MK6-83,GuideToPharmacology,1,activator
ATP5F1C,TRPVICIN,GuideToPharmacology,1,blocker
TRPV4,PHORBOL 12-MYRISTATE 13-ACETATE,GuideToPharmacology,1,activator
FGFR4,BAY1217389,GuideToPharmacology,1,inhibitor
TYK2,GOLIDOCITINIB,GuideToPharmacology,1,inhibitor
ARCN1,"[125I]VIP (HUMAN, MOUSE, RAT)",GuideToPharmacology,1,agonist
AQP9,3-N3-PHPA-LVA,GuideToPharmacology,1,inhibitor
FKBP1AP3,IBRUTINIB,GuideToPharmacology,1,inhibitor
ANXA4,"[ALA31,AIB32]NPY (PIG)",GuideToPharmacology,1,agonist
ANXA5,PYY-(3-36),GuideToPharmacology,1,agonist
ANXA5,NEUROPEPTIDE Y,GuideToPharmacology,1,agonist
A1BG,ASENAPINE,GuideToPharmacology,1,agonist
FRA17A,DONECOPRIDE,GuideToPharmacology,1,inhibitor
ACADVL,CHOLIC ACID,GuideToPharmacology,1,agonist
ANOP1,GLUTAMIC ACID,GuideToPharmacology,1,agonist
ARAF,[35S]NON-PEPTIDE OT ANTAGONIST,GuideToPharmacology,1,inhibitor
BCL2A1,PROTOPORPHYRIN IX CONTAINING CO,GuideToPharmacology,1,inhibitor
ARG2,COMPOUND RAC-16 [PMID: 15603962],GuideToPharmacology,1,blocker
ACTG1,CXCL12&BETA;,GuideToPharmacology,1,agonist
AOAH,4-(N-PROPYL)AMINO-3-NITROBENZOIC ACID,GuideToPharmacology,1,agonist
CMM,METYROSINE,GuideToPharmacology,1,inhibitor
BDNF,MIFEPRISTONE,GuideToPharmacology,1,agonist
BDNF,MIFEPRISTONE,GuideToPharmacology,1,inhibitor
ANXA3,"[ALA31,AIB32]NPY (PIG)",GuideToPharmacology,1,agonist
GNRHR,GANIRELIX ACETATE,GuideToPharmacology,1,inhibitor
CTRB1,RHO KINASE INHIBITOR IV,GuideToPharmacology,1,inhibitor
GTF2A1,COMPOUND 8C [PMID: 28760529],GuideToPharmacology,1,inhibitor
FRA9E,VLX1570,GuideToPharmacology,1,inhibitor
CHRNA3,[125I]EPIBATIDINE,GuideToPharmacology,1,agonist
DPYSL3,PRN1371,GuideToPharmacology,1,inhibitor
ASPH,CX516,GuideToPharmacology,1,modulator
DRD2,N-(4-CHLOROPHENYL)-2-[(PYRIDIN-4-YLMETHYL)AMINO]BENZAMIDE,GuideToPharmacology,1,inhibitor
AMY1B,OZANIMOD,GuideToPharmacology,1,agonist
CYP2C19,UE2343,GuideToPharmacology,1,inhibitor
DAZ1,M826,GuideToPharmacology,1,inhibitor
GOLGA1,NU-7026,GuideToPharmacology,1,inhibitor
A2M,ALMOTRIPTAN,GuideToPharmacology,1,agonist
NPFFR1,PANCREATIC POLYPEPTIDE,GuideToPharmacology,1,agonist
A1BG,OLANZAPINE,GuideToPharmacology,1,agonist
ANTP2,MAP4,GuideToPharmacology,1,inhibitor
DPP6,SUNITINIB,GuideToPharmacology,1,inhibitor
ACTA2,CCR2-RA-[R],GuideToPharmacology,1,modulator
FYN,COMPOUND 13 [PMID: 17502136],GuideToPharmacology,1,inhibitor
GRIN2B,COMPOUND 18C [PMID: 25901531],GuideToPharmacology,1,inhibitor
CDK19,CCT251545,GuideToPharmacology,1,inhibitor
DHODH,EMVODODSTAT,GuideToPharmacology,1,inhibitor
DPYS,DORSOMORPHIN,GuideToPharmacology,1,inhibitor
EPHB1,LONDAMOCITINIB,GuideToPharmacology,1,inhibitor
MAP3K9,CERDULATINIB,GuideToPharmacology,1,inhibitor
ALPL,PEPTIDE 5 [PMID: 28562585],GuideToPharmacology,1,agonist
A2M,5-HT-MODULINE,GuideToPharmacology,1,modulator
NBEAP1,HYPERFORIN,GuideToPharmacology,1,agonist
CTNS,PAMAPIMOD,GuideToPharmacology,1,inhibitor
H1-1,ZAPRINAST,GuideToPharmacology,1,inhibitor
BRAFPS1,FAMOTIDINE,GuideToPharmacology,1,agonist
DRD1,VEGF RECEPTOR TYROSINE KINASE INHIBITOR III,GuideToPharmacology,1,inhibitor
ETS2,COMPOUND 31 [PMID: 20936789],GuideToPharmacology,1,inhibitor
NKX2-5,RUBOXISTAURIN,GuideToPharmacology,1,inhibitor
FASLG,BIM 23023,GuideToPharmacology,1,agonist
ARG2,SKA-31,GuideToPharmacology,1,activator
AQP3,NOLPITANTIUM,GuideToPharmacology,1,inhibitor
GOLGA1,KU-0060648,GuideToPharmacology,1,inhibitor
NMUR1,COMPOUND 5D [PMID: 25815150],GuideToPharmacology,1,agonist
ACSL1,ENMD-2076,GuideToPharmacology,1,inhibitor
STK4,SBP-3264,GuideToPharmacology,1,inhibitor
AMY2B,S36541,GuideToPharmacology,1,inhibitor
ATP2B2,HYP 9,GuideToPharmacology,1,activator
FRA17A,TACRINE,GuideToPharmacology,1,inhibitor
FRA1G,PHENYLACETYL-ARG-VAL-ARG-4-AMIDINOBENZYLAMIDE,GuideToPharmacology,1,inhibitor
BTS1,S-(-)CPB,GuideToPharmacology,1,blocker
A2MP1,ASENAPINE,GuideToPharmacology,1,agonist
GMFA,UE2343,GuideToPharmacology,1,inhibitor
DLX6,PF-07062119,GuideToPharmacology,1,antibody
ANGPT2,[125I]NDP-MSH,GuideToPharmacology,1,agonist
BCL2L2,ALRT 1550,GuideToPharmacology,1,inhibitor
AQP9,"D(CH2)5[TYR(ME)2,THR4,PHE(3125I,4N3)-NH29]OVT",GuideToPharmacology,1,inhibitor
ABAT,FR194921,GuideToPharmacology,1,inhibitor
ABCD1,ASENAPINE,GuideToPharmacology,1,inhibitor
GARS1,RGFP109,GuideToPharmacology,1,inhibitor
APOF,METHADONE HYDROCHLORIDE,GuideToPharmacology,1,agonist
ARAF,"L-367,773",GuideToPharmacology,1,inhibitor
ACTBP3,[125I]CCL20 (HUMAN),GuideToPharmacology,1,agonist
GRIN2B,CONANTOKIN-G,GuideToPharmacology,1,inhibitor
F9,XL413,GuideToPharmacology,1,inhibitor
BAK1P1,XY101,GuideToPharmacology,1,agonist
ACRV1,RIMONABANT,GuideToPharmacology,1,inhibitor
ALDH9A1,ASPIRIN-TRIGGERED RESOLVIN D1,GuideToPharmacology,1,agonist
NATP,[125I]SB258585,GuideToPharmacology,1,inhibitor
AARS1,BRUCINE N-OXIDE,GuideToPharmacology,1,modulator
ABCA1,VISNAGIN,GuideToPharmacology,1,inhibitor
CCKBR,DESULFATED GASTRIN-14,GuideToPharmacology,1,agonist
EPB41,SILMITASERTIB,GuideToPharmacology,1,inhibitor
ATP2B2,SLG,GuideToPharmacology,1,activator
FRA7D,PBD150,GuideToPharmacology,1,inhibitor
FRA17A,EDROPHONIUM CATION,GuideToPharmacology,1,inhibitor
ACTA1,CCL15,GuideToPharmacology,1,agonist
ALAS2,PEXACERFONT,GuideToPharmacology,1,inhibitor
TSC22D3,RIPK3 INHIBITOR 18,GuideToPharmacology,1,inhibitor
BDM,ONAPRISTONE,GuideToPharmacology,1,inhibitor
ADH1C,PSN375963,GuideToPharmacology,1,agonist
GTF2F2P1,COMPOUND 36 [PMID: 34843241],GuideToPharmacology,1,blocker
F10,RUBOXISTAURIN,GuideToPharmacology,1,inhibitor
DUSP1,COMPOUND 6J [PMID: 27219676],GuideToPharmacology,1,inhibitor
DPAGT1,SERIBANTUMAB,GuideToPharmacology,1,antibody
ASS1P10,ASPARTIC ACID,GuideToPharmacology,1,agonist
LATS2,A-674563,GuideToPharmacology,1,inhibitor
A12M3,LY53857,GuideToPharmacology,1,inhibitor
SLC25A6,5PAM523,GuideToPharmacology,1,modulator
ARRB1,[3H]MUSCIMOL,GuideToPharmacology,1,agonist
DPP6,PAZOPANIB,GuideToPharmacology,1,inhibitor
SCTR,"SECRETIN HUMAN, SYNTHETIC",GuideToPharmacology,1,agonist
CCKBR,DESULFATED GASTRIN-17,GuideToPharmacology,1,agonist
A1BG,QUETIAPINE FUMARATE,GuideToPharmacology,1,agonist
A12M3,OLANZAPINE,GuideToPharmacology,1,inhibitor
BTD,APETX2,GuideToPharmacology,1,blocker
GART,NQN-1,GuideToPharmacology,1,inhibitor
EPHA3,COMPOUND 1 [WO2012007375],GuideToPharmacology,1,inhibitor
APOC4,"10,10-DIFLUORO TXA2",GuideToPharmacology,1,agonist
GMFA,AZD8329,GuideToPharmacology,1,inhibitor
NR3C2,AZD9567,GuideToPharmacology,1,agonist
DCR,ILOMASTAT,GuideToPharmacology,1,inhibitor
FCER1A,COMPOUND 49 [PMID: 30889352],GuideToPharmacology,1,inhibitor
A1BG,CAPESEROD,GuideToPharmacology,1,agonist
EFNB2,MILREBRUTINIB,GuideToPharmacology,1,inhibitor
APAF1,NALORPHINE,GuideToPharmacology,1,agonist
ALOX15,[125I][HIS9]GHRELIN (HUMAN),GuideToPharmacology,1,agonist
APOC3,TEI-9063,GuideToPharmacology,1,agonist
CTNNB1,COMPOUND 12 [PMID: 22521646],GuideToPharmacology,1,inhibitor
CD8B,DOXEPIN HYDROCHLORIDE,GuideToPharmacology,1,inhibitor
PKD2L1,FLUFENAMATE,GuideToPharmacology,1,blocker
GPC3,GSK8814,GuideToPharmacology,1,inhibitor
ACP5,(R)-2H [PMID:19625189],GuideToPharmacology,1,modulator
PRDM1,COMPOUND 1F [PMID: 2153213],GuideToPharmacology,1,inhibitor
ANK3,UCM 724,GuideToPharmacology,1,inhibitor
APBA1,LY2940094,GuideToPharmacology,1,inhibitor
CTSO,7-HYDROXYSTAUROSPORINE,GuideToPharmacology,1,inhibitor
A2M,ALNIDITAN,GuideToPharmacology,1,agonist
A2M,ROXINDOLE,GuideToPharmacology,1,agonist
A2MP1,FROVATRIPTAN,GuideToPharmacology,1,agonist
A2M,RAUWOLSCINE,GuideToPharmacology,1,inhibitor
A2MP1,OCAPERIDONE,GuideToPharmacology,1,inhibitor
A2MP1,[3H]SUMATRIPTAN,GuideToPharmacology,1,agonist
A12M1,&ALPHA;-METHYL-5-HT,GuideToPharmacology,1,agonist
A12M3,MIANSERIN,GuideToPharmacology,1,inhibitor
A12M4,AGOMELATINE,GuideToPharmacology,1,inhibitor
A12M4,TERGURIDE,GuideToPharmacology,1,inhibitor
HTR2C,[125I]DOI,GuideToPharmacology,1,agonist
HTR2C,ROXINDOLE,GuideToPharmacology,1,inhibitor
NAT1,&ALPHA;-METHYL-5-HT,GuideToPharmacology,1,agonist
NAT1,BIMU 1,GuideToPharmacology,1,agonist
NAT2,[125I]LSD,GuideToPharmacology,1,agonist
SERPINA3,[3H]8-OH-DPAT,GuideToPharmacology,1,agonist
ABL1,COMPOUND 33A [PMID: 35944901],GuideToPharmacology,1,inhibitor
PLK3,COMPOUND 21 [PMID: 23981033],GuideToPharmacology,1,inhibitor
ABL1,NILOTINIB,GuideToPharmacology,1,inhibitor
ABL1,IMATINIB,GuideToPharmacology,1,inhibitor
DMXL1,ILOMASTAT,GuideToPharmacology,1,inhibitor
ABCB7,BMY-7378,GuideToPharmacology,1,inhibitor
ABCB7,OXYMETAZOLINE HYDROCHLORIDE,GuideToPharmacology,1,agonist
DAPK3,QUINAPRILAT,GuideToPharmacology,1,inhibitor
ACADSB,COMPOUND 21 [PMID: 34855405],GuideToPharmacology,1,agonist
KLF9,HG2+,GuideToPharmacology,1,inhibitor
ACADSB,"[125I][NLE75,TYR77]APELIN-36 (HUMAN)",GuideToPharmacology,1,agonist
BTF3,HG2+,GuideToPharmacology,1,inhibitor
BTD,GD3+,GuideToPharmacology,1,blocker
BTD,H+,GuideToPharmacology,1,activator
BTD,ZN2+,GuideToPharmacology,1,blocker
ABAT,PENECA,GuideToPharmacology,1,agonist
ABAT,LUF5962,GuideToPharmacology,1,inhibitor
ABCA1,TCPA,GuideToPharmacology,1,agonist
ABCA1,VIPADENANT,GuideToPharmacology,1,inhibitor
ABCA2,GS9667,GuideToPharmacology,1,agonist
ABCA2,3-ISOBUTYL-8-PYRROLIDINOXANTHINE,GuideToPharmacology,1,inhibitor
ABCA2,MRS3558,GuideToPharmacology,1,agonist
ABCA2,AS100,GuideToPharmacology,1,inhibitor
ABCA2,PSB36,GuideToPharmacology,1,inhibitor
ABCA3,MRS5698,GuideToPharmacology,1,agonist
ABCA3,PENECA,GuideToPharmacology,1,agonist
ABCA3,GALANGIN,GuideToPharmacology,1,inhibitor
CATHL1L,ESOMEPRAZOLE SODIUM,GuideToPharmacology,1,inhibitor
CATHL1L,OMEPRAZOLE,GuideToPharmacology,1,inhibitor
ATR,CAMONSERTIB,GuideToPharmacology,1,inhibitor
EEF1G,DANUSERTIB,GuideToPharmacology,1,inhibitor
EEF1D,RHO KINASE INHIBITOR IV,GuideToPharmacology,1,inhibitor
EEF1D,DANUSERTIB,GuideToPharmacology,1,inhibitor
EEF1D,COMPOUND 46 [PMID: 16451062],GuideToPharmacology,1,inhibitor
EEF1G,VIC 1911,GuideToPharmacology,1,inhibitor
EEF1G,SNS-314,GuideToPharmacology,1,inhibitor
GRIK5,EXAMPLE 2 [WO2013054185],GuideToPharmacology,1,inhibitor
ASIC2,BAG-2,GuideToPharmacology,1,agonist
ACAT2,BAY86-7548,GuideToPharmacology,1,inhibitor
LPAR4,VENETOCLAX,GuideToPharmacology,1,inhibitor
ASIC2,"[125I][D-TYR6,&BETA;-ALA11,PHE13,NLE14]BOMBESIN-(6-14)",GuideToPharmacology,1,agonist
FMOD,COMPOUND J [PMID: 21907142],GuideToPharmacology,1,inhibitor
FMO5,LY2811376,GuideToPharmacology,1,inhibitor
ABR,NORADRENALINE,GuideToPharmacology,1,agonist
ABR,ZN2+,GuideToPharmacology,1,modulator
ABR,METOPROLOL,GuideToPharmacology,1,inhibitor
ACAA1,FENOTEROL,GuideToPharmacology,1,agonist
AMFR,CP-195543,GuideToPharmacology,1,inhibitor
EFNA1,COMPOUND 31 [PMID: 24915291],GuideToPharmacology,1,inhibitor
CYP27A1,COMPOUND 4 [PMID: 19954973],GuideToPharmacology,1,inhibitor
ACP5,ENCALERET,GuideToPharmacology,1,modulator
DBIP2,M826,GuideToPharmacology,1,inhibitor
CACNA1D,NITRENDIPINE,GuideToPharmacology,1,inhibitor
ATP6V0A1,ABT-639,GuideToPharmacology,1,blocker
ATP6AP1,ABT-639,GuideToPharmacology,1,blocker
ATP6AP1,ANANDAMIDE,GuideToPharmacology,1,blocker
ACRV1,CANNABIDIOL,GuideToPharmacology,1,modulator
ACRV1,AM11542,GuideToPharmacology,1,agonist
CNR2,MDMB-FUBINACA,GuideToPharmacology,1,agonist
CNR2,[3H]HU-243,GuideToPharmacology,1,agonist
CNR2,AM7499,GuideToPharmacology,1,agonist
CNR2,OLORINAB,GuideToPharmacology,1,agonist
CCKBR,JNJ-26070109,GuideToPharmacology,1,inhibitor
CCKBR,AG-041R,GuideToPharmacology,1,inhibitor
CCKAR,CE-326597,GuideToPharmacology,1,agonist
ACTBP2,[3H]ANCRIVIROC,GuideToPharmacology,1,inhibitor
ACTB,[3H]BANYU (I),GuideToPharmacology,1,inhibitor
GMFB,LONCASTUXIMAB TESIRINE,GuideToPharmacology,1,antibody
ACTBP5,[125I]CCL1 (HUMAN),GuideToPharmacology,1,agonist
ACTBP6,VERCIRNON,GuideToPharmacology,1,modulator
GLRA2,PF-07062119,GuideToPharmacology,1,antibody
GLRA2,CATUMAXOMAB,GuideToPharmacology,1,antibody
GLRA2,TEPLIZUMAB,GuideToPharmacology,1,antibody
EGR3,COMPOUND 74 [PMID: 24793884],GuideToPharmacology,1,inhibitor
CFTR,PHENYLGLYCINE-01,GuideToPharmacology,1,activator
EIF5AP3,PREXASERTIB,GuideToPharmacology,1,inhibitor
EIF5AP3,PF-477736,GuideToPharmacology,1,inhibitor
CHEK2,PF-477736,GuideToPharmacology,1,inhibitor
CHEK2,7-HYDROXYSTAUROSPORINE,GuideToPharmacology,1,inhibitor
FNTAP2,COMPOUND 20 [PMID: 12372533],GuideToPharmacology,1,inhibitor
BVR1,3-PHENYL-CPP,GuideToPharmacology,1,blocker
BTS1,FENOFIBRIC ACID,GuideToPharmacology,1,blocker
CLCN4,ZN2+,GuideToPharmacology,1,blocker
BTS1,NIFLUMIC ACID,GuideToPharmacology,1,blocker
HPGD,OBICETRAPIB,GuideToPharmacology,1,inhibitor
FRA1C,WX-UK1,GuideToPharmacology,1,inhibitor
DPYD,ZOTIRACICLIB,GuideToPharmacology,1,inhibitor
DPYD,LY3022855,GuideToPharmacology,1,antibody
DPYD,PAZOPANIB,GuideToPharmacology,1,inhibitor
FRA1B,"METHYL 5-[(4-TERT-BUTYLBENZOYL)AMINO]-2H-1,2,4-TRIAZOLE-3-CARBOXYLATE",GuideToPharmacology,1,inhibitor
DPYD,ADRIXETINIB,GuideToPharmacology,1,inhibitor
DPYD,VIMSELTINIB,GuideToPharmacology,1,inhibitor
DPYD,GTP-14564,GuideToPharmacology,1,inhibitor
CPT1B,FLURBIPROFEN,GuideToPharmacology,1,inhibitor
CPT1B,BROMFENAC,GuideToPharmacology,1,inhibitor
ALAS2,ONO-2333MS,GuideToPharmacology,1,inhibitor
ALAS2,UROCORTIN 1,GuideToPharmacology,1,agonist
ALB,[125I]ANTISAUVAGINE,GuideToPharmacology,1,inhibitor
ACHE,KBP-088,GuideToPharmacology,1,agonist
DTX1,GILTERITINIB,GuideToPharmacology,1,inhibitor
C6,CARBENOXOLONE,GuideToPharmacology,1,inhibitor
C8B,CARBENOXOLONE,GuideToPharmacology,1,inhibitor
C7,CARBENOXOLONE,GuideToPharmacology,1,inhibitor
ACTG1,SDF1 P2G,GuideToPharmacology,1,inhibitor
EGR4,"6-PHENYL[5H]PYRROLO[2,3-B]PYRAZINE",GuideToPharmacology,1,inhibitor
ACTG1,CX549,GuideToPharmacology,1,inhibitor
AMHR2,PRANLUKAST,GuideToPharmacology,1,inhibitor
COX6A1,NEFAZODONE,GuideToPharmacology,1,inhibitor
BLMH,DIPHOSPHOGLYCOLYL PROLINE,GuideToPharmacology,1,inhibitor
FPGS,TOMINOSTAT,GuideToPharmacology,1,inhibitor
DUSP2,DDR-IN-1,GuideToPharmacology,1,inhibitor
APOB,"15-DEOXY-&DELTA;12,14-PGJ2",GuideToPharmacology,1,agonist
DUSP1,NILOTINIB,GuideToPharmacology,1,inhibitor
FRV3,NEPICASTAT,GuideToPharmacology,1,inhibitor
APOB,DINOPROST,GuideToPharmacology,1,agonist
ABCD1,UNC9994,GuideToPharmacology,1,agonist
ABCD1,ROPINIROLE,GuideToPharmacology,1,agonist
ABCD1,(-)-STEPHOLIDINE,GuideToPharmacology,1,inhibitor
GLI1,EPIGALLOCATECHIN-3-GALLATE,GuideToPharmacology,1,inhibitor
GLI1,C646,GuideToPharmacology,1,inhibitor
DXO,MM-151,GuideToPharmacology,1,antibody
DXO,AFATINIB,GuideToPharmacology,1,inhibitor
APOBER1,17-PHENYL-&OMEGA;-TRINOR-PGE2,GuideToPharmacology,1,agonist
DXO,ZIPALERTINIB,GuideToPharmacology,1,inhibitor
APOC1,DINOPROST,GuideToPharmacology,1,agonist
APOC1P1,BUTAPROST (FREE ACID FORM),GuideToPharmacology,1,agonist
AQP8,ALPROSTADIL,GuideToPharmacology,1,agonist
APOC1P1,L-826266,GuideToPharmacology,1,inhibitor
CHI3L2,DILAZEP,GuideToPharmacology,1,inhibitor
BCYRN1P2,16&ALPHA;-HYDROXYESTRONE,GuideToPharmacology,1,agonist
ERBB4,DACOMITINIB ANHYDROUS,GuideToPharmacology,1,inhibitor
BCYRN1P2,PROPYLPYRAZOLETRIOL,GuideToPharmacology,1,agonist
BCYRN1P2,TAMOXIFEN,GuideToPharmacology,1,agonist
BCYRN1P2,TAMOXIFEN,GuideToPharmacology,1,inhibitor
ESR2,DIARYLPROPIONITRILE,GuideToPharmacology,1,agonist
ALDH1B1,SPARSENTAN,GuideToPharmacology,1,inhibitor
ALDH1B1,"[18F]ET-1 (HUMAN, MOUSE, RAT)",GuideToPharmacology,1,agonist
ALDH1B1,SB234551,GuideToPharmacology,1,inhibitor
ALDH1A3,RO 46-8443,GuideToPharmacology,1,inhibitor
BLVRA,PIRIDRONIC ACID,GuideToPharmacology,1,inhibitor
BMAL1,FLUNITRAZEPAM,GuideToPharmacology,1,modulator
BMAL1,CGS8216,GuideToPharmacology,1,agonist
ARNT,OCINAPLON,GuideToPharmacology,1,modulator
ARR3,ISOGUVACINE,GuideToPharmacology,1,agonist
ARR3,[3H]MUSCIMOL,GuideToPharmacology,1,agonist
ARRB1,BRETAZENIL,GuideToPharmacology,1,modulator
ARRB1,PICROTOXIN,GuideToPharmacology,1,blocker
ARRB2,LAU159,GuideToPharmacology,1,modulator
ARRB2,ISONIPECOTIC ACID,GuideToPharmacology,1,agonist
ART4,ISONIPECOTIC ACID,GuideToPharmacology,1,inhibitor
ARVCF,TPMPA,GuideToPharmacology,1,inhibitor
GABRR3,TRANS-3-ACPBPA,GuideToPharmacology,1,inhibitor
GABRR3,ISOGUVACINE,GuideToPharmacology,1,agonist
ART3,PICROTOXIN,GuideToPharmacology,1,blocker
ARVCF,ISONIPECOTIC ACID,GuideToPharmacology,1,inhibitor
ALOX12P1,M1152,GuideToPharmacology,1,agonist
ALOX12P1,GALMIC,GuideToPharmacology,1,agonist
GALR2,GALANIN(D-TRP2) (PIG),GuideToPharmacology,1,agonist
ALOX12P2,C7,GuideToPharmacology,1,inhibitor
CXCR5,COMPOUND 12  [PMID: 12014956],GuideToPharmacology,1,inhibitor
ALOX15,"L-692,429",GuideToPharmacology,1,modulator
ALOX15,"L-692,429",GuideToPharmacology,1,agonist
ASPH,GYKI53784,GuideToPharmacology,1,inhibitor
ALPL,[125I]GLP-1-(7-37) (HUMAN),GuideToPharmacology,1,agonist
ALPL,ORFORGLIPRON,GuideToPharmacology,1,agonist
ASS1P2,CX516,GuideToPharmacology,1,modulator
GRIA3,CX516,GuideToPharmacology,1,modulator
ASS1P2,LY392098,GuideToPharmacology,1,modulator
BDM,PREDNISONE,GuideToPharmacology,1,agonist
GRIN2A,[3H]CGP61594,GuideToPharmacology,1,inhibitor
GRIN2A,CONANTOKIN-G,GuideToPharmacology,1,inhibitor
ASS1P14,CONANTOKIN-G,GuideToPharmacology,1,inhibitor
ASS1P14,D-CCPENE,GuideToPharmacology,1,inhibitor
GLRA1,PICROTIN,GuideToPharmacology,1,blocker
ASS1P14,N1-DANSYL-SPERMINE,GuideToPharmacology,1,blocker
GLRA1,PICROTOXIN,GuideToPharmacology,1,blocker
ASS1P14,UBP141,GuideToPharmacology,1,inhibitor
GLRA1,H+,GuideToPharmacology,1,modulator
ASAH1,ZN2+,GuideToPharmacology,1,modulator
ARVD4,PICROTIN,GuideToPharmacology,1,blocker
GNRHR,HISTRELIN ACETATE,GuideToPharmacology,1,agonist
DLX6,INDUSATUMAB VEDOTIN,GuideToPharmacology,1,antibody
ARL3,ZD7288,GuideToPharmacology,1,blocker
PRDM1,COMPOUND 17 [PMID: 15686906],GuideToPharmacology,1,inhibitor
ADH1C,COMPOUND 8G [PMID: 21444206],GuideToPharmacology,1,agonist
ADH1C,COMPOUND 23 [PMID: 21444206],GuideToPharmacology,1,agonist
ADH1C,APD668,GuideToPharmacology,1,agonist
ADH1C,MBX-2982,GuideToPharmacology,1,agonist
ACTL6A,SPHINGOSYLPHOSPHORYLCHOLINE,GuideToPharmacology,1,agonist
ADH6,JNJ-63533054,GuideToPharmacology,1,agonist
ACTN4,"7&BETA;, 25-DIHYDROXYCHOLESTEROL",GuideToPharmacology,1,agonist
ACTN2,ASN04421891,GuideToPharmacology,1,agonist
ACTN3,CANNABIDIOL,GuideToPharmacology,1,agonist
ADAR,NEUROPEPTIDE HEAD ACTIVATOR,GuideToPharmacology,1,agonist
ADCY3,"CP55,244",GuideToPharmacology,1,agonist
ADCY3,[3H]RIMONABANT,GuideToPharmacology,1,agonist
ADD3,SETOGEPRAM,GuideToPharmacology,1,inhibitor
ADRA1A,R-SPONDIN-1,GuideToPharmacology,1,agonist
NOS2,PIBTU,GuideToPharmacology,1,inhibitor
DPH1,TEPROTUMUMAB,GuideToPharmacology,1,antibody
FRA14B,COMPOUND 7 [PMID: 31381331],GuideToPharmacology,1,inhibitor
EPHA3,COMPOUND 7 [WO2012007375],GuideToPharmacology,1,inhibitor
DLD,BRODALUMAB,GuideToPharmacology,1,antibody
EPHA7,COMPOUND 7 [WO2012007375],GuideToPharmacology,1,inhibitor
APOC3,ALPROSTADIL,GuideToPharmacology,1,agonist
APOC3,BUTAPROST (FREE ACID FORM),GuideToPharmacology,1,agonist
AEBP1,LPA,GuideToPharmacology,1,agonist
MPPED2,"INOSITOL 2,4,5-TRISPHOSPHATE",GuideToPharmacology,1,activator
APOC3,BMY 45778,GuideToPharmacology,1,agonist
GPX1P2,SAFUSIDENIB,GuideToPharmacology,1,inhibitor
BPI,TOBRAMYCIN,GuideToPharmacology,1,agonist
BSG,GOITRIN,GuideToPharmacology,1,agonist
BRCA2,SCUTELLAREIN,GuideToPharmacology,1,agonist
EPHB1,RUXOLITINIB,GuideToPharmacology,1,inhibitor
EPHB2,GANDOTINIB,GuideToPharmacology,1,inhibitor
EPHB2,"2-TERT-BUTYL-9-FLUORO-1,6-DIHYDROBENZO[H]IMIDAZO[4,5-F]ISOQUINOLIN-7-ONE",GuideToPharmacology,1,inhibitor
EPHB2,ZOTIRACICLIB,GuideToPharmacology,1,inhibitor
EPHB2,WXFL10203614,GuideToPharmacology,1,inhibitor
EPHB2,GOLIDOCITINIB,GuideToPharmacology,1,inhibitor
NUDT2,DIFELIKEFALIN,GuideToPharmacology,1,agonist
FRA2G,AVORALSTAT,GuideToPharmacology,1,inhibitor
NUDT2,NOR-BINALTORPHIMINE,GuideToPharmacology,1,inhibitor
DRD2,PAZOPANIB,GuideToPharmacology,1,inhibitor
DRD2,VANDETANIB,GuideToPharmacology,1,inhibitor
DRD2,RIVOCERANIB,GuideToPharmacology,1,inhibitor
ATP5F1E,RILUZOLE,GuideToPharmacology,1,activator
ATP5F1E,BL-1249,GuideToPharmacology,1,activator
ARG2,NITRENDIPINE,GuideToPharmacology,1,blocker
BAAT,CLOFILIUM,GuideToPharmacology,1,blocker
KCNT1,CLOFILIUM,GuideToPharmacology,1,blocker
LTB4R,FENCLONINE,GuideToPharmacology,1,inhibitor
TPH2,DEXFENFLURAMINE,GuideToPharmacology,1,inhibitor
CMM,METYROSINE,GuideToPharmacology,1,inhibitor
TPH2,&ALPHA;-PROPYLDOPACETAMIDE,GuideToPharmacology,1,inhibitor
ANGPT1,[125I]NDP-MSH,GuideToPharmacology,1,agonist
ANGPT2,RY764,GuideToPharmacology,1,agonist
ETFB,COPANLISIB,GuideToPharmacology,1,inhibitor
ETFB,APITOLISIB,GuideToPharmacology,1,inhibitor
DTNA,GILTERITINIB,GuideToPharmacology,1,inhibitor
ANOP1,COMPOUND 11C [PMID: 17929793],GuideToPharmacology,1,modulator
BLK,FARNESYL DIPHOSPHATE,GuideToPharmacology,1,inhibitor
SLC25A5,GLUTAMIC ACID,GuideToPharmacology,1,agonist
ANPEP,GSK1331268,GuideToPharmacology,1,modulator
SLC25A5,LU AF21934,GuideToPharmacology,1,modulator
SLC25A5,VU0400195,GuideToPharmacology,1,modulator
SLC25A6,LY341495,GuideToPharmacology,1,inhibitor
GRM6,LSP4-2022,GuideToPharmacology,1,agonist
GRM6,GLUTAMIC ACID,GuideToPharmacology,1,agonist
GRM8,GLUTAMIC ACID,GuideToPharmacology,1,agonist
ANTP2,LY341495,GuideToPharmacology,1,inhibitor
NR3C2,ESAXERENONE,GuideToPharmacology,1,inhibitor
NR3C2,FINERENONE,GuideToPharmacology,1,inhibitor
MAPK13,PF-03715455,GuideToPharmacology,1,inhibitor
CTNNB1,7-HYDROXYSTAUROSPORINE,GuideToPharmacology,1,inhibitor
ERVT3,XMD8-92,GuideToPharmacology,1,inhibitor
CTNNA2,COMPOUND 11 [PMID: 26431428],GuideToPharmacology,1,inhibitor
CTNNA2,PAMAPIMOD,GuideToPharmacology,1,inhibitor
ERCC1,STAUROSPORINE,GuideToPharmacology,1,inhibitor
ERCC6,"COMPOUND 3A [PIPIONNE ET AL, 2018]",GuideToPharmacology,1,inhibitor
ERCC4,IACS-52825,GuideToPharmacology,1,inhibitor
MMP7,ILOMASTAT,GuideToPharmacology,1,inhibitor
MMP7,DOXYCYCLINE ANHYDROUS,GuideToPharmacology,1,inhibitor
DCT,ILOMASTAT,GuideToPharmacology,1,inhibitor
FSHMD1A,PIRLINDOLE,GuideToPharmacology,1,inhibitor
ECI1,ONO-4817,GuideToPharmacology,1,inhibitor
CRKL,ABX-1431,GuideToPharmacology,1,inhibitor
ANTP4,ALEMCINAL,GuideToPharmacology,1,agonist
ANTP4,MOTILIN,GuideToPharmacology,1,agonist
FSHMD1B,LAZABEMIDE,GuideToPharmacology,1,inhibitor
FSHMD1B,LINEZOLID,GuideToPharmacology,1,inhibitor
AADAC,KT 5720,GuideToPharmacology,1,modulator
AADAC,HIMBACINE,GuideToPharmacology,1,inhibitor
AADAC,MUSCARINIC TOXIN 2,GuideToPharmacology,1,inhibitor
AAMP,ARECAIDINE PROPARGYL ESTER,GuideToPharmacology,1,agonist
AAMP,HIMBACINE,GuideToPharmacology,1,inhibitor
AAMP,ATROPINE,GuideToPharmacology,1,inhibitor
DRD5P2,REPOTRECTINIB,GuideToPharmacology,1,inhibitor
SERPINC1,MECAMYLAMINE,GuideToPharmacology,1,blocker
ATF1,&ALPHA;-CONOTOXIN MII,GuideToPharmacology,1,inhibitor
AQP3,HEMOKININ 1,GuideToPharmacology,1,agonist
AQP3,FK 224,GuideToPharmacology,1,inhibitor
APBA1,JTC-801,GuideToPharmacology,1,inhibitor
APBA1,NIK-21273,GuideToPharmacology,1,inhibitor
APBA1,J-113397,GuideToPharmacology,1,inhibitor
GPR35,TAREXTUMAB,GuideToPharmacology,1,antibody
NPFFR1,[125I]NPFF,GuideToPharmacology,1,agonist
AMPD2,GUE1654,GuideToPharmacology,1,modulator
APBA2,ACT-335827,GuideToPharmacology,1,inhibitor
APBA2,DANAVOREXTON,GuideToPharmacology,1,agonist
APBA2,JH112,GuideToPharmacology,1,inhibitor
APBB1,YNT-185,GuideToPharmacology,1,agonist
APBB1,MK-3697,GuideToPharmacology,1,inhibitor
EXTL1,IL-94,GuideToPharmacology,1,inhibitor
EXT3,COMPOUND 4 [PMID: 24432870],GuideToPharmacology,1,inhibitor
APBB1,TCS 1102,GuideToPharmacology,1,inhibitor
ATP1B1,PPADS,GuideToPharmacology,1,inhibitor
ATP1B1,AMLODIPINE BESYLATE,GuideToPharmacology,1,modulator
APEH,URIDINE 5'-TRIPHOSPHATE,GuideToPharmacology,1,agonist
APEH,NAADP,GuideToPharmacology,1,agonist
BIRC3,2-THIO-UDP,GuideToPharmacology,1,agonist
BIRC3,UDP-GALACTOSE,GuideToPharmacology,1,agonist
AIRE,3-PHENACYL-UDP,GuideToPharmacology,1,agonist
APCS,URIDINE 5'-TRIPHOSPHATE,GuideToPharmacology,1,agonist
APCS,MRS4062,GuideToPharmacology,1,agonist
APC,PSB1114,GuideToPharmacology,1,agonist
ADCYAP1R1,"[125I]VIP (HUMAN, MOUSE, RAT)",GuideToPharmacology,1,agonist
APOE,AY77,GuideToPharmacology,1,agonist
GPX2,JBI-589,GuideToPharmacology,1,inhibitor
PPID,RENCOFILSTAT,GuideToPharmacology,1,inhibitor
PIK3CB,NVP-CLR457,GuideToPharmacology,1,inhibitor
F7,KU-0060648,GuideToPharmacology,1,inhibitor
FTH1P3,ADENOSINE,GuideToPharmacology,1,inhibitor
F7R,NVP-CLR457,GuideToPharmacology,1,inhibitor
F7R,VULOLISIB,GuideToPharmacology,1,inhibitor
GPR34,APILIMOD,GuideToPharmacology,1,inhibitor
APOA1,IS20,GuideToPharmacology,1,agonist
F2,STAUROSPORINE,GuideToPharmacology,1,inhibitor
APOA1,PROKINETICIN-2,GuideToPharmacology,1,agonist
FRA5A,UK-356202,GuideToPharmacology,1,inhibitor
APOA1,MIT1,GuideToPharmacology,1,agonist
DPP4,ELENESTINIB,GuideToPharmacology,1,inhibitor
DPP6,KBP-7018,GuideToPharmacology,1,inhibitor
DPP4,ENMD-2076,GuideToPharmacology,1,inhibitor
DPP6,SU-14813,GuideToPharmacology,1,inhibitor
FABP1,PLOGOSERTIB,GuideToPharmacology,1,inhibitor
FABP1,GSK579289A,GuideToPharmacology,1,inhibitor
FABP1,COMPOUND 2 [PMID: 19097784],GuideToPharmacology,1,inhibitor
GNAI2,TALAZOPARIB,GuideToPharmacology,1,inhibitor
CD24P4,COMPOUND 58 [PMID: 25037917],GuideToPharmacology,1,inhibitor
FRA6F,WLL-VS,GuideToPharmacology,1,inhibitor
FRA6F,NIC-0102,GuideToPharmacology,1,inhibitor
PSMB8,ZETOMIPZOMIB,GuideToPharmacology,1,inhibitor
CTAG1B,CC-90005,GuideToPharmacology,1,inhibitor
CTAA1,PKCBETA INHIBITOR,GuideToPharmacology,1,inhibitor
CTBP2,CC-90005,GuideToPharmacology,1,inhibitor
CTAA2,G&OUML; 6983,GuideToPharmacology,1,inhibitor
CTBP2,PKC&THETA; INHIBITOR 14,GuideToPharmacology,1,inhibitor
NRG1,NC1,GuideToPharmacology,1,inhibitor
CTSS,RKI-1447,GuideToPharmacology,1,inhibitor
CTSW,Y27632,GuideToPharmacology,1,inhibitor
CTSS,STAUROSPORINE,GuideToPharmacology,1,inhibitor
FANCG,RIPK3 INHIBITOR 18,GuideToPharmacology,1,inhibitor
FANCG,NECROSTATIN-1,GuideToPharmacology,1,inhibitor
BCHE,RO 41-5253,GuideToPharmacology,1,inhibitor
BCHEL1,TRIFAROTENE,GuideToPharmacology,1,agonist
PTK2B,KBP-7018,GuideToPharmacology,1,inhibitor
HCN2,BEXAROTENE,GuideToPharmacology,1,agonist
BCHEL3,AHPN,GuideToPharmacology,1,agonist
GAB1,A1120,GuideToPharmacology,1,inhibitor
RXRG,BEXAROTENE,GuideToPharmacology,1,agonist
PTK2B,SUNITINIB,GuideToPharmacology,1,inhibitor
CTPS1,RKI-1447,GuideToPharmacology,1,inhibitor
NIPSNAP2,GEMCITABINE,GuideToPharmacology,1,inhibitor
CTRB1,RIPASUDIL,GuideToPharmacology,1,inhibitor
APRT,H3 14S18 STAPLED B-CHAIN,GuideToPharmacology,1,agonist
APPL1,A(10-24)INSL3,GuideToPharmacology,1,inhibitor
KLK3,COMPOUND 10D [PMID: 34855388],GuideToPharmacology,1,agonist
AMT,CENERIMOD,GuideToPharmacology,1,agonist
AMT,OZANIMOD,GuideToPharmacology,1,agonist
CD9,VILAZODONE HYDROCHLORIDE,GuideToPharmacology,1,inhibitor
SIGMAR1,DEXTROMETHORPHAN POLISTIREX,GuideToPharmacology,1,agonist
CD5L,"IBUPROFEN, SODIUM SALT",GuideToPharmacology,1,inhibitor
GYPB,COMPOUND 6F [PMID: 35476936],GuideToPharmacology,1,inhibitor
CD44,ELOBIXIBAT,GuideToPharmacology,1,inhibitor
FCAR,SK1-I,GuideToPharmacology,1,inhibitor
FCER1A,ROME,GuideToPharmacology,1,inhibitor
MS4A2,DORSOMORPHIN,GuideToPharmacology,1,inhibitor
FASLG,SRIF-28,GuideToPharmacology,1,agonist
FASLG,SIFA-ASN(ACNH-&BETA;-GLC)-TYR3-OCTREOTATE,GuideToPharmacology,1,agonist
FASLG,[111IN]DOTA-BOC-ATE,GuideToPharmacology,1,agonist
SHROOM2,LANREOTIDE ACETATE,GuideToPharmacology,1,agonist
FBN1,DANUSERTIB,GuideToPharmacology,1,inhibitor
BCGF1,KB-141,GuideToPharmacology,1,agonist
FGF2,GSK329,GuideToPharmacology,1,inhibitor
TLR4,RESATORVID,GuideToPharmacology,1,inhibitor
DMBT1,FLAGELLIN,GuideToPharmacology,1,agonist
APOC4,ILOPROST,GuideToPharmacology,1,agonist
APOC4,DINOPROST,GuideToPharmacology,1,agonist
ARHGAP4,MT-8,GuideToPharmacology,1,inhibitor
FRDA2,"INHIBITOR 1 [COLOMBO ET AL., 2012]",GuideToPharmacology,1,inhibitor
ATP2B2,SAG,GuideToPharmacology,1,activator
ATP2B3,BI 749327,GuideToPharmacology,1,blocker
ATP3,ADP RIBOSE,GuideToPharmacology,1,activator
ATP2B2,BI 749327,GuideToPharmacology,1,blocker
ATP3,H+,GuideToPharmacology,1,blocker
ATP4A,GD3+,GuideToPharmacology,1,blocker
MCOLN3,SF-21,GuideToPharmacology,1,activator
PKD2L1,GD3+,GuideToPharmacology,1,blocker
MCOLN3,ESTRADIOL 3-METHYL ETHER,GuideToPharmacology,1,inhibitor
TRPV4,PROPOFOL,GuideToPharmacology,1,inhibitor
TYK2,CERDULATINIB,GuideToPharmacology,1,inhibitor
UTS2R,SB-706375,GuideToPharmacology,1,inhibitor
CDH13,[11C]DTBZ,GuideToPharmacology,1,inhibitor
UTS2R,4-CL-CINNAMOYL-C[DCYS-4PAL-DTRP-ORN-VAL-CYS]-HIS-AMIDE,GuideToPharmacology,1,inhibitor
ARCN2,BAY 55-9837,GuideToPharmacology,1,agonist
AQP9,"D(CH2)5[TYR(ME)2,THR4]OVT",GuideToPharmacology,1,inhibitor
AR,DVDAVP,GuideToPharmacology,1,agonist
ABCC6,LIT-001,GuideToPharmacology,1,agonist
ABCC6,DVDAVP,GuideToPharmacology,1,agonist
AR,"[TBAA1,D-TYR(ET)2,VAL4,LYS6,ARG-NH28,DES-GLY9]AVP",GuideToPharmacology,1,inhibitor
GNG10,SM-337,GuideToPharmacology,1,inhibitor
ABCC6,SATAVAPTAN,GuideToPharmacology,1,inhibitor
ABCC6,YM 218,GuideToPharmacology,1,inhibitor
ABCC6,"[125I]D(CH2)5[D-TYR(ET)2,VAL4,TYR-NH29]AVP",GuideToPharmacology,1,inhibitor
ANXA5,NPY-(3-36) (PIG),GuideToPharmacology,1,agonist
ANXA4,NEUROPEPTIDE Y,GuideToPharmacology,1,agonist
ABCA2,ROLOFYLLINE,GuideToPharmacology,1,inhibitor
GLI1,LYS-COA,GuideToPharmacology,1,inhibitor
HBEGF,GILTERITINIB,GuideToPharmacology,1,inhibitor
GLG1,COMPOUND 50 [PMID: 24313754],GuideToPharmacology,1,inhibitor
HRH3,VUF14862,GuideToPharmacology,1,inhibitor
AMELX,HTMT,GuideToPharmacology,1,agonist
ACSL1,VS-4718,GuideToPharmacology,1,inhibitor
CPT2,HR1405-01,GuideToPharmacology,1,inhibitor
CSTF3,CAPIVASERTIB,GuideToPharmacology,1,inhibitor
GRIN2A,PLAZINEMDOR,GuideToPharmacology,1,modulator
GAS2,CUDC-101,GuideToPharmacology,1,inhibitor
ERPL2,MEK INHIBITOR II,GuideToPharmacology,1,inhibitor
CCND1,T0070907,GuideToPharmacology,1,inhibitor
SIGMAR1,E-52862,GuideToPharmacology,1,inhibitor
FRA11F,ABRILUMAB,GuideToPharmacology,1,antibody
ACAT1,DNAL-CYC(CYS-TYR-DTRP-ORN-VAL)-NAL-NH2,GuideToPharmacology,1,inhibitor
NAT1,RELENOPRIDE,GuideToPharmacology,1,agonist
XIAP,"[ILE5,TRP23]PTHRP-(2-36) (HUMAN)",GuideToPharmacology,1,agonist
AQP7,&BETA;-PHENYLETHYLAMINE,GuideToPharmacology,1,agonist
NAT1,SB 203186,GuideToPharmacology,1,inhibitor
ADCY3,RIMONABANT,GuideToPharmacology,1,inhibitor
NKX2-5,ENZASTAURIN,GuideToPharmacology,1,inhibitor
NUDT2,ADL5747,GuideToPharmacology,1,agonist
FDX1,CERDULATINIB,GuideToPharmacology,1,inhibitor
ABAT,TONAPOFYLLINE,GuideToPharmacology,1,inhibitor
ACTN3,AM251,GuideToPharmacology,1,agonist
ART4,TPMPA,GuideToPharmacology,1,inhibitor
APP,COMPOUND 54,GuideToPharmacology,1,agonist
ACHE,&ALPHA;-CGRP,GuideToPharmacology,1,agonist
ACSL1,COMPOUND 30 [PMID: 23414845],GuideToPharmacology,1,inhibitor
CA4,COMPOUND 5B  [PMID: 31287314],GuideToPharmacology,1,inhibitor
ATP4B,ADENOSINE,GuideToPharmacology,1,blocker
ATP5F1BP1,ALLICIN,GuideToPharmacology,1,blocker
ANXA13,SCH 900271,GuideToPharmacology,1,agonist
A12M3,&ALPHA;-METHYL-5-HT,GuideToPharmacology,1,agonist
CHKB,CIMETIDINE,GuideToPharmacology,1,inhibitor
CD27,INHIBITOR CB3,GuideToPharmacology,1,inhibitor
AANAT,CHF-6366,GuideToPharmacology,1,inhibitor
ARCN1,RO 25-1392,GuideToPharmacology,1,agonist
APOF,NFP,GuideToPharmacology,1,inhibitor
APEX1,COMPOUND 20O [PMID: 22984835],GuideToPharmacology,1,inhibitor
ALDH3A2,F2L,GuideToPharmacology,1,agonist
FRA1A,EP-7041,GuideToPharmacology,1,inhibitor
ALCAM,MEVIDALEN,GuideToPharmacology,1,modulator
APBA2,HTL6641,GuideToPharmacology,1,inhibitor
BAK1,VERATRIDINE,GuideToPharmacology,1,activator
MS4A2,NG-25,GuideToPharmacology,1,inhibitor
BCYRN1P2,CAMIZESTRANT,GuideToPharmacology,1,inhibitor
AARS1,AQ-RA 741,GuideToPharmacology,1,inhibitor
AQP5,HEMOKININ 1,GuideToPharmacology,1,agonist
GRIN2B,[3H]CGP61594,GuideToPharmacology,1,inhibitor
ERCC3,CEP-1347,GuideToPharmacology,1,inhibitor
C1QBP,CROFELEMER,GuideToPharmacology,1,inhibitor
A12M4,ORG 12962,GuideToPharmacology,1,agonist
EEF1D,ENMD-2076,GuideToPharmacology,1,inhibitor
FOLR2,ODANACATIB,GuideToPharmacology,1,inhibitor
ACADM,IRBESARTAN,GuideToPharmacology,1,inhibitor
AMH,LY255283,GuideToPharmacology,1,inhibitor
ABCF1,OXYMETAZOLINE HYDROCHLORIDE,GuideToPharmacology,1,agonist
AMD1P2,FAMOTIDINE,GuideToPharmacology,1,inhibitor
ATP7B,MARGATOXIN,GuideToPharmacology,1,blocker
BDM,CICLESONIDE,GuideToPharmacology,1,agonist
BRDT,COHUMULONE,GuideToPharmacology,1,agonist
ALDH3B2,[125I]CATHEPSIN G (HUMAN),GuideToPharmacology,1,agonist
EFNA4,I-BET282,GuideToPharmacology,1,inhibitor
ERBB4,IBRUTINIB,GuideToPharmacology,1,inhibitor
HTR2C,[3H]8-OH-DPAT,GuideToPharmacology,1,agonist
LTB4R,&ALPHA;-PROPYLDOPACETAMIDE,GuideToPharmacology,1,inhibitor
BCL2A1,ZINC PROTOPORPHYRIN IX,GuideToPharmacology,1,inhibitor
BEVI,ARD-266,GuideToPharmacology,1,inhibitor
ABCA2,AS94,GuideToPharmacology,1,inhibitor
F5,COMPOUND 41 [PMID: 31855425],GuideToPharmacology,1,inhibitor
GCK,PHENINDIONE,GuideToPharmacology,1,inhibitor
ATF3,[125I]&ALPHA;-CONOTOXIN MII,GuideToPharmacology,1,inhibitor
SHROOM2,[111IN]DOTA-BOC-ATE,GuideToPharmacology,1,agonist
CRK,HEXACHLOROPHENE,GuideToPharmacology,1,inhibitor
EPHA7,COMPOUND 1 [WO2012007375],GuideToPharmacology,1,inhibitor
ANXA2P3,PEPTIDE YY,GuideToPharmacology,1,agonist
ACTG1,MOTIXAFORTIDE,GuideToPharmacology,1,inhibitor
CPD,NORENDOXIFEN,GuideToPharmacology,1,inhibitor
A1BG,THIORIDAZINE,GuideToPharmacology,1,inhibitor
A2M,"L-772,405",GuideToPharmacology,1,agonist
A2M,CAPESEROD,GuideToPharmacology,1,agonist
A2M,GR-55562,GuideToPharmacology,1,inhibitor
A12M2,[3H]8-OH-DPAT,GuideToPharmacology,1,agonist
A12M2,OLANZAPINE,GuideToPharmacology,1,agonist
A12M1,BRL-15572,GuideToPharmacology,1,agonist
A12M3,QUETIAPINE FUMARATE,GuideToPharmacology,1,agonist
A12M3,QUETIAPINE FUMARATE,GuideToPharmacology,1,inhibitor
A12M3,TERGURIDE,GuideToPharmacology,1,agonist
A12M3,COMPOUND 3B [PMID:28943244],GuideToPharmacology,1,inhibitor
A12M4,CAPESEROD,GuideToPharmacology,1,agonist
A12M4,&ALPHA;-METHYL-5-HT,GuideToPharmacology,1,agonist
A12M4,ORG-37684,GuideToPharmacology,1,agonist
HTR2C,TERGURIDE,GuideToPharmacology,1,inhibitor
NAT1,TROPISETRON,GuideToPharmacology,1,inhibitor
NATP,CERLAPIRDINE,GuideToPharmacology,1,inhibitor
CACNA1S,COMPOUND 14 [PMID: 30925062],GuideToPharmacology,1,inhibitor
CA9,COMPOUND 14 [PMID: 30925062],GuideToPharmacology,1,inhibitor
CSTP1,CAPIVASERTIB,GuideToPharmacology,1,inhibitor
HBEGF,ENVONALKIB,GuideToPharmacology,1,inhibitor
ABCB7,[125I]HEAT (BE2254),GuideToPharmacology,1,inhibitor
ABCB7,WB 4101,GuideToPharmacology,1,inhibitor
ABCA4,[125I]HEAT (BE2254),GuideToPharmacology,1,inhibitor
ABCA4,WB 4101,GuideToPharmacology,1,inhibitor
ABCA4,MIANSERIN,GuideToPharmacology,1,inhibitor
ABCA4,SNAP5089,GuideToPharmacology,1,inhibitor
ABL1,RX821002,GuideToPharmacology,1,inhibitor
ABL1,MUSCARINIC TOXIN 3,GuideToPharmacology,1,inhibitor
ABL1,OXYMETAZOLINE HYDROCHLORIDE,GuideToPharmacology,1,agonist
AOC1,RX821002,GuideToPharmacology,1,inhibitor
AOC1,TERGURIDE,GuideToPharmacology,1,inhibitor
AOC1,WB 4101,GuideToPharmacology,1,inhibitor
AOC1,OXYMETAZOLINE HYDROCHLORIDE,GuideToPharmacology,1,agonist
ABL2,TERGURIDE,GuideToPharmacology,1,inhibitor
GNA11,PXS-4728A,GuideToPharmacology,1,inhibitor
DAPK3,TRANDOLAPRILAT,GuideToPharmacology,1,inhibitor
ABAT,VIPADENANT,GuideToPharmacology,1,inhibitor
ABCA1,GALANGIN,GuideToPharmacology,1,inhibitor
ABCA1,REGADENOSON ANHYDROUS,GuideToPharmacology,1,agonist
ABCA1,CVT-6883,GuideToPharmacology,1,inhibitor
ABCA3,REGADENOSON ANHYDROUS,GuideToPharmacology,1,agonist
ABCA3,VISNAGIN,GuideToPharmacology,1,inhibitor
ABCA3,ROLOFYLLINE,GuideToPharmacology,1,inhibitor
ABCA3,TONAPOFYLLINE,GuideToPharmacology,1,inhibitor
ACADM,TELMISARTAN,GuideToPharmacology,1,inhibitor
ASIC2,MK-5046,GuideToPharmacology,1,agonist
ABO,(-)-RO 363,GuideToPharmacology,1,agonist
DNMT3B,COMPOUND 13R [PMID: 23639540],GuideToPharmacology,1,inhibitor
EFNA4,AMREDOBRESIB,GuideToPharmacology,1,inhibitor
GCLC,(+)-JQ1,GuideToPharmacology,1,inhibitor
GLC3B,COMPOUND 50 [PMID: 24313754],GuideToPharmacology,1,inhibitor
EFNB2,BMS-986142,GuideToPharmacology,1,inhibitor
EFNB2,COMPOUND 31 [PMID: 24915291],GuideToPharmacology,1,inhibitor
EFNB2,BRANEBRUTINIB,GuideToPharmacology,1,inhibitor
EFNB2,GDC-0834,GuideToPharmacology,1,inhibitor
ASIC1,[DES-ARG11]T-KININ,GuideToPharmacology,1,agonist
ASIC1,"[DES-PRO8,DES-PHE9,DES-ARG10]KALLIDIN",GuideToPharmacology,1,agonist
ASIC1,"[LEU8,DES-ARG9]BRADYKININ",GuideToPharmacology,1,inhibitor
ACACA,C3A,GuideToPharmacology,1,agonist
FRA20A,TACRINE,GuideToPharmacology,1,inhibitor
CD27,INHIBITOR E18,GuideToPharmacology,1,inhibitor
FRA20A,PHYSOSTIGMINE,GuideToPharmacology,1,inhibitor
BDKRB2,"[THI5,8,D-PHE7]BRADYKININ",GuideToPharmacology,1,inhibitor
ACACB,AVACOPAN,GuideToPharmacology,1,inhibitor
ACACB,NDT9520492,GuideToPharmacology,1,inhibitor
C1QBP,MONNA,GuideToPharmacology,1,inhibitor
C1QBP,DCDPC,GuideToPharmacology,1,blocker
CYP27B1,COMPOUND 4 [PMID: 19954973],GuideToPharmacology,1,inhibitor
DAZ1,PRALNACASAN,GuideToPharmacology,1,inhibitor
ATP6V0A1,Z944,GuideToPharmacology,1,blocker
ATP6V1E1,(-)-(S)-BAYK8644,GuideToPharmacology,1,activator
ATP6V0A1,ANANDAMIDE,GuideToPharmacology,1,blocker
FOLR2,K777,GuideToPharmacology,1,inhibitor
ACTA1,CCL14,GuideToPharmacology,1,agonist
ACTB,RO116-4875/608,GuideToPharmacology,1,inhibitor
CELA1,"ETHYL 3-[(E)-2-AMINO-1-CYANOETHENYL]-6,7-DICHLORO-1-METHYL-1H-INDOLE-2-CARBOXYLATE",GuideToPharmacology,1,inhibitor
CFTR,GLYBURIDE,GuideToPharmacology,1,blocker
CFTR,CROFELEMER,GuideToPharmacology,1,inhibitor
CPT2,"IBUPROFEN, SODIUM SALT",GuideToPharmacology,1,inhibitor
CPT2,ROFECOXIB,GuideToPharmacology,1,inhibitor
CPT2,SULINDAC,GuideToPharmacology,1,inhibitor
C4A,CARBENOXOLONE,GuideToPharmacology,1,inhibitor
C3AR1,CARBENOXOLONE,GuideToPharmacology,1,inhibitor
C1S,CARBENOXOLONE,GuideToPharmacology,1,inhibitor
ACTBP9,SX-517,GuideToPharmacology,1,inhibitor
EGR4,JNJ-7706621,GuideToPharmacology,1,inhibitor
EIF4A1,K-00546,GuideToPharmacology,1,inhibitor
EIF4A1,JNJ-7706621,GuideToPharmacology,1,inhibitor
CDK4,BSJ-04-132,GuideToPharmacology,1,inhibitor
EIF4EBP2,ASNUCICLIB,GuideToPharmacology,1,inhibitor
EIF4G1,CGP74514A,GuideToPharmacology,1,inhibitor
EIF4G1,ENITOCICLIB,GuideToPharmacology,1,inhibitor
EIF4EBP2,MEVOCICLIB,GuideToPharmacology,1,inhibitor
CORD1,5H3'FPE,GuideToPharmacology,1,inhibitor
EIF4G1,ZOTIRACICLIB,GuideToPharmacology,1,inhibitor
HLA-E,DECITABINE,GuideToPharmacology,1,inhibitor
CD8B2,LEVOMILNACIPRAN,GuideToPharmacology,1,inhibitor
ELK1,STAUROSPORINE,GuideToPharmacology,1,inhibitor
CD8B2,TRIMIPRAMINE,GuideToPharmacology,1,inhibitor
APAF1,ETORPHINE,GuideToPharmacology,1,agonist
APAF1,DYNORPHIN A-(1-13),GuideToPharmacology,1,agonist
CRIP2,KT-109,GuideToPharmacology,1,inhibitor
DHODH,COMPOUND 19 [PMID: 35925768],GuideToPharmacology,1,inhibitor
CRIP2,DO34,GuideToPharmacology,1,inhibitor
DHODH,BRD9185,GuideToPharmacology,1,inhibitor
ABCD1,QUETIAPINE FUMARATE,GuideToPharmacology,1,inhibitor
ABCD1,RACLOPRIDE,GuideToPharmacology,1,inhibitor
CXCR3,ENARODUSTAT,GuideToPharmacology,1,inhibitor
DXO,CUDC-101,GuideToPharmacology,1,inhibitor
DXO,SUNVOZERTINIB,GuideToPharmacology,1,inhibitor
BLVRA,ISOPENTENYL PYROPHOSPHATE,GuideToPharmacology,1,inhibitor
CCR10,BMS-214662,GuideToPharmacology,1,inhibitor
FYB1,COMPOUND 13 [PMID: 17502136],GuideToPharmacology,1,inhibitor
GSM1,IGE HEAVY CHAIN,GuideToPharmacology,1,agonist
ENG,COMPOUND 8E [PMID: 24432909],GuideToPharmacology,1,inhibitor
ENO1,COMPOUND 8E [PMID: 24432909],GuideToPharmacology,1,inhibitor
ALDOA,N-VALERIC ACID,GuideToPharmacology,1,agonist
ALDOA,BUTYRIC ACID,GuideToPharmacology,1,agonist
DPYSL2,LY2874455,GuideToPharmacology,1,inhibitor
DPYSL2,SU-11652,GuideToPharmacology,1,inhibitor
DPYSL2,DERAZANTINIB,GuideToPharmacology,1,inhibitor
DPYSL3,COMPOUND 29 [PMID: 36356320],GuideToPharmacology,1,inhibitor
DPYSL3,DERAZANTINIB,GuideToPharmacology,1,inhibitor
DRD1,FORETINIB,GuideToPharmacology,1,inhibitor
DRD3,IBCASERTIB,GuideToPharmacology,1,inhibitor
ALDH3B2,CHENODEOXYCHOLIC ACID,GuideToPharmacology,1,inhibitor
ALDH9A1,BMS-986235,GuideToPharmacology,1,agonist
APOC2,DINOPROST,GuideToPharmacology,1,agonist
APOC2,LATANOPROST (FREE ACID FORM),GuideToPharmacology,1,agonist
GABRA1,BRETAZENIL,GuideToPharmacology,1,modulator
ARNT,[3H]MUSCIMOL,GuideToPharmacology,1,agonist
ARNT,FLUNITRAZEPAM,GuideToPharmacology,1,modulator
ARNT,ISOGUVACINE,GuideToPharmacology,1,agonist
ARNT,BRETAZENIL,GuideToPharmacology,1,modulator
GALR2,GALANIN-LIKE PEPTIDE,GuideToPharmacology,1,agonist
CXCR5,BPH-715,GuideToPharmacology,1,inhibitor
CD14,SKF89976A,GuideToPharmacology,1,inhibitor
ASS1P2,GYKI53784,GuideToPharmacology,1,inhibitor
ALPG,ADOMEGLIVANT,GuideToPharmacology,1,inhibitor
BDM,DIFLUPREDNATE,GuideToPharmacology,1,agonist
BDM,LEO 134310,GuideToPharmacology,1,agonist
BDM,METHYLPREDNISOLONE,GuideToPharmacology,1,agonist
GRIK3,[3H]UBP310,GuideToPharmacology,1,inhibitor
GRIN2B,ONFASPRODIL,GuideToPharmacology,1,modulator
GRIN2C,GLYCINE,GuideToPharmacology,1,agonist
GRIN2B,GLYCINE,GuideToPharmacology,1,agonist
GRIN2C,GLYCINE,GuideToPharmacology,1,agonist
GRIN2C,NMDA,GuideToPharmacology,1,agonist
GNRHR,D-24710,GuideToPharmacology,1,inhibitor
ALDH3B1,G-1,GuideToPharmacology,1,agonist
ACADVL,CHENODEOXYCHOLIC ACID,GuideToPharmacology,1,agonist
DLX4,VOSORITIDE,GuideToPharmacology,1,agonist
ANXA13,MONOMETHYL FUMARATE,GuideToPharmacology,1,agonist
ARL1,ZD7288,GuideToPharmacology,1,blocker
GDF2,TUCIDINOSTAT,GuideToPharmacology,1,inhibitor
GARS1,ABEXINOSTAT,GuideToPharmacology,1,inhibitor
LRRC32,VORINOSTAT,GuideToPharmacology,1,inhibitor
GARS1,BUTYRIC ACID,GuideToPharmacology,1,inhibitor
GARS1,ROMIDEPSIN,GuideToPharmacology,1,inhibitor
GARS1,CUDC-101,GuideToPharmacology,1,inhibitor
GAS1,CUDC-101,GuideToPharmacology,1,inhibitor
GAS1,ROMIDEPSIN,GuideToPharmacology,1,inhibitor
AMD1,HISTAMINE,GuideToPharmacology,1,agonist
AMD1,OXO-ARPROMIDINE,GuideToPharmacology,1,agonist
AMD1,CLOBENPROPIT,GuideToPharmacology,1,inhibitor
AMD1P2,RANITIDINE HYDROCHLORIDE,GuideToPharmacology,1,inhibitor
HRH3,UCL-2138,GuideToPharmacology,1,inhibitor
HRH3,VUF 4904,GuideToPharmacology,1,inhibitor
GMFA,AZD4017,GuideToPharmacology,1,inhibitor
GMFA,ABT-384,GuideToPharmacology,1,inhibitor
PRDM1,GLPDGG PEPTIDE [PMID: 20494585],GuideToPharmacology,1,inhibitor
ADH1C,COMPOUND 58 [PMID: 21273063],GuideToPharmacology,1,agonist
ADCY3,AM251,GuideToPharmacology,1,agonist
ADAM10,LODOXAMIDE TROMETHAMINE,GuideToPharmacology,1,agonist
ADCY3,GSK575594A,GuideToPharmacology,1,agonist
ADCY3,PALMIDROL,GuideToPharmacology,1,agonist
GRK3,PAMP-12 (HUMAN),GuideToPharmacology,1,agonist
FRA1L,NTE-2,GuideToPharmacology,1,inhibitor
APOC3,ILOPROST,GuideToPharmacology,1,agonist
APOC3,ESUBERAPROST,GuideToPharmacology,1,agonist
FOXL2,RESVERATROL,GuideToPharmacology,1,agonist
EPHB3,JAK3 INHIBITOR II,GuideToPharmacology,1,inhibitor
EPHB3,IBRUTINIB,GuideToPharmacology,1,inhibitor
EPHB3,AT-9283,GuideToPharmacology,1,inhibitor
EPHB3,LEPZACITINIB,GuideToPharmacology,1,inhibitor
EPHB3,JAK3 INHIBITOR IV,GuideToPharmacology,1,inhibitor
CD79B,DIOA,GuideToPharmacology,1,inhibitor
DRD2,ENMD-2076,GuideToPharmacology,1,inhibitor
DRD2,IBCASERTIB,GuideToPharmacology,1,inhibitor
GPM6B,ARS-1620,GuideToPharmacology,1,inhibitor
DPT,RIVOCERANIB,GuideToPharmacology,1,inhibitor
ARF4P1,FLINDOKALNER,GuideToPharmacology,1,activator
ARF5,NS8593,GuideToPharmacology,1,inhibitor
BAAT,LY97241,GuideToPharmacology,1,blocker
ATP7A,MARGATOXIN,GuideToPharmacology,1,blocker
ATP5PO,ANANDAMIDE,GuideToPharmacology,1,blocker
GRIK1-AS2,LY97241,GuideToPharmacology,1,blocker
AZF2,L735821,GuideToPharmacology,1,blocker
AZGP1,FLINDOKALNER,GuideToPharmacology,1,activator
AZF2,EZOGABINE,GuideToPharmacology,1,modulator
FRA10D,COMPOUND 10 [PMID: 22533316],GuideToPharmacology,1,inhibitor
FRA10D,"COMPOUND 1 [GOTTELAND ET AL., 1997]",GuideToPharmacology,1,inhibitor
FRA10D,COMPOUND 8 [PMID: 22533316],GuideToPharmacology,1,inhibitor
EPHX2,PP2,GuideToPharmacology,1,inhibitor
EPS8,MLI-2,GuideToPharmacology,1,inhibitor
BCL3,AZ12260493,GuideToPharmacology,1,agonist
BAK1P2,TO-901317,GuideToPharmacology,1,agonist
CLN8,COMPOUND 22M [PMID: 19831390],GuideToPharmacology,1,inhibitor
ADH1A,TCLPA5,GuideToPharmacology,1,inhibitor
GDI1,MG149,GuideToPharmacology,1,inhibitor
SLC47A2,CIMETIDINE,GuideToPharmacology,1,inhibitor
AMY2B,S36540,GuideToPharmacology,1,inhibitor
MCHR1,VENETOCLAX,GuideToPharmacology,1,inhibitor
ANCR,SHU9119,GuideToPharmacology,1,agonist
ANOP1,COMPOUND 10I [PMID: 23084894],GuideToPharmacology,1,modulator
DRD4,RIPK3 INHIBITOR 18,GuideToPharmacology,1,inhibitor
BLK,FARNESOL,GuideToPharmacology,1,inhibitor
ANPEP,RO4491533,GuideToPharmacology,1,modulator
ANPEP,LY395756,GuideToPharmacology,1,agonist
ANOP1,CIS-10 [PMID: 15771457],GuideToPharmacology,1,modulator
ANPEP,GLUTAMIC ACID,GuideToPharmacology,1,agonist
SLC25A4,(+)-MCPG,GuideToPharmacology,1,inhibitor
ANPEP,(+)-MCPG,GuideToPharmacology,1,inhibitor
MAP2K1,COMPOUND 3 [PMID: 31804822],GuideToPharmacology,1,modulator
MAP2K1,E6201,GuideToPharmacology,1,inhibitor
AADAC,BIPERIDEN,GuideToPharmacology,1,inhibitor
AANAT,BRUCINE N-OXIDE,GuideToPharmacology,1,modulator
AANAT,AQ-RA 741,GuideToPharmacology,1,inhibitor
AARS1,IPEROXO,GuideToPharmacology,1,agonist
AARS1,LY2119620,GuideToPharmacology,1,modulator
AARS1,AMITRIPTYLINE HYDROCHLORIDE,GuideToPharmacology,1,inhibitor
AARS1,TIOTROPIUM,GuideToPharmacology,1,inhibitor
AARS1,MUSCARINIC TOXIN 2,GuideToPharmacology,1,inhibitor
AAVS1,TIOTROPIUM,GuideToPharmacology,1,inhibitor
AAVS1,MUSCARINIC TOXIN 7,GuideToPharmacology,1,inhibitor
AAVS1,MUSCARINIC TOXIN 3,GuideToPharmacology,1,inhibitor
ANK3,UCSF4226,GuideToPharmacology,1,agonist
ANK2,UCSF4226,GuideToPharmacology,1,agonist
ANK2,IIK7,GuideToPharmacology,1,agonist
APOF,DYNORPHIN A-(1-13),GuideToPharmacology,1,agonist
APOF,TRAMADOL,GuideToPharmacology,1,agonist
APOF,AR-M1000390,GuideToPharmacology,1,agonist
APOF,BMS-986121,GuideToPharmacology,1,modulator
H1-0,COMPOUND 7C [PMID: 22041175],GuideToPharmacology,1,inhibitor
BARD1,GNE-616,GuideToPharmacology,1,blocker
BAX,&MU;-CONOTOXIN GIIIA,GuideToPharmacology,1,blocker
NKX3-2,FUNAPIDE,GuideToPharmacology,1,inhibitor
BBS2,&BETA;-SCORPION TOXIN CN2,GuideToPharmacology,1,activator
SCN9A,N-ME-AMINOPYRIMIDINONE 9,GuideToPharmacology,1,inhibitor
SCN9A,VERATRIDINE,GuideToPharmacology,1,activator
SCN9A,GNE-616,GuideToPharmacology,1,blocker
BBS2,GNE-131,GuideToPharmacology,1,inhibitor
ATF4,IVERMECTIN,GuideToPharmacology,1,modulator
ATF1,&ALPHA;-CONOTOXIN TXIA,GuideToPharmacology,1,inhibitor
ATF4P1,RGIA4,GuideToPharmacology,1,inhibitor
AQP3,KASSININ,GuideToPharmacology,1,agonist
NMUR1,COMPOUND 8D [PMID: 24999562],GuideToPharmacology,1,agonist
NUAK1,CERDULATINIB,GuideToPharmacology,1,inhibitor
SLCO2B1,VERLUKAST,GuideToPharmacology,1,inhibitor
ARAF,"L-366,875",GuideToPharmacology,1,inhibitor
ARAF,"L-366,509",GuideToPharmacology,1,inhibitor
APBB2,GLAXOSMITHKLINE COMPOUND 5H [PMID:20542694],GuideToPharmacology,1,inhibitor
GPX2,O-F-AMIDINE,GuideToPharmacology,1,inhibitor
BCKDHA,TZD18,GuideToPharmacology,1,agonist
CCND1,EDAGLITAZONE,GuideToPharmacology,1,agonist
CCND1,[125I]SB-236636,GuideToPharmacology,1,agonist
CCND1,TZD18,GuideToPharmacology,1,agonist
CCND1,GW7845,GuideToPharmacology,1,agonist
CCND1,SB-219993,GuideToPharmacology,1,agonist
CCND1,2-CHLORO-5-NITRO-N-PHENYLBENZAMIDE,GuideToPharmacology,1,inhibitor
F5,HS-173,GuideToPharmacology,1,inhibitor
F5,RISOVALISIB,GuideToPharmacology,1,inhibitor
PIK3CB,COMPOUND 41 [PMID: 31855425],GuideToPharmacology,1,inhibitor
PIK3CB,COPANLISIB,GuideToPharmacology,1,inhibitor
PIK3CB,PI-3065,GuideToPharmacology,1,inhibitor
F7R,CZC 24832,GuideToPharmacology,1,inhibitor
F7,UMBRALISIB,GuideToPharmacology,1,inhibitor
F7R,APITOLISIB,GuideToPharmacology,1,inhibitor
COL9A2,INAMRINONE,GuideToPharmacology,1,inhibitor
COL11A1,ROFLUMILAST,GuideToPharmacology,1,inhibitor
PDE9A,ZAPRINAST,GuideToPharmacology,1,inhibitor
F9,COMPOUND 20 [PMID: 22136433],GuideToPharmacology,1,inhibitor
FABP5,CZS-241,GuideToPharmacology,1,inhibitor
FABP5,AXITINIB,GuideToPharmacology,1,inhibitor
BDNF,MEDROXYPROGESTERONE ACETATE,GuideToPharmacology,1,agonist
BDNF,ORG2058,GuideToPharmacology,1,agonist
FRA6B,AVAGACESTAT,GuideToPharmacology,1,inhibitor
BDNF,ASOPRISNIL,GuideToPharmacology,1,inhibitor
GM2A,PEMBROLIZUMAB,GuideToPharmacology,1,antibody
FRA2J,PHENYLACETYL-ARG-VAL-ARG-4-AMIDINOBENZYLAMIDE,GuideToPharmacology,1,inhibitor
F12,MTK458,GuideToPharmacology,1,activator
APOA4,[125I]PRRP31,GuideToPharmacology,1,agonist
APOA4,"NPY-(18-36) (HUMAN, PIG)",GuideToPharmacology,1,agonist
XIAP,TIP39-(9-39) (HUMAN/BOVINE),GuideToPharmacology,1,inhibitor
XIAP,[TYR36]-PTHRP-(1-36) AMIDE (HUMAN),GuideToPharmacology,1,agonist
PANX2,CARBENOXOLONE,GuideToPharmacology,1,inhibitor
BIRC5,TIP39-(7-39) (MOUSE),GuideToPharmacology,1,inhibitor
BIRC5,TIP39,GuideToPharmacology,1,agonist
H1-2,COMPOUND 1 [PMID: 31465224],GuideToPharmacology,1,inhibitor
APLP1,LV-2211,GuideToPharmacology,1,agonist
BCL2L1,TO-901317,GuideToPharmacology,1,agonist
BAK1P1,TO-901317,GuideToPharmacology,1,agonist
TEX28,PREXASERTIB,GuideToPharmacology,1,inhibitor
CTRB1,GSK269962A,GuideToPharmacology,1,inhibitor
APPL1,INSL3 [A(5-26):B(7-27)],GuideToPharmacology,1,agonist
CXADR,LY2584702,GuideToPharmacology,1,inhibitor
AMT,NIBR-0213,GuideToPharmacology,1,inhibitor
AMY1C,OZANIMOD,GuideToPharmacology,1,agonist
AMY1C,SLB736,GuideToPharmacology,1,agonist
FTH1P21,MYRIOCIN,GuideToPharmacology,1,inhibitor
AMY2A,OZANIMOD,GuideToPharmacology,1,agonist
FAU,HG-9-91-01,GuideToPharmacology,1,inhibitor
FCGR2B,COMPOUND 27 [PMID: 21123062],GuideToPharmacology,1,inhibitor
CD9,CITALOPRAM,GuideToPharmacology,1,inhibitor
GAST,COMPOUND 1J [PMID: 26314925],GuideToPharmacology,1,inhibitor
CHI3L1,COMPOUND 16 [PMID: 19097778],GuideToPharmacology,1,inhibitor
CD3E,SERGLIFLOZIN,GuideToPharmacology,1,inhibitor
HOXD9,COMPOUND 14I [PMID: 37204466],GuideToPharmacology,1,inhibitor
MS4A2,TIRBANIBULIN,GuideToPharmacology,1,inhibitor
FAS,[125I]TYR10-CST14,GuideToPharmacology,1,agonist
FASLG,"MALTOTRIOSE-[125I][TYR3,THR8]OCTREOTIDE",GuideToPharmacology,1,agonist
SHROOM2,BIM 23023,GuideToPharmacology,1,agonist
AQP2,BIM 23023,GuideToPharmacology,1,agonist
AQP1,NNC269100,GuideToPharmacology,1,agonist
GKP5,CHAETOCIN,GuideToPharmacology,1,inhibitor
THRB,KB-141,GuideToPharmacology,1,agonist
FGB,COMPOUND 5 [PMID: 23232060],GuideToPharmacology,1,inhibitor
DNMT3A,COMPOUND 13R [PMID: 23639540],GuideToPharmacology,1,inhibitor
ATP1B1P1,ASP7663,GuideToPharmacology,1,activator
ATP1B1P1,CHLOROPICRIN,GuideToPharmacology,1,activator
ATP1B1P1,BENZYL BROMIDE,GuideToPharmacology,1,activator
ATP1B1P1,SALIRASIB,GuideToPharmacology,1,activator
ATP2B1,METHYLPREDNISOLONE,GuideToPharmacology,1,activator
ATP2B2,FLUFENAMATE,GuideToPharmacology,1,activator
TRPM8,ANANDAMIDE,GuideToPharmacology,1,blocker
TRPM5,H+,GuideToPharmacology,1,blocker
ALDH7A1,ESTRADIOL 3-METHYL ETHER,GuideToPharmacology,1,blocker
ALDH7A1,ESTRADIOL 3-METHYL ETHER,GuideToPharmacology,1,inhibitor
TRPM8,PF-05105679,GuideToPharmacology,1,blocker
TRPM5,APV207094A,GuideToPharmacology,1,modulator
TRPV4,GSK1016790A,GuideToPharmacology,1,activator
TRPV4,PUERARIN,GuideToPharmacology,1,activator
ATP5F1C,VERBASCOSIDE,GuideToPharmacology,1,blocker
FGFR4,LUVIXASERTIB,GuideToPharmacology,1,inhibitor
FGR,PRN694,GuideToPharmacology,1,inhibitor
CDKN2C,LESINURAD,GuideToPharmacology,1,inhibitor
FGF1,NIK INHIBITOR 12F,GuideToPharmacology,1,inhibitor
UTS2R,U-II-(4-11) (HUMAN),GuideToPharmacology,1,agonist
FUT6,T-690,GuideToPharmacology,1,inhibitor
ARCN2,"[LYS15,ARG16,LEU27]VIP-(1-7)/GRF-(8-27)-NH2",GuideToPharmacology,1,agonist
AQP9,LIT-001,GuideToPharmacology,1,agonist
ANXA3,PYY-(3-36),GuideToPharmacology,1,agonist
ANXA5,FMS586,GuideToPharmacology,1,inhibitor
AMPD3,AMITRIPTYLINE HYDROCHLORIDE,GuideToPharmacology,1,inhibitor
ATP2B4,ZN2+,GuideToPharmacology,1,blocker
NUDT2,NFP,GuideToPharmacology,1,inhibitor
ARVCF,PICROTOXIN,GuideToPharmacology,1,blocker
DTNA,ADRIXETINIB,GuideToPharmacology,1,inhibitor
AMD1,ASENAPINE,GuideToPharmacology,1,inhibitor
ANK3,S24773,GuideToPharmacology,1,agonist
ATF4,[125I]EPIBATIDINE,GuideToPharmacology,1,agonist
BCAT2,TROPICAMIDE,GuideToPharmacology,1,inhibitor
GRIA3,LY392098,GuideToPharmacology,1,modulator
A1BG,BMY-7378,GuideToPharmacology,1,agonist
EPHB1,DELGOCITINIB,GuideToPharmacology,1,inhibitor
PTGES,LY3023703,GuideToPharmacology,1,inhibitor
PDK2,AZD7545,GuideToPharmacology,1,inhibitor
DRD3,LENVATINIB,GuideToPharmacology,1,inhibitor
APOC2,SULPROSTONE,GuideToPharmacology,1,agonist
ATP6AP1,Z944,GuideToPharmacology,1,blocker
CHEK2,PREXASERTIB,GuideToPharmacology,1,inhibitor
ACADL,P32 [PMID: 27108698],GuideToPharmacology,1,agonist
AARS1,ATROPINE,GuideToPharmacology,1,inhibitor
ELANE,TAKINIB,GuideToPharmacology,1,inhibitor
ASS1P14,D-AP5,GuideToPharmacology,1,inhibitor
TAS2R46,3&BETA;-HYDROXYDIHYDROCOSTUNOLIDE,GuideToPharmacology,1,inhibitor
DAGLA,RYANODINE,GuideToPharmacology,1,activator
DAGLA,RYANODINE,GuideToPharmacology,1,blocker
GALR2,GALANIN(9-29) (RAT/MOUSE),GuideToPharmacology,1,agonist
BPGM,D-(-)-AMYGDALIN,GuideToPharmacology,1,agonist
EPHB3,TOFACITINIB,GuideToPharmacology,1,inhibitor
CD9,DAPOXETINE,GuideToPharmacology,1,inhibitor
EEF1G,COMPOUND 46 [PMID: 16451062],GuideToPharmacology,1,inhibitor
FFAR3,N-VALERIC ACID,GuideToPharmacology,1,agonist
APAF1,[LEU]ENKEPHALIN,GuideToPharmacology,1,agonist
AAVS1,ATROPINE,GuideToPharmacology,1,inhibitor
APOC2,LATANOPROSTENE BUNOD,GuideToPharmacology,1,agonist
ACP3,ALANINE,GuideToPharmacology,1,agonist
ADCY3,CANNABIDIOL,GuideToPharmacology,1,inhibitor
FAP,RIPK3 INHIBITOR 18,GuideToPharmacology,1,inhibitor
AMHR2,POBILUKAST,GuideToPharmacology,1,inhibitor
BPI,DIPHENIDOL,GuideToPharmacology,1,agonist
CRH,GGSTOP,GuideToPharmacology,1,inhibitor
AANAT,IPEROXO,GuideToPharmacology,1,agonist
ABR,NIP,GuideToPharmacology,1,inhibitor
SLC13A5,PF-06649298,GuideToPharmacology,1,inhibitor
CCNA2,IGN523,GuideToPharmacology,1,antibody
ABL2,GUANABENZ,GuideToPharmacology,1,agonist
AXL,"COMPOUND 1 [CRUZ-L&OACUTE;PEZ ET AL., 2019]",GuideToPharmacology,1,inhibitor
HRH3,CLOBENPROPIT,GuideToPharmacology,1,inhibitor
ANXA3,BIIE0246,GuideToPharmacology,1,inhibitor
ASGR1,H+,GuideToPharmacology,1,inhibitor
ATP2B2,H+,GuideToPharmacology,1,blocker
GPR21,ABT-737,GuideToPharmacology,1,inhibitor
CRHR2,4-OME-ARM1,GuideToPharmacology,1,activator
APOE,AZ7188,GuideToPharmacology,1,inhibitor
GRIN2B,[3H]D-ASPARTIC ACID,GuideToPharmacology,1,agonist
NUDT2,PROBE 2.1 [PMID: 24187130],GuideToPharmacology,1,agonist
ARRB2,[3H]MUSCIMOL,GuideToPharmacology,1,agonist
APBA2,YNT-185,GuideToPharmacology,1,agonist
F5,VULOLISIB,GuideToPharmacology,1,inhibitor
CFTR,IVACAFTOR,GuideToPharmacology,1,activator
CACNA1F,(-)-(S)-BAYK8644,GuideToPharmacology,1,activator
CYP2D7BP,COMPOUND 3V [PMID: 27390066],GuideToPharmacology,1,inhibitor
CTAA1,RUBOXISTAURIN,GuideToPharmacology,1,inhibitor
ARG2,MAUROTOXIN,GuideToPharmacology,1,blocker
AMPH,RADIOPROTECTIN-1,GuideToPharmacology,1,agonist
CSTP1,AFURESERTIB,GuideToPharmacology,1,inhibitor
GRM6,HOMO-AMPA,GuideToPharmacology,1,agonist
AADAC,N-DESMETHYLCLOZAPINE,GuideToPharmacology,1,modulator
AMFR,[3H]LTB4,GuideToPharmacology,1,agonist
NATP,FLUPERLAPINE,GuideToPharmacology,1,inhibitor
NUDT2,ICI-199441,GuideToPharmacology,1,agonist
GPM6B,LUNA18,GuideToPharmacology,1,inhibitor
CMKLR1,FENCLONINE,GuideToPharmacology,1,inhibitor
ATF4,NS1738,GuideToPharmacology,1,modulator
ARHGAP35,LUMINESPIB,GuideToPharmacology,1,inhibitor
AAK1,BMS-911172,GuideToPharmacology,1,inhibitor
FMO5,COMPOUND 11D  [PMID: 23981898],GuideToPharmacology,1,inhibitor
CACNA1H,ANANDAMIDE,GuideToPharmacology,1,blocker
PTGES,COMPOUND III [PMID: 24045148],GuideToPharmacology,1,inhibitor
AQP4,[3H]GR100679,GuideToPharmacology,1,inhibitor
GPS1,JZL195,GuideToPharmacology,1,inhibitor
NR3C2,RU28318,GuideToPharmacology,1,inhibitor
ANK3,CIFEA,GuideToPharmacology,1,agonist
AQP2,[125I]TYR11-SRIF-14,GuideToPharmacology,1,agonist
UTS2R,[3-IODO-TYR6]U-II-(4-11) (HUMAN),GuideToPharmacology,1,agonist
CRIP1,LEI105,GuideToPharmacology,1,inhibitor
NKX2-5,7-HYDROXYSTAUROSPORINE,GuideToPharmacology,1,inhibitor
ABCC6,RWJ-351647,GuideToPharmacology,1,inhibitor
ALDH2,ABT-670,GuideToPharmacology,1,agonist
CXCR3,VADADUSTAT,GuideToPharmacology,1,inhibitor
AMD1,KETOTIFEN FUMARATE,GuideToPharmacology,1,inhibitor
ESRRG,DORSOMORPHIN,GuideToPharmacology,1,inhibitor
AR,"[PHAA1,D-TYR(ME)2,ARG6,TYR-NH29]AVP",GuideToPharmacology,1,inhibitor
ACACB,N-METHYL-PHE-LYS-PRO-D-CHA-CHA-D-ARG-CO2H,GuideToPharmacology,1,agonist
EGR4,COMPOUND 5G [PMID: 36385925],GuideToPharmacology,1,inhibitor
AMPH,DODECYLPHOSPHATE,GuideToPharmacology,1,agonist
CTNNA2,YL5084,GuideToPharmacology,1,inhibitor
ARR3,BRETAZENIL,GuideToPharmacology,1,modulator
NBEAP1,RIFAMPIN,GuideToPharmacology,1,agonist
TRPV4,GD3+,GuideToPharmacology,1,blocker
EPHB2,COMPOUND 13 [PMID: 35653642],GuideToPharmacology,1,inhibitor
FRA2G,LANADELUMAB-FLYO,GuideToPharmacology,1,antibody
ATF6B,COMPOUND 34 [PMID: 20866075],GuideToPharmacology,1,inhibitor
A1BG,"L-772,405",GuideToPharmacology,1,agonist
A1BG,"LY 165,163",GuideToPharmacology,1,agonist
ABAT,GS9667,GuideToPharmacology,1,agonist
ABAT,REGADENOSON ANHYDROUS,GuideToPharmacology,1,agonist
ABCA1,BINODENOSON,GuideToPharmacology,1,agonist
ABCA1,ADENOSINE,GuideToPharmacology,1,agonist
ABCA1,(S)-PIA,GuideToPharmacology,1,agonist
ABCA2,ADENOSINE,GuideToPharmacology,1,agonist
ABCA1,MSX-2,GuideToPharmacology,1,inhibitor
ABCA1,TOZADENANT,GuideToPharmacology,1,inhibitor
ABCA1,PBF-509,GuideToPharmacology,1,inhibitor
ABCA1,ROLOFYLLINE,GuideToPharmacology,1,inhibitor
ABCA1,TONAPOFYLLINE,GuideToPharmacology,1,inhibitor
ABCA2,TCPA,GuideToPharmacology,1,agonist
ABCA2,AS96,GuideToPharmacology,1,inhibitor
ABCA2,(S)-PIA,GuideToPharmacology,1,agonist
ABCA2,CVT-6883,GuideToPharmacology,1,inhibitor
ABCA3,MRS3558,GuideToPharmacology,1,agonist
ABCA2,PENTOXIFYLLINE,GuideToPharmacology,1,inhibitor
ABCA3,GS9667,GuideToPharmacology,1,agonist
ABCA3,BINODENOSON,GuideToPharmacology,1,agonist
ABCA3,(S)-PIA,GuideToPharmacology,1,agonist
ABCA3,PSB36,GuideToPharmacology,1,inhibitor
ABCA3,VIPADENANT,GuideToPharmacology,1,inhibitor
ABCC8,REPAGLINIDE,GuideToPharmacology,1,inhibitor
CATHL1L,TEGOPRAZAN,GuideToPharmacology,1,inhibitor
GLB1,GSK8814,GuideToPharmacology,1,inhibitor
ACLY,BMS-303141,GuideToPharmacology,1,inhibitor
ACAT2,"[D-PHE6, STAT13, LEU14}BN(6-14)",GuideToPharmacology,1,inhibitor
FMO5,NB-360,GuideToPharmacology,1,inhibitor
FMOD,EXAMPLE 92 [WO2012095521],GuideToPharmacology,1,inhibitor
FMOD,HYDROXYETHYLAMINE TRANSITION-STATE INHIBITOR 1,GuideToPharmacology,1,inhibitor
ABO,ESMOLOL,GuideToPharmacology,1,inhibitor
ABO,NIP,GuideToPharmacology,1,inhibitor
DNMT3B,ZILURGISERTIB,GuideToPharmacology,1,inhibitor
GLUD1P3,HISTAMINE,GuideToPharmacology,1,activator
HCK,SLC-0111,GuideToPharmacology,1,inhibitor
CASP3,M826,GuideToPharmacology,1,inhibitor
DBH,URACIL 20,GuideToPharmacology,1,inhibitor
FNTBL1,K777,GuideToPharmacology,1,inhibitor
FOLR2L,K777,GuideToPharmacology,1,inhibitor
FOLR2,BALICATIB,GuideToPharmacology,1,inhibitor
RND3,PGF1&ALPHA;,GuideToPharmacology,1,activator
ACRV1,IBIPINABANT,GuideToPharmacology,1,inhibitor
CNR2,VICASINABIN,GuideToPharmacology,1,agonist
CNR2,ANANDAMIDE,GuideToPharmacology,1,agonist
CNR2,LY2828360,GuideToPharmacology,1,agonist
CCKAR,JMV180,GuideToPharmacology,1,agonist
CNR2,IBIPINABANT,GuideToPharmacology,1,inhibitor
ALDH2,ML398,GuideToPharmacology,1,inhibitor
CCR3,OLECLUMAB,GuideToPharmacology,1,antibody
DXO,DBPR112,GuideToPharmacology,1,inhibitor
DXO,DACOMITINIB ANHYDROUS,GuideToPharmacology,1,inhibitor
APOBER1,SULPROSTONE,GuideToPharmacology,1,agonist
APOBER1,EPOPROSTENOL,GuideToPharmacology,1,agonist
GTF2IP1,TRIPLE MODULATOR 10 [PMID: 29878767],GuideToPharmacology,1,inhibitor
APOC1,ALPROSTADIL,GuideToPharmacology,1,agonist
APOC1,PGD2,GuideToPharmacology,1,agonist
APOC1,ILOPROST,GuideToPharmacology,1,agonist
APOC1,19(R)-OH-PGE2,GuideToPharmacology,1,agonist
AQP8,BUTAPROST (FREE ACID FORM),GuideToPharmacology,1,agonist
AQP8,EPOPROSTENOL,GuideToPharmacology,1,agonist
APOC1P1,SULPROSTONE,GuideToPharmacology,1,agonist
EN1,RITUXIMAB,GuideToPharmacology,1,antibody
EN1,CP-724714,GuideToPharmacology,1,inhibitor
EN1,TESEVATINIB,GuideToPharmacology,1,inhibitor
BCYRN1P2,DIARYLPROPIONITRILE,GuideToPharmacology,1,agonist
ESR2,NORENDOXIFEN,GuideToPharmacology,1,agonist
BCYRN1P2,GIREDESTRANT,GuideToPharmacology,1,inhibitor
ESR2,TAMOXIFEN,GuideToPharmacology,1,agonist
ESR2,TAMOXIFEN,GuideToPharmacology,1,inhibitor
ALDH1B1,MACITENTAN,GuideToPharmacology,1,inhibitor
ALDH1B1,ZIBOTENTAN,GuideToPharmacology,1,inhibitor
BCL5,INT-767,GuideToPharmacology,1,agonist
BMAL1,[3H]MUSCIMOL,GuideToPharmacology,1,agonist
BMAL1,ZN2+,GuideToPharmacology,1,modulator
BMAL1,BRETAZENIL,GuideToPharmacology,1,modulator
BMAL1,PICROTOXIN,GuideToPharmacology,1,blocker
ARR3,ISONIPECOTIC ACID,GuideToPharmacology,1,agonist
ARR3,RO15-4513,GuideToPharmacology,1,modulator
ARRB1,ZN2+,GuideToPharmacology,1,modulator
ARRB1,[18F]FLUOROETHYLFLUMAZENIL,GuideToPharmacology,1,modulator
ARRB2,BRETAZENIL,GuideToPharmacology,1,modulator
ARSA,PICROTOXIN,GuideToPharmacology,1,blocker
ARRB2,PICROTOXIN,GuideToPharmacology,1,blocker
ARVCF,ISOGUVACINE,GuideToPharmacology,1,agonist
ART2P,PICROTOXIN,GuideToPharmacology,1,blocker
ALOX12P1,GALANIN-LIKE PEPTIDE,GuideToPharmacology,1,agonist
ALOX12P1,"[SAR1, D-ALA12]GALANIN(1-16)",GuideToPharmacology,1,agonist
ALOX12P1,GALANIN(D-TRP2) (PIG),GuideToPharmacology,1,agonist
ALOX12P1,C7,GuideToPharmacology,1,inhibitor
ALPI,MGIPANT-1,GuideToPharmacology,1,inhibitor
ASPH,[3H]AMPA,GuideToPharmacology,1,agonist
ASS1,[3H]AMPA,GuideToPharmacology,1,agonist
BDM,PREDNISOLONE,GuideToPharmacology,1,agonist
GRIN2B,GLYCINE,GuideToPharmacology,1,agonist
GRIN2A,NYX-2925,GuideToPharmacology,1,modulator
GRIN2A,[3H]D-ASPARTIC ACID,GuideToPharmacology,1,agonist
GRIN2A,N1-DANSYL-SPERMINE,GuideToPharmacology,1,blocker
GRIN2C,LEVORPHANOL,GuideToPharmacology,1,blocker
ASS1P14,ASPARTIC ACID,GuideToPharmacology,1,agonist
ASS1P14,GV196771A,GuideToPharmacology,1,inhibitor
ASS1P14,NMDA,GuideToPharmacology,1,agonist
GRIA2,IPN60090,GuideToPharmacology,1,inhibitor
ARVD3,TROPISETRON,GuideToPharmacology,1,inhibitor
ARVD3,PICROTIN,GuideToPharmacology,1,blocker
ARVD3,GINKGOLIDE B,GuideToPharmacology,1,blocker
ASAH1,GINKGOLIDE B,GuideToPharmacology,1,blocker
CD24P2,GT-0198,GuideToPharmacology,1,inhibitor
ANXA11,D-LACTIC ACID,GuideToPharmacology,1,agonist
PHOX2A,ZD7288,GuideToPharmacology,1,blocker
GRINA,LUMINESPIB,GuideToPharmacology,1,inhibitor
GRIN2C,ALVESPIMYCIN,GuideToPharmacology,1,inhibitor
GDF2,ABEXINOSTAT,GuideToPharmacology,1,inhibitor
GAPDHL17,VORINOSTAT,GuideToPharmacology,1,inhibitor
GAPDHP1,PANOBINOSTAT,GuideToPharmacology,1,inhibitor
AMELX,SELIFORANT,GuideToPharmacology,1,inhibitor
AMELX,ADRIFORANT,GuideToPharmacology,1,inhibitor
AMELX,CLOBENPROPIT,GuideToPharmacology,1,agonist
ACTN1,GPR15L (71-81),GuideToPharmacology,1,agonist
ADH6,COMPOUND 1A [PMID: 24900311],GuideToPharmacology,1,agonist
ADH6,LP-360924,GuideToPharmacology,1,agonist
ACTN3,ANANDAMIDE,GuideToPharmacology,1,agonist
ADD3,"6-NONYLPYRIDINE-2,4-DIOL",GuideToPharmacology,1,agonist
ADCY3,T1117,GuideToPharmacology,1,agonist
ADCY3,N-OLEOYLETHANOLAMIDE,GuideToPharmacology,1,agonist
AMCN,TALQUETAMAB,GuideToPharmacology,1,antibody
GLRA1,LIGELIZUMAB,GuideToPharmacology,1,antibody
ADFN,LPA,GuideToPharmacology,1,agonist
GLRA1,OMALIZUMAB,GuideToPharmacology,1,antibody
BAK1,GNE-616,GuideToPharmacology,1,blocker
CD8B,QUETIAPINE FUMARATE,GuideToPharmacology,1,inhibitor
CD8B,MILNACIPRAN,GuideToPharmacology,1,inhibitor
CD8B,NEFAZODONE,GuideToPharmacology,1,inhibitor
DRD5P1,K-252A,GuideToPharmacology,1,inhibitor
NOS1,GW274150,GuideToPharmacology,1,inhibitor
DAP,SACUBITRILAT,GuideToPharmacology,1,inhibitor
ATHS,RGIA4,GuideToPharmacology,1,inhibitor
CHRNA3,&ALPHA;-CONOTOXIN MII,GuideToPharmacology,1,inhibitor
CHRNA3,MECAMYLAMINE,GuideToPharmacology,1,blocker
CHRNA3,VARENICLINE,GuideToPharmacology,1,agonist
ZFHX3,[125I]EPIBATIDINE,GuideToPharmacology,1,agonist
ZFHX3,[125I]EPIBATIDINE,GuideToPharmacology,1,agonist
ATF4,AQW051,GuideToPharmacology,1,agonist
ATF3,MECAMYLAMINE,GuideToPharmacology,1,blocker
AQP3,PHYLLOMEDUSIN,GuideToPharmacology,1,agonist
AQP3,"[3H]SP (HUMAN, MOUSE, RAT)",GuideToPharmacology,1,agonist
AQP4,YM44781,GuideToPharmacology,1,inhibitor
AQP4,NEUROKININ A,GuideToPharmacology,1,agonist
APBA1,UFP-102,GuideToPharmacology,1,agonist
ANXA6,MECLINERTANT,GuideToPharmacology,1,inhibitor
ANXA1,RF9,GuideToPharmacology,1,inhibitor
ANXA1,NEUROPEPTIDE FF,GuideToPharmacology,1,agonist
NPFFR1,RF9,GuideToPharmacology,1,inhibitor
APBB1,ACT-335827,GuideToPharmacology,1,inhibitor
APBA2,SB-410220,GuideToPharmacology,1,inhibitor
APBA2,[3H]SB-674042,GuideToPharmacology,1,inhibitor
APBB1,[3H]SB-674042,GuideToPharmacology,1,inhibitor
EXT3,RKI-1447,GuideToPharmacology,1,inhibitor
EXT3,BJG-05-039,GuideToPharmacology,1,modulator
EXTL1,COMPOUND 4 [PMID: 24432870],GuideToPharmacology,1,inhibitor
ATP1A4,A317491,GuideToPharmacology,1,inhibitor
ATP1A4,CAMLIPIXANT,GuideToPharmacology,1,inhibitor
APEH,AR-C67085,GuideToPharmacology,1,agonist
APEX1,INS49266,GuideToPharmacology,1,inhibitor
APEX1,[3H]PSB-0413,GuideToPharmacology,1,inhibitor
APEX1,REGRELOR,GuideToPharmacology,1,inhibitor
BIRC2,PPADS,GuideToPharmacology,1,inhibitor
APC,AR-C126313,GuideToPharmacology,1,inhibitor
AIRE,INS48823,GuideToPharmacology,1,agonist
AIRE,PPADS,GuideToPharmacology,1,inhibitor
CTRB1,SAR407899,GuideToPharmacology,1,inhibitor
APRT,COMPOUND 10D [PMID: 34855388],GuideToPharmacology,1,agonist
APPL1,RLF-(A11-B10)-ISOPEPTIDE AMIDEA26 (XA11-B10),GuideToPharmacology,1,inhibitor
KLK3,R3(B&DELTA;23-27)R/I5 CHIMERIC PEPTIDE,GuideToPharmacology,1,inhibitor
DAGLA,PROCAINE,GuideToPharmacology,1,blocker
AMT,VPC23019,GuideToPharmacology,1,inhibitor
RYR3,DANTROLENE,GuideToPharmacology,1,inhibitor
AMT,BMS-986166,GuideToPharmacology,1,agonist
GYPB,WP1066,GuideToPharmacology,1,inhibitor
CD3E,ENAVOGLIFLOZIN,GuideToPharmacology,1,inhibitor
FAS,BIM 23052,GuideToPharmacology,1,agonist
MS4A2,IBRUTINIB,GuideToPharmacology,1,inhibitor
MS4A2,SI306,GuideToPharmacology,1,inhibitor
MS4A2,ENMD-2076,GuideToPharmacology,1,inhibitor
FASLG,ANALOG 3 [PMID:18543899],GuideToPharmacology,1,inhibitor
SHROOM2,BIM 23034,GuideToPharmacology,1,agonist
FASLG,SIFA-ASN(ACNH-&BETA;-GLC)-PEG-TYR3-OCTREOTATE,GuideToPharmacology,1,agonist
SHROOM2,NOC-ATE,GuideToPharmacology,1,agonist
AQP1,BIM 23052,GuideToPharmacology,1,agonist
AQP2,BIM 23454,GuideToPharmacology,1,inhibitor
GRIN1,COMPOUND 53 [PMID: 33038794],GuideToPharmacology,1,agonist
TLE5,SUCCINIC ACID,GuideToPharmacology,1,agonist
HLA-DMA,AZ1366,GuideToPharmacology,1,inhibitor
FRA8B,YZM18,GuideToPharmacology,1,inhibitor
DMP1,MOTOLIMOD,GuideToPharmacology,1,agonist
APOC4,[125I]SAP,GuideToPharmacology,1,inhibitor
DNMT3A,H. POLYGYRUS TGF-&BETA; MIMIC,GuideToPharmacology,1,agonist
APOC4,[3H]SQ-29548,GuideToPharmacology,1,inhibitor
FRDA2,COMPOUND 5 [PMID: 21741839],GuideToPharmacology,1,inhibitor
ATP1B1P1,ALLYL ISOTHIOCYANATE,GuideToPharmacology,1,activator
FRA8D,"INHIBITOR 1 [COLOMBO ET AL., 2012]",GuideToPharmacology,1,inhibitor
TTR,TAFAMIDIS,GuideToPharmacology,1,inhibitor
H1-5,ANATUMOMAB MAFENATOX,GuideToPharmacology,1,antibody
ATP2A3,PICO145,GuideToPharmacology,1,blocker
ATP1B1P1,AM-0902,GuideToPharmacology,1,blocker
ATP2B2,NORGESTIMATE,GuideToPharmacology,1,blocker
ATP3,NADIDE,GuideToPharmacology,1,activator
PKD2L1,PHENAMIL,GuideToPharmacology,1,blocker
TRPV6,TRPV6 INHIBITOR CIS-22鈥堿,GuideToPharmacology,1,inhibitor
TRPV4,NSC600684,GuideToPharmacology,1,blocker
HCVS,EXAMPLE 25 [WO2018228934],GuideToPharmacology,1,inhibitor
BCL7A,"CALCITRIOL-26,23-LACTONE",GuideToPharmacology,1,agonist
AQP9,YM 218,GuideToPharmacology,1,inhibitor
AQP9,RWJ-351647,GuideToPharmacology,1,inhibitor
AQP9,"[PHAA1,D-TYR2,VAL4,ARG6,ARG-NH29]AVP",GuideToPharmacology,1,inhibitor
AR,ARGIPRESSIN,GuideToPharmacology,1,agonist
ABCC6,ARGIPRESSIN,GuideToPharmacology,1,agonist
ABCC6,"[TBAA1,D-TYR(ET)2,VAL4,LYS6,ARG-NH28,DES-GLY9]AVP",GuideToPharmacology,1,inhibitor
ABCC6,"[PHAA1,D-TYR(ME)2,ARG6,TYR-NH29]AVP",GuideToPharmacology,1,inhibitor
ANXA3,NPY-(16-36) (PIG),GuideToPharmacology,1,agonist
BCAT2,ZN2+,GuideToPharmacology,1,agonist
A2M,FROVATRIPTAN,GuideToPharmacology,1,agonist
A2M,OLANZAPINE,GuideToPharmacology,1,agonist
A2M,ELETRIPTAN,GuideToPharmacology,1,agonist
A12M3,[3H]8-OH-DPAT,GuideToPharmacology,1,agonist
A12M3,LORCASERIN,GuideToPharmacology,1,agonist
A12M3,AGOMELATINE,GuideToPharmacology,1,inhibitor
A12M4,RAUWOLSCINE,GuideToPharmacology,1,inhibitor
A12M4,EGIS-7625,GuideToPharmacology,1,inhibitor
HTR2C,EGIS-7625,GuideToPharmacology,1,inhibitor
HTR2C,SB 243213,GuideToPharmacology,1,inhibitor
NATP,RO 04-6790,GuideToPharmacology,1,inhibitor
SERPINA3,2-BROMO-LSD,GuideToPharmacology,1,inhibitor
SERPINA3,PIRENPERONE,GuideToPharmacology,1,inhibitor
SERPINA3,THIORIDAZINE,GuideToPharmacology,1,inhibitor
FRA17A,RIVASTIGMINE,GuideToPharmacology,1,inhibitor
TRDMT1,BMS-986260,GuideToPharmacology,1,inhibitor
CNN1,COMPOUND 21 [PMID: 23981033],GuideToPharmacology,1,inhibitor
ACVR2B,BIMAGRUMAB,GuideToPharmacology,1,antibody
CSTP1,PIFUSERTIB,GuideToPharmacology,1,inhibitor
HBEGF,CRIZOTINIB,GuideToPharmacology,1,inhibitor
CXCL1,KT-109,GuideToPharmacology,1,inhibitor
ABCF1,BMY-7378,GuideToPharmacology,1,inhibitor
ABCF1,L-765314,GuideToPharmacology,1,inhibitor
ABCF1,WB 4101,GuideToPharmacology,1,inhibitor
ABCA4,PRAZOSIN,GuideToPharmacology,1,inhibitor
ABCA4,BMY-7378,GuideToPharmacology,1,inhibitor
ABL1,GUANABENZ,GuideToPharmacology,1,agonist
AOC1,MK-912,GuideToPharmacology,1,inhibitor
ABL2,ROXINDOLE,GuideToPharmacology,1,inhibitor
ABL2,OXYMETAZOLINE HYDROCHLORIDE,GuideToPharmacology,1,agonist
ABL2,ALL-TRANS-4-OXO-RETINOIC ACID,GuideToPharmacology,1,inhibitor
BEVI,NANDROLONE DECANOATE,GuideToPharmacology,1,agonist
BEVI,STANOLONE,GuideToPharmacology,1,agonist
DAPK3,RAMIPRILAT,GuideToPharmacology,1,inhibitor
ABAT,CVT-6883,GuideToPharmacology,1,inhibitor
ABAT,MSX-2,GuideToPharmacology,1,inhibitor
ABCA1,2-CHLOROADENOSINE,GuideToPharmacology,1,agonist
ACADM,VALSARTAN,GuideToPharmacology,1,inhibitor
GSTA1,ENOBLITUZUMAB,GuideToPharmacology,1,antibody
GPR22,VENETOCLAX,GuideToPharmacology,1,inhibitor
ASIC2,COMPOUND 9F [PMID: 24412111],GuideToPharmacology,1,agonist
GPR22,A-1331852,GuideToPharmacology,1,inhibitor
FMOD,NB-360,GuideToPharmacology,1,inhibitor
ABO,CYANOPINDOLOL,GuideToPharmacology,1,inhibitor
ABO,METOPROLOL,GuideToPharmacology,1,inhibitor
ACAA1,L-748328,GuideToPharmacology,1,inhibitor
AMFR,12R-HETE,GuideToPharmacology,1,agonist
AMFR,LY255283,GuideToPharmacology,1,inhibitor
EEGV1,PRN694,GuideToPharmacology,1,inhibitor
EFNA2,GSK329,GuideToPharmacology,1,inhibitor
EFNA4,BZT-7,GuideToPharmacology,1,inhibitor
EFNA5,CCT244747,GuideToPharmacology,1,inhibitor
EFNA4,PELABRESIB,GuideToPharmacology,1,inhibitor
EFNA4,(+)-JQ1,GuideToPharmacology,1,inhibitor
EFNB2,ZANUBRUTINIB,GuideToPharmacology,1,inhibitor
EFNB2,LFM-A13,GuideToPharmacology,1,inhibitor
EFNB2,COMPOUND 71 [WO2018191577A1],GuideToPharmacology,1,inhibitor
EFNB2,CGI560,GuideToPharmacology,1,inhibitor
BDKRB2,BRADYKININ,GuideToPharmacology,1,agonist
BDKRB2,NPC-349,GuideToPharmacology,1,inhibitor
FRA20A,RIVASTIGMINE,GuideToPharmacology,1,inhibitor
EFNB3,BAY-524,GuideToPharmacology,1,inhibitor
EGI,STO609,GuideToPharmacology,1,inhibitor
ELF1,CDK INHIBITOR 4.35,GuideToPharmacology,1,inhibitor
CYP2A7,SILMITASERTIB,GuideToPharmacology,1,inhibitor
CACNA1F,NITRENDIPINE,GuideToPharmacology,1,inhibitor
ATP6V1G2,SNX482,GuideToPharmacology,1,inhibitor
CYP7A1,BOCEPREVIR,GuideToPharmacology,1,inhibitor
FOLR2,L873724,GuideToPharmacology,1,inhibitor
RHOC,ALPROSTADIL,GuideToPharmacology,1,activator
CCKBR,TETRONOTHIODIN,GuideToPharmacology,1,inhibitor
CFTR,CBIQ,GuideToPharmacology,1,activator
CFTR,GLYH-101,GuideToPharmacology,1,blocker
CPT2,ESFLURBIPROFEN,GuideToPharmacology,1,inhibitor
CPT2,SC-236,GuideToPharmacology,1,inhibitor
CPT1B,SULINDAC,GuideToPharmacology,1,inhibitor
C5AR1,CARBENOXOLONE,GuideToPharmacology,1,inhibitor
EGR4,CDK INHIBITOR 4.35,GuideToPharmacology,1,inhibitor
EGR4,CDK4 INHIBITOR,GuideToPharmacology,1,inhibitor
EIF4A1,COMPOUND 5G [PMID: 36385925],GuideToPharmacology,1,inhibitor
EIF4A1,RO3306,GuideToPharmacology,1,inhibitor
EIF4A1,RONICICLIB,GuideToPharmacology,1,inhibitor
EIF4A1,CGP74514A,GuideToPharmacology,1,inhibitor
CDK4,CGP74514A,GuideToPharmacology,1,inhibitor
CDK4,RIBOCICLIB,GuideToPharmacology,1,inhibitor
EIF4E,ZOTIRACICLIB,GuideToPharmacology,1,inhibitor
EIF4EBP1,CIMPUCICLIB,GuideToPharmacology,1,inhibitor
EIF4EP1,DS96432529,GuideToPharmacology,1,inhibitor
EIF4EBP2,CGP74514A,GuideToPharmacology,1,inhibitor
EIF4G1,ASNUCICLIB,GuideToPharmacology,1,inhibitor
EIF4G1,CDK INHIBITOR 4.35,GuideToPharmacology,1,inhibitor
SLC31A2,5H3'FPE,GuideToPharmacology,1,inhibitor
MAP3K8,SULFAPHENAZOLE,GuideToPharmacology,1,inhibitor
CYP1B1,5H3'FPE,GuideToPharmacology,1,inhibitor
AMPD1,ONO-2570366,GuideToPharmacology,1,inhibitor
GLRB,NURULIMAB,GuideToPharmacology,1,antibody
CD8B2,BUPROPION HYDROCHLORIDE,GuideToPharmacology,1,inhibitor
APAF1,AZD7268,GuideToPharmacology,1,agonist
APAF1,DELTORPHIN II,GuideToPharmacology,1,agonist
APAF1,DIPRENORPHINE,GuideToPharmacology,1,agonist
GPI,T863,GuideToPharmacology,1,inhibitor
DAPK1,ZY15557,GuideToPharmacology,1,inhibitor
BLMH,6-FLUOROMEVALONATE 5-DIPHOSPHATE,GuideToPharmacology,1,inhibitor
ABCD1,OLANZAPINE,GuideToPharmacology,1,inhibitor
ALDH1A1,RACLOPRIDE,GuideToPharmacology,1,inhibitor
ALDH2,BENPERIDOL,GuideToPharmacology,1,inhibitor
ALDH2,TERGURIDE,GuideToPharmacology,1,inhibitor
GLI1,SGC-CBP30,GuideToPharmacology,1,inhibitor
ERAP2,COMPOUND 3V [PMID: 27390066],GuideToPharmacology,1,inhibitor
PRLHR,COMPOUND 6EE [PMID: 22364528],GuideToPharmacology,1,inhibitor
EZH2,UNC1999,GuideToPharmacology,1,inhibitor
DXO,BPIQ-I,GuideToPharmacology,1,inhibitor
DXO,JND3229,GuideToPharmacology,1,inhibitor
DXO,ICOTINIB,GuideToPharmacology,1,inhibitor
BCL5,"COMPOUND 3F [FESTA ET AL., 2019]",GuideToPharmacology,1,inhibitor
BCL5,NIDUFEXOR,GuideToPharmacology,1,agonist
H2BC5,BEMARITUZUMAB,GuideToPharmacology,1,antibody
GSPT1,IGE HEAVY CHAIN,GuideToPharmacology,1,agonist
FYN,BINDARIT,GuideToPharmacology,1,inhibitor
ABCD2,HWL-088,GuideToPharmacology,1,agonist
AMD1,(S)-CETIRIZINE,GuideToPharmacology,1,inhibitor
SLC40A1,LY2928057,GuideToPharmacology,1,antibody
ADH4,TUG-1197,GuideToPharmacology,1,agonist
DPYSL3,PALIFERMIN,GuideToPharmacology,1,agonist
DPYSL3,BEMARITUZUMAB,GuideToPharmacology,1,antibody
DR1,COMPOUND 29 [PMID: 36356320],GuideToPharmacology,1,inhibitor
DPYSL3,LY2874455,GuideToPharmacology,1,inhibitor
DR1,DERAZANTINIB,GuideToPharmacology,1,inhibitor
DR1,PRN1371,GuideToPharmacology,1,inhibitor
DRD1,IBCASERTIB,GuideToPharmacology,1,inhibitor
DRD1,SU-14813,GuideToPharmacology,1,inhibitor
DPYS,"COMPOUND 1 [CRUZ-L&OACUTE;PEZ ET AL., 2019]",GuideToPharmacology,1,inhibitor
DRD1,TIVOZANIB,GuideToPharmacology,1,inhibitor
DPYS,GTP-14564,GuideToPharmacology,1,inhibitor
DPYS,SGI-1776,GuideToPharmacology,1,inhibitor
DPYS,ONVANSERTIB,GuideToPharmacology,1,inhibitor
ALDH3B2,3570-0208 [PMID:19807662],GuideToPharmacology,1,inhibitor
HRH3,ST-1006,GuideToPharmacology,1,agonist
HOXB2,MIRVETUXIMAB SORAVTANSINE,GuideToPharmacology,1,antibody
ALDH3B2,CYCLOSPORIN H,GuideToPharmacology,1,inhibitor
ALDH9A1,RESOLVIN D1,GuideToPharmacology,1,agonist
ALDH9A1,F PEPTIDE,GuideToPharmacology,1,agonist
ALDH9A1,MHC BINDING PEPTIDE,GuideToPharmacology,1,agonist
APOC2,"13,14-DIHYDRO-16-M-CHLOROPHENOXY-W-TETRANOR-PGF1&ALPHA;",GuideToPharmacology,1,agonist
APOC2,PGD2,GuideToPharmacology,1,agonist
ALDH9A1,PBP10,GuideToPharmacology,1,modulator
HRH3,GR 175737,GuideToPharmacology,1,agonist
GABRA1,INDIPLON,GuideToPharmacology,1,modulator
GABRA1,ISOGUVACINE,GuideToPharmacology,1,agonist
GABRA1,[3H]MUSCIMOL,GuideToPharmacology,1,agonist
ENO2,IBRUTINIB,GuideToPharmacology,1,inhibitor
GABRA1,PICROTOXIN,GuideToPharmacology,1,blocker
GABRA1,FLUNITRAZEPAM,GuideToPharmacology,1,modulator
BDM,C108297,GuideToPharmacology,1,agonist
HRH3,ST-1478,GuideToPharmacology,1,inhibitor
BDM,AZD2906,GuideToPharmacology,1,agonist
BDM,BENZODROCORTISONE,GuideToPharmacology,1,agonist
GRIN2C,[3H]D-ASPARTIC ACID,GuideToPharmacology,1,agonist
GRIN2B,NMDA,GuideToPharmacology,1,agonist
GRIN2B,N1-DANSYL-SPERMINE,GuideToPharmacology,1,blocker
GRIN2B,D-AP5,GuideToPharmacology,1,inhibitor
DLX3,NESIRITIDE,GuideToPharmacology,1,agonist
DHFRP3,SOMATROGON,GuideToPharmacology,1,agonist
ACP3,GLYCINE,GuideToPharmacology,1,agonist
ANXA13,5-METHYL NICOTINIC ACID,GuideToPharmacology,1,agonist
ANXA13,COMPOUND (+)17A [PMID: 20363624],GuideToPharmacology,1,agonist
ARL1,ZATEBRADINE,GuideToPharmacology,1,blocker
GDF2,RGFP109,GuideToPharmacology,1,inhibitor
AMELX,ST-1006,GuideToPharmacology,1,agonist
GARS1,VORINOSTAT,GuideToPharmacology,1,inhibitor
MSTN,CUDC-101,GuideToPharmacology,1,inhibitor
HDAC4,CUDC-101,GuideToPharmacology,1,inhibitor
GART,PANOBINOSTAT,GuideToPharmacology,1,inhibitor
MSTN,VORINOSTAT,GuideToPharmacology,1,inhibitor
GAS1,VORINOSTAT,GuideToPharmacology,1,inhibitor
PRDM1,DFGYVAE,GuideToPharmacology,1,inhibitor
EP300,STAUROSPORINE,GuideToPharmacology,1,inhibitor
ENPEP,SGI-1776,GuideToPharmacology,1,inhibitor
PRDM1,COMPOUND 11NN [PMID: 1656041],GuideToPharmacology,1,inhibitor
AMD1,THIORIDAZINE,GuideToPharmacology,1,inhibitor
AMD1,OLANZAPINE,GuideToPharmacology,1,inhibitor
HRH3,CIPRALISANT,GuideToPharmacology,1,agonist
AMD1P2,ST-1006,GuideToPharmacology,1,agonist
PRDM1,COMPOUND 2F [PMID: 2153213],GuideToPharmacology,1,inhibitor
H1-2,TEPP-46,GuideToPharmacology,1,activator
PRDM1,FPYVAE PEPTIDE [PMID: 20494585],GuideToPharmacology,1,inhibitor
BAK1P1,ALRT 1550,GuideToPharmacology,1,inhibitor
GPS2,ALA(1-NAPH)-PRO-CN,GuideToPharmacology,1,inhibitor
PRDM1,COMPOUND 29 [PMID: 15686906],GuideToPharmacology,1,inhibitor
FANCG,GSK3145095,GuideToPharmacology,1,inhibitor
CUX1,COMPOUND 24 [PMID: 15955699],GuideToPharmacology,1,inhibitor
APP,A(4-24)(F23A)H2,GuideToPharmacology,1,agonist
APPL1,A(&DELTA;10/15C)INSL3,GuideToPharmacology,1,inhibitor
AMT,ST-1478,GuideToPharmacology,1,agonist
AMY1B,TY-52156,GuideToPharmacology,1,inhibitor
AMY1B,VPC23019,GuideToPharmacology,1,inhibitor
ADH1C,AS1269574,GuideToPharmacology,1,agonist
GRK3,SRIF-28,GuideToPharmacology,1,agonist
SPTSSB,COMPOUND 18 [PMID: 32330443],GuideToPharmacology,1,inhibitor
FCN1,SBP-3264,GuideToPharmacology,1,inhibitor
FCN1,STAUROSPORINE,GuideToPharmacology,1,inhibitor
FCGR3A,TOMIVOSERTIB,GuideToPharmacology,1,inhibitor
CD9,AMITRIPTYLINE HYDROCHLORIDE,GuideToPharmacology,1,inhibitor
CYBB,COMPOUND 14N [PMID: 25589934],GuideToPharmacology,1,inhibitor
GABPB1,"1,3-DITOLYLGUANIDINE",GuideToPharmacology,1,agonist
CD9,TRIMIPRAMINE,GuideToPharmacology,1,inhibitor
CD3D,SERGLIFLOZIN,GuideToPharmacology,1,inhibitor
BLVRB,J-104118,GuideToPharmacology,1,inhibitor
BLVRB,1-ALLYL-2-[3-(ISOPROPYLAMINO)PROPOXY]-9H-CARBAZOLE,GuideToPharmacology,1,inhibitor
HBG2,SLF1081851,GuideToPharmacology,1,inhibitor
GRK3,TAN-67,GuideToPharmacology,1,agonist
BLVRB,"COMPOUND 1C [BROWN ET AL., 1997]",GuideToPharmacology,1,inhibitor
FRA10C,COMPOUND 1B [PMID: 9871762],GuideToPharmacology,1,inhibitor
FASLG,NOC-ATE,GuideToPharmacology,1,agonist
STOM,MPI-0485520,GuideToPharmacology,1,inhibitor
AQP1,SRIF-28,GuideToPharmacology,1,agonist
HLA-DMB,NVP鈥怲NKS656,GuideToPharmacology,1,inhibitor
TEC,PRN694,GuideToPharmacology,1,inhibitor
THRB,COMPOUND 16G [PMID: 35507418],GuideToPharmacology,1,agonist
NR2C2,VITAMIN A,GuideToPharmacology,1,agonist
FGB,STAUROSPORINE,GuideToPharmacology,1,inhibitor
ATP1B1P1,ALLICIN,GuideToPharmacology,1,activator
FXYD2,GD3+,GuideToPharmacology,1,blocker
ATP2B2,HYPERFORIN,GuideToPharmacology,1,activator
ATP2B1,GD3+,GuideToPharmacology,1,activator
ATP5F1A,H+,GuideToPharmacology,1,activator
ATP5A2,H+,GuideToPharmacology,1,activator
TRPV4,CURCUMIN,GuideToPharmacology,1,activator
TRPV4,GSK2193874,GuideToPharmacology,1,blocker
FGR,IBRUTINIB,GuideToPharmacology,1,inhibitor
GCF1,VINCRISTINE,GuideToPharmacology,1,inhibitor
FUT6,VENGLUSTAT,GuideToPharmacology,1,inhibitor
ARCN2,RO 25-1392,GuideToPharmacology,1,agonist
ANXA2P3,"[ALA31,AIB32]NPY (PIG)",GuideToPharmacology,1,agonist
ANXA4,PEPTIDE YY,GuideToPharmacology,1,agonist
ANXA4,(S)-VU0637120,GuideToPharmacology,1,modulator
ANXA4,PANCREATIC POLYPEPTIDE,GuideToPharmacology,1,agonist
GPX1P2,VORASIDENIB,GuideToPharmacology,1,inhibitor
FOXL2,(-)-&ALPHA;-THUJONE,GuideToPharmacology,1,agonist
EPHB3,NIK INHIBITOR 12F,GuideToPharmacology,1,inhibitor
EPHB3,"2-TERT-BUTYL-9-FLUORO-1,6-DIHYDROBENZO[H]IMIDAZO[4,5-F]ISOQUINOLIN-7-ONE",GuideToPharmacology,1,inhibitor
NUDT2,DYNORPHIN A-(1-13),GuideToPharmacology,1,agonist
NUDT2,TRAMADOL,GuideToPharmacology,1,agonist
DPT,KBP-7018,GuideToPharmacology,1,inhibitor
DPT,IBCASERTIB,GuideToPharmacology,1,inhibitor
ARG1,NS309,GuideToPharmacology,1,activator
KCNT2,PHORBOL 12-MYRISTATE 13-ACETATE,GuideToPharmacology,1,inhibitor
BAD,NS3623,GuideToPharmacology,1,activator
BAD,RILUZOLE,GuideToPharmacology,1,blocker
LTC4S,TK05,GuideToPharmacology,1,inhibitor
STX2,RKI-1447,GuideToPharmacology,1,inhibitor
STX2,COMPOUND 14 [PMID: 19831390],GuideToPharmacology,1,inhibitor
EPS8,NIK INHIBITOR 12F,GuideToPharmacology,1,inhibitor
BAK1P2,AZ12260493,GuideToPharmacology,1,agonist
AMPH,DECYL DIHYDROGEN PHOSPHATE,GuideToPharmacology,1,agonist
AMPD3,DIOCTANOYLGLYCEROL PYROPHOSPHATE,GuideToPharmacology,1,inhibitor
GLI3,LYS-COA,GuideToPharmacology,1,inhibitor
GLI3,EPIGALLOCATECHIN-3-GALLATE,GuideToPharmacology,1,inhibitor
EPS15,BAFETINIB,GuideToPharmacology,1,inhibitor
MKNK2,TOMIVOSERTIB,GuideToPharmacology,1,inhibitor
AMY2B,SNAP-7941,GuideToPharmacology,1,inhibitor
AMY2B,PYRROLIDINE MCHR1 ANTAGONIST 1,GuideToPharmacology,1,inhibitor
AMY2B,COMPOUND (R)-10H [PMID: 22490048],GuideToPharmacology,1,inhibitor
ANGPT1,SHU9119,GuideToPharmacology,1,inhibitor
DRD4,SU11274,GuideToPharmacology,1,inhibitor
ANOP1,LY341495,GuideToPharmacology,1,inhibitor
SLC25A4,GLUTAMIC ACID,GuideToPharmacology,1,agonist
SLC25A4,VU0650786,GuideToPharmacology,1,modulator
SLC25A4,RO4491533,GuideToPharmacology,1,modulator
MAP2K1,NEDOMETINIB,GuideToPharmacology,1,inhibitor
CTNS,SP600125,GuideToPharmacology,1,inhibitor
AADAC,MILAMELINE,GuideToPharmacology,1,agonist
AADAC,ATROPINE,GuideToPharmacology,1,inhibitor
AADAC,MUSCARINIC TOXIN 3,GuideToPharmacology,1,inhibitor
AAMP,[3H]DIMETHYL-W84,GuideToPharmacology,1,modulator
AAMP,LY2119620,GuideToPharmacology,1,modulator
AAMP,UMECLIDINIUM BROMIDE,GuideToPharmacology,1,inhibitor
AANAT,AFDX384,GuideToPharmacology,1,inhibitor
AANAT,GLYCOPYRRONIUM,GuideToPharmacology,1,inhibitor
AARS1,BIPERIDEN,GuideToPharmacology,1,inhibitor
AARS1,HIMBACINE,GuideToPharmacology,1,inhibitor
AARS1,STAUROSPORINE,GuideToPharmacology,1,modulator
AARS1,MUSCARINIC TOXIN 7,GuideToPharmacology,1,inhibitor
AARS1,UMECLIDINIUM BROMIDE,GuideToPharmacology,1,inhibitor
AAVS1,BRUCINE N-OXIDE,GuideToPharmacology,1,modulator
AAVS1,AFDX384,GuideToPharmacology,1,inhibitor
MYLK,RKI-1447,GuideToPharmacology,1,inhibitor
BBS1,GNE-616,GuideToPharmacology,1,blocker
SCN9A,GNE-131,GuideToPharmacology,1,inhibitor
AQP3,SEPTIDE,GuideToPharmacology,1,agonist
A1BG,BRL-15572,GuideToPharmacology,1,agonist
A1BG,TERGURIDE,GuideToPharmacology,1,agonist
A1BG,ROXINDOLE,GuideToPharmacology,1,agonist
A1BG,[3H]P-MPPF,GuideToPharmacology,1,inhibitor
A1BG,WAY-100135,GuideToPharmacology,1,inhibitor
A2M,BRL-15572,GuideToPharmacology,1,agonist
AQP4,FK-888,GuideToPharmacology,1,inhibitor
A2MP1,5-HT-MODULINE,GuideToPharmacology,1,modulator
A2MP1,LYSERGIC ACID,GuideToPharmacology,1,agonist
A2MP1,CAPESEROD,GuideToPharmacology,1,agonist
A2MP1,QUETIAPINE FUMARATE,GuideToPharmacology,1,agonist
A2MP1,"L-772,405",GuideToPharmacology,1,inhibitor
A12M1,QUETIAPINE FUMARATE,GuideToPharmacology,1,agonist
A12M1,[3H]8-OH-DPAT,GuideToPharmacology,1,agonist
A12M1,ELETRIPTAN,GuideToPharmacology,1,agonist
A12M1,5-FLUOROTRYPTAMINE,GuideToPharmacology,1,agonist
A12M3,MESULERGINE,GuideToPharmacology,1,inhibitor
A12M3,SB 221284,GuideToPharmacology,1,inhibitor
A12M4,GLEMANSERIN,GuideToPharmacology,1,inhibitor
AQP3,T2328,GuideToPharmacology,1,inhibitor
HTR2C,(+)-DOI,GuideToPharmacology,1,agonist
SERPINA3,OLANZAPINE,GuideToPharmacology,1,inhibitor
SERPINA3,MESULERGINE,GuideToPharmacology,1,inhibitor
AQP5,PD 154740,GuideToPharmacology,1,inhibitor
DNTT,BIMAGRUMAB,GuideToPharmacology,1,antibody
CSTF3,AKT INHIBITOR VIII,GuideToPharmacology,1,modulator
CSTP1,NTQ1062,GuideToPharmacology,1,inhibitor
FKBP2,CAPIVASERTIB,GuideToPharmacology,1,inhibitor
CSTF3,NTQ1062,GuideToPharmacology,1,inhibitor
ABCB7,SNAP5089,GuideToPharmacology,1,inhibitor
ANXA6,CONTULAKIN-G,GuideToPharmacology,1,agonist
ABCB7,MIANSERIN,GuideToPharmacology,1,inhibitor
BEVI,PRUXELUTAMIDE,GuideToPharmacology,1,inhibitor
BTG1,HG2+,GuideToPharmacology,1,inhibitor
ANXA7,JMV458,GuideToPharmacology,1,agonist
AQP5,HG2+,GuideToPharmacology,1,inhibitor
ACADSB,"[125I][GLP65NLE75,TYR77]APELIN-13",GuideToPharmacology,1,agonist
ACADSB,CYCLO APELIN-12 (7-12),GuideToPharmacology,1,agonist
BTC,H+,GuideToPharmacology,1,activator
ABAT,MRS3558,GuideToPharmacology,1,agonist
ABAT,TCPA,GuideToPharmacology,1,agonist
ABAT,AS100,GuideToPharmacology,1,inhibitor
ABAT,NELADENOSON,GuideToPharmacology,1,agonist
ACTBP2,AZD5672,GuideToPharmacology,1,inhibitor
SLCO1B3,RIFAMYCIN SV,GuideToPharmacology,1,inhibitor
GLRA2,MUROMONAB-CD3,GuideToPharmacology,1,antibody
GLRA2,TEPODITAMAB,GuideToPharmacology,1,antibody
GLRA2,TARLATAMAB,GuideToPharmacology,1,antibody
GATM,ODRONEXTAMAB,GuideToPharmacology,1,antibody
ACTG1P7,CHEMERIN,GuideToPharmacology,1,agonist
BTS1,ZN2+,GuideToPharmacology,1,blocker
FRA1C,DABIGATRAN,GuideToPharmacology,1,inhibitor
CPT1B,FK-881,GuideToPharmacology,1,inhibitor
SLCO2B1,RIFAMYCIN SV,GuideToPharmacology,1,inhibitor
GPR19,LAMPALIZUMAB,GuideToPharmacology,1,antibody
GLG1,SGC-CBP30,GuideToPharmacology,1,inhibitor
ELAVL1,RIVOCERANIB,GuideToPharmacology,1,inhibitor
C4BPB,CARBENOXOLONE,GuideToPharmacology,1,inhibitor
ACTBP8,VCXCL1,GuideToPharmacology,1,agonist
SLCO2B1,GLYBURIDE,GuideToPharmacology,1,inhibitor
C5,CARBENOXOLONE,GuideToPharmacology,1,inhibitor
EGR4,RONICICLIB,GuideToPharmacology,1,inhibitor
CYP4A11,EPALRESTAT,GuideToPharmacology,1,inhibitor
COX6A1,TROLEANDOMYCIN,GuideToPharmacology,1,inhibitor
FPGS,COMPOUND 18 [PMID: 15664838],GuideToPharmacology,1,inhibitor
DUSP1,IMATINIB,GuideToPharmacology,1,inhibitor
DUSP1,DDR-IN-1,GuideToPharmacology,1,inhibitor
ARAF,"L-367,938",GuideToPharmacology,1,inhibitor
DUSP2,RIPK3 INHIBITOR 18,GuideToPharmacology,1,inhibitor
APOBEC1,DINOPROST,GuideToPharmacology,1,agonist
APOBEC1,FEVIPIPRANT,GuideToPharmacology,1,inhibitor
ABCD1,TERGURIDE,GuideToPharmacology,1,agonist
ABCD1,TERGURIDE,GuideToPharmacology,1,inhibitor
ABCD1,VILAZODONE HYDROCHLORIDE,GuideToPharmacology,1,agonist
ABCD1,BENPERIDOL,GuideToPharmacology,1,inhibitor
ABCD1,SUMANIROLE,GuideToPharmacology,1,agonist
APLP2,CV-6209,GuideToPharmacology,1,inhibitor
NOS2,GW274150,GuideToPharmacology,1,inhibitor
GATA2,MYCOPHENOLATE,GuideToPharmacology,1,inhibitor
EPHA7,TAKINIB,GuideToPharmacology,1,inhibitor
APOE,C391,GuideToPharmacology,1,inhibitor
ITPKC,GNF362,GuideToPharmacology,1,inhibitor
MPPED2,IP3,GuideToPharmacology,1,activator
ITPR1,"INOSITOL 2,4,5-TRISPHOSPHATE",GuideToPharmacology,1,activator
AEBP1,DIOCTANOYLGLYCEROL PYROPHOSPHATE,GuideToPharmacology,1,inhibitor
BMPR2,DEXTROMETHORPHAN POLISTIREX,GuideToPharmacology,1,agonist
ZFP36L2,ACESULFAME,GuideToPharmacology,1,agonist
BCKDHA,PRISTANIC ACID,GuideToPharmacology,1,agonist
BNIP1,EPIGALLOCATECHIN-3-GALLATE,GuideToPharmacology,1,agonist
TAS2R46,ANDROGRAPHOLIDE,GuideToPharmacology,1,agonist
EPHB1,GOLIDOCITINIB,GuideToPharmacology,1,inhibitor
EPHB1,CERDULATINIB,GuideToPharmacology,1,inhibitor
EPHB1,LEPZACITINIB,GuideToPharmacology,1,inhibitor
EPHB1,JAK3 INHIBITOR II,GuideToPharmacology,1,inhibitor
EPHB1,ITACITINIB,GuideToPharmacology,1,inhibitor
EPHB1,LORPUCITINIB,GuideToPharmacology,1,inhibitor
EPHB2,JNJ-7706621,GuideToPharmacology,1,inhibitor
CCND1,ELAFIBRANOR,GuideToPharmacology,1,agonist
EPHB1,WXFL10203614,GuideToPharmacology,1,inhibitor
EPHB1,TOFACITINIB,GuideToPharmacology,1,inhibitor
EPHB1,NIK INHIBITOR 12F,GuideToPharmacology,1,inhibitor
EPHB2,JAK3 INHIBITOR II,GuideToPharmacology,1,inhibitor
EPHB2,ITACITINIB,GuideToPharmacology,1,inhibitor
CD74,DIOA,GuideToPharmacology,1,inhibitor
DRD2,LY2874455,GuideToPharmacology,1,inhibitor
ATP5ME,BL-1249,GuideToPharmacology,1,activator
ATP5PB,AVE1231,GuideToPharmacology,1,blocker
ATP5MC2P1,R-(+)-METHANANDAMIDE,GuideToPharmacology,1,inhibitor
ARF5,SKA-31,GuideToPharmacology,1,activator
ARF6,SKA-31,GuideToPharmacology,1,activator
ARG1,SKA-31,GuideToPharmacology,1,activator
ARG2,TRAM-34,GuideToPharmacology,1,blocker
ARG2,RILUZOLE,GuideToPharmacology,1,activator
ASIP,NA+,GuideToPharmacology,1,activator
KCNT2,NIFLUMIC ACID,GuideToPharmacology,1,activator
ASL,NA+,GuideToPharmacology,1,activator
ASMT,VU0134992,GuideToPharmacology,1,blocker
ALDH7A1P3,&ALPHA;-DENDROTOXIN,GuideToPharmacology,1,blocker
ACVRL1,LPA,GuideToPharmacology,1,agonist
TPH2,6-FLUOROTRYPTOPHAN,GuideToPharmacology,1,inhibitor
ADH1A,LPA,GuideToPharmacology,1,agonist
CMM,&ALPHA;-PROPYLDOPACETAMIDE,GuideToPharmacology,1,inhibitor
ANGPT2,MCL0129,GuideToPharmacology,1,inhibitor
BCKDHA,ELAFIBRANOR,GuideToPharmacology,1,agonist
ETFB,IZORLISIB,GuideToPharmacology,1,inhibitor
HLA-H,RO-5045337,GuideToPharmacology,1,inhibitor
DRD4,VABAMETKIB,GuideToPharmacology,1,inhibitor
BCKDHA,N-OLEOYLETHANOLAMIDE,GuideToPharmacology,1,agonist
ANOP1,COMPOUND 12E [PMID: 22266036],GuideToPharmacology,1,modulator
BLK,GERANYL DIPHOSPHATE,GuideToPharmacology,1,inhibitor
ANPEP,LY341495,GuideToPharmacology,1,inhibitor
SLC25A6,AZD9272,GuideToPharmacology,1,modulator
CCND1,TRIPLE MODULATOR 10 [PMID: 29878767],GuideToPharmacology,1,agonist
SLC25A5,LY341495,GuideToPharmacology,1,inhibitor
SLC25A6,BASIMGLURANT,GuideToPharmacology,1,modulator
SLC25A5,COMPOUND 7 [PMID: 20638279],GuideToPharmacology,1,modulator
SLC25A6,COMPOUND 24 [PMID: 23374867],GuideToPharmacology,1,modulator
SLC25A5,VU0359516,GuideToPharmacology,1,modulator
F3,COMPOUND 41 [PMID: 31855425],GuideToPharmacology,1,inhibitor
SLC25A5,VU0080241,GuideToPharmacology,1,modulator
SLC25A6,COMPOUND 47 [PMID: 21295468],GuideToPharmacology,1,modulator
SLC25A6,ACDPP,GuideToPharmacology,1,inhibitor
ANTP2,LSP4-2022,GuideToPharmacology,1,agonist
SLC25A6,[3H]M-MPEP,GuideToPharmacology,1,inhibitor
NR3C2,ALDOSTERONE,GuideToPharmacology,1,agonist
CCND1,BEXAROTENE,GuideToPharmacology,1,inhibitor
NR3C2,ONAPRISTONE,GuideToPharmacology,1,inhibitor
CTNNA1,ASTX029,GuideToPharmacology,1,inhibitor
H1-1,"NITROFURANTOIN, MACROCRYSTALS",GuideToPharmacology,1,inhibitor
F5,KU-0060648,GuideToPharmacology,1,inhibitor
CENPE,CARBOXYATRACTYLOSIDE,GuideToPharmacology,1,inhibitor
H4F3,ZAPRINAST,GuideToPharmacology,1,inhibitor
CTNND1,NEFLAMAPIMOD,GuideToPharmacology,1,inhibitor
CTNNA1P1,COMPOUND 11 [PMID: 26431428],GuideToPharmacology,1,inhibitor
PIK3CB,KU-0060648,GuideToPharmacology,1,inhibitor
CTNNA2,TANZISERTIB,GuideToPharmacology,1,inhibitor
ERBB3,STAUROSPORINE,GuideToPharmacology,1,inhibitor
MAP3K5,GS-444217,GuideToPharmacology,1,inhibitor
PIK3CB,PICTILISIB,GuideToPharmacology,1,inhibitor
ERN1,COMPOUND 10 [PMID: 23147077],GuideToPharmacology,1,inhibitor
ERCC6,NIK INHIBITOR 12F,GuideToPharmacology,1,inhibitor
ERCC4,CEP-1347,GuideToPharmacology,1,inhibitor
ERVK2,RIPK3 INHIBITOR 18,GuideToPharmacology,1,inhibitor
F7,VULOLISIB,GuideToPharmacology,1,inhibitor
MLKL,COMPOUND 56 [PMID: 36136378],GuideToPharmacology,1,inhibitor
DBT,ILOMASTAT,GuideToPharmacology,1,inhibitor
FKBP4,SAR260301,GuideToPharmacology,1,inhibitor
DCX,ILOMASTAT,GuideToPharmacology,1,inhibitor
DCR,CL82198,GuideToPharmacology,1,inhibitor
DBT,ARP100,GuideToPharmacology,1,inhibitor
FSHMD1A,BEFLOXATONE,GuideToPharmacology,1,inhibitor
CRKL,CAY10499,GuideToPharmacology,1,inhibitor
ECI1,ILOMASTAT,GuideToPharmacology,1,inhibitor
ANTP4,"[BPA1,ILE13]MOTILIN (HUMAN)",GuideToPharmacology,1,agonist
ANTP4,ROXITHROMYCIN,GuideToPharmacology,1,agonist
AADAC,BRUCINE N-OXIDE,GuideToPharmacology,1,modulator
AADAC,AQ-RA 741,GuideToPharmacology,1,inhibitor
AADAC,KT 5823,GuideToPharmacology,1,modulator
AADAC,VU0029767,GuideToPharmacology,1,modulator
PDE5A,ZAPRINAST,GuideToPharmacology,1,inhibitor
AAMP,AMITRIPTYLINE HYDROCHLORIDE,GuideToPharmacology,1,inhibitor
AAMP,GLYCOPYRRONIUM,GuideToPharmacology,1,inhibitor
ANK3,BOMPPA,GuideToPharmacology,1,agonist
ANK3,IIK7,GuideToPharmacology,1,agonist
ANK3,UCM1014,GuideToPharmacology,1,agonist
APOF,(-)-BREMAZOCINE,GuideToPharmacology,1,inhibitor
APOH,GYPGQV-NH2,GuideToPharmacology,1,agonist
F9,GDC-0339,GuideToPharmacology,1,inhibitor
GRID1,O-F-AMIDINE,GuideToPharmacology,1,inhibitor
F7,APITOLISIB,GuideToPharmacology,1,inhibitor
F7R,OMIPALISIB,GuideToPharmacology,1,inhibitor
F7R,PUQUITINIB,GuideToPharmacology,1,inhibitor
COL9A2,ENOXIMONE,GuideToPharmacology,1,inhibitor
FRA6B,SCH-900229,GuideToPharmacology,1,inhibitor
APOA1,[125I]BH-MIT1,GuideToPharmacology,1,agonist
GSTM5P1,DOOKU1,GuideToPharmacology,1,inhibitor
FRA5B,BIS-TRIAZOLE DERIVATIVE 10,GuideToPharmacology,1,inhibitor
APOA2,MIT1,GuideToPharmacology,1,agonist
APOA2,[125I]BH-MIT1,GuideToPharmacology,1,agonist
DPP6,GTP-14564,GuideToPharmacology,1,inhibitor
FABP1,ONVANSERTIB,GuideToPharmacology,1,inhibitor
FABP1,DUAL BRD4/PLK1 INHIBITOR 23,GuideToPharmacology,1,inhibitor
FABP5,XMD8-92,GuideToPharmacology,1,inhibitor
GNAI2P1,TALAZOPARIB,GuideToPharmacology,1,inhibitor
NBEAP1,MIFEPRISTONE,GuideToPharmacology,1,agonist
FRA6F,IXAZOMIB,GuideToPharmacology,1,inhibitor
FRA6F,ZETOMIPZOMIB,GuideToPharmacology,1,inhibitor
CSTB,RIPASUDIL,GuideToPharmacology,1,inhibitor
CSTF1,STAUROSPORINE,GuideToPharmacology,1,inhibitor
CTBS,CHELERYTHRINE,GuideToPharmacology,1,inhibitor
NKX2-5,G&OUML; 6983,GuideToPharmacology,1,inhibitor
CTAA2,RUBOXISTAURIN,GuideToPharmacology,1,inhibitor
FRA4A,TAFOLECIMAB,GuideToPharmacology,1,antibody
CTSS,COMPOUND 20 [PMID: 22136433],GuideToPharmacology,1,inhibitor
GOLGA2,COMPOUND I [PMID: 29351497],GuideToPharmacology,1,inhibitor
FANCG,SZM594,GuideToPharmacology,1,inhibitor
RIPK2,GSK583,GuideToPharmacology,1,inhibitor
BCHE,TRIFAROTENE,GuideToPharmacology,1,agonist
BCHE,AGN193836,GuideToPharmacology,1,agonist
BCHE,BMS614,GuideToPharmacology,1,inhibitor
HCN2,SULINDAC,GuideToPharmacology,1,inhibitor
GM2A,TORIPALIMAB,GuideToPharmacology,1,antibody
BCL2,GSK4112,GuideToPharmacology,1,agonist
CTPS1,GSK269962A,GuideToPharmacology,1,inhibitor
CTRB1,COMPOUND 8 [PMID: 25898023],GuideToPharmacology,1,inhibitor
PANX3,CARBENOXOLONE,GuideToPharmacology,1,inhibitor
FAH,GW5074,GuideToPharmacology,1,inhibitor
APLP1,LV-2186,GuideToPharmacology,1,agonist
